Drug,Classes,Groups,Gene,Protein,Gene Type,Drug Action,DrugBank.ID
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,F2,Prothrombin,enzyme,activator,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,PROC,Vitamin K-dependent protein C,enzyme,inactivator,DB00025
Desmopressin,Antidiuretic AgentsHemostaticsRenal Agents,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,inducer,DB00035
Desmopressin,Antidiuretic AgentsHemostaticsRenal Agents,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB00035
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB00041
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,PLA2G4A,Cytosolic phospholipase A2,enzyme,inducer,DB00041
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00041
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,inducer,DB00041
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00041
Human Serum Albumin,Serum substitutes,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00062
Human Serum Albumin,Serum substitutes,approved,MPO,Myeloperoxidase,enzyme,substrate,DB00062
Human Serum Albumin,Serum substitutes,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,inducer,DB00062
Pegvisomant,Hormone Replacement Agents,approved,CYP27A1,"Sterol 26-hydroxylase, mitochondrial",enzyme,inducer,DB00082
Pegvisomant,Hormone Replacement Agents,approved,GLUL,Glutamine synthetase,enzyme,inhibitor,DB00082
Pegvisomant,Hormone Replacement Agents,approved,CYP2C18,Cytochrome P450 2C18,enzyme,inhibitor,DB00082
Pegvisomant,Hormone Replacement Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00082
Pegvisomant,Hormone Replacement Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00082
Pegvisomant,Hormone Replacement Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00082
Pegvisomant,Hormone Replacement Agents,approved,CYP4A11,Cytochrome P450 4A11,enzyme,inhibitor,DB00082
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinducer,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinducer,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00091
Enfuvirtide,HIV Fusion Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00109
Enfuvirtide,HIV Fusion Inhibitors,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00109
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00118
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SRM,Spermidine synthase,enzyme,substrate,DB00118
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CEPT1,Choline/ethanolaminephosphotransferase 1,enzyme,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CHKB,Choline/ethanolamine kinase,enzyme,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CHAT,Choline O-acetyltransferase,enzyme,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CHKA,Choline kinase alpha,enzyme,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CHDH,"Choline dehydrogenase, mitochondrial",enzyme,substrate,DB00122
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,XDH,Xanthine dehydrogenase/oxidase,enzyme,inhibitor,DB00127
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SAT1,Diamine acetyltransferase 1,enzyme,substrate,DB00127
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SAT2,Diamine acetyltransferase 2,enzyme,substrate,DB00127
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,F13A1,Coagulation factor XIII A chain,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,GLS,"Glutaminase kidney isoform, mitochondrial",enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,GLS2,"Glutaminase liver isoform, mitochondrial",enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM2,Protein-glutamine gamma-glutamyltransferase 2,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM5,Protein-glutamine gamma-glutamyltransferase 5,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM6,Protein-glutamine gamma-glutamyltransferase 6,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM1,Protein-glutamine gamma-glutamyltransferase K,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM4,Protein-glutamine gamma-glutamyltransferase 4,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM3,Protein-glutamine gamma-glutamyltransferase E,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,TGM7,Protein-glutamine gamma-glutamyltransferase Z,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,GMPS,GMP synthase [glutamine-hydrolyzing],enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,ASNS,Asparagine synthetase [glutamine-hydrolyzing],enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,CCBL1,Kynurenine--oxoglutarate transaminase 1,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,PFAS,Phosphoribosylformylglycinamidine synthase,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,PET112L,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,GFPT2,Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 2,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,CAD,CAD protein,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,QARS,Glutamine--tRNA ligase,enzyme,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,NADSYN1,Glutamine-dependent NAD(+) synthetase,enzyme,substrate,DB00130
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AMPD1,AMP deaminase 1,enzyme,substrate,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,APRT,Adenine phosphoribosyltransferase,enzyme,substrate,DB00131
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,GLUL,Glutamine synthetase,enzyme,inhibitor,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,enzyme,inhibitor,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MAT2A,S-adenosylmethionine synthase isoform type-2,enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MSRB2,"Methionine-R-sulfoxide reductase B2, mitochondrial",enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MAT1A,S-adenosylmethionine synthase isoform type-1,enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SEPX1,Methionine-R-sulfoxide reductase B1,enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MSRA,Mitochondrial peptide methionine sulfoxide reductase,enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MARS,"Methionine--tRNA ligase, cytoplasmic",enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MARS2,"Methionine--tRNA ligase, mitochondrial",enzyme,substrate,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MAT2B,Methionine adenosyltransferase 2 subunit beta,enzyme,substrate,DB00134
Calcitriol,Bone Density Conservation AgentsVitaminsCalcium Channel AgonistsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,substrateinducer,DB00136
Calcitriol,Bone Density Conservation AgentsVitaminsCalcium Channel AgonistsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00136
Riboflavin,Vitamin B ComplexPhotosensitizing Agents,approvednutraceutical,MAOA,Amine oxidase [flavin-containing] A,enzyme,cofactor,DB00140
Riboflavin,Vitamin B ComplexPhotosensitizing Agents,approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,enzyme,cofactor,DB00140
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA2,Glutathione S-transferase A2,enzyme,substrate,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA1,Glutathione S-transferase A1,enzyme,substrate,DB00143
Calcidiol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP27B1,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",enzyme,substrate,DB00146
Calcidiol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,substrate,DB00146
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TDO2,"Tryptophan 2,3-dioxygenase",enzyme,substrate,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,DDC,Aromatic-L-amino-acid decarboxylase,enzyme,substrate,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,trpS,Tryptophan--tRNA ligase,enzyme,substrateinhibitor,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,WARS2,"Tryptophan--tRNA ligase, mitochondrial",enzyme,substrateinhibitor,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TPH1,Tryptophan 5-hydroxylase 1,enzyme,substrate,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TPH2,Tryptophan 5-hydroxylase 2,enzyme,substrate,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,WARS,"Tryptophan--tRNA ligase, cytoplasmic",enzyme,substrateinhibitor,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,IDO1,"Indoleamine 2,3-dioxygenase 1",enzyme,substrate,DB00150
Ergocalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,substrate,DB00153
Ergocalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP27B1,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",enzyme,substrate,DB00153
Ergocalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP27A1,"Sterol 26-hydroxylase, mitochondrial",enzyme,substrate,DB00153
Ergocalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00153
Ergocalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2R1,Vitamin D 25-hydroxylase,enzyme,substrate,DB00153
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AOX1,Aldehyde oxidase,enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH6,Alcohol dehydrogenase 6,enzyme,substrateactivator,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AKR1A1,Alcohol dehydrogenase [NADP(+)],enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH1A,Alcohol dehydrogenase 1A,enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH1B,Alcohol dehydrogenase 1B,enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH4,Alcohol dehydrogenase 4,enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH5,Alcohol dehydrogenase class-3,enzyme,substrate,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH7,Alcohol dehydrogenase class 4 mu/sigma chain,enzyme,substrate,DB00157
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GGH,Gamma-glutamyl hydrolase,enzyme,substrate,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,enzyme,substrate,DB00158
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,VARS,Valine--tRNA ligase,enzyme,substrate,DB00161
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,PCCB,"Propionyl-CoA carboxylase beta chain, mitochondrial",enzyme,substrate,DB00161
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",enzyme,substrate,DB00161
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitorinducer,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,CYP26A1,Cytochrome P450 26A1,enzyme,inducer,DB00162
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA2,Glutathione S-transferase A2,enzyme,inducer,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTP1,Glutathione S-transferase P,enzyme,inhibitor,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTO1,Glutathione S-transferase omega-1,enzyme,inhibitor,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTM3,Glutathione S-transferase Mu 3,enzyme,inducer,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GCLC,Glutamate--cysteine ligase catalytic subunit,enzyme,inducer,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,NQO1,NAD(P)H dehydrogenase [quinone] 1,enzyme,inducer,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,HMOX1,Heme oxygenase 1,enzyme,inducer,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SOD1,Superoxide dismutase [Cu-Zn],enzyme,inducer,DB00163
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2R1,Vitamin D 25-hydroxylase,enzyme,substrate,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP27A1,"Sterol 26-hydroxylase, mitochondrial",enzyme,substrate,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2J2,Cytochrome P450 2J2,enzyme,substrate,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,substrate,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00169
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00169
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,AOX1,Aldehyde oxidase,enzyme,inhibitor,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,enzyme,substrate,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP1A1,Cytochrome P450 1A1,enzyme,substrateinducer,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinducer,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00170
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00175
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00176
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00176
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00182
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrateinhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2A13,Cytochrome P450 2A13,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrateinducer,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinducer,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,inhibitor,DB00184
Cevimeline,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00185
Cevimeline,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00185
Cevimeline,,approved,FMO1,Dimethylaniline monooxygenase [N-oxide-forming] 1,enzyme,substrate,DB00185
Bortezomib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00188
Bortezomib,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00188
Bortezomib,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00188
Bortezomib,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00188
Bortezomib,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00188
Bortezomib,,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00188
Bortezomib,,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00188
Bortezomib,,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00188
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,MAOB,Amine oxidase [flavin-containing] B,enzyme,inhibitor,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00191
Tramadol,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00193
Tramadol,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00193
Tramadol,,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00193
Betaxolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsEENT Preparations,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00195
Betaxolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsEENT Preparations,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00195
Fluconazole,Antifungal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00196
Fluconazole,Antifungal Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00196
Fluconazole,Antifungal Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00196
Fluconazole,Antifungal Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00196
Fluconazole,Antifungal Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00196
Fluconazole,Antifungal Agents,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB00196
Troglitazone,,withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00197
Troglitazone,,withdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00197
Troglitazone,,withdrawn,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00197
Troglitazone,,withdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00197
Troglitazone,,withdrawn,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00197
Troglitazone,,withdrawn,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00197
Troglitazone,,withdrawn,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00197
Troglitazone,,withdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00197
Troglitazone,,withdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitorinducer,DB00197
Troglitazone,,withdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitorinducer,DB00197
Troglitazone,,withdrawn,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00197
Troglitazone,,withdrawn,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00197
Troglitazone,,withdrawn,,UDP-glucuronosyltransferase 1-6,enzyme,substrateinhibitor,DB00197
Troglitazone,,withdrawn,,UDP-glucuronosyltransferase 1-7,enzyme,substrate,DB00197
Troglitazone,,withdrawn,UGT1A8,UDP-glucuronosyltransferase 1-8,enzyme,substrate,DB00197
Troglitazone,,withdrawn,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00197
Troglitazone,,withdrawn,UGT1A10,UDP-glucuronosyltransferase 1-10,enzyme,substrate,DB00197
Troglitazone,,withdrawn,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00197
Troglitazone,,withdrawn,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00197
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00199
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00201
Sildenafil,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00203
Sildenafil,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00203
Sildenafil,,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00203
Sildenafil,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00203
Sildenafil,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00203
Sildenafil,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00203
Sildenafil,,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00203
Sildenafil,,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitor,DB00203
Pyrimethamine,AntimalarialsAntiprotozoal AgentsFolic Acid Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00205
Pyrimethamine,AntimalarialsAntiprotozoal AgentsFolic Acid Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00205
Pyrimethamine,AntimalarialsAntiprotozoal AgentsFolic Acid Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00205
Azithromycin,Anti-Bacterial AgentsMacrolides,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00207
Azithromycin,Anti-Bacterial AgentsMacrolides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00207
Azithromycin,Anti-Bacterial AgentsMacrolides,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00207
Ticlopidine,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00208
Ticlopidine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00208
Ticlopidine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00208
Ticlopidine,,approved,MPO,Myeloperoxidase,enzyme,substrate,DB00208
Ticlopidine,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00208
Ticlopidine,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00208
Ticlopidine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00208
Ticlopidine,,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00208
Ticlopidine,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00208
Ticlopidine,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00208
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00213
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00213
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinducer,DB00213
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00213
Torasemide,Antihypertensive AgentsDiureticsSodium Potassium Chloride Symporter Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00214
Torasemide,Antihypertensive AgentsDiureticsSodium Potassium Chloride Symporter Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00214
Torasemide,Antihypertensive AgentsDiureticsSodium Potassium Chloride Symporter Inhibitors,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00214
Torasemide,Antihypertensive AgentsDiureticsSodium Potassium Chloride Symporter Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00214
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00215
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inducer,DB00216
Nelfinavir,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00220
Nelfinavir,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00220
Nelfinavir,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00220
Nelfinavir,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00220
Nelfinavir,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00220
Nelfinavir,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00220
Nelfinavir,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00220
Nelfinavir,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00220
Indinavir,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00224
Indinavir,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00224
Indinavir,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00224
Indinavir,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00224
Indinavir,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00224
Indinavir,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00224
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,PON3,Serum paraoxonase/lactonase 3,enzyme,substrate,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00227
Temazepam,Benzodiazepines,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00231
Temazepam,Benzodiazepines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00231
Temazepam,Benzodiazepines,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00231
Temazepam,Benzodiazepines,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00231
Temazepam,Benzodiazepines,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00231
Reboxetine,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00234
Reboxetine,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitorinducer,DB00234
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinducer,DB00238
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00238
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00238
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00238
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00238
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00238
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00238
Oxiconazole,Antifungal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00239
Oxiconazole,Antifungal Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00239
Ranolazine,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00243
Ranolazine,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00243
Benzatropine,Dopamine Uptake InhibitorsAntiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00245
Benzatropine,Dopamine Uptake InhibitorsAntiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00245
Ziprasidone,Antipsychotic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00246
Ziprasidone,Antipsychotic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00246
Ziprasidone,Antipsychotic Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00246
Ziprasidone,Antipsychotic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00246
Ziprasidone,Antipsychotic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00246
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,NAT2,Arylamine N-acetyltransferase 2,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,MPO,Myeloperoxidase,enzyme,substrate,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00250
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitorinducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inducer,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB00252
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,COMT,Catechol O-methyltransferase,enzyme,substrate,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00255
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitorinducer,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitorinducer,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,CYP3A7,Cytochrome P450 3A7,enzyme,inducer,DB00257
Sulfanilamide,Anti-Bacterial AgentsSulfonamidesHomeopathic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00259
Sulfanilamide,Anti-Bacterial AgentsSulfonamidesHomeopathic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00259
Sulfanilamide,Anti-Bacterial AgentsSulfonamidesHomeopathic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00259
Sulfanilamide,Anti-Bacterial AgentsSulfonamidesHomeopathic Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00259
Sulfanilamide,Anti-Bacterial AgentsSulfonamidesHomeopathic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00259
Metoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00264
Metoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00264
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00268
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00273
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00273
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,ADA,Adenosine deaminase,enzyme,inhibitorinducer,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrateinhibitor,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00277
Argatroban,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00278
Argatroban,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00278
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00281
Clemastine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00283
Clemastine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00283
Venlafaxine,Antidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00285
Venlafaxine,Antidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00285
Venlafaxine,Antidepressive Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00285
Venlafaxine,Antidepressive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00285
Venlafaxine,Antidepressive Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00285
Conjugated Estrogens,Estrogens,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,COMT,Catechol O-methyltransferase,enzyme,substrate,DB00286
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00289
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00289
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00289
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB00292
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,inhibitor,DB00292
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00292
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,UGT1A8,UDP-glucuronosyltransferase 1-8,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00295
Ropivacaine,"Anesthetics, Local",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00296
Ropivacaine,"Anesthetics, Local",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00296
Ropivacaine,"Anesthetics, Local",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00296
Ropivacaine,"Anesthetics, Local",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00296
Bupivacaine,"Anesthetics, Local",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00297
Bupivacaine,"Anesthetics, Local",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00297
Bupivacaine,"Anesthetics, Local",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00297
Bupivacaine,"Anesthetics, Local",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00297
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,AK2,"Adenylate kinase 2, mitochondrial",enzyme,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,,"Adenylate kinase 4, mitochondrial",enzyme,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,NME1,Nucleoside diphosphate kinase A,enzyme,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,NME2,Nucleoside diphosphate kinase B,enzyme,substrate,DB00300
Bexarotene,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00307
Bexarotene,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00307
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,CYP2A6,Cytochrome P450 2A6,enzyme,inducer,DB00312
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrateinducer,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,UGT1A8,UDP-glucuronosyltransferase 1-8,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,UGT1A10,UDP-glucuronosyltransferase 1-10,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,,UDP-glucuronosyltransferase 1-6,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00313
Zolmitriptan,Serotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00315
Zolmitriptan,Serotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00315
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,,UDP-glucuronosyltransferase 1-6,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,UGT1A10,UDP-glucuronosyltransferase 1-10,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,SULT1A1,Sulfotransferase 1A1,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,,Sulfotransferase 1A3/1A4,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,SULT1E1,Estrogen sulfotransferase,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,SULT2A1,Bile salt sulfotransferase,enzyme,substrate,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,NAT2,Arylamine N-acetyltransferase 2,enzyme,inhibitor,DB00316
Gefitinib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00317
Gefitinib,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00317
Gefitinib,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,,DB00317
Gefitinib,,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrateinhibitor,DB00317
Gefitinib,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00317
Gefitinib,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00317
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB00318
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitor,DB00321
Nitroprusside,,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00325
Nitroprusside,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00325
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00327
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00327
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00327
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00327
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00327
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,CES1,Liver carboxylesterase 1,enzyme,substrate,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrateinhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrateinhibitor,DB00328
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00332
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00332
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP19A1,Cytochrome P450 19A1,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00333
Olanzapine,Antipsychotic Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00334
Nitrofural,Anti-Infective Agents,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00336
Nitrofural,Anti-Infective Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00336
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitorinducer,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB00338
Pyrazinamide,Antitubercular Agents,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00339
Pyrazinamide,Antitubercular Agents,approved,AOX1,Aldehyde oxidase,enzyme,substrate,DB00339
Pyrazinamide,Antitubercular Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00339
Pyrazinamide,Antitubercular Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00339
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CYP2J2,Cytochrome P450 2J2,enzyme,inhibitor,DB00342
Diltiazem,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00343
Diltiazem,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00343
Diltiazem,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00343
Diltiazem,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00343
Diltiazem,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00343
Diltiazem,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00343
Diltiazem,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00343
Trimethadione,Anticonvulsants,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00347
Trimethadione,Anticonvulsants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00347
Trimethadione,Anticonvulsants,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00347
Trimethadione,Anticonvulsants,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00347
Trimethadione,Anticonvulsants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00347
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00349
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00349
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00349
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00349
Chlorzoxazone,"Muscle Relaxants, Central",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitor,DB00356
Chlorzoxazone,"Muscle Relaxants, Central",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00356
Chlorzoxazone,"Muscle Relaxants, Central",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00356
Chlorzoxazone,"Muscle Relaxants, Central",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00356
Chlorzoxazone,"Muscle Relaxants, Central",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00356
Chlorzoxazone,"Muscle Relaxants, Central",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00356
Aminoglutethimide,"Antineoplastic Agents, HormonalAromatase Inhibitors",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00357
Aminoglutethimide,"Antineoplastic Agents, HormonalAromatase Inhibitors",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00357
Aminoglutethimide,"Antineoplastic Agents, HormonalAromatase Inhibitors",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB00357
Mefloquine,Antimalarials,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00358
Mefloquine,Antimalarials,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00358
Mefloquine,Antimalarials,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00358
Mefloquine,Antimalarials,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00358
Mefloquine,Antimalarials,approved,ACHE,Acetylcholinesterase,enzyme,inhibitor,DB00358
Sulfadiazine,Antiprotozoal AgentsAnti-Infective AgentsCoccidiostats,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00359
Sulfadiazine,Antiprotozoal AgentsAnti-Infective AgentsCoccidiostats,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00359
Sulfadiazine,Antiprotozoal AgentsAnti-Infective AgentsCoccidiostats,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00359
Sulfadiazine,Antiprotozoal AgentsAnti-Infective AgentsCoccidiostats,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00359
Vinorelbine,"Antineoplastic Agents, Phytogenic",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00361
Vinorelbine,"Antineoplastic Agents, Phytogenic",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00361
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB00363
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00365
Levonorgestrel,"Contraceptives, Oral, SyntheticContraceptive Agents, FemaleContraceptive Agents",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00367
Levonorgestrel,"Contraceptives, Oral, SyntheticContraceptive Agents, FemaleContraceptive Agents",approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00367
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00370
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00371
Timolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00373
Timolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00373
Palonosetron,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00377
Palonosetron,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00377
Palonosetron,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00377
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00379
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00379
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00379
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00379
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00379
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00381
Phenylephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor AgonistsCardiotonic AgentsMydriaticsNasal Decongestants,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00388
Phenylephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor AgonistsCardiotonic AgentsMydriaticsNasal Decongestants,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00388
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00390
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00393
Progesterone,ProgestinsContraceptive Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00396
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB00397
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00397
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrateinhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inhibitor,DB00398
Griseofulvin,Antifungal AgentsAnti-Bacterial Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00400
Griseofulvin,Antifungal AgentsAnti-Bacterial Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00400
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00401
Eszopiclone,Hypnotics and Sedatives,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00402
Alprazolam,Anti-Anxiety AgentsHypnotics and SedativesGABA ModulatorsBenzodiazepines,approvedillicitinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00404
Alprazolam,Anti-Anxiety AgentsHypnotics and SedativesGABA ModulatorsBenzodiazepines,approvedillicitinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00404
Alprazolam,Anti-Anxiety AgentsHypnotics and SedativesGABA ModulatorsBenzodiazepines,approvedillicitinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00404
Alprazolam,Anti-Anxiety AgentsHypnotics and SedativesGABA ModulatorsBenzodiazepines,approvedillicitinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00404
Rosiglitazone,,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00412
Rosiglitazone,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00412
Rosiglitazone,,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00412
Rosiglitazone,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00412
Rosiglitazone,,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00412
Rosiglitazone,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00412
Rosiglitazone,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00412
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00418
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00420
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitorinducer,DB00421
Methylphenidate,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00422
Methylphenidate,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedinvestigational,,Carboxylesterase,enzyme,substrate,DB00422
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00425
Famciclovir,"Antiviral AgentsProdrugsNucleic Acids, Nucleotides, and Nucleosides",approved,AOX1,Aldehyde oxidase,enzyme,substrate,DB00426
Famciclovir,"Antiviral AgentsProdrugsNucleic Acids, Nucleotides, and Nucleosides",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00426
Streptozocin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00428
Streptozocin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00428
Streptozocin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB00428
Trifluridine,Antiviral AgentsAntimetabolites,approved,TK1,"Thymidine kinase, cytosolic",enzyme,substrate,DB00432
Trifluridine,Antiviral AgentsAntimetabolites,approved,TYMP,Thymidine phosphorylase,enzyme,substrate,DB00432
Prochlorperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00433
Prochlorperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00433
Nitric Oxide,Bronchodilator AgentsEndothelium-Dependent Relaxing FactorsFree Radical ScavengersNeurotransmitter Agents,approved,ALDH2,"Aldehyde dehydrogenase, mitochondrial",enzyme,inhibitor,DB00435
Nitric Oxide,Bronchodilator AgentsEndothelium-Dependent Relaxing FactorsFree Radical ScavengersNeurotransmitter Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00435
Nitric Oxide,Bronchodilator AgentsEndothelium-Dependent Relaxing FactorsFree Radical ScavengersNeurotransmitter Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00435
Nitric Oxide,Bronchodilator AgentsEndothelium-Dependent Relaxing FactorsFree Radical ScavengersNeurotransmitter Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00435
Allopurinol,Gout SuppressantsEnzyme InhibitorsAntimetabolitesFree Radical Scavengers,approved,AOX1,Aldehyde oxidase,enzyme,substrate,DB00437
Allopurinol,Gout SuppressantsEnzyme InhibitorsAntimetabolitesFree Radical Scavengers,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00437
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00439
Trimethoprim,Anti-Infective Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00440
Trimethoprim,Anti-Infective Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00440
Trimethoprim,Anti-Infective Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00440
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,CDA,Cytidine deaminase,enzyme,substrate,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,DCK,Deoxycytidine kinase,enzyme,substrate,DB00441
Betamethasone,Anti-Asthmatic AgentsAnti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00443
Betamethasone,Anti-Asthmatic AgentsAnti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,CYP19A1,Cytochrome P450 19A1,enzyme,substrateinducer,DB00443
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00444
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00444
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00444
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00444
Epirubicin,"Antibiotics, Antineoplastic",approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00445
Epirubicin,"Antibiotics, Antineoplastic",approved,PLA2G4A,Cytosolic phospholipase A2,enzyme,inhibitor,DB00445
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,cat3,Chloramphenicol acetyltransferase 3,enzyme,substrate,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,cat,Chloramphenicol acetyltransferase,enzyme,substrate,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,,Chloramphenicol 3-O phosphotransferase,enzyme,substrate,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00446
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitorinducer,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,CYP4A11,Cytochrome P450 4A11,enzyme,inducer,DB00448
Levothyroxine,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00451
Levothyroxine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00451
Pethidine,Adjuvants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00454
Pethidine,Adjuvants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00454
Pethidine,Adjuvants,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00454
Pethidine,Adjuvants,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00454
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00455
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00455
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitorinducer,DB00455
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB00455
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00455
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00458
Nabumetone,Cyclooxygenase 2 Inhibitors,approved,MPO,Myeloperoxidase,enzyme,inhibitor,DB00461
Nabumetone,Cyclooxygenase 2 Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00461
Picrotoxin,GABA AntagonistsConvulsantsStimulants,experimental,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00466
Picrotoxin,GABA AntagonistsConvulsantsStimulants,experimental,GLUL,Glutamine synthetase,enzyme,inhibitor,DB00466
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitorinducer,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitorinducer,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00468
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00470
Montelukast,Anti-Arrhythmia Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00471
Montelukast,Anti-Arrhythmia Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00471
Montelukast,Anti-Arrhythmia Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00471
Montelukast,Anti-Arrhythmia Agents,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00471
Montelukast,Anti-Arrhythmia Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00471
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP2B,CYP2B protein,enzyme,inhibitor,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00472
Chlordiazepoxide,"Anti-Anxiety AgentsHypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00475
Chlordiazepoxide,"Anti-Anxiety AgentsHypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00475
Duloxetine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00476
Duloxetine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00476
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00477
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00481
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00481
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,AOX1,Aldehyde oxidase,enzyme,inhibitor,DB00481
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00481
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00481
Celecoxib,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00482
Celecoxib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00482
Celecoxib,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00482
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00490
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00490
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00490
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00490
Entacapone,Enzyme InhibitorsAntiparkinson AgentsAntidyskinetics,approvedinvestigational,COMT,Catechol O-methyltransferase,enzyme,inhibitor,DB00494
Entacapone,Enzyme InhibitorsAntiparkinson AgentsAntidyskinetics,approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00494
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,TK1,"Thymidine kinase, cytosolic",enzyme,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00495
Darifenacin,Antispasmodic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00496
Darifenacin,Antispasmodic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00496
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00497
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00497
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00497
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00497
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00499
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00499
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00499
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrateinhibitor,DB00499
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00499
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00499
Tolmetin,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,TDO2,"Tryptophan 2,3-dioxygenase",enzyme,inhibitor,DB00500
Tolmetin,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,MPO,Myeloperoxidase,enzyme,inhibitor,DB00500
Cimetidine,Adjuvants,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00501
Cimetidine,Adjuvants,approved,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00501
Cimetidine,Adjuvants,approved,FMO1,Dimethylaniline monooxygenase [N-oxide-forming] 1,enzyme,substrate,DB00501
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CBR1,Carbonyl reductase [NADPH] 1,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00502
Ritonavir,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00503
Ritonavir,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00503
Ritonavir,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00503
Ritonavir,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinducer,DB00503
Ritonavir,,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00503
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00514
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,MPO,Myeloperoxidase,enzyme,inducer,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,inducer,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,CYP4A11,Cytochrome P450 4A11,enzyme,inducer,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,nat,Arylamine N-acetyltransferase,enzyme,inhibitor,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,GSTT1,Glutathione S-transferase theta-1,enzyme,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,,Metallothionein-1A,enzyme,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,,Metallothionein-2,enzyme,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,SOD1,Superoxide dismutase [Cu-Zn],enzyme,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,GSTP1,Glutathione S-transferase P,enzyme,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,NQO1,NAD(P)H dehydrogenase [quinone] 1,enzyme,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,GSTM1,Glutathione S-transferase Mu 1,enzyme,substrate,DB00515
Albendazole,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00518
Albendazole,,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00518
Albendazole,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitorinducer,DB00518
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,GSTT1,Glutathione S-transferase theta-1,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,,Metallothionein-1A,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,,Metallothionein-2,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,MPO,Myeloperoxidase,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,SOD1,Superoxide dismutase [Cu-Zn],enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,GSTP1,Glutathione S-transferase P,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,GSTM1,Glutathione S-transferase Mu 1,enzyme,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,NQO1,NAD(P)H dehydrogenase [quinone] 1,enzyme,substrate,DB00526
Lercanidipine,Antihypertensive AgentsCalcium Channel Blockers,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00528
Lercanidipine,Antihypertensive AgentsCalcium Channel Blockers,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00528
Lercanidipine,Antihypertensive AgentsCalcium Channel Blockers,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00528
Lercanidipine,Antihypertensive AgentsCalcium Channel Blockers,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00528
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inhibitor,DB00530
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinducer,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinducer,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00531
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00531
Mephenytoin,Anticonvulsants,investigationalwithdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00532
Mephenytoin,Anticonvulsants,investigationalwithdrawn,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00532
Mephenytoin,Anticonvulsants,investigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00532
Mephenytoin,Anticonvulsants,investigationalwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00532
Mephenytoin,Anticonvulsants,investigationalwithdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00532
Mephenytoin,Anticonvulsants,investigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00532
Rofecoxib,,investigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00533
Rofecoxib,,investigationalwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00533
Rofecoxib,,investigationalwithdrawn,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00533
Rofecoxib,,investigationalwithdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00533
Rofecoxib,,investigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00533
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00537
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00537
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00537
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00537
Toremifene,"Antineoplastic Agents, HormonalBone Density Conservation AgentsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00539
Toremifene,"Antineoplastic Agents, HormonalBone Density Conservation AgentsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00539
Toremifene,"Antineoplastic Agents, HormonalBone Density Conservation AgentsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00539
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00540
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00541
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,TYMP,Thymidine phosphorylase,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,UPP1,Uridine phosphorylase 1,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,UPP2,Uridine phosphorylase 2,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,MTHFR,Methylenetetrahydrofolate reductase,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,TYMS,Thymidylate synthase,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,UMPS,Uridine 5'-monophosphate synthase,enzyme,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,PPAT,Amidophosphoribosyltransferase,enzyme,substrate,DB00544
Adinazolam,Antidepressive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00546
Adinazolam,Antidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00546
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00549
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00549
Propylthiouracil,AntimetabolitesAntithyroid Agents,approved,MPO,Myeloperoxidase,enzyme,inhibitor,DB00550
Propylthiouracil,AntimetabolitesAntithyroid Agents,approved,DBH,Dopamine beta-hydroxylase,enzyme,inhibitor,DB00550
Methoxsalen,Photosensitizing AgentsCross-Linking ReagentsPigmenting Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00553
Methoxsalen,Photosensitizing AgentsCross-Linking ReagentsPigmenting Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrateinhibitor,DB00553
Methoxsalen,Photosensitizing AgentsCross-Linking ReagentsPigmenting Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00553
Methoxsalen,Photosensitizing AgentsCross-Linking ReagentsPigmenting Agents,approved,CYP2A13,Cytochrome P450 2A13,enzyme,inhibitor,DB00553
Methoxsalen,Photosensitizing AgentsCross-Linking ReagentsPigmenting Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00553
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00554
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00554
Lamotrigine,AnticonvulsantsCalcium Channel BlockersAntidepressive Agents,approvedinvestigational,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00555
Lamotrigine,AnticonvulsantsCalcium Channel BlockersAntidepressive Agents,approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00555
Bosentan,Antihypertensive Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00559
Bosentan,Antihypertensive Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB00559
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,MTHFR,Methylenetetrahydrofolate reductase,enzyme,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,AOX1,Aldehyde oxidase,enzyme,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",enzyme,inhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,FPGS,"Folylpolyglutamate synthase, mitochondrial",enzyme,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,GGH,Gamma-glutamyl hydrolase,enzyme,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,DHFR,Dihydrofolate reductase,enzyme,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,TYMS,Thymidylate synthase,enzyme,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ATIC,Bifunctional purine biosynthesis protein PURH,enzyme,inhibitor,DB00563
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitorinducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitorinducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00564
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00567
Cinnarizine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00568
Cinnarizine,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00568
Cinnarizine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00568
Cinnarizine,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00568
Cinnarizine,,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00568
Cinnarizine,,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00568
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00570
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00571
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00575
Valdecoxib,"Anti-Inflammatory Agents, Non-Steroidal",investigationalwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00580
Valdecoxib,"Anti-Inflammatory Agents, Non-Steroidal",investigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00580
Valdecoxib,"Anti-Inflammatory Agents, Non-Steroidal",investigationalwithdrawn,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00580
Valdecoxib,"Anti-Inflammatory Agents, Non-Steroidal",investigationalwithdrawn,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00580
Valdecoxib,"Anti-Inflammatory Agents, Non-Steroidal",investigationalwithdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00580
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,FMO1,Dimethylaniline monooxygenase [N-oxide-forming] 1,enzyme,substrate,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00582
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00582
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00586
Fluticasone Propionate,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00588
Fluticasone Propionate,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00588
Fluticasone Propionate,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00588
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00589
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00590
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00590
Ethosuximide,AnticonvulsantsSuccinimides,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00593
Ethosuximide,AnticonvulsantsSuccinimides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00593
Ethosuximide,AnticonvulsantsSuccinimides,approved,CYP3A43,Cytochrome P450 3A43,enzyme,substrate,DB00593
Ethosuximide,AnticonvulsantsSuccinimides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00593
Ethosuximide,AnticonvulsantsSuccinimides,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00593
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,ABP1,Amiloride-sensitive amine oxidase [copper-containing],enzyme,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,ABP1,Amiloride-sensitive amine oxidase [copper-containing],enzyme,inhibitor,DB00594
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00599
Linezolid,Anti-Bacterial Agents,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB00601
Linezolid,Anti-Bacterial Agents,approvedinvestigational,MAOB,Amine oxidase [flavin-containing] B,enzyme,inhibitor,DB00601
Medroxyprogesterone Acetate,"Antineoplastic Agents, HormonalContraceptive Agents, FemaleContraceptive Agents, MaleContraceptive Agents",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00603
Medroxyprogesterone Acetate,"Antineoplastic Agents, HormonalContraceptive Agents, FemaleContraceptive Agents, MaleContraceptive Agents",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00603
Medroxyprogesterone Acetate,"Antineoplastic Agents, HormonalContraceptive Agents, FemaleContraceptive Agents, MaleContraceptive Agents",approvedinvestigational,HSD3B2,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,enzyme,inhibitor,DB00603
Medroxyprogesterone Acetate,"Antineoplastic Agents, HormonalContraceptive Agents, FemaleContraceptive Agents, MaleContraceptive Agents",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00603
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00604
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00605
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00605
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00607
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00607
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00608
Bisoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholytics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00612
Bisoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholytics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00612
Amodiaquine,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00613
Amodiaquine,,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00613
Amodiaquine,,approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00613
Amodiaquine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00613
Amodiaquine,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00613
Furazolidone,"Anti-Infective Agents, LocalAnti-Infective Agents, UrinaryAntitrichomonal AgentsMonoamine Oxidase Inhibitors",approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,inhibitor,DB00614
Furazolidone,"Anti-Infective Agents, LocalAnti-Infective Agents, UrinaryAntitrichomonal AgentsMonoamine Oxidase Inhibitors",approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB00614
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00615
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00615
Paramethadione,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00617
Paramethadione,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00617
Paramethadione,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00617
Paramethadione,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00617
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00619
Triamcinolone,Anti-Inflammatory AgentsGlucocorticoids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00620
Triamcinolone,Anti-Inflammatory AgentsGlucocorticoids,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB00620
Triamcinolone,Anti-Inflammatory AgentsGlucocorticoids,approved,BCHE,Cholinesterase,enzyme,inducer,DB00620
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00622
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00623
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00623
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00623
Testosterone,Androgens,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB00624
Testosterone,Androgens,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,enzyme,inducer,DB00624
Testosterone,Androgens,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00624
Testosterone,Androgens,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP2A13,Cytochrome P450 2A13,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinducer,DB00624
Testosterone,Androgens,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,CYP3A43,Cytochrome P450 3A43,enzyme,substrate,DB00624
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00625
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00625
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitorinducer,DB00625
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00625
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00625
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00625
Dexmedetomidine,"Hypnotics and SedativesAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor Agonists",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00633
Dexmedetomidine,"Hypnotics and SedativesAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor Agonists",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00633
Dexmedetomidine,"Hypnotics and SedativesAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor Agonists",approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00633
Dexmedetomidine,"Hypnotics and SedativesAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor Agonists",approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00633
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00635
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB00635
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB00636
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,GSTA2,Glutathione S-transferase A2,enzyme,inhibitor,DB00636
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00636
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00636
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00636
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00636
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,CYP4A11,Cytochrome P450 4A11,enzyme,substrateinducer,DB00636
Astemizole,Histamine Antagonists,approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00637
Astemizole,Histamine Antagonists,approvedwithdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00637
Astemizole,Histamine Antagonists,approvedwithdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00637
Astemizole,Histamine Antagonists,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00637
Astemizole,Histamine Antagonists,approvedwithdrawn,CYP2J2,Cytochrome P450 2J2,enzyme,substrate,DB00637
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,ADA,Adenosine deaminase,enzyme,substrate,DB00640
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,ADK,Adenosine kinase,enzyme,substrate,DB00640
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00641
Pemetrexed,,approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,inducer,DB00642
Pemetrexed,,approvedinvestigational,SLC29A1,Equilibrative nucleoside transporter 1,enzyme,inducer,DB00642
Mebendazole,Tubulin ModulatorsAntinematodal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00643
Mebendazole,Tubulin ModulatorsAntinematodal Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00643
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00647
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00647
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00647
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00647
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,inducer,DB00647
Estrone,EstrogensAnti-menopausal Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,CYP4A11,Cytochrome P450 4A11,enzyme,substrate,DB00655
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00656
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinducer,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00661
Nilutamide,Antineoplastic AgentsAndrogen Antagonists,approved,POR,NADPH--cytochrome P450 reductase,enzyme,substrate,DB00665
Nilutamide,Antineoplastic AgentsAndrogen Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00665
Nilutamide,Antineoplastic AgentsAndrogen Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00665
Nilutamide,Antineoplastic AgentsAndrogen Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00665
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,HNMT,Histamine N-methyltransferase,enzyme,substrate,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00667
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00668
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00672
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00672
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00672
Aprepitant,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00673
Aprepitant,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00673
Aprepitant,,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00673
Aprepitant,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00673
Aprepitant,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00673
Aprepitant,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00673
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00674
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrateinhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,FMO1,Dimethylaniline monooxygenase [N-oxide-forming] 1,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CES1,Liver carboxylesterase 1,enzyme,inhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,SULT1A1,Sulfotransferase 1A1,enzyme,substrate,DB00675
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,UGT1A10,UDP-glucuronosyltransferase 1-10,enzyme,substrate,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,UGT2B17,UDP-glucuronosyltransferase 2B17,enzyme,substrate,DB00678
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00679
Warfarin,AnticoagulantsRodenticides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00682
Warfarin,AnticoagulantsRodenticides,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00682
Warfarin,AnticoagulantsRodenticides,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00682
Warfarin,AnticoagulantsRodenticides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00682
Warfarin,AnticoagulantsRodenticides,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00682
Warfarin,AnticoagulantsRodenticides,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00682
Warfarin,AnticoagulantsRodenticides,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00682
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,CYP4B1,Cytochrome P450 4B1,enzyme,substrate,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00683
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,,UDP-glucuronosyltransferase 1-7,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,,UDP-glucuronosyltransferase 1-6,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,UGT1A8,UDP-glucuronosyltransferase 1-8,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,UGT1A10,UDP-glucuronosyltransferase 1-10,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,CES1,Liver carboxylesterase 1,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,,Cocaine esterase,enzyme,,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00688
Flurazepam,,approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00690
Flurazepam,,approvedillicit,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00690
Flurazepam,,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00690
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,POR,NADPH--cytochrome P450 reductase,enzyme,substrate,DB00694
Ergotamine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00696
Ergotamine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00696
Eplerenone,Mineralocorticoid Receptor Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00700
Eplerenone,Mineralocorticoid Receptor Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00700
Eplerenone,Mineralocorticoid Receptor Antagonists,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00700
Eplerenone,Mineralocorticoid Receptor Antagonists,approved,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,inhibitor,DB00700
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00701
Methazolamide,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00703
Methazolamide,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00703
Methazolamide,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00703
Methazolamide,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00703
Methazolamide,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00703
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00705
Delavirdine,Reverse Transcriptase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00705
Tamsulosin,Adrenergic alpha-1 Receptor Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00706
Tamsulosin,Adrenergic alpha-1 Receptor Antagonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00706
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,CMPK1,UMP-CMP kinase,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,PGK1,Phosphoglycerate kinase 1,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,NME1,Nucleoside diphosphate kinase A,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,NME2,Nucleoside diphosphate kinase B,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,PCYT1A,Choline-phosphate cytidylyltransferase A,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,,Ethanolamine-phosphate cytidylyltransferase,enzyme,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,,"5'(3')-deoxyribonucleotidase, cytosolic type",enzyme,substrate,DB00709
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB00712
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00715
Norethindrone,"Contraceptives, Oral, Synthetic",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00717
Norethindrone,"Contraceptives, Oral, Synthetic",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00717
Norethindrone,"Contraceptives, Oral, Synthetic",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00717
Norethindrone,"Contraceptives, Oral, Synthetic",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB00717
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,AK2,"Adenylate kinase 2, mitochondrial",enzyme,substrate,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,,"Adenylate kinase 4, mitochondrial",enzyme,substrate,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,NME1,Nucleoside diphosphate kinase A,enzyme,substrate,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,NME2,Nucleoside diphosphate kinase B,enzyme,substrate,DB00718
Imiquimod,"Antineoplastic AgentsAdjuvants, ImmunologicInterferon Inducers",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00724
Imiquimod,"Antineoplastic AgentsAdjuvants, ImmunologicInterferon Inducers",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00724
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00726
Thiabendazole,Anthelmintics,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00730
Thiabendazole,Anthelmintics,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00730
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00731
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00734
Esomeprazole,Proton Pump InhibitorsHistamine Antagonists,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00736
Esomeprazole,Proton Pump InhibitorsHistamine Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00736
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP4A11,Cytochrome P450 4A11,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00738
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00738
Riluzole,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00740
Riluzole,,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00740
Hydrocortisone,Anti-Inflammatory Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,substrate,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,substrate,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB00741
Zileuton,"Anti-Inflammatory Agents, Non-SteroidalLipoxygenase InhibitorsLeukotriene Antagonists",approvedinvestigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00744
Zileuton,"Anti-Inflammatory Agents, Non-SteroidalLipoxygenase InhibitorsLeukotriene Antagonists",approvedinvestigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00744
Zileuton,"Anti-Inflammatory Agents, Non-SteroidalLipoxygenase InhibitorsLeukotriene Antagonists",approvedinvestigationalwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00744
Zileuton,"Anti-Inflammatory Agents, Non-SteroidalLipoxygenase InhibitorsLeukotriene Antagonists",approvedinvestigationalwithdrawn,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00744
Zileuton,"Anti-Inflammatory Agents, Non-SteroidalLipoxygenase InhibitorsLeukotriene Antagonists",approvedinvestigationalwithdrawn,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00744
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitorinducer,DB00745
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00745
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitorinducer,DB00745
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitorinducer,DB00745
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB00745
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitorinducer,DB00745
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00748
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00748
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00748
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00748
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00748
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00748
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00748
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00749
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00749
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00749
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,UGT1A10,UDP-glucuronosyltransferase 1-10,enzyme,substrate,DB00749
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00749
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00751
Tranylcypromine,Antidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00752
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitorinducer,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,enzyme,inhibitor,DB00753
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CYP4A11,Cytochrome P450 4A11,enzyme,substrate,DB00755
Dolasetron,Serotonin AntagonistsAntiemetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00757
Dolasetron,Serotonin AntagonistsAntiemetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00757
Dolasetron,Serotonin AntagonistsAntiemetics,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00757
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitor,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00758
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,CES1,Liver carboxylesterase 1,enzyme,substrate,DB00758
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,CES1,Liver carboxylesterase 1,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,,Cocaine esterase,enzyme,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,BCHE,Cholinesterase,enzyme,substrate,DB00762
Methimazole,Antithyroid Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00763
Methimazole,Antithyroid Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00763
Malathion,Cholinesterase InhibitorsInsecticides,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00772
Malathion,Cholinesterase InhibitorsInsecticides,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00772
Etoposide,"Antineoplastic Agents, Phytogenic",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinducer,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,GSTT1,Glutathione S-transferase theta-1,enzyme,substrate,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,GSTP1,Glutathione S-transferase P,enzyme,substrate,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,substrate,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00773
Oxcarbazepine,Anticonvulsants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00776
Oxcarbazepine,Anticonvulsants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00776
Oxcarbazepine,Anticonvulsants,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB00776
Roxithromycin,Macrolides,approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00778
Roxithromycin,Macrolides,approvedwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00778
Roxithromycin,Macrolides,approvedwithdrawn,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00778
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,substrate,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP3A43,Cytochrome P450 3A43,enzyme,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00780
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00783
Mefenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00784
Mefenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00784
Naproxen,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00788
Naproxen,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00788
Naproxen,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00788
Naproxen,,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00788
Naproxen,,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00788
Primidone,AnticonvulsantsBarbiturates,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinducer,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB00794
Candesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00796
Candesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00796
Candesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00796
Candesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00796
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00802
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00802
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00802
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00812
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00812
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00813
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00813
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00813
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00814
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00814
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",enzyme,inhibitor,DB00814
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB00814
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,UGT1A8,UDP-glucuronosyltransferase 1-8,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,FAAH,Fatty-acid amide hydrolase 1,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,,UDP-glucuronosyltransferase 1-6,enzyme,substrate,DB00818
Disulfiram,Enzyme InhibitorsAlcohol Deterrents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00822
Disulfiram,Enzyme InhibitorsAlcohol Deterrents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00822
Disulfiram,Enzyme InhibitorsAlcohol Deterrents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00822
Disulfiram,Enzyme InhibitorsAlcohol Deterrents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00822
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00829
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,conversion inhibitor,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00831
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00834
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00834
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB00834
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00834
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00835
Loperamide,Antidiarrheals,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00836
Loperamide,Antidiarrheals,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00836
Loperamide,Antidiarrheals,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00836
Loperamide,Antidiarrheals,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00836
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,CYP3A43,Cytochrome P450 3A43,enzyme,substrate,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00842
Donepezil,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00843
Donepezil,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00843
Donepezil,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00843
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00849
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00850
Dacarbazine,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00851
Dacarbazine,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00851
Dacarbazine,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00851
Pseudoephedrine,,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB00852
Pseudoephedrine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00852
Chlorphenesin,"Muscle Relaxants, Central",approvedwithdrawn,CYP2B,CYP2B protein,enzyme,inducer,DB00856
Chlorphenesin,"Muscle Relaxants, Central",approvedwithdrawn,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB00856
Chlorphenesin,"Muscle Relaxants, Central",approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00856
Chlorphenesin,"Muscle Relaxants, Central",approvedwithdrawn,XDH,Xanthine dehydrogenase/oxidase,enzyme,inhibitor,DB00856
Chlorphenesin,"Muscle Relaxants, Central",approvedwithdrawn,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB00856
Chlorphenesin,"Muscle Relaxants, Central",approvedwithdrawn,BCHE,Cholinesterase,enzyme,inducer,DB00856
Terbinafine,Antifungal Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB00857
Terbinafine,Antifungal Agents,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00857
Prednisolone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00860
Prednisolone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00860
Vardenafil,Vasodilator AgentsPhosphodiesterase 5 InhibitorsAnti-Impotence Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00862
Vardenafil,Vasodilator AgentsPhosphodiesterase 5 InhibitorsAnti-Impotence Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00862
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00863
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00863
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00863
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00863
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB00863
Tacrolimus,,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00864
Tacrolimus,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00864
Tacrolimus,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00864
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00865
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB00865
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,POR,NADPH--cytochrome P450 reductase,enzyme,substrate,DB00865
Dorzolamide,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00869
Dorzolamide,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00869
Suprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00870
Suprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedwithdrawn,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00870
Suprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedwithdrawn,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00870
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00877
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00877
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00877
Chlorhexidine,"Anti-Infective AgentsAnti-Infective Agents, LocalDisinfectantsMouthwashes",approved,HNMT,Histamine N-methyltransferase,enzyme,inhibitor,DB00878
Chlorhexidine,"Anti-Infective AgentsAnti-Infective Agents, LocalDisinfectantsMouthwashes",approved,cat,Chloramphenicol acetyltransferase,enzyme,inhibitor,DB00878
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB00882
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00882
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00882
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00882
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00882
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00882
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00882
Isosorbide Dinitrate,Vasodilator AgentsNitric Oxide Donors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00883
Isosorbide Dinitrate,Vasodilator AgentsNitric Oxide Donors,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00883
Granisetron,Serotonin AntagonistsAntiemetics,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00889
Granisetron,Serotonin AntagonistsAntiemetics,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00889
Granisetron,Serotonin AntagonistsAntiemetics,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB00889
Granisetron,Serotonin AntagonistsAntiemetics,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00889
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00897
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitorinducer,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,CYP4A11,Cytochrome P450 4A11,enzyme,inducer,DB00898
Ondansetron,Antipsychotic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00904
Ondansetron,Antipsychotic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00904
Ondansetron,Antipsychotic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00904
Ondansetron,Antipsychotic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00904
Ondansetron,Antipsychotic Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00904
Ondansetron,Antipsychotic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00904
Ondansetron,Antipsychotic Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00904
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00907
Quinidine,Anti-Arrhythmia Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00908
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,AOX1,Aldehyde oxidase,enzyme,substrate,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00909
Paricalcitol,,approvedinvestigational,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,substrate,DB00910
Paricalcitol,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00910
Paricalcitol,,approvedinvestigational,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB00910
Repaglinide,Hypoglycemic AgentsAntidiabetic AgentsMeglitinides,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00912
Repaglinide,Hypoglycemic AgentsAntidiabetic AgentsMeglitinides,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00912
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,DDC,Aromatic-L-amino-acid decarboxylase,enzyme,inducer,DB00915
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,inhibitor,DB00915
Metronidazole,Antiprotozoal AgentsAnti-Infective AgentsRadiation-Sensitizing Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00916
Metronidazole,Antiprotozoal AgentsAnti-Infective AgentsRadiation-Sensitizing Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00916
Metronidazole,Antiprotozoal AgentsAnti-Infective AgentsRadiation-Sensitizing Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00916
Dinoprostone,OxytocicsProstaglandins,approved,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00917
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00918
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00921
Cyclobenzaprine,"Tranquilizing AgentsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00924
Cyclobenzaprine,"Tranquilizing AgentsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00924
Cyclobenzaprine,"Tranquilizing AgentsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00924
Etretinate,,withdrawn,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00926
Etretinate,,withdrawn,CYP26A1,Cytochrome P450 26A1,enzyme,substrate,DB00926
Tipranavir,Anti-HIV Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00932
Tipranavir,Anti-HIV Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00932
Tipranavir,Anti-HIV Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00932
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00934
Salmeterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00938
Salmeterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00938
Salmeterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00938
Salmeterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00938
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,DCK,Deoxycytidine kinase,enzyme,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP3A43,Cytochrome P450 3A43,enzyme,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00943
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00945
Phenprocoumon,Anticoagulants,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00946
Phenprocoumon,Anticoagulants,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00946
Phenprocoumon,Anticoagulants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00946
Felbamate,Anticonvulsants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00949
Felbamate,Anticonvulsants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00949
Felbamate,Anticonvulsants,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00949
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinhibitorinducer,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,NAT2,Arylamine N-acetyltransferase 2,enzyme,substrate,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,nat,Arylamine N-acetyltransferase,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00951
Rizatriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00953
Rizatriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00953
Hydrocodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00956
Hydrocodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00956
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,inducer,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,MPO,Myeloperoxidase,enzyme,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,GSTT1,Glutathione S-transferase theta-1,enzyme,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,,Metallothionein-1A,enzyme,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,,Metallothionein-2,enzyme,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,SOD1,Superoxide dismutase [Cu-Zn],enzyme,,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,GSTP1,Glutathione S-transferase P,enzyme,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,GSTM1,Glutathione S-transferase Mu 1,enzyme,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,NQO1,NAD(P)H dehydrogenase [quinone] 1,enzyme,substrate,DB00958
Zaleplon,Hypnotics and Sedatives,approvedillicitinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00962
Zaleplon,Hypnotics and Sedatives,approvedillicitinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00962
Zaleplon,Hypnotics and Sedatives,approvedillicitinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB00962
Zaleplon,Hypnotics and Sedatives,approvedillicitinvestigational,AOX1,Aldehyde oxidase,enzyme,substrate,DB00962
Desloratadine,"Cholinergic AntagonistsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00967
Desloratadine,"Cholinergic AntagonistsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00967
Desloratadine,"Cholinergic AntagonistsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00967
Desloratadine,"Cholinergic AntagonistsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00967
Alosetron,,approvedwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00969
Alosetron,,approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00969
Alosetron,,approvedwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00969
Alosetron,,approvedwithdrawn,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00969
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00972
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB00972
Ezetimibe,Cholesterol Absorption Inhibitors,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00973
Edetic Acid,AnticoagulantsChelating AgentsFood Additives,approved,ADA,Adenosine deaminase,enzyme,inhibitor,DB00974
Edetic Acid,AnticoagulantsChelating AgentsFood Additives,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00974
Edetic Acid,AnticoagulantsChelating AgentsFood Additives,approved,PON3,Serum paraoxonase/lactonase 3,enzyme,inhibitor,DB00974
Edetic Acid,AnticoagulantsChelating AgentsFood Additives,approved,CYP19A1,Cytochrome P450 19A1,enzyme,substrate,DB00974
Telithromycin,Ketolides,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB00976
Telithromycin,Ketolides,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00976
Telithromycin,Ketolides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00976
Telithromycin,Ketolides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB00976
Telithromycin,Ketolides,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00976
Ethinyl Estradiol,Estrogens,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00977
Ethinyl Estradiol,Estrogens,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00977
Ramelteon,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00980
Ramelteon,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00980
Ramelteon,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00980
Formoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00983
Formoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00983
Formoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00983
Formoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB00983
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,CDA,Cytidine deaminase,enzyme,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,NT5E,5'-nucleotidase,enzyme,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,,Deoxycytidylate deaminase,enzyme,substrate,DB00987
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,substrate,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,COMT,Catechol O-methyltransferase,enzyme,substrate,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DBH,Dopamine beta-hydroxylase,enzyme,substrate,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00988
Rivastigmine,Neuroprotective AgentsCholinesterase InhibitorsCholinergic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00989
Rivastigmine,Neuroprotective AgentsCholinesterase InhibitorsCholinergic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00989
Exemestane,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00990
Exemestane,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00990
Azathioprine,"Antirheumatic AgentsImmunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00993
Azathioprine,"Antirheumatic AgentsImmunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,TPMT,Thiopurine S-methyltransferase,enzyme,substrate,DB00993
Azathioprine,"Antirheumatic AgentsImmunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,GSTA1,Glutathione S-transferase A1,enzyme,substrate,DB00993
Azathioprine,"Antirheumatic AgentsImmunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,GSTA2,Glutathione S-transferase A2,enzyme,substrate,DB00993
Azathioprine,"Antirheumatic AgentsImmunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,GSTM1,Glutathione S-transferase Mu 1,enzyme,substrate,DB00993
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,CBR1,Carbonyl reductase [NADPH] 1,enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,,Carbonyl reductase [NADPH] 3,enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,AKR1A1,Alcohol dehydrogenase [NADP(+)],enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,AKR1C3,Aldo-keto reductase family 1 member C3,enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NQO1,NAD(P)H dehydrogenase [quinone] 1,enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NOS1,"Nitric oxide synthase, brain",enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NOS2,"Nitric oxide synthase, inducible",enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NOS3,"Nitric oxide synthase, endothelial",enzyme,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NDUFS2,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",enzyme,,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NDUFS3,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",enzyme,,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,NDUFS7,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",enzyme,,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,POR,NADPH--cytochrome P450 reductase,enzyme,substrate,DB00997
Levobupivacaine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01002
Levobupivacaine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01002
Letrozole,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,substrateinhibitor,DB01006
Letrozole,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01006
Letrozole,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrateinhibitor,DB01006
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01007
Busulfan,"Immunosuppressive AgentsAntineoplastic Agents, AlkylatingAlkylating AgentsMyeloablative Agonists",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01008
Busulfan,"Immunosuppressive AgentsAntineoplastic Agents, AlkylatingAlkylating AgentsMyeloablative Agonists",approvedinvestigational,GSTA2,Glutathione S-transferase A2,enzyme,substrate,DB01008
Busulfan,"Immunosuppressive AgentsAntineoplastic Agents, AlkylatingAlkylating AgentsMyeloablative Agonists",approvedinvestigational,GSTA1,Glutathione S-transferase A1,enzyme,substrate,DB01008
Busulfan,"Immunosuppressive AgentsAntineoplastic Agents, AlkylatingAlkylating AgentsMyeloablative Agonists",approvedinvestigational,GSTM1,Glutathione S-transferase Mu 1,enzyme,substrate,DB01008
Busulfan,"Immunosuppressive AgentsAntineoplastic Agents, AlkylatingAlkylating AgentsMyeloablative Agonists",approvedinvestigational,GSTP1,Glutathione S-transferase P,enzyme,substrate,DB01008
Busulfan,"Immunosuppressive AgentsAntineoplastic Agents, AlkylatingAlkylating AgentsMyeloablative Agonists",approvedinvestigational,MGST2,Microsomal glutathione S-transferase 2,enzyme,substrate,DB01008
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01009
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,inhibitor,DB01011
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01011
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitorinducer,DB01011
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB01011
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01011
Cinacalcet,Calcimimetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01012
Cinacalcet,Calcimimetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01012
Cinacalcet,Calcimimetics,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01012
Clobetasol propionate,Anti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01013
Clobetasol propionate,Anti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01013
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,NAT1,Arylamine N-acetyltransferase 1,enzyme,substrate,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,NAT2,Arylamine N-acetyltransferase 2,enzyme,substrate,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01015
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01016
Guanfacine,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01018
Guanfacine,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01018
Guanfacine,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01018
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01023
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB01024
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB01024
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB01024
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,,UDP-glucuronosyltransferase 1-7,enzyme,substrate,DB01024
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,,UDP-glucuronosyltransferase 1-6,enzyme,substrate,DB01024
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitorinducer,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP26A1,Cytochrome P450 26A1,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP51A1,Lanosterol 14-alpha demethylase,enzyme,inhibitor,DB01026
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01028
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01029
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01032
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,TPMT,Thiopurine S-methyltransferase,enzyme,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,AOX1,Aldehyde oxidase,enzyme,substrate,DB01033
Procainamide,Anti-Arrhythmia Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01035
Procainamide,Anti-Arrhythmia Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB01035
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01036
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01037
Fenofibrate,Hypolipidemic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01039
Fenofibrate,Hypolipidemic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01039
Fenofibrate,Hypolipidemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01039
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,PTGS2,Prostaglandin G/H synthase 2,enzyme,substrate,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01041
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01043
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitorinducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrateinhibitorinducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP3A43,Cytochrome P450 3A43,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP3A7,Cytochrome P450 3A7,enzyme,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,CYP4A11,Cytochrome P450 4A11,enzyme,inducer,DB01045
Abacavir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ADH6,Alcohol dehydrogenase 6,enzyme,substrate,DB01048
Abacavir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB01048
Abacavir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ADK,Adenosine kinase,enzyme,substrate,DB01048
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB01050
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01054
Praziquantel,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01058
Praziquantel,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01058
Praziquantel,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01058
Praziquantel,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01058
Praziquantel,,approved,CYP3A43,Cytochrome P450 3A43,enzyme,substrate,DB01058
Praziquantel,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01058
Praziquantel,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01058
Norfloxacin,Anti-Infective AgentsQuinolones,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01059
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01062
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01062
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01062
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01062
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CYP1A1,Cytochrome P450 1A1,enzyme,substrateinhibitor,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CYP1B1,Cytochrome P450 1B1,enzyme,substrateinhibitor,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,ASMT,Acetylserotonin O-methyltransferase,enzyme,substrate,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,IDO1,"Indoleamine 2,3-dioxygenase 1",enzyme,substrate,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,MPO,Myeloperoxidase,enzyme,substrateinhibitor,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01065
Glipizide,Hypoglycemic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01067
Glipizide,Hypoglycemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01067
Clonazepam,AnticonvulsantsGABA ModulatorsBenzodiazepines,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01068
Clonazepam,AnticonvulsantsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01068
Clonazepam,AnticonvulsantsGABA ModulatorsBenzodiazepines,approvedillicit,NAT2,Arylamine N-acetyltransferase 2,enzyme,substrate,DB01068
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01069
Mequitazine,Histamine H1 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01071
Mequitazine,Histamine H1 Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01071
Atazanavir,Anti-HIV AgentsHIV Protease Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01072
Atazanavir,Anti-HIV AgentsHIV Protease Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01072
Perhexiline,Vasodilator AgentsCalcium Channel BlockersCardiovascular Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01074
Perhexiline,Vasodilator AgentsCalcium Channel BlockersCardiovascular Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01074
Perhexiline,Vasodilator AgentsCalcium Channel BlockersCardiovascular Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01074
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01075
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB01076
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01079
Orlistat,Enzyme InhibitorsAnti-Obesity Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01083
Orlistat,Enzyme InhibitorsAnti-Obesity Agents,approvedinvestigational,PLA2G4A,Cytosolic phospholipase A2,enzyme,inhibitor,DB01083
Pilocarpine,Cholinergic Agents,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrateinhibitor,DB01085
Pilocarpine,Cholinergic Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01085
Pilocarpine,Cholinergic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01085
Primaquine,Antimalarials,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01087
Primaquine,Antimalarials,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitorinducer,DB01087
Primaquine,Antimalarials,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01087
Primaquine,Antimalarials,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB01087
Primaquine,Antimalarials,approved,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB01087
Dimethyl sulfoxide,Free Radical ScavengersSolventsCryoprotective Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01093
Dimethyl sulfoxide,Free Radical ScavengersSolventsCryoprotective Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01093
Dimethyl sulfoxide,Free Radical ScavengersSolventsCryoprotective Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01093
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitorinducer,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB01095
Leflunomide,Antirheumatic AgentsImmunosuppressive AgentsEnzyme InhibitorsAdjuvants,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01097
Leflunomide,Antirheumatic AgentsImmunosuppressive AgentsEnzyme InhibitorsAdjuvants,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01097
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01098
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01100
Capecitabine,Prodrugs,approvedinvestigational,TYMP,Thymidine phosphorylase,enzyme,substrate,DB01101
Capecitabine,Prodrugs,approvedinvestigational,CES1,Liver carboxylesterase 1,enzyme,substrate,DB01101
Capecitabine,Prodrugs,approvedinvestigational,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],enzyme,substrate,DB01101
Capecitabine,Prodrugs,approvedinvestigational,CDA,Cytidine deaminase,enzyme,substrate,DB01101
Capecitabine,Prodrugs,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01101
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,HNMT,Histamine N-methyltransferase,enzyme,inhibitor,DB01103
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01103
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01103
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitor,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,substrate,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,CYP2B,CYP2B protein,enzyme,inhibitor,DB01104
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01110
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01114
Nifedipine,Dihydropyridines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01115
Nifedipine,Dihydropyridines,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01115
Nifedipine,Dihydropyridines,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01115
Nifedipine,Dihydropyridines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01115
Nifedipine,Dihydropyridines,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01115
Nifedipine,Dihydropyridines,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB01115
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01118
Gliclazide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01120
Gliclazide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01120
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01124
Dutasteride,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01126
Dutasteride,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01126
Econazole,,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01127
Econazole,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01127
Econazole,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01127
Bicalutamide,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01128
Bicalutamide,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01128
Bicalutamide,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01128
Bicalutamide,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01128
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01129
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01129
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB01129
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB01129
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01129
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01129
Proguanil,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01131
Proguanil,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01131
Proguanil,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01131
Proguanil,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01131
Proguanil,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01131
Proguanil,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01131
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB01132
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB01132
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01132
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01132
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01132
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01132
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,XDH,Xanthine dehydrogenase/oxidase,enzyme,,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01136
Levofloxacin,Quinolones,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01137
Levofloxacin,Quinolones,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01137
Sulfinpyrazone,Uricosuric Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01138
Micafungin,Antifungal Agents,approvedinvestigational,COMT,Catechol O-methyltransferase,enzyme,substrate,DB01141
Micafungin,Antifungal Agents,approvedinvestigational,ARSA,Arylsulfatase A,enzyme,substrate,DB01141
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01142
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,CYP2B,CYP2B protein,enzyme,inhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01149
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01151
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitor,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01156
Halothane,"Anesthetics, InhalationAnesthetics",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01159
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01166
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01166
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01166
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01166
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01166
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01166
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01167
Procarbazine,Antineoplastic Agents,approved,XDH,Xanthine dehydrogenase/oxidase,enzyme,,DB01168
Procarbazine,Antineoplastic Agents,approved,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB01168
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01169
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB01171
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB01171
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01171
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB01171
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01171
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01171
Kanamycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAminoglycosides,approved,aac,Aminoglycoside 2'-N-acetyltransferase,enzyme,,DB01172
Kanamycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAminoglycosides,approved,knt,Kanamycin nucleotidyltransferase,enzyme,,DB01172
Kanamycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAminoglycosides,approved,aphA1,Aminoglycoside 3'-phosphotransferase,enzyme,,DB01172
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitorinducer,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,CYP2E1,Cytochrome P450 2E1,enzyme,,DB01173
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitorinducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrateinducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP4A11,Cytochrome P450 4A11,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP2C18,Cytochrome P450 2C18,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP3A7,Cytochrome P450 3A7,enzyme,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CYP4B1,Cytochrome P450 4B1,enzyme,inducer,DB01174
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01175
Idarubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01177
Idarubicin,"Antibiotics, AntineoplasticAntibiotics",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01177
Podofilox,"Antineoplastic Agents, PhytogenicTubulin ModulatorsKeratolytic AgentsAntimitotic Agents",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01179
Podofilox,"Antineoplastic Agents, PhytogenicTubulin ModulatorsKeratolytic AgentsAntimitotic Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01179
Ifosfamide,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01181
Ifosfamide,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01181
Ifosfamide,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01181
Ifosfamide,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01181
Ifosfamide,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB01181
Ifosfamide,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinducer,DB01181
Ifosfamide,,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01181
Ifosfamide,,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01181
Ifosfamide,,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01181
Ifosfamide,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01181
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01182
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01182
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01182
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01182
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01182
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01183
Domperidone,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01184
Domperidone,,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01184
Domperidone,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01184
Domperidone,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01184
Domperidone,,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01184
Domperidone,,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01184
Domperidone,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01184
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01186
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01191
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01191
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01191
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01191
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01191
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01191
Oxymorphone,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01192
Oxymorphone,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01192
Flecainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01195
Flecainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approvedwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01195
Zopiclone,Hypnotics and Sedatives,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01198
Zopiclone,Hypnotics and Sedatives,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01198
Zopiclone,Hypnotics and Sedatives,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01198
Zopiclone,Hypnotics and Sedatives,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01198
Zopiclone,Hypnotics and Sedatives,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01198
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01200
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB01201
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01201
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB01201
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP2D6,Cytochrome P450 2D6,enzyme,inducer,DB01201
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP3A43,Cytochrome P450 3A43,enzyme,inducer,DB01201
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB01201
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,CYP3A7,Cytochrome P450 3A7,enzyme,inducer,DB01201
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01204
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB01204
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01204
Lomustine,"Antineoplastic Agents, Alkylating",approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01206
Lomustine,"Antineoplastic Agents, Alkylating",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01206
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01211
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB01211
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB01211
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01211
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01211
Fomepizole,Antidotes,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01213
Fomepizole,Antidotes,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01213
Finasteride,5-alpha Reductase InhibitorsSkin and Mucous Membrane Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01216
Finasteride,5-alpha Reductase InhibitorsSkin and Mucous Membrane Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01216
Finasteride,5-alpha Reductase InhibitorsSkin and Mucous Membrane Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01216
Anastrozole,"Antineoplastic Agents, HormonalAromatase Inhibitors",approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01217
Anastrozole,"Antineoplastic Agents, HormonalAromatase Inhibitors",approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01217
Anastrozole,"Antineoplastic Agents, HormonalAromatase Inhibitors",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01217
Anastrozole,"Antineoplastic Agents, HormonalAromatase Inhibitors",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01217
Halofantrine,AntimalarialsAntiprotozoal Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01218
Halofantrine,AntimalarialsAntiprotozoal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01218
Halofantrine,AntimalarialsAntiprotozoal Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01218
Halofantrine,AntimalarialsAntiprotozoal Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01218
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01221
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01223
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01223
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01223
Quetiapine,Antipsychotic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01224
Quetiapine,Antipsychotic Agents,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01224
Quetiapine,Antipsychotic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01224
Quetiapine,Antipsychotic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01224
Quetiapine,Antipsychotic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01224
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01227
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01227
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01227
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,CYP19A1,Cytochrome P450 19A1,enzyme,substrate,DB01227
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB01229
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,substrate,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01232
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01233
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB01233
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,inducer,DB01233
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,inhibitor,DB01233
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,inhibitor,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitorinducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP3A43,Cytochrome P450 3A43,enzyme,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,CYP4A11,Cytochrome P450 4A11,enzyme,inducer,DB01234
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DDC,Aromatic-L-amino-acid decarboxylase,enzyme,,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01235
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01236
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01238
Gemfibrozil,Hypolipidemic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitorinducer,DB01241
Gemfibrozil,Hypolipidemic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01241
Gemfibrozil,Hypolipidemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01241
Gemfibrozil,Hypolipidemic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01241
Gemfibrozil,Hypolipidemic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01241
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01242
Docetaxel,Antineoplastic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,substrateinhibitorinducer,DB01248
Mitiglinide,Hypoglycemic Agents,approvedinvestigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB01252
Mitiglinide,Hypoglycemic Agents,approvedinvestigational,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB01252
Dasatinib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01254
Dasatinib,,approvedinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB01254
Dasatinib,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01254
Dasatinib,,approvedinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,substrate,DB01254
Dasatinib,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01254
Dasatinib,,approvedinvestigational,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB01254
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01259
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01259
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01259
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01259
Sitagliptin,Dipeptidyl-Peptidase IV Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01261
Sitagliptin,Dipeptidyl-Peptidase IV Inhibitors,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01261
Sunitinib,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB01268
Sunitinib,,approvedinvestigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01268
Sunitinib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01268
Arformoterol,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01274
Arformoterol,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01274
Arformoterol,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01274
Arformoterol,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01274
Nelarabine,,approvedinvestigational,ADA,Adenosine deaminase,enzyme,substrate,DB01280
Nelarabine,,approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,substrate,DB01280
Nelarabine,,approvedinvestigational,DGUOK,"Deoxyguanosine kinase, mitochondrial",enzyme,substrate,DB01280
Lumiracoxib,Cyclooxygenase 2 Inhibitors,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01283
Lumiracoxib,Cyclooxygenase 2 Inhibitors,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01283
Lumiracoxib,Cyclooxygenase 2 Inhibitors,approvedinvestigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB01283
Lumiracoxib,Cyclooxygenase 2 Inhibitors,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01283
Corticotropin,HormonesDiagnostic Agents,approved,HSD3B2,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,enzyme,inducer,DB01285
Corticotropin,HormonesDiagnostic Agents,approved,CYP27B1,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",enzyme,inducer,DB01285
Corticotropin,HormonesDiagnostic Agents,approved,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,inducer,DB01285
Glucosamine,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01296
Glucosamine,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01296
Fosphenytoin,Anticonvulsants,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinducer,DB01320
Fosphenytoin,Anticonvulsants,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinducer,DB01320
Fosphenytoin,Anticonvulsants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinducer,DB01320
Fosphenytoin,Anticonvulsants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01320
Fosphenytoin,Anticonvulsants,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB01320
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CYP2E1,Cytochrome P450 2E1,enzyme,,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01355
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP3A43,Cytochrome P450 3A43,enzyme,inducer,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP2C18,Cytochrome P450 2C18,enzyme,inhibitor,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01361
Mibefradil,,withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01388
Mibefradil,,withdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01388
Mibefradil,,withdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01388
Mibefradil,,withdrawn,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB01388
Mibefradil,,withdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB01388
Mibefradil,,withdrawn,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,inhibitor,DB01388
Mibefradil,,withdrawn,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,inhibitor,DB01388
Mibefradil,,withdrawn,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01388
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01392
Bezafibrate,Hypolipidemic Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB01393
Bezafibrate,Hypolipidemic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01393
Bezafibrate,Hypolipidemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01393
Colchicine,Gout SuppressantsTubulin Modulators,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitorinducer,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitorinducer,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB01394
Drospirenone,Mineralocorticoid Receptor Antagonists,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB01395
Drospirenone,Mineralocorticoid Receptor Antagonists,approved,BCHE,Cholinesterase,enzyme,substrate,DB01395
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01396
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,,DB01396
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01403
Danazol,,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB01406
Danazol,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01406
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB01407
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01407
Tiotropium,Cholinergic Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01409
Tiotropium,Cholinergic Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01409
Ciclesonide,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01410
Ciclesonide,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,,DB01410
Ciclesonide,,approvedinvestigational,CES1,Liver carboxylesterase 1,enzyme,substrate,DB01410
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,,DB01411
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01411
Theobromine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01412
Theobromine,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01412
Acenocoumarol,Anticoagulants,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01418
Acenocoumarol,Anticoagulants,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01418
Acenocoumarol,Anticoagulants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01418
Acenocoumarol,Anticoagulants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01418
Testosterone Propionate,,approved,COMT,Catechol O-methyltransferase,enzyme,inhibitor,DB01420
Testosterone Propionate,,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inducer,DB01420
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,substrate,DB01424
Aminophenazone,Pyrazolones,approvedwithdrawn,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01424
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinhibitor,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB01435
Glutethimide,Hypnotics and Sedatives,approvedillicit,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,inhibitor,DB01437
Glutethimide,Hypnotics and Sedatives,approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,inducer,DB01437
Bufotenine,,experimentalillicit,MAOA,Amine oxidase [flavin-containing] A,enzyme,,DB01445
Bufotenine,,experimentalillicit,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB01445
Ethylmorphine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01466
Ethylmorphine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,POR,NADPH--cytochrome P450 reductase,enzyme,,DB01466
Ethylmorphine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01466
Ethylmorphine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01466
Ethylmorphine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB01466
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,inhibitor,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inhibitor,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,inhibitor,DB01544
Dihydrocodeine,"Analgesics, Opioid",approvedexperimentalillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01551
Dihydrocodeine,"Analgesics, Opioid",approvedexperimentalillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01551
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01558
Clotiazepam,Benzodiazepines,approvedillicit,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01559
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01589
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01595
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01601
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01601
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitorinducer,DB01601
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01601
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB01601
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01601
Pipotiazine,Phenothiazines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01621
Pipotiazine,Phenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01621
Pipotiazine,Phenothiazines,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01621
Pipotiazine,Phenothiazines,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01621
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01623
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01623
Etoricoxib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01628
Etoricoxib,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB01628
Etoricoxib,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01628
Etoricoxib,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01628
Etoricoxib,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB01628
Etoricoxib,,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB01628
Rutin,,experimental,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01698
Rutin,,experimental,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01698
Rutin,,experimental,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01698
Rutin,,experimental,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01698
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,CYP3A7,Cytochrome P450 3A7,enzyme,substrateinhibitor,DB01708
Pyridoxine-5'-Phosphate,,experimental,PNPO,Pyridoxine-5'-phosphate oxidase,enzyme,,DB02209
Pyridoxine-5'-Phosphate,,experimental,,Pyridoxine 5'-phosphate phosphatase,enzyme,substrate,DB02209
Calcipotriol,Dermatologic AgentsAntipsoriatic Agents,approved,MPO,Myeloperoxidase,enzyme,inhibitor,DB02300
Calcipotriol,Dermatologic AgentsAntipsoriatic Agents,approved,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",enzyme,substrate,DB02300
Nicotinamide,,experimental,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB02701
Nicotinamide,,experimental,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB02701
Nicotinamide,,experimental,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB02701
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitorinducer,DB02709
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrateinhibitor,DB02709
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,CYP1B1,Cytochrome P450 1B1,enzyme,inhibitor,DB02709
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB02709
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,substrate,DB02901
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,substrate,DB02901
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,CYP19A1,Cytochrome P450 19A1,enzyme,substrate,DB02901
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP2A13,Cytochrome P450 2A13,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB03783
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB03783
Thiotepa,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB04572
Thiotepa,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04572
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04574
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB04574
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB04574
Aldosterone,,experimental,CYP11B1,"Cytochrome P450 11B1, mitochondrial",enzyme,substrate,DB04630
Aldosterone,,experimental,CYP11B2,"Cytochrome P450 11B2, mitochondrial",enzyme,substrate,DB04630
Aldosterone,,experimental,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,inducer,DB04630
Licofelone,,investigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB04725
Licofelone,,investigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB04725
Licofelone,,investigational,CYP2J2,Cytochrome P450 2J2,enzyme,substrate,DB04725
Licofelone,,investigational,CYP2B7,Cytochrome P450 2B7 isoform,enzyme,substrate,DB04725
Licofelone,,investigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB04725
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,ARSA,Arylsulfatase A,enzyme,inhibitor,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,PLA2G4A,Cytosolic phospholipase A2,enzyme,inhibitor,DB04786
Bifonazole,Antifungal Agents,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB04794
Bifonazole,Antifungal Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB04794
Bifonazole,Antifungal Agents,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB04794
Bifonazole,Antifungal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB04794
Metamizole,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB04817
Metamizole,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB04817
Ethyl carbamate,"Antineoplastic AgentsCarcinogensAnesthetics, Intravenous",withdrawn,PLA2G4A,Cytosolic phospholipase A2,enzyme,substrate,DB04827
Ethyl carbamate,"Antineoplastic AgentsCarcinogensAnesthetics, Intravenous",withdrawn,MPO,Myeloperoxidase,enzyme,inducer,DB04827
Ethyl carbamate,"Antineoplastic AgentsCarcinogensAnesthetics, Intravenous",withdrawn,AOX1,Aldehyde oxidase,enzyme,substrate,DB04827
Debrisoquin,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04840
Debrisoquin,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB04840
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB04841
Tetrabenazine,Adrenergic Uptake Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04844
Tetrabenazine,Adrenergic Uptake Inhibitors,approved,CBR1,Carbonyl reductase [NADPH] 1,enzyme,substrate,DB04844
Dronedarone,Anti-Arrhythmia Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB04855
Dexloxiglumide,,investigational,CYP3A5,Cytochrome P450 3A5,enzyme,,DB04856
Dexloxiglumide,,investigational,CYP3A4,Cytochrome P450 3A4,enzyme,,DB04856
Dexloxiglumide,,investigational,CYP2C9,Cytochrome P450 2C9,enzyme,,DB04856
Nilotinib,Antineoplastic Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,inducer,DB04868
Lorcaserin,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB04871
Lorcaserin,,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB04871
Lorcaserin,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB04871
Lorcaserin,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB04871
Lorcaserin,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04871
Lorcaserin,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04871
Lorcaserin,,approved,FMO1,Dimethylaniline monooxygenase [N-oxide-forming] 1,enzyme,substrate,DB04871
Lorcaserin,,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB04871
Bicifadine,,investigational,CYP2D6,Cytochrome P450 2D6,enzyme,,DB04889
Bicifadine,,investigational,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB04889
Tesmilifene,Antineoplastic AgentsPlatelet Aggregation InhibitorsHistamine Antagonists,investigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB04905
Tesmilifene,Antineoplastic AgentsPlatelet Aggregation InhibitorsHistamine Antagonists,investigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04905
Tesmilifene,Antineoplastic AgentsPlatelet Aggregation InhibitorsHistamine Antagonists,investigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB04905
Clevidipine,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB04920
Clevidipine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04920
Clevidipine,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB04920
Clevidipine,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB04920
Clevidipine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB04920
Clevidipine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB04920
Clevidipine,,approved,BCHE,Cholinesterase,enzyme,substrate,DB04920
Permethrin,,approvedinvestigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinducer,DB04930
Permethrin,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04930
Ospemifene,Estrogen Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04938
Ospemifene,Estrogen Antagonists,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB04938
Ospemifene,Estrogen Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB04938
Ospemifene,Estrogen Antagonists,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB04938
Iloperidone,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04946
Iloperidone,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04946
Iloperidone,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB04946
Iloperidone,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB04946
Iloperidone,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB04946
Iloperidone,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB04946
Ezogabine,Anticonvulsants,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB04953
Ezogabine,Anticonvulsants,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB04953
Ezogabine,Anticonvulsants,approved,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB04953
Ezogabine,Anticonvulsants,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB04953
Ezogabine,Anticonvulsants,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB04953
Ezogabine,Anticonvulsants,approved,NAT2,Arylamine N-acetyltransferase 2,enzyme,substrate,DB04953
Azimilide,Anti-Arrhythmia Agents,investigational,CYP1A1,Cytochrome P450 1A1,enzyme,,DB04957
Azimilide,Anti-Arrhythmia Agents,investigational,CYP3A4,Cytochrome P450 3A4,enzyme,,DB04957
Azimilide,Anti-Arrhythmia Agents,investigational,CYP3A5,Cytochrome P450 3A5,enzyme,,DB04957
Banoxantrone,Antineoplastic Agents,investigational,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB04975
Banoxantrone,Antineoplastic Agents,investigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04975
Banoxantrone,Antineoplastic Agents,investigational,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB04975
Aplidine,Antineoplastic Agents,investigational,CYP3A4,Cytochrome P450 3A4,enzyme,,DB04977
Aplidine,Antineoplastic Agents,investigational,CYP2A6,Cytochrome P450 2A6,enzyme,,DB04977
Aplidine,Antineoplastic Agents,investigational,CYP2E1,Cytochrome P450 2E1,enzyme,,DB04977
Aplidine,Antineoplastic Agents,investigational,CYP4A11,Cytochrome P450 4A11,enzyme,,DB04977
Indacaterol,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB05039
Indacaterol,,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB05039
Trabectedin,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB05109
Trabectedin,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB05109
Trabectedin,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB05109
Trabectedin,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB05109
Trabectedin,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB05109
Trabectedin,"Antineoplastic Agents, Alkylating",approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB05109
Rotigotine,Antidyskinetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB05271
Rotigotine,Antidyskinetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB05271
Rotigotine,Antidyskinetics,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB05271
Vandetanib,,approved,FMO1,Dimethylaniline monooxygenase [N-oxide-forming] 1,enzyme,substrate,DB05294
Vandetanib,,approved,FMO3,Dimethylaniline monooxygenase [N-oxide-forming] 3,enzyme,substrate,DB05294
Vandetanib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB05294
GTS-21,Nicotinic Agonists,investigational,CYP1A2,Cytochrome P450 1A2,enzyme,,DB05708
GTS-21,Nicotinic Agonists,investigational,CYP2E1,Cytochrome P450 2E1,enzyme,,DB05708
ado-trastuzumab emtansine,Antineoplastic AgentsTubulin ModulatorsMonoclonal antibodies,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB05773
ado-trastuzumab emtansine,Antineoplastic AgentsTubulin ModulatorsMonoclonal antibodies,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB05773
dehydroepiandrosterone sulfate,,investigational,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB05804
dehydroepiandrosterone sulfate,,investigational,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB05804
dehydroepiandrosterone sulfate,,investigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB05804
Abiraterone,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB05812
Abiraterone,,approved,SULT2A1,Bile salt sulfotransferase,enzyme,substrate,DB05812
Abiraterone,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB05812
Abiraterone,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB05812
substance P,,investigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB05875
substance P,,investigational,BCHE,Cholinesterase,enzyme,substrate,DB05875
substance P,,investigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB05875
Sertindole,Antipsychotic Agents,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06144
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB06148
Rufinamide,,approved,CES1,Liver carboxylesterase 1,enzyme,substrate,DB06201
Rufinamide,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB06201
Rufinamide,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB06201
Alogliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06203
Alogliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06203
Tapentadol,,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB06204
Tapentadol,,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB06204
Tapentadol,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB06204
Tapentadol,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06204
Tapentadol,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB06204
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06207
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB06207
Prasugrel,Platelet Aggregation Inhibitors,approved,,Cocaine esterase,enzyme,substrate,DB06209
Prasugrel,Platelet Aggregation Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06209
Prasugrel,Platelet Aggregation Inhibitors,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB06209
Prasugrel,Platelet Aggregation Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06209
Prasugrel,Platelet Aggregation Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB06209
Eltrombopag,Thrombopoietic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB06210
Eltrombopag,Thrombopoietic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB06210
Eltrombopag,Thrombopoietic Agents,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB06210
Eltrombopag,Thrombopoietic Agents,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB06210
Asenapine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06216
Asenapine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB06216
Asenapine,,approved,UGT1A4,UDP-glucuronosyltransferase 1-4,enzyme,substrate,DB06216
Asenapine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06216
Rivaroxaban,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06228
Rivaroxaban,,approved,CYP2J2,Cytochrome P450 2J2,enzyme,substrate,DB06228
Rivaroxaban,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06228
Udenafil,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06267
Udenafil,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06267
Sitaxentan,,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB06268
Sitaxentan,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB06268
Sitaxentan,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB06268
Temsirolimus,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB06287
Temsirolimus,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB06287
Temsirolimus,,approved,CYP3A7,Cytochrome P450 3A7,enzyme,substrate,DB06287
Temsirolimus,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB06287
SIMEPREVIR,Protease Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06290
SIMEPREVIR,Protease Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB06290
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,CYP2A6,Cytochrome P450 2A6,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB06292
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB06292
Saxagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06335
Saxagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06335
Etravirine,Reverse Transcriptase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB06414
Etravirine,Reverse Transcriptase Inhibitors,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB06414
Etravirine,Reverse Transcriptase Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB06414
Pazopanib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB06589
Pazopanib,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06589
Pazopanib,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB06589
Pazopanib,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06589
Agomelatine,Antidepressive Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB06594
Agomelatine,Antidepressive Agents,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB06594
Apixaban,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06605
Apixaban,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06605
Apixaban,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB06605
Apixaban,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06605
Apixaban,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB06605
Apixaban,,approved,CYP2J2,Cytochrome P450 2J2,enzyme,substrate,DB06605
Apixaban,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06605
Axitinib,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06626
Axitinib,,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06626
Axitinib,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06626
Axitinib,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB06626
Axitinib,,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB06626
Liraglutide,,approved,DPP4,Dipeptidyl peptidase 4,enzyme,substrate,DB06655
Liraglutide,,approved,MME,Neprilysin,enzyme,substrate,DB06655
Vilazodone,Serotonin Uptake InhibitorsSerotonin Receptor AgonistsAntidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06684
Vilazodone,Serotonin Uptake InhibitorsSerotonin Receptor AgonistsAntidepressive Agents,approved,CYP2C18,Cytochrome P450 2C18,enzyme,substrate,DB06684
Vilazodone,Serotonin Uptake InhibitorsSerotonin Receptor AgonistsAntidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06684
Dabigatran etexilate,Antithrombins,approved,CES1,Liver carboxylesterase 1,enzyme,substrate,DB06695
Dabigatran etexilate,Antithrombins,approved,,Cocaine esterase,enzyme,substrate,DB06695
Dabigatran etexilate,Antithrombins,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB06695
Dabigatran etexilate,Antithrombins,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,,DB06695
Dabigatran etexilate,Antithrombins,approved,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB06695
Dabigatran etexilate,Antithrombins,approved,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,inhibitor,DB06695
Artemether,Antifungal AgentsAntimalarialsAntiprotozoal AgentsCoccidiostatsSchistosomicides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB06697
Artemether,Antifungal AgentsAntimalarialsAntiprotozoal AgentsCoccidiostatsSchistosomicides,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06697
Artemether,Antifungal AgentsAntimalarialsAntiprotozoal AgentsCoccidiostatsSchistosomicides,approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrateinducer,DB06697
Artemether,Antifungal AgentsAntimalarialsAntiprotozoal AgentsCoccidiostatsSchistosomicides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06697
Artemether,Antifungal AgentsAntimalarialsAntiprotozoal AgentsCoccidiostatsSchistosomicides,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinducer,DB06697
Artemether,Antifungal AgentsAntimalarialsAntiprotozoal AgentsCoccidiostatsSchistosomicides,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06697
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06702
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06702
Lumefantrine,Antimalarials,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06708
Lumefantrine,Antimalarials,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB06708
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB06710
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB06710
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06710
Nilvadipine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB06712
Nilvadipine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB06712
Nilvadipine,,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB06712
Nilvadipine,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB06712
Nilvadipine,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB06712
Nilvadipine,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB06712
Nilvadipine,,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB06712
Sulfaphenazole,Anti-Bacterial AgentsAnti-Infective AgentsSulfonamides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB06729
Sulfaphenazole,Anti-Bacterial AgentsAnti-Infective AgentsSulfonamides,approved,CYP2A6,Cytochrome P450 2A6,enzyme,inhibitor,DB06729
Sulfaphenazole,Anti-Bacterial AgentsAnti-Infective AgentsSulfonamides,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB06729
Sulfaphenazole,Anti-Bacterial AgentsAnti-Infective AgentsSulfonamides,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB06729
Sulfaphenazole,Anti-Bacterial AgentsAnti-Infective AgentsSulfonamides,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB06729
Gestodene,"Contraceptives, Oral, SyntheticProgestins",approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB06730
Gestodene,"Contraceptives, Oral, SyntheticProgestins",approved,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB06730
Seproxetine,,investigational,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB06731
Seproxetine,,investigational,CYP3A7,Cytochrome P450 3A7,enzyme,inhibitor,DB06731
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,PTGS1,Prostaglandin G/H synthase 1,enzyme,substrate,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB06738
Gavestinel,,investigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06741
Gavestinel,,investigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB06741
Gavestinel,,investigational,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB06741
Gavestinel,,investigational,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB06741
Gavestinel,,investigational,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB06741
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP1A1,Cytochrome P450 1A1,enzyme,,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,ALDH2,"Aldehyde dehydrogenase, mitochondrial",enzyme,substrate,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP2B6,Cytochrome P450 2B6,enzyme,substrate,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06770
Benzyl alcohol,"Anesthetics, LocalPediculicides",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06770
Cabazitaxel,Antineoplastic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06772
Cabazitaxel,Antineoplastic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB06772
Cabazitaxel,Antineoplastic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB06772
Chenodeoxycholic acid,Gastrointestinal AgentsCathartics,approved,CYP27A1,"Sterol 26-hydroxylase, mitochondrial",enzyme,substrate,DB06777
Chenodeoxycholic acid,Gastrointestinal AgentsCathartics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06777
Chenodeoxycholic acid,Gastrointestinal AgentsCathartics,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,inhibitor,DB06777
Niclosamide,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB06803
Niclosamide,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB06803
Nandrolone decanoate,Anabolic Agents,approvedillicit,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB08804
Nandrolone decanoate,Anabolic Agents,approvedillicit,MAOB,Amine oxidase [flavin-containing] B,enzyme,inhibitor,DB08804
Nandrolone decanoate,Anabolic Agents,approvedillicit,MAOA,Amine oxidase [flavin-containing] A,enzyme,inhibitor,DB08804
Vismodegib,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB08828
Vismodegib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08828
Vismodegib,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB08828
Vismodegib,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB08828
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 3A1,enzyme,inducer,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 3A2,enzyme,inducer,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 2A1,enzyme,inducer,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 2A2,enzyme,inducer,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 2B1,enzyme,inducer,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 2B2,enzyme,inducer,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,,Cytochrome P450 2B9,enzyme,inducer,DB08834
Ellagic Acid,Antineoplastic Agents,investigational,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitorinducer,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitor,DB08846
Pitavastatin,Hypolipidemic Agents,approved,UGT2B7,UDP-glucuronosyltransferase 2B7,enzyme,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB08860
Rilpivirine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitorinducer,DB08864
Rilpivirine,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB08864
Rilpivirine,,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB08864
Rilpivirine,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB08864
Crizotinib,Protein Kinase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB08865
Crizotinib,Protein Kinase Inhibitors,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB08865
Fingolimod,,approvedinvestigational,,Leukotriene-B(4) omega-hydroxylase 1,enzyme,substrate,DB08868
Fingolimod,,approvedinvestigational,,Sphingosine kinase 1,enzyme,substrate,DB08868
Fingolimod,,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB08868
Fingolimod,,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB08868
Fingolimod,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08868
Fingolimod,,approvedinvestigational,,Cytochrome P450 4F12,enzyme,substrate,DB08868
Brentuximab vedotin,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB08870
Brentuximab vedotin,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB08870
Boceprevir,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB08873
Boceprevir,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrateinhibitor,DB08873
Cabozantinib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08875
Cabozantinib,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB08875
Vemurafenib,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB08881
Vemurafenib,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB08881
Vemurafenib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB08881
Perampanel,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB08883
Perampanel,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB08883
Mirabegron,"Muscle Relaxants, Genitourinary",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08893
Mirabegron,"Muscle Relaxants, Genitourinary",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB08893
Mirabegron,"Muscle Relaxants, Genitourinary",approved,BCHE,Cholinesterase,enzyme,substrate,DB08893
Tofacitinib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08895
Tofacitinib,,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB08895
Regorafenib,Antineoplastic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrateinhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inhibitor,DB08896
Enzalutamide,Antineoplastic Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB08899
Enzalutamide,Antineoplastic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB08899
Enzalutamide,Antineoplastic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB08899
Enzalutamide,Antineoplastic Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inducer,DB08899
Enzalutamide,Antineoplastic Agents,approved,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB08899
Enzalutamide,Antineoplastic Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB08899
Enzalutamide,Antineoplastic Agents,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inhibitor,DB08899
Ponatinib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08901
Ponatinib,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrateinhibitor,DB08901
Ponatinib,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB08901
Ponatinib,,approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB08901
Canagliflozin,Antidiabetic Agents,approved,UGT1A9,UDP-glucuronosyltransferase 1-9,enzyme,substrate,DB08907
Canagliflozin,Antidiabetic Agents,approved,UGT2B4,UDP-glucuronosyltransferase 2B4,enzyme,substrate,DB08907
Canagliflozin,Antidiabetic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08907
Pomalidomide,Immunosuppressive Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB08910
Pomalidomide,Immunosuppressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08910
Trametinib,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB08911
Trametinib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB08911
Dabrafenib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB08912
Dabrafenib,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB08912
Levomilnacipran,Serotonin Uptake Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08918
Levomilnacipran,Serotonin Uptake Inhibitors,approved,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB08918
Levomilnacipran,Serotonin Uptake Inhibitors,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB08918
Levomilnacipran,Serotonin Uptake Inhibitors,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB08918
Levomilnacipran,Serotonin Uptake Inhibitors,approved,CYP2J2,Cytochrome P450 2J2,enzyme,substrate,DB08918
Dolutegravir,,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB08930
Dolutegravir,,approved,,"POU domain, class 2, transcription factor 2",enzyme,inhibitor,DB08930
Dolutegravir,,approved,CYP3A4,CYP3A,enzyme,substrate,DB08930
MACITENTAN,Vasodilator Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08932
MACITENTAN,Vasodilator Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB08932
LULICONAZOLE,Antifungal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB08933
LULICONAZOLE,Antifungal Agents,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB08933
Etanercept,Immunosuppressive Agents,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB00005
Bivalirudin,Antithrombins,approvedinvestigational,MPO,Myeloperoxidase,enzyme,inhibitor,DB00006
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00030
Insulin Lispro,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00046
Insulin Glargine,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00047
"Insulin, porcine",Hypoglycemic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB00071
Trastuzumab,Antineoplastic Agents,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00072
Streptokinase,Fibrinolytic AgentsThrombolytic Agents,approved,PLA2G4A,Cytosolic phospholipase A2,enzyme,inducer,DB00086
Octreotide,"Antineoplastic Agents, HormonalGastrointestinal AgentsHormone Replacement Agents",approvedinvestigational,MPO,Myeloperoxidase,enzyme,inhibitor,DB00104
Oxytocin,OxytocicsAnti-tocolytic AgentsLabor Induction Agents,approved,PREP,Prolyl endopeptidase,enzyme,substrate,DB00107
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MMAB,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",enzyme,substrate,DB00115
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,CYP1B1,Cytochrome P450 1B1,enzyme,inducer,DB00121
Thiamine,Vitamin B ComplexVitamins,approvednutraceutical,CYP4B1,Cytochrome P450 4B1,enzyme,inducer,DB00152
Pyridoxine,Vitamin B ComplexVitamins,approvednutraceutical,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB00165
Lipoic Acid,Vitamin B ComplexAntioxidantsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,POR,NADPH--cytochrome P450 reductase,enzyme,inhibitor,DB00166
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ADK,Adenosine kinase,enzyme,substrate,DB00171
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PRODH,"Proline dehydrogenase 1, mitochondrial",enzyme,substrate,DB00172
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,inhibitor,DB00173
Valsartan,Angiotensin Receptor Antagonists,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00177
Ramipril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00178
Masoprocol,Antineoplastic AgentsAntioxidantsCyclooxygenase InhibitorsLipoxygenase Inhibitors,approved,CYP2J2,Cytochrome P450 2J2,enzyme,inhibitor,DB00179
Flunisolide,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00180
Pentagastrin,Diagnostic Agents,approved,BCHE,Cholinesterase,enzyme,inducer,DB00183
Lorazepam,Hypnotics and SedativesBenzodiazepines,approved,,UDP-glucuronosyltransferase 2B15,enzyme,substrate,DB00186
Vidarabine,Antiviral AgentsAntimetabolites,approved,ADA,Adenosine deaminase,enzyme,substrate,DB00194
Succinylcholine,"Neuromuscular Depolarizing AgentsMuscle relaxant, Skeletal",approved,BCHE,Cholinesterase,enzyme,substrate,DB00202
Dofetilide,Anti-Arrhythmia AgentsPotassium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00204
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB00206
Trospium,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00209
Midodrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00211
Glimepiride,Hypoglycemic AgentsImmunosuppressive AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00222
Enflurane,"Anesthetics, InhalationAnesthetics",approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB00228
Aminosalicylic Acid,Antitubercular Agents,approved,MPO,Myeloperoxidase,enzyme,inhibitor,DB00233
Alclometasone,AntipruriticsCorticosteroids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00240
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,substrate,DB00242
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00248
Doxycycline,Anti-Bacterial AgentsAntimalarialsTetracyclines,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00254
Cycloserine,"AntimetabolitesAnti-Infective Agents, UrinaryAntibiotics, AntitubercularAntibiotics",approved,DDC,Aromatic-L-amino-acid decarboxylase,enzyme,inhibitor,DB00260
Anagrelide,Antithrombins,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00261
Carmustine,"Antineoplastic Agents, Alkylating",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00262
Sulfisoxazole,Anti-Infective AgentsSulfonamides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00263
Dicoumarol,AnticoagulantsEnzyme InhibitorsUncoupling Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB00266
Chlorotrianisene,"Antineoplastic Agents, HormonalEstrogens, Non-Steroidal",withdrawn,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB00269
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00270
Amsacrine,Antineoplastic AgentsIntercalating Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00276
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00280
Bleomycin,"Antibiotics, Antineoplastic",approved,,Bleomycin hydrolase,enzyme,substrate,DB00290
Chlorambucil,"Antineoplastic Agents, Alkylating",approved,GSTP1,Glutathione S-transferase P,enzyme,substrate,DB00291
Etonogestrel,Contraceptive Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00294
Flucloxacillin,Anti-Bacterial AgentsPenicillins,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00301
Mitomycin,"Nucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAlkylating AgentsCross-Linking Reagents",approved,POR,NADPH--cytochrome P450 reductase,enzyme,substrate,DB00305
Vindesine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00309
Dihydroergotamine,"Vasoconstrictor AgentsDopamine AgonistsAnalgesics, Non-NarcoticAnti-migraine Agents",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00320
Floxuridine,"Antineoplastic AgentsAntimetabolites, Antineoplastic",approved,TYMP,Thymidine phosphorylase,enzyme,substrate,DB00322
Tolcapone,Antidyskinetics,approvedwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00323
Fluorometholone,Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinducer,DB00324
Pimecrolimus,"Anti-Inflammatory Agents, Non-SteroidalDermatologic AgentsImmunosuppressive Agents",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00337
Protriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00344
Alfuzosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor Antagonists,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00346
Tioguanine,"Antimetabolites, Antineoplastic",approved,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,enzyme,substrate,DB00352
Methylergometrine,Oxytocics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00353
Tetrahydrobiopterin,Dietary SupplementsSupplements,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB00360
Doxylamine,Histamine H1 AntagonistsAntiemetics,approved,CYP2B,CYP2B protein,enzyme,inducer,DB00366
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00368
Cidofovir,Antineoplastic AgentsAntiviral AgentsAnti-HIV AgentsRadiation-Sensitizing Agents,approved,TYMP,Thymidine phosphorylase,enzyme,inhibitor,DB00369
Treprostinil,AntithrombinsAnticoagulants,approvedinvestigational,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00374
Tacrine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,withdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00382
Triamterene,DiureticsEpithelial Sodium Channel Blockers,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00384
Carbimazole,Antithyroid Agents,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00389
Sulpiride,"Antidepressive Agents, Second-GenerationAntipsychotic AgentsDopamine AntagonistsAntidepressive Agents",approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00391
Ethopropazine,Muscarinic AntagonistsHistamine AntagonistsAdrenergic AntagonistsAntidyskinetics,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00392
Beclomethasone,Anti-Arrhythmia AgentsCorticosteroids,approvedinvestigational,CYP3A5,Cytochrome P450 3A5,enzyme,inducer,DB00394
Carisoprodol,"Muscle Relaxants, CentralNeuromuscular AgentsMuscle relaxant, Skeletal",approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00395
Remoxipride,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00409
Carbachol,"Cardiotonic AgentsAnalgesics, Non-NarcoticCholinergic AgonistsMiotics",approved,PLA2G4A,Cytosolic phospholipase A2,enzyme,inducer,DB00411
Acetohexamide,Hypoglycemic AgentsAntidiabetic Agents,withdrawn,CBR1,Carbonyl reductase [NADPH] 1,enzyme,substrate,DB00414
Triprolidine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00427
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,UGT1A3,UDP-glucuronosyltransferase 1-3,enzyme,substrate,DB00434
Bendroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,TPMT,Thiopurine S-methyltransferase,enzyme,inhibitor,DB00436
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,substrate,DB00457
Acitretin,Keratolytic Agents,approved,CYP26A1,Cytochrome P450 26A1,enzyme,substrate,DB00459
Enoxacin,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00467
Tenoxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00469
Brimonidine,Antihypertensive AgentsAdrenergic alpha-2 Receptor AgonistsEENT Preparations,approved,AOX1,Aldehyde oxidase,enzyme,substrate,DB00484
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00485
Pefloxacin,Nucleic Acid Synthesis InhibitorsAnti-Infective Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00487
Miglitol,,approved,AMY2A,Pancreatic alpha-amylase,enzyme,,DB00491
Triflupromazine,Antipsychotic Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00508
Aminocaproic Acid,,approvedinvestigational,AOX1,Aldehyde oxidase,enzyme,substrate,DB00513
Trandolapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,CES1,Liver carboxylesterase 1,enzyme,substrate,DB00519
Caspofungin,Antifungal Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00520
Carteolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00521
Alitretinoin,Antineoplastic Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00523
Cinchocaine,"Anesthetics, Local",approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00527
Benazepril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,MTHFR,Methylenetetrahydrofolate reductase,enzyme,substrate,DB00542
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00543
Pyridostigmine,Antimyasthenic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00545
Hydroxyzine,Hypnotics and SedativesAntipruriticsHistamine H1 Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00557
Atropine,"Anti-Arrhythmia AgentsBronchodilator AgentsMuscarinic AntagonistsParasympatholyticsAdjuvants, AnesthesiaMydriatics",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00572
Fenfluramine,Serotonin Uptake InhibitorsAppetite DepressantsSerotonin Receptor AgonistsSerotonin AgentsStimulants,illicitwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00574
Sulfamethizole,Anti-Infective Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00576
Carbenicillin,Anti-Bacterial AgentsPenicillins,approved,PLA2G4A,Cytosolic phospholipase A2,enzyme,inhibitor,DB00578
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00584
Nizatidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00585
Fluocinolone Acetonide,Anti-Inflammatory AgentsGlucocorticoids,approvedinvestigational,PLA2G4A,Cytosolic phospholipase A2,enzyme,inhibitor,DB00591
Piperazine,Antinematodal Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00592
Labetalol,Antihypertensive AgentsSympathomimeticsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB00598
Ivermectin,InsecticidesAntiparasitic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00602
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00627
Clorazepate,,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00628
Guanabenz,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00629
Clofarabine,Purine analogues,approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,substrate,DB00631
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00669
Isoflurophate,Cholinesterase InhibitorsProtease InhibitorsAnti-glaucoma AgentsOphthalmics,approvedwithdrawn,BCHE,Cholinesterase,enzyme,inhibitor,DB00677
Tobramycin,Anti-Bacterial AgentsAminoglycosides,approvedinvestigational,aac,Aminoglycoside 2'-N-acetyltransferase,enzyme,substrate,DB00684
Fluorescein,Contrast MediaFluorescent Dyes,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00693
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",enzyme,inhibitor,DB00695
Tizanidine,"AnalgesicsAnticonvulsantsParasympatholyticsMuscle Relaxants, CentralAdrenergic alpha-2 Receptor AgonistsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00697
Nitrofurantoin,"Anti-Infective AgentsAnti-Infective Agents, Urinary",approved,POR,NADPH--cytochrome P450 reductase,enzyme,substrate,DB00698
Nicergoline,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00699
Icodextrin,"Dialysis SolutionsDiuretics, Osmotic",approvedinvestigational,AMY2A,Pancreatic alpha-amylase,enzyme,substrate,DB00702
Naltrexone,Appetite DepressantsNarcotic AntagonistsCentral Nervous System DepressantsAlcohol Antagonists,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB00704
Sufentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, Anesthesia",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00708
Diethylcarbamazine,Lipoxygenase InhibitorsFilaricides,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00711
Azatadine,Histamine H1 Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00719
Clodronate,Bone Density Conservation AgentsAntihypocalcemic AgentsBisphosphonates,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB00720
Procaine,"Anesthetics, Local",approvedinvestigational,BCHE,Cholinesterase,enzyme,inhibitor,DB00721
Nitroglycerin,Vasodilator AgentsExplosive Agents,approvedinvestigational,ALDH2,"Aldehyde dehydrogenase, mitochondrial",enzyme,substrate,DB00727
Meclizine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine AntagonistsAntiemetics,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB00737
Mannitol,"Sweetening AgentsDiuretics, Osmotic",approvedinvestigational,mtlD,Mannitol dehydrogenase,enzyme,substrate,DB00742
Deferoxamine,Chelating AgentsSiderophores,approvedinvestigational,XDH,Xanthine dehydrogenase/oxidase,enzyme,inhibitor,DB00746
Ethotoin,Anticonvulsants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00754
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00759
Meropenem,Anti-Bacterial Agents,approvedinvestigational,bla,Beta-lactamase OXA-10,enzyme,substrate,DB00760
Mometasone,,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB00764
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00768
Hydrocortamate,Anti-Inflammatory AgentsCorticosteroids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00769
Nalidixic Acid,Anti-Bacterial Agents,approved,TDO2,"Tryptophan 2,3-dioxygenase",enzyme,inhibitor,DB00779
Perindopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00790
Tripelennamine,Anti-Allergic AgentsHistamine Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00792
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,CYP3A5,Cytochrome P450 3A5,enzyme,substrate,DB00795
Tazarotene,Dermatologic AgentsKeratolytic AgentsTeratogensProdrugs,approvedinvestigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB00799
Dicyclomine,Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodics,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inducer,DB00804
Minaprine,Antidepressive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00805
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00806
Indapamide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00808
Biperiden,Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00810
Ribavirin,Antiviral AgentsAntimetabolites,approved,ADK,Adenosine kinase,enzyme,substrate,DB00811
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB00819
Tadalafil,Vasodilator AgentsPhosphodiesterase 5 Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00820
Phensuximide,Anticonvulsants,approved,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00832
Cefaclor,Anti-Bacterial AgentsCephalosporins,approved,MPO,Myeloperoxidase,enzyme,inducer,DB00833
Dobutamine,SympathomimeticsCardiotonic AgentsAdrenergic beta-1 Receptor Agonists,approved,COMT,Catechol O-methyltransferase,enzyme,substrate,DB00841
Clofazimine,"Anti-Inflammatory Agents, Non-SteroidalLeprostatic AgentsColoring AgentsAntimycobacterialsDyes",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00845
Cysteamine,Radiation-Protective AgentsOphthalmics,approvedinvestigational,MPO,Myeloperoxidase,enzyme,substrate,DB00847
Temozolomide,"Antineoplastic Agents, Alkylating",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB00853
Drostanolone,,approvedillicit,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB00858
Diflunisal,"Anti-Inflammatory Agents, Non-Steroidal",approved,UGT1A8,UDP-glucuronosyltransferase 1-8,enzyme,substrate,DB00861
Alprenolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00866
Ritodrine,SympathomimeticsAdrenergic beta-2 Receptor AgonistsTocolytic Agents,approved,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",enzyme,inhibitor,DB00867
Terbutaline,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB00871
Conivaptan,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00872
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,DDC,Aromatic-L-amino-acid decarboxylase,enzyme,inducer,DB00875
Eprosartan,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00876
Emtricitabine,,approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,substrate,DB00879
Risedronate,Bone Density Conservation AgentsCalcium Channel BlockersAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB00884
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB00887
Sulfapyridine,Dermatologic AgentsAnti-Infective AgentsSulfonamides,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB00891
Oxybuprocaine,"Anesthetics, Local",approved,BCHE,Cholinesterase,enzyme,substrate,DB00892
Ethacrynic acid,Enzyme InhibitorsDiuretics,approved,GSTA2,Glutathione S-transferase A2,enzyme,inhibitor,DB00903
Tiagabine,AnticonvulsantsNeurotransmitter Uptake InhibitorsGABA Agonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00906
Tinidazole,Antiprotozoal AgentsAnti-Infective Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00911
Phenformin,Hypoglycemic Agents,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00914
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00925
Famotidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB00927
Azacitidine,"Enzyme InhibitorsAntimetabolites, Antineoplastic",approvedinvestigational,CDA,Cytidine deaminase,enzyme,substrate,DB00928
Mesoridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB00933
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00936
Fulvestrant,"Antineoplastic AgentsAntineoplastic Agents, HormonalEstrogen Antagonists",approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB00947
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB00950
Naratriptan,Serotonin AntagonistsSerotonin Receptor Agonists,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,enzyme,substrate,DB00952
Methylprednisolone,Anti-Inflammatory AgentsGlucocorticoidsNeuroprotective AgentsAntiemetics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB00959
Pindolol,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitorinducer,DB00960
Bromfenac,,approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB00963
Telmisartan,,approvedinvestigational,CYP2C19,Cytochrome P450 2C19,enzyme,inhibitor,DB00966
Methyldopa,Antihypertensive AgentsSympatholyticsAdrenergic alpha-2 Receptor Agonists,approved,COMT,Catechol O-methyltransferase,enzyme,substrate,DB00968
Lomefloxacin,Anti-Infective Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB00978
Cyclopentolate,Muscarinic AntagonistsParasympatholyticsMydriatics,approved,BCHE,Cholinesterase,enzyme,substrate,DB00979
Nandrolone phenpropionate,Anabolic Agents,approvedillicit,CYP19A1,Cytochrome P450 19A1,enzyme,substrate,DB00984
Oxaprozin,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB00991
Gabapentin,Anti-Anxiety AgentsAntiparkinson AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersAntimanic AgentsExcitatory Amino Acid Antagonists,approvedinvestigational,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",enzyme,inhibitor,DB00996
Frovatriptan,Serotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB00998
Salbutamol,Adrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01001
Hydroxyurea,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis InhibitorsAntisickling Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01005
Balsalazide,"Anti-Inflammatory Agents, Non-SteroidalGastrointestinal Agents",approvedinvestigational,azr,NADPH azoreductase,enzyme,substrate,DB01014
Isosorbide Mononitrate,Vasodilator AgentsNitric Oxide Donors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01020
Trichlormethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,TPMT,Thiopurine S-methyltransferase,enzyme,inhibitor,DB01021
Topotecan,Topoisomerase I Inhibitors,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitorinducer,DB01030
Lubiprostone,Laxatives,approvedinvestigational,CBR1,Carbonyl reductase [NADPH] 1,enzyme,substrate,DB01046
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01049
Tocainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersSodium Channel Blockers,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01056
Amoxicillin,Anti-Bacterial AgentsPenicillins,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrate,DB01060
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01064
Benzocaine,"Anesthetics, Local",approved,CES1,Liver carboxylesterase 1,enzyme,inhibitor,DB01086
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,CYP1A1,Cytochrome P450 1A1,enzyme,inhibitor,DB01092
Hesperetin,,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01094
Oxamniquine,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01096
Sibutramine,Appetite DepressantsAntidepressive AgentsStimulants,approvedillicitinvestigationalwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01105
Methyprylon,Hypnotics and Sedatives,approvedillicitwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01107
Heparin,Fibrinolytic AgentsAnticoagulantsHeparins,approvedinvestigational,HPSE,Heparanase,enzyme,substrate,DB01109
Trimethaphan,"Antihypertensive AgentsAdjuvants, AnesthesiaNicotinic AntagonistsGanglionic Blockers",approved,BCHE,Cholinesterase,enzyme,,DB01116
Atovaquone,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01117
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,GLUL,Glutamine synthetase,enzyme,inhibitor,DB01119
Ambenonium,Anti-Arrhythmia AgentsAntimyasthenic Agents,approved,BCHE,Cholinesterase,enzyme,,DB01122
Doxacurium chloride,,approved,BCHE,Cholinesterase,enzyme,substrate,DB01135
Amifostine,Radiation-Protective Agents,approvedinvestigational,ALPL,"Alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,DB01143
Diclofenamide,Carbonic Anhydrase InhibitorsAnti-glaucoma AgentsOphthalmics,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inducer,DB01144
Sertaconazole,Antifungal Agents,approved,CYP51A1,Lanosterol 14-alpha demethylase,enzyme,inhibitor,DB01153
Thiamylal,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01154
Chloroprocaine,"Anesthetics, Local",approved,BCHE,Cholinesterase,enzyme,substrate,DB01161
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,CYP1A2,Cytochrome P450 1A2,enzyme,inhibitor,DB01165
Guanethidine,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01170
Cyclizine,Histamine H1 AntagonistsAntiemetics,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01176
Clindamycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntibiotics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01190
Acebutolol,Antihypertensive AgentsSympathomimeticsAdrenergic beta-1 Receptor AntagonistsAnti-Arrhythmia Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01193
Brinzolamide,Anti-glaucoma AgentsOphthalmics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01194
Estramustine,"Antineoplastic Agents, HormonalAntineoplastic Agents, Alkylating",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01196
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01197
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,GLUL,Glutamine synthetase,enzyme,inducer,DB01212
Estazolam,,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01215
Dantrolene,"Muscle Relaxants, Central",approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01219
Rifaximin,Gastrointestinal AgentsAnti-Infective Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01220
Budesonide,Corticosteroids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01222
Enoxaparin,Fibrinolytic AgentsAnticoagulantsHeparins,approved,MPO,Myeloperoxidase,enzyme,Other,DB01225
Encainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersSodium Channel Blockers,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01228
Epoprostenol,Platelet Aggregation InhibitorsAntihypertensive Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01240
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01244
Decamethonium,Neuromuscular Depolarizing Agents,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB01245
Alimemazine,Antipruritics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01246
Ergonovine,Oxytocics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01253
Retapamulin,Anti-Bacterial Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01256
Aliskiren,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01258
Decitabine,"Enzyme InhibitorsAntimetabolites, AntineoplasticTeratogens",approvedinvestigational,DCK,Deoxycytidine kinase,enzyme,,DB01262
Posaconazole,Antifungal Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01263
Darunavir,HIV Protease Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01264
Hydralazine,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01275
Rolitetracycline,Tetracyclines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01301
Oxtriphylline,Bronchodilator Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01303
Insulin Aspart,Hypoglycemic AgentsAntidiabetic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB01306
Insulin Detemir,Antidiabetic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB01307
Insulin Glulisine,Antidiabetic Agents,approved,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB01309
Fosamprenavir,Prodrugs,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01319
Josamycin,Anti-Bacterial AgentsMacrolides,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01321
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,TPMT,Thiopurine S-methyltransferase,enzyme,substrate,DB01327
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,penP,Beta-lactamase,enzyme,substrate,DB01331
Cefradine,Anti-Bacterial AgentsCephalosporins,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01333
Pancuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB01337
Pipecuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,BCHE,Cholinesterase,enzyme,inhibitor,DB01338
Tasosartan,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01349
Amobarbital,,approvedillicit,CYP2A6,Cytochrome P450 2A6,enzyme,inducer,DB01351
Mestranol,,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB01357
Ephedrine,,approved,BCHE,Cholinesterase,enzyme,substrate,DB01364
Rasagiline,Neuroprotective AgentsMonoamine Oxidase Inhibitors,approved,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01367
Quinupristin,Anti-Bacterial Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01369
Cortisone acetate,Corticosteroids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01380
Ginkgo biloba,,approvednutraceutical,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB01381
Paramethasone,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01384
Neostigmine,,approved,BCHE,Cholinesterase,enzyme,,DB01400
Temafloxacin,Anti-Bacterial Agents,withdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,substrateinhibitor,DB01405
Bambuterol,,approved,BCHE,Cholinesterase,enzyme,substrateinhibitor,DB01408
Ajmaline,Anti-Arrhythmia Agents,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01426
Aprindine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01429
Allylestrenol,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01431
4-Methoxyamphetamine,,experimentalillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01472
Ecgonine,,experimentalillicit,BCHE,Cholinesterase,enzyme,,DB01525
1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine,,experimentalillicit,CYP2D6,Cytochrome P450 2D6,enzyme,,DB01562
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01576
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB01577
Oxprenolol,Anti-Anxiety AgentsAntihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01580
Sulfamethazine,Sulfonamides,approved,nat,Arylamine N-acetyltransferase,enzyme,substrate,DB01582
Liotrix,Hormone Replacement Agents,approved,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB01583
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,CYP2E1,Cytochrome P450 2E1,enzyme,inhibitorinducer,DB01586
Ketazolam,Benzodiazepines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB01587
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01588
Everolimus,Immunosuppressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01590
Solifenacin,Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodics,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB01591
Deferasirox,Iron Chelating Agents,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,inducer,DB01609
Hydroxychloroquine,Antirheumatic AgentsEnzyme InhibitorsAntimalarials,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB01611
Amyl Nitrite,Vasodilator Agents,approved,ALDH2,"Aldehyde dehydrogenase, mitochondrial",enzyme,substrate,DB01612
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB01624
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,CYP1A2,Cytochrome P450 1A2,enzyme,substrate,DB01645
S-Adenosyl-L-Homocysteine,,experimental,HNMT,Histamine N-methyltransferase,enzyme,,DB01752
Dalfopristin,Anti-Bacterial Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB01764
3'-Phosphate-Adenosine-5'-Diphosphate,,experimental,aac,Aminoglycoside 2'-N-acetyltransferase,enzyme,,DB01842
"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB01922
Coenzyme A,,nutraceutical,aac,Aminoglycoside 2'-N-acetyltransferase,enzyme,,DB01992
Isatin,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB02095
Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,,experimental,CES1,Liver carboxylesterase 1,enzyme,,DB02161
N-Methyl-N-Propargyl-1(R)-Aminoindan,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB02211
"N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside",,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB02218
Beta-D-Glucose,,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB02379
2-Hydroxyethyl Disulfide,,experimental,GSTA1,Glutathione S-transferase A1,enzyme,,DB02486
4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,,experimental,CYP2C9,Cytochrome P450 2C9,enzyme,,DB02507
Farnesol,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB02509
2'-Deoxycytidine,,experimental,DCK,Deoxycytidine kinase,enzyme,,DB02594
"5-Chloro-6-[(2-Iminopyrrolidin-1-Yl)Methyl]Pyrimidine-2,4(1h,3h)-Dione",,experimental,TYMP,Thymidine phosphorylase,enzyme,,DB02631
Diethylphosphono Group,,experimental,BCHE,Cholinesterase,enzyme,,DB02811
Methylphosphinic Acid,,experimental,BCHE,Cholinesterase,enzyme,,DB02845
"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB02889
[(1e)-4-Phenylbut-1-Enyl]Benzene,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB02939
N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,,experimental,GSTA1,Glutathione S-transferase A1,enzyme,,DB02943
Pyroglutamic Acid,,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB03088
5-Hydroxymethyl-Chonduritol,,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB03092
Acetylcholine,Vasodilator AgentsCholinergic AgonistsCholinergic Agents,experimental,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB03128
Flavin adenine dinucleotide,,approved,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB03147
"1-Beta-Ribofuranosyl-1,3-Diazepinone",,experimental,CDA,Cytidine deaminase,enzyme,,DB03185
Riboflavin Monophosphate,,experimental,POR,NADPH--cytochrome P450 reductase,enzyme,,DB03247
"4,6-Dideoxy-4-Amino-Alpha-D-Glucose",,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB03439
"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB03495
"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",,experimental,CBR1,Carbonyl reductase [NADPH] 1,enzyme,,DB03556
Butanoic Acid,,experimental,BCHE,Cholinesterase,enzyme,,DB03568
Phencyclidine,Enzyme InhibitorsHallucinogensExcitatory Amino Acid Antagonists,illicit,CYP2B6,Cytochrome P450 2B6,enzyme,inhibitor,DB03575
S-Benzyl-Glutathione,,experimental,GSTA1,Glutathione S-transferase A1,enzyme,,DB03602
Ribostamycin,Anti-Bacterial AgentsAminoglycosides,experimental,aac,Aminoglycoside 2'-N-acetyltransferase,enzyme,,DB03615
Vanoxerine,Dopamine Uptake InhibitorsAppetite Depressants,experimental,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB03701
O-Sialic Acid,,experimental,CES1,Liver carboxylesterase 1,enzyme,,DB03721
6-Deoxy-Alpha-D-Glucose,,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB03773
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,BCHE,Cholinesterase,enzyme,,DB03814
2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,,experimental,ARSA,Arylsulfatase A,enzyme,,DB03821
Ethyl Dihydrogen Phosphate,,experimental,BCHE,Cholinesterase,enzyme,,DB03822
N-Propargyl-1(S)-Aminoindan,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB03894
Acarbose Derived Hexasaccharide,,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB03971
Glycerol,,experimental,CYP2E1,Cytochrome P450 2E1,enzyme,inducer,DB04077
S-Hexylglutathione,,experimental,GSTA1,Glutathione S-transferase A1,enzyme,,DB04132
Lauryl Dimethylamine-N-Oxide,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB04147
Quercetin,Antioxidants,experimental,CYP2C8,Cytochrome P450 2C8,enzyme,inhibitor,DB04216
Butyrylthiocholine,,experimental,BCHE,Cholinesterase,enzyme,,DB04250
Monoisopropyl Ester Phosphonic Acid Group,,experimental,BCHE,Cholinesterase,enzyme,,DB04251
5-Hydroxy-N-Propargyl-1(R)-Aminoindan,,experimental,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB04307
Inosine,,investigational,XDH,Xanthine dehydrogenase/oxidase,enzyme,substrateinducer,DB04335
"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",,experimental,AMY2A,Pancreatic alpha-amylase,enzyme,,DB04453
"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",,experimental,CBR1,Carbonyl reductase [NADPH] 1,enzyme,,DB04463
N-Methylnaloxonium,,experimental,CES1,Liver carboxylesterase 1,enzyme,,DB04509
Arachidonic Acid,,experimental,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB04557
Dantron,MutagensCathartics,investigationalwithdrawn,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB04816
Iproniazid,,withdrawn,MAOB,Amine oxidase [flavin-containing] B,enzyme,,DB04818
Zomepirac,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04828
Ticrynafen,Antihypertensive AgentsDiureticsUricosuric Agents,withdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,,DB04831
Methaqualone,,illicitwithdrawn,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04833
Maraviroc,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04835
Cyproterone acetate,,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,enzyme,inhibitor,DB04839
Ixabepilone,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB04845
Tirapazamine,Antineoplastic AgentsRadiation-Sensitizing Agents,investigational,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB04858
Nebivolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsVasodilator Agents,approvedinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB04861
Calanolide A,Anti-HIV AgentsReverse Transcriptase Inhibitors,investigational,CYP3A4,Cytochrome P450 3A4,enzyme,,DB04886
Ximelagatran,Antithrombins,approvedinvestigationalwithdrawn,CYP2C9,Cytochrome P450 2C9,enzyme,substrate,DB04898
Benzoxazinorifamycin,"Anti-Bacterial AgentsLeprostatic AgentsAntibiotics, Antitubercular",investigational,CYP3A4,Cytochrome P450 3A4,enzyme,,DB04934
Troxacitabine,Antineoplastic AgentsAnti-HIV Agents,investigational,DCK,Deoxycytidine kinase,enzyme,activator,DB04961
Duramycin,,investigational,PLA2G4A,Cytosolic phospholipase A2,enzyme,inhibitor,DB05029
Erdosteine,,investigational,ADA,Adenosine deaminase,enzyme,inhibitor,DB05057
Cimicoxib,,investigational,PTGS2,Prostaglandin G/H synthase 2,enzyme,inhibitor,DB05095
Elafin,,investigational,MPO,Myeloperoxidase,enzyme,inhibitor,DB05161
Sofalcone,,investigational,CBR1,Carbonyl reductase [NADPH] 1,enzyme,inhibitor,DB05197
RHIIP,,investigational,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB05215
Beraprost,,investigational,CYP2C8,Cytochrome P450 2C8,enzyme,substrate,DB05229
Methsuximide,AnticonvulsantsSuccinimides,approved,CYP2C19,Cytochrome P450 2C19,enzyme,substrateinhibitor,DB05246
inhaled insulin,,approvedinvestigational,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB05278
HIIP,,investigational,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB05283
recombinant human GM-CSF,,investigational,BCHE,Cholinesterase,enzyme,inhibitor,DB05386
corticotropin-releasing factor,,investigational,DBH,Dopamine beta-hydroxylase,enzyme,inducer,DB05394
Telaprevir,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB05521
Sulfathiazole,Anti-Infective Agents,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB06147
Sulfadimethoxine,Anti-Infective Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,inhibitor,DB06150
Rimonabant,,approvedinvestigational,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06155
Tolvaptan,Vasopressin receptor antagonists,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06212
Avanafil,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06237
Droxidopa,Antiparkinson Agents,approvedinvestigational,DDC,Aromatic-L-amino-acid decarboxylase,enzyme,substrate,DB06262
Bosutinib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06616
Dalfampridine,Potassium Channel Blockers,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB06637
Ethanolamine Oleate,Sclerosing Solutions,approved,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB06689
Mepyramine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB06691
Mevastatin,Antifungal AgentsAnti-Bacterial AgentsAnticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,experimental,CES1,Liver carboxylesterase 1,enzyme,inhibitor,DB06693
Desvenlafaxine,Serotonin Uptake InhibitorsNeurotransmitter Uptake InhibitorsAntidepressive Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB06700
Dexmethylphenidate,,approved,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB06701
Norelgestromin,"Contraceptive AgentsContraceptives, Oral, Combined",approved,STS,Steryl-sulfatase,enzyme,inhibitor,DB06713
Fospropofol,Hypnotics and Sedatives,approvedillicit,ALPL,"Alkaline phosphatase, tissue-nonspecific isozyme",enzyme,substrate,DB06716
Buserelin,,approved,CYP19A1,Cytochrome P450 19A1,enzyme,inducer,DB06719
Lornoxicam,"Anti-Inflammatory Agents, Non-Steroidal",approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB06725
Bufuralol,Adrenergic beta-Antagonists,experimentalinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB06726
Sparteine,OxytocicsAnti-Arrhythmia Agents,experimental,CYP2D6,Cytochrome P450 2D6,enzyme,substrateinhibitor,DB06727
Aniline,Carcinogens,experimental,CYP2E1,Cytochrome P450 2E1,enzyme,substrate,DB06728
beta-Naphthoflavone,Enzyme Inhibitors,experimental,CYP1A2,Cytochrome P450 1A2,enzyme,inducer,DB06732
Ambroxol,Expectorants,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB06742
Dalteparin,AntithrombinsFibrinolytic AgentsAnticoagulantsHeparins,approved,HPSE,Heparanase,enzyme,substrate,DB06779
Methylnaltrexone,Narcotic Antagonists,approved,CYP2D6,Cytochrome P450 2D6,enzyme,inhibitor,DB06800
Nonoxynol-9,Contraceptive Agents,approvedwithdrawn,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB06804
Pralatrexate,,approved,FPGS,"Folylpolyglutamate synthase, mitochondrial",enzyme,substrate,DB06813
Raltegravir,Anti-HIV Agents,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,enzyme,substrate,DB06817
Tinzaparin,AntithrombinsHeparins,approved,,A disintegrin and metalloproteinase with thrombospondin motifs 4,enzyme,inhibitor,DB06822
Ethyl biscoumacetate,Anticoagulants,withdrawn,GLUL,Glutamine synthetase,enzyme,inhibitor,DB08794
Sulfamoxole,Anti-Bacterial AgentsAnti-Infective Agents,approved,CYP2C9,Cytochrome P450 2C9,enzyme,substrateinhibitor,DB08798
Tofisopam,Antidepressive AgentsBenzodiazepines,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB08811
Lurasidone,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08815
Ticagrelor,Platelet Aggregation Inhibitors,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08816
Tafluprost,"Prostaglandins, SyntheticOphthalmics",approved,PTGS2,Prostaglandin G/H synthase 2,enzyme,inducer,DB08819
Ivacaftor,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrateinhibitor,DB08820
Deferiprone,Chelating AgentsIron Chelating Agents,approved,,UDP-glucuronosyltransferase 1-6,enzyme,substrate,DB08826
Lomitapide,Hypolipidemic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08827
Estradiol valerate/Dienogest,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08866
Ruxolitinib,,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08877
Aminopterin,Folic Acid Antagonists,investigationalwithdrawn,DHFR,Dihydrofolate reductase,enzyme,inhibitor,DB08878
Linagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,inhibitor,DB08882
Aclidinium,Muscarinic AntagonistsAntispasmodics,approved,BCHE,Cholinesterase,enzyme,substrate,DB08897
Bedaquiline,Antitubercular Agents,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08903
Fluticasone furoate,Corticosteroids,approved,CYP3A4,Cytochrome P450 3A4,enzyme,substrate,DB08906
Glycerol Phenylbutyrate,Ammonia Detoxicants,approved,PNLIP,Pancreatic triacylglycerol lipase,enzyme,substrate,DB08909
Zuclopenthixol acetate,,experimentalinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB08919
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,CYP2D6,Cytochrome P450 2D6,enzyme,substrate,DB08920
Cetuximab,Antineoplastic Agents,approved,EGFR,Epidermal growth factor receptor,target,antagonist,DB00002
Cetuximab,Antineoplastic Agents,approved,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,C1R,Complement C1r subcomponent,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,C1QA,Complement C1q subcomponent subunit A,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,C1QB,Complement C1q subcomponent subunit B,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,C1QC,Complement C1q subcomponent subunit C,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,C1S,Complement C1s subcomponent,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00002
Cetuximab,Antineoplastic Agents,approved,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00002
Denileukin diftitox,Antineoplastic Agents,approvedinvestigational,IL2RA,Interleukin-2 receptor subunit alpha,target,binder,DB00004
Denileukin diftitox,Antineoplastic Agents,approvedinvestigational,IL2RB,Interleukin-2 receptor subunit beta,target,agonist,DB00004
Denileukin diftitox,Antineoplastic Agents,approvedinvestigational,IL2RG,Cytokine receptor common subunit gamma,target,,DB00004
Etanercept,Immunosuppressive Agents,approvedinvestigational,TNF,Tumor necrosis factor,target,antibody,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,LTA,Lymphotoxin-alpha,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,C1S,Complement C1s subcomponent,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00005
Etanercept,Immunosuppressive Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00005
Peginterferon alfa-2a,Immunosuppressive Agents,approvedinvestigational,IFNAR2,Interferon alpha/beta receptor 2,target,agonist,DB00008
Peginterferon alfa-2a,Immunosuppressive Agents,approvedinvestigational,IFNAR1,Interferon alpha/beta receptor 1,target,agonist,DB00008
Alteplase,Thrombolytic Agents,approved,PLG,Plasminogen,target,activator,DB00009
Alteplase,Thrombolytic Agents,approved,FGA,Fibrinogen alpha chain,target,,DB00009
Alteplase,Thrombolytic Agents,approved,PLAUR,Urokinase plasminogen activator surface receptor,target,,DB00009
Alteplase,Thrombolytic Agents,approved,SERPINE1,Plasminogen activator inhibitor 1,target,,DB00009
Interferon alfa-n1,Antiviral AgentsImmunologic FactorsImmunosuppressive Agents,approved,IFNAR2,Interferon alpha/beta receptor 2,target,agonist,DB00011
Interferon alfa-n1,Antiviral AgentsImmunologic FactorsImmunosuppressive Agents,approved,IFNAR1,Interferon alpha/beta receptor 1,target,agonist,DB00011
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,PLG,Plasminogen,target,activator,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,PLAUR,Urokinase plasminogen activator surface receptor,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,PLAU,Urokinase-type plasminogen activator,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,PLAT,Tissue-type plasminogen activator,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,SERPINE1,Plasminogen activator inhibitor 1,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,SERPINB2,Plasminogen activator inhibitor 2,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,SERPINA5,Plasma serine protease inhibitor,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,LRP2,Low-density lipoprotein receptor-related protein 2,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,ST14,Suppressor of tumorigenicity 14 protein,target,,DB00013
Urokinase,Thrombolytic Agents,approvedinvestigationalwithdrawn,NID1,Nidogen-1,target,,DB00013
Goserelin,,approved,LHCGR,Lutropin-choriogonadotropic hormone receptor,target,agonist,DB00014
Goserelin,,approved,GNRHR,Gonadotropin-releasing hormone receptor,target,agonist,DB00014
Reteplase,Fibrinolytic AgentsThrombolytic Agents,approved,PLG,Plasminogen,target,activator,DB00015
Reteplase,Fibrinolytic AgentsThrombolytic Agents,approved,FGA,Fibrinogen alpha chain,target,,DB00015
Reteplase,Fibrinolytic AgentsThrombolytic Agents,approved,PLAUR,Urokinase plasminogen activator surface receptor,target,,DB00015
Reteplase,Fibrinolytic AgentsThrombolytic Agents,approved,SERPINE1,Plasminogen activator inhibitor 1,target,,DB00015
Interferon alfa-n3,Immunosuppressive Agents,approvedinvestigational,IFNAR1,Interferon alpha/beta receptor 1,target,agonist,DB00018
Interferon alfa-n3,Immunosuppressive Agents,approvedinvestigational,IFNAR2,Interferon alpha/beta receptor 2,target,agonist,DB00018
Pegfilgrastim,Immunosuppressive AgentsAntineutropenic Agents,approved,CSF3R,Granulocyte colony-stimulating factor receptor,target,agonist,DB00019
Pegfilgrastim,Immunosuppressive AgentsAntineutropenic Agents,approved,ELANE,Neutrophil elastase,target,,DB00019
Sargramostim,Immunosuppressive Agents,approvedinvestigational,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,target,agonist,DB00020
Sargramostim,Immunosuppressive Agents,approvedinvestigational,IL3RA,Interleukin-3 receptor subunit alpha,target,agonist,DB00020
Sargramostim,Immunosuppressive Agents,approvedinvestigational,CSF2RB,Cytokine receptor common subunit beta,target,agonist,DB00020
Sargramostim,Immunosuppressive Agents,approvedinvestigational,SDC2,Syndecan-2,target,agonist,DB00020
Sargramostim,Immunosuppressive Agents,approvedinvestigational,PRG2,Bone marrow proteoglycan,target,,DB00020
Peginterferon alfa-2b,Immunosuppressive Agents,approved,IFNAR1,Interferon alpha/beta receptor 1,target,agonist,DB00022
Peginterferon alfa-2b,Immunosuppressive Agents,approved,IFNAR2,Interferon alpha/beta receptor 2,target,agonist,DB00022
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,F10,Coagulation factor X,target,activator,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,F9,Coagulation factor IX,target,cofactor,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,VWF,von Willebrand factor,target,binder,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,PHYH,"Phytanoyl-CoA dioxygenase, peroxisomal",target,antagonist,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,ASGR2,Asialoglycoprotein receptor 2,target,binder,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,HSPA5,78 kDa glucose-regulated protein,target,chaperone,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,CALR,Calreticulin,target,chaperone,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,CANX,Calnexin,target,chaperone,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,LMAN1,Protein ERGIC-53,target,chaperone,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,LRP1,Prolow-density lipoprotein receptor-related protein 1,target,modulator,DB00025
Antihemophilic Factor,CoagulantsThrombotic Agents,approvedinvestigational,MCFD2,Multiple coagulation factor deficiency protein 2,target,modulator,DB00025
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR1B,High affinity immunoglobulin gamma Fc receptor IB,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,antagonist,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,C3,Complement C3,target,binder,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,C4A,Complement C4-A,target,binder,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,C4B,Complement C4-B,target,binder,DB00028
Intravenous Immunoglobulin,Immunologic FactorsImmunosuppressive AgentsAnti-Infective Agents,approvedinvestigational,C5,Complement C5,target,binder,DB00028
Anistreplase,Fibrinolytic AgentsThrombolytic Agents,approved,PLG,Plasminogen,target,activator,DB00029
Anistreplase,Fibrinolytic AgentsThrombolytic Agents,approved,FGA,Fibrinogen alpha chain,target,,DB00029
Anistreplase,Fibrinolytic AgentsThrombolytic Agents,approved,PLAUR,Urokinase plasminogen activator surface receptor,target,,DB00029
Anistreplase,Fibrinolytic AgentsThrombolytic Agents,approved,SERPINE1,Plasminogen activator inhibitor 1,target,,DB00029
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,INSR,Insulin receptor,target,agonist,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,IGF1R,Insulin-like growth factor 1 receptor,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,RB1,Retinoblastoma-associated protein,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,CTSD,Cathepsin D,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,IDE,Insulin-degrading enzyme,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,PCSK2,Neuroendocrine convertase 2,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,CPE,Carboxypeptidase E,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,PCSK1,Neuroendocrine convertase 1,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,NOV,Protein NOV homolog,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,LRP2,Low-density lipoprotein receptor-related protein 2,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,IGFBP7,Insulin-like growth factor-binding protein 7,target,,DB00030
Insulin Regular,Antidiabetic Agents,approvedexperimentalinvestigational,SYTL4,Synaptotagmin-like protein 4,target,,DB00030
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,PLG,Plasminogen,target,activator,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,FGA,Fibrinogen alpha chain,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,PLAUR,Urokinase plasminogen activator surface receptor,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,SERPINE1,Plasminogen activator inhibitor 1,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,SERPINB2,Plasminogen activator inhibitor 2,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,CLEC3B,Tetranectin,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,KRT8,"Keratin, type II cytoskeletal 8",target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,ANXA2,Annexin A2,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,CALR,Calreticulin,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,CANX,Calnexin,target,,DB00031
Tenecteplase,Fibrinolytic AgentsThrombolytic Agents,approved,LRP1,Prolow-density lipoprotein receptor-related protein 1,target,,DB00031
Menotropins,"Fertility Agents, FemaleFertility Agents",approved,FSHR,Follicle-stimulating hormone receptor,target,binder,DB00032
Menotropins,"Fertility Agents, FemaleFertility Agents",approved,LHCGR,Lutropin-choriogonadotropic hormone receptor,target,,DB00032
Interferon gamma-1b,Immunosuppressive Agents,approvedinvestigational,IFNGR1,Interferon gamma receptor 1,target,binder,DB00033
Interferon gamma-1b,Immunosuppressive Agents,approvedinvestigational,IFNGR2,Interferon gamma receptor 2,target,binder,DB00033
"Interferon Alfa-2a, Recombinant",,approved,IFNAR1,Interferon alpha/beta receptor 1,target,,DB00034
"Interferon Alfa-2a, Recombinant",,approved,IFNAR2,Interferon alpha/beta receptor 2,target,,DB00034
Desmopressin,Antidiuretic AgentsHemostaticsRenal Agents,approved,AVPR2,Vasopressin V2 receptor,target,agonist,DB00035
Desmopressin,Antidiuretic AgentsHemostaticsRenal Agents,approved,AVPR1A,Vasopressin V1a receptor,target,,DB00035
Desmopressin,Antidiuretic AgentsHemostaticsRenal Agents,approved,AVPR1B,Vasopressin V1b receptor,target,,DB00035
Coagulation factor VIIa,CoagulantsThrombotic Agents,approved,F10,Coagulation factor X,target,,DB00036
Coagulation factor VIIa,CoagulantsThrombotic Agents,approved,HPN,Serine protease hepsin,target,,DB00036
Coagulation factor VIIa,CoagulantsThrombotic Agents,approved,TFPI,Tissue factor pathway inhibitor,target,,DB00036
Coagulation factor VIIa,CoagulantsThrombotic Agents,approved,GGCX,Vitamin K-dependent gamma-carboxylase,target,,DB00036
Coagulation factor VIIa,CoagulantsThrombotic Agents,approved,F7,Coagulation factor VII,target,,DB00036
Coagulation factor VIIa,CoagulantsThrombotic Agents,approved,F3,Tissue factor,target,,DB00036
Palifermin,Anti-Mucositis Agents,approved,FGFR2,Fibroblast growth factor receptor 2,target,binder,DB00039
Palifermin,Anti-Mucositis Agents,approved,NRP1,Neuropilin-1,target,,DB00039
Palifermin,Anti-Mucositis Agents,approved,FGFR1,Fibroblast growth factor receptor 1,target,,DB00039
Palifermin,Anti-Mucositis Agents,approved,FGFR4,Fibroblast growth factor receptor 4,target,,DB00039
Palifermin,Anti-Mucositis Agents,approved,FGFR3,Fibroblast growth factor receptor 3,target,,DB00039
Palifermin,Anti-Mucositis Agents,approved,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,target,,DB00039
Glucagon recombinant,Hypoglycemic Agents,approved,GCGR,Glucagon receptor,target,agonist,DB00040
Glucagon recombinant,Hypoglycemic Agents,approved,GLP2R,Glucagon-like peptide 2 receptor,target,,DB00040
Glucagon recombinant,Hypoglycemic Agents,approved,GLP1R,Glucagon-like peptide 1 receptor,target,,DB00040
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,IL2RB,Interleukin-2 receptor subunit beta,target,agonistmodulator,DB00041
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,IL2RA,Interleukin-2 receptor subunit alpha,target,agonistmodulator,DB00041
Aldesleukin,Antineoplastic AgentsAnti-HIV Agents,approved,IL2RG,Cytokine receptor common subunit gamma,target,agonist,DB00041
Botulinum Toxin Type B,Antidystonic Agents,approved,VAMP2,Vesicle-associated membrane protein 2,target,binder,DB00042
Botulinum Toxin Type B,Antidystonic Agents,approved,VAMP1,Vesicle-associated membrane protein 1,target,binder,DB00042
Botulinum Toxin Type B,Antidystonic Agents,approved,SYT2,Synaptotagmin-2,target,,DB00042
Omalizumab,Anti-Allergic AgentsAnti-Asthmatic AgentsImmunosuppressive Agents,approvedinvestigational,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,target,,DB00043
Omalizumab,Anti-Allergic AgentsAnti-Asthmatic AgentsImmunosuppressive Agents,approvedinvestigational,MS4A2,High affinity immunoglobulin epsilon receptor subunit beta,target,antagonist,DB00043
Insulin Lispro,Hypoglycemic AgentsAntidiabetic Agents,approved,INSR,Insulin receptor,target,agonist,DB00046
Insulin Lispro,Hypoglycemic AgentsAntidiabetic Agents,approved,IGF1R,Insulin-like growth factor 1 receptor,target,,DB00046
Insulin Glargine,Hypoglycemic AgentsAntidiabetic Agents,approved,INSR,Insulin receptor,target,agonist,DB00047
Insulin Glargine,Hypoglycemic AgentsAntidiabetic Agents,approved,IGF1R,Insulin-like growth factor 1 receptor,target,agonist,DB00047
Collagenase,,approvedinvestigational,COL1A1,Collagen alpha-1(I) chain,target,,DB00048
Collagenase,,approvedinvestigational,COL2A1,Collagen alpha-1(II) chain,target,,DB00048
Collagenase,,approvedinvestigational,COL3A1,Collagen alpha-1(III) chain,target,,DB00048
Collagenase,,approvedinvestigational,COL1A2,Collagen alpha-2(I) chain,target,,DB00048
Cetrorelix,Hormone AntagonistsFertility Agents,approvedinvestigational,GNRHR,Gonadotropin-releasing hormone receptor,target,antagonist,DB00050
Cetrorelix,Hormone AntagonistsFertility Agents,approvedinvestigational,LHCGR,Lutropin-choriogonadotropic hormone receptor,target,,DB00050
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,TNF,Tumor necrosis factor,target,antibody,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,C1R,Complement C1r subcomponent,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,C1QA,Complement C1q subcomponent subunit A,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,C1QB,Complement C1q subcomponent subunit B,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,C1QC,Complement C1q subcomponent subunit C,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,C1S,Complement C1s subcomponent,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00051
Adalimumab,Antirheumatic AgentsAnti-Inflammatory AgentsImmunosuppressive Agents,approved,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00051
Somatropin recombinant,Hormone Replacement Agents,approvedinvestigational,GHR,Growth hormone receptor,target,binder,DB00052
Somatropin recombinant,Hormone Replacement Agents,approvedinvestigational,PRLR,Prolactin receptor,target,,DB00052
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,ITGB3,Integrin beta-3,target,antagonist,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,ITGA2B,Integrin alpha-IIb,target,antagonist,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,C1R,Complement C1r subcomponent,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,C1QA,Complement C1q subcomponent subunit A,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,C1QB,Complement C1q subcomponent subunit B,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,C1QC,Complement C1q subcomponent subunit C,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,C1S,Complement C1s subcomponent,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00054
Abciximab,AnticoagulantsPlatelet Aggregation Inhibitors,approved,VTN,Vitronectin,target,,DB00054
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,F8,Coagulation factor VIII,target,multitarget,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,F5,Coagulation factor V,target,multitarget,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,SERPINE1,Plasminogen activator inhibitor 1,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,THBD,Thrombomodulin,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,PROS1,Vitamin K-dependent protein S,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,CP,Ceruloplasmin,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,F2,Prothrombin,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,PF4,Platelet factor 4,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,SERPINA5,Plasma serine protease inhibitor,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,SERPINB6,Serpin B6,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,GGCX,Vitamin K-dependent gamma-carboxylase,target,,DB00055
Drotrecogin alfa,Antisepsis,approvedinvestigationalwithdrawn,PROCR,Endothelial protein C receptor,target,,DB00055
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,CD33,Myeloid cell surface antigen CD33,target,antibody,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,C1R,Complement C1r subcomponent,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,C1QA,Complement C1q subcomponent subunit A,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,C1QB,Complement C1q subcomponent subunit B,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,C1QC,Complement C1q subcomponent subunit C,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,C1S,Complement C1s subcomponent,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00056
Gemtuzumab ozogamicin,Antineoplastic AgentsImmunotoxins,approvedinvestigationalwithdrawn,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00056
Interferon beta-1a,Antineoplastic AgentsAntiviral AgentsImmunologic FactorsImmunosuppressive Agents,approvedinvestigational,IFNAR1,Interferon alpha/beta receptor 1,target,agonist,DB00060
Interferon beta-1a,Antineoplastic AgentsAntiviral AgentsImmunologic FactorsImmunosuppressive Agents,approvedinvestigational,IFNAR2,Interferon alpha/beta receptor 2,target,,DB00060
Pegademase bovine,Enzyme Replacement Agents,approved,GRB2,Growth factor receptor-bound protein 2,target,binder,DB00061
Human Serum Albumin,Serum substitutes,approved,APOE,Apolipoprotein E,target,,DB00062
Human Serum Albumin,Serum substitutes,approved,SAA1,Serum amyloid A-1 protein,target,,DB00062
Human Serum Albumin,Serum substitutes,approved,AMBP,Protein AMBP,target,,DB00062
Serum albumin iodonated,Diagnostic Agents,approved,APOE,Apolipoprotein E,target,,DB00064
Serum albumin iodonated,Diagnostic Agents,approved,SAA1,Serum amyloid A-1 protein,target,,DB00064
Serum albumin iodonated,Diagnostic Agents,approved,AMBP,Protein AMBP,target,,DB00064
Vasopressin,Antidiuretic Agents,approved,AVPR2,Vasopressin V2 receptor,target,agonist,DB00067
Vasopressin,Antidiuretic Agents,approved,AVPR1A,Vasopressin V1a receptor,target,,DB00067
Vasopressin,Antidiuretic Agents,approved,AVPR1B,Vasopressin V1b receptor,target,,DB00067
Interferon beta-1b,"Adjuvants, ImmunologicImmunosuppressive Agents",approved,IFNAR1,Interferon alpha/beta receptor 1,target,agonist,DB00068
Interferon beta-1b,"Adjuvants, ImmunologicImmunosuppressive Agents",approved,IFNAR2,Interferon alpha/beta receptor 2,target,agonist,DB00068
Interferon alfacon-1,Antiviral AgentsImmunosuppressive Agents,approved,IFNAR1,Interferon alpha/beta receptor 1,target,binder,DB00069
Interferon alfacon-1,Antiviral AgentsImmunosuppressive Agents,approved,IFNAR2,Interferon alpha/beta receptor 2,target,binder,DB00069
Hyaluronidase,"Adjuvants, AnesthesiaPermeabilizing Agents",approvedinvestigational,TGFB1,Transforming growth factor beta-1,target,inhibitor,DB00070
"Insulin, porcine",Hypoglycemic Agents,approved,INSR,Insulin receptor,target,binder,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,IGF1R,Insulin-like growth factor 1 receptor,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,IDE,Insulin-degrading enzyme,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,HLA-DQA2,"HLA class II histocompatibility antigen, DQ alpha 2 chain",target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,HLA-DQB1,"HLA class II histocompatibility antigen, DQ beta 1 chain",target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,RB1,Retinoblastoma-associated protein,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,CTSD,Cathepsin D,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,CPE,Carboxypeptidase E,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,PCSK2,Neuroendocrine convertase 2,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,PCSK1,Neuroendocrine convertase 1,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,NOV,Protein NOV homolog,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,LRP2,Low-density lipoprotein receptor-related protein 2,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,IGFBP7,Insulin-like growth factor-binding protein 7,target,,DB00071
"Insulin, porcine",Hypoglycemic Agents,approved,SYTL4,Synaptotagmin-like protein 4,target,,DB00071
Trastuzumab,Antineoplastic Agents,approvedinvestigational,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,antibody,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,EGFR,Epidermal growth factor receptor,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,C1S,Complement C1s subcomponent,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00072
Trastuzumab,Antineoplastic Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00072
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,MS4A1,B-lymphocyte antigen CD20,target,antibody,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,C1R,Complement C1r subcomponent,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,C1QA,Complement C1q subcomponent subunit A,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,C1QB,Complement C1q subcomponent subunit B,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,C1QC,Complement C1q subcomponent subunit C,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,C1S,Complement C1s subcomponent,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00073
Rituximab,Antineoplastic AgentsImmunologic FactorsAntirheumatic Agents,approved,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00073
Basiliximab,Immunosuppressive Agents,approvedinvestigational,IL2RA,Interleukin-2 receptor subunit alpha,target,antibody,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,IL2RB,Interleukin-2 receptor subunit beta,target,antibody,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,C1S,Complement C1s subcomponent,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00074
Basiliximab,Immunosuppressive Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00074
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,CD3D,T-cell surface glycoprotein CD3 delta chain,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,CD3E,T-cell surface glycoprotein CD3 epsilon chain,target,binder,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,CD3G,T-cell surface glycoprotein CD3 gamma chain,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,CD247,T-cell surface glycoprotein CD3 zeta chain,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,C1S,Complement C1s subcomponent,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00075
Muromonab,Immunologic FactorsImmunosuppressive Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00075
Ibritumomab,,approved,MS4A1,B-lymphocyte antigen CD20,target,antibody,DB00078
Ibritumomab,,approved,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00078
Ibritumomab,,approved,C1R,Complement C1r subcomponent,target,,DB00078
Ibritumomab,,approved,C1QA,Complement C1q subcomponent subunit A,target,,DB00078
Ibritumomab,,approved,C1QB,Complement C1q subcomponent subunit B,target,,DB00078
Ibritumomab,,approved,C1QC,Complement C1q subcomponent subunit C,target,,DB00078
Ibritumomab,,approved,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00078
Ibritumomab,,approved,C1S,Complement C1s subcomponent,target,,DB00078
Ibritumomab,,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00078
Ibritumomab,,approved,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00078
Ibritumomab,,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00078
Ibritumomab,,approved,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00078
Tositumomab,,approved,MS4A1,B-lymphocyte antigen CD20,target,antibody,DB00081
Tositumomab,,approved,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00081
Tositumomab,,approved,C1R,Complement C1r subcomponent,target,,DB00081
Tositumomab,,approved,C1QA,Complement C1q subcomponent subunit A,target,,DB00081
Tositumomab,,approved,C1QB,Complement C1q subcomponent subunit B,target,,DB00081
Tositumomab,,approved,C1QC,Complement C1q subcomponent subunit C,target,,DB00081
Tositumomab,,approved,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00081
Tositumomab,,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00081
Tositumomab,,approved,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00081
Tositumomab,,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00081
Tositumomab,,approved,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00081
Botulinum Toxin Type A,Neuromuscular Blocking AgentsAnti-Wrinkle AgentsAntidystonic Agents,approvedinvestigational,SNAP25,Synaptosomal-associated protein 25,target,inhibitor,DB00083
Botulinum Toxin Type A,Neuromuscular Blocking AgentsAnti-Wrinkle AgentsAntidystonic Agents,approvedinvestigational,RHOB,Rho-related GTP-binding protein RhoB,target,,DB00083
Streptokinase,Fibrinolytic AgentsThrombolytic Agents,approved,PLG,Plasminogen,target,activator,DB00086
Streptokinase,Fibrinolytic AgentsThrombolytic Agents,approved,F2R,Proteinase-activated receptor 1,target,cleavage,DB00086
Alemtuzumab,,approvedinvestigational,CD52,CAMPATH-1 antigen,target,antibody,DB00087
Alemtuzumab,,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00087
Alemtuzumab,,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00087
Alemtuzumab,,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00087
Alemtuzumab,,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00087
Alemtuzumab,,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00087
Alemtuzumab,,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00087
Alemtuzumab,,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00087
Alemtuzumab,,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00087
Alemtuzumab,,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00087
Alemtuzumab,,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00087
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,CAMLG,Calcium signal-modulating cyclophilin ligand,target,binder,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,PPP3R2,Calcineurin subunit B type 2,target,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,PPIA,Peptidyl-prolyl cis-trans isomerase A,target,,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",target,binder,DB00091
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,CD2,T-cell surface antigen CD2,target,inhibitor,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,C1R,Complement C1r subcomponent,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,C1QA,Complement C1q subcomponent subunit A,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,C1QB,Complement C1q subcomponent subunit B,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,C1QC,Complement C1q subcomponent subunit C,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00092
Alefacept,Dermatologic AgentsImmunosuppressive Agents,approvedwithdrawn,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00092
Efalizumab,Immunosuppressive Agents,approvedinvestigational,ITGAL,Integrin alpha-L,target,antibody,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00095
Efalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00095
Choriogonadotropin alfa,Fertility AgentsGonadotropins,approved,LHCGR,Lutropin-choriogonadotropic hormone receptor,target,,DB00097
Choriogonadotropin alfa,Fertility AgentsGonadotropins,approved,FSHR,Follicle-stimulating hormone receptor,target,binder,DB00097
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,CD1A,T-cell surface glycoprotein CD1a,target,inhibitor,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,MR1,Major histocompatibility complex class I-related gene protein,target,antagonist,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,ITGAL,Integrin alpha-L,target,,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,CD86,T-lymphocyte activation antigen CD86,target,,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,CD4,T-cell surface glycoprotein CD4,target,,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,ITGB1,Integrin beta-1,target,,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,ITGAV,Integrin alpha-V,target,,DB00098
Antithymocyte globulin,Immunologic FactorsImmunosuppressive Agents,approved,ITGB3,Integrin beta-3,target,,DB00098
Filgrastim,Immunosuppressive AgentsAntineutropenic AgentsHematopoietic Agents,approved,CSF3R,Granulocyte colony-stimulating factor receptor,target,stimulator,DB00099
Filgrastim,Immunosuppressive AgentsAntineutropenic AgentsHematopoietic Agents,approved,ELANE,Neutrophil elastase,target,other/unknown,DB00099
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,F10,Coagulation factor X,target,activator,DB00100
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,F11,Coagulation factor XI,target,ligand,DB00100
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,F7,Coagulation factor VII,target,ligand,DB00100
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,F8,Coagulation factor VIII,target,cofactor,DB00100
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,F2,Prothrombin,target,,DB00100
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,LRP1,Prolow-density lipoprotein receptor-related protein 1,target,,DB00100
Coagulation Factor IX,CoagulantsThrombotic Agents,approved,GGCX,Vitamin K-dependent gamma-carboxylase,target,,DB00100
Becaplermin,Angiogenesis Inducing Agents,approvedinvestigational,PDGFRB,Platelet-derived growth factor receptor beta,target,,DB00102
Becaplermin,Angiogenesis Inducing Agents,approvedinvestigational,PDGFRA,Platelet-derived growth factor receptor alpha,target,,DB00102
Becaplermin,Angiogenesis Inducing Agents,approvedinvestigational,A2M,Alpha-2-macroglobulin,target,,DB00102
Octreotide,"Antineoplastic Agents, HormonalGastrointestinal AgentsHormone Replacement Agents",approvedinvestigational,SSTR1,Somatostatin receptor type 1,target,,DB00104
Octreotide,"Antineoplastic Agents, HormonalGastrointestinal AgentsHormone Replacement Agents",approvedinvestigational,SSTR5,Somatostatin receptor type 5,target,,DB00104
Octreotide,"Antineoplastic Agents, HormonalGastrointestinal AgentsHormone Replacement Agents",approvedinvestigational,SSTR2,Somatostatin receptor type 2,target,binder,DB00104
"Interferon Alfa-2b, Recombinant",Immunosuppressive Agents,approved,IFNAR2,Interferon alpha/beta receptor 2,target,binder,DB00105
"Interferon Alfa-2b, Recombinant",Immunosuppressive Agents,approved,IFNAR1,Interferon alpha/beta receptor 1,target,binder,DB00105
Oxytocin,OxytocicsAnti-tocolytic AgentsLabor Induction Agents,approved,OXTR,Oxytocin receptor,target,agonist,DB00107
Oxytocin,OxytocicsAnti-tocolytic AgentsLabor Induction Agents,approved,OXT,Oxytocin-neurophysin 1,target,binder,DB00107
Natalizumab,Immunosuppressive Agents,approvedinvestigational,ITGA4,Integrin alpha-4,target,antibody,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00108
Natalizumab,Immunosuppressive Agents,approvedinvestigational,ICAM1,Intercellular adhesion molecule 1,target,,DB00108
Palivizumab,Antiviral Agents,approvedinvestigational,F,Fusion glycoprotein F0,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00110
Palivizumab,Antiviral Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00110
Daclizumab,Immunosuppressive Agents,approvedinvestigational,IL2RA,Interleukin-2 receptor subunit alpha,target,antibody,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,IL2RB,Interleukin-2 receptor subunit beta,target,antibody,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00111
Daclizumab,Immunosuppressive Agents,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00111
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,VEGFA,Vascular endothelial growth factor A,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,C1R,Complement C1r subcomponent,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,C1QA,Complement C1q subcomponent subunit A,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,C1QB,Complement C1q subcomponent subunit B,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,C1QC,Complement C1q subcomponent subunit C,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,FCGR3A,Low affinity immunoglobulin gamma Fc region receptor III-A,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,target,,DB00112
Bevacizumab,Angiogenesis Inhibitors,approvedinvestigational,FCGR2C,Low affinity immunoglobulin gamma Fc region receptor II-c,target,,DB00112
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,AGXT2,"Alanine--glyoxylate aminotransferase 2, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GAD1,Glutamate decarboxylase 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,CBS,Cystathionine beta-synthase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,KYNU,Kynureninase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,NFS1,"Cysteine desulfurase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GOT1,"Aspartate aminotransferase, cytoplasmic",target,activator,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,OAT,"Ornithine aminotransferase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,ODC1,Ornithine decarboxylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,AADAT,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,inhibitor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PNPO,Pyridoxine-5'-phosphate oxidase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SGPL1,Sphingosine-1-phosphate lyase 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,TAT,Tyrosine aminotransferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,CCBL1,Kynurenine--oxoglutarate transaminase 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,THNSL1,Threonine synthase-like 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PYGL,"Glycogen phosphorylase, liver form",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SPTLC2,Serine palmitoyltransferase 2,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,CSAD,Cysteine sulfinic acid decarboxylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,HDC,Histidine decarboxylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,ADC,Arginine decarboxylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SDS,L-serine dehydratase/L-threonine deaminase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GCAT,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GLDC,"Glycine dehydrogenase [decarboxylating], mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GPT,Alanine aminotransferase 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PSAT1,Phosphoserine aminotransferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,ALAS1,"5-aminolevulinate synthase, nonspecific, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,AGXT,Serine--pyruvate aminotransferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PDXP,Pyridoxal phosphate phosphatase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SPTLC1,Serine palmitoyltransferase 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,CTH,Cystathionine gamma-lyase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PROSC,Proline synthase co-transcribed bacterial homolog protein,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,FTCD,Formimidoyltransferase-cyclodeaminase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GOT2,"Aspartate aminotransferase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PYGB,"Glycogen phosphorylase, brain form",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PYGM,"Glycogen phosphorylase, muscle form",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,DDC,Aromatic-L-amino-acid decarboxylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SHMT2,"Serine hydroxymethyltransferase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GIG18,Aspartate aminotransferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GAD1,GAD1 protein,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,,Serine hydroxymethyltransferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,,Selenocysteine lyase variant,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,,Phosphorylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,,Ornithine aminotransferase variant,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,ALAS1,5-aminolevulinate synthase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GAD2,"Glutamate decarboxylase 2 (Pancreatic islets and brain, 65kDa)",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,DDC,DDC protein,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,CCBL2,Kynurenine--oxoglutarate transaminase 3,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GADL1,Glutamate decarboxylase-like protein 1,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SCLY,Selenocysteine lyase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,IGSF10,Immunoglobulin superfamily member 10,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,AGXT2L2,5-phosphohydroxy-L-lysine phospho-lyase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GAD1,"Glutamate decarboxylase 1 (Brain, 67kDa)",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SHMT2,"Serine hydroxymethyltransferase, mitochondrial",target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GPT2,Alanine aminotransferase 2,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,MOCOS,Molybdenum cofactor sulfurase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SDSL,Serine dehydratase-like,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,pcap,P-selectin cytoplasmic tail-associated protein (PCAP),target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,,Hepatic peroxysomal alanine:glyoxylate aminotransferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SRR,Serine racemase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SEPSECS,O-phosphoseryl-tRNA(Sec) selenium transferase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,SPTLC3,Serine palmitoyltransferase 3,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,GAD65,Glutamic acid decarboxylase,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,TLH6,Alanine-glyoxylate aminotransferase homolog,target,cofactor,DB00114
Pyridoxal Phosphate,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,nutraceutical,CSAD,Cysteine sulfinic acid decarboxylase,target,cofactor,DB00114
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MTR,Methionine synthase,target,cofactor,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MUT,"Methylmalonyl-CoA mutase, mitochondrial",target,cofactor,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MTRR,Methionine synthase reductase,target,cofactor,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MMAA,"Methylmalonic aciduria type A protein, mitochondrial",target,cofactor,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MMACHC,Methylmalonic aciduria and homocystinuria type C protein,target,cofactor,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,target,cofactor,DB00115
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AMT,"Aminomethyltransferase, mitochondrial",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ALDH1L1,Cytosolic 10-formyltetrahydrofolate dehydrogenase,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTR,Methionine synthase,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FTCD,Formimidoyltransferase-cyclodeaminase,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ATIC,Bifunctional purine biosynthesis protein PURH,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SHMT2,"Serine hydroxymethyltransferase, mitochondrial",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,,Serine hydroxymethyltransferase,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTHFR,Methylenetetrahydrofolate reductase,target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SHMT2,"Serine hydroxymethyltransferase, mitochondrial",target,cofactor,DB00116
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTFMT,"Methionyl-tRNA formyltransferase, mitochondrial",target,cofactor,DB00116
L-Histidine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,HDC,Histidine decarboxylase,target,,DB00117
L-Histidine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,HARS,"Histidine--tRNA ligase, cytoplasmic",target,,DB00117
L-Histidine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC38A3,Sodium-coupled neutral amino acid transporter 3,target,,DB00117
L-Histidine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,HAL,Histidine ammonia-lyase,target,,DB00117
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GNMT,Glycine N-methyltransferase,target,cofactor,DB00118
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AMD1,S-adenosylmethionine decarboxylase proenzyme,target,cofactor,DB00118
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MAT2A,S-adenosylmethionine synthase isoform type-2,target,cofactor,DB00118
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CBS,Cystathionine beta-synthase,target,activator,DB00118
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MAT1A,S-adenosylmethionine synthase isoform type-1,target,cofactor,DB00118
S-Adenosylmethionine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,COMT,Catechol O-methyltransferase,target,cofactor,DB00118
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A3,Monocarboxylate transporter 4,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A2,Monocarboxylate transporter 8,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AGXT2,"Alanine--glyoxylate aminotransferase 2, mitochondrial",target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A5,Monocarboxylate transporter 6,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PKLR,Pyruvate kinase PKLR,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A6,Monocarboxylate transporter 7,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A7,Monocarboxylate transporter 2,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PDHB,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PKM2,Pyruvate kinase PKM,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,inhibitor,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A4,Monocarboxylate transporter 5,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A8,Monocarboxylate transporter 3,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A1,Monocarboxylate transporter 1,target,,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PC,"Pyruvate carboxylase, mitochondrial",target,,DB00119
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TAT,Tyrosine aminotransferase,target,,DB00120
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC7A8,Large neutral amino acids transporter small subunit 2,target,,DB00120
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,FARSA,Phenylalanine--tRNA ligase alpha subunit,target,,DB00120
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,PAH,Phenylalanine-4-hydroxylase,target,,DB00120
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,FARS2,"Phenylalanine--tRNA ligase, mitochondrial",target,,DB00120
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,FARSB,Phenylalanine--tRNA ligase beta subunit,target,,DB00120
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TH,Tyrosine 3-monooxygenase,target,binder,DB00120
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PCCB,"Propionyl-CoA carboxylase beta chain, mitochondrial",target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,HLCS,Biotin--protein ligase,target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC5A6,Sodium-dependent multivitamin transporter,target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,MCCC2,"Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial",target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACACB,Acetyl-CoA carboxylase 2,target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,MCCC1,"Methylcrotonoyl-CoA carboxylase subunit alpha, mitochondrial",target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PC,"Pyruvate carboxylase, mitochondrial",target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PCCA,"Propionyl-CoA carboxylase alpha chain, mitochondrial",target,,DB00121
Biotin,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACACA,Acetyl-CoA carboxylase 1,target,,DB00121
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PCYT1B,Choline-phosphate cytidylyltransferase B,target,product of,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACHE,Acetylcholinesterase,target,product of,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PCYT1A,Choline-phosphate cytidylyltransferase A,target,product of,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PLD2,Phospholipase D2,target,product of,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,BCHE,Cholinesterase,target,product of,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PLD1,Phospholipase D1,target,product of,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,target,product of,DB00122
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC7A1,High affinity cationic amino acid transporter 1,target,,DB00123
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC7A4,Cationic amino acid transporter 4,target,,DB00123
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC7A3,Cationic amino acid transporter 3,target,,DB00123
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC7A2,Low affinity cationic amino acid transporter 2,target,,DB00123
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,KARS,Lysine--tRNA ligase,target,,DB00123
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,NOS3,"Nitric oxide synthase, endothelial",target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC7A3,Cationic amino acid transporter 3,target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,ADC,Arginine decarboxylase,target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,ASL,Argininosuccinate lyase,target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,NOS2,"Nitric oxide synthase, inducible",target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC7A1,High affinity cationic amino acid transporter 1,target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,ARG2,"Arginase-2, mitochondrial",target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC7A4,Cationic amino acid transporter 4,target,,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,ASS1,Argininosuccinate synthase,target,,DB00125
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,LCT,Lactase-phlorizin hydrolase,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,SP_0314,Hyaluronate lyase,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,xylA,Xylose isomerase,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,PLOD2,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 2",target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,PHYH,"Phytanoyl-CoA dioxygenase, peroxisomal",target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,PLOD3,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,BBOX1,Gamma-butyrobetaine dioxygenase,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,DBH,Dopamine beta-hydroxylase,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,PAM,Peptidyl-glycine alpha-amidating monooxygenase,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,P4HA1,Prolyl 4-hydroxylase subunit alpha-1,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,LEPRE1,Prolyl 3-hydroxylase 1,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,OGFOD2,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 2,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,ALKBH2,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 2,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,LEPREL1,Prolyl 3-hydroxylase 2,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,LEPREL2,Prolyl 3-hydroxylase 3,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,OGFOD1,2-oxoglutarate and iron-dependent oxygenase domain-containing protein 1,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,EGLN2,Egl nine homolog 2,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,ALKBH3,Alpha-ketoglutarate-dependent dioxygenase alkB homolog 3,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,KDM5D,Lysine-specific demethylase 5D,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,EGLN1,Egl nine homolog 1,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,SLC23A1,Solute carrier family 23 member 1,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,PLOD1,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",target,activator,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,EGLN3,Egl nine homolog 3,target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,TMLHE,"Trimethyllysine dioxygenase, mitochondrial",target,,DB00126
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,P4HTM,Transmembrane prolyl 4-hydroxylase,target,,DB00126
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SMS,Spermine synthase,target,ligand,DB00127
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SMOX,Spermine oxidase,target,ligand,DB00127
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ODC1,Ornithine decarboxylase,target,product of,DB00127
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,RNASE1,Ribonuclease pancreatic,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,LYZ,Lysozyme C,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC25A13,Calcium-binding mitochondrial carrier protein Aralar2,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GOT1,"Aspartate aminotransferase, cytoplasmic",target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC25A13,Calcium-binding mitochondrial carrier protein Aralar2,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASPA,Aspartoacylase,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASNS,Asparagine synthetase [glutamine-hydrolyzing],target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASS1,Argininosuccinate synthase,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ACY1,Aminoacylase-1,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GOT2,"Aspartate aminotransferase, mitochondrial",target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,DARS,"Aspartate--tRNA ligase, cytoplasmic",target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC25A12,Calcium-binding mitochondrial carrier protein Aralar1,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASPH,Aspartyl/asparaginyl beta-hydroxylase,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PAICS,Multifunctional protein ADE2,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,CAD,CAD protein,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ADSS,Adenylosuccinate synthetase isozyme 2,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC1A1,Excitatory amino acid transporter 3,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GIG18,Aspartate aminotransferase,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASS1,"Argininosuccinate synthetase, isoform CRA_a",target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,DARS2,"Aspartate--tRNA ligase, mitochondrial",target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASRGL1,Isoaspartyl peptidase/L-asparaginase,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB00128
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ACY3,Aspartoacylase-2,target,,DB00128
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,OAT,"Ornithine aminotransferase, mitochondrial",target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,OTC,"Ornithine carbamoyltransferase, mitochondrial",target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ARG1,Arginase-1,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,OAZ1,Ornithine decarboxylase antizyme 1,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A2,Low affinity cationic amino acid transporter 2,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC25A2,Mitochondrial ornithine transporter 2,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A4,Cationic amino acid transporter 4,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A1,High affinity cationic amino acid transporter 1,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ARG2,"Arginase-2, mitochondrial",target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC25A15,Mitochondrial ornithine transporter 1,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A3,Cationic amino acid transporter 3,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,OAZ2,Ornithine decarboxylase antizyme 2,target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GATM,"Glycine amidinotransferase, mitochondrial",target,,DB00129
L-Ornithine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,OAZ3,Ornithine decarboxylase antizyme 3,target,,DB00129
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,CTPS,CTP synthase 1,target,antagonist,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,PPAT,Amidophosphoribosyltransferase,target,product of,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,GLUL,Glutamine synthetase,target,product of,DB00130
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CREB1,Cyclic AMP-responsive element-binding protein 1,target,activator,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PIM1,Serine/threonine-protein kinase pim-1,target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PYGL,"Glycogen phosphorylase, liver form",target,activator,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,target,activator,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,HINT1,Histidine triad nucleotide-binding protein 1,target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSS1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSS2,"Acetyl-coenzyme A synthetase, cytoplasmic",target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKAA1,5'-AMP-activated protein kinase catalytic subunit alpha-1,target,activator,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKAB2,5'-AMP-activated protein kinase subunit beta-2,target,activator,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ADCY1,Adenylate cyclase type 1,target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSL1,Long-chain-fatty-acid--CoA ligase 1,target,product of,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FBP1,"Fructose-1,6-bisphosphatase 1",target,antagonistinhibitory allosteric modulator,DB00131
Adenosine monophosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ADK,Adenosine kinase,target,product of,DB00131
Alpha-Linolenic Acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FADS1,Fatty acid desaturase 1,target,ligand,DB00132
Alpha-Linolenic Acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FADS2,Fatty acid desaturase 2,target,ligand,DB00132
Alpha-Linolenic Acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC8A1,Sodium/calcium exchanger 1,target,,DB00132
Alpha-Linolenic Acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,TRPV1,Transient receptor potential cation channel subfamily V member 1,target,,DB00132
Alpha-Linolenic Acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ELOVL4,Elongation of very long chain fatty acids protein 4,target,,DB00132
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,CBS,Cystathionine beta-synthase,target,,DB00133
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SDS,L-serine dehydratase/L-threonine deaminase,target,,DB00133
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SRR,Serine racemase,target,,DB00133
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SPTLC2,Serine palmitoyltransferase 2,target,,DB00133
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SPTLC1,Serine palmitoyltransferase 1,target,,DB00133
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SARS,"Serine--tRNA ligase, cytoplasmic",target,,DB00133
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AGXT,Serine--pyruvate aminotransferase,target,,DB00133
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MTRR,Methionine synthase reductase,target,product of,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,MTR,Methionine synthase,target,product of,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,METAP2,Methionine aminopeptidase 2,target,product of,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,BHMT,Betaine--homocysteine S-methyltransferase 1,target,product of,DB00134
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,target,product of,DB00134
L-Tyrosine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,TH,Tyrosine 3-monooxygenase,target,binder,DB00135
L-Tyrosine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,YARS2,"Tyrosine--tRNA ligase, mitochondrial",target,,DB00135
L-Tyrosine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,YARS,"Tyrosine--tRNA ligase, cytoplasmic",target,,DB00135
L-Tyrosine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,TAT,Tyrosine aminotransferase,target,,DB00135
L-Cystine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A11,Cystine/glutamate transporter,target,,DB00138
L-Cystine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,CTNS,Cystinosin,target,,DB00138
L-Cystine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A9,"B(0,+)-type amino acid transporter 1",target,,DB00138
L-Cystine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC3A1,Neutral and basic amino acid transport protein rBAT,target,,DB00138
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SDHC,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SUCNR1,Succinate receptor 1,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,OXCT2,"Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,TMLHE,"Trimethyllysine dioxygenase, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SUCLA2,"Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC25A10,Mitochondrial dicarboxylate carrier,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,HSD17B6,17-beta-hydroxysteroid dehydrogenase type 6,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC13A3,Solute carrier family 13 member 3,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC13A2,Solute carrier family 13 member 2,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC13A1,Solute carrier family 13 member 1,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SUCLG2,"Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SDHD,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,P4HA2,Prolyl 4-hydroxylase subunit alpha-2,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PLOD3,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,BBOX1,Gamma-butyrobetaine dioxygenase,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,P4HA1,Prolyl 4-hydroxylase subunit alpha-1,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SDHB,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",target,inhibitor,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SUCLG1,"Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PLOD1,"Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ASPH,Aspartyl/asparaginyl beta-hydroxylase,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,LEPRE1,Prolyl 3-hydroxylase 1,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,LEPREL1,Prolyl 3-hydroxylase 2,target,,DB00139
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,LEPREL2,Prolyl 3-hydroxylase 3,target,,DB00139
Riboflavin,Vitamin B ComplexPhotosensitizing Agents,approvednutraceutical,RFK,Riboflavin kinase,target,ligand,DB00140
Riboflavin,Vitamin B ComplexPhotosensitizing Agents,approvednutraceutical,ribE,Riboflavin synthase,target,other,DB00140
Riboflavin,Vitamin B ComplexPhotosensitizing Agents,approvednutraceutical,BLVRB,Flavin reductase (NADPH),target,product of,DB00140
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,B4GALT3,"Beta-1,4-galactosyltransferase 3",target,,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,B4GALT4,"Beta-1,4-galactosyltransferase 4",target,,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,B4GALT2,"Beta-1,4-galactosyltransferase 2",target,,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,NAGK,N-acetyl-D-glucosamine kinase,target,,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,target,,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,NAGLU,Alpha-N-acetylglucosaminidase,target,activator,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,RENBP,N-acylglucosamine 2-epimerase,target,,DB00141
N-Acetyl-D-glucosamine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,B4GALT1,"Beta-1,4-galactosyltransferase 1",target,,DB00141
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRM1,Metabotropic glutamate receptor 1,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRM4,Metabotropic glutamate receptor 4,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIK4,"Glutamate receptor ionotropic, kainate 4",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIK5,"Glutamate receptor ionotropic, kainate 5",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRM7,Metabotropic glutamate receptor 7,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRM8,Metabotropic glutamate receptor 8,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC1A7,Excitatory amino acid transporter 5,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,OPLAH,5-oxoprolinase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,PFAS,Phosphoribosylformylglycinamidine synthase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN2D,"Glutamate receptor ionotropic, NMDA 2D",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRID2,"Glutamate receptor ionotropic, delta-2",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN3B,"Glutamate receptor ionotropic, NMDA 3B",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,PET112L,"Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GLS,"Glutaminase kidney isoform, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GOT2,"Aspartate aminotransferase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,EPRS,Bifunctional glutamate/proline--tRNA ligase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,ASNS,Asparagine synthetase [glutamine-hydrolyzing],target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GLUL,Glutamine synthetase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GOT1,"Aspartate aminotransferase, cytoplasmic",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,TAT,Tyrosine aminotransferase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GPT,Alanine aminotransferase 1,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GGCX,Vitamin K-dependent gamma-carboxylase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC1A3,Excitatory amino acid transporter 1,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC1A2,Excitatory amino acid transporter 2,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC1A1,Excitatory amino acid transporter 3,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GCLC,Glutamate--cysteine ligase catalytic subunit,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC1A6,Excitatory amino acid transporter 4,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GLUD2,"Glutamate dehydrogenase 2, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GMPS,GMP synthase [glutamine-hydrolyzing],target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,FPGS,"Folylpolyglutamate synthase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,ENPEP,Glutamyl aminopeptidase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN2C,"Glutamate receptor ionotropic, NMDA 2C",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GIG18,Aspartate aminotransferase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,EARS2,"Probable glutamate--tRNA ligase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,LGSN,Lengsin,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,NADSYN1,Glutamine-dependent NAD(+) synthetase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,CCBL2,Kynurenine--oxoglutarate transaminase 3,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,NAGS,"N-acetylglutamate synthase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,AADAT,"Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GPT2,Alanine aminotransferase 2,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC25A18,Mitochondrial glutamate carrier 2,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC25A22,Mitochondrial glutamate carrier 1,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,AASS,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GLS2,"Glutaminase liver isoform, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,DNPEP,Aspartyl aminopeptidase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRID1,"Glutamate receptor ionotropic, delta-1",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC7A11,Cystine/glutamate transporter,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,PGCP,Carboxypeptidase Q,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,PSAT1,Phosphoserine aminotransferase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GLUD1,"Glutamate dehydrogenase 1, mitochondrial",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIK1,"Glutamate receptor ionotropic, kainate 1",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIA1,Glutamate receptor 1,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GCLM,Glutamate--cysteine ligase regulatory subunit,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,FOLH1,Glutamate carboxypeptidase 2,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GAD2,Glutamate decarboxylase 2,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GAD1,Glutamate decarboxylase 1,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,FTCD,Formimidoyltransferase-cyclodeaminase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIA2,Glutamate receptor 2,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIA3,Glutamate receptor 3,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIA4,Glutamate receptor 4,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,ALDH18A1,Delta-1-pyrroline-5-carboxylate synthase,target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,GRIK3,"Glutamate receptor ionotropic, kainate 3",target,,DB00142
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MGST3,Microsomal glutathione S-transferase 3,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,TXNDC12,Thioredoxin domain-containing protein 12,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA1,Glutathione S-transferase A1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA2,Glutathione S-transferase A2,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MGST1,Microsomal glutathione S-transferase 1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ESD,S-formylglutathione hydrolase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GGT1,Gamma-glutamyltranspeptidase 1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTM2,Glutathione S-transferase Mu 2,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GLRX,Glutaredoxin-1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX4,"Phospholipid hydroperoxide glutathione peroxidase, mitochondrial",target,cofactor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTM5,Glutathione S-transferase Mu 5,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX6,Glutathione peroxidase 6,target,cofactor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX1,Glutathione peroxidase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX8,Probable glutathione peroxidase 8,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX7,Glutathione peroxidase 7,target,cofactor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MGST2,Microsomal glutathione S-transferase 2,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTO2,Glutathione S-transferase omega-2,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GLRX2,"Glutaredoxin-2, mitochondrial",target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GLO1,Lactoylglutathione lyase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,LTC4S,Leukotriene C4 synthase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSR,"Glutathione reductase, mitochondrial",target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSS,Glutathione synthetase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTM1,Glutathione S-transferase Mu 1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTK1,Glutathione S-transferase kappa 1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA3,Glutathione S-transferase A3,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTM3,Glutathione S-transferase Mu 3,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA4,Glutathione S-transferase A4,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTM4,Glutathione S-transferase Mu 4,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTA5,Glutathione S-transferase A5,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTP1,Glutathione S-transferase P,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTO1,Glutathione S-transferase omega-1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX1,Glutathione peroxidase 1,target,cofactor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX2,Glutathione peroxidase 2,target,cofactor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTT1,Glutathione S-transferase theta-1,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GSTZ1,Maleylacetoacetate isomerase,target,,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX5,Epididymal secretory glutathione peroxidase,target,cofactor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GPX3,Glutathione peroxidase 3,target,cofactor,DB00143
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,DGKG,Diacylglycerol kinase gamma,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,DGKD,Diacylglycerol kinase delta,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PTDSS2,Phosphatidylserine synthase 2,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SMPD4,Sphingomyelin phosphodiesterase 4,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SMPD3,Sphingomyelin phosphodiesterase 3,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ATP8A1,Probable phospholipid-transporting ATPase IA,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKCA,Protein kinase C alpha type,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PTDSS1,Phosphatidylserine synthase 1,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PISD,Phosphatidylserine decarboxylase proenzyme,target,,DB00144
Phosphatidylserine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SCARB1,Scavenger receptor class B member 1,target,,DB00144
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GCAT,"2-amino-3-ketobutyrate coenzyme A ligase, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ALAS1,"5-aminolevulinate synthase, nonspecific, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ALAS2,"5-aminolevulinate synthase, erythroid-specific, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GCSH,"Glycine cleavage system H protein, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GARS,Glycine--tRNA ligase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,antagonist,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,BAAT,Bile acid-CoA:amino acid N-acyltransferase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GPR18,N-arachidonyl glycine receptor,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GSS,Glutathione synthetase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GRIN2C,"Glutamate receptor ionotropic, NMDA 2C",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,,Serine hydroxymethyltransferase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLYAT,Glycine N-acyltransferase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC36A1,Proton-coupled amino acid transporter 1,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SHMT2,"Serine hydroxymethyltransferase, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLYATL2,Glycine N-acyltransferase-like protein 2,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLYATL1,Glycine N-acyltransferase-like protein 1,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AGXT2,"Alanine--glyoxylate aminotransferase 2, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC32A1,Vesicular inhibitory amino acid transporter,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PIPOX,Peroxisomal sarcosine oxidase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC6A5,Sodium- and chloride-dependent glycine transporter 2,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GRIN3B,"Glutamate receptor ionotropic, NMDA 3B",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLDC,"Glycine dehydrogenase [decarboxylating], mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC6A9,Sodium- and chloride-dependent glycine transporter 1,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLRA1,Glycine receptor subunit alpha-1,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AGXT,Serine--pyruvate aminotransferase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLRB,Glycine receptor subunit beta,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLRA3,Glycine receptor subunit alpha-3,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GLRA2,Glycine receptor subunit alpha-2,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GNMT,Glycine N-methyltransferase,target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SHMT2,"Serine hydroxymethyltransferase, mitochondrial",target,,DB00145
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GATM,"Glycine amidinotransferase, mitochondrial",target,,DB00145
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CKM,Creatine kinase M-type,target,ligand,DB00148
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CKMT1A,"Creatine kinase U-type, mitochondrial",target,ligand,DB00148
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CKB,Creatine kinase B-type,target,ligand,DB00148
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CKMT2,"Creatine kinase S-type, mitochondrial",target,ligand,DB00148
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC6A8,Sodium- and chloride-dependent creatine transporter 1,target,,DB00148
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,GAMT,Guanidinoacetate N-methyltransferase,target,product of,DB00148
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,LARS2,"Probable leucine--tRNA ligase, mitochondrial",target,,DB00149
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,,DB00149
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",target,,DB00149
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,LCMT2,Leucine carboxyl methyltransferase 2,target,,DB00149
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,LCMT1,Leucine carboxyl methyltransferase 1,target,,DB00149
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,LARS,"Leucine--tRNA ligase, cytoplasmic",target,,DB00149
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,WARS2,"Tryptophan--tRNA ligase, mitochondrial",target,inhibitor,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,trpS,Tryptophan--tRNA ligase,target,inhibitor,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,WARS,"Tryptophan--tRNA ligase, cytoplasmic",target,inhibitor,DB00150
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,GCLM,Glutamate--cysteine ligase regulatory subunit,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,GCLC,Glutamate--cysteine ligase catalytic subunit,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CDO-1,Cysteine dioxygenase,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,GOT1,"Aspartate aminotransferase, cytoplasmic",target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CTH,Cystathionine gamma-lyase,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CBS,Cystathionine beta-synthase,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CARS,"Cysteine--tRNA ligase, cytoplasmic",target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,MGMT,Methylated-DNA--protein-cysteine methyltransferase,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,GSS,Glutathione synthetase,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,SLC19A3,Thiamine transporter 2,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CARS2,"Probable cysteine--tRNA ligase, mitochondrial",target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CSAD,Cysteine sulfinic acid decarboxylase,target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,NFS1,"Cysteine desulfurase, mitochondrial",target,,DB00151
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,CDO1,Cysteine dioxygenase type 1,target,,DB00151
Thiamine,Vitamin B ComplexVitamins,approvednutraceutical,TPK1,Thiamin pyrophosphokinase 1,target,ligand,DB00152
Thiamine,Vitamin B ComplexVitamins,approvednutraceutical,SLC19A2,Thiamine transporter 1,target,binder,DB00152
Dihomo-<U+03B3>-linolenic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00154
Dihomo-<U+03B3>-linolenic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PTGS2,Prostaglandin G/H synthase 2,target,,DB00154
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASS1,Argininosuccinate synthase,target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,DDAH2,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 2",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASS1,"Argininosuccinate synthetase, isoform CRA_a",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,OTC,"Ornithine carbamoyltransferase, mitochondrial",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,NOS1,"Nitric oxide synthase, brain",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,NOS2,"Nitric oxide synthase, inducible",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,NOS3,"Nitric oxide synthase, endothelial",target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PADI6,Protein-arginine deiminase type-6,target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PADI1,Protein-arginine deiminase type-1,target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PADI3,Protein-arginine deiminase type-3,target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PADI2,Protein-arginine deiminase type-2,target,,DB00155
L-Citrulline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PADI4,Protein-arginine deiminase type-4,target,,DB00155
L-Threonine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,THNSL1,Threonine synthase-like 1,target,,DB00156
L-Threonine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TARS,"Threonine--tRNA ligase, cytoplasmic",target,,DB00156
L-Threonine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,TARS2,"Threonine--tRNA ligase, mitochondrial",target,,DB00156
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,UGDH,UDP-glucose 6-dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH1A,Alcohol dehydrogenase 1A,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,SORD,Sorbitol dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH4,Alcohol dehydrogenase 4,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH1C,Alcohol dehydrogenase 1C,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH1B,Alcohol dehydrogenase 1B,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH7,Alcohol dehydrogenase class 4 mu/sigma chain,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,GPD1,"Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,LDHAL6A,L-lactate dehydrogenase A-like 6A,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ADH5,Alcohol dehydrogenase class-3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AKR1B1,Aldose reductase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B10,3-hydroxyacyl-CoA dehydrogenase type-2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MDH2,"Malate dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,LDHA,L-lactate dehydrogenase A chain,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ME2,"NAD-dependent malic enzyme, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B4,Peroxisomal multifunctional enzyme type 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,LDHAL6B,L-lactate dehydrogenase A-like 6B,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,LDHC,L-lactate dehydrogenase C chain,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,LDHB,L-lactate dehydrogenase B chain,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,EHHADH,Peroxisomal bifunctional enzyme,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ME3,"NADP-dependent malic enzyme, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,BDH1,"D-beta-hydroxybutyrate dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MDH1,"Malate dehydrogenase, cytoplasmic",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HIBADH,"3-hydroxyisobutyrate dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B3,Testosterone 17-beta-dehydrogenase 3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ME1,NADP-dependent malic enzyme,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,PHGDH,D-3-phosphoglycerate dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B7,3-keto-steroid reductase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,IDH3G,"Isocitrate dehydrogenase [NAD] subunit gamma, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,IDH3B,"Isocitrate dehydrogenase [NAD] subunit beta, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,IDH3A,"Isocitrate dehydrogenase [NAD] subunit alpha, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B2,Estradiol 17-beta-dehydrogenase 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,RDH5,11-cis retinol dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,H6PD,GDH/6PGL endoplasmic bifunctional protein,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD17B8,Estradiol 17-beta-dehydrogenase 8,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AKR1C4,Aldo-keto reductase family 1 member C4,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HPGD,15-hydroxyprostaglandin dehydrogenase [NAD(+)],target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,TSTA3,GDP-L-fucose synthase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AKR1C1,Aldo-keto reductase family 1 member C1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD3B2,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD3B1,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HADHA,"Trifunctional enzyme subunit alpha, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH2,"Aldehyde dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HSD11B2,Corticosteroid 11-beta-dehydrogenase isozyme 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AKR1C2,Aldo-keto reductase family 1 member C2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NSDHL,"Sterol-4-alpha-carboxylate 3-dehydrogenase, decarboxylating",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH3B2,Aldehyde dehydrogenase family 3 member B2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH6A1,"Methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH1A1,Retinal dehydrogenase 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,GAPDHS,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH9A1,4-trimethylaminobutyraldehyde dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH1A3,Aldehyde dehydrogenase family 1 member A3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH1B1,"Aldehyde dehydrogenase X, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH3B1,Aldehyde dehydrogenase family 3 member B1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH1A2,Retinal dehydrogenase 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH3A2,Fatty aldehyde dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH7A1,Alpha-aminoadipic semialdehyde dehydrogenase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,BLVRB,Flavin reductase (NADPH),target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,PYCR2,Pyrroline-5-carboxylate reductase 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,PYCR1,"Pyrroline-5-carboxylate reductase 1, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,GLUD1,"Glutamate dehydrogenase 1, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,PDHB,"Pyruvate dehydrogenase E1 component subunit beta, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,PDHA2,"Pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,PDHA1,"Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,BLVRA,Biliverdin reductase A,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ACADS,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,DHFR,Dihydrofolate reductase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,OGDH,"2-oxoglutarate dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,GLUD2,"Glutamate dehydrogenase 2, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,DHCR7,7-dehydrocholesterol reductase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND2,NADH-ubiquinone oxidoreductase chain 2,target,binder,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AASS,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND3,NADH-ubiquinone oxidoreductase chain 3,target,binder,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS7,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 7, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,ALDH4A1,"Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,CYB5R3,NADH-cytochrome b5 reductase 3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA11,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 11,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND4,NADH-ubiquinone oxidoreductase chain 4,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,QDPR,Dihydropteridine reductase,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,target,binder,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NNT,"NAD(P) transhydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA9,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND4L,NADH-ubiquinone oxidoreductase chain 4L,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA10,"NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA7,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA1,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND6,NADH-ubiquinone oxidoreductase chain 6,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,MT-ND5,NADH-ubiquinone oxidoreductase chain 5,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA4,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA6,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFAB1,"Acyl carrier protein, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA2,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA8,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 8,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA3,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB8,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFC2,NADH dehydrogenase [ubiquinone] 1 subunit C2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB1,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS1,"NADH-ubiquinone oxidoreductase 75 kDa subunit, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB10,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 10,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB4,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 4,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB3,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB2,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 2, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB9,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS2,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 2, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB5,"NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFC1,"NADH dehydrogenase [ubiquinone] 1 subunit C1, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFB6,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFV3,"NADH dehydrogenase [ubiquinone] flavoprotein 3, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,DLD,"Dihydrolipoyl dehydrogenase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS3,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 3, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,GSR,"Glutathione reductase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA12,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 12,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS5,NADH dehydrogenase [ubiquinone] iron-sulfur protein 5,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS4,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFV1,"NADH dehydrogenase [ubiquinone] flavoprotein 1, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFV2,"NADH dehydrogenase [ubiquinone] flavoprotein 2, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA13,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,CDO1,Cysteine dioxygenase type 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFA4L2,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4-like 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,NDUFS8,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 8, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,CYP4A11,Cytochrome P450 4A11,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,DLAT,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,AMT,"Aminomethyltransferase, mitochondrial",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,SC4MOL,Methylsterol monooxygenase 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HMOX1,Heme oxygenase 1,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,HMOX2,Heme oxygenase 2,target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",target,,DB00157
NADH,Dietary SupplementsMicronutrientsSupplements,nutraceutical,TYR,Tyrosinase,target,,DB00157
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,FOLR2,Folate receptor beta,target,binder,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,FOLR3,Folate receptor gamma,target,binder,DB00158
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PPARD,Peroxisome proliferator-activated receptor delta,target,agonist,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FADS1,Fatty acid desaturase 1,target,agonist,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSL4,Long-chain-fatty-acid--CoA ligase 4,target,inducer,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSL3,Long-chain-fatty-acid--CoA ligase 3,target,inducer,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FFAR1,Free fatty acid receptor 1,target,agonist,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC8A1,Sodium/calcium exchanger 1,target,inhibitor,DB00159
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,TRPV1,Transient receptor potential cation channel subfamily V member 1,target,inducer,DB00159
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AGXT,Serine--pyruvate aminotransferase,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,inhibitor,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,KYNU,Kynureninase,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AARS2,"Alanine--tRNA ligase, mitochondrial",target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AGXT2L2,5-phosphohydroxy-L-lysine phospho-lyase,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GPT2,Alanine aminotransferase 2,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,GPT,Alanine aminotransferase 1,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,NFS1,"Cysteine desulfurase, mitochondrial",target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC36A1,Proton-coupled amino acid transporter 1,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC7A8,Large neutral amino acids transporter small subunit 2,target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AGXT2,"Alanine--glyoxylate aminotransferase 2, mitochondrial",target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,AARS,"Alanine--tRNA ligase, cytoplasmic",target,,DB00160
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC1A4,Neutral amino acid transporter A,target,,DB00160
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,PCCB,"Propionyl-CoA carboxylase beta chain, mitochondrial",target,,DB00161
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",target,,DB00161
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,VARS,Valine--tRNA ligase,target,,DB00161
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RDH12,Retinol dehydrogenase 12,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,DHRS3,Short-chain dehydrogenase/reductase 3,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,ALDH1A3,Aldehyde dehydrogenase family 1 member A3,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RETSAT,"All-trans-retinol 13,14-reductase",target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RDH11,Retinol dehydrogenase 11,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,DHRS4,Dehydrogenase/reductase SDR family member 4,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RDH14,Retinol dehydrogenase 14,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RDH8,Retinol dehydrogenase 8,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,LRAT,Lecithin retinol acyltransferase,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RBP1,Retinol-binding protein 1,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RDH5,11-cis retinol dehydrogenase,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RDH13,Retinol dehydrogenase 13,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RBP3,Retinol-binding protein 3,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,ALDH1A2,Retinal dehydrogenase 2,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,ALDH1A1,Retinal dehydrogenase 1,target,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RLBP1,Retinaldehyde-binding protein 1,target,,DB00162
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKCB,Protein kinase C beta type,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ALOX5,Arachidonate 5-lipoxygenase,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKCA,Protein kinase C alpha type,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,DGKA,Diacylglycerol kinase alpha,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PPP2CB,Serine/threonine-protein phosphatase 2A catalytic subunit beta isoform,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PPP2CA,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SEC14L4,SEC14-like protein 4,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SEC14L3,SEC14-like protein 3,target,,DB00163
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SEC14L2,SEC14-like protein 2,target,,DB00163
Lipoic Acid,Vitamin B ComplexAntioxidantsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,LIPT1,"Lipoyltransferase 1, mitochondrial",target,,DB00166
Lipoic Acid,Vitamin B ComplexAntioxidantsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,LIAS,"Lipoyl synthase, mitochondrial",target,,DB00166
Lipoic Acid,Vitamin B ComplexAntioxidantsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC5A6,Sodium-dependent multivitamin transporter,target,,DB00166
L-Isoleucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,IARS2,"Isoleucine--tRNA ligase, mitochondrial",target,,DB00167
L-Isoleucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB00167
L-Isoleucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",target,,DB00167
L-Isoleucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,,DB00167
L-Isoleucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,IARS,"Isoleucine--tRNA ligase, cytoplasmic",target,,DB00167
Aspartame,Sweetening AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,TRPV1,Transient receptor potential cation channel subfamily V member 1,target,inducer,DB00168
Aspartame,Sweetening AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,TAS1R2,Taste receptor type 1 member 2,target,agonist,DB00168
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,GGCX,Vitamin K-dependent gamma-carboxylase,target,cofactor,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,VKORC1,Vitamin K epoxide reductase complex subunit 1,target,cofactor,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,VKORC1L1,Vitamin K epoxide reductase complex subunit 1-like protein 1,target,cofactor,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,F2,Prothrombin,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,F7,Coagulation factor VII,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,F9,Coagulation factor IX,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,F10,Coagulation factor X,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PROC,Vitamin K-dependent protein C,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PROS1,Vitamin K-dependent protein S,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PROZ,Vitamin K-dependent protein Z,target,activator,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB00170
Menadione,VitaminsAntifibrinolytic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,BGLAP,Osteocalcin,target,agonist,DB00170
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABL2,Abelson tyrosine-protein kinase 2,target,inhibitor,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCB1,Multidrug resistance protein 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCG1,ATP-binding cassette sub-family G member 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC2,Canalicular multispecific organic anion transporter 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCA1,ATP-binding cassette sub-family A member 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSS2,"Acetyl-coenzyme A synthetase, cytoplasmic",target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,,ALK tyrosine kinase receptor,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,NAE1,NEDD8-activating enzyme E1 regulatory subunit,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PRKAA1,5'-AMP-activated protein kinase catalytic subunit alpha-1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ARAF,Serine/threonine-protein kinase A-Raf,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACVRL1,Serine/threonine-protein kinase receptor R3,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSL1,Long-chain-fatty-acid--CoA ligase 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,NT5C2,Cytosolic purine 5'-nucleotidase,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ASNA1,ATPase ASNA1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC9,ATP-binding cassette sub-family C member 9,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AKT1,RAC-alpha serine/threonine-protein kinase,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ADRBK1,Beta-adrenergic receptor kinase 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,APAF1,Apoptotic protease-activating factor 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACSS1,"Acetyl-coenzyme A synthetase 2-like, mitochondrial",target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACVR1B,Activin receptor type-1B,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACVR1,Activin receptor type-1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCB11,Bile salt export pump,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ASNS,Asparagine synthetase [glutamine-hydrolyzing],target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,CDK15,Cyclin-dependent kinase 15,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC25A4,ADP/ATP translocase 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC8,ATP-binding cassette sub-family C member 8,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ASS1,Argininosuccinate synthase,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AFG3L2,AFG3-like protein 2,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ADRBK2,Beta-adrenergic receptor kinase 2,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,AMHR2,Anti-Muellerian hormone type-2 receptor,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,TNK2,Activated CDC42 kinase 1,target,,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABL1,Tyrosine-protein kinase ABL1,target,inhibitor,DB00171
Adenosine triphosphate,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ADCY1,Adenylate cyclase type 1,target,,DB00171
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,P4HA2,Prolyl 4-hydroxylase subunit alpha-2,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PRODH,"Proline dehydrogenase 1, mitochondrial",target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PPIH,Peptidyl-prolyl cis-trans isomerase H,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PROSC,Proline synthase co-transcribed bacterial homolog protein,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,P4HA1,Prolyl 4-hydroxylase subunit alpha-1,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PPIB,Peptidyl-prolyl cis-trans isomerase B,target,binder,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PPIC,Peptidyl-prolyl cis-trans isomerase C,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PPIA,Peptidyl-prolyl cis-trans isomerase A,target,binder,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PPIG,Peptidyl-prolyl cis-trans isomerase G,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,LEPRE1,Prolyl 3-hydroxylase 1,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,P5CR2,Pyrroline-5-carboxylate reductase,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PARS2,"Probable proline--tRNA ligase, mitochondrial",target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,LEPREL1,Prolyl 3-hydroxylase 2,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,LEPREL2,Prolyl 3-hydroxylase 3,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PYCRL,Pyrroline-5-carboxylate reductase 3,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,C14orf149,Trans-L-3-hydroxyproline dehydratase,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PYCR1,"Pyrroline-5-carboxylate reductase 1, mitochondrial",target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,EPRS,Bifunctional glutamate/proline--tRNA ligase,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC6A14,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC6A7,Sodium-dependent proline transporter,target,,DB00172
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,PYCR2,Pyrroline-5-carboxylate reductase 2,target,,DB00172
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,APRT,Adenine phosphoribosyltransferase,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACACB,Acetyl-CoA carboxylase 2,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ACP1,Low molecular weight phosphotyrosine protein phosphatase,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,PECR,Peroxisomal trans-2-enoyl-CoA reductase,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,mutY,A/G-specific adenine glycosylase,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ptd,Nucleoside deoxyribosyltransferase-I,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SRPK2,SRSF protein kinase 2,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ruvB,Holliday junction ATP-dependent DNA helicase RuvB,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,MTAP,S-methyl-5'-thioadenosine phosphorylase,target,,DB00173
Adenine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB00173
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC1A5,Neutral amino acid transporter B(0),target,,DB00174
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASRGL1,Isoaspartyl peptidase/L-asparaginase,target,,DB00174
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,NARS2,"Probable asparagine--tRNA ligase, mitochondrial",target,,DB00174
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC38A3,Sodium-coupled neutral amino acid transporter 3,target,,DB00174
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,ASNS,Asparagine synthetase [glutamine-hydrolyzing],target,,DB00174
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,NARS,"Asparagine--tRNA ligase, cytoplasmic",target,,DB00174
Baclofen,"Neuromuscular AgentsMuscle relaxant, Skeletal",approved,GABBR1,Gamma-aminobutyric acid type B receptor subunit 1,target,agonist,DB00181
Baclofen,"Neuromuscular AgentsMuscle relaxant, Skeletal",approved,GABBR2,Gamma-aminobutyric acid type B receptor subunit 2,target,agonist,DB00181
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,negative modulator,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,CARTPT,Cocaine- and amphetamine-regulated transcript protein,target,agonist,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,TAAR1,Trace amine-associated receptor 1,target,agonist,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,stimulator,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,ADRA1A,Alpha adrenergic receptor,target,agonist,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,ADRB1,Beta adrenergic receptor,target,agonist,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,DRD2,D(2) dopamine receptor,target,binder,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,MAOB,Amine oxidase [flavin-containing] B,target,,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,SLC6A4,Sodium-dependent serotonin transporter,target,binder,DB00182
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNB2,Neuronal acetylcholine receptor subunit beta-2,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA5,Neuronal acetylcholine receptor subunit alpha-5,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA9,Neuronal acetylcholine receptor subunit alpha-9,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNB3,Neuronal acetylcholine receptor subunit beta-3,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHRNB4,Neuronal acetylcholine receptor subunit beta-4,target,agonist,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CYP19A1,Cytochrome P450 19A1,target,,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,CHAT,Choline O-acetyltransferase,target,,DB00184
Cevimeline,,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,agonist,DB00185
Cevimeline,,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,agonist,DB00185
Lorazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00186
Lorazepam,Hypnotics and SedativesBenzodiazepines,approved,TSPO,Translocator protein,target,other,DB00186
Bortezomib,,approvedinvestigational,PSMD2,26S proteasome non-ATPase regulatory subunit 2,target,inhibitor,DB00188
Bortezomib,,approvedinvestigational,PSMB1,Proteasome subunit beta type-1,target,antagonist,DB00188
Bortezomib,,approvedinvestigational,PSMB5,Proteasome subunit beta type-5,target,antagonist,DB00188
Bortezomib,,approvedinvestigational,PSMB2,Proteasome subunit beta type-2,target,antagonist,DB00188
Bortezomib,,approvedinvestigational,PSMD1,26S proteasome non-ATPase regulatory subunit 1,target,inhibitor,DB00188
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,MAOA,Amine oxidase [flavin-containing] A,target,antagonist,DB00191
Phentermine,Adrenergic AgentsCentral Nervous System StimulantsSympathomimeticsAppetite DepressantsStimulants,approvedillicit,MAOB,Amine oxidase [flavin-containing] B,target,antagonist,DB00191
Tramadol,,approvedinvestigational,OPRM1,Mu-type opioid receptor,target,agonist,DB00193
Tramadol,,approvedinvestigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00193
Tramadol,,approvedinvestigational,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00193
Tramadol,,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00193
Tramadol,,approvedinvestigational,OPRK1,Kappa-type opioid receptor,target,agonist,DB00193
Tramadol,,approvedinvestigational,OPRD1,Delta-type opioid receptor,target,agonist,DB00193
Tramadol,,approvedinvestigational,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00193
Tramadol,,approvedinvestigational,CHRFAM7A,Alpha-7 nicotinic cholinergic receptor subunit,target,antagonist,DB00193
Tramadol,,approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00193
Vidarabine,Antiviral AgentsAntimetabolites,approved,BALF5,DNA polymerase catalytic subunit,target,inhibitor,DB00194
Vidarabine,Antiviral AgentsAntimetabolites,approved,ORF36,Thymidine kinase,target,inducer,DB00194
Vidarabine,Antiviral AgentsAntimetabolites,approved,TK,Thymidine kinase,target,inducer,DB00194
Betaxolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsEENT Preparations,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00195
Betaxolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsEENT Preparations,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00195
Troglitazone,,withdrawn,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00197
Troglitazone,,withdrawn,ACSL4,Long-chain-fatty-acid--CoA ligase 4,target,inhibitor,DB00197
Troglitazone,,withdrawn,SERPINE1,Plasminogen activator inhibitor 1,target,antagonist,DB00197
Troglitazone,,withdrawn,SLC29A1,Equilibrative nucleoside transporter 1,target,inhibitor,DB00197
Troglitazone,,withdrawn,ESRRG,Estrogen-related receptor gamma,target,inverse agonist,DB00197
Troglitazone,,withdrawn,ESRRA,Steroid hormone receptor ERR1,target,inverse agonist,DB00197
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,NA,Neuraminidase,target,inhibitor,DB00198
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,CES1,Liver carboxylesterase 1,target,other,DB00198
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,NEU1,Sialidase-1,target,inhibitor,DB00198
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,NEU2,Sialidase-2,target,inhibitor,DB00198
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,rplV,50S ribosomal protein L22,target,inhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,rplD,50S ribosomal protein L4,target,inhibitor,DB00199
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,MTR,Methionine synthase,target,cofactor,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,MUT,"Methylmalonyl-CoA mutase, mitochondrial",target,cofactor,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,MTRR,Methionine synthase reductase,target,other,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,MMAA,"Methylmalonic aciduria type A protein, mitochondrial",target,other/unknown,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,TCN1,Transcobalamin-1,target,other,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,AMN,Protein amnionless,target,other,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,CUBN,Cubilin,target,other,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,MMAB,"Cob(I)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",target,other,DB00200
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,MMACHC,Methylmalonic aciduria and homocystinuria type C protein,target,other/unknown,DB00200
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,ADORA1,Adenosine receptor A1,target,antagonistmultitarget,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,ADORA2A,Adenosine receptor A2a,target,antagonistmultitarget,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,RYR1,Ryanodine receptor 1,target,,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,PDE1A,Cyclic nucleotide phosphodiesterase,target,"inhibitor, competitive",DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,PRKDC,DNA-dependent protein kinase catalytic subunit,target,,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,PIK3CD,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",target,,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",target,,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,PIK3CB,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",target,,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,ITPR1,"Inositol 1,4,5-trisphosphate receptor",target,,DB00201
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,,Serine-protein kinase ATM,target,,DB00201
Succinylcholine,"Neuromuscular Depolarizing AgentsMuscle relaxant, Skeletal",approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,agonist,DB00202
Succinylcholine,"Neuromuscular Depolarizing AgentsMuscle relaxant, Skeletal",approved,CHRFAM7A,Alpha-7 nicotinic cholinergic receptor subunit,target,agonist,DB00202
Succinylcholine,"Neuromuscular Depolarizing AgentsMuscle relaxant, Skeletal",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,agonist,DB00202
Succinylcholine,"Neuromuscular Depolarizing AgentsMuscle relaxant, Skeletal",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,agonist,DB00202
Succinylcholine,"Neuromuscular Depolarizing AgentsMuscle relaxant, Skeletal",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,agonist,DB00202
Sildenafil,,approvedinvestigational,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB00203
Sildenafil,,approvedinvestigational,PDE6G,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,inhibitor,DB00203
Sildenafil,,approvedinvestigational,PDE6H,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,inhibitor,DB00203
Dofetilide,Anti-Arrhythmia AgentsPotassium Channel Blockers,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00204
Dofetilide,Anti-Arrhythmia AgentsPotassium Channel Blockers,approved,KCNK2,Potassium channel subfamily K member 2,target,inhibitor,DB00204
Dofetilide,Anti-Arrhythmia AgentsPotassium Channel Blockers,approved,KCNJ12,ATP-sensitive inward rectifier potassium channel 12,target,inhibitor,DB00204
Pyrimethamine,AntimalarialsAntiprotozoal AgentsFolic Acid Antagonists,approved,DHFR,Dihydrofolate reductase,target,inhibitor,DB00205
Pyrimethamine,AntimalarialsAntiprotozoal AgentsFolic Acid Antagonists,approved,,Bifunctional dihydrofolate reductase-thymidylate synthase,target,inhibitor,DB00205
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB00206
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,SLC18A1,Chromaffin granule amine transporter,target,,DB00206
Azithromycin,Anti-Bacterial AgentsMacrolides,approved,rplD,50S ribosomal protein L4,target,inhibitor,DB00207
Azithromycin,Anti-Bacterial AgentsMacrolides,approved,rplV,50S ribosomal protein L22,target,inhibitor,DB00207
Adapalene,"Anti-Inflammatory Agents, Non-SteroidalDermatologic Agents",approved,RARG,Retinoic acid receptor gamma,target,agonist,DB00210
Adapalene,"Anti-Inflammatory Agents, Non-SteroidalDermatologic Agents",approved,RARB,Retinoic acid receptor beta,target,agonist,DB00210
Adapalene,"Anti-Inflammatory Agents, Non-SteroidalDermatologic Agents",approved,RXRG,Retinoic acid receptor RXR-gamma,target,agonist,DB00210
Adapalene,"Anti-Inflammatory Agents, Non-SteroidalDermatologic Agents",approved,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00210
Adapalene,"Anti-Inflammatory Agents, Non-SteroidalDermatologic Agents",approved,RARA,Retinoic acid receptor alpha,target,agonist,DB00210
Adapalene,"Anti-Inflammatory Agents, Non-SteroidalDermatologic Agents",approved,RXRA,Retinoic acid receptor RXR-alpha,target,other/unknown,DB00210
Midodrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00211
Midodrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB00211
Midodrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB00211
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,HRH1,Histamine H1 receptor,target,binder,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,ADRA1A,Alpha-1A adrenergic receptor,target,binder,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,binder,DB00215
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1F,5-hydroxytryptamine receptor 1F,target,agonist,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1E,5-hydroxytryptamine receptor 1E,target,agonist,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB00216
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR7,5-hydroxytryptamine receptor 7,target,agonist,DB00216
Bethanidine,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,ADRA2A,Alpha-2 adrenergic receptor,target,agonist,DB00217
Bethanidine,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inhibitor,DB00217
Bethanidine,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,ADRB1,Beta adrenergic receptor,target,antagonist,DB00217
Moxifloxacin,Quinolones,approvedinvestigational,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00218
Moxifloxacin,Quinolones,approvedinvestigational,gyrA,DNA gyrase subunit A,target,inhibitor,DB00218
Moxifloxacin,Quinolones,approvedinvestigational,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00218
Isoetarine,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB00221
Isoetarine,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00221
Glimepiride,Hypoglycemic AgentsImmunosuppressive AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,inhibitor,DB00222
Glimepiride,Hypoglycemic AgentsImmunosuppressive AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inhibitor,DB00222
Glimepiride,Hypoglycemic AgentsImmunosuppressive AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,inducer,DB00222
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,ITGAL,Integrin alpha-L,target,other/unknown,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,HDAC2,Histone deacetylase 2,target,other,DB00227
Enflurane,"Anesthetics, InhalationAnesthetics",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00228
Enflurane,"Anesthetics, InhalationAnesthetics",approved,GLRA1,Glycine receptor (alpha-1/beta),target,agonist,DB00228
Enflurane,"Anesthetics, InhalationAnesthetics",approved,KCNN4,Intermediate conductance calcium-activated potassium channel protein 4,target,inhibitor,DB00228
Enflurane,"Anesthetics, InhalationAnesthetics",approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inducer,DB00228
Enflurane,"Anesthetics, InhalationAnesthetics",approved,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,inhibitor,DB00228
Enflurane,"Anesthetics, InhalationAnesthetics",approved,GRIA1,Glutamate receptor 1,target,antagonist,DB00228
Enflurane,"Anesthetics, InhalationAnesthetics",approved,ATP5D,"ATP synthase subunit delta, mitochondrial",target,other/unknown,DB00228
Temazepam,Benzodiazepines,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB00231
Temazepam,Benzodiazepines,approved,TSPO,Translocator protein,target,other,DB00231
Temazepam,Benzodiazepines,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00231
Methyclothiazide,Sodium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00232
Methyclothiazide,Sodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00232
Methyclothiazide,Sodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00232
Methyclothiazide,Sodium Chloride Symporter Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00232
Aminosalicylic Acid,Antitubercular Agents,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00233
Aminosalicylic Acid,Antitubercular Agents,approved,CHUK,Inhibitor of nuclear factor kappa-B kinase subunit alpha,target,inhibitor,DB00233
Aminosalicylic Acid,Antitubercular Agents,approved,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00233
Aminosalicylic Acid,Antitubercular Agents,approved,PLA2G2E,Group IIE secretory phospholipase A2,target,unknown,DB00233
Aminosalicylic Acid,Antitubercular Agents,approved,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,unknown,DB00233
Butabarbital,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00237
Butabarbital,Hypnotics and SedativesBarbiturates,approvedillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00237
Butabarbital,Hypnotics and SedativesBarbiturates,approvedillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00237
Butabarbital,Hypnotics and SedativesBarbiturates,approvedillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB00237
Butabarbital,Hypnotics and SedativesBarbiturates,approvedillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00237
Oxiconazole,Antifungal Agents,approved,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB00239
Oxiconazole,Antifungal Agents,approved,ERG7,Lanosterol synthase,target,inhibitor,DB00239
Butalbital,,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00241
Butalbital,,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00241
Butalbital,,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00241
Butalbital,,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00241
Butalbital,,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00241
Butalbital,,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00241
Butalbital,,approvedillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00241
Butalbital,,approvedillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00241
Butalbital,,approvedillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB00241
Butalbital,,approvedillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00241
Butalbital,,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00241
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,RRM2,Ribonucleoside-diphosphate reductase subunit M2,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,POLA1,DNA polymerase alpha catalytic subunit,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,POLE,DNA polymerase epsilon catalytic subunit A,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,POLE2,DNA polymerase epsilon subunit 2,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,POLE3,DNA polymerase epsilon subunit 3,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,POLE4,DNA polymerase epsilon subunit 4,target,inhibitor,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,PNP,Purine nucleoside phosphorylase,target,inducer,DB00242
Ranolazine,,approvedinvestigational,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00243
Ranolazine,,approvedinvestigational,SCN9A,Sodium channel protein type 9 subunit alpha,target,inhibitor,DB00243
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,CHUK,Inhibitor of nuclear factor kappa-B kinase subunit alpha,target,inhibitor,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,inhibitor,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,MPO,Myeloperoxidase,target,,DB00244
Mesalazine,"Anti-Inflammatory Agents, Non-Steroidal",approved,nat,Arylamine N-acetyltransferase,target,,DB00244
Benzatropine,Dopamine Uptake InhibitorsAntiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00245
Benzatropine,Dopamine Uptake InhibitorsAntiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00245
Benzatropine,Dopamine Uptake InhibitorsAntiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00245
Ziprasidone,Antipsychotic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,DRD5,D(1B) dopamine receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR1E,5-hydroxytryptamine receptor 1E,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00246
Ziprasidone,Antipsychotic Agents,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00246
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,binder,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR1F,5-hydroxytryptamine receptor 1F,target,binder,DB00247
Methysergide,Vasoconstrictor AgentsSerotonin Antagonists,approved,HTR1E,5-hydroxytryptamine receptor 1E,target,binder,DB00247
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,DRD2,D(2) dopamine receptor,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,DRD3,D(3) dopamine receptor,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,DRD4,D(4) dopamine receptor,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,DRD5,D(1B) dopamine receptor,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,DRD1,D(1A) dopamine receptor,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,binder,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,binder,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,binder,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRB1,Beta-1 adrenergic receptor,target,binder,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,ADRB2,Beta-2 adrenergic receptor,target,binder,DB00248
Cabergoline,Antineoplastic AgentsAntiparkinson AgentsDopamine Agonists,approved,DRD1,D(1) dopamine receptor,target,agonist,DB00248
Idoxuridine,Antiviral AgentsNucleic Acid Synthesis Inhibitors,approved,TK,Thymidine kinase,target,unknown,DB00249
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,folP2,Inactive dihydropteroate synthase 2,target,inhibitor,DB00250
Dapsone,AntimalarialsFolic Acid AntagonistsAnti-Infective AgentsLeprostatic AgentsAntimycobacterials,approvedinvestigational,folP1,Dihydropteroate synthase 1,target,inhibitor,DB00250
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB00252
Doxycycline,Anti-Bacterial AgentsAntimalarialsTetracyclines,approvedinvestigational,rpsI,30S ribosomal protein S9,target,inhibitor,DB00254
Doxycycline,Anti-Bacterial AgentsAntimalarialsTetracyclines,approvedinvestigational,rpsD,30S ribosomal protein S4,target,inhibitor,DB00254
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,ESR1,Estrogen receptor,target,agonist,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,ESRRG,Estrogen-related receptor gamma,target,agonist,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,ESR2,Estrogen receptor beta,target,agonist,DB00255
Lymecycline,Anti-Bacterial AgentsAntiprotozoal AgentsTetracyclines,approved,rpsI,30S ribosomal protein S9,target,inhibitor,DB00256
Lymecycline,Anti-Bacterial AgentsAntiprotozoal AgentsTetracyclines,approved,rpsD,30S ribosomal protein S4,target,inhibitor,DB00256
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,ERG11,Lanosterol 14-alpha demethylase,target,antagonistinhibitor,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,KCNN4,Intermediate conductance calcium-activated potassium channel protein 4,target,inhibitor,DB00257
Cycloserine,"AntimetabolitesAnti-Infective Agents, UrinaryAntibiotics, AntitubercularAntibiotics",approved,ddlA,D-alanine--D-alanine ligase A,target,inhibitor,DB00260
Cycloserine,"AntimetabolitesAnti-Infective Agents, UrinaryAntibiotics, AntitubercularAntibiotics",approved,alr,Alanine racemase,target,inhibitor,DB00260
Carmustine,"Antineoplastic Agents, Alkylating",approved,GSR,"Glutathione reductase, mitochondrial",target,inhibitor,DB00262
Metoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00264
Metoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00264
Dicoumarol,AnticoagulantsEnzyme InhibitorsUncoupling Agents,approved,VKORC1,Vitamin K epoxide reductase complex subunit 1,target,inhibitor,DB00266
Dicoumarol,AnticoagulantsEnzyme InhibitorsUncoupling Agents,approved,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,inhibitor,DB00266
Dicoumarol,AnticoagulantsEnzyme InhibitorsUncoupling Agents,approved,CRYZ,Quinone oxidoreductase,target,inhibitor,DB00266
Cefmenoxime,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00267
Cefmenoxime,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB00267
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD3,D(3) dopamine receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD2,D(2) dopamine receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD4,D(4) dopamine receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD5,D(1B) dopamine receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00268
Ropinirole,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00268
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00270
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB00270
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB00270
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB00270
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,inhibitor,DB00270
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00270
Isradipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB00270
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB00273
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB00273
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,GRIK1,"Glutamate receptor ionotropic, kainate 1",target,antagonist,DB00273
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00273
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00273
Topiramate,AnticonvulsantsAnti-Obesity AgentsNeuroprotective Agents,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00273
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,mecA,Penicillin binding protein 2a,target,inhibitor,DB00274
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB00274
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB00274
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB00274
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,dacA,D-alanyl-D-alanine carboxypeptidase DacA,target,inhibitor,DB00274
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,dacC,D-alanyl-D-alanine carboxypeptidase DacC,target,inhibitor,DB00274
Amsacrine,Antineoplastic AgentsIntercalating Agents,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00276
Amsacrine,Antineoplastic AgentsIntercalating Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00276
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,ADORA1,Adenosine receptor A1,target,antagonist,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,ADORA2A,Adenosine receptor A2a,target,antagonist,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,ADORA2B,Adenosine receptor A2b,target,antagonist,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB00277
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,HDAC2,Histone deacetylase 2,target,activator,DB00277
Liothyronine,Hormone Replacement Agents,approved,THRA,Thyroid hormone receptor alpha,target,agonist,DB00279
Liothyronine,Hormone Replacement Agents,approved,THRB,Thyroid hormone receptor beta,target,agonist,DB00279
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00280
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00280
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00280
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00280
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,KCND2,Potassium voltage-gated channel subfamily D member 2,target,inhibitor,DB00280
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,KCND3,Potassium voltage-gated channel subfamily D member 3,target,inhibitor,DB00280
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,SCN9A,Sodium channel protein type 9 subunit alpha,target,inhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,EGFR,Epidermal growth factor receptor,target,antagonist,DB00281
Pamidronate,Bone Density Conservation AgentsBisphosphonates,approved,FDPS,Farnesyl pyrophosphate synthase,target,inhibitor,DB00282
Acarbose,,approvedinvestigational,MGAM,"Maltase-glucoamylase, intestinal",target,inhibitor,DB00284
Acarbose,,approvedinvestigational,AMY2A,Pancreatic alpha-amylase,target,inhibitor,DB00284
Acarbose,,approvedinvestigational,GAA,Lysosomal alpha-glucosidase,target,inhibitor,DB00284
Acarbose,,approvedinvestigational,SI,"Sucrase-isomaltase, intestinal",target,inhibitor,DB00284
Venlafaxine,Antidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00285
Venlafaxine,Antidepressive Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00285
Venlafaxine,Antidepressive Agents,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00285
Amcinonide,GlucocorticoidsCorticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00288
Amcinonide,GlucocorticoidsCorticosteroids,approved,ANXA1,Annexin A1,target,agonist,DB00288
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB00289
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,,DB00289
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A3,Sodium-dependent dopamine transporter,target,binder,DB00289
Atomoxetine,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,GRIN1,NMDA receptor,target,blocker,DB00289
Bleomycin,"Antibiotics, Antineoplastic",approved,LIG1,DNA ligase 1,target,inhibitor,DB00290
Bleomycin,"Antibiotics, Antineoplastic",approved,LIG3,DNA ligase 3,target,inhibitor,DB00290
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB00292
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00292
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00292
Raltitrexed,,approvedinvestigational,TYMS,Thymidylate synthase,target,inhibitor,DB00293
Raltitrexed,,approvedinvestigational,FPGS,"Folylpolyglutamate synthase, mitochondrial",target,antagonist,DB00293
Etonogestrel,Contraceptive Agents,approvedinvestigational,PGR,Progesterone receptor,target,agonist,DB00294
Etonogestrel,Contraceptive Agents,approvedinvestigational,ESR1,Estrogen receptor,target,agonist,DB00294
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,OPRM1,Mu-type opioid receptor,target,agonist,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,OPRK1,Kappa-type opioid receptor,target,agonist,DB00295
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,OPRD1,Delta-type opioid receptor,target,agonist,DB00295
Bupivacaine,"Anesthetics, Local",approvedinvestigational,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00297
Bupivacaine,"Anesthetics, Local",approvedinvestigational,PTGER1,Prostaglandin E2 receptor EP1 subtype,target,other/unknown,DB00297
Dapiprazole,Antimydriatic AgentsOphthalmics,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00298
Dapiprazole,Antimydriatic AgentsOphthalmics,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00298
Dapiprazole,Antimydriatic AgentsOphthalmics,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00298
Penciclovir,Antiviral Agents,approved,UL30,DNA polymerase catalytic subunit,target,inhibitor,DB00299
Penciclovir,Antiviral Agents,approved,TK,Thymidine kinase,target,inducer,DB00299
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,mrdA,Penicillin-binding protein 2,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,mrdA,Penicillin-binding protein 2,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB00303
Ertapenem,Anti-Bacterial Agents,approvedinvestigational,dacC,D-alanyl-D-alanine carboxypeptidase DacC,target,inhibitor,DB00303
Desogestrel,"Contraceptives, Oral, SyntheticProgestins",approved,PGR,Progesterone receptor,target,agonist,DB00304
Desogestrel,"Contraceptives, Oral, SyntheticProgestins",approved,ESR1,Estrogen receptor,target,agonist,DB00304
Talbutal,,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00306
Talbutal,,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00306
Talbutal,,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00306
Talbutal,,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00306
Talbutal,,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00306
Talbutal,,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00306
Talbutal,,approvedillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00306
Talbutal,,approvedillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00306
Talbutal,,approvedillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB00306
Talbutal,,approvedillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00306
Talbutal,,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00306
Bexarotene,,approvedinvestigational,RXRA,Retinoic acid receptor RXR-alpha,target,agonist,DB00307
Bexarotene,,approvedinvestigational,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00307
Bexarotene,,approvedinvestigational,RXRG,Retinoic acid receptor RXR-gamma,target,agonist,DB00307
Ibutilide,Anti-Arrhythmia Agents,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,activator,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,target,activator,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,activator,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,CACNG1,Voltage-dependent calcium channel gamma-1 subunit,target,activator,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,KCNK1,Potassium channel subfamily K member 1,target,inhibitor,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,KCNK6,Potassium channel subfamily K member 6,target,inhibitor,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,KCNH6,Potassium voltage-gated channel subfamily H member 6,target,inhibitor,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,KCNH7,Potassium voltage-gated channel subfamily H member 7,target,inhibitor,DB00308
Ibutilide,Anti-Arrhythmia Agents,approved,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,inhibitor,DB00308
Ethoxzolamide,DiureticsCarbonic Anhydrase Inhibitors,withdrawn,CA1,Carbonic anhydrase 1,target,inhibitor,DB00311
Ethoxzolamide,DiureticsCarbonic Anhydrase Inhibitors,withdrawn,CA2,Carbonic anhydrase 2,target,inhibitor,DB00311
Ethoxzolamide,DiureticsCarbonic Anhydrase Inhibitors,withdrawn,CA4,Carbonic anhydrase 4,target,inhibitor,DB00311
Ethoxzolamide,DiureticsCarbonic Anhydrase Inhibitors,withdrawn,CA7,Carbonic anhydrase 7,target,inhibitor,DB00311
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GRIA2,Glutamate receptor 2,target,antagonist,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00312
Pentobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbiturates",approved,GRIN1,NMDA receptor,target,antagonist,DB00312
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,HDAC9,Histone deacetylase 9,target,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",target,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,OGDH,"2-oxoglutarate dehydrogenase, mitochondrial",target,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",target,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,SCN1A,Sodium channel protein,target,,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,HDAC2,Histone deacetylase 2,target,,DB00313
Zolmitriptan,Serotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00315
Zolmitriptan,Serotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00315
Zolmitriptan,Serotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1F,5-hydroxytryptamine receptor 1F,target,agonist,DB00315
Zolmitriptan,Serotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00315
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00316
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,OPRM1,Mu-type opioid receptor,target,partial agonist,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,OPRK1,Kappa-type opioid receptor,target,partial agonist,DB00318
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB00318
Piperacillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00319
Piperacillin,Anti-Bacterial AgentsPenicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00319
Piperacillin,Anti-Bacterial AgentsPenicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00319
Piperacillin,Anti-Bacterial AgentsPenicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00319
Dihydroergotamine,"Vasoconstrictor AgentsDopamine AgonistsAnalgesics, Non-NarcoticAnti-migraine Agents",approved,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00320
Dihydroergotamine,"Vasoconstrictor AgentsDopamine AgonistsAnalgesics, Non-NarcoticAnti-migraine Agents",approved,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00320
Dihydroergotamine,"Vasoconstrictor AgentsDopamine AgonistsAnalgesics, Non-NarcoticAnti-migraine Agents",approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00320
Dihydroergotamine,"Vasoconstrictor AgentsDopamine AgonistsAnalgesics, Non-NarcoticAnti-migraine Agents",approved,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB00320
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,OPRD1,Delta-type opioid receptor,target,agonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,NTRK1,High affinity nerve growth factor receptor,target,agonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,NTRK2,BDNF/NT-3 growth factors receptor,target,agonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,KCND2,Potassium voltage-gated channel subfamily D member 2,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,KCND3,Potassium voltage-gated channel subfamily D member 3,target,inhibitor,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HRH2,Histamine H2 receptor,target,blocker,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HRH4,Histamine H4 receptor,target,binder,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,agonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,binder,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR1D,5-hydroxytryptamine receptor 1D,target,binder,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,OPRM1,Mu-type opioid receptor,target,binder,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR1B,5-hydroxytryptamine receptor 1B,target,binder,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,target,,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ADRB1,Beta adrenergic receptor,target,binder,DB00321
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB00327
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,OPRD1,Delta-type opioid receptor,target,partial agonist,DB00327
Hydromorphone,"Analgesics, OpioidNarcotics",approvedillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB00327
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,PLA2G2A,"Phospholipase A2, membrane associated",target,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,PTGR2,Prostaglandin reductase 2,target,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,activator,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,GLO1,Lactoylglutathione lyase,target,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,GPR44,Prostaglandin D2 receptor 2,target,other/unknown,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,PPARA,Peroxisome proliferator-activated receptor alpha,target,agonist,DB00328
Ethambutol,Antitubercular Agents,approved,embC,Probable arabinosyltransferase C,target,inhibitor,DB00330
Ethambutol,Antitubercular Agents,approved,embB,Probable arabinosyltransferase B,target,inhibitor,DB00330
Ethambutol,Antitubercular Agents,approved,embA,Probable arabinosyltransferase A,target,inhibitor,DB00330
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00332
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00332
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00332
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,OPRM1,Mu-type opioid receptor,target,agonist,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,antagonist,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,OPRD1,Delta-type opioid receptor,target,agonist,DB00333
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00333
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonistagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,DRD5,D(1B) dopamine receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,DRD3,D(3) dopamine receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,DRD4,D(4) dopamine receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR1E,5-hydroxytryptamine receptor 1E,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,,5-hydroxytryptamine receptor 5A,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,DRD1,D(1) dopamine receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HRH2,Histamine H2 receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,HRH4,Histamine H4 receptor,target,antagonist,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,GABRA1,GABA-A receptor (anion channel),target,,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ADRB1,Beta adrenergic receptor,target,,DB00334
Atenolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00335
Atenolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,,DB00335
Nitrofural,Anti-Infective Agents,approved,poxB,Pyruvate dehydrogenase [ubiquinone],target,inhibitor,DB00336
Nitrofural,Anti-Infective Agents,approved,gor,Glutathione reductase,target,inhibitor,DB00336
Nitrofural,Anti-Infective Agents,approved,mdh,Malate dehydrogenase,target,inhibitor,DB00336
Nitrofural,Anti-Infective Agents,approved,citC,[Citrate [pro-3S]-lyase] ligase,target,inhibitor,DB00336
Pimecrolimus,"Anti-Inflammatory Agents, Non-SteroidalDermatologic AgentsImmunosuppressive Agents",approvedinvestigational,MTOR,Serine/threonine-protein kinase mTOR,target,potentiator,DB00337
Pimecrolimus,"Anti-Inflammatory Agents, Non-SteroidalDermatologic AgentsImmunosuppressive Agents",approvedinvestigational,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,potentiator,DB00337
Metixene,,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00340
Metixene,,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00340
Metixene,,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00340
Metixene,,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00340
Metixene,,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00340
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,HRH1,Histamine H1 receptor,target,antagonist,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CHRM1,Muscarinic acetylcholine receptor M1,target,binder,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CHRM5,Muscarinic acetylcholine receptor M5,target,binder,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CHRM4,Muscarinic acetylcholine receptor M4,target,binder,DB00342
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,CHRM2,Muscarinic acetylcholine receptor M2,target,binder,DB00342
Protriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00344
Protriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00344
Alfuzosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00346
Alfuzosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00346
Alfuzosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00346
Alfuzosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor Antagonists,approvedinvestigational,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,,DB00346
Minoxidil,Antihypertensive AgentsVasodilator Agents,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inducer,DB00350
Minoxidil,Antihypertensive AgentsVasodilator Agents,approved,PTGS1,Prostaglandin G/H synthase 1,target,inducer,DB00350
Megestrol acetate,"Antineoplastic Agents, HormonalAppetite Stimulants",approved,PGR,Progesterone receptor,target,agonist,DB00351
Megestrol acetate,"Antineoplastic Agents, HormonalAppetite Stimulants",approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00351
Buclizine,Cholinergic AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00354
Buclizine,Cholinergic AntagonistsHistamine Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00354
Aztreonam,Anti-Bacterial Agents,approved,pbpC,Penicillin-binding protein 3,target,inhibitor,DB00355
Aztreonam,Anti-Bacterial Agents,approved,ampC,Beta-lactamase,target,potentiator,DB00355
Aminoglutethimide,"Antineoplastic Agents, HormonalAromatase Inhibitors",approved,CYP19A1,Cytochrome P450 19A1,target,inhibitor,DB00357
Aminoglutethimide,"Antineoplastic Agents, HormonalAromatase Inhibitors",approved,CYP11A1,"Cholesterol side-chain cleavage enzyme, mitochondrial",target,inhibitor,DB00357
Mefloquine,Antimalarials,approved,HBA1,Hemoglobin subunit alpha,target,antagonist,DB00358
Mefloquine,Antimalarials,approved,ADORA2A,Adenosine receptor A2a,target,antagonist,DB00358
Tetrahydrobiopterin,Dietary SupplementsSupplements,approvedinvestigational,NOS3,"Nitric oxide synthase, endothelial",target,cofactor,DB00360
Tetrahydrobiopterin,Dietary SupplementsSupplements,approvedinvestigational,PAH,Phenylalanine-4-hydroxylase,target,cofactor,DB00360
Tetrahydrobiopterin,Dietary SupplementsSupplements,approvedinvestigational,TH,Tyrosine 3-monooxygenase,target,cofactor,DB00360
Tetrahydrobiopterin,Dietary SupplementsSupplements,approvedinvestigational,TPH1,Tryptophan 5-hydroxylase 1,target,cofactor,DB00360
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR1E,5-hydroxytryptamine receptor 1E,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,HRH4,Histamine H4 receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00363
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,CALY,Neuron-specific vesicular protein calcyon,target,unknown,DB00363
Sucralfate,,approved,FGF2,Fibroblast growth factor 2,target,agonist,DB00364
Sucralfate,,approved,EGF,Pro-epidermal growth factor,target,inducer,DB00364
Sucralfate,,approved,FGA,Fibrinogen alpha chain,target,antagonist,DB00364
Sucralfate,,approved,FGB,Fibrinogen beta chain,target,antagonist,DB00364
Sucralfate,,approved,FGG,Fibrinogen gamma chain,target,antagonist,DB00364
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,gyrA,DNA gyrase subunit A,target,inhibitor,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00365
Doxylamine,Histamine H1 AntagonistsAntiemetics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00366
Doxylamine,Histamine H1 AntagonistsAntiemetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00366
Levonorgestrel,"Contraceptives, Oral, SyntheticContraceptive Agents, FemaleContraceptive Agents",approvedinvestigational,PGR,Progesterone receptor,target,binder,DB00367
Levonorgestrel,"Contraceptives, Oral, SyntheticContraceptive Agents, FemaleContraceptive Agents",approvedinvestigational,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,target,inhibitor,DB00367
Levonorgestrel,"Contraceptives, Oral, SyntheticContraceptive Agents, FemaleContraceptive Agents",approvedinvestigational,ESR1,Estrogen receptor,target,other,DB00367
Levonorgestrel,"Contraceptives, Oral, SyntheticContraceptive Agents, FemaleContraceptive Agents",approvedinvestigational,AR,Androgen receptor,target,agonist,DB00367
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,PAH,Phenylalanine-4-hydroxylase,target,inhibitor,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC18A2,Synaptic vesicular amine transporter,target,binder,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC18A1,Chromaffin granule amine transporter,target,binder,DB00368
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,ADRA2C,Alpha-2C adrenergic receptor,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HTR7,5-hydroxytryptamine receptor 7,target,binding,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,ADRA1A,Alpha-1 adrenergic receptor,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,DRD2,D(2) dopamine receptor,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,DRD3,D(3) dopamine receptor,target,,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,SLC6A4,Sodium-dependent serotonin transporter,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,SLC6A3,Sodium-dependent dopamine transporter,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HTR2B,5-hydroxytryptamine receptor 2B,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,DRD1,D(1) dopamine receptor,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,HRH3,Histamine H3 receptor,target,antagonist,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,ADRA1A,Alpha-1A adrenergic receptor,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,ADRB1,Beta-1 adrenergic receptor,target,binder,DB00370
Mirtazapine,"Histamine H1 AntagonistsAntidepressive Agents, TricyclicAdrenergic alpha-Antagonists",approved,ADRB2,Beta-2 adrenergic receptor,target,binder,DB00370
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,agonist,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,agonist,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,agonist,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,agonist,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,agonist,DB00371
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00371
Thiethylperazine,AntiemeticsDopamine Antagonists,withdrawn,DRD2,D(2) dopamine receptor,target,antagonist,DB00372
Thiethylperazine,AntiemeticsDopamine Antagonists,withdrawn,DRD1,D(1A) dopamine receptor,target,antagonist,DB00372
Thiethylperazine,AntiemeticsDopamine Antagonists,withdrawn,DRD4,D(4) dopamine receptor,target,antagonist,DB00372
Timolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00373
Timolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00373
Timolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,E,Lysozyme,target,,DB00373
Treprostinil,AntithrombinsAnticoagulants,approvedinvestigational,PTGIR,Prostacyclin receptor,target,agonist,DB00374
Treprostinil,AntithrombinsAnticoagulants,approvedinvestigational,PPARD,Peroxisome proliferator-activated receptor delta,target,agonist,DB00374
Treprostinil,AntithrombinsAnticoagulants,approvedinvestigational,P2RY12,P2Y purinoceptor 12,target,agonist,DB00374
Trihexyphenidyl,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00376
Trihexyphenidyl,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00376
Trihexyphenidyl,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00376
Trihexyphenidyl,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00376
Trihexyphenidyl,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00376
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00379
Mexiletine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,AHR,Aryl hydrocarbon receptor,target,agonist,DB00379
Dexrazoxane,Antineoplastic AgentsChelating AgentsCardiovascular Agents,approvedwithdrawn,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00380
Dexrazoxane,Antineoplastic AgentsChelating AgentsCardiovascular Agents,approvedwithdrawn,TOP2B,DNA topoisomerase 2-beta,target,,DB00380
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNA2D3,Voltage-dependent calcium channel subunit alpha-2/delta-3,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CACNB1,Voltage-gated calcium channel beta 1 subunit splice variant CavB1d,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00381
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,SMPD1,Sphingomyelin phosphodiesterase,target,,DB00381
Tacrine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,withdrawn,ACHE,Acetylcholinesterase,target,inhibitor,DB00382
Tacrine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,withdrawn,BCHE,Cholinesterase,target,inhibitor,DB00382
Oxyphencyclimine,Cholinergic AntagonistsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00383
Oxyphencyclimine,Cholinergic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00383
Oxyphencyclimine,Cholinergic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00383
Triamterene,DiureticsEpithelial Sodium Channel Blockers,approved,SCNN1G,Amiloride-sensitive sodium channel subunit gamma,target,inhibitor,DB00384
Triamterene,DiureticsEpithelial Sodium Channel Blockers,approved,SCNN1A,Amiloride-sensitive sodium channel subunit alpha,target,inhibitor,DB00384
Triamterene,DiureticsEpithelial Sodium Channel Blockers,approved,SCNN1B,Amiloride-sensitive sodium channel subunit beta,target,inhibitor,DB00384
Triamterene,DiureticsEpithelial Sodium Channel Blockers,approved,SCNN1D,Amiloride-sensitive sodium channel subunit delta,target,inhibitor,DB00384
Valrubicin,,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00385
Procyclidine,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00387
Procyclidine,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00387
Procyclidine,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00387
Procyclidine,Antiparkinson AgentsMuscarinic AntagonistsAntidyskinetics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00387
Phenylephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor AgonistsCardiotonic AgentsMydriaticsNasal Decongestants,approved,ADRA1A,Alpha-1A adrenergic receptor,target,,DB00388
Phenylephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor AgonistsCardiotonic AgentsMydriaticsNasal Decongestants,approved,ADRA1B,Alpha-1B adrenergic receptor,target,,DB00388
Phenylephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor AgonistsCardiotonic AgentsMydriaticsNasal Decongestants,approved,ADRA1D,Alpha-1D adrenergic receptor,target,,DB00388
Sulpiride,"Antidepressive Agents, Second-GenerationAntipsychotic AgentsDopamine AntagonistsAntidepressive Agents",approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00391
Sulpiride,"Antidepressive Agents, Second-GenerationAntipsychotic AgentsDopamine AntagonistsAntidepressive Agents",approved,DRD3,D(3) dopamine receptor,target,antagonist,DB00391
Ethopropazine,Muscarinic AntagonistsHistamine AntagonistsAdrenergic AntagonistsAntidyskinetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00392
Ethopropazine,Muscarinic AntagonistsHistamine AntagonistsAdrenergic AntagonistsAntidyskinetics,approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00392
Ethopropazine,Muscarinic AntagonistsHistamine AntagonistsAdrenergic AntagonistsAntidyskinetics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00392
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB4,Voltage-dependent L-type calcium channel subunit beta-4,target,inhibitor,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,NR3C2,Mineralocorticoid receptor,target,antagonist,DB00393
Nimodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,AHR,Aryl hydrocarbon receptor,target,agonist,DB00393
Progesterone,ProgestinsContraceptive Agents,approved,PGR,Progesterone receptor,target,agonist,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,ESR1,Estrogen receptor,target,agonist,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,NR3C2,Mineralocorticoid receptor,target,antagonist,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",target,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,OPRK1,Kappa-type opioid receptor,target,activator,DB00396
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00397
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00397
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,DRD1,D(1A) dopamine receptor,target,partial agonist,DB00397
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB00397
Phenylpropanolamine,SympathomimeticsAppetite DepressantsAdrenergic alpha-AgonistsNasal Decongestants,approvedwithdrawn,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00397
Sorafenib,Antineoplastic Agents,approvedinvestigational,BRAF,Serine/threonine-protein kinase B-raf,target,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,RAF1,RAF proto-oncogene serine/threonine-protein kinase,target,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,FLT4,Vascular endothelial growth factor receptor 3,target,antagonist,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,KDR,Vascular endothelial growth factor receptor 2,target,antagonist,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,antagonist,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,PDGFRB,Platelet-derived growth factor receptor beta,target,antagonist,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,KIT,Mast/stem cell growth factor receptor Kit,target,antagonist,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,FGFR1,Fibroblast growth factor receptor 1,target,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,FLT1,Vascular endothelial growth factor receptor 1,target,inhibitor,DB00398
Zoledronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,FDPS,Farnesyl pyrophosphate synthase,target,inhibitor,DB00399
Zoledronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,GGPS1,Geranylgeranyl pyrophosphate synthase,target,inhibitor,DB00399
Griseofulvin,Antifungal AgentsAnti-Bacterial Agents,approved,TUB2,Tubulin beta chain,target,inhibitor,DB00400
Griseofulvin,Antifungal AgentsAnti-Bacterial Agents,approved,TUB1,Tubulin alpha chain,target,inhibitor,DB00400
Griseofulvin,Antifungal AgentsAnti-Bacterial Agents,approved,KRT12,"Keratin, type I cytoskeletal 12",target,other/unknown,DB00400
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00401
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB00401
Eszopiclone,Hypnotics and Sedatives,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,agonist,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,agonist,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,agonist,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,TSPO,Translocator protein,target,agonist,DB00402
Eszopiclone,Hypnotics and Sedatives,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00402
Ardeparin,AntithrombinsHeparins,approvedwithdrawn,SERPINC1,Antithrombin-III,target,potentiator,DB00407
Ardeparin,AntithrombinsHeparins,approvedwithdrawn,SERPIND1,Heparin cofactor 2,target,agonist,DB00407
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR1E,5-hydroxytryptamine receptor 1E,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,,5-hydroxytryptamine receptor 5A,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR6,5-hydroxytryptamine receptor 6,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HTR7,5-hydroxytryptamine receptor 7,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,DRD1,D(1) dopamine receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,DRD3,D(3) dopamine receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,DRD4,D(4) dopamine receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,DRD5,D(1B) dopamine receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HRH1,Histamine H1 receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HRH2,Histamine H2 receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,HRH4,Histamine H4 receptor,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,SLC6A4,Sodium-dependent serotonin transporter,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,binder,DB00408
Loxapine,Antipsychotic AgentsDopamine Antagonists,approved,SLC6A3,Sodium-dependent dopamine transporter,target,binder,DB00408
Remoxipride,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,DRD2,D(2) dopamine receptor,target,antagonist,DB00409
Remoxipride,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,DRD4,D(4) dopamine receptor,target,antagonist,DB00409
Remoxipride,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,DRD3,D(3) dopamine receptor,target,antagonist,DB00409
Remoxipride,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,other/unknown,DB00409
Remoxipride,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,antagonist,DB00409
Carbachol,"Cardiotonic AgentsAnalgesics, Non-NarcoticCholinergic AgonistsMiotics",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,agonist,DB00411
Carbachol,"Cardiotonic AgentsAnalgesics, Non-NarcoticCholinergic AgonistsMiotics",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,agonist,DB00411
Carbachol,"Cardiotonic AgentsAnalgesics, Non-NarcoticCholinergic AgonistsMiotics",approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,agonist,DB00411
Rosiglitazone,,approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00412
Rosiglitazone,,approvedinvestigational,ACSL4,Long-chain-fatty-acid--CoA ligase 4,target,inhibitor,DB00412
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD3,D(3) dopamine receptor,target,agonist,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD2,D(2) dopamine receptor,target,agonist,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD4,D(4) dopamine receptor,target,agonist,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,partial agonist,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2B,5-hydroxytryptamine receptor 2B,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,unknown,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD5,D(1B) dopamine receptor,target,unknown,DB00413
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00415
Penicillin V,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,,DB00417
Penicillin V,Anti-Bacterial AgentsPenicillins,approved,mecA,MecA PBP2' (penicillin binding protein 2'),target,inhibitor,DB00417
Penicillin V,Anti-Bacterial AgentsPenicillins,approved,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,,DB00417
Penicillin V,Anti-Bacterial AgentsPenicillins,approved,,Penicillin acylase,target,,DB00417
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GRIA2,Glutamate receptor 2,target,antagonist,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00418
Secobarbital,"Hypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBarbituratesAdjuvants",approved,GRIN1,NMDA receptor,target,antagonist,DB00418
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00420
Promazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00420
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,NR3C2,Mineralocorticoid receptor,target,antagonist,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,AR,Androgen receptor,target,antagonist,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,PGR,Progesterone receptor,target,agonist,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,NR3C1,Glucocorticoid receptor,target,antagonist,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,CYP11B2,"Cytochrome P450 11B2, mitochondrial",target,antagonist,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase,target,antagonist,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,SHBG,Sex hormone-binding globulin,target,binder,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,CACNG1,Voltage-dependent calcium channel,target,,DB00421
Methylphenidate,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedinvestigational,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00422
Methylphenidate,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedinvestigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00422
Methylphenidate,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedinvestigational,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00422
Hyoscyamine,Anti-Arrhythmia AgentsMuscarinic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00424
Hyoscyamine,Anti-Arrhythmia AgentsMuscarinic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00424
Hyoscyamine,Anti-Arrhythmia AgentsMuscarinic AntagonistsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00424
Hyoscyamine,Anti-Arrhythmia AgentsMuscarinic AntagonistsAntispasmodics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00424
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,agonist,DB00425
Zolpidem,Hypnotics and SedativesGABA-A Receptor Agonists,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,agonist,DB00425
Famciclovir,"Antiviral AgentsProdrugsNucleic Acids, Nucleotides, and Nucleosides",approved,UL30,DNA polymerase catalytic subunit,target,inhibitor,DB00426
Famciclovir,"Antiviral AgentsProdrugsNucleic Acids, Nucleotides, and Nucleosides",approved,ORF28,DNA polymerase catalytic subunit,target,inhibitor,DB00426
Streptozocin,"Antibiotics, AntineoplasticAntibiotics",approved,SLC2A2,"Solute carrier family 2, facilitated glucose transporter member 2",target,ligand,DB00428
Streptozocin,"Antibiotics, AntineoplasticAntibiotics",approved,BT_4395,O-GlcNAcase BT_4395,target,antagonist,DB00428
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB00430
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB00430
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB00430
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,ponB,Penicillin-binding protein 1B,target,inhibitor,DB00430
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,dacC,D-alanyl-D-alanine carboxypeptidase DacC,target,inhibitor,DB00430
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB00430
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,mecA,Penicillin binding protein 2a,target,inhibitor,DB00430
Lindane,InsecticidesAntiscabies Agents,approvedwithdrawn,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,antagonist,DB00431
Lindane,InsecticidesAntiscabies Agents,approvedwithdrawn,GLRA1,Glycine receptor subunit alpha-1,target,antagonist,DB00431
Lindane,InsecticidesAntiscabies Agents,approvedwithdrawn,GLRA2,Glycine receptor subunit alpha-2,target,antagonist,DB00431
Lindane,InsecticidesAntiscabies Agents,approvedwithdrawn,GLRA3,Glycine receptor subunit alpha-3,target,antagonist,DB00431
Lindane,InsecticidesAntiscabies Agents,approvedwithdrawn,GLRB,Glycine receptor subunit beta,target,antagonist,DB00431
Trifluridine,Antiviral AgentsAntimetabolites,approved,TYMS,Thymidylate synthase,target,inhibitor,DB00432
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00434
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00434
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00434
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00434
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00434
Cyproheptadine,Anti-Allergic AgentsGastrointestinal AgentsSerotonin AntagonistsAntipruriticsHistamine H1 Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00434
Bendroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB00436
Bendroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,inducer,DB00436
Bendroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00436
Bendroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00436
Bendroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00436
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,ponB,Penicillin-binding protein 1B,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 2,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,pbpG,D-alanyl-D-alanine endopeptidase,target,inhibitor,DB00438
Trimethoprim,Anti-Infective Agents,approved,TYMS,Thymidylate synthase,target,inhibitor,DB00440
Trimethoprim,Anti-Infective Agents,approved,DHFR,Dihydrofolate reductase,target,inhibitor,DB00440
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,inhibitor,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,TYMS,Thymidylate synthase,target,inhibitor,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,CMPK1,UMP-CMP kinase,target,inhibitor,DB00441
Epirubicin,"Antibiotics, Antineoplastic",approved,CHD1,Chromodomain-helicase-DNA-binding protein 1,target,antagonist,DB00445
Epirubicin,"Antibiotics, Antineoplastic",approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00445
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,rplP,50S ribosomal protein L16,target,inhibitor,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,draA,Dr hemagglutinin structural subunit,target,antagonist,DB00446
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,CD55,Complement decay-accelerating factor,target,other,DB00446
Loracarbef,Anti-Bacterial AgentsAntibiotics,withdrawn,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00447
Loracarbef,Anti-Bacterial AgentsAntibiotics,withdrawn,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00447
Dipivefrin,Adrenergic AgonistsOphthalmics,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00449
Dipivefrin,Adrenergic AgonistsOphthalmics,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00449
Dipivefrin,Adrenergic AgonistsOphthalmics,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00449
Dipivefrin,Adrenergic AgonistsOphthalmics,approved,BCHE,Cholinesterase,target,potentiator,DB00449
Dipivefrin,Adrenergic AgonistsOphthalmics,approved,ACHE,Acetylcholinesterase,target,,DB00449
Droperidol,"Antipsychotic AgentsAdjuvants, AnesthesiaAntiemeticsDopamine Antagonists",approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00450
Droperidol,"Antipsychotic AgentsAdjuvants, AnesthesiaAntiemeticsDopamine Antagonists",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00450
Levothyroxine,,approved,THRA,Thyroid hormone receptor alpha,target,agonist,DB00451
Levothyroxine,,approved,THRB,Thyroid hormone receptor beta,target,agonist,DB00451
Framycetin,Anti-Bacterial AgentsAminoglycosidesAntibiotics,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB00452
Framycetin,Anti-Bacterial AgentsAminoglycosidesAntibiotics,approved,CXCR4,C-X-C chemokine receptor type 4,target,antagonist,DB00452
Clomocycline,Tetracyclines,approved,rpsD,30S ribosomal protein S4,target,inhibitor,DB00453
Clomocycline,Tetracyclines,approved,rpsI,30S ribosomal protein S9,target,inhibitor,DB00453
Pethidine,Adjuvants,approved,OPRK1,Kappa-type opioid receptor,target,,DB00454
Pethidine,Adjuvants,approved,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,antagonist,DB00454
Pethidine,Adjuvants,approved,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,antagonist,DB00454
Pethidine,Adjuvants,approved,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,antagonist,DB00454
Pethidine,Adjuvants,approved,GRIN2C,"Glutamate receptor ionotropic, NMDA 2C",target,antagonist,DB00454
Pethidine,Adjuvants,approved,GRIN2D,"Glutamate receptor ionotropic, NMDA 2D",target,antagonist,DB00454
Pethidine,Adjuvants,approved,CHRM1,Muscarinic acetylcholine receptor,target,binder,DB00454
Pethidine,Adjuvants,approved,OPRM1,Mu-type opioid receptor,target,agonist,DB00454
Pethidine,Adjuvants,approved,SLC6A3,Sodium-dependent dopamine transporter,target,,DB00454
Pethidine,Adjuvants,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB00454
Pethidine,Adjuvants,approved,SLC6A4,Sodium-dependent serotonin transporter,target,binding,DB00454
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,,D-alanyl-D-alanine carboxypeptidase,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,ampC,Beta-lactamase,target,potentiator,DB00456
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,KCNH6,Potassium voltage-gated channel subfamily H member 6,target,inhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,KCNH7,Potassium voltage-gated channel subfamily H member 7,target,inhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,binder,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,binder,DB00457
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,KCND2,Potassium voltage-gated channel subfamily D member 2,target,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,KCND3,Potassium voltage-gated channel subfamily D member 3,target,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,snf,Transporter,target,,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonistbinder,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,DRD1,D(1) dopamine receptor,target,binder,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,DRD2,D(2) dopamine receptor,target,binder,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A3,Sodium-dependent dopamine transporter,target,,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,activator,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR6,5-hydroxytryptamine receptor 6,target,binder,DB00458
Acitretin,Keratolytic Agents,approved,RXRA,Retinoic acid receptor RXR-alpha,target,agonist,DB00459
Acitretin,Keratolytic Agents,approved,RARA,Retinoic acid receptor alpha,target,agonist,DB00459
Acitretin,Keratolytic Agents,approved,RARB,Retinoic acid receptor beta,target,agonist,DB00459
Acitretin,Keratolytic Agents,approved,RARG,Retinoic acid receptor gamma,target,agonist,DB00459
Acitretin,Keratolytic Agents,approved,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00459
Acitretin,Keratolytic Agents,approved,RXRG,Retinoic acid receptor RXR-gamma,target,agonist,DB00459
Acitretin,Keratolytic Agents,approved,RBP1,Retinol-binding protein 1,target,agonist,DB00459
Nabumetone,Cyclooxygenase 2 Inhibitors,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00461
Nabumetone,Cyclooxygenase 2 Inhibitors,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00461
Methylscopolamine bromide,ParasympatholyticsCholinergic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00462
Methylscopolamine bromide,ParasympatholyticsCholinergic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00462
Methylscopolamine bromide,ParasympatholyticsCholinergic AntagonistsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00462
Metharbital,,withdrawn,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00463
Metharbital,,withdrawn,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00463
Metharbital,,withdrawn,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00463
Metharbital,,withdrawn,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00463
Metharbital,,withdrawn,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00463
Metharbital,,withdrawn,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00463
Metharbital,,withdrawn,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00463
Metharbital,,withdrawn,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00463
Metharbital,,withdrawn,GRIA2,Glutamate receptor 2,target,antagonist,DB00463
Metharbital,,withdrawn,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00463
Metharbital,,withdrawn,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00463
Sodium Tetradecyl Sulfate,Sclerosing SolutionsSurface-Active Agents,approved,PROC,Vitamin K-dependent protein C,target,inhibitor,DB00464
Sodium Tetradecyl Sulfate,Sclerosing SolutionsSurface-Active Agents,approved,PROS1,Vitamin K-dependent protein S,target,inhibitor,DB00464
Ketorolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00465
Ketorolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00465
Picrotoxin,GABA AntagonistsConvulsantsStimulants,experimental,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,antagonist,DB00466
Picrotoxin,GABA AntagonistsConvulsantsStimulants,experimental,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,antagonist,DB00466
Picrotoxin,GABA AntagonistsConvulsantsStimulants,experimental,GLRA2,Glycine receptor subunit alpha-2,target,antagonist,DB00466
Picrotoxin,GABA AntagonistsConvulsantsStimulants,experimental,GLRA3,Glycine receptor subunit alpha-3,target,antagonist,DB00466
Enoxacin,,approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB00467
Enoxacin,,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00467
Enoxacin,,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00467
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,GP9,Platelet glycoprotein IX,target,other,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,KCNN4,Intermediate conductance calcium-activated potassium channel protein 4,target,inhibitor,DB00468
Tenoxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00469
Tenoxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00469
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CNR1,Cannabinoid receptor 1,target,agonist,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,CNR2,Cannabinoid receptor 2,target,agonist,DB00470
Montelukast,Anti-Arrhythmia Agents,approved,CYSLTR1,Cysteinyl leukotriene receptor 1,target,antagonist,DB00471
Montelukast,Anti-Arrhythmia Agents,approved,ALOX5,Arachidonate 5-lipoxygenase,target,other/unknown,DB00471
Hexylcaine,"Anesthetics, Local",approvedwithdrawn,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00473
Hexylcaine,"Anesthetics, Local",approvedwithdrawn,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00473
Duloxetine,,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00476
Duloxetine,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00476
Duloxetine,,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00476
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,DRD1,D(1) dopamine receptor,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,DRD3,D(3) dopamine receptor,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,DRD4,D(4) dopamine receptor,target,binder,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,DRD5,D(1B) dopamine receptor,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,binder,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HTR2A,5-hydroxytryptamine 2 receptor,target,binder,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ADRA1A,Alpha-1 adrenergic receptor,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ADRA2A,Alpha-2 adrenergic receptor,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,SMPD1,Sphingomyelin phosphodiesterase,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,CALM1,Calmodulin,target,,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ORM1,alpha1-acid glycoprotein,target,binder,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HTR6,5-hydroxytryptamine receptor 6,target,binder,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HTR7,5-hydroxytryptamine receptor 7,target,binder,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,HRH4,Histamine H4 receptor,target,binder,DB00477
Amikacin,Anti-Bacterial AgentsAminoglycosides,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB00479
Lenalidomide,Antineoplastic Agents,approved,,Protein cereblon,target,inhibitor,DB00480
Lenalidomide,Antineoplastic Agents,approved,TNFSF11,Tumor necrosis factor ligand superfamily member 11,target,inhibitor,DB00480
Lenalidomide,Antineoplastic Agents,approved,CDH5,Cadherin-5,target,antagonist,DB00480
Lenalidomide,Antineoplastic Agents,approved,PTGS2,Prostaglandin G/H synthase 2,target,negative modulator,DB00480
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,ESR1,Estrogen receptor,target,agonist,DB00481
Raloxifene,Bone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor ModulatorsAntihypocalcemic Agents,approvedinvestigational,ESR2,Estrogen receptor beta,target,agonist,DB00481
Celecoxib,,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00482
Celecoxib,,approvedinvestigational,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,inhibitor,DB00482
Gallamine Triethiodide,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00483
Gallamine Triethiodide,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,ACHE,Acetylcholinesterase,target,inhibitor,DB00483
Gallamine Triethiodide,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB00483
Brimonidine,Antihypertensive AgentsAdrenergic alpha-2 Receptor AgonistsEENT Preparations,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00484
Brimonidine,Antihypertensive AgentsAdrenergic alpha-2 Receptor AgonistsEENT Preparations,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00484
Brimonidine,Antihypertensive AgentsAdrenergic alpha-2 Receptor AgonistsEENT Preparations,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00484
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,LMHCC_2184,Penicillin-binding protein 3 (Pbp 3) (Pspb20),target,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,LMHCC_2773,D-alanyl-D-alanine carboxypeptidase DacA (DD-peptidase) (DD-carboxypeptidase) (CPase) (Penicillin-binding protein5) (PBP-5),target,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00485
Nabilone,,approvedinvestigational,CNR2,Cannabinoid receptor 2,target,partial agonist,DB00486
Nabilone,,approvedinvestigational,CNR1,Cannabinoid receptor 1,target,partial agonist,DB00486
Pefloxacin,Nucleic Acid Synthesis InhibitorsAnti-Infective Agents,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00487
Pefloxacin,Nucleic Acid Synthesis InhibitorsAnti-Infective Agents,approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB00487
Pefloxacin,Nucleic Acid Synthesis InhibitorsAnti-Infective Agents,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00487
Pefloxacin,Nucleic Acid Synthesis InhibitorsAnti-Infective Agents,approved,,DNA topoisomerase 1,target,,DB00487
Sotalol,,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00489
Sotalol,,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00489
Sotalol,,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00489
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,partial agonist,DB00490
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB00490
Miglitol,,approved,MGAM,"Maltase-glucoamylase, intestinal",target,antagonistinhibitor,DB00491
Miglitol,,approved,GAA,Lysosomal alpha-glucosidase,target,antagonist,DB00491
Miglitol,,approved,,Neutral alpha-glucosidase AB,target,antagonist,DB00491
Miglitol,,approved,,Neutral alpha-glucosidase C,target,antagonist,DB00491
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,pbpC,Penicillin-binding protein 3,target,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00493
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,pol,Reverse Transcriptase,target,inhibitor,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,TERT,Telomerase reverse transcriptase,target,inhibitor,DB00495
Darifenacin,Antispasmodic Agents,approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00496
Darifenacin,Antispasmodic Agents,approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00496
Darifenacin,Antispasmodic Agents,approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00496
Darifenacin,Antispasmodic Agents,approvedinvestigational,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00496
Darifenacin,Antispasmodic Agents,approvedinvestigational,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00496
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,OPRM1,Mu-type opioid receptor,target,agonist,DB00497
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,OPRK1,Kappa-type opioid receptor,target,agonist,DB00497
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,OPRD1,Delta-type opioid receptor,target,agonist,DB00497
Oxycodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitinvestigational,ORM1,alpha1-acid glycoprotein,target,binder,DB00497
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,AR,Androgen receptor,target,antagonist,DB00499
Flutamide,"Antineoplastic Agents, HormonalAndrogen Antagonists",approved,AHR,Aryl hydrocarbon receptor,target,agonist,DB00499
Tolmetin,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00500
Tolmetin,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00500
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,antagonist,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,other/unknown,DB00502
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,DRD3,D(3) dopamine receptor,target,inverse agonist,DB00502
Tridihexethyl,Cholinergic AntagonistsAntispasmodics,withdrawn,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00505
Tridihexethyl,Cholinergic AntagonistsAntispasmodics,withdrawn,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00505
Tridihexethyl,Cholinergic AntagonistsAntispasmodics,withdrawn,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00505
Triflupromazine,Antipsychotic Agents,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00508
Triflupromazine,Antipsychotic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00508
Triflupromazine,Antipsychotic Agents,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB00508
Triflupromazine,Antipsychotic Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00508
Triflupromazine,Antipsychotic Agents,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00508
Dextrothyroxine,Hypolipidemic Agents,approved,THRA,Thyroid hormone receptor alpha,target,agonist,DB00509
Dextrothyroxine,Hypolipidemic Agents,approved,THRB,Thyroid hormone receptor beta,target,agonist,DB00509
Dextrothyroxine,Hypolipidemic Agents,approved,TPO,Thyroid peroxidase,target,,DB00509
Vancomycin,Anti-Bacterial Agents,approved,gtfA,Glycosyltransferase GtfA,target,other,DB00512
Aminocaproic Acid,,approvedinvestigational,PLG,Plasminogen,target,inhibitor,DB00513
Aminocaproic Acid,,approvedinvestigational,PLAT,Tissue-type plasminogen activator,target,antagonist,DB00513
Aminocaproic Acid,,approvedinvestigational,LPA,Apolipoprotein(a),target,other,DB00513
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,agonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,OPRS1,"HCG20471, isoform CRA_c",target,agonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,,Membrane-associated progesterone receptor component 1,target,binder,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CHRNB4,Neuronal acetylcholine receptor subunit beta-4,target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CHRNB2,Neuronal acetylcholine receptor subunit beta-2,target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,OPRM1,Mu-type opioid receptor,target,agonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,OPRD1,Delta-type opioid receptor,target,agonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,,NADPH oxidase,target,inhibitor,DB00514
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB00514
Anisotropine Methylbromide,Muscarinic AntagonistsCholinergic Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00517
Anisotropine Methylbromide,Muscarinic AntagonistsCholinergic Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00517
Anisotropine Methylbromide,Muscarinic AntagonistsCholinergic Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00517
Albendazole,,approved,,Tubulin beta-2 chain,target,inhibitor,DB00518
Albendazole,,approved,TUBA1A,Tubulin alpha-1A chain,target,inhibitor,DB00518
Albendazole,,approved,TUBB2C,Tubulin beta-4B chain,target,inhibitor,DB00518
Albendazole,,approved,SO_0970,Fumarate reductase flavoprotein subunit,target,inhibitor,DB00518
Carteolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00521
Carteolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,partial agonist,DB00521
Alitretinoin,Antineoplastic Agents,approvedinvestigational,RARA,Retinoic acid receptor alpha,target,agonist,DB00523
Alitretinoin,Antineoplastic Agents,approvedinvestigational,RXRA,Retinoic acid receptor RXR-alpha,target,agonist,DB00523
Alitretinoin,Antineoplastic Agents,approvedinvestigational,RARB,Retinoic acid receptor beta,target,agonist,DB00523
Alitretinoin,Antineoplastic Agents,approvedinvestigational,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00523
Alitretinoin,Antineoplastic Agents,approvedinvestigational,RARG,Retinoic acid receptor gamma,target,agonist,DB00523
Alitretinoin,Antineoplastic Agents,approvedinvestigational,RXRG,Retinoic acid receptor RXR-gamma,target,agonist,DB00523
Cinchocaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00527
Cinchocaine,"Anesthetics, Local",approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00527
Cinchocaine,"Anesthetics, Local",approved,CALM1,Calmodulin,target,inhibitor,DB00527
Foscarnet,Antiviral AgentsReverse Transcriptase Inhibitors,approved,UL54,DNA polymerase catalytic subunit,target,inhibitor,DB00529
Foscarnet,Antiviral AgentsReverse Transcriptase Inhibitors,approved,UL30,DNA polymerase catalytic subunit,target,inhibitor,DB00529
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,EGFR,Epidermal growth factor receptor,target,antagonist,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,agonist,DB00530
Rofecoxib,,investigationalwithdrawn,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00533
Rofecoxib,,investigationalwithdrawn,ELN,Elastin,target,other/unknown,DB00533
Chlormerodrin,"Diagnostic AgentsDiuretics, Mercurial",approvedwithdrawn,SLC12A1,Solute carrier family 12 member 1,target,inducer,DB00534
Chlormerodrin,"Diagnostic AgentsDiuretics, Mercurial",approvedwithdrawn,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",target,inhibitor,DB00534
Cefdinir,Anti-Bacterial AgentsAnti-Infective AgentsCephalosporins,approved,penA,Penicillin-binding protein 2,target,inhibitor,DB00535
Cefdinir,Anti-Bacterial AgentsAnti-Infective AgentsCephalosporins,approved,pbp3,PBP3,target,inhibitor,DB00535
Cefdinir,Anti-Bacterial AgentsAnti-Infective AgentsCephalosporins,approved,MPO,Myeloperoxidase,target,inhibitor,DB00535
Guanidine,,approved,argG,Argininosuccinate synthase,target,,DB00536
Guanidine,,approved,GAMT,Guanidinoacetate N-methyltransferase,target,,DB00536
Guanidine,,approved,RNASE1,Ribonuclease pancreatic,target,,DB00536
Guanidine,,approved,DLG4,Disks large homolog 4,target,,DB00536
Guanidine,,approved,E,Lysozyme,target,,DB00536
Guanidine,,approved,ALDH2,"Aldehyde dehydrogenase, mitochondrial",target,,DB00536
Guanidine,,approved,rocF,Arginase,target,,DB00536
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00537
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,gyrA,DNA gyrase subunit A,target,inhibitor,DB00537
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00537
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR6,5-hydroxytryptamine receptor 6,target,binder,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA2A,Alpha-2 adrenergic receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRB1,Beta adrenergic receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,,Sigma receptor,target,binder,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,,5-hydroxytryptamine receptor 1C,target,antagonist,DB00540
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,TUBB,Tubulin beta chain,target,inhibitor,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,TUBA4A,Tubulin alpha-4A chain,target,inhibitor,DB00541
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,DRD3,D(3) dopamine receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,DRD4,D(4) dopamine receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,ADRA1A,Alpha-1 adrenergic receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,CHRM1,Muscarinic acetylcholine receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,ADRA2A,Alpha-2 adrenergic receptor,target,antagonist,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,HRH4,Histamine H4 receptor,target,binder,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,GABRA1,GABA-A receptor (anion channel),target,binder,DB00543
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,SLC6A3,Sodium-dependent dopamine transporter,target,binder,DB00543
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,TYMS,Thymidylate synthase,target,other/unknown,DB00544
Pyridostigmine,Antimyasthenic Agents,approved,ACHE,Acetylcholinesterase,target,antagonistinhibitor,DB00545
Pyridostigmine,Antimyasthenic Agents,approved,BCHE,Cholinesterase,target,antagonist,DB00545
Adinazolam,Antidepressive Agents,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00546
Adinazolam,Antidepressive Agents,approved,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00546
Azelaic Acid,Antineoplastic AgentsDermatologic Agents,approved,trxB,Thioredoxin reductase,target,inhibitor,DB00548
Azelaic Acid,Antineoplastic AgentsDermatologic Agents,approved,AKR1D1,3-oxo-5-beta-steroid 4-dehydrogenase,target,inhibitor,DB00548
Azelaic Acid,Antineoplastic AgentsDermatologic Agents,approved,SRD5A2,3-oxo-5-alpha-steroid 4-dehydrogenase 2,target,inhibitor,DB00548
Azelaic Acid,Antineoplastic AgentsDermatologic Agents,approved,TYR,Tyrosinase,target,inhibitor,DB00548
Azelaic Acid,Antineoplastic AgentsDermatologic Agents,approved,polA,DNA polymerase I,target,inhibitor,DB00548
Acetohydroxamic Acid,Enzyme Inhibitors,approved,ureC,Urease subunit alpha,target,inhibitor,DB00551
Acetohydroxamic Acid,Enzyme Inhibitors,approved,MMP12,Macrophage metalloelastase,target,inhibitor,DB00551
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00554
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00554
Zanamivir,Antiviral AgentsEnzyme Inhibitors,approvedinvestigational,NA,Neuraminidase,target,inhibitor,DB00558
Zanamivir,Antiviral AgentsEnzyme Inhibitors,approvedinvestigational,NA,Neuraminidase,target,inhibitor,DB00558
Zanamivir,Antiviral AgentsEnzyme Inhibitors,approvedinvestigational,NEU2,Sialidase-2,target,inhibitor,DB00558
Bosentan,Antihypertensive Agents,approvedinvestigational,EDNRA,Endothelin-1 receptor,target,antagonist,DB00559
Bosentan,Antihypertensive Agents,approvedinvestigational,EDNRB,Endothelin B receptor,target,antagonist,DB00559
Tigecycline,Anti-Bacterial AgentsTetracyclines,approved,rpsI,30S ribosomal protein S9,target,adduct,DB00560
Tigecycline,Anti-Bacterial AgentsTetracyclines,approved,rpsL,30S ribosomal protein S12,target,adduct,DB00560
Tigecycline,Anti-Bacterial AgentsTetracyclines,approved,rpsM,30S ribosomal protein S13,target,adduct,DB00560
Tigecycline,Anti-Bacterial AgentsTetracyclines,approved,rpsN,30S ribosomal protein S14,target,adduct,DB00560
Tigecycline,Anti-Bacterial AgentsTetracyclines,approved,rpsS,30S ribosomal protein S19,target,adduct,DB00560
Doxapram,,approved,KCNK3,Potassium channel subfamily K member 3,target,inhibitor,DB00561
Doxapram,,approved,KCNK9,Potassium channel subfamily K member 9,target,inhibitor,DB00561
Benzthiazide,Stimulants,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB00562
Benzthiazide,Stimulants,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00562
Benzthiazide,Stimulants,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00562
Benzthiazide,Stimulants,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00562
Benzthiazide,Stimulants,approved,CA9,Carbonic anhydrase 9,target,inhibitor,DB00562
Benzthiazide,Stimulants,approved,CA12,Carbonic anhydrase 12,target,inhibitor,DB00562
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00567
Cinnarizine,,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00568
Cinnarizine,,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00568
Cinnarizine,,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00568
Cinnarizine,,approved,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,target,inhibitor,DB00568
Cinnarizine,,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB00568
Cinnarizine,,approved,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB00568
Cinnarizine,,approved,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB00568
Cinnarizine,,approved,CACNA1I,Voltage-dependent T-type calcium channel subunit alpha-1I,target,inhibitor,DB00568
Cinnarizine,,approved,DRD2,D(2) dopamine receptor,target,other/unknown,DB00568
Cinnarizine,,approved,DRD1,D(1) dopamine receptor,target,binder,DB00568
Cinnarizine,,approved,CHRM1,Muscarinic acetylcholine receptor,target,binder,DB00568
Fondaparinux sodium,AntithrombinsAnticoagulants,approvedinvestigational,SERPINC1,Antithrombin-III,target,potentiator,DB00569
Fondaparinux sodium,AntithrombinsAnticoagulants,approvedinvestigational,F10,Coagulation factor X,target,inhibitor,DB00569
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBA1A,Tubulin alpha-1A chain,target,adduct,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBB,Tubulin beta chain,target,adduct,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBD1,Tubulin delta chain,target,adduct,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBG1,Tubulin gamma-1 chain,target,adduct,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBE1,Tubulin epsilon chain,target,adduct,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,JUN,Transcription factor AP-1,target,other/unknown,DB00570
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,ADRB3,Beta-3 adrenergic receptor,target,antagonist,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,other/unknown,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,other/unknown,DB00571
Atropine,"Anti-Arrhythmia AgentsBronchodilator AgentsMuscarinic AntagonistsParasympatholyticsAdjuvants, AnesthesiaMydriatics",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00572
Atropine,"Anti-Arrhythmia AgentsBronchodilator AgentsMuscarinic AntagonistsParasympatholyticsAdjuvants, AnesthesiaMydriatics",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00572
Atropine,"Anti-Arrhythmia AgentsBronchodilator AgentsMuscarinic AntagonistsParasympatholyticsAdjuvants, AnesthesiaMydriatics",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00572
Atropine,"Anti-Arrhythmia AgentsBronchodilator AgentsMuscarinic AntagonistsParasympatholyticsAdjuvants, AnesthesiaMydriatics",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00572
Atropine,"Anti-Arrhythmia AgentsBronchodilator AgentsMuscarinic AntagonistsParasympatholyticsAdjuvants, AnesthesiaMydriatics",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00572
Fenoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsPropionates",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00573
Fenoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsPropionates",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00573
Fenfluramine,Serotonin Uptake InhibitorsAppetite DepressantsSerotonin Receptor AgonistsSerotonin AgentsStimulants,illicitwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00574
Fenfluramine,Serotonin Uptake InhibitorsAppetite DepressantsSerotonin Receptor AgonistsSerotonin AgentsStimulants,illicitwithdrawn,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB00574
Fenfluramine,Serotonin Uptake InhibitorsAppetite DepressantsSerotonin Receptor AgonistsSerotonin AgentsStimulants,illicitwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00574
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB00575
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,UL30,DNA polymerase catalytic subunit,target,inhibitor,DB00577
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,TK,Thymidine kinase,target,inducer,DB00577
Mazindol,Adrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine Uptake Inhibitors,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00579
Mazindol,Adrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine Uptake Inhibitors,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00579
Mazindol,Adrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine Uptake Inhibitors,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00579
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC22A4,Solute carrier family 22 member 4,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC22A5,Solute carrier family 22 member 5,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,CRAT,Carnitine O-acetyltransferase,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC25A29,Mitochondrial carnitine/acylcarnitine carrier protein CACL,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC25A20,Mitochondrial carnitine/acylcarnitine carrier protein,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,CROT,Peroxisomal carnitine O-octanoyltransferase,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,CPT2,"Carnitine O-palmitoyltransferase 2, mitochondrial",target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,CPT1A,"Carnitine O-palmitoyltransferase 1, liver isoform",target,activator,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,XDH,Xanthine dehydrogenase/oxidase,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,CES1,Liver carboxylesterase 1,target,,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,MPO,Myeloperoxidase,target,,DB00583
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ALOX5,Arachidonate 5-lipoxygenase,target,potentiator,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SCN4A,Sodium channel protein type 4 subunit alpha,target,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ACCN2,Acid-sensing ion channel 1,target,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,target,other,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,target,other,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PLA2G2A,"Phospholipase A2, membrane associated",target,inhibitor,DB00586
Fluticasone Propionate,,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00588
Fluticasone Propionate,,approved,PGR,Progesterone receptor,target,agonist,DB00588
Fluticasone Propionate,,approved,PLA2G4A,Cytosolic phospholipase A2,target,inhibitor,DB00588
Fluticasone Propionate,,approved,NR3C2,Mineralocorticoid receptor,target,antagonist,DB00588
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,DRD2,D(2) dopamine receptor,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,DRD3,D(3) dopamine receptor,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,DRD4,D(4) dopamine receptor,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,DRD5,D(1B) dopamine receptor,target,antagonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,ADRA2A,Alpha-2A adrenergic receptor,target,other/unknown,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,ADRA2B,Alpha-2B adrenergic receptor,target,other/unknown,DB00589
Lisuride,Antiparkinson AgentsDopamine AgonistsSerotonin Receptor AgonistsAntidyskinetics,approved,ADRA2C,Alpha-2C adrenergic receptor,target,other/unknown,DB00589
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00590
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00590
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00590
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00590
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,KCNH6,Potassium voltage-gated channel subfamily H member 6,target,inhibitor,DB00590
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,KCNH7,Potassium voltage-gated channel subfamily H member 7,target,inhibitor,DB00590
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SCNN1A,Amiloride-sensitive sodium channel subunit alpha,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SCNN1B,Amiloride-sensitive sodium channel subunit beta,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SCNN1G,Amiloride-sensitive sodium channel subunit gamma,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SCNN1D,Amiloride-sensitive sodium channel subunit delta,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,ABP1,Amiloride-sensitive amine oxidase [copper-containing],target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,ACCN1,Acid-sensing ion channel 2,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,ACCN2,Acid-sensing ion channel 1,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SLC9A1,Sodium/hydrogen exchanger 1,target,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,PLAU,Urokinase-type plasminogen activator,target,inhibitor,DB00594
Oxytetracycline,Tetracyclines,approved,rpsI,30S ribosomal protein S9,target,inhibitor,DB00595
Oxytetracycline,Tetracyclines,approved,rpsD,30S ribosomal protein S4,target,inhibitor,DB00595
Labetalol,Antihypertensive AgentsSympathomimeticsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00598
Labetalol,Antihypertensive AgentsSympathomimeticsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00598
Labetalol,Antihypertensive AgentsSympathomimeticsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approved,ADRA1A,Alpha-1 adrenergic receptor,target,antagonist,DB00598
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GRIA2,Glutamate receptor 2,target,antagonist,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00599
Thiopental,"Hypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousGABA Modulators",approved,FAAH,Fatty-acid amide hydrolase 1,target,inhibitor,DB00599
Ivermectin,InsecticidesAntiparasitic Agents,approved,GLRA3,Glycine receptor subunit alpha-3,target,agonist,DB00602
Ivermectin,InsecticidesAntiparasitic Agents,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,agonist,DB00602
Medroxyprogesterone Acetate,"Antineoplastic Agents, HormonalContraceptive Agents, FemaleContraceptive Agents, MaleContraceptive Agents",approvedinvestigational,PGR,Progesterone receptor,target,agonist,DB00603
Medroxyprogesterone Acetate,"Antineoplastic Agents, HormonalContraceptive Agents, FemaleContraceptive Agents, MaleContraceptive Agents",approvedinvestigational,ESR1,Estrogen receptor,target,agonist,DB00603
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,HTR4,5-hydroxytryptamine receptor 4,target,agonist,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,HTR3A,5-hydroxytryptamine receptor 3A,target,agonist,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00604
Cisapride,Serotonin Receptor AgonistsProkinetic Agents,approvedinvestigationalwithdrawn,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00604
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00605
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00605
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,AKR1B1,Aldose reductase,target,inhibitor,DB00605
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,MAPK3,Mitogen-activated protein kinase 3,target,inhibitor,DB00605
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,PPARD,Peroxisome proliferator-activated receptor delta,target,negative modulator,DB00605
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,GPR44,Prostaglandin D2 receptor 2,target,antagonist,DB00605
Cyclothiazide,Antihypertensive AgentsDiuretics,approved,FXYD2,Sodium/potassium-transporting ATPase subunit gamma,target,inhibitor,DB00606
Cyclothiazide,Antihypertensive AgentsDiuretics,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00606
Cyclothiazide,Antihypertensive AgentsDiuretics,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00606
Cyclothiazide,Antihypertensive AgentsDiuretics,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00606
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00607
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00607
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00607
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00607
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00607
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,GSTA2,Glutathione S-transferase A2,target,,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,TNF,Tumor necrosis factor,target,,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,TLR9,Toll-like receptor 9,target,,DB00608
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,GST,Glutathione S-transferase,target,,DB00608
Ethionamide,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,adduct,DB00609
Ethionamide,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,katG,Catalase-peroxidase,target,other/unknown,DB00609
Butorphanol,"Analgesics, OpioidNarcoticsAntitussive AgentsNarcotic Antagonists",approvedillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB00611
Butorphanol,"Analgesics, OpioidNarcoticsAntitussive AgentsNarcotic Antagonists",approvedillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB00611
Butorphanol,"Analgesics, OpioidNarcoticsAntitussive AgentsNarcotic Antagonists",approvedillicit,OPRM1,Mu-type opioid receptor,target,partial antagonist,DB00611
Bisoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholytics,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00612
Bisoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholytics,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00612
Amodiaquine,,approved,HNMT,Histamine N-methyltransferase,target,inhibitor,DB00613
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,rpoA,DNA-directed RNA polymerase subunit alpha,target,inhibitor,DB00615
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,rpoB,DNA-directed RNA polymerase subunit beta,target,inhibitor,DB00615
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,rpoC,DNA-directed RNA polymerase subunit beta',target,inhibitor,DB00615
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,HSP90AA1,Heat shock protein HSP 90-alpha,target,other/unknown,DB00615
Rifabutin,"Anti-Bacterial AgentsAntibiotics, Antitubercular",approved,HSP90B1,Endoplasmin,target,other/unknown,DB00615
Candoxatril,Prodrugs,approved,MME,Neprilysin,target,inhibitor,DB00616
Candoxatril,Prodrugs,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00616
Demeclocycline,Anti-Bacterial AgentsTetracyclines,approved,rpsI,30S ribosomal protein S9,target,inhibitor,DB00618
Demeclocycline,Anti-Bacterial AgentsTetracyclines,approved,rpsD,30S ribosomal protein S4,target,inhibitor,DB00618
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,BCR/ABL fusion,BCR/ABL fusion protein isoform X9,target,inhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,KIT,Mast/stem cell growth factor receptor Kit,target,antagonistmultitarget,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,RET,RET proto-oncogene,target,inhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,NTRK1,High affinity nerve growth factor receptor,target,antagonist,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,CSF1R,Macrophage colony-stimulating factor 1 receptor,target,antagonist,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,PDGFRA,Platelet-derived growth factor receptor alpha,target,antagonist,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,DDR1,Epithelial discoidin domain-containing receptor 1,target,antagonist,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,ABL1,Tyrosine-protein kinase ABL1,target,inhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,PDGFRB,Platelet-derived growth factor receptor beta,target,antagonist,DB00619
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,PDE1A,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",target,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,PDE1B,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",target,inhibitor,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00622
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,CALM1,Calmodulin,target,other/unknown,DB00622
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00623
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00623
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CALM1,Calmodulin,target,inhibitor,DB00623
Bacitracin,,approved,IDE,Insulin-degrading enzyme,target,inhibitor,DB00626
Bacitracin,,approved,A2M,Alpha-2-macroglobulin,target,inhibitor,DB00626
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,GPR109B,Hydroxycarboxylic acid receptor 3,target,agonist,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,GPR109A,Hydroxycarboxylic acid receptor 2,target,agonist,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,QPRT,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,binder,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,NNMT,Nicotinamide N-methyltransferase,target,binder,DB00627
Clorazepate,,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00628
Clorazepate,,approvedillicit,TSPO,Translocator protein,target,agonist,DB00628
Guanabenz,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00629
Guanabenz,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,binder,DB00629
Alendronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,FDPS,Farnesyl pyrophosphate synthase,target,inhibitor,DB00630
Alendronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,PTPN4,Tyrosine-protein phosphatase non-receptor type 4,target,inhibitor,DB00630
Alendronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,PTPRS,Receptor-type tyrosine-protein phosphatase S,target,inhibitor,DB00630
Alendronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,PTPRE,Receptor-type tyrosine-protein phosphatase epsilon,target,inhibitor,DB00630
Alendronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,ATP6V1A,V-type proton ATPase catalytic subunit A,target,inhibitor,DB00630
Clofarabine,Purine analogues,approvedinvestigational,POLA1,DNA polymerase alpha catalytic subunit,target,inhibitor,DB00631
Clofarabine,Purine analogues,approvedinvestigational,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,inhibitor,DB00631
Docosanol,Antiviral AgentsDermatologic Agents,approvedinvestigational,BLLF1,Envelope glycoprotein GP350,target,intercalation,DB00632
Docosanol,Antiviral AgentsDermatologic Agents,approvedinvestigational,BLLF1,Envelope glycoprotein GP340,target,intercalation,DB00632
Sulfacetamide,"Anti-Infective Agents, LocalAnti-Infective Agents, UrinarySulfonamides",approved,folP,Dihydropteroate synthase,target,inhibitor,DB00634
Sulfacetamide,"Anti-Infective Agents, LocalAnti-Infective Agents, UrinarySulfonamides",approved,sulI,Dihydropteroate synthase type-1,target,inhibitor,DB00634
Sulfacetamide,"Anti-Infective Agents, LocalAnti-Infective Agents, UrinarySulfonamides",approved,FOL1,Folic acid synthesis protein FOL1,target,inhibitor,DB00634
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00635
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,ligand,DB00635
Astemizole,Histamine Antagonists,approvedwithdrawn,HRH1,Histamine H1 receptor,target,antagonist,DB00637
Astemizole,Histamine Antagonists,approvedwithdrawn,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00637
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,ADORA2A,Adenosine receptor A2a,target,agonist,DB00640
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,ADORA2B,Adenosine receptor A2b,target,agonist,DB00640
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,ADORA3,Adenosine receptor A3,target,agonist,DB00640
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,ADORA1,Adenosine receptor A1,target,agonist,DB00640
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,ITGB2,Integrin beta-2,target,other,DB00641
Pemetrexed,,approvedinvestigational,TYMS,Thymidylate synthase,target,inhibitor,DB00642
Pemetrexed,,approvedinvestigational,ATIC,Bifunctional purine biosynthesis protein PURH,target,inhibitor,DB00642
Pemetrexed,,approvedinvestigational,DHFR,Dihydrofolate reductase,target,inhibitor,DB00642
Pemetrexed,,approvedinvestigational,GART,Trifunctional purine biosynthetic protein adenosine-3,target,inhibitor,DB00642
Mebendazole,Tubulin ModulatorsAntinematodal Agents,approved,TUBA1A,Tubulin alpha-1A chain,target,inhibitor,DB00643
Mebendazole,Tubulin ModulatorsAntinematodal Agents,approved,TUBB2C,Tubulin beta-4B chain,target,inhibitor,DB00643
Gonadorelin,,approved,GNRHR,Gonadotropin-releasing hormone receptor,target,agonist,DB00644
Gonadorelin,,approved,GNRHR2,Putative gonadotropin-releasing hormone II receptor,target,agonist,DB00644
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,OPRM1,Mu-type opioid receptor,target,agonist,DB00647
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,OPRD1,Delta-type opioid receptor,target,agonist,DB00647
Dextropropoxyphene,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicitwithdrawn,OPRK1,Kappa-type opioid receptor,target,antagonist,DB00647
Mitotane,"Antineoplastic Agents, Hormonal",approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",target,inducer,DB00648
Mitotane,"Antineoplastic Agents, Hormonal",approved,FDX1,"Adrenodoxin, mitochondrial",target,unknown,DB00648
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,inhibitor,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,inhibitor,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,ADORA1,Adenosine receptor A1,target,antagonist,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,ADORA2A,Adenosine receptor A2a,target,antagonist,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE7A,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",target,inhibitor,DB00651
Dyphylline,"Phosphodiesterase InhibitorsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,PDE7B,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",target,inhibitor,DB00651
Pentazocine,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaNarcotic Antagonists",approved,OPRM1,Mu-type opioid receptor,target,antagonist,DB00652
Pentazocine,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaNarcotic Antagonists",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00652
Pentazocine,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaNarcotic Antagonists",approved,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,agonist,DB00652
Magnesium Sulfate,Anti-Arrhythmia AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersTocolytic AgentsAnesthetics,approved,CACNG1,Voltage-dependent calcium channel gamma-1 subunit,target,,DB00653
Magnesium Sulfate,Anti-Arrhythmia AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersTocolytic AgentsAnesthetics,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,,DB00653
Magnesium Sulfate,Anti-Arrhythmia AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersTocolytic AgentsAnesthetics,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,,DB00653
Magnesium Sulfate,Anti-Arrhythmia AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersTocolytic AgentsAnesthetics,approved,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,target,,DB00653
Magnesium Sulfate,Anti-Arrhythmia AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersTocolytic AgentsAnesthetics,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,,DB00653
Magnesium Sulfate,Anti-Arrhythmia AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersTocolytic AgentsAnesthetics,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,,DB00653
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,partial agonist,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00656
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00656
Acamprosate,Alcohol Deterrents,approvedinvestigational,GABRA1,GABA-A receptor (anion channel),target,positive modulator,DB00659
Acamprosate,Alcohol Deterrents,approvedinvestigational,GRIN1,Glutamate (NMDA) receptor,target,antagonist,DB00659
Acamprosate,Alcohol Deterrents,approvedinvestigational,GRM5,Metabotropic glutamate receptor 5,target,antagonist,DB00659
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB4,Voltage-dependent L-type calcium channel subunit beta-4,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1I,Voltage-dependent T-type calcium channel subunit alpha-1I,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1A,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,other,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SLC6A4,Sodium-dependent serotonin transporter,target,other/unknown,DB00661
Nafarelin,Antiendometriotic agentGonadotropin-releasing hormone agonist,approved,GNRHR,Gonadotropin-releasing hormone receptor,target,agonist,DB00666
Nafarelin,Antiendometriotic agentGonadotropin-releasing hormone agonist,approved,GNRHR2,Putative gonadotropin-releasing hormone II receptor,target,agonist,DB00666
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,HRH1,Histamine H1 receptor,target,agonist,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,HRH2,Histamine H2 receptor,target,agonist,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,HRH3,Histamine H3 receptor,target,agonist,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,HRH4,Histamine H4 receptor,target,agonist,DB00667
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,PAH,Phenylalanine-4-hydroxylase,target,antagonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,TNF,Tumor necrosis factor,target,antagonist,DB00668
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00669
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00669
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1F,5-hydroxytryptamine receptor 1F,target,agonist,DB00669
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00669
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA1,Acetylcholine receptor subunit alpha,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNB1,Acetylcholine receptor subunit beta,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRND,Acetylcholine receptor subunit delta,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNG,Acetylcholine receptor subunit gamma,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNE,Acetylcholine receptor subunit epsilon,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA5,Neuronal acetylcholine receptor subunit alpha-5,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA9,Neuronal acetylcholine receptor subunit alpha-9,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNB2,Neuronal acetylcholine receptor subunit beta-2,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNB3,Neuronal acetylcholine receptor subunit beta-3,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,CHRNB4,Neuronal acetylcholine receptor subunit beta-4,target,allosteric modulator,DB00674
Galantamine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,approved,BCHE,Cholinesterase,target,inhibitor,DB00674
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,ESR1,Estrogen receptor,target,antagonistagonist,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,ESR2,Estrogen receptor beta,target,antagonistagonist,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,,"3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase",target,,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,PRKCA,Protein kinase C,target,,DB00675
Isoflurophate,Cholinesterase InhibitorsProtease InhibitorsAnti-glaucoma AgentsOphthalmics,approvedwithdrawn,ACHE,Acetylcholinesterase,target,inhibitor,DB00677
Isoflurophate,Cholinesterase InhibitorsProtease InhibitorsAnti-glaucoma AgentsOphthalmics,approvedwithdrawn,BCHE,Cholinesterase,target,inhibitor,DB00677
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00679
Thioridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00679
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB00683
Tobramycin,Anti-Bacterial AgentsAminoglycosides,approvedinvestigational,rpsL,30S ribosomal protein S12,target,inhibitor,DB00684
Trovafloxacin,Anti-Infective AgentsFluoroquinolonesQuinolones,approvedwithdrawn,gyrA,DNA gyrase subunit A,target,inhibitor,DB00685
Trovafloxacin,Anti-Infective AgentsFluoroquinolonesQuinolones,approvedwithdrawn,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00685
Trovafloxacin,Anti-Infective AgentsFluoroquinolonesQuinolones,approvedwithdrawn,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00685
Pentosan Polysulfate,,approved,FGF2,Fibroblast growth factor 2,target,antagonist,DB00686
Pentosan Polysulfate,,approved,FGF1,Fibroblast growth factor 1,target,antagonist,DB00686
Pentosan Polysulfate,,approved,FGF4,Fibroblast growth factor 4,target,inhibitor,DB00686
Fludrocortisone,Anti-Inflammatory Agents,approved,NR3C2,Mineralocorticoid receptor,target,agonist,DB00687
Fludrocortisone,Anti-Inflammatory Agents,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00687
Fludrocortisone,Anti-Inflammatory Agents,approved,AR,Androgen receptor,target,agonist,DB00687
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1,target,inhibitor,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,inhibitor,DB00688
Flurazepam,,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00690
Flurazepam,,approvedillicit,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB00690
Moexipril,Angiotensin-Converting Enzyme Inhibitors,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00691
Moexipril,Angiotensin-Converting Enzyme Inhibitors,approved,ACE2,Angiotensin-converting enzyme 2,target,inhibitor,DB00691
Phentolamine,Antihypertensive AgentsAdrenergic alpha-Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00692
Phentolamine,Antihypertensive AgentsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00692
Fluorescein,Contrast MediaFluorescent Dyes,approved,,Ig kappa chain V-II region RPMI 6410,target,other,DB00693
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,TOP2B,DNA topoisomerase 2-beta,target,inhibitor,DB00694
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00695
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,,DB00695
Ergotamine,,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00696
Ergotamine,,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00696
Ergotamine,,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00696
Ergotamine,,approved,DRD2,D(2) dopamine receptor,target,agonist,DB00696
Ergotamine,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,partial agonist,DB00696
Ergotamine,,approved,ADRA1B,Alpha-1B adrenergic receptor,target,partial agonist,DB00696
Ergotamine,,approved,ADRA1D,Alpha-1D adrenergic receptor,target,partial agonist,DB00696
Ergotamine,,approved,ADRA2A,Alpha-2A adrenergic receptor,target,partial agonist,DB00696
Ergotamine,,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonistpartial agonist,DB00696
Ergotamine,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00696
Ergotamine,,approved,DRD1,D(1) dopamine receptor,target,agonist,DB00696
Ergotamine,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00696
Ergotamine,,approved,HTR1F,5-hydroxytryptamine receptor 1F,target,agonist,DB00696
Ergotamine,,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00696
Tizanidine,"AnalgesicsAnticonvulsantsParasympatholyticsMuscle Relaxants, CentralAdrenergic alpha-2 Receptor AgonistsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00697
Tizanidine,"AnalgesicsAnticonvulsantsParasympatholyticsMuscle Relaxants, CentralAdrenergic alpha-2 Receptor AgonistsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00697
Tizanidine,"AnalgesicsAnticonvulsantsParasympatholyticsMuscle Relaxants, CentralAdrenergic alpha-2 Receptor AgonistsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00697
Tizanidine,"AnalgesicsAnticonvulsantsParasympatholyticsMuscle Relaxants, CentralAdrenergic alpha-2 Receptor AgonistsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,NISCH,Nischarin,target,agonist,DB00697
Nitrofurantoin,"Anti-Infective AgentsAnti-Infective Agents, Urinary",approved,ydbK,Probable pyruvate-flavodoxin oxidoreductase,target,potentiator,DB00698
Nitrofurantoin,"Anti-Infective AgentsAnti-Infective Agents, Urinary",approved,nfsA,Oxygen-insensitive NADPH nitroreductase,target,potentiator,DB00698
Nitrofurantoin,"Anti-Infective AgentsAnti-Infective Agents, Urinary",approved,rpsJ,30S ribosomal protein S10,target,,DB00698
Methazolamide,,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00703
Methazolamide,,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00703
Methazolamide,,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00703
Methazolamide,,approved,CA7,Carbonic anhydrase 7,target,inhibitor,DB00703
Naltrexone,Appetite DepressantsNarcotic AntagonistsCentral Nervous System DepressantsAlcohol Antagonists,approvedinvestigational,OPRD1,Delta-type opioid receptor,target,antagonist,DB00704
Naltrexone,Appetite DepressantsNarcotic AntagonistsCentral Nervous System DepressantsAlcohol Antagonists,approvedinvestigational,OPRM1,Mu-type opioid receptor,target,antagonist,DB00704
Naltrexone,Appetite DepressantsNarcotic AntagonistsCentral Nervous System DepressantsAlcohol Antagonists,approvedinvestigational,OPRK1,Kappa-type opioid receptor,target,antagonist,DB00704
Naltrexone,Appetite DepressantsNarcotic AntagonistsCentral Nervous System DepressantsAlcohol Antagonists,approvedinvestigational,OPRS1,"HCG20471, isoform CRA_c",target,antagonist,DB00704
Tamsulosin,Adrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00706
Tamsulosin,Adrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00706
Tamsulosin,Adrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00706
Porfimer,Antineoplastic AgentsDermatologic AgentsPhotosensitizing Agents,approvedinvestigational,LDLR,Low-density lipoprotein receptor,target,other/unknown,DB00707
Porfimer,Antineoplastic AgentsDermatologic AgentsPhotosensitizing Agents,approvedinvestigational,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,antagonist,DB00707
Sufentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, Anesthesia",approvedinvestigational,OPRM1,Mu-type opioid receptor,target,agonist,DB00708
Sufentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, Anesthesia",approvedinvestigational,OPRD1,Delta-type opioid receptor,target,agonist,DB00708
Sufentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, Anesthesia",approvedinvestigational,OPRK1,Kappa-type opioid receptor,target,other,DB00708
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,pol,Reverse Transcriptase,target,inhibitor,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,P,Protein P,target,inhibitor,DB00709
Ibandronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approvedinvestigational,FDPS,Farnesyl pyrophosphate synthase,target,inhibitor,DB00710
Diethylcarbamazine,Lipoxygenase InhibitorsFilaricides,approved,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00711
Diethylcarbamazine,Lipoxygenase InhibitorsFilaricides,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00711
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00712
Oxacillin,Penicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00713
Oxacillin,Penicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00713
Oxacillin,Penicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00713
Oxacillin,Penicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB00713
Oxacillin,Penicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00713
Oxacillin,Penicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00713
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD3,D(3) dopamine receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD4,D(4) dopamine receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD2,D(2) dopamine receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD5,D(1B) dopamine receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00714
Apomorphine,Antiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,CALY,Neuron-specific vesicular protein calcyon,target,agonist,DB00714
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,other/unknown,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00715
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00715
Nedocromil,Anti-Allergic AgentsAnti-Asthmatic AgentsAnti-Inflammatory Agents,approved,CYSLTR1,Cysteinyl leukotriene receptor 1,target,suppressor,DB00716
Nedocromil,Anti-Allergic AgentsAnti-Asthmatic AgentsAnti-Inflammatory Agents,approved,CYSLTR2,Cysteinyl leukotriene receptor 2,target,antagonist,DB00716
Nedocromil,Anti-Allergic AgentsAnti-Asthmatic AgentsAnti-Inflammatory Agents,approved,FPR1,fMet-Leu-Phe receptor,target,antagonist,DB00716
Nedocromil,Anti-Allergic AgentsAnti-Asthmatic AgentsAnti-Inflammatory Agents,approved,PTGDR,Prostaglandin D2 receptor,target,unknown,DB00716
Nedocromil,Anti-Allergic AgentsAnti-Asthmatic AgentsAnti-Inflammatory Agents,approved,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB00716
Clodronate,Bone Density Conservation AgentsAntihypocalcemic AgentsBisphosphonates,approvedinvestigational,SLC25A4,ADP/ATP translocase 1,target,inhibitor,DB00720
Clodronate,Bone Density Conservation AgentsAntihypocalcemic AgentsBisphosphonates,approvedinvestigational,SLC25A5,ADP/ATP translocase 2,target,inhibitor,DB00720
Clodronate,Bone Density Conservation AgentsAntihypocalcemic AgentsBisphosphonates,approvedinvestigational,SLC25A6,ADP/ATP translocase 3,target,inhibitor,DB00720
Procaine,"Anesthetics, Local",approvedinvestigational,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00721
Procaine,"Anesthetics, Local",approvedinvestigational,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00721
Procaine,"Anesthetics, Local",approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00721
Procaine,"Anesthetics, Local",approvedinvestigational,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00721
Procaine,"Anesthetics, Local",approvedinvestigational,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB00721
Procaine,"Anesthetics, Local",approvedinvestigational,KCNMA1,Calcium-activated potassium channel,target,binder,DB00721
Procaine,"Anesthetics, Local",approvedinvestigational,MAOA,Monoamine oxidase,target,,DB00721
Lisinopril,,approvedinvestigational,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00722
Lisinopril,,approvedinvestigational,ACE2,Angiotensin-converting enzyme 2,target,inhibitor,DB00722
Methoxamine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00723
Methoxamine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB00723
Methoxamine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,binder,DB00723
Imiquimod,"Antineoplastic AgentsAdjuvants, ImmunologicInterferon Inducers",approvedinvestigational,TLR7,Toll-like receptor 7,target,agonist,DB00724
Imiquimod,"Antineoplastic AgentsAdjuvants, ImmunologicInterferon Inducers",approvedinvestigational,TLR8,Toll-like receptor 8,target,agonist,DB00724
Homatropine Methylbromide,Muscarinic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00725
Homatropine Methylbromide,Muscarinic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00725
Homatropine Methylbromide,Muscarinic AntagonistsAntispasmodics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00725
Homatropine Methylbromide,Muscarinic AntagonistsAntispasmodics,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00725
Homatropine Methylbromide,Muscarinic AntagonistsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00725
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,DRD2,D(2) dopamine receptor,target,other/unknown,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA2B,Alpha-2B adrenergic receptor,target,other/unknown,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,binder,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR1D,5-hydroxytryptamine receptor 1D,target,binder,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA2A,Alpha-2A adrenergic receptor,target,desensitize the target,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,DRD1,D(1) dopamine receptor,target,binder,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRB1,Beta adrenergic receptor,target,binder,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM1,Muscarinic acetylcholine receptor,target,binder,DB00726
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,,5-hydroxytryptamine receptor 1C,target,binder,DB00726
Rocuronium,"Muscle relaxant, Skeletal",approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB00728
Rocuronium,"Muscle relaxant, Skeletal",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00728
Rocuronium,"Muscle relaxant, Skeletal",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00728
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00731
Pralidoxime,Cholinesterase Reactivators,approved,ACHE,Acetylcholinesterase,target,activator,DB00733
Pralidoxime,Cholinesterase Reactivators,approved,BCHE,Cholinesterase,target,activator,DB00733
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,DRD3,D(3) dopamine receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,DRD4,D(4) dopamine receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,antagonistagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00734
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,antagonist,DB00734
Pentamidine,Antifungal AgentsAntiprotozoal AgentsTrypanocidal Agents,approved,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,target,other,DB00738
Hetacillin,Penicillins,approvedwithdrawn,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB00739
Hetacillin,Penicillins,approvedwithdrawn,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB00739
Hetacillin,Penicillins,approvedwithdrawn,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00739
Hetacillin,Penicillins,approvedwithdrawn,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00739
Hetacillin,Penicillins,approvedwithdrawn,penA,Penicillin-binding protein 2B,target,inhibitor,DB00739
Riluzole,,approvedinvestigational,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00740
Riluzole,,approvedinvestigational,SLC7A11,Cystine/glutamate transporter,target,inducer,DB00740
Hydrocortisone,Anti-Inflammatory Agents,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,ANXA1,Annexin A1,target,agonist,DB00741
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00745
Modafinil,Central Nervous System StimulantsAppetite DepressantsNeuroprotective AgentsStimulants,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,partial agonist,DB00745
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00747
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,SI,"Sucrase-isomaltase, intestinal",target,inhibitor,DB00747
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00747
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00747
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00747
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00747
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00749
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00749
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,RXRA,Retinoic acid receptor RXR-alpha,target,other,DB00749
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,HRH2,Histamine H2 receptor,target,antagonist,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,unknown,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,unknown,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00751
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00751
Tranylcypromine,Antidepressive Agents,approved,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB00752
Tranylcypromine,Antidepressive Agents,approved,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB00752
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,inhibitor,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,GLRA1,Glycine receptor subunit alpha-1,target,agonist,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,GRIA1,Glutamate receptor 1,target,antagonist,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inducer,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,ATP5D,"ATP synthase subunit delta, mitochondrial",target,unknown,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,CALM1,Calmodulin,target,other/unknown,DB00753
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00753
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,RXRG,Retinoic acid receptor RXR-gamma,target,agonist,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,RARG,Retinoic acid receptor gamma,target,agonist,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,ALDH1A1,Retinal dehydrogenase 1,target,,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,GPRC5A,Retinoic acid-induced protein 3,target,,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,NR0B1,Nuclear receptor subfamily 0 group B member 1,target,,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,ALDH1A2,Retinal dehydrogenase 2,target,,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,RARRES1,Retinoic acid receptor responder protein 1,target,agonist,DB00755
Hexachlorophene,Anti-Infective Agents,approvedwithdrawn,dld,D-lactate dehydrogenase,target,inhibitor,DB00756
Hexachlorophene,Anti-Infective Agents,approvedwithdrawn,SDHD,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",target,inhibitor,DB00756
Hexachlorophene,Anti-Infective Agents,approvedwithdrawn,GLUD1,"Glutamate dehydrogenase 1, mitochondrial",target,inhibitor,DB00756
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,rpsG,30S ribosomal protein S7,target,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,rpsN,30S ribosomal protein S14,target,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,rpsC,30S ribosomal protein S3,target,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,rpsH,30S ribosomal protein S8,target,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,rpsS,30S ribosomal protein S19,target,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,PRNP,Major prion protein,target,inhibitor,DB00759
Potassium Chloride,,approvedwithdrawn,SLC12A2,Solute carrier family 12 member 2,target,,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A1,Solute carrier family 12 member 1,target,binder,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A5,Solute carrier family 12 member 5,target,,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A6,Solute carrier family 12 member 6,target,,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A7,Solute carrier family 12 member 7,target,,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A4,Solute carrier family 12 member 4,target,,DB00761
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,TOP1,DNA topoisomerase 1,target,inhibitor,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,TOP1MT,"DNA topoisomerase I, mitochondrial",target,inhibitor,DB00762
Benzquinamide,Antipsychotic AgentsAntiemetics,withdrawn,HRH1,Histamine H1 receptor,target,antagonist,DB00767
Benzquinamide,Antipsychotic AgentsAntiemetics,withdrawn,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00767
Benzquinamide,Antipsychotic AgentsAntiemetics,withdrawn,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00767
Benzquinamide,Antipsychotic AgentsAntiemetics,withdrawn,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00767
Benzquinamide,Antipsychotic AgentsAntiemetics,withdrawn,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00767
Benzquinamide,Antipsychotic AgentsAntiemetics,withdrawn,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00767
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00768
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,S100A1,Protein S100-A1,target,antagonist,DB00768
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,S100A12,Protein S100-A12,target,antagonist,DB00768
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,S100B,Protein S100-B,target,other/unknown,DB00768
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,S100A13,Protein S100-A13,target,other/unknown,DB00768
Olopatadine,Histamine H1 AntagonistsHistamine Antagonists,approved,S100A2,Protein S100-A2,target,antagonist,DB00768
Alprostadil,,approvedinvestigational,PTGER2,Prostaglandin E2 receptor EP2 subtype,target,agonist,DB00770
Alprostadil,,approvedinvestigational,PTGER1,Prostaglandin E2 receptor EP1 subtype,target,agonist,DB00770
Etoposide,"Antineoplastic Agents, Phytogenic",approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,TOP2B,DNA topoisomerase 2-beta,target,inhibitor,DB00773
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA9,Carbonic anhydrase 9,target,inhibitor,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA12,Carbonic anhydrase 12,target,inhibitor,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,other/unknown,DB00774
Hydroflumethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,other/unknown,DB00774
Tirofiban,Fibrinolytic AgentsPlatelet Aggregation Inhibitors,approved,ITGA2B,Integrin alpha-IIb,target,antagonist,DB00775
Tirofiban,Fibrinolytic AgentsPlatelet Aggregation Inhibitors,approved,ITGB3,Integrin beta-3,target,antagonist,DB00775
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00777
Propiomazine,Hypnotics and SedativesHistamine AntagonistsAntiemetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00777
Roxithromycin,Macrolides,approvedwithdrawn,rplJ,50S ribosomal protein L10,target,inhibitor,DB00778
Roxithromycin,Macrolides,approvedwithdrawn,ABCB1,Multidrug resistance protein 1,target,,DB00778
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOA,Amine oxidase [flavin-containing] A,target,antagonist,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOB,Amine oxidase [flavin-containing] B,target,antagonist,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,AOC3,Membrane primary amine oxidase,target,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,GPT,Alanine aminotransferase 1,target,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,GPT2,Alanine aminotransferase 2,target,inhibitor,DB00780
Phenelzine,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,GAD65,Glutamic acid decarboxylase,target,inhibitor,DB00780
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,ESR1,Estrogen receptor,target,agonist,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,ESR2,Estrogen receptor beta,target,agonist,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,,DB00783
Mefenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00784
Mefenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00784
Cryptenamine,,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00785
Cryptenamine,,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00785
Cryptenamine,,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00785
Cryptenamine,,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00785
Cryptenamine,,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00785
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP1,Interstitial collagenase,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP2,72 kDa type IV collagenase,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP3,Stromelysin-1,target,antagonist,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP7,Matrilysin,target,antagonist,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP8,Neutrophil collagenase,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,,Matrix metalloproteinase-9,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP10,Stromelysin-2,target,antagonist,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP11,Stromelysin-3,target,antagonist,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP12,Macrophage metalloelastase,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP13,Collagenase 3,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP14,Matrix metalloproteinase-14,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP15,Matrix metalloproteinase-15,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP16,Matrix metalloproteinase-16,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP17,Matrix metalloproteinase-17,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP19,Matrix metalloproteinase-19,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP20,Matrix metalloproteinase-20,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP21,Matrix metalloproteinase-21,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP23A,Matrix metalloproteinase-23,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP24,Matrix metalloproteinase-24,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP25,Matrix metalloproteinase-25,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP26,Matrix metalloproteinase-26,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP27,Matrix metalloproteinase-27,target,inhibitor,DB00786
Marimastat,Enzyme Inhibitors,approvedinvestigational,MMP28,Matrix metalloproteinase-28,target,inhibitor,DB00786
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,TK,Thymidine kinase,target,potentiator,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,UL30,DNA polymerase catalytic subunit,target,inhibitor,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,ORF28,DNA polymerase catalytic subunit,target,inhibitor,DB00787
Naproxen,,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00788
Naproxen,,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00788
Primidone,AnticonvulsantsBarbiturates,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GRIA2,Glutamate receptor 2,target,antagonist,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00794
Primidone,AnticonvulsantsBarbiturates,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00794
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,CHUK,Inhibitor of nuclear factor kappa-B kinase subunit alpha,target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,SLC7A11,Cystine/glutamate transporter,target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,ACAT1,"Acetyl-CoA acetyltransferase, mitochondrial",target,inhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,TBXAS1,Thromboxane-A synthase,target,antagonist,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,PLA2G1B,Phospholipase A2,target,antagonist,DB00795
Tolazoline,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00797
Tolazoline,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00797
Tolazoline,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,HRH1,Histamine H1 receptor,target,agonist,DB00797
Tolazoline,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,HRH2,Histamine H2 receptor,target,agonist,DB00797
Tolazoline,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,binder,DB00797
Tolazoline,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,binder,DB00797
Gentamicin,Aminoglycosides,approved,rpsL,30S ribosomal protein S12,target,adduct,DB00798
Gentamicin,Aminoglycosides,approved,LRP2,Low-density lipoprotein receptor-related protein 2,target,other/unknown,DB00798
Tazarotene,Dermatologic AgentsKeratolytic AgentsTeratogensProdrugs,approvedinvestigational,RARA,Retinoic acid receptor alpha,target,agonist,DB00799
Tazarotene,Dermatologic AgentsKeratolytic AgentsTeratogensProdrugs,approvedinvestigational,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00799
Tazarotene,Dermatologic AgentsKeratolytic AgentsTeratogensProdrugs,approvedinvestigational,RARG,Retinoic acid receptor gamma,target,agonist,DB00799
Tazarotene,Dermatologic AgentsKeratolytic AgentsTeratogensProdrugs,approvedinvestigational,RARB,Retinoic acid receptor beta,target,agonist,DB00799
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,DRD5,D(1B) dopamine receptor,target,agonist,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,DRD1,D(1A) dopamine receptor,target,agonist,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,,DB00800
Fenoldopam,Antihypertensive AgentsVasodilator AgentsDopamine Agonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,,DB00800
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00801
Halazepam,Anti-Anxiety AgentsHypnotics and SedativesBenzodiazepinesNeuromuscular Agents,approvedillicitwithdrawn,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00801
Dicyclomine,Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00804
Dicyclomine,Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00804
Minaprine,Antidepressive Agents,approved,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB00805
Minaprine,Antidepressive Agents,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB00805
Minaprine,Antidepressive Agents,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00805
Minaprine,Antidepressive Agents,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB00805
Minaprine,Antidepressive Agents,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB00805
Minaprine,Antidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00805
Minaprine,Antidepressive Agents,approved,DRD1,D(1A) dopamine receptor,target,agonist,DB00805
Minaprine,Antidepressive Agents,approved,DRD2,D(2) dopamine receptor,target,agonist,DB00805
Minaprine,Antidepressive Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,agonist,DB00805
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB00806
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,ADORA1,Adenosine receptor A1,target,antagonist,DB00806
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB00806
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB00806
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,ADORA2A,Adenosine receptor A2a,target,antagonist,DB00806
Pentoxifylline,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator AgentsFree Radical ScavengersRadiation-Protective AgentsHematologic AgentsHemorrheologic Agents,approvedinvestigational,NT5E,5'-nucleotidase,target,inhibitor,DB00806
Indapamide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,KCNQ1,Potassium voltage-gated channel subfamily KQT member 1,target,inhibitor,DB00808
Indapamide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,KCNE1,Potassium voltage-gated channel subfamily E member 1,target,inhibitor,DB00808
Tropicamide,Muscarinic AntagonistsMydriaticsDiagnostic Agents,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00809
Tropicamide,Muscarinic AntagonistsMydriaticsDiagnostic Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00809
Tropicamide,Muscarinic AntagonistsMydriaticsDiagnostic Agents,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00809
Tropicamide,Muscarinic AntagonistsMydriaticsDiagnostic Agents,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00809
Biperiden,Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00810
Biperiden,Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB00810
Ribavirin,Antiviral AgentsAntimetabolites,approved,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1,target,inhibitor,DB00811
Ribavirin,Antiviral AgentsAntimetabolites,approved,ADK,Adenosine kinase,target,activator,DB00811
Ribavirin,Antiviral AgentsAntimetabolites,approved,L,RNA-directed RNA polymerase L,target,antagonist,DB00811
Ribavirin,Antiviral AgentsAntimetabolites,approved,PB1,RNA-directed RNA polymerase catalytic subunit,target,inhibitor,DB00811
Ribavirin,Antiviral AgentsAntimetabolites,approved,NT5C2,Cytosolic purine 5'-nucleotidase,target,inducer,DB00811
Ribavirin,Antiviral AgentsAntimetabolites,approved,ENPP1,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,target,inhibitor,DB00811
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00812
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGIS,Prostacyclin synthase,target,inhibitor,DB00812
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00812
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,OPRM1,Mu-type opioid receptor,target,agonist,DB00813
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,OPRD1,Delta-type opioid receptor,target,agonist,DB00813
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,OPRK1,Kappa-type opioid receptor,target,agonist,DB00813
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00814
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00814
Rosoxacin,Anti-Infective Agents,approved,gyrB,DNA gyrase subunit B,target,inhibitor,DB00817
Rosoxacin,Anti-Infective Agents,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00817
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,SCN4A,Sodium channel protein type 4 subunit alpha,target,inhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,SCN2A,Sodium channel protein type 2 subunit alpha,target,inhibitor,DB00818
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00818
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00819
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CA14,Carbonic anhydrase 14,target,inhibitor,DB00819
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00819
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CA3,Carbonic anhydrase 3,target,inhibitor,DB00819
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00819
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,CA7,Carbonic anhydrase 7,target,inhibitor,DB00819
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,AQP1,Aquaporin-1,target,inhibitor,DB00819
Tadalafil,Vasodilator AgentsPhosphodiesterase 5 Inhibitors,approvedinvestigational,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB00820
Tadalafil,Vasodilator AgentsPhosphodiesterase 5 Inhibitors,approvedinvestigational,PDE11A,"Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A",target,inhibitor,DB00820
Carprofen,"Anti-Inflammatory Agents, Non-SteroidalPhotosensitizing Agents",approvedwithdrawn,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00821
Carprofen,"Anti-Inflammatory Agents, Non-SteroidalPhotosensitizing Agents",approvedwithdrawn,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00821
Disulfiram,Enzyme InhibitorsAlcohol Deterrents,approved,ALDH2,"Aldehyde dehydrogenase, mitochondrial",target,inhibitor,DB00822
Disulfiram,Enzyme InhibitorsAlcohol Deterrents,approved,DBH,Dopamine beta-hydroxylase,target,inhibitor,DB00822
Ethynodiol,"Contraceptives, Oral, Synthetic",approved,PGR,Progesterone receptor,target,agonist,DB00823
Ethynodiol,"Contraceptives, Oral, Synthetic",approved,ESR1,Estrogen receptor,target,agonist,DB00823
Enprofylline,Anti-Asthmatic AgentsAnti-Arrhythmia AgentsBronchodilator AgentsAdenosine A2 Receptor Antagonists,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB00824
Enprofylline,Anti-Asthmatic AgentsAnti-Arrhythmia AgentsBronchodilator AgentsAdenosine A2 Receptor Antagonists,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB00824
Enprofylline,Anti-Asthmatic AgentsAnti-Arrhythmia AgentsBronchodilator AgentsAdenosine A2 Receptor Antagonists,approved,ADORA2B,Adenosine receptor A2b,target,antagonist,DB00824
Enprofylline,Anti-Asthmatic AgentsAnti-Arrhythmia AgentsBronchodilator AgentsAdenosine A2 Receptor Antagonists,approved,ADORA1,Adenosine receptor A1,target,,DB00824
Enprofylline,Anti-Asthmatic AgentsAnti-Arrhythmia AgentsBronchodilator AgentsAdenosine A2 Receptor Antagonists,approved,ADORA2A,Adenosine receptor A2a,target,,DB00824
Enprofylline,Anti-Asthmatic AgentsAnti-Arrhythmia AgentsBronchodilator AgentsAdenosine A2 Receptor Antagonists,approved,ADORA3,Adenosine receptor A3,target,,DB00824
Menthol,Antipruritics,approved,TRPM8,Transient receptor potential cation channel subfamily M member 8,target,inducer,DB00825
Menthol,Antipruritics,approved,TRPA1,Transient receptor potential cation channel subfamily A member 1,target,inducer,DB00825
Menthol,Antipruritics,approved,TRPV3,Transient receptor potential cation channel subfamily V member 3,target,inducer,DB00825
Menthol,Antipruritics,approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00825
Cinoxacin,,approvedwithdrawn,gyrA,DNA gyrase subunit A,target,inhibitor,DB00827
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,TSPO,Translocator protein,target,potentiator,DB00829
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00829
Phenmetrazine,Central Nervous System StimulantsSympathomimeticsAppetite Depressants,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00830
Phenmetrazine,Central Nervous System StimulantsSympathomimeticsAppetite Depressants,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00830
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CALY,Neuron-specific vesicular protein calcyon,target,antagonist,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,CALM1,Calmodulin,target,inhibitor,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,,DB00831
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,S100A4,Protein S100-A4,target,inhibitor,DB00831
Cefaclor,Anti-Bacterial AgentsCephalosporins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00833
Cefaclor,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00833
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,PGR,Progesterone receptor,target,antagonist,DB00834
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,NR3C1,Glucocorticoid receptor,target,antagonist,DB00834
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00835
Brompheniramine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00835
Loperamide,Antidiarrheals,approved,OPRM1,Mu-type opioid receptor,target,agonist,DB00836
Loperamide,Antidiarrheals,approved,OPRD1,Delta-type opioid receptor,target,agonist,DB00836
Loperamide,Antidiarrheals,approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00836
Loperamide,Antidiarrheals,approved,CACNA1A,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,target,inhibitor,DB00836
Loperamide,Antidiarrheals,approved,POMC,Pro-opiomelanocortin,target,modulator,DB00836
Loperamide,Antidiarrheals,approved,CALM1,Calmodulin,target,inhibitor,DB00836
Progabide,Antiparkinson AgentsAnticonvulsantsAntidepressive AgentsGABA AgonistsAntidyskinetics,approvedinvestigational,GABBR1,Gamma-aminobutyric acid type B receptor subunit 1,target,agonist,DB00837
Progabide,Antiparkinson AgentsAnticonvulsantsAntidepressive AgentsGABA AgonistsAntidyskinetics,approvedinvestigational,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB00837
Dobutamine,SympathomimeticsCardiotonic AgentsAdrenergic beta-1 Receptor Agonists,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB00841
Dobutamine,SympathomimeticsCardiotonic AgentsAdrenergic beta-1 Receptor Agonists,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00841
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB00842
Oxazepam,Anti-Anxiety AgentsHypnotics and SedativesGABA Modulators,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00842
Donepezil,,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB00843
Donepezil,,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,other/unknown,DB00843
Nalbuphine,,approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00844
Nalbuphine,,approved,OPRM1,Mu-type opioid receptor,target,antagonist,DB00844
Nalbuphine,,approved,OPRD1,Delta-type opioid receptor,target,antagonist,DB00844
Clofazimine,"Anti-Inflammatory Agents, Non-SteroidalLeprostatic AgentsColoring AgentsAntimycobacterialsDyes",approvedinvestigational,GK0582,Uncharacterized oxidoreductase CzcO-like,target,inhibitor,DB00845
Cysteamine,Radiation-Protective AgentsOphthalmics,approvedinvestigational,SST,Somatostatin,target,binder,DB00847
Cysteamine,Radiation-Protective AgentsOphthalmics,approvedinvestigational,NPY2R,Neuropeptide Y receptor type 2,target,other/unknown,DB00847
Levamisole,"Antirheumatic AgentsAdjuvants, ImmunologicAntinematodal Agents",withdrawn,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,agonist,DB00848
Levamisole,"Antirheumatic AgentsAdjuvants, ImmunologicAntinematodal Agents",withdrawn,ALPPL2,"Alkaline phosphatase, placental-like",target,inhibitor,DB00848
Levamisole,"Antirheumatic AgentsAdjuvants, ImmunologicAntinematodal Agents",withdrawn,,Acetylcholine receptor subunit alpha-type unc-38,target,activator,DB00848
Levamisole,"Antirheumatic AgentsAdjuvants, ImmunologicAntinematodal Agents",withdrawn,,Acetylcholine receptor subunit alpha-type unc-63,target,activator,DB00848
Levamisole,"Antirheumatic AgentsAdjuvants, ImmunologicAntinematodal Agents",withdrawn,,Acetylcholine receptor subunit beta-type lev-1,target,activator,DB00848
Levamisole,"Antirheumatic AgentsAdjuvants, ImmunologicAntinematodal Agents",withdrawn,,Acetylcholine receptor subunit beta-type unc-29,target,activator,DB00848
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GRIA2,Glutamate receptor 2,target,antagonist,DB00849
Methylphenobarbital,Hypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB00849
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00850
Perphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,CALM1,Calmodulin,target,inhibitor,DB00850
Dacarbazine,"Antineoplastic Agents, Alkylating",approvedinvestigational,POLA2,DNA polymerase alpha subunit B,target,other/unknown,DB00851
Dacarbazine,"Antineoplastic Agents, Alkylating",approvedinvestigational,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",target,inhibitor,DB00851
Pseudoephedrine,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00852
Pseudoephedrine,,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00852
Pseudoephedrine,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00852
Pseudoephedrine,,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00852
Pseudoephedrine,,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00852
Pseudoephedrine,,approved,ADRB2,Beta-2 adrenergic receptor,target,partial agonist,DB00852
Pseudoephedrine,,approved,ADRB1,Beta-1 adrenergic receptor,target,agonistpartial agonist,DB00852
Pseudoephedrine,,approved,,"Nuclear factor of activated T-cells, cytoplasmic 1",target,,DB00852
Pseudoephedrine,,approved,TNF,Tumor necrosis factor,target,,DB00852
Pseudoephedrine,,approved,,activator protein 1,target,,DB00852
Pseudoephedrine,,approved,IL2,Interleukin-2,target,,DB00852
Levorphanol,"Analgesics, OpioidNarcotics",approved,OPRM1,Mu-type opioid receptor,target,agonist,DB00854
Levorphanol,"Analgesics, OpioidNarcotics",approved,OPRD1,Delta-type opioid receptor,target,agonist,DB00854
Levorphanol,"Analgesics, OpioidNarcotics",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00854
Diflunisal,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00861
Diflunisal,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00861
Vardenafil,Vasodilator AgentsPhosphodiesterase 5 InhibitorsAnti-Impotence Agents,approved,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB00862
Vardenafil,Vasodilator AgentsPhosphodiesterase 5 InhibitorsAnti-Impotence Agents,approved,PDE6G,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,allosteric modulator,DB00862
Vardenafil,Vasodilator AgentsPhosphodiesterase 5 InhibitorsAnti-Impotence Agents,approved,PDE6H,"Retinal cone rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,allosteric modulator,DB00862
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC18A2,Synaptic vesicular amine transporter,target,inducer,DB00865
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00865
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00865
Benzphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00865
Alprenolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00866
Alprenolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB00866
Alprenolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00866
Dorzolamide,,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00869
Dorzolamide,,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00869
Dorzolamide,,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00869
Suprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedwithdrawn,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00870
Suprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedwithdrawn,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00870
Conivaptan,,approvedinvestigational,AVPR1A,Vasopressin V1a receptor,target,antagonist,DB00872
Conivaptan,,approvedinvestigational,AVPR2,Vasopressin V2 receptor,target,antagonist,DB00872
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,DRD2,D(2) dopamine receptor,target,antagonist,DB00875
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00875
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,DRD1,D(1A) dopamine receptor,target,antagonist,DB00875
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00875
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00875
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,MTOR,Serine/threonine-protein kinase mTOR,target,inhibitor,DB00877
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,other,DB00877
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,FGF2,Fibroblast growth factor 2,target,other/unknown,DB00877
Chlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB00880
Chlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00880
Chlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00880
Chlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00880
Risedronate,Bone Density Conservation AgentsCalcium Channel BlockersAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approvedinvestigational,FDPS,Farnesyl pyrophosphate synthase,target,inhibitor,DB00884
Omapatrilat,,investigational,ACE,Angiotensin-converting enzyme,target,,DB00886
Omapatrilat,,investigational,MME,Neprilysin,target,,DB00886
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC12A2,Solute carrier family 12 member 2,target,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC12A4,Solute carrier family 12 member 4,target,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC12A5,Solute carrier family 12 member 5,target,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,CFTR,Cystic fibrosis transmembrane conductance regulator,target,antagonist,DB00887
Iron Dextran,HematinicsAnti-anemic AgentsSupplements,approved,HBB,Hemoglobin subunit beta,target,activator,DB00893
Iron Dextran,HematinicsAnti-anemic AgentsSupplements,approved,HBA1,Hemoglobin subunit alpha,target,activator,DB00893
Iron Dextran,HematinicsAnti-anemic AgentsSupplements,approved,FTH1,Ferritin heavy chain,target,other,DB00893
Iron Dextran,HematinicsAnti-anemic AgentsSupplements,approved,FTL,Ferritin light chain,target,other,DB00893
Benzylpenicilloyl Polylysine,,approved,FCER1G,High affinity immunoglobulin epsilon receptor subunit gamma,target,agonist,DB00895
Benzylpenicilloyl Polylysine,,approved,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,target,agonist,DB00895
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,TSPO,Translocator protein,target,other,DB00897
Triazolam,"Anti-Anxiety AgentsAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00897
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,GLRA1,Glycine receptor subunit alpha-1,target,agonist,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,GLRA2,Glycine receptor subunit alpha-2,target,agonist,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,ADH1A,Alcohol dehydrogenase 1A,target,agonist,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,ADH1B,Alcohol dehydrogenase 1B,target,agonist,DB00898
Ethanol,"Anti-Infective Agents, LocalCentral Nervous System DepressantsSolvents",approved,ADH1C,Alcohol dehydrogenase 1C,target,agonist,DB00898
Remifentanil,"Hypnotics and SedativesAnesthetics, IntravenousAnalgesics, Opioid",approved,OPRM1,Mu-type opioid receptor,target,agonist,DB00899
Remifentanil,"Hypnotics and SedativesAnesthetics, IntravenousAnalgesics, Opioid",approved,OPRD1,Delta-type opioid receptor,target,agonist,DB00899
Remifentanil,"Hypnotics and SedativesAnesthetics, IntravenousAnalgesics, Opioid",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB00899
Didanosine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,pol,Reverse Transcriptase,target,inhibitor,DB00900
Didanosine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,PNP,Purine nucleoside phosphorylase,target,,DB00900
Ethacrynic acid,Enzyme InhibitorsDiuretics,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB00903
Ethacrynic acid,Enzyme InhibitorsDiuretics,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00903
Ondansetron,Antipsychotic Agents,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00904
Ondansetron,Antipsychotic Agents,approved,HTR4,5-hydroxytryptamine receptor 4,target,agonist,DB00904
Ondansetron,Antipsychotic Agents,approved,OPRM1,Mu-type opioid receptor,target,other/unknown,DB00904
Ondansetron,Antipsychotic Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,other/unknown,DB00904
Ondansetron,Antipsychotic Agents,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,other/unknown,DB00904
Bimatoprost,Anti-glaucoma Agents,approvedinvestigational,PTGFR,Prostaglandin F2-alpha receptor,target,agonist,DB00905
Bimatoprost,Anti-glaucoma Agents,approvedinvestigational,PTGER1,Prostaglandin E2 receptor EP1 subtype,target,agonist,DB00905
Bimatoprost,Anti-glaucoma Agents,approvedinvestigational,PTGER3,Prostaglandin E2 receptor EP3 subtype,target,agonist,DB00905
Bimatoprost,Anti-glaucoma Agents,approvedinvestigational,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB00905
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SCN11A,Sodium channel protein type 11 subunit alpha,target,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00907
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00907
Quinidine,Anti-Arrhythmia Agents,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,KCNK1,Potassium channel subfamily K member 1,target,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,KCNK6,Potassium channel subfamily K member 6,target,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB00908
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN2A,Sodium channel protein type 2 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN3A,Sodium channel protein type 3 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN4A,Sodium channel protein type 4 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN9A,Sodium channel protein type 9 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN11A,Sodium channel protein type 11 subunit alpha,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN1B,Sodium channel subunit beta-1,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN2B,Sodium channel subunit beta-2,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN3B,Sodium channel subunit beta-3,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,SCN4B,Sodium channel subunit beta-4,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CACNA1I,Voltage-dependent T-type calcium channel subunit alpha-1I,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA1,Carbonic anhydrase 1,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA2,Carbonic anhydrase 2,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA3,Carbonic anhydrase 3,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA4,Carbonic anhydrase 4,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA5A,"Carbonic anhydrase 5A, mitochondrial",target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA5B,"Carbonic anhydrase 5B, mitochondrial",target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA6,Carbonic anhydrase 6,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA7,Carbonic anhydrase 7,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA8,Carbonic anhydrase-related protein,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA9,Carbonic anhydrase 9,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA10,Carbonic anhydrase-related protein 10,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA11,Carbonic anhydrase-related protein 11,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA12,Carbonic anhydrase 12,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA13,Carbonic anhydrase 13,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,CA14,Carbonic anhydrase 14,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB00909
Zonisamide,AntioxidantsAnticonvulsants,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB00909
Repaglinide,Hypoglycemic AgentsAntidiabetic AgentsMeglitinides,approvedinvestigational,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB00912
Repaglinide,Hypoglycemic AgentsAntidiabetic AgentsMeglitinides,approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB00912
Phenformin,Hypoglycemic Agents,approvedwithdrawn,PRKAA1,5'-AMP-activated protein kinase catalytic subunit alpha-1,target,activator,DB00914
Phenformin,Hypoglycemic Agents,approvedwithdrawn,KCNJ8,ATP-sensitive inward rectifier potassium channel 8,target,inhibitor,DB00914
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,M,Matrix protein 2,target,inhibitor,DB00915
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00915
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,DRD2,D(2) dopamine receptor,target,agonist,DB00915
Metronidazole,Antiprotozoal AgentsAnti-Infective AgentsRadiation-Sensitizing Agents,approved,rdxA,Oxygen-insensitive NADPH nitroreductase,target,potentiator,DB00916
Metronidazole,Antiprotozoal AgentsAnti-Infective AgentsRadiation-Sensitizing Agents,approved,,Iron hydrogenase 1,target,inhibitor,DB00916
Dinoprostone,OxytocicsProstaglandins,approved,PTGER2,Prostaglandin E2 receptor EP2 subtype,target,agonist,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,PTGER1,Prostaglandin E2 receptor EP1 subtype,target,agonist,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,PTGER3,Prostaglandin E2 receptor EP3 subtype,target,agonist,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,PTGER4,Prostaglandin E2 receptor EP4 subtype,target,agonist,DB00917
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00918
Almotriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00918
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE7A,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE7B,"cAMP-specific 3',5'-cyclic phosphodiesterase 7B",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE8A,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PDE8B,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8B",target,inhibitor,DB00920
Ketotifen,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",target,inhibitor,DB00920
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,OPRM1,Mu-type opioid receptor,target,partial agonist,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,OPRK1,Kappa-type opioid receptor,target,antagonist,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,OPRD1,Delta-type opioid receptor,target,antagonist,DB00921
Levosimendan,Phosphodiesterase InhibitorsAnti-Arrhythmia AgentsCardiotonic AgentsVasodilator Agents,approvedinvestigational,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,potentiator,DB00922
Levosimendan,Phosphodiesterase InhibitorsAnti-Arrhythmia AgentsCardiotonic AgentsVasodilator Agents,approvedinvestigational,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,inducer,DB00922
Levosimendan,Phosphodiesterase InhibitorsAnti-Arrhythmia AgentsCardiotonic AgentsVasodilator Agents,approvedinvestigational,KCNJ8,ATP-sensitive inward rectifier potassium channel 8,target,inducer,DB00922
Levosimendan,Phosphodiesterase InhibitorsAnti-Arrhythmia AgentsCardiotonic AgentsVasodilator Agents,approvedinvestigational,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB00922
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,CALM1,Calmodulin,target,inhibitor,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB00925
Etretinate,,withdrawn,RARA,Retinoic acid receptor alpha,target,agonist,DB00926
Etretinate,,withdrawn,RXRA,Retinoic acid receptor RXR-alpha,target,agonist,DB00926
Etretinate,,withdrawn,RARB,Retinoic acid receptor beta,target,agonist,DB00926
Etretinate,,withdrawn,RXRG,Retinoic acid receptor RXR-gamma,target,agonist,DB00926
Etretinate,,withdrawn,RXRB,Retinoic acid receptor RXR-beta,target,agonist,DB00926
Etretinate,,withdrawn,RARG,Retinoic acid receptor gamma,target,agonist,DB00926
Azacitidine,"Enzyme InhibitorsAntimetabolites, Antineoplastic",approvedinvestigational,DNMT1,DNA (cytosine-5)-methyltransferase 1,target,inhibitor,DB00928
Misoprostol,"OxytocicsAnti-Ulcer AgentsAbortifacient Agents, NonsteroidalAbortifacient AgentsProstaglandins",approved,PTGER3,Prostaglandin E2 receptor EP3 subtype,target,agonist,DB00929
Misoprostol,"OxytocicsAnti-Ulcer AgentsAbortifacient Agents, NonsteroidalAbortifacient AgentsProstaglandins",approved,PTGER2,Prostaglandin E2 receptor EP2 subtype,target,agonist,DB00929
Misoprostol,"OxytocicsAnti-Ulcer AgentsAbortifacient Agents, NonsteroidalAbortifacient AgentsProstaglandins",approved,PTGER4,Prostaglandin E2 receptor EP4 subtype,target,agonist,DB00929
Mesoridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00933
Mesoridazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00933
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,ADRA1A,Alpha-1 adrenergic receptor,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,binder,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,binder,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,DRD2,D(2) dopamine receptor,target,binder,DB00934
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,ADRA2A,Alpha-2 adrenergic receptor,target,antagonist,DB00934
Oxymetazoline,SympathomimeticsAdrenergic alpha-AgonistsNasal Decongestants,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00935
Oxymetazoline,SympathomimeticsAdrenergic alpha-AgonistsNasal Decongestants,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00935
Oxymetazoline,SympathomimeticsAdrenergic alpha-AgonistsNasal Decongestants,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB00935
Oxymetazoline,SympathomimeticsAdrenergic alpha-AgonistsNasal Decongestants,approved,ADRA2B,Alpha-2B adrenergic receptor,target,binder,DB00935
Oxymetazoline,SympathomimeticsAdrenergic alpha-AgonistsNasal Decongestants,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB00935
Oxymetazoline,SympathomimeticsAdrenergic alpha-AgonistsNasal Decongestants,approved,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB00935
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,AKR1C1,Aldo-keto reductase family 1 member C1,target,inhibitor,DB00936
Diethylpropion,Appetite DepressantsStimulants,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00937
Diethylpropion,Appetite DepressantsStimulants,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB00937
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00939
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00939
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00939
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,target,other,DB00939
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,target,other,DB00939
Methantheline,Muscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00940
Methantheline,Muscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,HRH2,Histamine H2 receptor,target,antagonist,DB00940
Demecarium,Cholinergic Agents,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB00944
Demecarium,Cholinergic Agents,approved,BCHE,Cholinesterase,target,inhibitor,DB00944
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,AKR1C1,Aldo-keto reductase family 1 member C1,target,inhibitor,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,PRKAA1,5'-AMP-activated protein kinase,target,activator,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,EDNRA,Endothelin-1 receptor,target,,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,TP53,Cellular tumor antigen p53,target,acetylation,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,HSPA5,78 kDa glucose-regulated protein,target,binding,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,,Ribosomal protein S6 kinase alpha-3,target,,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,NFKBIA,NF-kappa-B inhibitor alpha,target,,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,NFKB2,Nuclear factor NF-kappa-B,target,antagonist,DB00945
Mezlocillin,Penicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00948
Mezlocillin,Penicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB00948
Mezlocillin,Penicillins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB00948
Felbamate,Anticonvulsants,approved,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,antagonist,DB00949
Felbamate,Anticonvulsants,approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB00949
Felbamate,Anticonvulsants,approved,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,antagonist,DB00949
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,katG,Catalase-peroxidase,target,other/unknown,DB00951
Isoniazid,Antitubercular AgentsFatty Acid Synthesis Inhibitors,approved,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,adduct,DB00951
Naratriptan,Serotonin AntagonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00952
Naratriptan,Serotonin AntagonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00952
Naratriptan,Serotonin AntagonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1F,5-hydroxytryptamine receptor 1F,target,agonist,DB00952
Naratriptan,Serotonin AntagonistsSerotonin Receptor Agonists,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB00952
Rizatriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00953
Rizatriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00953
Rizatriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approved,HTR1F,5-hydroxytryptamine receptor 1F,target,agonist,DB00953
Netilmicin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAminoglycosides,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB00955
Hydrocodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB00956
Hydrocodone,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB00956
Norgestimate,"Contraceptives, Oral, SyntheticContraceptive Agents",approved,PGR,Progesterone receptor,target,agonist,DB00957
Norgestimate,"Contraceptives, Oral, SyntheticContraceptive Agents",approved,ESR1,Estrogen receptor,target,agonist,DB00957
Pindolol,,approved,ADRB1,Beta-1 adrenergic receptor,target,partial agonist,DB00960
Pindolol,,approved,ADRB2,Beta-2 adrenergic receptor,target,partial agonist,DB00960
Pindolol,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB00960
Pindolol,,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,other/unknown,DB00960
Zaleplon,Hypnotics and Sedatives,approvedillicitinvestigational,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB00962
Zaleplon,Hypnotics and Sedatives,approvedillicitinvestigational,TSPO,Translocator protein,target,other,DB00962
Bromfenac,,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00963
Bromfenac,,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00963
Apraclonidine,Adrenergic alpha-2 Receptor AgonistsAnti-glaucoma AgentsEENT PreparationsOphthalmics,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00964
Apraclonidine,Adrenergic alpha-2 Receptor AgonistsAnti-glaucoma AgentsEENT PreparationsOphthalmics,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00964
Apraclonidine,Adrenergic alpha-2 Receptor AgonistsAnti-glaucoma AgentsEENT PreparationsOphthalmics,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB00964
Telmisartan,,approvedinvestigational,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB00966
Telmisartan,,approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,partial agonist,DB00966
Methyldopa,Antihypertensive AgentsSympatholyticsAdrenergic alpha-2 Receptor Agonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,,DB00968
Methyldopa,Antihypertensive AgentsSympatholyticsAdrenergic alpha-2 Receptor Agonists,approved,DDC,Aromatic-L-amino-acid decarboxylase,target,,DB00968
Dactinomycin,"Anti-Bacterial AgentsProtein Synthesis InhibitorsNucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAntibiotics",approved,TOP2A,DNA topoisomerase 2,target,,DB00970
Ezetimibe,Cholesterol Absorption Inhibitors,approved,SOAT1,Sterol O-acyltransferase 1,target,inhibitor,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,NPC1L1,Niemann-Pick C1-like protein 1,target,inhibitor,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,ANPEP,Aminopeptidase N,target,other,DB00973
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,inhibitor,DB00975
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,ADA,Adenosine deaminase,target,inhibitor,DB00975
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB00975
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB00975
Ethinyl Estradiol,Estrogens,approved,ESR1,Estrogen receptor,target,agonist,DB00977
Ethinyl Estradiol,Estrogens,approved,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,agonist,DB00977
Lomefloxacin,Anti-Infective Agents,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB00978
Lomefloxacin,Anti-Infective Agents,approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB00978
Lomefloxacin,Anti-Infective Agents,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00978
Ramelteon,,approvedinvestigational,MTNR1A,Melatonin receptor type 1A,target,multitarget,DB00980
Ramelteon,,approvedinvestigational,MTNR1B,Melatonin receptor type 1B,target,multitarget,DB00980
Glycopyrrolate,"Muscarinic AntagonistsAdjuvants, AnesthesiaCholinergic Antagonists",approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00986
Glycopyrrolate,"Muscarinic AntagonistsAdjuvants, AnesthesiaCholinergic Antagonists",approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00986
Glycopyrrolate,"Muscarinic AntagonistsAdjuvants, AnesthesiaCholinergic Antagonists",approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,binder,DB00986
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,POLB,DNA polymerase beta,target,inhibitor,DB00987
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DRD2,D(2) dopamine receptor,target,agonist,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DRD1,D(1A) dopamine receptor,target,agonist,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DRD5,D(1B) dopamine receptor,target,agonist,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DRD3,D(3) dopamine receptor,target,agonist,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DRD4,D(4) dopamine receptor,target,agonist,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inducer,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DBH,Dopamine beta-hydroxylase,target,ligand,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,binder,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,HTR7,5-hydroxytryptamine receptor 7,target,binder,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,DRD1,D(1) dopamine receptor,target,agonist,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,,DB00988
Rivastigmine,Neuroprotective AgentsCholinesterase InhibitorsCholinergic Agents,approvedinvestigational,ACHE,Acetylcholinesterase,target,inhibitor,DB00989
Rivastigmine,Neuroprotective AgentsCholinesterase InhibitorsCholinergic Agents,approvedinvestigational,BCHE,Cholinesterase,target,inhibitor,DB00989
Oxaprozin,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB00991
Oxaprozin,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00991
Neomycin,AminoglycosidesAntibiotics,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB00994
Auranofin,Antirheumatic Agents,approved,PRDX5,"Peroxiredoxin-5, mitochondrial",target,inhibitor,DB00995
Auranofin,Antirheumatic Agents,approved,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,inhibitor,DB00995
Gabapentin,Anti-Anxiety AgentsAntiparkinson AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersAntimanic AgentsExcitatory Amino Acid Antagonists,approvedinvestigational,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB00996
Gabapentin,Anti-Anxiety AgentsAntiparkinson AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersAntimanic AgentsExcitatory Amino Acid Antagonists,approvedinvestigational,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,inhibitor,DB00996
Gabapentin,Anti-Anxiety AgentsAntiparkinson AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersAntimanic AgentsExcitatory Amino Acid Antagonists,approvedinvestigational,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,target,inhibitor,DB00996
Gabapentin,Anti-Anxiety AgentsAntiparkinson AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersAntimanic AgentsExcitatory Amino Acid Antagonists,approvedinvestigational,ADORA1,Adenosine receptor A1,target,agonist,DB00996
Gabapentin,Anti-Anxiety AgentsAntiparkinson AgentsAnalgesicsAnticonvulsantsCalcium Channel BlockersAntimanic AgentsExcitatory Amino Acid Antagonists,approvedinvestigational,GRIN1,NMDA receptor,target,,DB00996
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00997
Frovatriptan,Serotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB00998
Frovatriptan,Serotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB00998
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB00999
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00999
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB00999
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB00999
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA9,Carbonic anhydrase 9,target,inhibitor,DB00999
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA12,Carbonic anhydrase 12,target,inhibitor,DB00999
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,other/unknown,DB00999
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01000
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01000
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01000
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,mecA,Penicillin binding protein 2a,target,inhibitor,DB01000
Salbutamol,Adrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01001
Salbutamol,Adrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01001
Cromoglicic acid,Anti-Asthmatic Agents,approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,inhibitor,DB01003
Cromoglicic acid,Anti-Asthmatic Agents,approved,S100P,Protein S100-P,target,antagonist,DB01003
Ganciclovir,Antiviral Agents,approvedinvestigational,UL30,DNA polymerase catalytic subunit,target,inhibitor,DB01004
Ganciclovir,Antiviral Agents,approvedinvestigational,TK,Thymidine kinase,target,inducer,DB01004
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,ERG11,Lanosterol 14-alpha demethylase,target,antagonist,DB01007
Tioconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approved,CYP51A1,Lanosterol 14-alpha demethylase,target,inhibitor,DB01007
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CXCR1,C-X-C chemokine receptor type 1,target,other,DB01009
Edrophonium,Cholinesterase InhibitorsAntidotes,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB01010
Edrophonium,Cholinesterase InhibitorsAntidotes,approved,BCHE,Cholinesterase,target,inhibitor,DB01010
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,CYP11B1,"Cytochrome P450 11B1, mitochondrial",target,inhibitor,DB01011
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,camC,Camphor 5-monooxygenase,target,other/unknown,DB01011
Balsalazide,"Anti-Inflammatory Agents, Non-SteroidalGastrointestinal Agents",approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB01014
Balsalazide,"Anti-Inflammatory Agents, Non-SteroidalGastrointestinal Agents",approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01014
Balsalazide,"Anti-Inflammatory Agents, Non-SteroidalGastrointestinal Agents",approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01014
Balsalazide,"Anti-Inflammatory Agents, Non-SteroidalGastrointestinal Agents",approvedinvestigational,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB01014
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,folP,Dihydropteroate synthase,target,inhibitor,DB01015
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,folC,Bifunctional protein FolC,target,inhibitor,DB01015
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,modulator,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,KCNJ5,G protein-activated inward rectifier potassium channel 4,target,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCC9,ATP-binding cassette sub-family C member 9,target,modulator,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCB11,Bile salt export pump,target,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCA1,ATP-binding cassette sub-family A member 1,target,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,CFTR,Cystic fibrosis transmembrane conductance regulator,target,antagonist,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,modulator,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,KCNJ11,Mitochondrial ATP-sensitive potassium channel,target,,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,CPT1A,"Carnitine O-palmitoyltransferase 1, liver isoform",target,,DB01016
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,rpsI,30S ribosomal protein S9,target,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,rpsD,30S ribosomal protein S4,target,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,IL1B,Interleukin-1 beta,target,modulator,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,,Matrix metalloproteinase-9,target,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,VEGFA,Vascular endothelial growth factor A,target,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,CASP1,Caspase-1,target,negative modulator,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,CASP3,Caspase-3,target,negative modulator,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,CYCS,Cytochrome c,target,negative modulator,DB01017
Guanfacine,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB01018
Guanfacine,Antihypertensive AgentsAdrenergic alpha-2 Receptor Agonists,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,binder,DB01018
Trichlormethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB01021
Trichlormethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB01021
Trichlormethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB01021
Trichlormethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB01021
Trichlormethiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB01021
Phylloquinone,VitaminsAntifibrinolytic AgentsVitamin K,approved,GGCX,Vitamin K-dependent gamma-carboxylase,target,inducer,DB01022
Phylloquinone,VitaminsAntifibrinolytic AgentsVitamin K,approved,BGLAP,Osteocalcin,target,agonist,DB01022
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,CALM1,Calmodulin,target,other,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,PDE1B,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,PDE1A,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",target,inhibitor,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,NR3C2,Mineralocorticoid receptor,target,antagonist,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,TNNC2,"Troponin C, skeletal muscle",target,other,DB01023
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,other,DB01023
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1,target,inhibitor,DB01024
Mycophenolic acid,"Enzyme InhibitorsAntibiotics, Antineoplastic",approved,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,inhibitor,DB01024
Amlexanox,Anti-Allergic AgentsAnti-Inflammatory AgentsAnti-Ulcer Agents,approvedinvestigational,S100A12,Protein S100-A12,target,antagonist,DB01025
Amlexanox,Anti-Allergic AgentsAnti-Inflammatory AgentsAnti-Ulcer Agents,approvedinvestigational,S100A13,Protein S100-A13,target,antagonist,DB01025
Amlexanox,Anti-Allergic AgentsAnti-Inflammatory AgentsAnti-Ulcer Agents,approvedinvestigational,IL3,Interleukin-3,target,antagonist,DB01025
Amlexanox,Anti-Allergic AgentsAnti-Inflammatory AgentsAnti-Ulcer Agents,approvedinvestigational,FGF1,Fibroblast growth factor 1,target,inhibitor,DB01025
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,AR,Androgen receptor,target,binder,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,,Steroid 21-hydroxylase,target,,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,target,,DB01026
Methoxyflurane,"Anesthetics, Inhalation",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,GRIA1,Glutamate receptor 1,target,antagonist,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,GLRA1,Glycine receptor subunit alpha-1,target,agonist,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,inhibitor,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inducer,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,ATP5D,"ATP synthase subunit delta, mitochondrial",target,unknown,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,target,unknown,DB01028
Methoxyflurane,"Anesthetics, Inhalation",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01028
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB01029
Irbesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approvedinvestigational,JUN,Transcription factor AP-1,target,other/unknown,DB01029
Topotecan,Topoisomerase I Inhibitors,approvedinvestigational,TOP1,DNA topoisomerase 1,target,inhibitor,DB01030
Topotecan,Topoisomerase I Inhibitors,approvedinvestigational,TOP1MT,"DNA topoisomerase I, mitochondrial",target,inhibitor,DB01030
Ethinamate,,approvedillicitwithdrawn,CA1,Carbonic anhydrase 1,target,inhibitor,DB01031
Ethinamate,,approvedillicitwithdrawn,CA2,Carbonic anhydrase 2,target,inhibitor,DB01031
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A6,Solute carrier family 22 member 6,target,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A11,Solute carrier family 22 member 11,target,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A8,Solute carrier family 22 member 8,target,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,PANX1,Pannexin-1,target,antagonist,DB01032
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,target,inhibitor,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,PPAT,Amidophosphoribosyltransferase,target,,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,IMPDH1,Inosine-5'-monophosphate dehydrogenase,target,Inhibitor,DB01033
Cerulenin,Antifungal Agents,approved,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,inhibitor,DB01034
Cerulenin,Antifungal Agents,approved,fabF,3-oxoacyl-[acyl-carrier-protein] synthase 2,target,inhibitor,DB01034
Cerulenin,Antifungal Agents,approved,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,inhibitor,DB01034
Cerulenin,Antifungal Agents,approved,FASN,Fatty acid synthase,target,inhibitor,DB01034
Procainamide,Anti-Arrhythmia Agents,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01035
Procainamide,Anti-Arrhythmia Agents,approved,DNMT1,DNA (cytosine-5)-methyltransferase 1,target,other,DB01035
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01036
Tolterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01036
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01037
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01037
Carphenazine,Antipsychotic Agents,withdrawn,DRD2,D(2) dopamine receptor,target,antagonist,DB01038
Carphenazine,Antipsychotic Agents,withdrawn,DRD1,D(1A) dopamine receptor,target,antagonist,DB01038
Carphenazine,Antipsychotic Agents,withdrawn,DRD5,D(1B) dopamine receptor,target,antagonist,DB01038
Fenofibrate,Hypolipidemic Agents,approved,PPARA,Peroxisome proliferator-activated receptor alpha,target,agonist,DB01039
Fenofibrate,Hypolipidemic Agents,approved,mmp20,Metalloproteinase,target,inhibitor,DB01039
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,,Protein cereblon,target,inhibitor,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,TNF,Tumor necrosis factor,target,inhibitor,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,antagonist,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,FGFR2,Fibroblast growth factor receptor 2,target,antagonist,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,PTGS2,Prostaglandin G/H synthase 2,target,antagonist,DB01041
Thalidomide,Immunosuppressive AgentsAngiogenesis InhibitorsLeprostatic AgentsTeratogens,approvedinvestigationalwithdrawn,ORM1,alpha1-acid glycoprotein,target,binder,DB01041
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,antagonist,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,antagonist,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,CHRFAM7A,Alpha-7 nicotinic cholinergic receptor subunit,target,antagonist,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,DRD2,D(2) dopamine receptor,target,agonist,DB01043
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,binder,DB01043
Gatifloxacin,QuinolonesAntibiotics,approvedinvestigational,gyrA,DNA gyrase subunit A,target,inhibitor,DB01044
Gatifloxacin,QuinolonesAntibiotics,approvedinvestigational,gyrB,DNA gyrase subunit B,target,inhibitor,DB01044
Gatifloxacin,QuinolonesAntibiotics,approvedinvestigational,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01044
Gatifloxacin,QuinolonesAntibiotics,approvedinvestigational,parE,DNA topoisomerase 4 subunit B,target,inhibitor,DB01044
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,rpoB,DNA-directed RNA polymerase subunit beta,target,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,rpoC,DNA-directed RNA polymerase subunit beta',target,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,agonist,DB01045
Fluocinonide,Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids,approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB01047
Fluocinonide,Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids,approvedinvestigational,SMO,Smoothened homolog,target,agonist,DB01047
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA2A,Alpha-2 adrenergic receptor,target,antagonist,DB01049
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1 adrenergic receptor,target,antagonist,DB01049
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,target,inhibitor,DB01049
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,HTR1A,Serotonin Receptors,target,antagonist,DB01049
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,DRD1,D(1A) dopamine receptor,target,antagonistagonist,DB01049
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonistagonist,DB01049
Ergoloid mesylate,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,GABRA1,GABA-A receptor (anion channel),target,agonist,DB01049
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,PTGS1,Prostaglandin G/H synthase 1,target,,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,BCL2,Apoptosis regulator Bcl-2,target,modulator,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,THBD,Thrombomodulin,target,modulator,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,PLAT,Tissue-type plasminogen activator,target,negative modulator,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,FABP2,"Fatty acid-binding protein, intestinal",target,binder,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,PPARG,Peroxisome proliferator-activated receptor gamma,target,activator,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,CFTR,Cystic fibrosis transmembrane conductance regulator,target,inhibitor,DB01050
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,gyrB,DNA gyrase subunit B,target,inhibitor,DB01051
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,,DNA topoisomerase 1,target,,DB01051
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNG1,Voltage-dependent calcium channel gamma-1 subunit,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,inhibitor,DB01054
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB01054
Mimosine,,approved,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,inhibitor,DB01055
Mimosine,,approved,CCL2,C-C motif chemokine 2,target,inhibitor,DB01055
Mimosine,,approved,TYR,Tyrosinase,target,inhibitor,DB01055
Norfloxacin,Anti-Infective AgentsQuinolones,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01059
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01062
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01062
Oxybutynin,"Muscarinic AntagonistsParasympatholyticsCholinergic AntagonistsAntispasmodicsMuscle Relaxants, Genitourinary",approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01062
Acetophenazine,Antipsychotic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01063
Acetophenazine,Antipsychotic Agents,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01063
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,MAPK1,Mitogen-activated protein kinase 1,target,inducer,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,PIK3R1,Phosphatidylinositol 3-kinase regulatory subunit alpha,target,agonist,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,PIK3R2,Phosphatidylinositol 3-kinase regulatory subunit beta,target,agonist,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,PIK3R3,Phosphatidylinositol 3-kinase regulatory subunit gamma,target,agonist,DB01064
Isoprenaline,SympathomimeticsBronchodilator AgentsCardiotonic AgentsAdrenergic beta-Agonists,approved,PDE4,CAMP phosphodiesterase,target,activator,DB01064
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,MTNR1A,Melatonin receptor type 1A,target,agonist,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,MTNR1B,Melatonin receptor type 1B,target,agonist,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,ESR1,Estrogen receptor,target,antagonist,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,RORB,Nuclear receptor ROR-beta,target,agonist,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CALM1,Calmodulin,target,,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,MPO,Myeloperoxidase,target,inhibitor,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,EPX,Eosinophil peroxidase,target,inhibitor,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,CALR,Calreticulin,target,,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,ASMT,Acetylserotonin O-methyltransferase,target,,DB01065
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB01065
Cefditoren,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB01066
Cefditoren,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01066
Glipizide,Hypoglycemic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB01067
Glipizide,Hypoglycemic Agents,approved,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB01067
Clonazepam,AnticonvulsantsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01068
Clonazepam,AnticonvulsantsGABA ModulatorsBenzodiazepines,approvedillicit,TSPO,Translocator protein,target,other/unknown,DB01068
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,unknown,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01069
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,CALM1,Calmodulin,target,inhibitor,DB01069
Fludarabine,Antineoplastic Agents,approved,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,inhibitor,DB01073
Fludarabine,Antineoplastic Agents,approved,POLA1,DNA polymerase alpha catalytic subunit,target,inhibitor,DB01073
Fludarabine,Antineoplastic Agents,approved,DCK,Deoxycytidine kinase,target,agonist,DB01073
Perhexiline,Vasodilator AgentsCalcium Channel BlockersCardiovascular Agents,approved,CPT1A,"Carnitine O-palmitoyltransferase 1, liver isoform",target,inhibitor,DB01074
Perhexiline,Vasodilator AgentsCalcium Channel BlockersCardiovascular Agents,approved,CPT2,"Carnitine O-palmitoyltransferase 2, mitochondrial",target,inhibitor,DB01074
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,DPP4,Dipeptidyl peptidase 4,target,inhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,AHR,Aryl hydrocarbon receptor,target,agonist,DB01076
Etidronic acid,Bone Density Conservation AgentsAntihypocalcemic AgentsBisphosphonates,approved,PTPRS,Receptor-type tyrosine-protein phosphatase S,target,inhibitor,DB01077
Etidronic acid,Bone Density Conservation AgentsAntihypocalcemic AgentsBisphosphonates,approved,ATP6V1A,V-type proton ATPase catalytic subunit A,target,inhibitor,DB01077
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,HTR4,5-hydroxytryptamine receptor 4,target,antagonistpartial agonist,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01079
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01079
Vigabatrin,Enzyme InhibitorsAnticonvulsantsGABA Agents,approved,GABBR1,Gamma-aminobutyric acid type B receptor subunit 1,target,agonist,DB01080
Vigabatrin,Enzyme InhibitorsAnticonvulsantsGABA Agents,approved,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,inhibitor,DB01080
Diphenoxylate,"Analgesics, OpioidAntidiarrhealsAntiperistaltic Agents",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01081
Diphenoxylate,"Analgesics, OpioidAntidiarrhealsAntiperistaltic Agents",approvedillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01081
Streptomycin,Aminoglycosides,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB01082
Orlistat,Enzyme InhibitorsAnti-Obesity Agents,approvedinvestigational,PNLIP,Pancreatic triacylglycerol lipase,target,inhibitor,DB01083
Orlistat,Enzyme InhibitorsAnti-Obesity Agents,approvedinvestigational,LIPF,Gastric triacylglycerol lipase,target,inhibitor,DB01083
Orlistat,Enzyme InhibitorsAnti-Obesity Agents,approvedinvestigational,FASN,Fatty acid synthase,target,inhibitor,DB01083
Pilocarpine,Cholinergic Agents,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,agonist,DB01085
Pilocarpine,Cholinergic Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,agonist,DB01085
Pilocarpine,Cholinergic Agents,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,agonist,DB01085
Primaquine,Antimalarials,approved,KRT7,"Keratin, type II cytoskeletal 7",target,other/unknown,DB01087
Primaquine,Antimalarials,approved,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,inhibitor,DB01087
Iloprost,,approvedinvestigational,PTGIR,Prostacyclin receptor,target,agonist,DB01088
Iloprost,,approvedinvestigational,PTGER1,Prostaglandin E2 receptor EP1 subtype,target,agonist,DB01088
Iloprost,,approvedinvestigational,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inducer,DB01088
Iloprost,,approvedinvestigational,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inducer,DB01088
Iloprost,,approvedinvestigational,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,inducer,DB01088
Iloprost,,approvedinvestigational,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,inducer,DB01088
Iloprost,,approvedinvestigational,PLAT,Tissue-type plasminogen activator,target,other/unknown,DB01088
Pentolinium,Antihypertensive AgentsNicotinic AntagonistsGanglionic Blockers,approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,antagonist,DB01090
Pentolinium,Antihypertensive AgentsNicotinic AntagonistsGanglionic Blockers,approved,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,antagonist,DB01090
Pentolinium,Antihypertensive AgentsNicotinic AntagonistsGanglionic Blockers,approved,CHRNB4,Neuronal acetylcholine receptor subunit beta-4,target,antagonist,DB01090
Hesperetin,,approved,SOAT1,Sterol O-acyltransferase 1,target,inhibitor,DB01094
Hesperetin,,approved,SOAT2,Sterol O-acyltransferase 2,target,inhibitor,DB01094
Hesperetin,,approved,MTTP,Microsomal triglyceride transfer protein large subunit,target,antagonist,DB01094
Leflunomide,Antirheumatic AgentsImmunosuppressive AgentsEnzyme InhibitorsAdjuvants,approvedinvestigational,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,inhibitor,DB01097
Leflunomide,Antirheumatic AgentsImmunosuppressive AgentsEnzyme InhibitorsAdjuvants,approvedinvestigational,AHR,Aryl hydrocarbon receptor,target,agonist,DB01097
Leflunomide,Antirheumatic AgentsImmunosuppressive AgentsEnzyme InhibitorsAdjuvants,approvedinvestigational,PTK2B,Protein-tyrosine kinase 2-beta,target,antagonist,DB01097
Flucytosine,Antifungal AgentsAntimetabolites,approved,DNMT1,DNA (cytosine-5)-methyltransferase 1,target,other,DB01099
Flucytosine,Antifungal AgentsAntimetabolites,approved,TMP1,Thymidylate synthase,target,inhibitor,DB01099
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01100
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,CALM1,Calmodulin,target,inhibitor,DB01100
Capecitabine,Prodrugs,approvedinvestigational,TYMS,Thymidylate synthase,target,inhibitor,DB01101
Arbutamine,,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01102
Arbutamine,,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01102
Arbutamine,,approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB01102
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,PLA2G6,85/88 kDa calcium-independent phospholipase A2,target,inhibitor,DB01103
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,PLA2G4A,Cytosolic phospholipase A2,target,inhibitor,DB01103
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,PLCL1,Inactive phospholipase C-like protein 1,target,inhibitor,DB01103
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01104
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01104
Sibutramine,Appetite DepressantsAntidepressive AgentsStimulants,approvedillicitinvestigationalwithdrawn,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01105
Sibutramine,Appetite DepressantsAntidepressive AgentsStimulants,approvedillicitinvestigationalwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01105
Sibutramine,Appetite DepressantsAntidepressive AgentsStimulants,approvedillicitinvestigationalwithdrawn,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01105
Levocabastine,"Histamine H1 Antagonists, Non-Sedating",approved,HRH1,Histamine H1 receptor,target,antagonist,DB01106
Levocabastine,"Histamine H1 Antagonists, Non-Sedating",approved,NTSR2,Neurotensin receptor type 2,target,partial antagonist,DB01106
Methyprylon,Hypnotics and Sedatives,approvedillicitwithdrawn,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB01107
Methyprylon,Hypnotics and Sedatives,approvedillicitwithdrawn,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01107
Trilostane,Anti-adrenal AgentsAnticorticosteroid,approvedinvestigationalwithdrawn,HSD3B1,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,target,inhibitor,DB01108
Trilostane,Anti-adrenal AgentsAnticorticosteroid,approvedinvestigationalwithdrawn,HSD3B2,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2,target,inhibitor,DB01108
Trilostane,Anti-adrenal AgentsAnticorticosteroid,approvedinvestigationalwithdrawn,ESR1,Estrogen receptor,target,allosteric modulator,DB01108
Trilostane,Anti-adrenal AgentsAnticorticosteroid,approvedinvestigationalwithdrawn,ESR2,Estrogen receptor beta,target,allosteric modulator,DB01108
Heparin,Fibrinolytic AgentsAnticoagulantsHeparins,approvedinvestigational,SERPINC1,Antithrombin-III,target,potentiator,DB01109
Heparin,Fibrinolytic AgentsAnticoagulantsHeparins,approvedinvestigational,F10,Coagulation factor X,target,inhibitor,DB01109
Heparin,Fibrinolytic AgentsAnticoagulantsHeparins,approvedinvestigational,SELP,P-selectin,target,inhibitor,DB01109
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,NOS3,"Nitric oxide synthase, endothelial",target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,NOS2,"Nitric oxide synthase, inducible",target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNMB1,Calcium-activated potassium channel subunit beta-1,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNMB2,Calcium-activated potassium channel subunit beta-2,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNMB3,Calcium-activated potassium channel subunit beta-3,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNMB4,Calcium-activated potassium channel subunit beta-4,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNN4,Intermediate conductance calcium-activated potassium channel protein 4,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNN1,Small conductance calcium-activated potassium channel protein 1,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNN2,Small conductance calcium-activated potassium channel protein 2,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNN3,Small conductance calcium-activated potassium channel protein 3,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNH6,Potassium voltage-gated channel subfamily H member 6,target,inhibitor,DB01110
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,KCNH7,Potassium voltage-gated channel subfamily H member 7,target,inhibitor,DB01110
Papaverine,,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB01113
Papaverine,,approved,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,inhibitor,DB01113
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01114
Nifedipine,Dihydropyridines,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CALM1,Calmodulin,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inhibitor,DB01115
Nifedipine,Dihydropyridines,approved,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB01115
Atovaquone,,approved,MT-CYB,Cytochrome b,target,inhibitor,DB01117
Atovaquone,,approved,PFF0160c,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,inhibitor,DB01117
Atovaquone,,approved,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,inhibitor,DB01117
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB01118
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,inhibitor,DB01118
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,inducer,DB01119
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB01119
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB01119
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,other,DB01119
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,other,DB01119
Diazoxide,Sodium Chloride Symporter Inhibitors,approved,SLC12A3,Solute carrier family 12 member 3,target,unknown,DB01119
Gliclazide,Hypoglycemic AgentsAntidiabetic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,binder,DB01120
Gliclazide,Hypoglycemic AgentsAntidiabetic Agents,approved,VEGFA,Vascular endothelial growth factor A,target,other/unknown,DB01120
Proflavine,"Anti-Infective Agents, Local",approved,F2,Prothrombin,target,other/unknown,DB01123
Proflavine,"Anti-Infective Agents, Local",approved,qacR,HTH-type transcriptional regulator QacR,target,,DB01123
Proflavine,"Anti-Infective Agents, Local",approved,lfrR,TetR family transcriptional repressor LfrR,target,,DB01123
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inhibitor,DB01124
Dutasteride,,approvedinvestigational,SRD5A2,3-oxo-5-alpha-steroid 4-dehydrogenase 2,target,inhibitor,DB01126
Dutasteride,,approvedinvestigational,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,target,inhibitor,DB01126
Proguanil,,approved,DHFR,Dihydrofolate reductase,target,inhibitor,DB01131
Proguanil,,approved,,Bifunctional dihydrofolate reductase-thymidylate synthase,target,inhibitor,DB01131
Tiludronate,Bone Density Conservation AgentsAntihypocalcemic Agents,approved,ATP6V1A,V-type proton ATPase catalytic subunit A,target,inhibitor,DB01133
Tiludronate,Bone Density Conservation AgentsAntihypocalcemic Agents,approved,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,inhibitor,DB01133
Doxacurium chloride,,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01135
Doxacurium chloride,,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01135
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,NDUFC2,NADH dehydrogenase [ubiquinone] 1 subunit C2,target,inhibitor,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,VEGFA,Vascular endothelial growth factor A,target,other,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,NPPB,Natriuretic peptides B,target,other,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,GJA1,Gap junction alpha-1 protein,target,other,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,VCAM1,Vascular cell adhesion protein 1,target,inhibitor,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,SELE,E-selectin,target,inhibitor,DB01136
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,HIF1A,Hypoxia-inducible factor 1-alpha,target,modulator,DB01136
Levofloxacin,Quinolones,approvedinvestigational,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01137
Levofloxacin,Quinolones,approvedinvestigational,gyrA,DNA gyrase subunit A,target,inhibitor,DB01137
Levofloxacin,Quinolones,approvedinvestigational,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01137
Sulfinpyrazone,Uricosuric Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,target,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCC1,Multidrug resistance-associated protein 1,target,inhibitor,DB01138
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,penA,Penicillin-binding protein 2B,target,inhibitor,DB01140
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HRH2,Histamine H2 receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HTR6,5-hydroxytryptamine receptor 6,target,binder,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,HRH4,Histamine H4 receptor,target,binder,DB01142
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,,DB01142
Amifostine,Radiation-Protective Agents,approvedinvestigational,ALPPL2,"Alkaline phosphatase, placental-like",target,inducer,DB01143
Amifostine,Radiation-Protective Agents,approvedinvestigational,ENPP1,Ectonucleotide pyrophosphatase/phosphodiesterase family member 1,target,inducer,DB01143
Diclofenamide,Carbonic Anhydrase InhibitorsAnti-glaucoma AgentsOphthalmics,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB01144
Diclofenamide,Carbonic Anhydrase InhibitorsAnti-glaucoma AgentsOphthalmics,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB01144
Diclofenamide,Carbonic Anhydrase InhibitorsAnti-glaucoma AgentsOphthalmics,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB01144
Diclofenamide,Carbonic Anhydrase InhibitorsAnti-glaucoma AgentsOphthalmics,approved,CA7,Carbonic anhydrase 7,target,inhibitor,DB01144
Diphenylpyraline,Histamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01146
Diphenylpyraline,Histamine Antagonists,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01146
Cloxacillin,Penicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01147
Cloxacillin,Penicillins,approved,ampC,Beta-lactamase,target,inducer,DB01147
Cloxacillin,Penicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB01147
Cloxacillin,Penicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB01147
Cloxacillin,Penicillins,approved,pbpB,Penicillin-binding protein 3,target,inhibitor,DB01147
Cloxacillin,Penicillins,approved,dacA,D-alanyl-D-alanine carboxypeptidase DacA,target,inhibitor,DB01147
Flavoxate,Parasympatholytics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01148
Flavoxate,Parasympatholytics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01148
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,ADRA1B,Alpha-1B adrenergic receptor,target,other/unknown,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01149
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01149
Cefprozil,Anti-Bacterial AgentsCephalosporins,approved,ponA,Penicillin-binding protein 1A,target,inhibitor,DB01150
Cefprozil,Anti-Bacterial AgentsCephalosporins,approved,pbpX,Penicillin-binding protein 2x,target,inhibitor,DB01150
Cefprozil,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB01150
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRB1,Beta-1 adrenergic receptor,target,other,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SMPD1,Sphingomyelin phosphodiesterase,target,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HRH1,Histamine H1 receptor,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA1A,Alpha-1 adrenergic receptor,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,snf,Transporter,target,,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,binder,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,binder,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,DRD2,D(2) dopamine receptor,target,binder,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ADRA2A,Alpha-2 adrenergic receptor,target,binder,DB01151
Thiamylal,,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB01154
Thiamylal,,approved,KCNJ8,ATP-sensitive inward rectifier potassium channel 8,target,inhibitor,DB01154
Thiamylal,,approved,KCNJ11,ATP-sensitive inward rectifier potassium channel 11,target,inhibitor,DB01154
Gemifloxacin,Anti-Bacterial AgentsQuinolones,approvedinvestigational,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01155
Gemifloxacin,Anti-Bacterial AgentsQuinolones,approvedinvestigational,gyrA,DNA gyrase subunit A,target,inhibitor,DB01155
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01156
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,antagonist,DB01156
Halothane,"Anesthetics, InhalationAnesthetics",approved,KCNK3,Potassium channel subfamily K member 3,target,binder,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,KCNK9,Potassium channel subfamily K member 9,target,binder,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,inhibitor,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GRIN3B,"Glutamate receptor ionotropic, NMDA 3B",target,antagonist,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,antagonist,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GLRA1,Glycine receptor subunit alpha-1,target,allosteric modulator,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,RHO,Rhodopsin,target,other,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,KCNJ6,G protein-activated inward rectifier potassium channel 2,target,inhibitor,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,KCNJ3,G protein-activated inward rectifier potassium channel 1,target,inhibitor,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,target,inhibitor,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,KCNN4,Intermediate conductance calcium-activated potassium channel protein 4,target,inhibitor,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,ATP5D,"ATP synthase subunit delta, mitochondrial",target,other/unknown,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,other/unknown,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,other/unknown,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GNG2,Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2,target,other/unknown,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,NPSR1,Neuropeptide S receptor,target,other/unknown,DB01159
Halothane,"Anesthetics, InhalationAnesthetics",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01159
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,PTGFR,Prostaglandin F2-alpha receptor,target,agonist,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,PTGIR,Prostacyclin receptor,target,antagonist,DB01160
Chloroprocaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB01161
Chloroprocaine,"Anesthetics, Local",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB01161
Chloroprocaine,"Anesthetics, Local",approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,antagonist,DB01161
Chloroprocaine,"Anesthetics, Local",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB01161
Chloroprocaine,"Anesthetics, Local",approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01161
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01162
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01162
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB01162
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01162
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,KCNH6,Potassium voltage-gated channel subfamily H member 6,target,inhibitor,DB01162
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,KCNH7,Potassium voltage-gated channel subfamily H member 7,target,inhibitor,DB01162
Amdinocillin,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",withdrawn,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB01163
Amdinocillin,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",withdrawn,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01163
Amdinocillin,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",withdrawn,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01163
Amdinocillin,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",withdrawn,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01163
Amdinocillin,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",withdrawn,penA,Penicillin-binding protein 2B,target,inhibitor,DB01163
Amdinocillin,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",withdrawn,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB01163
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01165
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB01165
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01165
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,CYP51A1,Lanosterol 14-alpha demethylase,target,inhibitor,DB01167
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB01167
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,inducer,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,inhibitor,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,JUN,Transcription factor AP-1,target,inducer,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,CCND1,G1/S-specific cyclin-D1,target,antagonist,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,MAPK3,Mitogen-activated protein kinase 3,target,inducer,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,MAPK1,Mitogen-activated protein kinase 1,target,inducer,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,AKT1,RAC-alpha serine/threonine-protein kinase,target,inducer,DB01169
Kanamycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAminoglycosides,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB01172
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,GRIN2D,"Glutamate receptor ionotropic, NMDA 2D",target,antagonist,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,antagonist,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,GRIN3B,"Glutamate receptor ionotropic, NMDA 3B",target,antagonist,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,HRH1,Histamine H1 receptor,target,antagonist,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01173
Orphenadrine,"Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsMuscle Relaxants, CentralAntidyskineticsMuscle relaxant, Skeletal",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB01173
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,GRIA2,Glutamate receptor 2,target,antagonist,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,GRIN1,NMDA receptor,target,antagonist,DB01174
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01175
Escitalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake Inhibitors",approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB01175
Cyclizine,Histamine H1 AntagonistsAntiemetics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01176
Cyclizine,Histamine H1 AntagonistsAntiemetics,approved,SULT1E1,Estrogen sulfotransferase,target,inhibitor,DB01176
Idarubicin,"Antibiotics, AntineoplasticAntibiotics",approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01177
Podofilox,"Antineoplastic Agents, PhytogenicTubulin ModulatorsKeratolytic AgentsAntimitotic Agents",approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01179
Podofilox,"Antineoplastic Agents, PhytogenicTubulin ModulatorsKeratolytic AgentsAntimitotic Agents",approved,TUBA4A,Tubulin alpha-4A chain,target,inhibitor,DB01179
Podofilox,"Antineoplastic Agents, PhytogenicTubulin ModulatorsKeratolytic AgentsAntimitotic Agents",approved,TUBB,Tubulin beta chain,target,inhibitor,DB01179
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01182
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01182
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,OPRM1,Mu-type opioid receptor,target,antagonist,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,OPRD1,Delta-type opioid receptor,target,antagonist,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,OPRK1,Kappa-type opioid receptor,target,antagonist,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,CREB1,Cyclic AMP-responsive element-binding protein 1,target,other/unknown,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,ESR1,Estrogen receptor,target,antagonistother/unknown,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,TLR4,Toll-like receptor 4,target,inhibitor,DB01183
Domperidone,,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB01184
Domperidone,,approvedinvestigational,DRD3,D(3) dopamine receptor,target,antagonist,DB01184
Fluoxymesterone,Anabolic Agents,approvedillicit,AR,Androgen receptor,target,agonist,DB01185
Fluoxymesterone,Anabolic Agents,approvedillicit,ESR1,Estrogen receptor,target,antagonist,DB01185
Fluoxymesterone,Anabolic Agents,approvedillicit,PRLR,Prolactin receptor,target,antagonist,DB01185
Fluoxymesterone,Anabolic Agents,approvedillicit,NR3C1,Glucocorticoid receptor,target,antagonist,DB01185
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,DRD2,D(2) dopamine receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,DRD3,D(3) dopamine receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,DRD4,D(4) dopamine receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,DRD5,D(1B) dopamine receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,DRD1,D(1A) dopamine receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB01186
Pergolide,Dopamine AgonistsAntidyskinetics,approvedwithdrawn,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB01186
Desflurane,"Anesthetics, Inhalation",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01189
Desflurane,"Anesthetics, Inhalation",approved,GLRA1,Glycine receptor subunit alpha-1,target,agonist,DB01189
Desflurane,"Anesthetics, Inhalation",approved,GRIA1,Glutamate receptor 1,target,antagonist,DB01189
Desflurane,"Anesthetics, Inhalation",approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inducer,DB01189
Desflurane,"Anesthetics, Inhalation",approved,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,inhibitor,DB01189
Desflurane,"Anesthetics, Inhalation",approved,ATP5D,"ATP synthase subunit delta, mitochondrial",target,other/unknown,DB01189
Desflurane,"Anesthetics, Inhalation",approved,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,target,unknown,DB01189
Clindamycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntibiotics,approved,rplJ,50S ribosomal protein L10,target,inhibitor,DB01190
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01191
Dexfenfluramine,Serotonin Uptake InhibitorsAnti-Obesity AgentsSerotonin Receptor Agonists,approvedillicitwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB01191
Oxymorphone,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedinvestigational,OPRM1,Mu-type opioid receptor,target,agonist,DB01192
Oxymorphone,"Analgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedinvestigational,OPRD1,Delta-type opioid receptor,target,antagonist,DB01192
Acebutolol,Antihypertensive AgentsSympathomimeticsAdrenergic beta-1 Receptor AntagonistsAnti-Arrhythmia Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,partial agonist,DB01193
Acebutolol,Antihypertensive AgentsSympathomimeticsAdrenergic beta-1 Receptor AntagonistsAnti-Arrhythmia Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,partial agonist,DB01193
Brinzolamide,Anti-glaucoma AgentsOphthalmics,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB01194
Brinzolamide,Anti-glaucoma AgentsOphthalmics,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB01194
Brinzolamide,Anti-glaucoma AgentsOphthalmics,approved,CA4,Carbonic anhydrase 4,target,inhibitor,DB01194
Brinzolamide,Anti-glaucoma AgentsOphthalmics,approved,CA5A,"Carbonic anhydrase 5A, mitochondrial",target,inhibitor,DB01194
Flecainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approvedwithdrawn,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01195
Flecainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approvedwithdrawn,SCN4A,Sodium channel protein type 4 subunit alpha,target,inhibitor,DB01195
Estramustine,"Antineoplastic Agents, HormonalAntineoplastic Agents, Alkylating",approved,MAP2,Microtubule-associated protein 2,target,antagonist,DB01196
Estramustine,"Antineoplastic Agents, HormonalAntineoplastic Agents, Alkylating",approved,MAP1A,Microtubule-associated protein 1A,target,antagonist,DB01196
Estramustine,"Antineoplastic Agents, HormonalAntineoplastic Agents, Alkylating",approved,ESR1,Estrogen receptor,target,agonist,DB01196
Estramustine,"Antineoplastic Agents, HormonalAntineoplastic Agents, Alkylating",approved,ESR2,Estrogen receptor beta,target,other/unknown,DB01196
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB01197
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,MMP2,72 kDa type IV collagenase,target,inhibitor,DB01197
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,,Matrix metalloproteinase-9,target,inhibitor,DB01197
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,LTA4H,Leukotriene A-4 hydrolase,target,,DB01197
Zopiclone,Hypnotics and Sedatives,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01198
Zopiclone,Hypnotics and Sedatives,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01198
Zopiclone,Hypnotics and Sedatives,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01198
Zopiclone,Hypnotics and Sedatives,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01198
Zopiclone,Hypnotics and Sedatives,approved,TSPO,Translocator protein,target,agonist,DB01198
Tubocurarine,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01199
Tubocurarine,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB01199
Tubocurarine,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,ACHE,Acetylcholinesterase,target,inhibitor,DB01199
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD2,D(2) dopamine receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD3,D(3) dopamine receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD4,D(4) dopamine receptor,target,antagonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD5,D(1B) dopamine receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB01200
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB01200
Levetiracetam,Nootropic AgentsAnticonvulsants,approvedinvestigational,SV2A,Synaptic vesicle glycoprotein 2A,target,agonist,DB01202
Levetiracetam,Nootropic AgentsAnticonvulsants,approvedinvestigational,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,target,inhibitor,DB01202
Nadolol,,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01203
Nadolol,,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01203
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01204
Flumazenil,GABA ModulatorsAntidotes,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,antagonist,DB01205
Flumazenil,GABA ModulatorsAntidotes,approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,antagonist,DB01205
Flumazenil,GABA ModulatorsAntidotes,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,antagonist,DB01205
Flumazenil,GABA ModulatorsAntidotes,approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01205
Lomustine,"Antineoplastic Agents, Alkylating",approved,STMN4,Stathmin-4,target,antagonist,DB01206
Ridogrel,Platelet Aggregation InhibitorsGastrointestinal AgentsEnzyme InhibitorsThrombolytic Agents,approved,TBXA2R,Thromboxane A2 receptor,target,antagonist,DB01207
Ridogrel,Platelet Aggregation InhibitorsGastrointestinal AgentsEnzyme InhibitorsThrombolytic Agents,approved,TBXAS1,Thromboxane-A synthase,target,inhibitor,DB01207
Sparfloxacin,,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01208
Sparfloxacin,,approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB01208
Sparfloxacin,,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB01208
Dezocine,"Analgesics, Opioid",approved,OPRM1,Mu-type opioid receptor,target,agonist,DB01209
Dezocine,"Analgesics, Opioid",approved,OPRK1,Kappa-type opioid receptor,target,antagonist,DB01209
Levobunolol,SympatholyticsAdrenergic beta-AntagonistsEENT Preparations,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01210
Levobunolol,SympatholyticsAdrenergic beta-AntagonistsEENT Preparations,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01210
Fomepizole,Antidotes,approved,ADH1A,Alcohol dehydrogenase 1A,target,inhibitor,DB01213
Fomepizole,Antidotes,approved,ADH1B,Alcohol dehydrogenase 1B,target,inhibitor,DB01213
Fomepizole,Antidotes,approved,ADH1C,Alcohol dehydrogenase 1C,target,inhibitor,DB01213
Fomepizole,Antidotes,approved,CAT,Catalase,target,inhibitor,DB01213
Metipranolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01214
Metipranolol,Antihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01214
Estazolam,,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01215
Estazolam,,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01215
Finasteride,5-alpha Reductase InhibitorsSkin and Mucous Membrane Agents,approved,SRD5A2,3-oxo-5-alpha-steroid 4-dehydrogenase 2,target,inhibitor,DB01216
Finasteride,5-alpha Reductase InhibitorsSkin and Mucous Membrane Agents,approved,SRD5A1,3-oxo-5-alpha-steroid 4-dehydrogenase 1,target,inhibitor,DB01216
Finasteride,5-alpha Reductase InhibitorsSkin and Mucous Membrane Agents,approved,AKR1D1,3-oxo-5-beta-steroid 4-dehydrogenase,target,inhibitor,DB01216
Halofantrine,AntimalarialsAntiprotozoal Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB01218
Halofantrine,AntimalarialsAntiprotozoal Agents,approved,,Plasmepsin-2,target,inhibitor,DB01218
Rifaximin,Gastrointestinal AgentsAnti-Infective Agents,approvedinvestigational,rpoB,DNA-directed RNA polymerase subunit beta,target,inhibitor,DB01220
Rifaximin,Gastrointestinal AgentsAnti-Infective Agents,approvedinvestigational,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,agonist,DB01220
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,TACR1,Substance-P receptor,target,antagonist,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,DRD2,D(2) dopamine receptor,target,agonistpartial agonist,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,OPRD1,Delta-type opioid receptor,target,binder,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,OPRM1,Mu-type opioid receptor,target,binder,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,CHRM1,Muscarinic acetylcholine receptor,target,binder,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,HTR2A,5-hydroxytryptamine receptor 2,target,antagonist,DB01221
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,HTR1A,5-hydroxytryptamine receptor 1,target,antagonist,DB01221
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB01223
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,ADORA1,Adenosine receptor A1,target,antagonist,DB01223
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,ADORA3,Adenosine receptor A3,target,antagonist,DB01223
Aminophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsCardiotonic AgentsMuscle Relaxants, Respiratory",approved,HDAC2,Histone deacetylase 2,target,activator,DB01223
Quetiapine,Antipsychotic Agents,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,other/unknown,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,other/unknown,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR1E,5-hydroxytryptamine receptor 1E,target,other/unknown,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,other/unknown,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR6,5-hydroxytryptamine receptor 6,target,other/unknown,DB01224
Quetiapine,Antipsychotic Agents,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,DRD5,D(1B) dopamine receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01224
Quetiapine,Antipsychotic Agents,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01224
Enoxaparin,Fibrinolytic AgentsAnticoagulantsHeparins,approved,SERPINC1,Antithrombin-III,target,potentiator,DB01225
Enoxaparin,Fibrinolytic AgentsAnticoagulantsHeparins,approved,F10,Coagulation factor X,target,inhibitor,DB01225
Mivacurium,,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01226
Mivacurium,,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonistpartial agonist,DB01226
Mivacurium,,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01226
Mivacurium,,approved,BCHE,Cholinesterase,target,,DB01226
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,OPRM1,Mu-type opioid receptor,target,agonist,DB01227
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,CHRNB4,Neuronal acetylcholine receptor subunit beta-4,target,other/unknown,DB01227
Levomethadyl Acetate,"Analgesics, OpioidNarcotics",approved,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,antagonist,DB01227
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBB1,Tubulin beta-1 chain,target,inhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,BCL2,Apoptosis regulator Bcl-2,target,inhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,inducer,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,MAP4,Microtubule-associated protein 4,target,,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,MAP2,Microtubule-associated protein 2,target,,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,MAPT,Microtubule-associated protein tau,target,,DB01229
Diphenidol,Antiemetics,approvedwithdrawn,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01231
Diphenidol,Antiemetics,approvedwithdrawn,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01231
Diphenidol,Antiemetics,approvedwithdrawn,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01231
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB01233
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,agonist,DB01233
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,HTR4,5-hydroxytryptamine receptor 4,target,agonist,DB01233
Metoclopramide,AntiemeticsDopamine AntagonistsProkinetic Agents,approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,agonist,DB01233
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,NR0B1,Nuclear receptor subfamily 0 group B member 1,target,stimulator,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,ANXA1,Annexin A1,target,agonist,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,NOS2,"Nitric oxide synthase, inducible",target,negative modulator,DB01234
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DRD1,D(1A) dopamine receptor,target,agonist,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DRD5,D(1B) dopamine receptor,target,agonist,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DRD2,D(2) dopamine receptor,target,agonist,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DRD3,D(3) dopamine receptor,target,agonist,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DRD4,D(4) dopamine receptor,target,agonist,DB01235
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,GLRA1,Glycine receptor subunit alpha-1,target,agonist,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,GRIA1,Glutamate receptor 1,target,antagonist,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,inducer,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,inhibitor,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,ATP5D,"ATP synthase subunit delta, mitochondrial",target,other/unknown,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,target,unknown,DB01236
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01236
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonistpartial agonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonistpartial agonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR1E,5-hydroxytryptamine receptor 1E,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,DRD1,D(1A) dopamine receptor,target,antagonistpartial agonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,DRD5,D(1B) dopamine receptor,target,antagonistpartial agonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,DRD3,D(3) dopamine receptor,target,antagonistpartial agonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,DRD4,D(4) dopamine receptor,target,antagonistpartial agonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,antagonistother/unknown,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01238
Aripiprazole,Antipsychotic Agents,approvedinvestigational,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01238
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,DRD2,D(2) dopamine receptor,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,DRD1,D(1A) dopamine receptor,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,DRD3,D(3) dopamine receptor,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,HRH1,Histamine H1 receptor,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01239
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01239
Epoprostenol,Platelet Aggregation InhibitorsAntihypertensive Agents,approved,P2RY12,P2Y purinoceptor 12,target,agonist,DB01240
Epoprostenol,Platelet Aggregation InhibitorsAntihypertensive Agents,approved,PTGIR,Prostacyclin receptor,target,agonist,DB01240
Epoprostenol,Platelet Aggregation InhibitorsAntihypertensive Agents,approved,PTGIS,Prostacyclin synthase,target,inducer,DB01240
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,GSTP1,Glutathione S-transferase P,target,inhibitor,DB01242
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,snf,Transporter,target,,DB01242
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,CACNA1A,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,target,inhibitor,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,inhibitor,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,KCNQ1,Potassium voltage-gated channel subfamily KQT member 1,target,inhibitor,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,other,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,CALM1,Calmodulin,target,binder,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,PDE1B,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",target,inhibitor,DB01244
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,PDE1A,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A",target,inhibitor,DB01244
Decamethonium,Neuromuscular Depolarizing Agents,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,partial agonist,DB01245
Decamethonium,Neuromuscular Depolarizing Agents,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB01245
Isocarboxazid,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01247
Isocarboxazid,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01247
Docetaxel,Antineoplastic Agents,approvedinvestigational,TUBB1,Tubulin beta-1 chain,target,,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,BCL2,Apoptosis regulator Bcl-2,target,,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,MAP2,Microtubule-associated protein 2,target,,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,MAP4,Microtubule-associated protein 4,target,,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,MAPT,Microtubule-associated protein tau,target,,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,binder,DB01248
Olsalazine,,approved,TPMT,Thiopurine S-methyltransferase,target,inhibitor,DB01250
Olsalazine,,approved,IFNG,Interferon gamma,target,,DB01250
Gliquidone,Antidiabetic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB01251
Gliquidone,Antidiabetic Agents,approved,KCNJ8,ATP-sensitive inward rectifier potassium channel 8,target,inhibitor,DB01251
Mitiglinide,Hypoglycemic Agents,approvedinvestigational,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB01252
Mitiglinide,Hypoglycemic Agents,approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB01252
Dasatinib,,approvedinvestigational,ABL1,Tyrosine-protein kinase ABL1,target,multitarget,DB01254
Dasatinib,,approvedinvestigational,SRC,Proto-oncogene tyrosine-protein kinase Src,target,multitarget,DB01254
Dasatinib,,approvedinvestigational,EPHA2,Ephrin type-A receptor 2,target,antagonist,DB01254
Dasatinib,,approvedinvestigational,LCK,Tyrosine-protein kinase Lck,target,multitarget,DB01254
Dasatinib,,approvedinvestigational,YES1,Tyrosine-protein kinase Yes,target,inhibitor,DB01254
Dasatinib,,approvedinvestigational,KIT,Mast/stem cell growth factor receptor Kit,target,antagonist,DB01254
Dasatinib,,approvedinvestigational,PDGFRB,Platelet-derived growth factor receptor beta,target,antagonist,DB01254
Dasatinib,,approvedinvestigational,STAT5B,Signal transducer and activator of transcription 5B,target,inhibitor,DB01254
Dasatinib,,approvedinvestigational,ABL2,Abelson tyrosine-protein kinase 2,target,multitarget,DB01254
Dasatinib,,approvedinvestigational,FYN,Tyrosine-protein kinase Fyn,target,multitarget,DB01254
Lisdexamfetamine,,approvedinvestigational,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01255
Lisdexamfetamine,,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01255
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,EGFR,Epidermal growth factor receptor,target,antagonist,DB01259
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,antagonist,DB01259
Decitabine,"Enzyme InhibitorsAntimetabolites, AntineoplasticTeratogens",approvedinvestigational,DNMT1,DNA (cytosine-5)-methyltransferase 1,target,inhibitor,DB01262
Telbivudine,,approvedinvestigational,P,Protein P,target,,DB01265
Paliperidone,Antipsychotic Agents,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,HRH1,Histamine H1 receptor,target,agonist,DB01267
Paliperidone,Antipsychotic Agents,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB01267
Paliperidone,Antipsychotic Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01267
Paliperidone,Antipsychotic Agents,approved,CYP3A4,Cytochrome P450 3A4,target,,DB01267
Paliperidone,Antipsychotic Agents,approved,CYP2D6,Cytochrome P450 2D6,target,,DB01267
Paliperidone,Antipsychotic Agents,approved,CYP3A5,Cytochrome P450 3A5,target,,DB01267
Sunitinib,,approvedinvestigational,PDGFRB,Platelet-derived growth factor receptor beta,target,antagonist,DB01268
Sunitinib,,approvedinvestigational,FLT1,Vascular endothelial growth factor receptor 1,target,antagonist,DB01268
Sunitinib,,approvedinvestigational,KIT,Mast/stem cell growth factor receptor Kit,target,antagonist,DB01268
Sunitinib,,approvedinvestigational,KDR,Vascular endothelial growth factor receptor 2,target,multitarget,DB01268
Sunitinib,,approvedinvestigational,FLT4,Vascular endothelial growth factor receptor 3,target,antagonist,DB01268
Sunitinib,,approvedinvestigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,multitarget,DB01268
Sunitinib,,approvedinvestigational,CSF1R,Macrophage colony-stimulating factor 1 receptor,target,other/unknown,DB01268
Sunitinib,,approvedinvestigational,PDGFRA,Platelet-derived growth factor receptor alpha,target,antagonist,DB01268
Idursulfase,Enzyme Replacement Agents,approved,PLIN3,Perilipin-3,target,,DB01271
Alglucosidase alfa,Enzyme Replacement Agents,approved,M6PR,Cation-dependent mannose-6-phosphate receptor,target,binder,DB01272
Varenicline,Nicotinic Agonists,approvedinvestigational,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,partial agonist,DB01273
Varenicline,Nicotinic Agonists,approvedinvestigational,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,agonist,DB01273
Varenicline,Nicotinic Agonists,approvedinvestigational,CHRNA3,Neuronal acetylcholine receptor subunit alpha-3,target,partial agonist,DB01273
Varenicline,Nicotinic Agonists,approvedinvestigational,CHRNA6,Neuronal acetylcholine receptor subunit alpha-6,target,partial agonist,DB01273
Hydralazine,,approved,AOC3,Membrane primary amine oxidase,target,inhibitor,DB01275
Hydralazine,,approved,P4HA1,Prolyl 4-hydroxylase subunit alpha-1,target,inhibitor,DB01275
Mecasermin,,approvedinvestigational,IGF1R,Insulin-like growth factor 1 receptor,target,agonist,DB01277
Mecasermin,,approvedinvestigational,IGFBP3,Insulin-like growth factor-binding protein 3,target,,DB01277
Mecasermin,,approvedinvestigational,INSR,Insulin receptor,target,,DB01277
Mecasermin,,approvedinvestigational,IGF2R,Cation-independent mannose-6-phosphate receptor,target,,DB01277
Pramlintide,,approvedinvestigational,CALCR,Calcitonin receptor,target,agonist,DB01278
Pramlintide,,approvedinvestigational,RAMP1,Receptor activity-modifying protein 1,target,agonist,DB01278
Pramlintide,,approvedinvestigational,RAMP2,Receptor activity-modifying protein 2,target,agonist,DB01278
Pramlintide,,approvedinvestigational,RAMP3,Receptor activity-modifying protein 3,target,agonist,DB01278
Galsulfase,Enzyme Replacement Agents,approvedinvestigational,PLIN3,Perilipin-3,target,,DB01279
Nelarabine,,approvedinvestigational,POLA1,DNA polymerase alpha catalytic subunit,target,inhibitor,DB01280
Abatacept,Antirheumatic AgentsImmunosuppressive Agents,approved,CD80,T-lymphocyte activation antigen CD80,target,antagonist,DB01281
Abatacept,Antirheumatic AgentsImmunosuppressive Agents,approved,CD86,T-lymphocyte activation antigen CD86,target,antagonist,DB01281
Lumiracoxib,Cyclooxygenase 2 Inhibitors,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01283
Lumiracoxib,Cyclooxygenase 2 Inhibitors,approvedinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01283
Corticotropin,HormonesDiagnostic Agents,approved,MC2R,Adrenocorticotropic hormone receptor,target,agonist,DB01285
Corticotropin,HormonesDiagnostic Agents,approved,CRH,Corticoliberin,target,agonist,DB01285
Fenoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01288
Fenoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01288
Fenoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB01288
Pirbuterol,Adrenergic beta-2 Receptor AgonistsBronchodilator AgentsCardiotonic Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01291
Pirbuterol,Adrenergic beta-2 Receptor AgonistsBronchodilator AgentsCardiotonic Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01291
Bevantolol,Adrenergic beta-1 Receptor Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01295
Bevantolol,Adrenergic beta-1 Receptor Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01295
Bevantolol,Adrenergic beta-1 Receptor Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01295
Glucosamine,,approved,,Matrix metalloproteinase-9,target,antagonist,DB01296
Glucosamine,,approved,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,antagonist,DB01296
Glucosamine,,approved,TNF,Tumor necrosis factor,target,,DB01296
Glucosamine,,approved,IFNG,Interferon gamma,target,,DB01296
Glucosamine,,approved,csn,Chitosanase,target,,DB01296
Sulfadoxine,,approved,,Dihydropteroate synthetase,target,,DB01299
Sulfadoxine,,approved,,Bifunctional dihydrofolate reductase-thymidylate synthase,target,inhibitor,DB01299
Rolitetracycline,Tetracyclines,approved,rpsI,30S ribosomal protein S9,target,inhibitor,DB01301
Oxtriphylline,Bronchodilator Agents,approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB01303
Oxtriphylline,Bronchodilator Agents,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB01303
Oxtriphylline,Bronchodilator Agents,approved,ADORA2A,Adenosine receptor A2a,target,antagonist,DB01303
Oxtriphylline,Bronchodilator Agents,approved,ADORA1,Adenosine receptor A1,target,antagonist,DB01303
Oxtriphylline,Bronchodilator Agents,approved,HDAC2,Histone deacetylase 2,target,activator,DB01303
Quinethazone,Sodium Chloride Symporter Inhibitors,approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB01325
Quinethazone,Sodium Chloride Symporter Inhibitors,approved,CA2,Carbonic anhydrase 2,target,inhibitor,DB01325
Quinethazone,Sodium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB01325
Quinethazone,Sodium Chloride Symporter Inhibitors,approved,SLC12A2,Solute carrier family 12 member 2,target,inhibitor,DB01325
Quinethazone,Sodium Chloride Symporter Inhibitors,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB01325
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,pbpC,Penicillin-binding protein 1C,target,inhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,PON1,Serum paraoxonase/arylesterase 1,target,inhibitor,DB01327
Cefonicid,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01328
Cefonicid,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01328
Cefonicid,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01328
Cefonicid,Anti-Bacterial AgentsCephalosporins,approved,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,inhibitor,DB01328
Cefonicid,Anti-Bacterial AgentsCephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01328
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,ponB,Penicillin-binding protein 1B,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,dacC,D-alanyl-D-alanine carboxypeptidase DacC,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,dacA,D-alanyl-D-alanine carboxypeptidase DacA,target,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,inhibitor,DB01329
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,dacC,D-alanyl-D-alanine carboxypeptidase DacC,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,dacA,D-alanyl-D-alanine carboxypeptidase DacA,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,pbpG,D-alanyl-D-alanine endopeptidase,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01331
Cefoxitin,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB01331
Ceftizoxime,Anti-Bacterial AgentsCephalosporins,approved,mecA,MecA PBP2' (penicillin binding protein 2'),target,inhibitor,DB01332
Ceftizoxime,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01332
Ceftizoxime,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01332
Ceftizoxime,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01332
Metocurine,,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01336
Metocurine,,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01336
Pancuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01337
Pancuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01337
Pancuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01337
Pipecuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01338
Pipecuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01338
Pipecuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01338
Quinidine barbiturate,,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01346
Quinidine barbiturate,,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01346
Quinidine barbiturate,,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01346
Quinidine barbiturate,,approved,KCNK1,Potassium channel subfamily K member 1,target,inhibitor,DB01346
Quinidine barbiturate,,approved,GRIA2,Glutamate receptor 2,target,antagonist,DB01346
Tasosartan,,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB01349
Tasosartan,,approved,AGTR2,Type-2 angiotensin II receptor,target,antagonist,DB01349
Amobarbital,,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01351
Amobarbital,,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01351
Amobarbital,,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01351
Amobarbital,,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01351
Amobarbital,,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01351
Amobarbital,,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01351
Amobarbital,,approvedillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01351
Amobarbital,,approvedillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01351
Amobarbital,,approvedillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB01351
Amobarbital,,approvedillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01351
Aprobarbital,,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01352
Aprobarbital,,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01352
Aprobarbital,,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01352
Aprobarbital,,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01352
Aprobarbital,,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01352
Aprobarbital,,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01352
Aprobarbital,,approvedillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01352
Aprobarbital,,approvedillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01352
Aprobarbital,,approvedillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB01352
Aprobarbital,,approvedillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01352
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB01353
Butethal,Hypnotics and SedativesBarbiturates,approvedillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01353
Heptabarbital,Barbiturates,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01354
Heptabarbital,Barbiturates,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01354
Heptabarbital,Barbiturates,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01354
Heptabarbital,Barbiturates,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01354
Heptabarbital,Barbiturates,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01354
Heptabarbital,Barbiturates,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01354
Heptabarbital,Barbiturates,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01354
Heptabarbital,Barbiturates,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01354
Heptabarbital,Barbiturates,approved,GRIA2,Glutamate receptor 2,target,antagonist,DB01354
Heptabarbital,Barbiturates,approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01354
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GRIA2,Glutamate receptor 2,target,antagonist,DB01355
Hexobarbital,Hypnotics and SedativesGABA ModulatorsBarbituratesAdjuvants,approved,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01355
Lithium,,approved,GSK3B,Glycogen synthase kinase-3 beta,target,inhibitor,DB01356
Lithium,,approved,IMPA1,Inositol monophosphatase 1,target,inhibitor,DB01356
Lithium,,approved,IMPA2,Inositol monophosphatase 2,target,inhibitor,DB01356
Lithium,,approved,GRIA3,Glutamate receptor 3,target,potentiator,DB01356
Penbutolol,Antihypertensive AgentsAdrenergic beta-Antagonists,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,antagonistpartial agonist,DB01359
Penbutolol,Antihypertensive AgentsAdrenergic beta-Antagonists,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,antagonistpartial agonist,DB01359
Penbutolol,Antihypertensive AgentsAdrenergic beta-Antagonists,approvedinvestigational,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01359
Penbutolol,Antihypertensive AgentsAdrenergic beta-Antagonists,approvedinvestigational,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB01359
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,rpmF,50S ribosomal protein L32,target,inhibitor,DB01361
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,rplD,50S ribosomal protein L4,target,inhibitor,DB01361
Ephedra,,approvednutraceuticalwithdrawn,SLC6A3,Sodium-dependent dopamine transporter,target,negative modulator,DB01363
Ephedra,,approvednutraceuticalwithdrawn,SLC6A2,Sodium-dependent noradrenaline transporter,target,negative modulator,DB01363
Ephedra,,approvednutraceuticalwithdrawn,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB01363
Ephedra,,approvednutraceuticalwithdrawn,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB01363
Ephedra,,approvednutraceuticalwithdrawn,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB01363
Ephedra,,approvednutraceuticalwithdrawn,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01363
Ephedra,,approvednutraceuticalwithdrawn,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01363
Ephedra,,approvednutraceuticalwithdrawn,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01363
Ephedra,,approvednutraceuticalwithdrawn,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01363
Ephedra,,approvednutraceuticalwithdrawn,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB01363
Ephedra,,approvednutraceuticalwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,negative modulator,DB01363
Ephedra,,approvednutraceuticalwithdrawn,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01363
Ephedra,,approvednutraceuticalwithdrawn,SLC18A1,Chromaffin granule amine transporter,target,inhibitor,DB01363
Ephedrine,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inverse agonist,DB01364
Ephedrine,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,,DB01364
Ephedrine,,approved,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01364
Ephedrine,,approved,ACHE,Acetylcholinesterase,target,,DB01364
Mephentermine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRA1A,Alpha adrenergic receptor,target,agonist,DB01365
Mephentermine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,ADRB1,Beta adrenergic receptor,target,agonist,DB01365
Rasagiline,Neuroprotective AgentsMonoamine Oxidase Inhibitors,approved,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01367
Rasagiline,Neuroprotective AgentsMonoamine Oxidase Inhibitors,approved,BCL2,Apoptosis regulator Bcl-2,target,activator,DB01367
Quinupristin,Anti-Bacterial Agents,approved,rplJ,50S ribosomal protein L10,target,inhibitor,DB01369
Quinupristin,Anti-Bacterial Agents,approved,rplV,50S ribosomal protein L22,target,inhibitor,DB01369
Aluminium,,approved,TF,Serotransferrin,target,,DB01370
Aluminium,,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,binder,DB01370
Calcium,,nutraceutical,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,ligand,DB01373
Calcium,,nutraceutical,ATP2C1,Calcium-transporting ATPase type 2C member 1,target,agonist,DB01373
Calcium,,nutraceutical,TNNC2,"Troponin C, skeletal muscle",target,agonist,DB01373
Calcium,,nutraceutical,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,agonist,DB01373
Calcium,,nutraceutical,SPTBN1,"Spectrin beta chain, non-erythrocytic 1",target,agonist,DB01373
Calcium,,nutraceutical,S100B,Protein S100-B,target,,DB01373
Calcium,,nutraceutical,CAST,Calpastatin,target,,DB01373
Calcium,,nutraceutical,COMP,Cartilage oligomeric matrix protein,target,,DB01373
Calcium,,nutraceutical,CALM1,Calmodulin,target,,DB01373
Dihydroxyaluminium,,approved,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,stimulator,DB01375
Dihydroxyaluminium,,approved,VDAC1,Voltage-dependent anion-selective channel protein 1,target,inhibitor,DB01375
Dihydroxyaluminium,,approved,VDAC2,Voltage-dependent anion-selective channel protein 2,target,inhibitor,DB01375
Dihydroxyaluminium,,approved,VDAC3,Voltage-dependent anion-selective channel protein 3,target,inhibitor,DB01375
Ginkgo biloba,,approvednutraceutical,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB01381
Ginkgo biloba,,approvednutraceutical,PLA2G2A,"Phospholipase A2, membrane associated",target,inhibitor,DB01381
Ginkgo biloba,,approvednutraceutical,GLRA1,Glycine receptor subunit alpha-1,target,antagonist,DB01381
Ginkgo biloba,,approvednutraceutical,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,negative modulator,DB01381
Ginkgo biloba,,approvednutraceutical,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,negative modulator,DB01381
Ginkgo biloba,,approvednutraceutical,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,negative modulator,DB01381
Glycodiazine,,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,other/unknown,DB01382
Glycodiazine,,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,inducer,DB01382
Mibefradil,,withdrawn,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNA1I,Voltage-dependent T-type calcium channel subunit alpha-1I,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,target,inhibitor,DB01388
Mibefradil,,withdrawn,CACNB4,Voltage-dependent L-type calcium channel subunit beta-4,target,inhibitor,DB01388
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,partial agonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,HTR1D,5-hydroxytryptamine receptor 1D,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,KCNJ1,ATP-sensitive potassium channel,target,,DB01392
Yohimbine,MydriaticsAdrenergic alpha-2 Receptor Antagonists,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB01392
Bezafibrate,Hypolipidemic Agents,approved,PPARA,Peroxisome proliferator-activated receptor alpha,target,agonist,DB01393
Bezafibrate,Hypolipidemic Agents,approved,PPARD,Peroxisome proliferator-activated receptor delta,target,agonist,DB01393
Bezafibrate,Hypolipidemic Agents,approved,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB01393
Colchicine,Gout SuppressantsTubulin Modulators,approved,TUBB1,Tubulin beta-1 chain,target,inhibitor,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,TUBB,Tubulin beta chain,target,inhibitor,DB01394
Drospirenone,Mineralocorticoid Receptor Antagonists,approved,PGR,Progesterone receptor,target,agonist,DB01395
Drospirenone,Mineralocorticoid Receptor Antagonists,approved,NR3C2,Mineralocorticoid receptor,target,antagonist,DB01395
Drospirenone,Mineralocorticoid Receptor Antagonists,approved,AR,Androgen receptor,target,antagonist,DB01395
Magnesium salicylate,,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01397
Magnesium salicylate,,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01397
Salicylate-sodium,"Anti-Inflammatory Agents, Non-SteroidalSalicylates",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01398
Salicylate-sodium,"Anti-Inflammatory Agents, Non-SteroidalSalicylates",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01398
Salsalate,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01399
Salsalate,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01399
Trisalicylate-choline,,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01401
Trisalicylate-choline,,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01401
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,DRD5,D(1B) dopamine receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,DRD3,D(3) dopamine receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,DRD4,D(4) dopamine receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,HRH1,Histamine H1 receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB01403
Methotrimeprazine,"Antipsychotic AgentsAnalgesics, Non-NarcoticDopamine Antagonists",approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB01403
Ginseng,,approvednutraceutical,IL6,Interleukin-6,target,antagonist,DB01404
Ginseng,,approvednutraceutical,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01404
Ginseng,,approvednutraceutical,AHR,Aryl hydrocarbon receptor,target,agonist,DB01404
Temafloxacin,Anti-Bacterial Agents,withdrawn,gyrA,DNA gyrase subunit A,target,inhibitor,DB01405
Temafloxacin,Anti-Bacterial Agents,withdrawn,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB01405
Danazol,,approved,ESR1,Estrogen receptor,target,agonist,DB01406
Danazol,,approved,AR,Androgen receptor,target,agonist,DB01406
Danazol,,approved,PGR,Progesterone receptor,target,agonist,DB01406
Danazol,,approved,GNRHR,Gonadotropin-releasing hormone receptor,target,negative modulator,DB01406
Danazol,,approved,GNRHR2,Putative gonadotropin-releasing hormone II receptor,target,negative modulator,DB01406
Danazol,,approved,CCL2,C-C motif chemokine 2,target,inhibitor,DB01406
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01407
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB01407
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB01407
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,NGF,Beta-nerve growth factor,target,stimulator,DB01407
Clenbuterol,SympathomimeticsBronchodilator AgentsAdrenergic beta-Agonists,approved,TNF,Tumor necrosis factor,target,other/unknown,DB01407
Tiotropium,Cholinergic Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01409
Tiotropium,Cholinergic Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01409
Tiotropium,Cholinergic Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01409
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,CYSLTR1,Cysteinyl leukotriene receptor 1,target,antagonist,DB01411
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,TNF,Tumor necrosis factor,target,other/unknown,DB01411
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,IL5,Interleukin-5,target,antagonist,DB01411
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,RNASE3,Eosinophil cationic protein,target,other/unknown,DB01411
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,other/unknown,DB01411
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,MUC2,Mucin-2,target,other/unknown,DB01411
Theobromine,,approved,ADORA1,Adenosine receptor A1,target,antagonist,DB01412
Theobromine,,approved,ADORA2A,Adenosine receptor A2a,target,antagonist,DB01412
Theobromine,,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB01412
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01413
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01413
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,pbpB,Penicillin-binding protein 3,target,inhibitor,DB01413
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 2,target,inhibitor,DB01413
Cefacetrile,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01414
Cefacetrile,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01414
Ceftibuten,Cephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01415
Ceftibuten,Cephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01415
Ceftibuten,Cephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01415
Ceftibuten,Cephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01415
Antrafenine,,approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01419
Antrafenine,,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01419
Paromomycin,Anti-Bacterial AgentsAmebicides,approvedinvestigational,rpsJ,30S ribosomal protein S10,target,inhibitor,DB01421
Nitroxoline,"Antifungal AgentsAnti-Infective Agents, Urinary",approved,METAP2,Methionine aminopeptidase 2,target,inhibitor,DB01422
Amrinone,Cardiotonic AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsCalcium Channel Blockers,approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB01427
Amrinone,Cardiotonic AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsCalcium Channel Blockers,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB01427
Amrinone,Cardiotonic AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsCalcium Channel Blockers,approved,TNF,Tumor necrosis factor,target,inhibitor,DB01427
Aprindine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01429
Aprindine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,CALM1,Calmodulin,target,inhibitor,DB01429
Allylestrenol,,approved,PGR,Progesterone receptor,target,agonist,DB01431
Allylestrenol,,approved,ESR1,Estrogen receptor,target,agonist,DB01431
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01435
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01435
Alfacalcidol,Bone Density Conservation Agents,approvednutraceutical,VDR,Vitamin D3 receptor,target,agonist,DB01436
Alfacalcidol,Bone Density Conservation Agents,approvednutraceutical,CYP27B1,"25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial",target,,DB01436
Glutethimide,Hypnotics and Sedatives,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,agonist,DB01437
Glutethimide,Hypnotics and Sedatives,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01437
3-Methylthiofentanyl,,experimentalillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01439
3-Methylthiofentanyl,,experimentalillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01439
3-Methylthiofentanyl,,experimentalillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB01439
Gamma Hydroxybutyric Acid,,approvedillicit,,Gamma-hydroxybutyrate (GHB) receptor,target,agonist,DB01440
Gamma Hydroxybutyric Acid,,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,agonist,DB01440
MMDA,,experimentalillicit,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB01442
MMDA,,experimentalillicit,SLC6A3,Sodium-dependent dopamine transporter,target,negative modulator,DB01442
MMDA,,experimentalillicit,SLC6A4,Sodium-dependent serotonin transporter,target,negative modulator,DB01442
MMDA,,experimentalillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,negative modulator,DB01442
MMDA,,experimentalillicit,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01442
MMDA,,experimentalillicit,SLC18A1,Chromaffin granule amine transporter,target,inhibitor,DB01442
MMDA,,experimentalillicit,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01442
MMDA,,experimentalillicit,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01442
Dimethylthiambutene,,experimentalillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01444
Dimethylthiambutene,,experimentalillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01444
Heroin,"Analgesics, OpioidNarcotics",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01452
Heroin,"Analgesics, OpioidNarcotics",approvedillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB01452
Heroin,"Analgesics, OpioidNarcotics",approvedillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01452
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC6A4,Sodium-dependent serotonin transporter,target,negative modulator,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC6A3,Sodium-dependent dopamine transporter,target,negative modulator,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,HTR2A,5-hydroxytryptamine receptor 2A,target,agonist,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,HTR2B,5-hydroxytryptamine receptor 2B,target,agonist,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,HTR2C,5-hydroxytryptamine receptor 2C,target,agonist,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,negative modulator,DB01454
4-Methoxyamphetamine,,experimentalillicit,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01472
4-Methoxyamphetamine,,experimentalillicit,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB01472
4-Methoxyamphetamine,,experimentalillicit,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01472
4-Methoxyamphetamine,,experimentalillicit,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB01472
4-Methoxyamphetamine,,experimentalillicit,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB01472
4-Methoxyamphetamine,,experimentalillicit,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01472
4-Methoxyamphetamine,,experimentalillicit,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01472
Barbital,,experimentalillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01483
Barbital,,experimentalillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01483
Barbital,,experimentalillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01483
Barbital,,experimentalillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01483
Barbital,,experimentalillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01483
Barbital,,experimentalillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01483
Barbital,,experimentalillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01483
Barbital,,experimentalillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01483
Barbital,,experimentalillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB01483
Barbital,,experimentalillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01483
Dimethyltryptamine,Serotonin Receptor Agonists,experimentalillicit,HTR6,5-hydroxytryptamine receptor 6,target,,DB01488
Dimethyltryptamine,Serotonin Receptor Agonists,experimentalillicit,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB01488
Dimethyltryptamine,Serotonin Receptor Agonists,experimentalillicit,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,,DB01488
Barbituric acid derivative,,experimentalillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01496
Barbituric acid derivative,,experimentalillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01496
Barbituric acid derivative,,experimentalillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01496
Barbituric acid derivative,,experimentalillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01496
Barbituric acid derivative,,experimentalillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01496
Barbituric acid derivative,,experimentalillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01496
Barbituric acid derivative,,experimentalillicit,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,antagonist,DB01496
Barbituric acid derivative,,experimentalillicit,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,antagonist,DB01496
Barbituric acid derivative,,experimentalillicit,GRIA2,Glutamate receptor 2,target,antagonist,DB01496
Barbituric acid derivative,,experimentalillicit,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,antagonist,DB01496
Etorphine,"Hypnotics and SedativesAnalgesics, OpioidNarcotics",illicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01497
Etorphine,"Hypnotics and SedativesAnalgesics, OpioidNarcotics",illicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01497
Etorphine,"Hypnotics and SedativesAnalgesics, OpioidNarcotics",illicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB01497
Etorphine,"Hypnotics and SedativesAnalgesics, OpioidNarcotics",illicit,OPRL1,Nociceptin receptor,target,agonist,DB01497
Etorphine,"Hypnotics and SedativesAnalgesics, OpioidNarcotics",illicit,TRIM13,E3 ubiquitin-protein ligase TRIM13,target,agonist,DB01497
Etorphine,"Hypnotics and SedativesAnalgesics, OpioidNarcotics",illicit,POMC,Pro-opiomelanocortin,target,,DB01497
Tenocyclidine,Neuroprotective Agents,experimentalillicit,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB01520
Tenocyclidine,Neuroprotective Agents,experimentalillicit,GRIN3B,"Glutamate receptor ionotropic, NMDA 3B",target,antagonist,DB01520
Tenocyclidine,Neuroprotective Agents,experimentalillicit,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,antagonist,DB01520
Tenocyclidine,Neuroprotective Agents,experimentalillicit,GRIN2C,"Glutamate receptor ionotropic, NMDA 2C",target,antagonist,DB01520
Tenocyclidine,Neuroprotective Agents,experimentalillicit,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,antagonist,DB01520
Tenocyclidine,Neuroprotective Agents,experimentalillicit,GRIN2D,"Glutamate receptor ionotropic, NMDA 2D",target,antagonist,DB01520
Tenocyclidine,Neuroprotective Agents,experimentalillicit,CHRFAM7A,Alpha-7 nicotinic cholinergic receptor subunit,target,antagonist,DB01520
Carfentanil,,experimentalillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01535
Carfentanil,,experimentalillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01535
Carfentanil,,experimentalillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB01535
4-Androstenedione,,experimentalillicit,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,inducer,DB01536
4-Androstenedione,,experimentalillicit,HSD3B1,3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 1,target,positive allosteric modulator,DB01536
4-Androstenedione,,experimentalillicit,eryF,6-deoxyerythronolide B hydroxylase,target,inducer,DB01536
4-Androstenedione,,experimentalillicit,AKR1C3,Aldo-keto reductase family 1 member C3,target,inducer,DB01536
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,TSPO,Translocator protein,target,agonist,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,agonist,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01544
Flunitrazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01544
Diprenorphine,,experimentalillicit,OPRM1,Mu-type opioid receptor,target,antagonist,DB01548
Diprenorphine,,experimentalillicit,OPRD1,Delta-type opioid receptor,target,antagonist,DB01548
Diprenorphine,,experimentalillicit,OPRK1,Kappa-type opioid receptor,target,antagonist,DB01548
Diprenorphine,,experimentalillicit,TRIM13,E3 ubiquitin-protein ligase TRIM13,target,,DB01548
Rolicyclidine,,experimentalillicit,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,,DB01549
Rolicyclidine,,experimentalillicit,DRD2,D(2) dopamine receptor,target,,DB01549
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01558
Bromazepam,Anti-Anxiety AgentsGABA ModulatorsBenzodiazepines,approvedillicit,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB01558
Clotiazepam,Benzodiazepines,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01559
Clotiazepam,Benzodiazepines,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01559
Androstanedione,,experimentalillicit,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB01561
Androstanedione,,experimentalillicit,ksi,Steroid Delta-isomerase,target,,DB01561
Dihydromorphine,,experimentalillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01565
Dihydromorphine,,experimentalillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01565
Dihydromorphine,,experimentalillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB01565
Dihydromorphine,,experimentalillicit,TRIM13,E3 ubiquitin-protein ligase TRIM13,target,agonist,DB01565
Dihydromorphine,,experimentalillicit,POMC,Pro-opiomelanocortin,target,agonist,DB01565
Fludiazepam,Benzodiazepines,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01567
Fludiazepam,Benzodiazepines,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01567
3-Methylfentanyl,Analgesics,experimentalillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01571
3-Methylfentanyl,Analgesics,experimentalillicit,OPRD1,Delta-type opioid receptor,target,agonist,DB01571
3-Methylfentanyl,Analgesics,experimentalillicit,OPRK1,Kappa-type opioid receptor,target,agonist,DB01571
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,SLC18A2,Synaptic vesicular amine transporter,target,inducer,DB01576
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,negative modulator,DB01576
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,negative modulator,DB01576
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,TAAR1,Trace amine-associated receptor 1,target,agonist,DB01576
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,ADRA1A,Alpha-1A adrenergic receptor,target,,DB01576
Dextroamphetamine,Central Nervous System StimulantsDopamine Uptake Inhibitors,approvedillicit,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01576
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC6A3,Sodium-dependent dopamine transporter,target,negative modulator,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC6A4,Sodium-dependent serotonin transporter,target,negative modulator,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,negative modulator,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC18A1,Chromaffin granule amine transporter,target,inhibitor,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,TAAR1,Trace amine-associated receptor 1,target,agonist,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01577
Phendimetrazine,Central Nervous System StimulantsAppetite Depressants,approvedillicit,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB01579
Phendimetrazine,Central Nervous System StimulantsAppetite Depressants,approvedillicit,SLC6A2,Sodium-dependent noradrenaline transporter,target,negative modulator,DB01579
Phendimetrazine,Central Nervous System StimulantsAppetite Depressants,approvedillicit,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB01579
Oxprenolol,Anti-Anxiety AgentsAntihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01580
Oxprenolol,Anti-Anxiety AgentsAntihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB01580
Liotrix,Hormone Replacement Agents,approved,THRA,Thyroid hormone receptor alpha,target,agonist,DB01583
Liotrix,Hormone Replacement Agents,approved,THRB,Thyroid hormone receptor beta,target,agonist,DB01583
Ketazolam,Benzodiazepines,approved,TSPO,Translocator protein,target,agonist,DB01587
Ketazolam,Benzodiazepines,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01587
Ketazolam,Benzodiazepines,approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01587
Ketazolam,Benzodiazepines,approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01587
Ketazolam,Benzodiazepines,approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01587
Ketazolam,Benzodiazepines,approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01587
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01588
Prazepam,Anti-Anxiety AgentsGABA Modulators,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01588
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01589
Quazepam,Hypnotics and SedativesBenzodiazepines,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB01589
Solifenacin,Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01591
Solifenacin,Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB01591
Solifenacin,Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB01591
Solifenacin,Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01591
Solifenacin,Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodics,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB01591
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01594
Cinolazepam,Hypnotics and SedativesBenzodiazepines,approved,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01594
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRB1,Gamma-aminobutyric acid receptor subunit beta-1,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRG1,Gamma-aminobutyric acid receptor subunit gamma-1,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRG2,Gamma-aminobutyric acid receptor subunit gamma-2,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRG3,Gamma-aminobutyric acid receptor subunit gamma-3,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRD,Gamma-aminobutyric acid receptor subunit delta,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRE,Gamma-aminobutyric acid receptor subunit epsilon,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRP,Gamma-aminobutyric acid receptor subunit pi,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRR1,Gamma-aminobutyric acid receptor subunit rho-1,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRR2,Gamma-aminobutyric acid receptor subunit rho-2,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRR3,Gamma-aminobutyric acid receptor subunit rho-3,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,GABRQ,Gamma-aminobutyric acid receptor subunit theta,target,potentiator,DB01595
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,SCN1A,Sodium channel protein type 1 subunit alpha,target,other/unknown,DB01595
Imipenem,Anti-Bacterial Agents,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB01598
Imipenem,Anti-Bacterial Agents,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB01598
Imipenem,Anti-Bacterial Agents,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01598
Imipenem,Anti-Bacterial Agents,approved,pbpC,Penicillin-binding protein 3,target,inhibitor,DB01598
Imipenem,Anti-Bacterial Agents,approved,blaZ,Beta-lactamase,target,other/unknown,DB01598
Probucol,AntioxidantsAnticholesteremic Agents,approved,ABCA1,ATP-binding cassette sub-family A member 1,target,inhibitor,DB01599
Probucol,AntioxidantsAnticholesteremic Agents,approved,CES1,Liver carboxylesterase 1,target,,DB01599
Tiaprofenic acid,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01600
Tiaprofenic acid,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01600
Meticillin,Anti-Bacterial AgentsPenicillins,approved,mecA,MecA PBP2' (penicillin binding protein 2'),target,inhibitor,DB01603
Meticillin,Anti-Bacterial AgentsPenicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB01603
Meticillin,Anti-Bacterial AgentsPenicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB01603
Meticillin,Anti-Bacterial AgentsPenicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB01603
Meticillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01603
Meticillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01603
Tazobactam,,approved,bla,Beta-lactamase SHV-1,target,inhibitor,DB01606
Tazobactam,,approved,bla,Beta-lactamase TEM,target,inhibitor,DB01606
Propericiazine,Phenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01608
Propericiazine,Phenothiazines,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01608
Propericiazine,Phenothiazines,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01608
Hydroxychloroquine,Antirheumatic AgentsEnzyme InhibitorsAntimalarials,approved,TLR7,Toll-like receptor 7,target,antagonist,DB01611
Hydroxychloroquine,Antirheumatic AgentsEnzyme InhibitorsAntimalarials,approved,TLR9,Toll-like receptor 9,target,antagonist,DB01611
Erythrityl Tetranitrate,Vasodilator Agents,approved,NPR1,Atrial natriuretic peptide receptor 1,target,agonist,DB01613
Erythrityl Tetranitrate,Vasodilator Agents,approved,NPR2,Atrial natriuretic peptide receptor 2,target,agonist,DB01613
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01614
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01614
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01614
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01614
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01614
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01614
Molindone,Antipsychotic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01618
Molindone,Antipsychotic Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01618
Molindone,Antipsychotic Agents,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01618
Molindone,Antipsychotic Agents,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,other/unknown,DB01618
Pipotiazine,Phenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01621
Pipotiazine,Phenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01621
Pipotiazine,Phenothiazines,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01621
Pipotiazine,Phenothiazines,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01621
Thioproperazine,Phenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01622
Thioproperazine,Phenothiazines,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01622
Thioproperazine,Phenothiazines,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01622
Thioproperazine,Phenothiazines,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01622
Thioproperazine,Phenothiazines,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01622
Thioproperazine,Phenothiazines,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB01622
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01623
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB01623
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01623
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,DRD1,D(1A) dopamine receptor,target,antagonist,DB01624
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,DRD5,D(1B) dopamine receptor,target,antagonist,DB01624
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB01624
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB01624
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB01624
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB01624
Zuclopenthixol,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB01624
Isopropamide,,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB01625
Isopropamide,,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB01625
Pargyline,,approved,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB01626
Pargyline,,approved,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01626
Methyl Nonanoate (Ester),,experimental,LCN2,Neutrophil gelatinase-associated lipocalin,target,,DB01631
Methyl Nonanoate (Ester),,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB01631
Alpha-Phosphoribosylpyrophosphoric Acid,,experimental,HGPRTase,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB01632
Alpha-Phosphoribosylpyrophosphoric Acid,,experimental,APRT,Adenine phosphoribosyltransferase,target,,DB01632
Alpha-Phosphoribosylpyrophosphoric Acid,,experimental,trpD,Anthranilate phosphoribosyltransferase,target,,DB01632
Alpha-Phosphoribosylpyrophosphoric Acid,,experimental,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB01632
Alpha-Phosphoribosylpyrophosphoric Acid,,experimental,pyrE,Orotate phosphoribosyltransferase,target,,DB01632
Alpha-Phosphoribosylpyrophosphoric Acid,,experimental,UCKL1,Uridine-cytidine kinase-like 1,target,,DB01632
D-Sorbitol,,experimental,xylA,Xylose isomerase,target,,DB01638
D-Sorbitol,,experimental,xylA,Xylose isomerase,target,,DB01638
D-Sorbitol,,experimental,xylA,Xylose isomerase,target,,DB01638
D-Sorbitol,,experimental,glcB,Malate synthase G,target,,DB01638
O1-Methyl-Glucose,,experimental,cel5A,Endoglucanase 5A,target,,DB01642
O1-Methyl-Glucose,,experimental,celCCF,Endoglucanase F,target,,DB01642
O1-Methyl-Glucose,,experimental,celA1,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",target,,DB01642
Thymidine-5'-Phosphate,,experimental,tmk,Thymidylate kinase,target,,DB01643
Thymidine-5'-Phosphate,,experimental,DTYMK,Thymidylate kinase,target,,DB01643
Thymidine-5'-Phosphate,,experimental,TK,Thymidine kinase,target,,DB01643
Thymidine-5'-Phosphate,,experimental,,PCZA361.16,target,,DB01643
Thymidine-5'-Phosphate,,experimental,dnaQ,DNA polymerase III subunit epsilon,target,,DB01643
Thymidine-5'-Phosphate,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB01643
Thymidine-5'-Phosphate,,experimental,TYMS,Thymidylate synthase,target,,DB01643
Thymidine-5'-Phosphate,,experimental,thyA,Thymidylate synthase,target,,DB01643
Thymidine-5'-Phosphate,,experimental,topA,DNA topoisomerase 1,target,,DB01643
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,ESR2,Estrogen receptor beta,target,,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,PTK2B,Protein-tyrosine kinase 2-beta,target,,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,NCOA1,Nuclear receptor coactivator 1,target,,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,ESR1,Estrogen receptor,target,,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,NCOA2,Nuclear receptor coactivator 2,target,,DB01645
N-Acetylmethionine,,experimental,Aaar,N-acylamino acid racemase,target,,DB01646
N-Acetylmethionine,,experimental,RHO,Rhodopsin,target,,DB01646
7-Methyl-Gpppa,,experimental,DCPS,m7GpppX diphosphatase,target,,DB01649
7-Methyl-Gpppa,,experimental,EIF4E,Eukaryotic translation initiation factor 4E,target,,DB01649
4-Hydroxybenzoyl Coenzyme A,,experimental,fcbB,4-chlorobenzoyl CoA dehalogenase,target,,DB01652
4-Hydroxybenzoyl Coenzyme A,,experimental,,4-hydroxybenzoyl-CoA thioesterase,target,,DB01652
Roflumilast,,approved,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,inhibitor,DB01656
Roflumilast,,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB01656
Roflumilast,,approved,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB01656
Roflumilast,,approved,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,inhibitor,DB01656
Adenosine-5'-Diphosphate Monothiophosphate,,experimental,recA,Protein RecA,target,,DB01660
Adenosine-5'-Diphosphate Monothiophosphate,,experimental,BST1,ADP-ribosyl cyclase 2,target,,DB01660
Adenosine-5'-Diphosphate Monothiophosphate,,experimental,recA,Protein RecA,target,,DB01660
Adenosine-5'-Diphosphate Monothiophosphate,,experimental,recA,Protein RecA,target,,DB01660
Adenosine-5'-Diphosphate Monothiophosphate,,experimental,SYN1,Synapsin-1,target,,DB01660
Adenosine-5'-Diphosphate Monothiophosphate,,experimental,BCKDK,"[3-methyl-2-oxobutanoate dehydrogenase [lipoamide]] kinase, mitochondrial",target,,DB01660
D-Myo-Inositol-Hexasulphate,,experimental,phyA,Myo-inositol hexaphosphate phosphohydrolase,target,,DB01666
D-Myo-Inositol-Hexasulphate,,experimental,FST,Follistatin,target,,DB01666
"2,3-Dihydroxy-Benzoic Acid",,experimental,dhbE,"2,3-dihydroxybenzoate-AMP ligase",target,,DB01672
"2,3-Dihydroxy-Benzoic Acid",,experimental,LCN2,Neutrophil gelatinase-associated lipocalin,target,,DB01672
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB01673
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine,,experimental,murC,UDP-N-acetylmuramate--L-alanine ligase,target,,DB01673
Fumarate,,experimental,mdh,Malate dehydrogenase,target,,DB01677
Fumarate,,experimental,fccA,Fumarate reductase flavoprotein subunit,target,,DB01677
Fumarate,,experimental,SO_0970,Fumarate reductase flavoprotein subunit,target,,DB01677
Fumarate,,experimental,ME2,"NAD-dependent malic enzyme, mitochondrial",target,,DB01677
Fumarate,,experimental,FAH,Fumarylacetoacetase,target,,DB01677
"N,N-dimethylarginine",Enzyme Inhibitors,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB01686
"N,N-dimethylarginine",Enzyme Inhibitors,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB01686
Dithioerythritol,Sulfhydryl Reagents,experimental,prfA,Listeriolysin regulatory protein,target,,DB01692
Dithioerythritol,Sulfhydryl Reagents,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB01692
Dithioerythritol,Sulfhydryl Reagents,experimental,TK1,"Thymidine kinase, cytosolic",target,,DB01692
Ribavirin Monophosphate,,experimental,,Genome polyprotein,target,,DB01693
Ribavirin Monophosphate,,experimental,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,,DB01693
D-tartaric acid,,experimental,dlgD,"2,3-diketo-L-gulonate reductase",target,,DB01694
D-tartaric acid,,experimental,B3GAT1,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,target,,DB01694
D-tartaric acid,,experimental,TREM1,Triggering receptor expressed on myeloid cells 1,target,,DB01694
D-tartaric acid,,experimental,DDX6,Probable ATP-dependent RNA helicase DDX6,target,,DB01694
D-tartaric acid,,experimental,TT_P0059,Cytochrome P450,target,,DB01694
D-tartaric acid,,experimental,HIF1AN,Hypoxia-inducible factor 1-alpha inhibitor,target,,DB01694
D-tartaric acid,,experimental,serA,D-3-phosphoglycerate dehydrogenase,target,,DB01694
D-tartaric acid,,experimental,lpxA,Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase,target,,DB01694
D-tartaric acid,,experimental,ATP6V1C1,V-type proton ATPase subunit C 1,target,,DB01694
D-tartaric acid,,experimental,rmlC,"dTDP-4-dehydrorhamnose 3,5-epimerase",target,,DB01694
D-tartaric acid,,experimental,VC_0232,Putative uncharacterized protein,target,,DB01694
D-tartaric acid,,experimental,phnA,Phosphonoacetate hydrolase,target,,DB01694
D-tartaric acid,,experimental,SP_1951,Putative uncharacterized protein,target,,DB01694
"2-(3,4-Dihydroxyphenyl)Acetic Acid",,experimental,mndD,"3,4-dihydroxyphenylacetate 2,3-dioxygenase",target,,DB01702
"2-(3,4-Dihydroxyphenyl)Acetic Acid",,experimental,,"Homoprotocatechuate 2,3-dioxygenase",target,,DB01702
"2-(3,4-Dihydroxyphenyl)Acetic Acid",,experimental,pac,Penicillin G acylase,target,,DB01702
"2-(3,4-Dihydroxyphenyl)Acetic Acid",,experimental,pcaG,"Protocatechuate 3,4-dioxygenase alpha chain",target,,DB01702
"2-(3,4-Dihydroxyphenyl)Acetic Acid",,experimental,pcaH,"Protocatechuate 3,4-dioxygenase beta chain",target,,DB01702
Bis(5-Amidino-Benzimidazolyl)Methane,,experimental,PRSS1,Trypsin-1,target,,DB01705
Bis(5-Amidino-Benzimidazolyl)Methane,,experimental,botB,Botulinum neurotoxin type B,target,,DB01705
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,ksi,Steroid Delta-isomerase,target,,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,SULT2A1,Bile salt sulfotransferase,target,,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,choB,Cholesterol oxidase,target,,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,SULT2B1,Sulfotransferase family cytosolic 2B member 1,target,,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,PPARA,Peroxisome proliferator-activated receptor alpha,target,activator,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,ESR1,Estrogen receptor,target,binder,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,agonist,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,ESR2,Estrogen receptor beta,target,activator,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,activator,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,NR1I3,Nuclear receptor subfamily 1 group I member 3,target,activator,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,GABRA1,GABA-A receptor (anion channel),target,antagonist,DB01708
Dehydroepiandrosterone,"Adjuvants, Immunologic",nutraceutical,GRIN1,NMDA receptor,target,agonist,DB01708
2-Phosphoglyceric Acid,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB01709
2-Phosphoglyceric Acid,,experimental,gpmI,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",target,,DB01709
2-Phosphoglyceric Acid,,experimental,TPI,Triosephosphate isomerase,target,,DB01709
Bis(Adenosine)-5'-Pentaphosphate,,experimental,adk,Adenylate kinase,target,,DB01717
Bis(Adenosine)-5'-Pentaphosphate,,experimental,adk,Adenylate kinase,target,,DB01717
Bis(Adenosine)-5'-Pentaphosphate,,experimental,,Adenylate kinase,target,,DB01717
Bis(Adenosine)-5'-Pentaphosphate,,experimental,AK2,"Adenylate kinase 2, mitochondrial",target,,DB01717
Bis(Adenosine)-5'-Pentaphosphate,,experimental,AK8,Adenylate kinase 8,target,,DB01717
Bis(Adenosine)-5'-Pentaphosphate,,experimental,adk,Adenylate kinase,target,,DB01717
Bis(Adenosine)-5'-Pentaphosphate,,experimental,AK1,Adenylate kinase isoenzyme 1,target,,DB01717
Cetyl-Trimethyl-Ammonium,,experimental,mmaA2,Cyclopropane mycolic acid synthase MmaA2,target,,DB01718
Cetyl-Trimethyl-Ammonium,,experimental,cmaA1,Cyclopropane mycolic acid synthase 1,target,,DB01718
Isocitric Acid,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB01727
Isocitric Acid,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB01727
Isocitric Acid,,experimental,ACO2,"Aconitate hydratase, mitochondrial",target,,DB01727
Isocitric Acid,,experimental,IDH2,"Isocitrate dehydrogenase [NADP], mitochondrial",target,,DB01727
Isocitric Acid,,experimental,IDH1,Isocitrate dehydrogenase [NADP] cytoplasmic,target,,DB01727
Isocitric Acid,,experimental,prpB,Methylisocitrate lyase,target,,DB01727
S-Adenosyl-L-Homocysteine,,experimental,hemK,Release factor glutamine methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,cbiF,Cobalt-precorrin-4 C(11)-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,PCMT1,Protein-L-isoaspartate(D-aspartate) O-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,,Genome polyprotein,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,cmaA2,Cyclopropane mycolic acid synthase 2,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,rsrIM,Modification methylase RsrI,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,TM_0488,Release factor glutamine methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,PRMT3,Protein arginine N-methyltransferase 3,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,HNMT,Histamine N-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,rsmH,Ribosomal RNA small subunit methyltransferase H,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,ermC',rRNA adenine N-6-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,GNMT,Glycine N-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,trmL,tRNA (cytidine(34)-2'-O)-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,pvuIIM,Modification methylase PvuII,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,DAM,DNA adenine methylase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,pcaA,Cyclopropane mycolic acid synthase 3,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,PRMT1,Protein arginine N-methyltransferase 1,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,cysG,Siroheme synthase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,hhaIM,Modification methylase HhaI,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,SETD7,Histone-lysine N-methyltransferase SETD7,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,trmD,tRNA (guanine-N(1)-)-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,mmaA2,Cyclopropane mycolic acid synthase MmaA2,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,DPH5,Diphthine synthase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,rdmB,RdmB,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,trmD,tRNA (guanine-N(1)-)-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,cobA,Uroporphyrinogen-III C-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,TTHA0667,Uncharacterized protein,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,cheR,Chemotaxis protein methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,taqIM,Modification methylase TaqI,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,pcm,Protein-L-isoaspartate O-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,COMTD1,Catechol O-methyltransferase domain-containing protein 1,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,dnrK,Carminomycin 4-O-methyltransferase,target,,DB01752
S-Adenosyl-L-Homocysteine,,experimental,GAMT,Guanidinoacetate N-methyltransferase,target,,DB01752
Beta-(2-Naphthyl)-Alanine,,experimental,YARS,"Tyrosine--tRNA ligase, cytoplasmic",target,,DB01766
Beta-(2-Naphthyl)-Alanine,,experimental,PIN1,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,target,,DB01766
Beta-(2-Naphthyl)-Alanine,,experimental,F2,Prothrombin,target,,DB01766
Hemi-Babim,,experimental,PRSS1,Trypsin-1,target,,DB01767
Hemi-Babim,,experimental,F2,Prothrombin,target,,DB01767
Double Oxidized Cysteine,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB01769
Double Oxidized Cysteine,,experimental,PREP,Prolyl endopeptidase,target,,DB01769
Double Oxidized Cysteine,,experimental,,Beta-lactamase IMP-1,target,,DB01769
Double Oxidized Cysteine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB01769
Double Oxidized Cysteine,,experimental,PARK7,Protein DJ-1,target,,DB01769
Double Oxidized Cysteine,,experimental,,Glyceraldehyde 3-phosphate dehydrogenase,target,,DB01769
Double Oxidized Cysteine,,experimental,def,Peptide deformylase,target,,DB01769
Double Oxidized Cysteine,,experimental,def,Peptide deformylase,target,,DB01769
Double Oxidized Cysteine,,experimental,sucP,Sucrose phosphorylase,target,,DB01769
Double Oxidized Cysteine,,experimental,GK2698,Hypothetical conserved protein,target,,DB01769
Double Oxidized Cysteine,,experimental,CRYBB1,Beta-crystallin B1,target,,DB01769
Double Oxidized Cysteine,,experimental,aglA,Alpha-glucosidase,target,,DB01769
Double Oxidized Cysteine,,experimental,thiM,Hydroxyethylthiazole kinase,target,,DB01769
Double Oxidized Cysteine,,experimental,CDC25B,M-phase inducer phosphatase 2,target,,DB01769
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB01782
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",,experimental,MAPK8IP1,C-Jun-amino-terminal kinase-interacting protein 1,target,,DB01782
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",,experimental,MAPK8,Mitogen-activated protein kinase 8,target,,DB01782
"2,6-Dihydroanthra/1,9-Cd/Pyrazol-6-One",,experimental,TTK,Dual specificity protein kinase TTK,target,,DB01782
Dimethylallyl Diphosphate,,experimental,FDPS,Farnesyl pyrophosphate synthase,target,,DB01785
Dimethylallyl Diphosphate,,experimental,IDI1,Isopentenyl-diphosphate Delta-isomerase 1,target,,DB01785
Dimethylallyl Diphosphate,,experimental,ispH,4-hydroxy-3-methylbut-2-enyl diphosphate reductase,target,,DB01785
D-Alanine,,experimental,nprS,Thermolysin,target,,DB01786
D-Alanine,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB01786
Piclamilast,Phosphodiesterase 4 Inhibitors,experimental,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,,DB01791
Piclamilast,Phosphodiesterase 4 Inhibitors,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB01791
Piclamilast,Phosphodiesterase 4 Inhibitors,experimental,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,,DB01791
Piclamilast,Phosphodiesterase 4 Inhibitors,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB01791
Quinolinic Acid,,experimental,nadC,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,,DB01796
Quinolinic Acid,,experimental,nadC,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,,DB01796
"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",,experimental,yopH,Tyrosine-protein phosphatase YopH,target,,DB01800
"N,4-Dihydroxy-N-Oxo-3-(Sulfooxy)Benzenaminium",,experimental,ARSA,Arylsulfatase A,target,,DB01800
Monoisopropylphosphorylserine,,experimental,PRSS2,Trypsin-2,target,,DB01805
Monoisopropylphosphorylserine,,experimental,apr,Subtilisin BPN',target,,DB01805
Monoisopropylphosphorylserine,,experimental,PRSS1,Trypsin-1,target,,DB01805
Monoisopropylphosphorylserine,,experimental,ACHE,Acetylcholinesterase,target,,DB01805
"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,experimental,HCK,Tyrosine-protein kinase HCK,target,,DB01809
"1-Ter-Butyl-3-P-Tolyl-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,experimental,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,,DB01809
"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",,experimental,,Cruzipain,target,,DB01810
"[1-(1-Methyl-4,5-Dioxo-Pent-2-Enylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester",,experimental,CTSF,Cathepsin F,target,,DB01810
Adenosine-3'-5'-Diphosphate,,experimental,HS3ST1,Heparan sulfate glucosamine 3-O-sulfotransferase 1,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,SULT2B1,Sulfotransferase family cytosolic 2B member 1,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,RNASE2,Non-secretory ribonuclease,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,SULT1A1,Sulfotransferase 1A1,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,HS3ST3A1,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,SULT2A1,Bile salt sulfotransferase,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,SULT1E1,Estrogen sulfotransferase,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,acpS,Holo-[acyl-carrier-protein] synthase,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,SULT1B1,Sulfotransferase family cytosolic 1B member 1,target,,DB01812
Adenosine-3'-5'-Diphosphate,,experimental,topA,DNA topoisomerase 1,target,,DB01812
Pyridoxyl-Glutamic Acid-5'-Monophosphate,,experimental,ilvE,Branched-chain-amino-acid aminotransferase,target,,DB01813
Pyridoxyl-Glutamic Acid-5'-Monophosphate,,experimental,hisC,Histidinol-phosphate aminotransferase,target,,DB01813
Phosphoenolpyruvate,,experimental,aroG,"Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive",target,,DB01819
Phosphoenolpyruvate,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB01819
Phosphoenolpyruvate,,experimental,ENO3,Beta-enolase,target,,DB01819
Phosphoenolpyruvate,,experimental,synC,Capsule biosynthesis protein,target,,DB01819
Phosphoenolpyruvate,,experimental,PCK1,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",target,,DB01819
Phosphoenolpyruvate,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB01819
Phosphoenolpyruvate,,experimental,aroF,Phospho-2-dehydro-3-deoxyheptonate aldolase,target,,DB01819
"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB01821
"L-N(Omega)-Nitroarginine-2,4-L-Diaminobutyric Amide",,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB01821
N-Butyl Isocyanide,,experimental,camC,Camphor 5-monooxygenase,target,,DB01826
N-Butyl Isocyanide,,experimental,,Cytochrome c',target,,DB01826
N-Butyl Isocyanide,,experimental,glbN,Group 1 truncated hemoglobin GlbN,target,,DB01826
N-Butyl Isocyanide,,experimental,MB,Myoglobin,target,,DB01826
Tryptophanyl-5'amp,,experimental,WARS,"Tryptophan--tRNA ligase, cytoplasmic",target,,DB01831
Tryptophanyl-5'amp,,experimental,trpS,Tryptophan--tRNA ligase,target,,DB01831
"(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene",,experimental,GSTP1,Glutathione S-transferase P,target,,DB01834
"(9r,10r)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene",,experimental,GSTM1,Glutathione S-transferase Mu 1,target,,DB01834
"1,2-Propanediol",,experimental,F13A1,Coagulation factor XIII A chain,target,,DB01839
"1,2-Propanediol",,experimental,linB,Haloalkane dehalogenase,target,,DB01839
"1,2-Propanediol",,experimental,cs1,Clavaminate synthase 1,target,,DB01839
"1,2-Propanediol",,experimental,fucO,Lactaldehyde reductase,target,,DB01839
"1,2-Propanediol",,experimental,dhaB1,B12-independent glycerol dehydratase,target,,DB01839
"4,6-Dideoxyglucose",,experimental,tvaI,Neopullulanase 1,target,,DB01841
"4,6-Dideoxyglucose",,experimental,cgt,Cyclomaltodextrin glucanotransferase,target,,DB01841
"4,6-Dideoxyglucose",,experimental,,"Glucan 1,4-alpha-maltohexaosidase",target,,DB01841
"4,6-Dideoxyglucose",,experimental,amyE,Alpha-amylase,target,,DB01841
"4,6-Dideoxyglucose",,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB01841
3'-Phosphate-Adenosine-5'-Diphosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB01842
3'-Phosphate-Adenosine-5'-Diphosphate,,experimental,aac,Aminoglycoside 2'-N-acetyltransferase,target,,DB01842
Dimethylformamide,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB01844
Dimethylformamide,,experimental,REN,Renin,target,,DB01844
Oxidized Coenzyme A,,experimental,frc,Formyl-coenzyme A transferase,target,,DB01846
Oxidized Coenzyme A,,experimental,,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,target,,DB01846
Tetrabutylammonium Ion,,experimental,kcsA,pH-gated potassium channel KcsA,target,,DB01851
Tetrabutylammonium Ion,,experimental,IGKC,Ig kappa chain C region,target,,DB01851
Bacteriochlorophyll A,,experimental,,Bacteriochlorophyll a protein,target,,DB01853
Bacteriochlorophyll A,,experimental,fmoA,Bacteriochlorophyll a protein,target,,DB01853
Phosphoaspartate,,experimental,pgmB,Beta-phosphoglucomutase,target,,DB01857
Phosphoaspartate,,experimental,glnG,Nitrogen regulation protein NR(I),target,,DB01857
"Glucose-Uridine-C1,5'-Diphosphate",,experimental,galT,Galactose-1-phosphate uridylyltransferase,target,,DB01861
"Glucose-Uridine-C1,5'-Diphosphate",,experimental,GALE,UDP-glucose 4-epimerase,target,,DB01861
1-(Isopropylthio)-Beta-Galactopyranside,,experimental,lacZ,Beta-galactosidase,target,,DB01862
1-(Isopropylthio)-Beta-Galactopyranside,,experimental,lacA,Galactoside O-acetyltransferase,target,,DB01862
1-(Isopropylthio)-Beta-Galactopyranside,,experimental,lacI,Lactose operon repressor,target,,DB01862
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,AKT1,RAC-alpha serine/threonine-protein kinase,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,PLEKHA4,Pleckstrin homology domain-containing family A member 4,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,BTK,Tyrosine-protein kinase BTK,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,ITPKA,Inositol-trisphosphate 3-kinase A,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,CYTH2,Cytohesin-2,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,CYTH3,Cytohesin-3,target,,DB01863
"Inositol 1,3,4,5-Tetrakisphosphate",,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB01863
5'-Guanosine-Diphosphate-Monothiophosphate,,experimental,ARF6,ADP-ribosylation factor 6,target,,DB01864
5'-Guanosine-Diphosphate-Monothiophosphate,,experimental,TGM3,Protein-glutamine gamma-glutamyltransferase E,target,,DB01864
5'-Guanosine-Diphosphate-Monothiophosphate,,experimental,ftsZ,Cell division protein FtsZ,target,,DB01864
5'-Guanosine-Diphosphate-Monothiophosphate,,experimental,RAB11A,Ras-related protein Rab-11A,target,,DB01864
[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,,experimental,,Cruzipain,target,,DB01871
[1-(1-Benzyl-3-Hydroxy-2-Oxo-Propylcarbamoyl)-2-Phenyl-Ethyl]-Carbamic Acid Benzyl Ester,,experimental,CTSF,Cathepsin F,target,,DB01871
Acetylgalactosamine-4-Sulfate,,experimental,,Chondroitinase (Chondroitin lyase),target,,DB01872
Acetylgalactosamine-4-Sulfate,,experimental,cslB,Chondroitinase-B,target,,DB01872
Acetylgalactosamine-4-Sulfate,,experimental,SP_0314,Hyaluronate lyase,target,,DB01872
Acetylgalactosamine-4-Sulfate,,experimental,cslA,Chondroitinase-AC,target,,DB01872
Epothilone D,,experimentalinvestigational,TUBA3C,Tubulin alpha-3C/D chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBB,Tubulin beta chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBB1,Tubulin beta-1 chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBB2C,Tubulin beta-4B chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBB4,Tubulin beta-4A chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBA4A,Tubulin alpha-4A chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBB3,Tubulin beta-3 chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBA1C,Tubulin alpha-1C chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBA8,Tubulin alpha-8 chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBA1B,Tubulin alpha-1B chain,target,,DB01873
Epothilone D,,experimentalinvestigational,TUBA1A,Tubulin alpha-1A chain,target,,DB01873
"3,4-Dihydroxycinnamic Acid",,experimental,pyp,Photoactive yellow protein,target,,DB01880
"3,4-Dihydroxycinnamic Acid",,experimental,hutH,Histidine ammonia-lyase,target,,DB01880
"3,4-Dihydroxycinnamic Acid",,experimental,MIF,Macrophage migration inhibitory factor,target,,DB01880
"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",,experimental,map,Methionine aminopeptidase,target,,DB01882
"(2s)-2-Amino-4-(Methylsulfanyl)-1-Pyridin-2-Ylbutane-1,1-Diol",,experimental,map,Methionine aminopeptidase,target,,DB01882
Inhibitor BEA369,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB01887
Inhibitor BEA369,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB01887
Deoxy-Bigchap,,experimental,IGF1,Insulin-like growth factor I,target,,DB01890
Deoxy-Bigchap,,experimental,PPARA,Peroxisome proliferator-activated receptor alpha,target,,DB01890
Tl-3-093,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB01891
Tl-3-093,,experimental,pol,Pol polyprotein,target,,DB01891
Hyperforin,,nutraceutical,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB01892
Hyperforin,,nutraceutical,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,,DB01892
Hyperforin,,nutraceutical,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB01892
"1-Ethyl-Pyrrolidine-2,5-Dione",,experimental,NSF,Vesicle-fusing ATPase,target,,DB01902
"1-Ethyl-Pyrrolidine-2,5-Dione",,experimental,ERO1LB,ERO1-like protein beta,target,,DB01902
D-Xylitol,,experimental,xylA,Xylose isomerase,target,,DB01904
D-Xylitol,,experimental,xylA,Xylose isomerase,target,,DB01904
D-Xylitol,,experimental,xylA,Xylose isomerase,target,,DB01904
D-Xylitol,,experimental,xylA,Xylose isomerase,target,,DB01904
D-Xylitol,,experimental,SP_0314,Hyaluronate lyase,target,,DB01904
2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB01905
2-(2-Hydroxy-5-Methoxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB01905
Adenosyl-Ornithine,Antifungal Agents,experimental,rdmB,RdmB,target,,DB01910
Adenosyl-Ornithine,Antifungal Agents,experimental,ermC',rRNA adenine N-6-methyltransferase,target,,DB01910
Adenosyl-Ornithine,Antifungal Agents,experimental,taqIM,Modification methylase TaqI,target,,DB01910
Adenosyl-Ornithine,Antifungal Agents,experimental,rsrIM,Modification methylase RsrI,target,,DB01910
"2,2':6',2''-Terpyridine Platinum(Ii)",,experimental,lytA,Autolysin,target,,DB01912
"2,2':6',2''-Terpyridine Platinum(Ii)",,experimental,,Truncated transposase,target,,DB01912
Lipid Fragment,,experimental,mxiM,Lipoprotein MxiM,target,,DB01913
D-Glucose in Linear Form,,experimental,malE,Maltose-binding periplasmic protein,target,,DB01914
D-Glucose in Linear Form,,experimental,xylA,Xylose isomerase,target,,DB01914
D-Glucose in Linear Form,,experimental,celCCF,Endoglucanase F,target,,DB01914
S-Hydroxycysteine,,experimental,C3,Complement C3,target,,DB01915
S-Hydroxycysteine,,experimental,azu,Azurin,target,,DB01915
S-Hydroxycysteine,,experimental,GSTP1,Glutathione S-transferase P,target,,DB01915
S-Hydroxycysteine,,experimental,ACAT2,"Acetyl-CoA acetyltransferase, cytosolic",target,,DB01915
S-Hydroxycysteine,,experimental,GSTA1,Glutathione S-transferase A1,target,,DB01915
S-Hydroxycysteine,,experimental,PMP2,Myelin P2 protein,target,,DB01915
S-Hydroxycysteine,,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB01915
S-Hydroxycysteine,,experimental,apr,Subtilisin BPN',target,,DB01915
Putrescine,,experimental,ODC1,Ornithine decarboxylase,target,,DB01917
Putrescine,,experimental,AMD1,S-adenosylmethionine decarboxylase proenzyme,target,,DB01917
Putrescine,,experimental,potF,Putrescine-binding periplasmic protein,target,,DB01917
"5-Chloryl-2,4,6-Quinazolinetriamine",,experimental,DFR1,Dihydrofolate reductase,target,,DB01929
"5-Chloryl-2,4,6-Quinazolinetriamine",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB01929
3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,,experimental,nprS,Thermolysin,target,,DB01935
3-{[(1r)-1-Benzyl-2-Sulfanylethyl]Amino}-3-Oxopropanoic Acid,,experimental,npr,Thermolysin,target,,DB01935
Formic Acid,Anti-Bacterial Agents,experimental,HMOX1,Heme oxygenase 1,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,RNASE1,Ribonuclease pancreatic,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,pyrD,Dihydroorotate dehydrogenase (quinone),target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,dhlB,(S)-2-haloacid dehalogenase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,bla,Beta-lactamase OXA-2,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,katA,Catalase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,ffh,Signal recognition particle protein,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,,Streptavidin,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,mgsA,Methylglyoxal synthase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,CTBP1,C-terminal-binding protein 1,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,pgl,6-phosphogluconolactonase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,citE,Citrate lyase subunit beta-like protein,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,CASK,Peripheral plasma membrane protein CASK,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,gmk,Guanylate kinase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,buk2,Probable butyrate kinase 2,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,A2LD1,Gamma-glutamylaminecyclotransferase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,PVALB,Parvalbumin alpha,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,ACYP2,Acylphosphatase-2,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,BC_2969,Uncharacterized protein,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,astA,Arginine N-succinyltransferase subunit alpha,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,yvyI,Putative mannose-6-phosphate isomerase YvyI,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,TM_1223,"ABC-type transporter, periplasmic subunit",target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,ycdX,Probable phosphatase YcdX,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,phzD1,Phenazine biosynthesis protein PhzD,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,oxdC,Oxalate decarboxylase OxdC,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,actIII,Putative ketoacyl reductase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,GPHN,Gephyrin,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,BC_1747,Glyoxalase family protein,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,CYTH2,Cytohesin-2,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,gcdA,Glutaconyl-CoA decarboxylase subunit alpha,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,TM_0065,"Transcriptional regulator, IclR family",target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,katA,Catalase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,TM_1070,Putative L-rhamnose mutarotase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,GST,Glutathione S-transferase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,HGPRTase,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,glsA1,Glutaminase 1,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,glsA1,Glutaminase 1,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,moaE,Molybdopterin synthase catalytic subunit,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,TM_1131,"Aminotransferase, putative",target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,fbpA,Iron binding protein FbpA,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,gyrB,DNA gyrase subunit B,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,ygbM,Putative hydroxypyruvate isomerase YgbM,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,hemB,Delta-aminolevulinic acid dehydratase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,aroA,3-phosphoshikimate 1-carboxyvinyltransferase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,apr,Subtilisin Carlsberg,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,FGF1,Fibroblast growth factor 1,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,def,Peptide deformylase,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,pabB,Para-aminobenzoate synthase component 1,target,,DB01942
Formic Acid,Anti-Bacterial Agents,experimental,CA2,Carbonic anhydrase 2,target,,DB01942
"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB01946
"3-[1-(3-Aminopropyl)-1h-Indol-3-Yl]-4-(1-Methyl-1h-Indol-3-Yl)-1h-Pyrrole-2,5-Dione",,experimental,DMPK,Myotonin-protein kinase,target,,DB01946
4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB01954
4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]-2-Pyrrolidinone,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB01954
"1,4-Butanediol",,experimental,MAN1B1,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",target,,DB01955
"1,4-Butanediol",,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB01955
"1,4-Butanediol",,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB01955
"1,4-Butanediol",,experimental,rsuA,Ribosomal small subunit pseudouridine synthase A,target,,DB01955
"1,4-Butanediol",,experimental,mepA,Penicillin-insensitive murein endopeptidase,target,,DB01955
2-Aminoethanesulfonic Acid,,experimental,tauD,Alpha-ketoglutarate-dependent taurine dioxygenase,target,,DB01956
2-Aminoethanesulfonic Acid,,experimental,cbh,Choloylglycine hydrolase,target,,DB01956
"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",,experimental,DFR1,Dihydrofolate reductase,target,,DB01958
"5-[4-Tert-Butylphenylsulfanyl]-2,4-Quinazolinediamine",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB01958
"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB01959
"3,5-Dimethyl-1-(3-Nitrophenyl)-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB01959
7n-Methyl-8-Hydroguanosine-5'-Diphosphate,,experimental,DCPS,m7GpppX diphosphatase,target,,DB01960
7n-Methyl-8-Hydroguanosine-5'-Diphosphate,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB01960
7n-Methyl-8-Hydroguanosine-5'-Diphosphate,,experimental,EIF4E,Eukaryotic translation initiation factor 4E,target,,DB01960
Phosphonotyrosine,,experimental,HCK,Tyrosine-protein kinase HCK,target,,DB01962
Phosphonotyrosine,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB01962
Phosphonotyrosine,,experimental,KIT,Mast/stem cell growth factor receptor Kit,target,,DB01962
"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB01965
"2'-Deoxyuridine 5'-Alpha,Beta-Imido-Triphosphate",,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB01965
"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",,experimental,zipA,Cell division protein ZipA homolog,target,,DB01967
"N-{3-[(7ar,12as,12bs)-7-Oxo-1,3,4,6,7,7a,12a,12b-Octahydroindolo[2,3-a]Quinolizin-12(2h)-Yl]Propyl}Propane-2-Sulfonamide",,experimental,zipA,Cell division protein ZipA,target,,DB01967
Guanosine-5'-Monophosphate,,experimental,GUK1,Guanylate kinase,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,pleD,Response regulator PleD,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,43,DNA polymerase,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,DLG4,Disks large homolog 4,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,GMPR,GMP reductase 1,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,,DB01972
Guanosine-5'-Monophosphate,,experimental,HINT1,Histidine triad nucleotide-binding protein 1,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,ATIC,Bifunctional purine biosynthesis protein PURH,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,pyrR,Bifunctional protein PyrR,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,purF,Amidophosphoribosyltransferase,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,TGM3,Protein-glutamine gamma-glutamyltransferase E,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,gpt,Xanthine phosphoribosyltransferase,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,cobU,Bifunctional adenosylcobalamin biosynthesis protein CobU,target,,DB01972
Guanosine-5'-Monophosphate,,experimental,purF,Amidophosphoribosyltransferase,target,,DB01972
O-Benzylsulfonyl-Serine,,experimental,,Subtilisin Savinase,target,,DB01973
O-Benzylsulfonyl-Serine,,experimental,PRSS2,Trypsin-2,target,,DB01973
O-Benzylsulfonyl-Serine,,experimental,clcD,Carboxymethylenebutenolidase,target,,DB01973
O-Benzylsulfonyl-Serine,,experimental,UL80,Capsid scaffolding protein,target,,DB01973
O-Benzylsulfonyl-Serine,,experimental,,Alkaline protease,target,,DB01973
AMPCPR,,experimental,nudF,ADP-ribose pyrophosphatase,target,,DB01975
AMPCPR,,experimental,MT1739,MutT/nudix family protein,target,,DB01975
D-Mannuronic Acid,,experimental,algQ1,AlgQ1,target,,DB01982
D-Mannuronic Acid,,experimental,algQ2,AlgQ2,target,,DB01982
Thiamin Diphosphate,,experimental,mdlC,Benzoylformate decarboxylase,target,,DB01987
Thiamin Diphosphate,,experimental,pox5,Pyruvate oxidase,target,,DB01987
Thiamin Diphosphate,,experimental,aceE,Pyruvate dehydrogenase E1 component,target,,DB01987
Thiamin Diphosphate,,experimental,por,Pyruvate-flavodoxin oxidoreductase,target,,DB01987
Thiamin Diphosphate,,experimental,ipdC,Indole-3-pyruvate decarboxylase,target,,DB01987
Thiamin Diphosphate,,experimental,,Carboxyethylarginine synthase,target,,DB01987
Thiamin Diphosphate,,experimental,tktA,Transketolase 1,target,,DB01987
Thiamin Diphosphate,,experimental,budB,"Acetolactate synthase, catabolic",target,,DB01987
Coenzyme A,,nutraceutical,acs,Acetyl-coenzyme A synthetase,target,,DB01992
Coenzyme A,,nutraceutical,DBI,Acyl-CoA-binding protein,target,,DB01992
Coenzyme A,,nutraceutical,frc,Formyl-coenzyme A transferase,target,,DB01992
Coenzyme A,,nutraceutical,CRAT,Carnitine O-acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,caiB,Crotonobetainyl-CoA:carnitine CoA-transferase,target,,DB01992
Coenzyme A,,nutraceutical,pflB,Formate acetyltransferase 1,target,,DB01992
Coenzyme A,,nutraceutical,glcB,Malate synthase G,target,,DB01992
Coenzyme A,,nutraceutical,mvaA,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB01992
Coenzyme A,,nutraceutical,coaD,Phosphopantetheine adenylyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,acpS,Holo-[acyl-carrier-protein] synthase,target,,DB01992
Coenzyme A,,nutraceutical,paiA,Protease synthase and sporulation negative regulatory protein PAI 1,target,,DB01992
Coenzyme A,,nutraceutical,aacC1,Gentamicin 3'-acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,lacA,Galactoside O-acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB01992
Coenzyme A,,nutraceutical,fadR,Fatty acid metabolism regulator protein,target,,DB01992
Coenzyme A,,nutraceutical,KAT5,Histone acetyltransferase KAT5,target,,DB01992
Coenzyme A,,nutraceutical,dapD,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",target,,DB01992
Coenzyme A,,nutraceutical,ACAT2,"Acetyl-CoA acetyltransferase, cytosolic",target,,DB01992
Coenzyme A,,nutraceutical,phbA,Acetyl-CoA acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,vatD,Streptogramin A acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,CS,"Citrate synthase, mitochondrial",target,,DB01992
Coenzyme A,,nutraceutical,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB01992
Coenzyme A,,nutraceutical,frc,Formyl-coenzyme A transferase,target,,DB01992
Coenzyme A,,nutraceutical,,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,target,,DB01992
Coenzyme A,,nutraceutical,coaA,Pantothenate kinase,target,,DB01992
Coenzyme A,,nutraceutical,rimL,Acetyl transferase,target,,DB01992
Coenzyme A,,nutraceutical,yvbK,Uncharacterized N-acetyltransferase YvbK,target,,DB01992
Coenzyme A,,nutraceutical,aac(6')-Iy,Aminoglycoside N(6')-acetyltransferase type 1,target,,DB01992
Coenzyme A,,nutraceutical,BC_2038,Acyl-CoA hydrolase,target,,DB01992
Coenzyme A,,nutraceutical,HI_0827,Uncharacterized acyl-CoA thioester hydrolase HI_0827,target,,DB01992
Coenzyme A,,nutraceutical,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB01992
Coenzyme A,,nutraceutical,mshD,Mycothiol acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,KAT2A,Histone acetyltransferase KAT2A,target,,DB01992
Coenzyme A,,nutraceutical,BH0798,Acyl-CoA hydrolase,target,,DB01992
Coenzyme A,,nutraceutical,KAT2B,Histone acetyltransferase KAT2B,target,,DB01992
Coenzyme A,,nutraceutical,menB,"1,4-Dihydroxy-2-naphthoyl-CoA synthase",target,,DB01992
Coenzyme A,,nutraceutical,cit,Citrate synthase,target,,DB01992
Coenzyme A,,nutraceutical,aac,Aminoglycoside 2'-N-acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,aac(6')-Ii,Aac(6')-Ii protein,target,,DB01992
Coenzyme A,,nutraceutical,sfp,4'-phosphopantetheinyl transferase sfp,target,,DB01992
Coenzyme A,,nutraceutical,PA3270,Uncharacterized protein,target,,DB01992
Coenzyme A,,nutraceutical,cysE,Serine acetyltransferase,target,,DB01992
Coenzyme A,,nutraceutical,gltA,Citrate synthase,target,,DB01992
Coenzyme A,,nutraceutical,fcbC,4-hydroxybenzoyl-CoA thioesterase,target,,DB01992
Coenzyme A,,nutraceutical,glmU,Bifunctional protein GlmU,target,,DB01992
3-Methylpyridine,,experimental,MMP13,Collagenase 3,target,,DB01996
3-Methylpyridine,,experimental,MMP3,Stromelysin-1,target,,DB01996
3-Bromo-7-Nitroindazole,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB01997
3-Bromo-7-Nitroindazole,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB01997
3-Bromo-7-Nitroindazole,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB01997
Gamma-Phenyl-Butyric Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB02000
Gamma-Phenyl-Butyric Acid,,experimental,npr,Thermolysin,target,,DB02000
"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",,experimental,DFR1,Dihydrofolate reductase,target,,DB02001
"5-(4-Morpholin-4-Yl-Phenylsulfanyl)-2,4-Quinazolinediamine",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB02001
Alpha-D-Glucose-6-Phosphate,,experimental,HK1,Hexokinase-1,target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,algC,Phosphomannomutase/phosphoglucomutase,target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,glvA,Maltose-6'-phosphate glucosidase,target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,otsA,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,glmS,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,bglT,6-phospho-beta-glucosidase BglT,target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB02007
Alpha-D-Glucose-6-Phosphate,,experimental,AKR1B1,Aldose reductase,target,,DB02007
Staurosporine,,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB02010
Staurosporine,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB02010
Staurosporine,,experimental,ITK,Tyrosine-protein kinase ITK/TSK,target,,DB02010
Staurosporine,,experimental,SYK,Tyrosine-protein kinase SYK,target,,DB02010
Staurosporine,,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB02010
Staurosporine,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB02010
Staurosporine,,experimental,CSK,Tyrosine-protein kinase CSK,target,,DB02010
Staurosporine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02010
Staurosporine,,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB02010
Staurosporine,,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB02010
Staurosporine,,experimental,PRKCQ,Protein kinase C theta type,target,,DB02010
Staurosporine,,experimental,ZAP70,Tyrosine-protein kinase ZAP-70,target,,DB02010
Dihydrofolic Acid,,experimental,folA,Dihydrofolate reductase,target,,DB02015
Dihydrofolic Acid,,experimental,ptr2,Putative pteridine reductase 2,target,,DB02015
4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,,experimental,tenA,Thiaminase-2,target,,DB02022
4-Amino-5-Hydroxymethyl-2-Methylpyrimidine,,experimental,thiD,Hydroxymethylpyrimidine/phosphomethylpyrimidine kinase,target,,DB02022
3-phenylpropionic acid,,experimental,aspC,Aspartate aminotransferase,target,,DB02024
3-phenylpropionic acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB02024
3-phenylpropionic acid,,experimental,,Aminotransferase,target,,DB02024
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02027
N-{(4s)-4-Amino-5-[(2-Aminoethyl)Amino]Pentyl}-N'-Nitroguanidine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02027
"(6s)-5,6,7,8-Tetrahydrofolate",,experimental,nos,Nitric oxide synthase oxygenase,target,,DB02031
"(6s)-5,6,7,8-Tetrahydrofolate",,experimental,thyA,Thymidylate synthase,target,,DB02031
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,,experimental,ACE,Angiotensin-converting enzyme,target,,DB02032
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,,experimental,blaFEZ-1,FEZ-1 protein,target,,DB02032
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,,experimental,blaB1,Carbapenem-hydrolyzing beta-lactamase BlaB-1,target,,DB02032
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,,experimental,,Metallo-beta-lactamase L1,target,,DB02032
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,,experimental,cphA,Beta-lactamase,target,,DB02032
1-(3-Mercapto-2-Methyl-Propionyl)-Pyrrolidine-2-Carboxylic Acid,,experimental,VC_A1006,"Organic hydroperoxide resistance protein, putative",target,,DB02032
S-Acetyl-Cysteine,,experimental,KAT5,Histone acetyltransferase KAT5,target,,DB02039
S-Acetyl-Cysteine,,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB02039
S-Acetyl-Cysteine,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB02039
S-Acetyl-Cysteine,,experimental,mvaS,3-hydroxy-3-methylglutaryl CoA synthase,target,,DB02039
2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,,experimental,actVA 6,ActVA 6 protein,target,,DB02042
2-(2-{2-[2-(2-Methoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol,,experimental,ndoA,mRNA interferase EndoA,target,,DB02042
N-(3-(Aminomethyl)Benzyl)Acetamidine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02044
N-(3-(Aminomethyl)Benzyl)Acetamidine,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02044
N-(3-(Aminomethyl)Benzyl)Acetamidine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02044
Indirubin-3'-Monoxime,,experimental,CDK5,Cyclin-dependent kinase 5,target,inhibitor,DB02052
Indirubin-3'-Monoxime,,experimental,CDK1,Cyclin-dependent kinase 1,target,binder,DB02052
Indirubin-3'-Monoxime,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB02052
Indirubin-3'-Monoxime,,experimental,CDK5R1,Cyclin-dependent kinase 5 activator 1,target,,DB02052
Indirubin-3'-Monoxime,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,inhibitor,DB02052
Ribose-5-Phosphate,,experimental,rpiA,Ribose-5-phosphate isomerase A,target,,DB02053
Ribose-5-Phosphate,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB02053
Ribose-5-Phosphate,,experimental,ndx4,ADP-ribose pyrophosphatase,target,,DB02053
Gabaculine,,experimental,OAT,"Ornithine aminotransferase, mitochondrial",target,,DB02054
Gabaculine,,experimental,hemL,"Glutamate-1-semialdehyde 2,1-aminomutase",target,,DB02054
SU4984,,experimental,FGFR2,Fibroblast growth factor receptor 2,target,,DB02058
SU4984,,experimental,FGFR1,Fibroblast growth factor receptor 1,target,,DB02058
Adenosine-5-Diphosphoribose,,experimental,rfbG,"CDP-glucose 4,6-dehydratase",target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,EEF2,Elongation factor 2,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,fucO,Lactaldehyde reductase,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,nudF,ADP-ribose pyrophosphatase,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,MT1739,MutT/nudix family protein,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,nudE,ADP compounds hydrolase NudE,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,ndx4,ADP-ribose pyrophosphatase,target,,DB02059
Adenosine-5-Diphosphoribose,,experimental,SIRT3,"NAD-dependent protein deacetylase sirtuin-3, mitochondrial",target,,DB02059
Cellobiose,,experimental,celCCG,Endoglucanase G,target,,DB02061
Cellobiose,,experimental,cel5A,Endoglucanase 5A,target,,DB02061
Cellobiose,,experimental,,Endoglucanase,target,,DB02061
"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",,experimental,MME,Neprilysin,target,,DB02062
"N-[3-[(1-Aminoethyl)(Hydroxy)Phosphoryl]-2-(1,1'-Biphenyl-4-Ylmethyl)Propanoyl]Alanine",,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB02062
Delta-Amino Valeric Acid,,experimental,GATM,"Glycine amidinotransferase, mitochondrial",target,,DB02068
Delta-Amino Valeric Acid,,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB02068
Biliverdine Ix Alpha,,experimental,HMOX1,Heme oxygenase 1,target,,DB02073
Biliverdine Ix Alpha,,experimental,MB,Myoglobin,target,,DB02073
Biliverdine Ix Alpha,,experimental,BLVRB,Flavin reductase (NADPH),target,,DB02073
6-Phosphogluconic Acid,,experimental,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",target,,DB02076
6-Phosphogluconic Acid,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB02076
6-Phosphogluconic Acid,,experimental,gntK,Thermoresistant gluconokinase,target,,DB02076
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02077
L-N(Omega)-Nitroarginine-(4r)-Amino-L-Proline Amide,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02077
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,lolB,Outer-membrane lipoprotein LolB,target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,PFN2,Profilin-2,target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,lolB,Outer-membrane lipoprotein LolB,target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,AGR_C_2535,Uncharacterized protein,target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,cysE,Serine acetyltransferase,target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,FYN,Tyrosine-protein kinase Fyn,target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,BCE_3424,"Transcriptional regulator, GntR family",target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,SPO2066,"ABC transporter, periplasmic substrate-binding protein",target,,DB02078
1-Methoxy-2-[2-(2-Methoxy-Ethoxy]-Ethane,,experimental,tkt2,Transketolase,target,,DB02078
"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB02080
"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",,experimental,lepB,Signal peptidase I,target,,DB02080
"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02091
"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine",,experimental,CCNA2,Cyclin-A2,target,,DB02091
Adenosine-2'-5'-Diphosphate,,experimental,RNASE3,Eosinophil cationic protein,target,,DB02098
Adenosine-2'-5'-Diphosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB02098
Adenosine-2'-5'-Diphosphate,,experimental,RNASE2,Non-secretory ribonuclease,target,,DB02098
Hadacidin,,experimental,purA,Adenylosuccinate synthetase,target,,DB02109
Hadacidin,,experimental,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB02109
Hadacidin,,experimental,Adss,Adenylosuccinate synthetase,target,inhibitor,DB02109
Protoporphyrin Ix Containing Co,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB02110
Protoporphyrin Ix Containing Co,,experimental,CYCS,Cytochrome c,target,,DB02110
Olomoucine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,inhibitor,DB02116
Olomoucine,,experimental,CDK5,Cyclin-dependent kinase 5,target,inhibitor,DB02116
Olomoucine,,experimental,CDK1,Cyclin-dependent kinase 1,target,binder,DB02116
Olomoucine,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB02116
"6-Hydroxymethyl-7,8-Dihydropterin",,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB02119
"6-Hydroxymethyl-7,8-Dihydropterin",,experimental,folB,Dihydroneopterin aldolase,target,,DB02119
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,experimental,cgt,Cyclomaltodextrin glucanotransferase,target,,DB02120
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB02120
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,experimental,,"Glucan 1,4-alpha-maltohexaosidase",target,,DB02120
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,experimental,amyE,Alpha-amylase,target,,DB02120
"6-Amino-4-Hydroxymethyl-Cyclohex-4-Ene-1,2,3-Triol",,experimental,tvaI,Neopullulanase 1,target,,DB02120
4-iodo-acetamido phenylboronic acid,,experimental,ampC,Beta-lactamase,target,,DB02122
4-iodo-acetamido phenylboronic acid,,experimental,bla,Beta-lactamase OXA-10,target,,DB02122
4-iodo-acetamido phenylboronic acid,,experimental,ampC,Beta-lactamase AmpC,target,,DB02122
4-Carboxycinnamic Acid,,experimental,HBA1,Hemoglobin subunit alpha,target,,DB02126
4-Carboxycinnamic Acid,,experimental,HBB,Hemoglobin subunit beta,target,,DB02126
Methylphosphonic Acid Diisopropyl Ester,,experimental,opd,Parathion hydrolase,target,,DB02127
Methylphosphonic Acid Diisopropyl Ester,,experimental,opd,Parathion hydrolase,target,,DB02127
Xanthine,,experimental,xapA,Purine nucleoside phosphorylase 2,target,,DB02134
Xanthine,,experimental,gpt,Xanthine phosphoribosyltransferase,target,,DB02134
Diethyl 4-Methylbenzylphosphonate,,experimental,opd,Parathion hydrolase,target,,DB02138
Diethyl 4-Methylbenzylphosphonate,,experimental,opd,Parathion hydrolase,target,,DB02138
Pyridoxamine-5'-Phosphate,,experimental,alr,Alanine racemase,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,hemL,"Glutamate-1-semialdehyde 2,1-aminomutase",target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,hisC,Histidinol-phosphate aminotransferase,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,dat,D-alanine aminotransferase,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,aspC,Aspartate aminotransferase,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,gabT,4-aminobutyrate aminotransferase GabT,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,CCBL1,Kynurenine--oxoglutarate transaminase 1,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,hisC,Histidinol-phosphate aminotransferase,target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,,DB02142
Pyridoxamine-5'-Phosphate,,experimental,arnB,UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase,target,,DB02142
Methionine Phosphonate,,experimental,metG,Methionine--tRNA ligase,target,,DB02151
Methionine Phosphonate,,experimental,map,Methionine aminopeptidase,target,,DB02151
K-252a,,experimental,MET,Hepatocyte growth factor receptor,target,,DB02152
K-252a,,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB02152
3-Sulfinoalanine,,experimental,pdxY,Pyridoxamine kinase,target,,DB02153
3-Sulfinoalanine,,experimental,blm,Beta-lactamase 2,target,,DB02153
3-Sulfinoalanine,,experimental,PAPOLA,Poly(A) polymerase alpha,target,,DB02153
3-Sulfinoalanine,,experimental,aroH,Chorismate mutase AroH,target,,DB02153
3-Sulfinoalanine,,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB02153
3-Sulfinoalanine,,experimental,luxS,S-ribosylhomocysteine lyase,target,,DB02153
3-Sulfinoalanine,,experimental,clcD,Carboxymethylenebutenolidase,target,,DB02153
3-Sulfinoalanine,,experimental,dmsA,Dimethyl sulfoxide/trimethylamine N-oxide reductase,target,,DB02153
3-Sulfinoalanine,,experimental,PRDX2,Peroxiredoxin-2,target,,DB02153
3-Sulfinoalanine,,experimental,def,Peptide deformylase,target,,DB02153
3-Sulfinoalanine,,experimental,,Malonamidase E2,target,,DB02153
3-Sulfinoalanine,,experimental,mvaS,HMG-CoA synthase,target,,DB02153
3-Sulfinoalanine,,experimental,tthHB8IM,Osmotically inducible protein C,target,,DB02153
"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",,experimental,,Beta-lactamase IMP-1,target,,DB02154
"2,3-Bis-Benzo[1,3]Dioxol-5-Ylmethyl-Succinic Acid",,experimental,blaIMP-1,Beta-lactamase,target,,DB02154
"(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol",,experimental,MTAP,S-methyl-5'-thioadenosine phosphorylase,target,,DB02158
"(1s)-1-(9-Deazaadenin-9-Yl)-1,4,5-Trideoxy-1,4-Imino-5-Methylthio-D-Ribitol",,experimental,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB02158
Malonic acid,,experimental,rsbQ,Sigma factor SigB regulation protein RsbQ,target,,DB02175
Malonic acid,,experimental,panD,Aspartate 1-decarboxylase,target,,DB02175
Malonic acid,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB02175
Malonic acid,,experimental,SCO1207,Putative cytochrome P450,target,,DB02175
Malonic acid,,experimental,SNRPA,U1 small nuclear ribonucleoprotein A,target,,DB02175
Malonic acid,,experimental,,Malonamidase E2,target,,DB02175
Malonic acid,,experimental,rimL,Acetyl transferase,target,,DB02175
Myristoyl-Coa,,experimental,NMT1,Glycylpeptide N-tetradecanoyltransferase,target,,DB02180
Myristoyl-Coa,,experimental,NMT2,Glycylpeptide N-tetradecanoyltransferase 2,target,,DB02180
2'-Deoxyguanosine-5'-Triphosphate,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB02181
2'-Deoxyguanosine-5'-Triphosphate,,experimental,NRDD,Anaerobic ribonucleoside-triphosphate reductase,target,,DB02181
N-Acetyl-D-Galactosamine 6-Sulfate,,experimental,cslA,Chondroitinase-AC,target,,DB02186
N-Acetyl-D-Galactosamine 6-Sulfate,,experimental,SP_0314,Hyaluronate lyase,target,,DB02186
"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",,experimental,zipA,Cell division protein ZipA homolog,target,,DB02191
"(7as,12ar,12bs)-1,2,3,4,7a,12,12a,12b-Octahydroindolo[2,3-a]Quinolizin-7(6h)-One",,experimental,zipA,Cell division protein ZipA,target,,DB02191
2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,experimental,F2,Prothrombin,target,,DB02193
2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB02193
2-(2-Hydroxy-Phenyl)-1h-Benzoimidazole-5-Carboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB02193
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,EXTL2,Exostosin-like 2,target,,DB02196
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,UAP1,UDP-N-acetylhexosamine pyrophosphorylase,target,,DB02196
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,GALE,UDP-glucose 4-epimerase,target,,DB02196
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,wecB,UDP-N-acetylglucosamine 2-epimerase,target,,DB02196
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB02196
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,murG,UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase,target,,DB02196
Uridine-Diphosphate-N-Acetylgalactosamine,,experimental,,WbpP,target,,DB02196
Malonate Ion,,experimental,aroG,Chorismate mutase AroH,target,,DB02201
Malonate Ion,,experimental,SDF2,Stromal cell-derived factor 2,target,,DB02201
"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",,experimental,,"Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",target,,DB02205
"6-(1,1-Dimethylallyl)-2-(1-Hydroxy-1-Methylethyl)-2,3-Dihydro-7h-Furo[3,2-G]Chromen-7-One",,experimental,GAPDHS,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",target,,DB02205
7-Nitroindazole,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02207
7-Nitroindazole,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02207
Pyridoxine-5'-Phosphate,,experimental,pdxJ,Pyridoxine 5'-phosphate synthase,target,,DB02209
Pyridoxine-5'-Phosphate,,experimental,ODC1,Ornithine decarboxylase,target,,DB02209
"Hexane-1,6-Diol",,experimental,NE0143,"Chain A, Red Copper Protein Nitrosocyanin",target,,DB02210
"Hexane-1,6-Diol",,experimental,HRAS,GTPase HRas,target,,DB02210
"Hexane-1,6-Diol",,experimental,NR3C1,Glucocorticoid receptor,target,,DB02210
"Hexane-1,6-Diol",,experimental,E,Lysozyme,target,,DB02210
"Hexane-1,6-Diol",,experimental,ruvB,Holliday junction ATP-dependent DNA helicase RuvB,target,,DB02210
"Hexane-1,6-Diol",,experimental,PLA2G1B,Phospholipase A2,target,,DB02210
Metanitrophenyl-Alpha-D-Galactoside,,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB02213
Metanitrophenyl-Alpha-D-Galactoside,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02213
S-Methylcysteine,,experimental,CTSD,Cathepsin D,target,,DB02216
S-Methylcysteine,,experimental,MGMT,Methylated-DNA--protein-cysteine methyltransferase,target,,DB02216
"N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB02218
"N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside",,experimental,,Amylase,target,,DB02218
"N-[4-Hydroxymethyl-Cyclohexan-6-Yl-1,2,3-Triol]-4,6-Dideoxy-4-Aminoglucopyranoside",,experimental,AMY2B,Alpha-amylase 2B,target,,DB02218
"1,2-Dihydroxybenzene",,experimental,catA,"Catechol 1,2-dioxygenase",target,,DB02232
"1,2-Dihydroxybenzene",,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB02232
Ethylisothiourea,,experimental,nos,Nitric oxide synthase oxygenase,target,,DB02234
Ethylisothiourea,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02234
Ethylisothiourea,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02234
Methionine Sulfoxide,,experimental,PROF,Protease,target,,DB02235
Methionine Sulfoxide,,experimental,APP,Amyloid beta A4 protein,target,,DB02235
Methionine Sulfoxide,,experimental,katA,Catalase,target,,DB02235
Glycinamide Ribonucleotide,,experimental,purT,Phosphoribosylglycinamide formyltransferase 2,target,,DB02236
Glycinamide Ribonucleotide,,experimental,purN,Phosphoribosylglycinamide formyltransferase,target,,DB02236
Glycinamide Ribonucleotide,,experimental,GART,Trifunctional purine biosynthetic protein adenosine-3,target,,DB02236
Maltotetraose,,experimental,amyP,"Glucan 1,4-alpha-maltotetraohydrolase",target,,DB02237
Maltotetraose,,experimental,tvaII,Neopullulanase 2,target,,DB02237
O-Succinylbenzoate,,experimental,Aaar,N-acylamino acid racemase,target,,DB02251
O-Succinylbenzoate,,experimental,menC,o-succinylbenzoate synthase,target,,DB02251
O-Succinylbenzoate,,experimental,Tfu_1410,O-succinylbenzoate-CoA synthase,target,,DB02251
GM6001,,experimental,lef,Lethal factor,target,,DB02255
GM6001,,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB02255
GM6001,,experimental,ACAN,Aggrecan core protein,target,,DB02255
2'-Deoxyuridine,,experimental,udp,Uridine phosphorylase,target,,DB02256
2'-Deoxyuridine,,experimental,thyA,Thymidylate synthase,target,,DB02256
4-Oxosebacic Acid,,experimental,hemB,Delta-aminolevulinic acid dehydratase,target,,DB02260
4-Oxosebacic Acid,,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB02260
Orotic Acid,,experimental,pyrDA,Dihydroorotate dehydrogenase A (fumarate),target,,DB02262
Orotic Acid,,experimental,pyrE,Orotate phosphoribosyltransferase,target,,DB02262
Orotic Acid,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB02262
Orotic Acid,,experimental,pyrD,Dihydroorotate dehydrogenase (quinone),target,,DB02262
Orotic Acid,,experimental,pyrC,Dihydroorotase,target,inhibitor,DB02262
Glyceraldehyde-3-Phosphate,,experimental,gap,Glyceraldehyde-3-phosphate dehydrogenase,target,,DB02263
Glyceraldehyde-3-Phosphate,,experimental,gapN,NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,target,,DB02263
Glyceraldehyde-3-Phosphate,,experimental,gapA,Glyceraldehyde-3-phosphate dehydrogenase A,target,,DB02263
O2-Sulfo-Glucuronic Acid,,experimental,FGF1,Fibroblast growth factor 1,target,,DB02264
O2-Sulfo-Glucuronic Acid,,experimental,HGF,Hepatocyte growth factor,target,,DB02264
O2-Sulfo-Glucuronic Acid,,experimental,HS3ST3A1,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,target,,DB02264
O2-Sulfo-Glucuronic Acid,,experimental,C3L,Complement control protein C3,target,,DB02264
Flufenamic Acid,,experimental,PTGS2,Prostaglandin G/H synthase 2,target,,DB02266
Flufenamic Acid,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB02266
Flufenamic Acid,,experimental,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB02266
Flufenamic Acid,,experimental,AR,Androgen receptor,target,,DB02266
Argininosuccinate,,experimental,ASL,Argininosuccinate lyase,target,,DB02267
Argininosuccinate,,experimental,argG,Argininosuccinate synthase,target,,DB02267
Dimethylallyl S-Thiolodiphosphate,,experimental,ispA,Farnesyl diphosphate synthase,target,,DB02270
Dimethylallyl S-Thiolodiphosphate,,experimental,tzs,Adenylate dimethylallyltransferase,target,,DB02270
Dimethylallyl S-Thiolodiphosphate,,experimental,miaA,tRNA dimethylallyltransferase,target,,DB02270
(R)-Mandelic Acid,,experimental,mdlC,Benzoylformate decarboxylase,target,,DB02280
(R)-Mandelic Acid,,experimental,mdlA,Mandelate racemase,target,,DB02280
Formycin,,experimental,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB02281
Formycin,,experimental,MTAP,S-methyl-5'-thioadenosine phosphorylase,target,,DB02281
5'-Deoxy-5'-Methylthioadenosine,,experimental,rsrIM,Modification methylase RsrI,target,,DB02282
5'-Deoxy-5'-Methylthioadenosine,,experimental,MTAP,S-methyl-5'-thioadenosine phosphorylase,target,,DB02282
"5,10-Methylene-6-Hydrofolic Acid",,experimental,thyA,Thymidylate synthase,target,,DB02301
"5,10-Methylene-6-Hydrofolic Acid",,experimental,fgs,Folylpolyglutamate synthase,target,,DB02301
"5,10-Methylene-6-Hydrofolic Acid",,experimental,thyA,Thymidylate synthase,target,,DB02301
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine,,experimental,ATIC,Bifunctional purine biosynthesis protein PURH,target,,DB02309
5--Monophosphate-9-Beta-D-Ribofuranosyl Xanthine,,experimental,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB02309
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,,experimental,murE,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",target,,DB02314
Uridine-5'-Diphosphate-N-Acetylmuramoyl-L-Alanine-D-Glutamate,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB02314
Cyclic Guanosine Monophosphate,,experimental,PDE2A,"cGMP-dependent 3',5'-cyclic phosphodiesterase",target,,DB02315
Cyclic Guanosine Monophosphate,,experimental,HCN2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,target,,DB02315
Cyclic Guanosine Monophosphate,,experimental,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,target,,DB02315
1-N-Acetyl-Beta-D-Glucosamine,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02320
1-N-Acetyl-Beta-D-Glucosamine,,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB02320
2-[2-(2-Hydroxy-Ethoxy)-Ethoxy]-Ethanol,,experimental,budB,"Acetolactate synthase, catabolic",target,,DB02327
2-[2-(2-Hydroxy-Ethoxy)-Ethoxy]-Ethanol,,experimental,ganB,"Arabinogalactan endo-1,4-beta-galactosidase",target,,DB02327
2-[2-(2-Hydroxy-Ethoxy)-Ethoxy]-Ethanol,,experimental,serC,Phosphoserine aminotransferase,target,,DB02327
Carbenoxolone,,experimental,,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,target,,DB02329
Carbenoxolone,,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,inhibitor,DB02329
Deoxyuridine-5'-Triphosphate,,experimental,maf,Septum formation protein Maf,target,,DB02333
Deoxyuridine-5'-Triphosphate,,experimental,pol,Pol polyprotein,target,,DB02333
Deoxyuridine-5'-Triphosphate,,experimental,dcd,Deoxycytidine triphosphate deaminase,target,,DB02333
Deoxyuridine-5'-Triphosphate,,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB02333
Deoxyuridine-5'-Triphosphate,,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB02333
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,,experimental,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,,DB02338
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,,experimental,zwf,Glucose-6-phosphate 1-dehydrogenase,target,,DB02338
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,,experimental,PTR1,Pteridine reductase 1,target,,DB02338
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,,experimental,gfo,Glucose--fructose oxidoreductase,target,,DB02338
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,,experimental,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB02338
Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate,,experimental,AASS,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",target,,DB02338
"Mdl 101,146",,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB02341
"Mdl 101,146",,experimental,ELANE,Neutrophil elastase,target,,DB02341
2-Methoxyestradiol,Antineoplastic AgentsTubulin Modulators,investigational,HIF1A,Hypoxia-inducible factor 1-alpha,target,,DB02342
2-Methoxyestradiol,Antineoplastic AgentsTubulin Modulators,investigational,COMT,Catechol O-methyltransferase,target,,DB02342
2-Methoxyestradiol,Antineoplastic AgentsTubulin Modulators,investigational,CYP1A1,Cytochrome P450 1A1,target,,DB02342
2-Methoxyestradiol,Antineoplastic AgentsTubulin Modulators,investigational,CYP1B1,Cytochrome P450 1B1,target,,DB02342
2-Methoxyestradiol,Antineoplastic AgentsTubulin Modulators,investigational,CYP19A1,Cytochrome P450 19A1,target,,DB02342
"3,6,9,12,15-Pentaoxaheptadecane",,experimental,kynU,Kynureninase,target,,DB02343
"3,6,9,12,15-Pentaoxaheptadecane",,experimental,murI,Glutamate racemase,target,,DB02343
"3,6,9,12,15-Pentaoxaheptadecane",,experimental,ACHE,Acetylcholinesterase,target,,DB02343
Selenocysteine,,experimental,CAMP,Cathelicidin antimicrobial peptide,target,,DB02345
Selenocysteine,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB02345
Selenocysteine,,experimental,fdhF,Formate dehydrogenase H,target,,DB02345
Selenocysteine,,experimental,sufS,Cysteine desulfurase,target,,DB02345
3-(Benzyloxy)Pyridin-2-Amine,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB02352
3-(Benzyloxy)Pyridin-2-Amine,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB02352
4-Aminobenzoic Acid,,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB02362
4-Aminobenzoic Acid,,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB02362
2'-Monophosphoadenosine-5'-Diphosphate,,experimental,aroE,Shikimate dehydrogenase,target,,DB02363
2'-Monophosphoadenosine-5'-Diphosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB02363
2'-Monophosphoadenosine-5'-Diphosphate,,experimental,folA,Dihydrofolate reductase,target,,DB02363
"1,10-Phenanthroline",,experimental,tar,Methyl-accepting chemotaxis protein II,target,,DB02365
"1,10-Phenanthroline",,experimental,,Metallo-beta-lactamase L1,target,,DB02365
Guanine,,experimental,TM_1596,Purine nucleoside phosphorylase,target,,DB02377
Guanine,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02377
Guanine,,experimental,xapA,Purine nucleoside phosphorylase 2,target,,DB02377
Guanine,,experimental,gpt,Xanthine phosphoribosyltransferase,target,,DB02377
Guanine,,experimental,GCH1,GTP cyclohydrolase 1,target,inhibitor,DB02377
Beta-D-Glucose,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02379
Beta-D-Glucose,,experimental,xylA,Xylose isomerase,target,,DB02379
Beta-D-Glucose,,experimental,GCK,Glucokinase,target,,DB02379
Beta-D-Glucose,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02379
Beta-D-Glucose,,experimental,galM,Aldose 1-epimerase,target,,DB02379
Beta-D-Glucose,,experimental,celA1,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",target,,DB02379
Beta-D-Glucose,,experimental,glk,Glucokinase,target,,DB02379
Beta-D-Glucose,,experimental,,Amylase,target,,DB02379
Beta-D-Glucose,,experimental,lecB,Fucose-binding lectin PA-IIL,target,,DB02379
Beta-D-Glucose,,experimental,BH0236,BH0236 protein,target,,DB02379
Beta-D-Glucose,,experimental,TM_0024,Laminarinase,target,,DB02379
Beta-D-Glucose,,experimental,xynA,"Endo-1,4-beta-xylanase A",target,,DB02379
Beta-D-Glucose,,experimental,celB,Cellulase B,target,,DB02379
Beta-D-Glucose,,experimental,cenC,Endoglucanase C,target,,DB02379
Beta-D-Glucose,,experimental,celS,"Cellulose 1,4-beta-cellobiosidase (reducing end) CelS",target,,DB02379
Beta-D-Glucose,,experimental,mglB,D-galactose-binding periplasmic protein,target,,DB02379
Beta-D-Glucose,,experimental,GLT6D1,Glycosyltransferase 6 domain-containing protein 1,target,,DB02379
Beta-D-Glucose,,experimental,GNPDA1,Glucosamine-6-phosphate isomerase 1,target,,DB02379
Beta-D-Glucose,,experimental,spoII,Beta-amylase,target,,DB02379
Beta-D-Glucose,,experimental,NUDT9,"ADP-ribose pyrophosphatase, mitochondrial",target,,DB02379
Beta-D-Glucose,,experimental,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,target,,DB02379
Beta-D-Glucose,,experimental,amyA,Cyclomaltodextrin glucanotransferase,target,,DB02379
Beta-D-Glucose,,experimental,entB,Enterotoxin type B,target,,DB02379
Beta-D-Glucose,,experimental,AMY1A,Alpha-amylase 1,target,,DB02379
Beta-D-Glucose,,experimental,malP,Maltodextrin phosphorylase,target,,DB02379
Beta-D-Glucose,,experimental,stxB,Shiga-like toxin 1 subunit B,target,,DB02379
Beta-D-Glucose,,experimental,NCAN,Neurocan core protein,target,,DB02379
Beta-D-Glucose,,experimental,,Beta-glucanase,target,,DB02379
Beta-D-Glucose,,experimental,gdhB,Quinoprotein glucose dehydrogenase B,target,,DB02379
Beta-D-Glucose,,experimental,,Alpha-amylase,target,,DB02379
Beta-D-Glucose,,experimental,amy,Alpha-amylase,target,,DB02379
Beta-D-Glucose,,experimental,celB,Cellulase B,target,,DB02379
Beta-D-Glucose,,experimental,cslB,Chondroitinase-B,target,,DB02379
Beta-D-Glucose,,experimental,aspA,Aspartate ammonia-lyase,target,,DB02379
Beta-D-Glucose,,experimental,cel5A,Endoglucanase 5A,target,,DB02379
Beta-D-Glucose,,experimental,LCTL,Lactase-like protein,target,,DB02379
Beta-D-Glucose,,experimental,ams,Amylosucrase,target,,DB02379
Beta-D-Glucose,,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB02379
Beta-D-Glucose,,experimental,moxC,Putative monooxygenase MoxC,target,,DB02379
Beta-D-Glucose,,experimental,Acel_0614,Endoglucanase E1,target,,DB02379
Beta-D-Glucose,,experimental,mglB,D-galactose-binding periplasmic protein,target,,DB02379
Beta-D-Glucose,,experimental,eco,Ecotin,target,,DB02379
Beta-D-Glucose,,experimental,mutY,A/G-specific adenine glycosylase,target,,DB02379
Beta-D-Glucose,,experimental,KRTAP5-2,Keratin-associated protein 5-2,target,,DB02379
Beta-D-Glucose,,experimental,SIGLEC1,Sialoadhesin,target,,DB02379
Beta-D-Glucose,,experimental,nplT,Neopullulanase,target,,DB02379
Beta-D-Glucose,,experimental,xynA,"Endo-1,4-beta-xylanase A",target,,DB02379
Beta-D-Glucose,,experimental,lamB,Maltoporin,target,,DB02379
Beta-D-Glucose,,experimental,,Hexokinase,target,,DB02379
Beta-D-Glucose,,experimental,tvaI,Neopullulanase 1,target,,DB02379
Beta-D-Glucose,,experimental,,"Endo-1,4-beta-xylanase",target,,DB02379
Beta-D-Glucose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB02379
Beta-D-Glucose,,experimental,lamB,Maltoporin,target,,DB02379
Beta-D-Glucose,,experimental,MB,Myoglobin,target,,DB02379
Beta-D-Glucose,,experimental,LGALS2,Galectin-2,target,,DB02379
Beta-D-Glucose,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB02379
Beta-D-Glucose,,experimental,HK1,Hexokinase-1,target,,DB02379
Beta-D-Glucose,,experimental,treZ,Malto-oligosyltrehalose trehalohydrolase,target,,DB02379
Beta-D-Glucose,,experimental,amyE,Alpha-amylase,target,,DB02379
Beta-D-Glucose,,experimental,ppgmk,Inorganic polyphosphate/ATP-glucomannokinase,target,,DB02379
Beta-D-Glucose,,experimental,cex,Exoglucanase/xylanase,target,,DB02379
Beta-D-Glucose,,experimental,budC,Diacetyl reductase [(S)-acetoin forming],target,,DB02379
Beta-D-Glucose,,experimental,cgt,Cyclomaltodextrin glucanotransferase,target,,DB02379
Beta-D-Glucose,,experimental,,Capsid protein VP1,target,,DB02379
Beta-D-Glucose,,experimental,celCCG,Endoglucanase G,target,,DB02379
Beta-D-Glucose,,experimental,,Hydrolase,target,,DB02379
Beta-D-Glucose,,experimental,LGALS7,Galectin-7,target,,DB02379
Beta-D-Glucose,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02379
Beta-D-Glucose,,experimental,KRTAP5-3,Keratin-associated protein 5-3,target,,DB02379
Beta-D-Glucose,,experimental,dmsA,Dimethyl sulfoxide/trimethylamine N-oxide reductase,target,,DB02379
Beta-D-Glucose,,experimental,celC307,Endoglucanase C307,target,,DB02379
Beta-D-Glucose,,experimental,AMY2B,Alpha-amylase 2B,target,,DB02379
Beta-D-Glucose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB02379
Beta-D-Glucose,,experimental,engF,"Endo-1,4-beta glucanase EngF",target,,DB02379
Beta-D-Glucose,,experimental,tvaII,Neopullulanase 2,target,,DB02379
Beta-D-Glucose,,experimental,celD,Endoglucanase E-4,target,,DB02379
Beta-D-Glucose,,experimental,botB,Botulinum neurotoxin type B,target,,DB02379
Beta-D-Glucose,,experimental,stxB2e,Orf protein,target,,DB02379
Beta-D-Glucose,,experimental,tetX,Tetanus toxin,target,,DB02379
Beta-D-Glucose,,experimental,xylA,Xylose isomerase,target,,DB02379
Beta-D-Glucose,,experimental,,"Glucan 1,4-alpha-maltohexaosidase",target,,DB02379
Beta-D-Glucose,,experimental,amyP,"Glucan 1,4-alpha-maltotetraohydrolase",target,,DB02379
Beta-D-Glucose,,experimental,celCCF,Endoglucanase F,target,,DB02379
Beta-D-Glucose,,experimental,gfo,Glucose--fructose oxidoreductase,target,,DB02379
Beta-D-Glucose,,experimental,9,Bifunctional tail protein,target,,DB02379
Beta-D-Glucose,,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB02379
Beta-D-Glucose,,experimental,SFTPD,Pulmonary surfactant-associated protein D,target,,DB02379
Beta-D-Glucose,,experimental,IFNB1,Interferon beta,target,,DB02379
Beta-D-Glucose,,experimental,malE,Maltose-binding periplasmic protein,target,,DB02379
Beta-D-Glucose,,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB02379
Beta-D-Glucose,,experimental,celA,Endoglucanase A,target,,DB02379
Namn,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02382
Namn,,experimental,nadC,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,,DB02382
Tolrestat,,withdrawn,AKR1B1,Aldose reductase,target,inhibitor,DB02383
Tolrestat,,withdrawn,AKR1A1,Alcohol dehydrogenase [NADP(+)],target,,DB02383
Tolrestat,,withdrawn,AKR1B10,Aldo-keto reductase family 1 member B10,target,,DB02383
Leucine Phosphonic Acid,Leucyl Aminopeptidase,experimental,LAP3,Cytosol aminopeptidase,target,,DB02386
Leucine Phosphonic Acid,Leucyl Aminopeptidase,experimental,,Bacterial leucyl aminopeptidase,target,,DB02386
"4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid",,experimental,,L-lactate dehydrogenase,target,,DB02401
"4-Hydroxy-1,2,5-Oxadiazole-3-Carboxylic Acid",,experimental,LDHB,L-lactate dehydrogenase B chain,target,,DB02401
"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",,experimental,DFR1,Dihydrofolate reductase,target,,DB02402
"5-(4-Methoxyphenoxy)-2,4-Quinazolinediamine",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB02402
6-O-Cyclohexylmethyl Guanine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02407
6-O-Cyclohexylmethyl Guanine,,experimental,CCNA2,Cyclin-A2,target,,DB02407
"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",,experimental,map,Methionine aminopeptidase,target,,DB02408
"(3s)-3-Amino-1-(Cyclopropylamino)Heptane-2,2-Diol",,experimental,map,Methionine aminopeptidase,target,,DB02408
N-Octyl-2-Hydroxyethyl Sulfoxide,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02415
N-Octyl-2-Hydroxyethyl Sulfoxide,,experimental,cirA,Colicin I receptor,target,,DB02415
N-Octyl-2-Hydroxyethyl Sulfoxide,,experimental,ompC,Outer membrane porin C,target,,DB02415
Geldanamycin,,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB02424
Geldanamycin,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB02424
"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",,experimental,,Dihydrofolate reductase,target,,DB02427
"2,4-Diamino-6-[N-(2',5'-Dimethoxybenzyl)-N-Methylamino]Quinazoline",,experimental,DHFR,Dihydrofolate reductase,target,,DB02427
Cytidine-5'-Triphosphate,,experimental,cca,CCA-adding enzyme,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,rfbF,Glucose-1-phosphate cytidylyltransferase,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,ispD,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,tagD,Glycerol-3-phosphate cytidylyltransferase,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,ispD,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,kpsU,3-deoxy-manno-octulosonate cytidylyltransferase,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,UCK2,Uridine-cytidine kinase 2,target,,DB02431
Cytidine-5'-Triphosphate,,experimental,coaBC,Coenzyme A biosynthesis bifunctional protein CoaBC,target,,DB02431
"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB02433
"{[(2,2-Dihydroxy-Ethyl)-(2,3,4,5-Tetrahydroxy-6-Phosphonooxy-Hexyl)-Amino]-Methyl}-Phosphonic Acid",,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB02433
Aminomethylcyclohexane,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB02435
Aminomethylcyclohexane,,experimental,PRSS1,Trypsin-1,target,,DB02435
(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,,experimental,iadA,Isoaspartyl dipeptidase,target,,DB02437
(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,,experimental,opd,Parathion hydrolase,target,,DB02437
(5r)-5-Amino-6-Hydroxyhexylcarbamic Acid,,experimental,folC,Bifunctional protein FolC,target,,DB02437
N-Octane,,experimental,clcA,H(+)/Cl(-) exchange transporter ClcA,target,,DB02440
N-Octane,,experimental,GLTP,Glycolipid transfer protein,target,,DB02440
N-Octane,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB02440
2-Deoxy-2-Amino Glucitol-6-Phosphate,,experimental,GNPDA1,Glucosamine-6-phosphate isomerase 1,target,,DB02445
2-Deoxy-2-Amino Glucitol-6-Phosphate,,experimental,nagB,Glucosamine-6-phosphate deaminase,target,,DB02445
2-Deoxy-2-Amino Glucitol-6-Phosphate,,experimental,glmS,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],target,,DB02445
N-Tridecanoic Acid,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB02448
N-Tridecanoic Acid,,experimental,PLA2G1B,Phospholipase A2,target,,DB02448
N-Tridecanoic Acid,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB02448
"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",,experimental,,Beta-lactamase IMP-1,target,,DB02450
"2-Benzo[1,3]Dioxol-5-Ylmethyl-3-Benzyl-Succinic Acid",,experimental,blaIMP-1,Beta-lactamase,target,,DB02450
Thymidine-5'-Triphosphate,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,rmlA2,Glucose-1-phosphate thymidylyltransferase 2,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,4,DNA primase/helicase,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,TK2,"Thymidine kinase 2, mitochondrial",target,,DB02452
Thymidine-5'-Triphosphate,,experimental,tdk,Thymidine kinase,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,nrdE,Ribonucleoside-diphosphate reductase 2 subunit alpha,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,TK1,"Thymidine kinase, cytosolic",target,,DB02452
Thymidine-5'-Triphosphate,,experimental,NRDD,Anaerobic ribonucleoside-triphosphate reductase,target,,DB02452
Thymidine-5'-Triphosphate,,experimental,tmk,Thymidylate kinase,target,,DB02452
"Glutathione S-(2,4 Dinitrobenzene)",,experimental,GSTM1,Glutathione S-transferase Mu 1,target,,DB02458
"Glutathione S-(2,4 Dinitrobenzene)",,experimental,GSTM2,Glutathione S-transferase Mu 2,target,,DB02458
Benzylamine,,experimental,PRSS2,Trypsin-2,target,,DB02464
Benzylamine,,experimental,PRSS1,Trypsin-1,target,,DB02464
S-Oxymethionine,,experimental,celA1,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",target,,DB02467
S-Oxymethionine,,experimental,RAB5A,Ras-related protein Rab-5A,target,,DB02467
S-Oxymethionine,,experimental,celB,Cellulase B,target,,DB02467
S-Oxymethionine,,experimental,mauC,Amicyanin,target,,DB02467
S-Oxymethionine,,experimental,,Aminopeptidase S,target,,DB02467
S-Oxymethionine,,experimental,thyA,Thymidylate synthase,target,,DB02467
Nojirimycine Tetrazole,,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB02471
Nojirimycine Tetrazole,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02471
Nojirimycine Tetrazole,,experimental,LCTL,Lactase-like protein,target,,DB02471
Phosphonothreonine,,experimental,RHO,Rhodopsin,target,,DB02482
Phosphonothreonine,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB02482
Phosphonothreonine,,experimental,PRKACB,cAMP-dependent protein kinase catalytic subunit beta,target,,DB02482
Phosphonothreonine,,experimental,CDK7,Cyclin-dependent kinase 7,target,,DB02482
Phosphonothreonine,,experimental,cobD,Threonine-phosphate decarboxylase,target,,DB02482
Phosphonothreonine,,experimental,S100A11,Protein S100-A11,target,,DB02482
Phosphonothreonine,,experimental,MAPK12,Mitogen-activated protein kinase 12,target,,DB02482
Phosphonothreonine,,experimental,PRKCQ,Protein kinase C theta type,target,,DB02482
Phosphonothreonine,,experimental,AURKA,Aurora kinase A,target,,DB02482
Phosphonothreonine,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB02482
Etheno-Nad,,experimental,LDHA,L-lactate dehydrogenase A chain,target,,DB02483
Etheno-Nad,,experimental,BST1,ADP-ribosyl cyclase 2,target,,DB02483
2-Hydroxyethyl Disulfide,,experimental,GSTA1,Glutathione S-transferase A1,target,,DB02486
2-Hydroxyethyl Disulfide,,experimental,E,Lysozyme,target,,DB02486
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,pdh,L-phenylalanine dehydrogenase,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL10L,60S ribosomal protein L10-like,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL13A,60S ribosomal protein L13a,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL23,60S ribosomal protein L23,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL15,60S ribosomal protein L15,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL19,60S ribosomal protein L19,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL23A,60S ribosomal protein L23a,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RSL24D1,Probable ribosome biogenesis protein RLP24,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL26L1,60S ribosomal protein L26-like 1,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL8,60S ribosomal protein L8,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL37,60S ribosomal protein L37,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL3,60S ribosomal protein L3,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,RPL11,60S ribosomal protein L11,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,NHP2L1,NHP2-like protein 1,target,,DB02494
Alpha-Hydroxy-Beta-Phenyl-Propionic Acid,,experimental,CPA1,Carboxypeptidase A1,target,,DB02494
1-Deoxy-D-Xylulose-5-Phosphate,,experimental,dxr,1-deoxy-D-xylulose 5-phosphate reductoisomerase,target,,DB02496
1-Deoxy-D-Xylulose-5-Phosphate,,experimental,pdxJ,Pyridoxine 5'-phosphate synthase,target,,DB02496
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,experimental,PPP1CA,Serine/threonine-protein phosphatase PP1-alpha catalytic subunit,target,,DB02506
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,experimental,PPP2R1A,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,target,,DB02506
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,experimental,PPP2CA,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,target,,DB02506
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,experimental,PPP2R5C,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,target,,DB02506
"2,6,8-Trimethyl-3-Amino-9-Benzyl-9-Methoxynonanoic Acid",,experimental,PPP2R2A,Serine/threonine-protein phosphatase 2A 55 kDa regulatory subunit B alpha isoform,target,,DB02506
Isopentyl Pyrophosphate,,experimental,ispA,Farnesyl diphosphate synthase,target,,DB02508
Isopentyl Pyrophosphate,,experimental,FDPS,Farnesyl pyrophosphate synthase,target,,DB02508
Isopentyl Pyrophosphate,,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB02508
Isopentyl Pyrophosphate,,experimental,ispA,Geranyltranstransferase (Farnesyldiphosphate synthase),target,,DB02508
"1,6-Fructose Diphosphate (Linear Form)",,experimental,ALDOA,Fructose-bisphosphate aldolase A,target,,DB02512
"1,6-Fructose Diphosphate (Linear Form)",,experimental,ALDOB,Fructose-bisphosphate aldolase B,target,,DB02512
3-Phosphoglycerol,,experimental,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",target,,DB02515
3-Phosphoglycerol,,experimental,ALDOB,Fructose-bisphosphate aldolase B,target,,DB02515
3-Phosphoglycerol,,experimental,pdxJ,Pyridoxine 5'-phosphate synthase,target,,DB02515
3-Phosphoglycerol,,experimental,TPI,Triosephosphate isomerase,target,,DB02515
Indirubin-5-Sulphonate,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02519
Indirubin-5-Sulphonate,,experimental,CRK2,Cell division control protein 2 homolog,target,,DB02519
"2,5,7-Trihydroxynaphthoquinone",,experimental,SCO1207,Putative cytochrome P450,target,,DB02521
"2,5,7-Trihydroxynaphthoquinone",,experimental,,Prenyltransferase,target,,DB02521
CRA_10655,,experimental,PRSS1,Trypsin-1,target,,DB02526
CRA_10655,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB02526
Cyclic Adenosine Monophosphate,,experimental,HCN2,Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,target,,DB02527
Cyclic Adenosine Monophosphate,,experimental,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,target,,DB02527
Cyclic Adenosine Monophosphate,,experimental,PRKAR2B,cAMP-dependent protein kinase type II-beta regulatory subunit,target,,DB02527
Cyclic Adenosine Monophosphate,,experimental,cyaB2,Adenylate cyclase,target,,DB02527
Cyclic Adenosine Monophosphate,,experimental,mll3241,Cyclic nucleotide-gated potassium channel mll3241,target,,DB02527
Cyclic Adenosine Monophosphate,,experimental,crp,cAMP-activated global transcriptional regulator CRP,target,,DB02527
"2,4,6-Triaminoquinazoline",,experimental,PTR1,Pteridine reductase 1,target,,DB02532
"2,4,6-Triaminoquinazoline",,experimental,DHRS4L1,Putative dehydrogenase/reductase SDR family member 4-like 2,target,,DB02532
Vorinostat,Antineoplastic AgentsHistone Deacetylase Inhibitors,approvedinvestigational,HDAC1,Histone deacetylase 1,target,inhibitor,DB02546
Vorinostat,Antineoplastic AgentsHistone Deacetylase Inhibitors,approvedinvestigational,HDAC2,Histone deacetylase 2,target,inhibitor,DB02546
Vorinostat,Antineoplastic AgentsHistone Deacetylase Inhibitors,approvedinvestigational,HDAC3,Histone deacetylase 3,target,inhibitor,DB02546
Vorinostat,Antineoplastic AgentsHistone Deacetylase Inhibitors,approvedinvestigational,HDAC6,Histone deacetylase 6,target,inhibitor,DB02546
Vorinostat,Antineoplastic AgentsHistone Deacetylase Inhibitors,approvedinvestigational,HDAC8,Histone deacetylase 8,target,,DB02546
Vorinostat,Antineoplastic AgentsHistone Deacetylase Inhibitors,approvedinvestigational,acuC1,Acetoin utilization protein,target,,DB02546
Geranyl Diphosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB02552
Geranyl Diphosphate,,experimental,ispDF,Bifunctional enzyme IspD/IspF,target,,DB02552
Geranyl Diphosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB02552
Geranyl Diphosphate,,experimental,FDPS,Farnesyl pyrophosphate synthase,target,,DB02552
Geranyl Diphosphate,,experimental,,Prenyltransferase,target,,DB02552
Geranyl Diphosphate,,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB02552
Geranyl Diphosphate,,experimental,Rv1086,"(2Z,6E)-farnesyl diphosphate synthase",target,,DB02552
Geranyl Diphosphate,,experimental,uppS,Decaprenyl diphosphate synthase,target,,DB02552
D-Phenylalanine,,experimental,CCBL1,Kynurenine--oxoglutarate transaminase 1,target,,DB02556
D-Phenylalanine,,experimental,CRH,Corticoliberin,target,,DB02556
"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB02559
"6-(Octahydro-1h-Indol-1-Ylmethyl)Decahydroquinazoline-2,4-Diamine",,experimental,,Dihydrofolate reductase,target,,DB02559
8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,,experimental,,Thiostrepton,target,,DB02566
8-Hydroxy-4-(1-Hydroxyethyl)Quinoline-2-Carboxylic Acid,,experimental,rplK,50S ribosomal protein L11,target,,DB02566
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,PFN2,Profilin-2,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,bpuJIR,Restriction endonuclease R.BpuJI,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,nir,Eight-heme nitrite reductase,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,SAV4671,Uncharacterized protein,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,GSU1007,"Sensor cyclic diguanylate phosphodiesterase, GAF and GAF domain-containing",target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,AFE_1514,Putative uncharacterized protein,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,gpmA,"2,3-bisphosphoglycerate-dependent phosphoglycerate mutase",target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,purA,Adenylosuccinate synthetase,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,SYNAS_17590,Hypothetical cytosolic protein,target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,RUMGNA_03254,"EDD domain protein, DegV family",target,,DB02580
1-(2-Methoxy-Ethoxy)-2-{2-[2-(2-Methoxy-Ethoxy]-Ethoxy}-Ethane,,experimental,VP2116,Uncharacterized protein,target,,DB02580
Forskolin,,experimental,ADCY2,Adenylate cyclase type 2,target,,DB02587
Forskolin,,experimental,GNAS,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,target,,DB02587
Forskolin,,experimental,ADCY5,Adenylate cyclase type 5,target,,DB02587
2'-Deoxycytidine,,experimental,aphA,Class B acid phosphatase,target,,DB02594
2'-Deoxycytidine,,experimental,TK2,"Thymidine kinase 2, mitochondrial",target,,DB02594
2'-Deoxycytidine,,experimental,DCK,Deoxycytidine kinase,target,,DB02594
Bulgecin A,,experimental,slt,Soluble lytic murein transglycosylase,target,,DB02595
Bulgecin A,,experimental,mltB,Membrane-bound lytic murein transglycosylase B,target,,DB02595
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,panC,Pantothenate synthetase,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,nadE,NH(3)-dependent NAD(+) synthetase,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,NMNAT3,Nicotinamide mononucleotide adenylyltransferase 3,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,cyaC,Adenylate cyclase,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,,NTPase P4,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,lipJ,Probable lignin peroxidase LipJ,target,,DB02596
"Alpha,Beta-Methyleneadenosine-5'-Triphosphate",,experimental,carA,Carbapenam-3-carboxylate synthase,target,,DB02596
"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",,experimental,nprS,Thermolysin,target,,DB02597
"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",,experimental,MME,Neprilysin,target,,DB02597
"[2(R,S)-2-Sulfanylheptanoyl]-Phe-Ala",,experimental,npr,Thermolysin,target,,DB02597
"Decylamine-N,N-Dimethyl-N-Oxide",,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02613
"Decylamine-N,N-Dimethyl-N-Oxide",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB02613
"Decylamine-N,N-Dimethyl-N-Oxide",,experimental,lytA,Autolysin,target,,DB02613
"Decylamine-N,N-Dimethyl-N-Oxide",,experimental,PNLIPRP2,Pancreatic lipase-related protein 2,target,,DB02613
1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,,experimental,bla,Beta-lactamase TEM,target,,DB02614
1(R)-1-Acetamido-2-(3-Carboxyphenyl)Ethyl Boronic Acid,,experimental,bla,Beta-lactamase TEM,target,,DB02614
Compound 19,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02615
Compound 19,,experimental,ESR1,Estrogen receptor,target,,DB02615
Latrunculin A,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,inhibitor,DB02621
Latrunculin A,,experimental,GSN,Gelsolin,target,,DB02621
Latrunculin A,,experimental,,Iota toxin component Ia,target,,DB02621
1-O-[P-Nitrophenyl]-Beta-D-Galactopyranose,Photoaffinity Labels,experimental,lacA,Galactoside O-acetyltransferase,target,,DB02632
1-O-[P-Nitrophenyl]-Beta-D-Galactopyranose,Photoaffinity Labels,experimental,lacZ,Beta-galactosidase,target,,DB02632
Cibacron Blue,,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB02633
Cibacron Blue,,experimental,GSTP1,Glutathione S-transferase P,target,,DB02633
Oxaloacetate Ion,,experimental,CS,"Citrate synthase, mitochondrial",target,,DB02637
Oxaloacetate Ion,,experimental,mdh,Malate dehydrogenase,target,,DB02637
Oxaloacetate Ion,,experimental,SPR,Sepiapterin reductase,target,,DB02637
Oxaloacetate Ion,,experimental,,Methylmalonyl-CoA carboxyltransferase 5S subunit,target,,DB02637
Oxaloacetate Ion,,experimental,DR_1240,Citrate lyase subunit beta-like protein,target,,DB02637
Terlipressin,Vasoconstrictor AgentsAntihypertensive Agents,approvedinvestigational,AVPR2,Vasopressin V2 receptor,target,agonist,DB02638
Terlipressin,Vasoconstrictor AgentsAntihypertensive Agents,approvedinvestigational,AVPR1B,Vasopressin V1b receptor,target,,DB02638
Terlipressin,Vasoconstrictor AgentsAntihypertensive Agents,approvedinvestigational,AVPR1A,Vasopressin V1a receptor,target,stimulator,DB02638
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,,experimental,bla,Beta-lactamase TEM,target,,DB02642
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,,experimental,bla,Beta-lactamase TEM,target,,DB02642
[[N-(Benzyloxycarbonyl)Amino]Methyl]Phosphate,,experimental,blaZ,Beta-lactamase,target,,DB02642
"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",,experimental,PIII,Penton protein,target,,DB02643
"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",,experimental,IGF1,Insulin-like growth factor I,target,,DB02643
"N-Dodecyl-N,N-Dimethyl-3-Ammonio-1-Propanesulfonate",,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB02643
N-Omega-Propyl-L-Arginine,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02644
N-Omega-Propyl-L-Arginine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02644
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,,experimental,CRAT,Carnitine O-acetyltransferase,target,,DB02648
(3-Carboxy-2-(R)-Hydroxy-Propyl)-Trimethyl-Ammonium,,experimental,CROT,Peroxisomal carnitine O-octanoyltransferase,target,,DB02648
D-Aspartic Acid,,experimental,nprS,Thermolysin,target,,DB02655
D-Aspartic Acid,,experimental,ansB,L-asparaginase,target,,DB02655
2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB02656
2-(4-Morpholinyl)-8-Phenyl-4h-1-Benzopyran-4-One,,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB02656
Glucosamine 6-Phosphate,,experimental,glmS,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],target,,DB02657
Glucosamine 6-Phosphate,,experimental,nagA,N-acetylglucosamine-6-phosphate deacetylase,target,,DB02657
Cholic Acid,,experimental,FECH,"Ferrochelatase, mitochondrial",target,,DB02659
Cholic Acid,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02659
Cholic Acid,,experimental,ESRRG,Estrogen-related receptor gamma,target,,DB02659
Cholic Acid,,experimental,FABP6,Gastrotropin,target,,DB02659
Cholic Acid,,experimental,COX4I1,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",target,,DB02659
Cholic Acid,,experimental,MT-CO1,Cytochrome c oxidase subunit 1,target,,DB02659
Cholic Acid,,experimental,MT-CO2,Cytochrome c oxidase subunit 2,target,,DB02659
Cholic Acid,,experimental,MT-CO3,Cytochrome c oxidase subunit 3,target,,DB02659
Cholic Acid,,experimental,COX5A,"Cytochrome c oxidase subunit 5A, mitochondrial",target,,DB02659
Cholic Acid,,experimental,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",target,,DB02659
Cholic Acid,,experimental,COX6C,Cytochrome c oxidase subunit 6C,target,,DB02659
Cholic Acid,,experimental,COX7B,"Cytochrome c oxidase subunit 7B, mitochondrial",target,,DB02659
Cholic Acid,,experimental,COX7C,"Cytochrome c oxidase subunit 7C, mitochondrial",target,,DB02659
Cholic Acid,,experimental,COX8A,"Cytochrome c oxidase subunit 8A, mitochondrial",target,,DB02659
Cholic Acid,,experimental,COX6A2,"Cytochrome c oxidase subunit 6A2, mitochondrial",target,,DB02659
Cholic Acid,,experimental,COX6B1,Cytochrome c oxidase subunit 6B1,target,,DB02659
Cholic Acid,,experimental,COX7A1,"Cytochrome c oxidase subunit 7A1, mitochondrial",target,,DB02659
Cholic Acid,,experimental,PLA2G1B,Phospholipase A2,target,,DB02659
Cholic Acid,,experimental,CES1,Liver carboxylesterase 1,target,,DB02659
Cholic Acid,,experimental,DKFZp686P18130,Ferrochelatase,target,,DB02659
Cholic Acid,,experimental,cbh,Choloylglycine hydrolase,target,,DB02659
RB106,,experimental,nprS,Thermolysin,target,,DB02669
RB106,,experimental,npr,Thermolysin,target,,DB02669
4-Deoxy-Alpha-D-Glucose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB02670
4-Deoxy-Alpha-D-Glucose,,experimental,SMARCA5,SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A member 5,target,,DB02670
1-Methylimidazole,,experimental,MB,Myoglobin,target,,DB02671
1-Methylimidazole,,experimental,fixL,Sensor protein FixL,target,,DB02671
Meta Vanadate,,experimental,CKS1B,Cyclin-dependent kinases regulatory subunit 1,target,,DB02681
Meta Vanadate,,experimental,udp,Uridine phosphorylase,target,,DB02681
"(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin",,experimental,PAH,Phenylalanine-4-hydroxylase,target,,DB02692
"(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02692
"(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin",,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02692
"(6r,1'r,2's)-5,6,7,8 Tetrahydrobiopterin",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02692
Hydroxyaminovaline,,experimental,MMP13,Collagenase 3,target,,DB02697
Hydroxyaminovaline,,experimental,MMP3,Stromelysin-1,target,,DB02697
Nicotinamide,,experimental,eta,Exotoxin A,target,,DB02701
Nicotinamide,,experimental,LDHA,L-lactate dehydrogenase A chain,target,,DB02701
Nicotinamide,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,binder,DB02701
Nicotinamide,,experimental,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",target,,DB02701
Nicotinamide,,experimental,BST1,ADP-ribosyl cyclase 2,target,,DB02701
Fusidic Acid,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,fusA,Elongation factor G,target,inhibitor,DB02703
Fusidic Acid,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,cat,Chloramphenicol acetyltransferase,target,inhibitor,DB02703
Fusidic Acid,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,cat3,Chloramphenicol acetyltransferase 3,target,inhibitor,DB02703
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB02709
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,CSNK2A1,Casein kinase II subunit alpha,target,,DB02709
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB02709
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB02709
5-Formyl-6-Hydrofolic Acid,,experimental,glyA,Serine hydroxymethyltransferase,target,,DB02718
5-Formyl-6-Hydrofolic Acid,,experimental,folA,Dihydrofolate reductase,target,,DB02718
4-Iodopyrazole,,experimental,cyp121,Mycocyclosin synthase,target,,DB02721
4-Iodopyrazole,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02721
4-Iodopyrazole,,experimental,ADH1B,Alcohol dehydrogenase 1B,target,,DB02721
4-Iodopyrazole,,experimental,ADH1A,Alcohol dehydrogenase 1A,target,,DB02721
Delta-2-Albomycin A1,,experimental,fhuD,Iron(3+)-hydroxamate-binding protein FhuD,target,,DB02724
Delta-2-Albomycin A1,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02724
2-Phosphoglycolic Acid,,experimental,nagB,Glucosamine-6-phosphate deaminase 1,target,,DB02726
2-Phosphoglycolic Acid,,experimental,pfkA,6-phosphofructokinase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,TPI1,Triosephosphate isomerase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,PKM2,Pyruvate kinase PKM,target,,DB02726
2-Phosphoglycolic Acid,,experimental,tpiA,Triosephosphate isomerase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,mgsA,Methylglyoxal synthase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,ENO2,Gamma-enolase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,tpiA,Triosephosphate isomerase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,aroG,"Phospho-2-dehydro-3-deoxyheptonate aldolase, Phe-sensitive",target,,DB02726
2-Phosphoglycolic Acid,,experimental,PKLR,Pyruvate kinase PKLR,target,,DB02726
2-Phosphoglycolic Acid,,experimental,TPI,Triosephosphate isomerase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,yniC,2-deoxyglucose-6-phosphate phosphatase,target,,DB02726
2-Phosphoglycolic Acid,,experimental,ENO3,Beta-enolase,target,,DB02726
Thimerosal,"Preservatives, PharmaceuticalAntiseptic Agents",experimental,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",target,,DB02731
Thimerosal,"Preservatives, PharmaceuticalAntiseptic Agents",experimental,TM_1359,Multi-sensor signal transduction histidine kinase,target,,DB02731
Purvalanol,,experimental,CRK2,Cell division control protein 2 homolog,target,,DB02733
Purvalanol,,experimental,CDK4,Cyclin-dependent kinase 4,target,,DB02733
Purvalanol,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,inhibitor,DB02733
Purvalanol,,experimental,MAPK3,Mitogen-activated protein kinase 3,target,inhibitor,DB02733
Purvalanol,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02733
Purvalanol,,experimental,SRPK2,SRSF protein kinase 2,target,,DB02733
4-Deoxy-D-Mannuronic Acid,,experimental,algQ1,AlgQ1,target,,DB02734
4-Deoxy-D-Mannuronic Acid,,experimental,algQ2,AlgQ2,target,,DB02734
3-Indolebutyric Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB02740
3-Indolebutyric Acid,,experimental,B2M,Beta-2-microglobulin,target,,DB02740
3-Indolebutyric Acid,,experimental,TRAC,T-cell receptor alpha chain C region,target,,DB02740
3-Indolebutyric Acid,,experimental,TRBC1,T-cell receptor beta-1 chain C region,target,,DB02740
3-Indolebutyric Acid,,experimental,HLA-A,"HLA class I histocompatibility antigen, A-2 alpha chain",target,,DB02740
Kifunensine,,experimental,MSDC,"Mannosyl-oligosaccharide alpha-1,2-mannosidase",target,,DB02742
Kifunensine,,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB02742
Kifunensine,,experimental,MAN1B1,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",target,,DB02742
Uridine,,experimental,LSM6,U6 snRNA-associated Sm-like protein LSm6,target,,DB02745
Uridine,,experimental,tsx,Nucleoside-specific channel-forming protein tsx,target,,DB02745
"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB02754
"9-Butyl-8-(3,4,5-Trimethoxybenzyl)-9h-Purin-6-Amine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB02754
Indolylpropionic Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB02758
Indolylpropionic Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB02758
Indolylpropionic Acid,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB02758
S-Mercaptocysteine,,experimental,MST,3-mercaptopyruvate sulfurtransferase,target,,DB02761
S-Mercaptocysteine,,experimental,c-des,L-cysteine/cystine lyase C-DES,target,,DB02761
S-Mercaptocysteine,,experimental,sseA,3-mercaptopyruvate sulfurtransferase,target,,DB02761
S-Mercaptocysteine,,experimental,hcp,Hydroxylamine reductase,target,,DB02761
S-Mercaptocysteine,,experimental,TST,Thiosulfate sulfurtransferase,target,,DB02761
S-Mercaptocysteine,,experimental,TTHA1028,Sulfurtransferase,target,,DB02761
S-Mercaptocysteine,,experimental,glpE,Thiosulfate sulfurtransferase GlpE,target,,DB02761
S-Mercaptocysteine,,experimental,hcp,Hydroxylamine reductase,target,,DB02761
S-Mercaptocysteine,,experimental,sufS,Cysteine desulfurase,target,,DB02761
5-Mercapto-2-Nitro-Benzoic Acid,,experimental,arsC,Protein ArsC,target,,DB02763
5-Mercapto-2-Nitro-Benzoic Acid,,experimental,IL12B,Interleukin-12 subunit beta,target,,DB02763
Hexane,Adhesives,experimental,,"Triosephosphate isomerase, glycosomal",target,,DB02764
Hexane,Adhesives,experimental,GLTP,Glycolipid transfer protein,target,,DB02764
Hexane,Adhesives,experimental,PRSS1,Trypsin-1,target,,DB02764
3-Hydroxy-Myristic Acid,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02767
3-Hydroxy-Myristic Acid,,experimental,tonB,Protein TonB,target,,DB02767
3-Hydroxy-Myristic Acid,,experimental,LY96,Lymphocyte antigen 96,target,,DB02767
3-Hydroxy-Myristic Acid,,experimental,TLR4,Toll-like receptor 4,target,,DB02767
Sucrose,,experimental,bgl3,Beta-glucosidase,target,,DB02772
Sucrose,,experimental,ams,Amylosucrase,target,,DB02772
Sucrose,,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB02772
Sucrose,,experimental,blaCTX-M-14,Beta-lactamase CTX-M,target,,DB02772
Sucrose,,experimental,hmuO,Heme oxygenase,target,,DB02772
Sucrose,,experimental,ATOX1,Copper transport protein ATOX1,target,,DB02772
Sucrose,,experimental,C22orf28,tRNA-splicing ligase RtcB homolog,target,,DB02772
Sucrose,,experimental,,Orange carotenoid-binding protein,target,,DB02772
Sucrose,,experimental,scrY,Sucrose porin,target,,DB02772
Sucrose,,experimental,sacB,Levansucrase,target,,DB02772
Sucrose,,experimental,blaCTX-M-27,Beta-lactamase CTX-M-27,target,,DB02772
Sucrose,,experimental,algD,GDP-mannose 6-dehydrogenase,target,,DB02772
Sucrose,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB02772
Sucrose,,experimental,ampC,Beta-lactamase,target,,DB02772
Sucrose,,experimental,nos,Nitric oxide synthase oxygenase,target,,DB02772
Sucrose,,experimental,LYZ,Lysozyme C,target,,DB02772
Sucrose,,experimental,maf,Septum formation protein Maf,target,,DB02772
"1,3-Propandiol",,experimental,ARF1,ADP-ribosylation factor 1,target,,DB02774
"1,3-Propandiol",,experimental,linB,Haloalkane dehalogenase,target,,DB02774
1-Hexadecanosulfonic Acid,,experimental,,Hydrolase,target,,DB02776
1-Hexadecanosulfonic Acid,,experimental,LIP1,Lipase 1,target,,DB02776
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,,experimental,GOT2,"Aspartate aminotransferase, mitochondrial",target,,DB02783
4'-Deoxy-4'-Acetylyamino-Pyridoxal-5'-Phosphate,,experimental,gabT,4-aminobutyrate aminotransferase GabT,target,,DB02783
P-Anisic Acid,,experimental,PLA2G1B,Phospholipase A2,target,,DB02795
P-Anisic Acid,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB02795
5-Hydroxymethylene-6-Hydrofolic Acid,,experimental,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,,DB02800
5-Hydroxymethylene-6-Hydrofolic Acid,,experimental,MPN_348,Probable 5-formyltetrahydrofolate cyclo-ligase,target,,DB02800
"2,3 -Anhydro-Quinic Acid",,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB02801
"2,3 -Anhydro-Quinic Acid",,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB02801
Diethylphosphono Group,,experimental,BCHE,Cholinesterase,target,,DB02811
Diethylphosphono Group,,experimental,fbpC,Diacylglycerol acyltransferase/mycolyltransferase Ag85C,target,,DB02811
"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",,experimental,chiB,Chitinase B,target,,DB02813
"2-Acetamido-2-Deoxy-D-Glucono-1,5-Lactone",,experimental,HEXB,Beta-hexosaminidase subunit beta,target,,DB02813
N-Pyridoxyl-Glycine-5-Monophosphate,,experimental,TM_1744,L-allo-threonine aldolase,target,,DB02824
N-Pyridoxyl-Glycine-5-Monophosphate,,experimental,glyA,Serine hydroxymethyltransferase,target,,DB02824
N-Pyridoxyl-Glycine-5-Monophosphate,,experimental,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,,DB02824
N-Pyridoxyl-Glycine-5-Monophosphate,,experimental,ODC1,Ornithine decarboxylase,target,,DB02824
Dihydrogenphosphate Ion,,experimental,pstS,Phosphate-binding protein PstS,target,,DB02831
Dihydrogenphosphate Ion,,experimental,DCXR,L-xylulose reductase,target,,DB02831
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02833
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(3-Nitro-Phenyl)-Amine,,experimental,CCNA2,Cyclin-A2,target,,DB02833
"Alpha-D-Glucose 1,6-Bisphosphate",,experimental,pgmB,Beta-phosphoglucomutase,target,,DB02835
"Alpha-D-Glucose 1,6-Bisphosphate",,experimental,PGM1,Phosphoglucomutase-1,target,,DB02835
Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB02836
Guanosine 5'-Diphosphate 2':3'-Cyclic Monophosphate,,experimental,relA,Bifunctional (p)ppGpp synthase/hydrolase RelA,target,,DB02836
"2,4-Dihydroxybenzoic Acid",,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB02839
"2,4-Dihydroxybenzoic Acid",,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB02839
[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB02841
[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,,experimental,bla,Beta-lactamase TEM,target,,DB02841
[(2-Ethoxy-1-Naphthoyl)Amino]Methylboronic Acid,,experimental,bla,Beta-lactamase TEM,target,,DB02841
Alpha-D-Glucose-1-Phosphate,,experimental,algC,Phosphomannomutase/phosphoglucomutase,target,,DB02843
Alpha-D-Glucose-1-Phosphate,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02843
Alpha-D-Glucose-1-Phosphate,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB02843
Alpha-D-Glucose-1-Phosphate,,experimental,malP,Maltodextrin phosphorylase,target,,DB02843
Alpha-D-Glucose-1-Phosphate,,experimental,agp,Glucose-1-phosphatase,target,,DB02843
Methylphosphinic Acid,,experimental,estA,Esterase,target,,DB02845
Methylphosphinic Acid,,experimental,BCHE,Cholinesterase,target,,DB02845
Methylphosphinic Acid,,experimental,ACHE,Acetylcholinesterase,target,,DB02845
Aetiocholanolone,,experimental,SULT2A1,Bile salt sulfotransferase,target,,DB02854
Aetiocholanolone,,experimental,HSD17B11,Estradiol 17-beta-dehydrogenase 11,target,,DB02854
Aetiocholanolone,,experimental,fabG3,3-alpha-(or 20-beta)-hydroxysteroid dehydrogenase,target,,DB02854
Aetiocholanolone,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB02854
Guanosine,,experimental,43,DNA polymerase,target,,DB02857
Guanosine,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02857
Guanosine,,experimental,TTHA1435,Purine nucleoside phosphorylase,target,,DB02857
3-Amino-5-Phenylpentane,,experimental,CTSL2,Cathepsin L2,target,,DB02869
3-Amino-5-Phenylpentane,,experimental,CTSK,Cathepsin K,target,,DB02869
6-Hydroxyuridine-5'-Phosphate,,experimental,UMPS,Uridine 5'-monophosphate synthase,target,,DB02890
6-Hydroxyuridine-5'-Phosphate,,experimental,pyrF,Orotidine 5'-phosphate decarboxylase,target,,DB02890
D-Methionine,,experimental,METAP2,Methionine aminopeptidase 2,target,,DB02893
D-Methionine,,experimental,VC_1968,"Transcriptional regulator, HTH_3 family",target,,DB02893
Acetylphosphate,,experimental,fcl,GDP-L-fucose synthase,target,,DB02897
Acetylphosphate,,experimental,pta,Phosphate acetyltransferase,target,,DB02897
N-Carboxymethionine,,experimental,thyA,Thymidylate synthase,target,,DB02899
N-Carboxymethionine,,experimental,ureC,Urease subunit alpha,target,,DB02899
N-Carboxymethionine,,experimental,ureB,Urease subunit beta,target,,DB02899
N-Carboxymethionine,,experimental,ureA,Urease subunit gamma,target,,DB02899
N-Carboxymethionine,,experimental,,Light-harvesting protein B-800/850 alpha chain,target,,DB02899
N-Carboxymethionine,,experimental,,Light-harvesting protein B-800/850 beta chain,target,,DB02899
N-Carboxymethionine,,experimental,TTHA1387,Probable rRNA methylase,target,,DB02899
Alpha-D-Mannose-6-Phosphate,,experimental,algC,Phosphomannomutase/phosphoglucomutase,target,,DB02900
Alpha-D-Mannose-6-Phosphate,,experimental,IGF2R,Cation-independent mannose-6-phosphate receptor,target,,DB02900
Alpha-D-Mannose-6-Phosphate,,experimental,M6PR,Cation-dependent mannose-6-phosphate receptor,target,,DB02900
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB02901
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,AR,Androgen receptor,target,,DB02901
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,,experimental,map,Methionine aminopeptidase,target,,DB02909
5-(2-Chlorophenyl)Furan-2-Carboxylic Acid,,experimental,map,Methionine aminopeptidase 2,target,,DB02909
Octanoyl-Coenzyme A,,experimental,ECHS1,"Enoyl-CoA hydratase, mitochondrial",target,,DB02910
Octanoyl-Coenzyme A,,experimental,DCI,"Enoyl-CoA delta isomerase 1, mitochondrial",target,,DB02910
Octanoyl-Coenzyme A,,experimental,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB02910
"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02915
"4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-(4-Trifluoromethyl-Phenyl)-Amine",,experimental,CCNA2,Cyclin-A2,target,,DB02915
"Biphenyl-2,3-Diol",,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB02923
"Biphenyl-2,3-Diol",,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB02923
"Biphenyl-2,3-Diol",,experimental,doxG,"1,2-dihydroxynaphthalene dioxygenase",target,,DB02923
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,,Chloramphenicol 3-O phosphotransferase,target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,purT,Phosphoribosylglycinamide formyltransferase 2,target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,cag-alfa,Cag alpha,target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,PMS2,Mismatch repair endonuclease PMS2,target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,dnaX,DNA polymerase III subunit tau,target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,pknB,Serine/threonine-protein kinase PknB,target,,DB02930
Phosphothiophosphoric Acid-Adenylate Ester,,experimental,recQ,ATP-dependent DNA helicase RecQ,target,,DB02930
5'-Deoxy-5'-(Methylthio)-Tubercidin,,experimental,MTAP,S-methyl-5'-thioadenosine phosphorylase,target,,DB02933
5'-Deoxy-5'-(Methylthio)-Tubercidin,,experimental,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB02933
"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",,experimental,nadE,NH(3)-dependent NAD(+) synthetase,target,,DB02937
"Gamma-Arsono-Beta, Gamma-Methyleneadenosine-5'-Diphosphate",,experimental,glpK,Glycerol kinase,target,,DB02937
"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",,experimental,,Thiostrepton,target,,DB02940
"(4s)-2-[(1e)-1-Aminoprop-1-Enyl]-4,5-Dihydro-1,3-Thiazole-4-Carboxylic Acid",,experimental,rplK,50S ribosomal protein L11,target,,DB02940
Hymenialdisine,,experimental,CDK5,Cyclin-dependent kinase 5,target,inhibitor,DB02950
Hymenialdisine,,experimental,CDK1,Cyclin-dependent kinase 1,target,,DB02950
Hymenialdisine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,inhibitor,DB02950
3-Hydroxypyruvic Acid,,experimental,TPI,Triosephosphate isomerase,target,,DB02951
3-Hydroxypyruvic Acid,,experimental,nanA,N-acetylneuraminate lyase,target,,DB02951
Alpha-Aminoisobutyric Acid,,experimental,CRH,Corticoliberin,target,,DB02952
Alpha-Aminoisobutyric Acid,,experimental,NPY,Pro-neuropeptide Y,target,,DB02952
(Carboxyhydroxyamino)Ethanoic Acid,,experimental,purA,Adenylosuccinate synthetase,target,,DB02954
(Carboxyhydroxyamino)Ethanoic Acid,,experimental,purA,Adenylosuccinate synthetase,target,,DB02954
Penicillin G Acyl-Serine,,experimental,blaR1,Regulatory protein BlaR1,target,,DB02968
Penicillin G Acyl-Serine,,experimental,pbp,Beta-lactam-inducible penicillin-binding protein,target,,DB02968
Uridine-5'-Monophosphate 2-Deoxy-2-Fluoro-Galactopyranosyl-Monophosphate Ester,,experimental,lgtC,Glycosyl transferase,target,,DB02976
Uridine-5'-Monophosphate 2-Deoxy-2-Fluoro-Galactopyranosyl-Monophosphate Ester,,experimental,lgtC,LgtC,target,,DB02976
Para-Mercury-Benzenesulfonic Acid,,experimental,CLC,Galectin-10,target,,DB02983
Para-Mercury-Benzenesulfonic Acid,,experimental,ESR2,Estrogen receptor beta,target,,DB02983
Cysteine-S-Acetamide,,experimental,OAS1,2'-5'-oligoadenylate synthase 1,target,,DB02987
Cysteine-S-Acetamide,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB02987
Hydroxydimethylarsine Oxide,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02994
Hydroxydimethylarsine Oxide,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02994
Hydroxydimethylarsine Oxide,,experimental,AKR1B1,Aldose reductase,target,,DB02994
Hydroxydimethylarsine Oxide,,experimental,GNAT1,Guanine nucleotide-binding protein G(t) subunit alpha-1,target,,DB02994
Methyltrienolone,,experimental,PGR,Progesterone receptor,target,,DB02998
Methyltrienolone,,experimental,AR,Androgen receptor,target,,DB02998
Methyltrienolone,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB02998
Quisqualate,Excitatory Amino Acid Agonists,experimental,GRIA2,Glutamate receptor 2,target,,DB02999
Quisqualate,Excitatory Amino Acid Agonists,experimental,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,,DB02999
Glutathione Sulfonic Acid,,experimental,gst,Glutathione S-transferase GstA,target,,DB03003
Glutathione Sulfonic Acid,,experimental,GSTM4,Glutathione S-transferase Mu 4,target,,DB03003
Glutathione Sulfonic Acid,,experimental,GSTA1,Glutathione S-transferase A1,target,,DB03003
Glutathione Sulfonic Acid,,experimental,GSTP1,Glutathione S-transferase P,target,,DB03003
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBA3C,Tubulin alpha-3C/D chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBB,Tubulin beta chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBB1,Tubulin beta-1 chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBB2C,Tubulin beta-4B chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBB4,Tubulin beta-4A chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBA4A,Tubulin alpha-4A chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBB3,Tubulin beta-3 chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBA1C,Tubulin alpha-1C chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBA8,Tubulin alpha-8 chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBA1B,Tubulin alpha-1B chain,target,,DB03010
Epothilone B,Antineoplastic AgentsTubulin Modulators,experimentalinvestigational,TUBA1A,Tubulin alpha-1A chain,target,,DB03010
Di(N-Acetyl-D-Glucosamine),,experimental,chb,Chitobiase,target,,DB03013
Di(N-Acetyl-D-Glucosamine),,experimental,LYZ,Lysozyme C,target,,DB03013
Di(N-Acetyl-D-Glucosamine),,experimental,B4GALT1,"Beta-1,4-galactosyltransferase 1",target,,DB03013
"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB03023
"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,experimental,LYN,Tyrosine-protein kinase Lyn,target,,DB03023
"1-Tert-Butyl-3-(4-Chloro-Phenyl)-1h-Pyrazolo[3,4-D]Pyrimidin-4-Ylamine",,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03023
Phosphoglycolohydroxamic Acid,,experimental,TPI1,Triosephosphate isomerase,target,,DB03026
Phosphoglycolohydroxamic Acid,,experimental,mgsA,Methylglyoxal synthase,target,,DB03026
Phosphoglycolohydroxamic Acid,,experimental,rhaD,Rhamnulose-1-phosphate aldolase,target,,DB03026
Phosphoglycolohydroxamic Acid,,experimental,fucA,L-fuculose phosphate aldolase,target,,DB03026
Phosphoglycolohydroxamic Acid,,experimental,kbaY,"D-tagatose-1,6-bisphosphate aldolase subunit KbaY",target,,DB03026
Phosphoglycolohydroxamic Acid,,experimental,fbaA,Fructose-bisphosphate aldolase class 2,target,,DB03026
1-Methyloxy-4-Sulfone-Benzene,,experimental,MMP13,Collagenase 3,target,,DB03033
1-Methyloxy-4-Sulfone-Benzene,,experimental,MMP3,Stromelysin-1,target,,DB03033
Udp-Glucuronic Acid,,experimental,hasB,UDP-glucose 6-dehydrogenase,target,,DB03041
Udp-Glucuronic Acid,,experimental,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,target,,DB03041
5-Phosphoarabinonic Acid,,experimental,pgiB,Glucose-6-phosphate isomerase B,target,,DB03042
5-Phosphoarabinonic Acid,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB03042
Tetrahydrofuran-2-Carboxylic Acid,,experimental,qheDH,Quinohemoprotein ethanol dehydrogenase type-1,target,,DB03051
Tetrahydrofuran-2-Carboxylic Acid,,experimental,putA,Bifunctional protein PutA,target,,DB03051
Acetoacetyl-Coenzyme A,,experimental,menB,"1,4-Dihydroxy-2-naphthoyl-CoA synthase",target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,,"Acyl-CoA dehydrogenase, short-chain specific",target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,mvaS,HMG-CoA synthase,target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,mvaS,3-hydroxy-3-methylglutaryl CoA synthase,target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,ACADS,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB03059
Acetoacetyl-Coenzyme A,,experimental,ECHS1,"Enoyl-CoA hydratase, mitochondrial",target,,DB03059
(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,Dietary SupplementsMicronutrientsSupplements,experimental,NMT1,Glycylpeptide N-tetradecanoyltransferase,target,,DB03062
(1-Methyl-1h-Imidazol-2-Yl)-(3-Methyl-4-{3-[(Pyridin-3-Ylmethyl)-Amino]-Propoxy}-Benzofuran-2-Yl)-Methanone,Dietary SupplementsMicronutrientsSupplements,experimental,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,target,,DB03062
"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB03077
"3-Amino-4-{3-[2-(2-Propoxy-Ethoxy)-Ethoxy]-Propylamino}-Cyclobut-3-Ene-1,2-Dione",,experimental,ctxB,Cholera enterotoxin B subunit,target,,DB03077
Hydroxyacetic Acid,Keratolytic Agents,experimental,G6PD,Glucose-6-phosphate 1-dehydrogenase,target,,DB03085
Hydroxyacetic Acid,Keratolytic Agents,experimental,thiO,Glycine oxidase,target,,DB03085
Pyroglutamic Acid,,experimental,VEGFA,Vascular endothelial growth factor A,target,,DB03088
Pyroglutamic Acid,,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB03088
Pyroglutamic Acid,,experimental,IGLC1,Ig lambda-1 chain C regions,target,,DB03088
Pyroglutamic Acid,,experimental,,Ig lambda chain V-II region MGC,target,,DB03088
Pyroglutamic Acid,,experimental,TFF2,Trefoil factor 2,target,,DB03088
Pyroglutamic Acid,,experimental,cycA,Cytochrome c2,target,,DB03088
Pyroglutamic Acid,,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB03088
Pyroglutamic Acid,,experimental,,"Endo-1,4-beta-xylanase",target,,DB03088
Pyroglutamic Acid,,experimental,nir,Dissimilatory copper-containing nitrite reductase,target,,DB03088
Pyroglutamic Acid,,experimental,KRTAP5-2,Keratin-associated protein 5-2,target,,DB03088
Pyroglutamic Acid,,experimental,HCRT,Orexin,target,,DB03088
Pyroglutamic Acid,,experimental,CCL8,C-C motif chemokine 8,target,,DB03088
Pyroglutamic Acid,,experimental,,Cytochrome c',target,,DB03088
Pyroglutamic Acid,,experimental,AMY2B,Alpha-amylase 2B,target,,DB03088
Pyroglutamic Acid,,experimental,ANG,Angiogenin,target,,DB03088
Pyroglutamic Acid,,experimental,cslB,Chondroitinase-B,target,,DB03088
Pyroglutamic Acid,,experimental,AMY1A,Alpha-amylase 1,target,,DB03088
5-Hydroxymethyl-Chonduritol,,experimental,AMY1A,Alpha-amylase 1,target,,DB03092
5-Hydroxymethyl-Chonduritol,,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB03092
5-Hydroxymethyl-Chonduritol,,experimental,AMY2B,Alpha-amylase 2B,target,,DB03092
6-Nitroindazole,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB03100
6-Nitroindazole,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03100
Ribose-1-Phosphate,,experimental,udp,Uridine phosphorylase,target,,DB03101
Ribose-1-Phosphate,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB03101
Myo-Inositol,,experimental,,1-phosphatidylinositol phosphodiesterase,target,,DB03106
Myo-Inositol,,experimental,GBA,Glucosylceramidase,target,,DB03106
Myo-Inositol,,experimental,plcA,1-phosphatidylinositol phosphodiesterase,target,,DB03106
Myo-Inositol,,experimental,CDIPT,CDP-diacylglycerol--inositol 3-phosphatidyltransferase,target,inhibitor,DB03106
N-Acetyl-D-Allosamine,,experimental,chiB,Chitinase B,target,,DB03109
N-Acetyl-D-Allosamine,,experimental,chiA,Chitinase A,target,,DB03109
N-Acetyl-D-Allosamine,,experimental,CHIT1,Chitotriosidase-1,target,,DB03109
Para-Toluene Sulfonate,,experimental,LYZ,Lysozyme C,target,,DB03120
Para-Toluene Sulfonate,,experimental,CTSH,Pro-cathepsin H,target,,DB03120
"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",,experimental,folA,Dihydrofolate reductase,target,,DB03125
"2,4-Diamino-5-(3,4,5-Trimethoxy-Benzyl)-Pyrimidin-1-Ium",,experimental,DHFR,Dihydrofolate reductase,target,,DB03125
Benzamidine,,experimental,KLK6,Kallikrein-6,target,,DB03127
Benzamidine,,experimental,PRSS2,Trypsin-2,target,,DB03127
Benzamidine,,experimental,PRSS3,Trypsin-3,target,,DB03127
Benzamidine,,experimental,ATOX1,Copper transport protein ATOX1,target,,DB03127
Benzamidine,,experimental,DCI,"Enoyl-CoA delta isomerase 1, mitochondrial",target,,DB03127
Benzamidine,,experimental,sprT,Trypsin,target,,DB03127
Benzamidine,,experimental,ST14,Suppressor of tumorigenicity 14 protein,target,,DB03127
Benzamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03127
Benzamidine,,experimental,PRSS1,Trypsin-1,target,,DB03127
Benzamidine,,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB03127
3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,,experimental,,"Triosephosphate isomerase, glycosomal",target,,DB03132
3-(2-Benzothiazolylthio)-1-Propanesulfonic Acid,,experimental,TPI1,Triosephosphate isomerase,target,,DB03132
4-Iodobenzo[B]Thiophene-2-Carboxamidine,,experimental,F2,Prothrombin,target,,DB03136
4-Iodobenzo[B]Thiophene-2-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB03136
4-Iodobenzo[B]Thiophene-2-Carboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03136
"3-({5-Benzyl-6-Hydroxy-2,4-Bis-(4-Hydroxy-Benzyl)-3-Oxo-[1,2,4]-Triazepane-1-Sulfonyl)-Benzonitrile",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03141
"3-({5-Benzyl-6-Hydroxy-2,4-Bis-(4-Hydroxy-Benzyl)-3-Oxo-[1,2,4]-Triazepane-1-Sulfonyl)-Benzonitrile",,experimental,ORF,V-1 protease,target,,DB03141
Alpha-L-Arabinose,,experimental,araC,Arabinose operon regulatory protein,target,,DB03142
Alpha-L-Arabinose,,experimental,araF,L-arabinose-binding periplasmic protein,target,,DB03142
Alpha-L-Arabinose,,experimental,galM,Aldose 1-epimerase,target,,DB03142
N-Omega-Hydroxy-L-Arginine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03144
N-Omega-Hydroxy-L-Arginine,,experimental,nos,Nitric oxide synthase oxygenase,target,,DB03144
N-Omega-Hydroxy-L-Arginine,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB03144
N-Omega-Hydroxy-L-Arginine,,experimental,ARG1,Arginase-1,target,,DB03144
N-Omega-Hydroxy-L-Arginine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03144
Flavin adenine dinucleotide,,approved,glf,UDP-galactopyranose mutase,target,,DB03147
Flavin adenine dinucleotide,,approved,hmp,Flavohemoprotein,target,,DB03147
Flavin adenine dinucleotide,,approved,thiO,Glycine oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,POR,NADPH--cytochrome P450 reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,GCDH,"Glutaryl-CoA dehydrogenase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,DAO,D-amino-acid oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,putA,Bifunctional protein PutA,target,,DB03147
Flavin adenine dinucleotide,,approved,phr,Deoxyribodipyrimidine photo-lyase,target,,DB03147
Flavin adenine dinucleotide,,approved,MAOA,Amine oxidase [flavin-containing] A,target,,DB03147
Flavin adenine dinucleotide,,approved,ACADS,"Short-chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,IL4I1,L-amino-acid oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,fadH,"2,4-dienoyl-CoA reductase [NADPH]",target,,DB03147
Flavin adenine dinucleotide,,approved,xecC,"2-oxopropyl-CoM reductase, carboxylating",target,,DB03147
Flavin adenine dinucleotide,,approved,pobA,p-hydroxybenzoate hydroxylase,target,,DB03147
Flavin adenine dinucleotide,,approved,NOS1,"Nitric oxide synthase, brain",target,,DB03147
Flavin adenine dinucleotide,,approved,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB03147
Flavin adenine dinucleotide,,approved,pobA,p-hydroxybenzoate hydroxylase,target,,DB03147
Flavin adenine dinucleotide,,approved,SO_0970,Fumarate reductase flavoprotein subunit,target,,DB03147
Flavin adenine dinucleotide,,approved,ERO1LB,ERO1-like protein beta,target,,DB03147
Flavin adenine dinucleotide,,approved,GSR,"Glutathione reductase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,fprA,NADPH-ferredoxin reductase FprA,target,,DB03147
Flavin adenine dinucleotide,,approved,CYB5R3,NADH-cytochrome b5 reductase 3,target,,DB03147
Flavin adenine dinucleotide,,approved,choA,Cholesterol oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,thyX,Thymidylate synthase ThyX,target,,DB03147
Flavin adenine dinucleotide,,approved,pox5,Pyruvate oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,trxB,Thioredoxin reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,gor,Glutathione reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,metF,"5,10-methylenetetrahydrofolate reductase",target,,DB03147
Flavin adenine dinucleotide,,approved,soxA,Monomeric sarcosine oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,TPR,Trypanothione reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB03147
Flavin adenine dinucleotide,,approved,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,XDH,Xanthine dehydrogenase/oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,choB,Cholesterol oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,dmg,"N,N-dimethylglycine oxidase",target,,DB03147
Flavin adenine dinucleotide,,approved,npr,NADH peroxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB03147
Flavin adenine dinucleotide,,approved,petH,Ferredoxin--NADP reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,dld,D-lactate dehydrogenase,target,,DB03147
Flavin adenine dinucleotide,,approved,cysJ,Sulfite reductase [NADPH] flavoprotein alpha-component,target,,DB03147
Flavin adenine dinucleotide,,approved,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,,DB03147
Flavin adenine dinucleotide,,approved,fpr,Ferredoxin--NADP reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,ACAD8,"Isobutyryl-CoA dehydrogenase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,,"Acyl-CoA dehydrogenase, short-chain specific",target,,DB03147
Flavin adenine dinucleotide,,approved,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,bphA4,Ferredoxin reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,,Dihydrolipoyl dehydrogenase,target,,DB03147
Flavin adenine dinucleotide,,approved,PSPTO1126,"Amine oxidase, flavin-containing protein",target,,DB03147
Flavin adenine dinucleotide,,approved,phrB,Deoxyribodipyrimidine photo-lyase,target,,DB03147
Flavin adenine dinucleotide,,approved,phr,Deoxyribodipyrimidine photo-lyase,target,,DB03147
Flavin adenine dinucleotide,,approved,nadB,L-aspartate oxidase,target,,DB03147
Flavin adenine dinucleotide,,approved,cry,Cryptochrome DASH,target,,DB03147
Flavin adenine dinucleotide,,approved,DLD,"Dihydrolipoyl dehydrogenase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,ifcA,Fumarate reductase flavoprotein subunit,target,,DB03147
Flavin adenine dinucleotide,,approved,CYB5R1,NADH-cytochrome b5 reductase 1,target,,DB03147
Flavin adenine dinucleotide,,approved,,Oxidoreductase,target,,DB03147
Flavin adenine dinucleotide,,approved,MAOB,Amine oxidase [flavin-containing] B,target,,DB03147
Flavin adenine dinucleotide,,approved,FDXR,"NADPH:adrenodoxin oxidoreductase, mitochondrial",target,,DB03147
Flavin adenine dinucleotide,,approved,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,target,,DB03147
Flavin adenine dinucleotide,,approved,murB,UDP-N-acetylenolpyruvoylglucosamine reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,GFER,FAD-linked sulfhydryl oxidase ALR,target,,DB03147
Flavin adenine dinucleotide,,approved,murB,UDP-N-acetylenolpyruvoylglucosamine reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,hmp,Flavohemoprotein,target,,DB03147
Flavin adenine dinucleotide,,approved,pheA2,Phenol 2-hydroxylase component B,target,,DB03147
Flavin adenine dinucleotide,,approved,metF,Methylenetetrahydrofolate reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,camA,Putidaredoxin reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,lpdA,NAD(P)H dehydrogenase (quinone),target,,DB03147
Flavin adenine dinucleotide,,approved,glf,UDP-galactopyranose mutase,target,,DB03147
Flavin adenine dinucleotide,,approved,abfD,4-hydroxybutyryl-CoA dehydratase/vinylacetyl-CoA-Delta-isomerase,target,,DB03147
Flavin adenine dinucleotide,,approved,pchF,4-cresol dehydrogenase [hydroxylating] flavoprotein subunit,target,,DB03147
Flavin adenine dinucleotide,,approved,ahpF,Alkyl hydroperoxide reductase subunit F,target,,DB03147
Flavin adenine dinucleotide,,approved,m-6,Outer membrane protein p64k or PM-6,target,,DB03147
Flavin adenine dinucleotide,,approved,GR2,Glutathione reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,pamO,Phenylacetone monooxygenase,target,,DB03147
Flavin adenine dinucleotide,,approved,benC,"Benzoate 1,2-dioxygenase electron transfer component",target,,DB03147
Flavin adenine dinucleotide,,approved,TT_C0779,Putative acyl-CoA dehydrogenase,target,,DB03147
Flavin adenine dinucleotide,,approved,fkbI,FkbI,target,,DB03147
Flavin adenine dinucleotide,,approved,lpdV,Dihydrolipoyl dehydrogenase,target,,DB03147
Flavin adenine dinucleotide,,approved,lpd,Dihydrolipoyl dehydrogenase,target,,DB03147
Flavin adenine dinucleotide,,approved,ahpF,Alkyl hydroperoxide reductase subunit F,target,,DB03147
Flavin adenine dinucleotide,,approved,petH,Ferredoxin--NADP reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,fpr,Ferredoxin--NADP reductase,target,,DB03147
Flavin adenine dinucleotide,,approved,mrsD,Mersacidin decarboxylase,target,,DB03147
Flavin adenine dinucleotide,,approved,fccA,Fumarate reductase flavoprotein subunit,target,,DB03147
Phosphomethylphosphonic Acid Adenosyl Ester,,experimental,prs,Ribose-phosphate pyrophosphokinase,target,,DB03148
Phosphomethylphosphonic Acid Adenosyl Ester,,experimental,MT1739,MutT/nudix family protein,target,,DB03148
Phosphomethylphosphonic Acid Adenosyl Ester,,experimental,ushA,Protein UshA,target,,DB03148
Phenylalanylmethane,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03149
Phenylalanylmethane,,experimental,CMA1,Chymase,target,,DB03149
Phenylalanylmethane,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03149
(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion,,experimental,,Oxidoreductase,target,,DB03151
(Mu-4-Sulfido)-Tetra-Nuclear Copper Ion,,experimental,nosZ,Nitrous-oxide reductase,target,,DB03151
B-2-Octylglucoside,,experimental,polA,"DNA polymerase I, thermostable",target,,DB03152
B-2-Octylglucoside,,experimental,aqpZ,Aquaporin Z,target,,DB03152
B-2-Octylglucoside,,experimental,TGM3,Protein-glutamine gamma-glutamyltransferase E,target,,DB03152
B-2-Octylglucoside,,experimental,puhA,H subunit of photosynthetic reaction center complex,target,,DB03152
B-2-Octylglucoside,,experimental,aqpZ,Aquaporin Z,target,,DB03152
B-2-Octylglucoside,,experimental,petB,Cytochrome b,target,,DB03152
B-2-Octylglucoside,,experimental,petA,Ubiquinol-cytochrome c reductase iron-sulfur subunit,target,,DB03152
B-2-Octylglucoside,,experimental,petC,Cytochrome c1,target,,DB03152
B-2-Octylglucoside,,experimental,RHO,Rhodopsin,target,,DB03152
D-Glucuronic Acid,,experimental,SP_0314,Hyaluronate lyase,target,,DB03156
D-Glucuronic Acid,,experimental,cslA,Chondroitinase-AC,target,,DB03156
D-Glucuronic Acid,,experimental,aguA,Alpha-glucuronidase,target,,DB03156
CRA_8696,,experimental,F2,Prothrombin,target,,DB03159
CRA_8696,,experimental,PRSS1,Trypsin-1,target,,DB03159
CRA_8696,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03159
Thymidine-5'-Diphospho-Beta-D-Xylose,,experimental,rmlB,"dTDP-glucose 4,6-dehydratase",target,,DB03161
Thymidine-5'-Diphospho-Beta-D-Xylose,,experimental,rmlC,"DTDP-4-dehydrorhamnose 3,5-epimerase",target,,DB03161
(S)-Hmg-Coa,,experimental,mvaA,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB03169
(S)-Hmg-Coa,,experimental,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB03169
(S)-Hmg-Coa,,experimental,mvaS,3-hydroxy-3-methylglutaryl CoA synthase,target,,DB03169
Indole-3-Propanol Phosphate,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB03171
Indole-3-Propanol Phosphate,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB03171
Indole-3-Propanol Phosphate,,experimental,trpB,Tryptophan synthase beta chain,target,,DB03171
"3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid",,experimental,THRB,Thyroid hormone receptor beta,target,,DB03176
"3,5-Dichloro-4-[(4-Hydroxy-3-Isopropylphenoxy)Phenylacetic Acid",,experimental,THRA,Thyroid hormone receptor alpha,target,,DB03176
Sphingosine,,experimental,GLTP,Glycolipid transfer protein,target,,DB03203
Sphingosine,,experimental,,Genome polyprotein,target,,DB03203
Sphingosine,,experimental,,Genome polyprotein,target,,DB03203
Sphingosine,,experimental,,Genome polyprotein,target,,DB03203
Sphingosine,,experimental,,Genome polyprotein,target,,DB03203
Sphingosine,,experimental,PVR,Poliovirus receptor,target,,DB03203
Pyrroloquinoline Quinone,,experimental,qheDH,Quinohemoprotein ethanol dehydrogenase type-1,target,,DB03205
Pyrroloquinoline Quinone,,experimental,gdhB,Quinoprotein glucose dehydrogenase B,target,,DB03205
Pyrroloquinoline Quinone,,experimental,qbdA,Quinohemoprotein alcohol dehydrogenase ADH IIB,target,,DB03205
Pyrroloquinoline Quinone,,experimental,pqqC,Pyrroloquinoline-quinone synthase,target,,DB03205
Pyrroloquinoline Quinone,,experimental,exaA,Quinoprotein ethanol dehydrogenase,target,,DB03205
1-Deoxynojirimycin,Antiviral AgentsEnzyme Inhibitors,experimental,MAN1B1,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",target,,DB03206
1-Deoxynojirimycin,Antiviral AgentsEnzyme Inhibitors,experimental,MSDC,"Mannosyl-oligosaccharide alpha-1,2-mannosidase",target,,DB03206
1-Deoxynojirimycin,Antiviral AgentsEnzyme Inhibitors,experimental,xylA,Xylose isomerase,target,,DB03206
1-Deoxynojirimycin,Antiviral AgentsEnzyme Inhibitors,experimental,bglA,Beta-glucosidase A,target,,DB03206
1-Deoxynojirimycin,Antiviral AgentsEnzyme Inhibitors,experimental,cgt,Cyclomaltodextrin glucanotransferase,target,,DB03206
Vinylglycine,,experimental,ACCS,1-aminocyclopropane-1-carboxylate synthase-like protein 1,target,,DB03214
Vinylglycine,,experimental,IL4I1,L-amino-acid oxidase,target,,DB03214
2'-Deoxyadenosine 5'-Triphosphate,,experimental,4,DNA primase/helicase,target,,DB03222
2'-Deoxyadenosine 5'-Triphosphate,,experimental,POLB,DNA polymerase beta,target,,DB03222
2'-Deoxyadenosine 5'-Triphosphate,,experimental,nrdE,Ribonucleoside-diphosphate reductase 2 subunit alpha,target,,DB03222
2'-Deoxyadenosine 5'-Triphosphate,,experimental,NRDD,Anaerobic ribonucleoside-triphosphate reductase,target,,DB03222
2'-Deoxyadenosine 5'-Triphosphate,,experimental,recA,Protein RecA,target,,DB03222
2'-Deoxyadenosine 5'-Triphosphate,,experimental,recA,Protein RecA,target,,DB03222
Trifluoroethanol,,experimental,,Alcohol dehydrogenase,target,,DB03226
Trifluoroethanol,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB03226
Trifluoroethanol,,experimental,HRAS,GTPase HRas,target,,DB03226
Nicotinamide Mononucleotide,,experimental,NMNAT1,Nicotinamide mononucleotide adenylyltransferase 1,target,,DB03227
Nicotinamide Mononucleotide,,experimental,NMNAT3,Nicotinamide mononucleotide adenylyltransferase 3,target,,DB03227
Nicotinamide Mononucleotide,,experimental,BST1,ADP-ribosyl cyclase 2,target,,DB03227
Nicotinamide Mononucleotide,,experimental,ligA,DNA ligase,target,,DB03227
2-Oxo-4-Methylpentanoic Acid,,experimental,cefE,Deacetoxycephalosporin C synthase,target,,DB03229
2-Oxo-4-Methylpentanoic Acid,,experimental,,D-2-hydroxyisocaproate dehydrogenase,target,,DB03229
Riboflavin Monophosphate,,experimental,tmd,Trimethylamine dehydrogenase,target,,DB03247
Riboflavin Monophosphate,,experimental,roo,Rubredoxin-oxygen oxidoreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,TM_0857,Riboflavin biosynthesis protein RibF,target,,DB03247
Riboflavin Monophosphate,,experimental,morB,Morphinone reductase,target,,DB03247
Riboflavin Monophosphate,,experimental,frp,NADPH-flavin oxidoreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,RPS6KA4,Ribosomal protein S6 kinase alpha-4,target,,DB03247
Riboflavin Monophosphate,,experimental,phzG,Phenazine biosynthesis protein PhzG,target,,DB03247
Riboflavin Monophosphate,,experimental,HAO2,Hydroxyacid oxidase 2,target,,DB03247
Riboflavin Monophosphate,,experimental,DR_A0214,NAD(P)H dehydrogenase (quinone),target,,DB03247
Riboflavin Monophosphate,,experimental,fldA,Flavodoxin-1,target,,DB03247
Riboflavin Monophosphate,,experimental,fni,Isopentenyl-diphosphate delta-isomerase,target,,DB03247
Riboflavin Monophosphate,,experimental,nox,NADH dehydrogenase,target,,DB03247
Riboflavin Monophosphate,,experimental,DvMF_2023,FMN-binding protein,target,,DB03247
Riboflavin Monophosphate,,experimental,BC_1844,Nitroreductase family protein,target,,DB03247
Riboflavin Monophosphate,,experimental,POR,NADPH--cytochrome P450 reductase,target,,DB03247
Riboflavin Monophosphate,,experimental,PPCDC,Phosphopantothenoylcysteine decarboxylase,target,,DB03247
Riboflavin Monophosphate,,experimental,phzG,PhzG,target,,DB03247
Riboflavin Monophosphate,,experimental,gltS,Ferredoxin-dependent glutamate synthase 2,target,,DB03247
Riboflavin Monophosphate,,experimental,pdxH,Pyridoxine/pyridoxamine 5'-phosphate oxidase,target,,DB03247
Riboflavin Monophosphate,,experimental,,Flavodoxin,target,,DB03247
Riboflavin Monophosphate,,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,aroC,Chorismate synthase,target,,DB03247
Riboflavin Monophosphate,,experimental,fadH,"2,4-dienoyl-CoA reductase [NADPH]",target,,DB03247
Riboflavin Monophosphate,,experimental,pyrDA,Dihydroorotate dehydrogenase A (fumarate),target,,DB03247
Riboflavin Monophosphate,,experimental,BLVRB,Flavin reductase (NADPH),target,,DB03247
Riboflavin Monophosphate,,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB03247
Riboflavin Monophosphate,,experimental,PNPO,Pyridoxine-5'-phosphate oxidase,target,,DB03247
Riboflavin Monophosphate,,experimental,,Major NAD(P)H-flavin oxidoreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,RFK,Riboflavin kinase,target,,DB03247
Riboflavin Monophosphate,,experimental,nfsA,Oxygen-insensitive NADPH nitroreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03247
Riboflavin Monophosphate,,experimental,pyrD,Dihydroorotate dehydrogenase (quinone),target,,DB03247
Riboflavin Monophosphate,,experimental,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB03247
Riboflavin Monophosphate,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB03247
Riboflavin Monophosphate,,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB03247
Riboflavin Monophosphate,,experimental,azoR,FMN-dependent NADH-azoreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,epiD,Epidermin decarboxylase,target,,DB03247
Riboflavin Monophosphate,,experimental,azoR,FMN-dependent NADH-azoreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,aroC,Chorismate synthase,target,,DB03247
Riboflavin Monophosphate,,experimental,isiB,Flavodoxin,target,,DB03247
Riboflavin Monophosphate,,experimental,DVU_2680,Flavodoxin,target,,DB03247
Riboflavin Monophosphate,,experimental,isiB,Flavodoxin,target,,DB03247
Riboflavin Monophosphate,,experimental,SMU_260,Putative uncharacterized protein,target,,DB03247
Riboflavin Monophosphate,,experimental,moxC,Putative monooxygenase MoxC,target,,DB03247
Riboflavin Monophosphate,,experimental,TM_0096,tRNA-dihydrouridine synthase,target,,DB03247
Riboflavin Monophosphate,,experimental,nrdI,Protein NrdI,target,,DB03247
Riboflavin Monophosphate,,experimental,pad1,Probable aromatic acid decarboxylase,target,,DB03247
Riboflavin Monophosphate,,experimental,mdlB,(S)-mandelate dehydrogenase,target,,DB03247
Riboflavin Monophosphate,,experimental,azr,FMN-dependent NADPH-azoreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,fldA,Flavodoxin,target,,DB03247
Riboflavin Monophosphate,,experimental,SGK1,Serine/threonine-protein kinase Sgk1,target,,DB03247
Riboflavin Monophosphate,,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB03247
Riboflavin Monophosphate,,experimental,fprA,Nitric oxide reductase,target,,DB03247
Riboflavin Monophosphate,,experimental,fni,Isopentenyl-diphosphate delta-isomerase,target,,DB03247
D-Lysine,,experimental,dadX,"Alanine racemase, catabolic",target,,DB03252
D-Lysine,,experimental,lysA,Diaminopimelate decarboxylase,target,,DB03252
Phenol,"Anti-Infective Agents, LocalSclerosing SolutionsDisinfectantsAntipsoriatic Agents",approvedexperimental,nprS,Thermolysin,target,,DB03255
Phenol,"Anti-Infective Agents, LocalSclerosing SolutionsDisinfectantsAntipsoriatic Agents",approvedexperimental,E,Lysozyme,target,,DB03255
Phenol,"Anti-Infective Agents, LocalSclerosing SolutionsDisinfectantsAntipsoriatic Agents",approvedexperimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03255
"5-Formyl-5,6,7,8-Tetrahydrofolate",,experimental,dmg,"N,N-dimethylglycine oxidase",target,,DB03256
"5-Formyl-5,6,7,8-Tetrahydrofolate",,experimental,glyA,Serine hydroxymethyltransferase,target,,DB03256
"5-Formyl-5,6,7,8-Tetrahydrofolate",,experimental,gcvT,Aminomethyltransferase,target,,DB03256
"5-Formyl-5,6,7,8-Tetrahydrofolate",,experimental,arnA,Bifunctional polymyxin resistance protein ArnA,target,,DB03256
"5-Formyl-5,6,7,8-Tetrahydrofolate",,experimental,FTCD,Formimidoyltransferase-cyclodeaminase,target,,DB03256
2'-Deoxycytidine-5'-Triphosphate,,experimental,polA,"DNA polymerase I, thermostable",target,,DB03258
2'-Deoxycytidine-5'-Triphosphate,,experimental,nrdE,Ribonucleoside-diphosphate reductase 2 subunit alpha,target,,DB03258
2'-Deoxycytidine-5'-Triphosphate,,experimental,NRDD,Anaerobic ribonucleoside-triphosphate reductase,target,,DB03258
2'-Deoxycytidine-5'-Triphosphate,,experimental,dcd,Deoxycytidine triphosphate deaminase,target,,DB03258
Dodecyl-Coa,,experimental,fadR,Fatty acid metabolism regulator protein,target,,DB03264
Dodecyl-Coa,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB03264
"7,8-Dihydro-L-Biopterin",,experimental,phhA,Phenylalanine-4-hydroxylase,target,,DB03271
"7,8-Dihydro-L-Biopterin",,experimental,TPH1,Tryptophan 5-hydroxylase 1,target,,DB03271
"7,8-Dihydro-L-Biopterin",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB03271
Amylotriose,,experimental,malE,Maltose binding protein,target,,DB03277
Amylotriose,,experimental,AMY2B,Alpha-amylase 2B,target,,DB03277
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,,experimental,DTYMK,Thymidylate kinase,target,,DB03280
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,,experimental,tmk,Thymidylate kinase,target,,DB03280
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,,experimental,TK,Thymidine kinase,target,,DB03280
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,,experimental,TK,Thymidine kinase,target,,DB03280
P1-(5'-Adenosyl)P5-(5'-Thymidyl)Pentaphosphate,,experimental,tmk,Thymidylate kinase,target,,DB03280
beta-L-fucose,,experimental,TM_0306,"Alpha-L-fucosidase, putative",target,,DB03283
beta-L-fucose,,experimental,ACHE,Acetylcholinesterase,target,,DB03283
Benzylsulfinic Acid,,experimental,HPN,Serine protease hepsin,target,,DB03297
Benzylsulfinic Acid,,experimental,,Extracellular subtilisin-like serine proteinase,target,,DB03297
Benzylsulfinic Acid,,experimental,estB,Carboxylesterase 2,target,,DB03297
Benzylsulfinic Acid,,experimental,rsbQ,Sigma factor SigB regulation protein RsbQ,target,,DB03297
Benzylsulfinic Acid,,experimental,SOD2,"Superoxide dismutase [Mn], mitochondrial",target,,DB03297
Benzylsulfinic Acid,,experimental,CMA1,Chymase,target,,DB03297
Benzylsulfinic Acid,,experimental,apr,Subtilisin BPN',target,,DB03297
N-Cyclohexyltaurine,,experimental,P/V,Phosphoprotein,target,,DB03309
N-Cyclohexyltaurine,,experimental,nirS,Nitrite reductase,target,,DB03309
N-Cyclohexyltaurine,,experimental,EN2,Homeobox protein engrailed-2,target,,DB03309
N-Cyclohexyltaurine,,experimental,rph,Ribonuclease PH,target,,DB03309
N-Cyclohexyltaurine,,experimental,,Cyanovirin-N,target,,DB03309
N-Cyclohexyltaurine,,experimental,SULT2B1,Sulfotransferase family cytosolic 2B member 1,target,,DB03309
Oxidized Glutathione Disulfide,,experimental,GSTM2,Glutathione S-transferase Mu 2,target,,DB03310
Oxidized Glutathione Disulfide,,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB03310
Cephalosporin C,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB03313
Cephalosporin C,,experimental,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB03313
Cephalosporin C,,experimental,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB03313
Cephalosporin C,,experimental,penA,Penicillin-binding protein 2B,target,inhibitor,DB03313
Cephalosporin C,,experimental,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB03313
Cephalosporin C,,experimental,pbp3,Penicillin-binding protein 3,target,inhibitor,DB03313
Fluorotryptophane,,experimental,TPI1,Triosephosphate isomerase,target,,DB03314
Fluorotryptophane,,experimental,GSTM1,Glutathione S-transferase Mu 1,target,,DB03314
Guanosine-3'-Monophosphate,,experimental,,Ribonuclease,target,,DB03315
Guanosine-3'-Monophosphate,,experimental,pyrR,Bifunctional protein PyrR,target,,DB03315
"1,4-Diethylene Dioxide",,experimental,apr,Subtilisin Carlsberg,target,,DB03316
"1,4-Diethylene Dioxide",,experimental,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,target,,DB03316
"1,4-Diethylene Dioxide",,experimental,EPN1,Epsin-1,target,,DB03316
"1,4-Diethylene Dioxide",,experimental,,Structural polyprotein,target,,DB03316
"1,4-Diethylene Dioxide",,experimental,TGFB3,Transforming growth factor beta-3,target,,DB03316
Heme C,,experimental,nrfA,Cytochrome c-552,target,,DB03317
Heme C,,experimental,cycA,Cytochrome c2,target,,DB03317
Heme C,,experimental,psbV,Cytochrome c-550,target,,DB03317
Heme C,,experimental,cycM,Cytochrome c-552,target,,DB03317
Heme C,,experimental,nirM,Cytochrome c-551,target,,DB03317
Heme C,,experimental,cyd,Cytochrome c3,target,,DB03317
Heme C,,experimental,Ddes_2150,Split-Soret cytochrome c,target,,DB03317
Heme C,,experimental,glbN,Group 1 truncated hemoglobin GlbN,target,,DB03317
Heme C,,experimental,,Cytochrome c-553,target,,DB03317
Heme C,,experimental,CYP2C9,Cytochrome P450 2C9,target,,DB03317
Heme C,,experimental,Ddes_2038,Nine-heme cytochrome c,target,,DB03317
Heme C,,experimental,,"Cytochrome c3, 13 kDa",target,,DB03317
Heme C,,experimental,ccpA,Cytochrome c551 peroxidase,target,,DB03317
Heme C,,experimental,DvMF_2499,Cytochrome c3,target,,DB03317
Heme C,,experimental,cycP,Cytochrome c',target,,DB03317
Heme C,,experimental,cytc3,Cytochrome c3,target,,DB03317
Heme C,,experimental,nirS,Nitrite reductase,target,,DB03317
Heme C,,experimental,hmcA,High-molecular-weight cytochrome c,target,,DB03317
Heme C,,experimental,cycA,Cytochrome c'',target,,DB03317
Heme C,,experimental,qheDH,Quinohemoprotein ethanol dehydrogenase type-1,target,,DB03317
Heme C,,experimental,nirS,Nitrite reductase,target,,DB03317
Heme C,,experimental,cc4,Cytochrome c4,target,,DB03317
Heme C,,experimental,CYCS,Cytochrome c,target,,DB03317
Maltose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB03323
Maltose,,experimental,AMY2B,Alpha-amylase 2B,target,,DB03323
Maltose,,experimental,aglA,Alpha-glucosidase,target,,DB03323
Maltose,,experimental,malE,Maltose binding protein,target,,DB03323
Maltose,,experimental,treZ,Malto-oligosyltrehalose trehalohydrolase,target,,DB03323
Maltose,,experimental,malE,Maltose-binding periplasmic protein,target,,DB03323
Maltose,,experimental,spoII,Beta-amylase,target,,DB03323
Maltose,,experimental,amyM,Maltogenic alpha-amylase,target,,DB03323
Maltose,,experimental,malP,Maltodextrin phosphorylase,target,,DB03323
Heptyl-Beta-D-Glucopyranoside,,experimental,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB03338
Heptyl-Beta-D-Glucopyranoside,,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB03338
Beta-Mercaptoethanol,,experimental,E,Lysozyme,target,,DB03345
Beta-Mercaptoethanol,,experimental,GLO1,Lactoylglutathione lyase,target,,DB03345
Beta-Mercaptoethanol,,experimental,PNPO,Pyridoxine-5'-phosphate oxidase,target,,DB03345
Beta-Mercaptoethanol,,experimental,gfo,Glucose--fructose oxidoreductase,target,,DB03345
Beta-Mercaptoethanol,,experimental,SERPINA1,Alpha-1-antitrypsin,target,,DB03345
Beta-Mercaptoethanol,,experimental,LGALS1,Galectin-1,target,,DB03345
Beta-Mercaptoethanol,,experimental,ninB,Protein ninB,target,,DB03345
Beta-Mercaptoethanol,,experimental,SCMH1,Polycomb protein SCMH1,target,,DB03345
Beta-Mercaptoethanol,,experimental,pdxH,Pyridoxine/pyridoxamine 5'-phosphate oxidase,target,,DB03345
Beta-Mercaptoethanol,,experimental,HP_0602,Endonuclease III,target,,DB03345
Triethyl Phosphate,,experimental,opd,Parathion hydrolase,target,,DB03347
Triethyl Phosphate,,experimental,opd,Parathion hydrolase,target,,DB03347
8-Bromo-Adenosine-5'-Monophosphate,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB03349
8-Bromo-Adenosine-5'-Monophosphate,,experimental,HINT1,Histidine triad nucleotide-binding protein 1,target,,DB03349
Cobalt Hexammine Ion,,experimental,tolC,Outer membrane protein TolC,target,,DB03350
Cobalt Hexammine Ion,,experimental,aroC,Chorismate synthase,target,,DB03350
S-Arsonocysteine,,experimental,arsC,Arsenate reductase,target,,DB03352
S-Arsonocysteine,,experimental,MST,3-mercaptopyruvate sulfurtransferase,target,,DB03352
S-Arsonocysteine,,experimental,arsC,Protein ArsC,target,,DB03352
5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,,experimental,thrS,Threonine--tRNA ligase,target,,DB03355
5'-O-(N-(L-Threonyl)-Sulfamoyl)Adenosine,,experimental,thrS,Threonine--tRNA ligase,target,,DB03355
"3,5-Diiodotyrosine",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB03374
"3,5-Diiodotyrosine",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB03374
"3,5-Diiodotyrosine",,experimental,BH0413,Alpha-amylase G-6,target,,DB03374
"3,5-Diiodotyrosine",,experimental,PRSS1,Trypsin-1,target,,DB03374
"3,5-Diiodotyrosine",,experimental,nikA,Nickel-binding periplasmic protein,target,,DB03374
"3,5-Diiodotyrosine",,experimental,IYD,Iodotyrosine dehalogenase 1,target,,DB03374
L-Tyrosinamide,,experimental,NPY,Pro-neuropeptide Y,target,,DB03380
L-Tyrosinamide,,experimental,BPHL,Valacyclovir hydrolase,target,,DB03380
Hexadecanal,,experimental,RHO,Rhodopsin,target,,DB03381
Hexadecanal,,experimental,DBI,Acyl-CoA-binding protein,target,,DB03381
S-Oxy Cysteine,,experimental,panD,Aspartate 1-decarboxylase,target,,DB03382
S-Oxy Cysteine,,experimental,PREP,Prolyl endopeptidase,target,,DB03382
S-Oxy Cysteine,,experimental,ppx,Exopolyphosphatase,target,,DB03382
S-Oxy Cysteine,,experimental,Rv2991,Conserved protein,target,,DB03382
S-Oxy Cysteine,,experimental,tpx,Probable thiol peroxidase,target,,DB03382
S-Oxy Cysteine,,experimental,SOD1,Superoxide dismutase [Cu-Zn],target,,DB03382
S-Oxy Cysteine,,experimental,npr,NADH peroxidase,target,,DB03382
4-Methylimidazole,,experimental,CA2,Carbonic anhydrase 2,target,,DB03385
4-Methylimidazole,,experimental,MB,Myoglobin,target,,DB03385
4-Methylimidazole,,experimental,CA5A,"Carbonic anhydrase 5A, mitochondrial",target,,DB03385
alpha-D-Xylopyranose,,experimental,cslB,Chondroitinase-B,target,,DB03389
alpha-D-Xylopyranose,,experimental,cslA,Chondroitinase-AC,target,,DB03389
alpha-D-Xylopyranose,,experimental,cex,Exoglucanase/xylanase,target,,DB03389
alpha-D-Xylopyranose,,experimental,galM,Aldose 1-epimerase,target,,DB03389
alpha-D-Xylopyranose,,experimental,,"Endo-beta-1,4-xylanase",target,,DB03389
alpha-D-Xylopyranose,,experimental,BH2105,Reducing end xylose-releasing exo-oligoxylanase,target,,DB03389
alpha-D-Xylopyranose,,experimental,,"Endo-1,4-beta-xylanase",target,,DB03389
alpha-D-Xylopyranose,,experimental,,"Endo-1,4-beta-xylanase",target,,DB03389
alpha-D-Xylopyranose,,experimental,xynA,"Endo-1,4-beta-xylanase A",target,,DB03389
alpha-D-Xylopyranose,,experimental,xlnA,"Endo-1,4-beta-xylanase A",target,,DB03389
alpha-D-Xylopyranose,,experimental,xlnA,"Endo-1,4-beta-xylanase",target,,DB03389
alpha-D-Xylopyranose,,experimental,,Hydrolase,target,,DB03389
alpha-D-Xylopyranose,,experimental,xyl,"Endo-1,4-beta-xylanase",target,,DB03389
alpha-D-Xylopyranose,,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB03389
alpha-D-Xylopyranose,,experimental,xynC,Endoxylanase,target,,DB03389
alpha-D-Xylopyranose,,experimental,spoII,Beta-amylase,target,,DB03389
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,glmU,Bifunctional protein GlmU,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,UAP1,UDP-N-acetylhexosamine pyrophosphorylase,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,GALE,UDP-glucose 4-epimerase,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,glmU,Bifunctional protein GlmU,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,galE,UDP-glucose 4-epimerase,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,EXTL2,Exostosin-like 2,target,,DB03397
Uridine-Diphosphate-N-Acetylglucosamine,,experimental,MGAT1,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",target,,DB03397
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,CYTH2,Cytohesin-2,target,,DB03401
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,EPN1,Epsin-1,target,,DB03401
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,PLCD1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",target,,DB03401
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,RDX,Radixin,target,,DB03401
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,SPTBN1,"Spectrin beta chain, non-erythrocytic 1",target,,DB03401
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",target,,DB03401
"D-Myo-Inositol-1,4,5-Triphosphate",,experimental,ITPKA,Inositol-trisphosphate 3-kinase A,target,,DB03401
Cytidine-5'-Monophosphate,,experimental,ispDF,Bifunctional enzyme IspD/IspF,target,,DB03403
Cytidine-5'-Monophosphate,,experimental,CMPK1,UMP-CMP kinase,target,,DB03403
Cytidine-5'-Monophosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB03403
Cytidine-5'-Monophosphate,,experimental,cmk,Cytidylate kinase,target,,DB03403
Cytidine-5'-Monophosphate,,experimental,UCK2,Uridine-cytidine kinase 2,target,,DB03403
Cytidine-5'-Monophosphate,,experimental,kpsU,3-deoxy-manno-octulosonate cytidylyltransferase,target,,DB03403
Cytidine-5'-Monophosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB03403
Cytidine-5'-Monophosphate,,experimental,cst-II,"Alpha-2,3-/2,8-sialyltransferase",target,,DB03403
Cytidine-5'-Monophosphate,,experimental,coaBC,Coenzyme A biosynthesis bifunctional protein CoaBC,target,,DB03403
Deoxyuridine-5'-Diphosphate,,experimental,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",target,,DB03413
Deoxyuridine-5'-Diphosphate,,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB03413
Deoxyuridine-5'-Diphosphate,,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB03413
Deoxyuridine-5'-Diphosphate,,experimental,Tcdut,Deoxyuridine triphosphatase,target,,DB03413
Deoxyuridine-5'-Diphosphate,,experimental,pol,Pol polyprotein,target,,DB03413
Uracil,,experimental,rsuA,Ribosomal small subunit pseudouridine synthase A,target,,DB03419
Uracil,,experimental,UL2,Uracil-DNA glycosylase,target,,DB03419
Uracil,,experimental,ung,Uracil-DNA glycosylase,target,,DB03419
Uracil,,experimental,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB03419
Uracil,,experimental,UCKL1,Uridine-cytidine kinase-like 1,target,,DB03419
Uracil,,experimental,udg,Uracil-DNA glycosylase,target,,DB03419
Uracil,,experimental,pdp,Pyrimidine-nucleoside phosphorylase,target,,DB03419
Bestatin,Antineoplastic AgentsImmunosuppressive AgentsHypolipidemic Agents,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB03424
Bestatin,Antineoplastic AgentsImmunosuppressive AgentsHypolipidemic Agents,experimental,,Bacterial leucyl aminopeptidase,target,,DB03424
SU9516,,experimental,CDK5,Cyclin-dependent kinase 5,target,inhibitor,DB03428
SU9516,,experimental,CDK1,Cyclin-dependent kinase 1,target,binder,DB03428
SU9516,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,inhibitor,DB03428
3[N-Morpholino]Propane Sulfonic Acid,,experimental,yicI,Alpha-xylosidase,target,,DB03434
3[N-Morpholino]Propane Sulfonic Acid,,experimental,GNLY,Granulysin,target,,DB03434
3[N-Morpholino]Propane Sulfonic Acid,,experimental,purT,Phosphoribosylglycinamide formyltransferase 2,target,,DB03434
Uridine-5'-Diphosphate,,experimental,EXTL2,Exostosin-like 2,target,,DB03435
Uridine-5'-Diphosphate,,experimental,GLT6D1,Glycosyltransferase 6 domain-containing protein 1,target,,DB03435
Uridine-5'-Diphosphate,,experimental,spsA,Spore coat polysaccharide biosynthesis protein SpsA,target,,DB03435
Uridine-5'-Diphosphate,,experimental,CMPK1,UMP-CMP kinase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,bgt,DNA beta-glucosyltransferase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,galE,UDP-glucose 4-epimerase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,target,,DB03435
Uridine-5'-Diphosphate,,experimental,wecB,UDP-N-acetylglucosamine 2-epimerase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,galT,Galactose-1-phosphate uridylyltransferase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,pol,Pol polyprotein,target,,DB03435
Uridine-5'-Diphosphate,,experimental,B3GAT1,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 1,target,,DB03435
Uridine-5'-Diphosphate,,experimental,otsA,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",target,,DB03435
Uridine-5'-Diphosphate,,experimental,galE,UDP-galactose 4-epimerase,target,,DB03435
Uridine-5'-Diphosphate,,experimental,GYG1,Glycogenin-1,target,,DB03435
"4,6-Dideoxy-4-Amino-Alpha-D-Glucose",,experimental,AMY1A,Alpha-amylase 1,target,,DB03439
"4,6-Dideoxy-4-Amino-Alpha-D-Glucose",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB03439
2'-Deoxyuridine 3'-Monophosphate,,experimental,RNASE4,Ribonuclease 4,target,,DB03448
2'-Deoxyuridine 3'-Monophosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03448
N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB03449
N-(4-(2-((3-Chlorophenylmethyl)Amino)Ethyl)Phenyl)-2-Thiophecarboxamidine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03449
Cephalothin Group,,experimental,bla,Beta-lactamase Toho-1,target,,DB03450
Cephalothin Group,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB03450
N-(Phosphonacetyl)-L-Aspartic Acid,,experimental,pyrB,Aspartate carbamoyltransferase catalytic chain,target,,DB03459
N-(Phosphonacetyl)-L-Aspartic Acid,,experimental,CAD,CAD protein,target,,DB03459
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,ADH1B,Alcohol dehydrogenase 1B,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,POR,NADPH--cytochrome P450 reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,aroE,Shikimate dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,adh,NADP-dependent isopropanol dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,fcl,GDP-L-fucose synthase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,asd,Aspartate-semialdehyde dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,fadH,"2,4-dienoyl-CoA reductase [NADPH]",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,ME1,NADP-dependent malic enzyme,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,pntB,NAD(P) transhydrogenase subunit beta,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,fabG,3-oxoacyl-[acyl-carrier-protein] reductase FabG,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,AKR1B1,Aldose reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,zwf,Glucose-6-phosphate 1-dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,AKR1C2,Aldo-keto reductase family 1 member C2,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,NNT,"NAD(P) transhydrogenase, mitochondrial",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,SPR,Sepiapterin reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,PTR1,Pteridine reductase 1,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,DCXR,L-xylulose reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,IDH1,Isocitrate dehydrogenase [NADP] cytoplasmic,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,folA,Dihydrofolate reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,AKR1C1,Aldo-keto reductase family 1 member C1,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,G6PD,Glucose-6-phosphate 1-dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,DHFR,Dihydrofolate reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,hldD,ADP-L-glycero-D-manno-heptose-6-epimerase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,BLVRB,Flavin reductase (NADPH),target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,,Dihydrofolate reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,CRYZ,Quinone oxidoreductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,DHRS11,Dehydrogenase/reductase SDR family member 11,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,MDH1,"Malate dehydrogenase, cytoplasmic",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,ydhF,Oxidoreductase YdhF,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,ptr2,Putative pteridine reductase 2,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,HSD17B8,Estradiol 17-beta-dehydrogenase 8,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,AKR1A1,Alcohol dehydrogenase [NADP(+)],target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,actIII,Putative ketoacyl reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,TM_0441,"Oxidoreductase, short chain dehydrogenase/reductase family",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,Tb11.02.2310,Prostaglandin F synthase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,yhdN,General stress protein 69,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,petH,Ferredoxin--NADP reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,mtdA,Bifunctional protein MdtA,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,TM_0920,Alcohol dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,FDXR,"NADPH:adrenodoxin oxidoreductase, mitochondrial",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,petH,Ferredoxin--NADP reductase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,dkgA,"2,5-diketo-D-gluconic acid reductase A",target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,iolS,Protein IolS,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,gapN,NADP-dependent glyceraldehyde-3-phosphate dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,PTGR1,Prostaglandin reductase 1,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,cysJ,Sulfite reductase [NADPH] flavoprotein alpha-component,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,AKR1B10,Aldo-keto reductase family 1 member B10,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,TM_0820,Alcohol dehydrogenase (NADP(+)),target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,aldH,NADP-dependent fatty aldehyde dehydrogenase,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,DHRS4L1,Putative dehydrogenase/reductase SDR family member 4-like 2,target,,DB03461
2'-Monophosphoadenosine 5'-Diphosphoribose,,experimental,TM_1009,Aldehyde reductase,target,,DB03461
Thymine,,experimental,phr,Deoxyribodipyrimidine photo-lyase,target,,DB03462
Thymine,,experimental,deoA,Thymidine phosphorylase,target,,DB03462
Heme D,,experimental,nirS,Nitrite reductase,target,,DB03469
Heme D,,experimental,nirS,Nitrite reductase,target,,DB03469
Cyclohexyl-Hexyl-Beta-D-Maltoside,,experimental,bla,Beta-lactamase SHV-2,target,,DB03472
Cyclohexyl-Hexyl-Beta-D-Maltoside,,experimental,bla,Beta-lactamase SHV-1,target,,DB03472
Alpha-D-Fucose,,experimental,LTF,Lactotransferrin,target,,DB03485
Alpha-D-Fucose,,experimental,araF,L-arabinose-binding periplasmic protein,target,,DB03485
3-Aminosuccinimide,,experimental,LYZ,Lysozyme C,target,,DB03487
3-Aminosuccinimide,,experimental,cheY,Chemotaxis protein CheY,target,,DB03487
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK2deltaT,Cyclin-dependent kinase 2,target,inhibitor,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK5,Cyclin-dependent kinase 5,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK9,Cyclin-dependent kinase 9,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK1,Cyclin-dependent kinase 1,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK6,Cyclin-dependent kinase 6,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,EGFR,Epidermal growth factor receptor,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK4,Cyclin-dependent kinase 4,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK8,Cyclin-dependent kinase 8,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,CDK7,Cyclin-dependent kinase 7,target,,DB03496
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03496
Malate Ion,,experimental,kaiB,Circadian clock protein KaiB,target,,DB03499
Malate Ion,,experimental,fumC,Fumarate hydratase class II,target,,DB03499
Malate Ion,,experimental,glcB,Malate synthase G,target,,DB03499
Malate Ion,,experimental,ME2,"NAD-dependent malic enzyme, mitochondrial",target,,DB03499
Malate Ion,,experimental,CS,"Citrate synthase, mitochondrial",target,,DB03499
Malate Ion,,experimental,synC,Capsule biosynthesis protein,target,,DB03499
Uridine Diphosphate Galactose,,experimental,B4GALT1,"Beta-1,4-galactosyltransferase 1",target,,DB03501
Uridine Diphosphate Galactose,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB03501
Uridine Diphosphate Galactose,,experimental,GALE,UDP-glucose 4-epimerase,target,,DB03501
6-O-Phosphoryl Inosine Monophosphate,,experimental,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB03510
6-O-Phosphoryl Inosine Monophosphate,,experimental,Adss,Adenylosuccinate synthetase,target,,DB03510
Equilenin,,experimental,ksi,Steroid Delta-isomerase,target,,DB03515
Equilenin,,experimental,ksi,Steroid Delta-isomerase,target,,DB03515
Eniluracil,"Enzyme InhibitorsAntineoplastics, Adjuncts",investigational,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB03516
Eniluracil,"Enzyme InhibitorsAntineoplastics, Adjuncts",investigational,AOX1,Aldehyde oxidase,target,,DB03516
Eniluracil,"Enzyme InhibitorsAntineoplastics, Adjuncts",investigational,XDH,Xanthine dehydrogenase/oxidase,target,inhibitor,DB03516
Acylated Ceftazidime,,experimental,blaR1,Regulatory protein BlaR1,target,,DB03530
Acylated Ceftazidime,,experimental,ampC,Beta-lactamase,target,,DB03530
Z-Pro-Prolinal,,experimental,PREP,Prolyl endopeptidase,target,,DB03535
Z-Pro-Prolinal,,experimental,,Prolyl endopeptidase,target,,DB03535
Benzoyl-Arginine-Alanine-Methyl Ketone,,experimental,,Cruzipain,target,,DB03536
Benzoyl-Arginine-Alanine-Methyl Ketone,,experimental,CTSF,Cathepsin F,target,,DB03536
"10-Propargyl-5,8-Dideazafolic Acid",,experimental,THYA,Thymidylate synthase,target,,DB03541
"10-Propargyl-5,8-Dideazafolic Acid",,experimental,thyA,Thymidylate synthase,target,,DB03541
"10-Propargyl-5,8-Dideazafolic Acid",,experimental,thyA,Thymidylate synthase,target,,DB03541
"10-Propargyl-5,8-Dideazafolic Acid",,experimental,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB03541
"10-Propargyl-5,8-Dideazafolic Acid",,experimental,TYMS,Thymidylate synthase,target,,DB03541
"10-Propargyl-5,8-Dideazafolic Acid",,experimental,DHRS4L1,Putative dehydrogenase/reductase SDR family member 4-like 2,target,,DB03541
1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,,experimental,trpF,N-(5'-phosphoribosyl)anthranilate isomerase,target,,DB03543
1-(O-Carboxy-Phenylamino)-1-Deoxy-D-Ribulose-5-Phosphate,,experimental,trpC,Tryptophan biosynthesis protein TrpCF,target,,DB03543
S-Phosphocysteine,,experimental,yjgF,Enamine/imine deaminase,target,,DB03544
S-Phosphocysteine,,experimental,chbB,"N,N'-diacetylchitobiose-specific phosphotransferase enzyme IIB component",target,,DB03544
"4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB03551
"4'-Deaza-1'-Aza-2'-Deoxy-1'-(9-Methylene)-Immucillin-H, (3r,4r)-N-[9-Deazahypoxanthin-9-Yl)Methyl]-4-Hydroxymethyl-Pyrrolidin-3-Ol",,experimental,punA,Purine nucleoside phosphorylase,target,,DB03551
Glutaric Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB03553
Glutaric Acid,,experimental,gadA,Glutamate decarboxylase alpha,target,,DB03553
Glutaric Acid,,experimental,ilvE,Branched-chain-amino-acid aminotransferase,target,,DB03553
"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",,experimental,CBR1,Carbonyl reductase [NADPH] 1,target,,DB03556
"2-(2-{2-[2-(2-{2-[2-(2-Ethoxy-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethoxy]-Ethoxy}-Ethoxy)-Ethanol, Polyethyleneglycol Peg400",,experimental,VC_A0897,DevB protein,target,,DB03556
Cyclohexylformamide,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB03559
Cyclohexylformamide,,experimental,ADH4,Alcohol dehydrogenase 4,target,,DB03559
"(4r)-2-Methylpentane-2,4-Diol",,experimental,,1-pyrroline-5-carboxylate dehydrogenase,target,,DB03564
"(4r)-2-Methylpentane-2,4-Diol",,experimental,xylA,Xylose isomerase,target,,DB03564
Spermidine,,experimental,potD,Spermidine/putrescine-binding periplasmic protein,target,,DB03566
Spermidine,,experimental,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,,DB03566
Spermidine,,experimental,aacC1,Gentamicin 3'-acetyltransferase,target,,DB03566
Butanoic Acid,,experimental,BCHE,Cholinesterase,target,,DB03568
Butanoic Acid,,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB03568
Butanoic Acid,,experimental,,(S)-2-haloacid dehalogenase,target,,DB03568
Tris-Hydroxymethyl-Methyl-Ammonium,,experimental,panC,Pantothenate synthetase,target,,DB03570
Tris-Hydroxymethyl-Methyl-Ammonium,,experimental,azu,Azurin,target,,DB03570
Tris-Hydroxymethyl-Methyl-Ammonium,,experimental,tenI,Regulatory protein TenI,target,,DB03570
WRR-99,,experimental,,Cruzipain,target,,DB03573
WRR-99,,experimental,CTSF,Cathepsin F,target,,DB03573
Phencyclidine,Enzyme InhibitorsHallucinogensExcitatory Amino Acid Antagonists,illicit,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,antagonist,DB03575
Phencyclidine,Enzyme InhibitorsHallucinogensExcitatory Amino Acid Antagonists,illicit,SIGMAR1,Sigma non-opioid intracellular receptor 1,target,,DB03575
"Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate",,experimental,pabC,Aminodeoxychorismate lyase,target,,DB03579
"Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate",,experimental,alr,Alanine racemase,target,,DB03579
"Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate",,experimental,arnB,UDP-4-amino-4-deoxy-L-arabinose--oxoglutarate aminotransferase,target,,DB03579
Glucose-6-Phosphate,,experimental,glmS,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],target,,DB03581
Glucose-6-Phosphate,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB03581
4-Deoxy-4-Thio-Beta-D-Glucopyranose,,experimental,celA1,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",target,,DB03584
4-Deoxy-4-Thio-Beta-D-Glucopyranose,,experimental,cel5A,Endoglucanase 5A,target,,DB03584
4-Deoxy-4-Thio-Beta-D-Glucopyranose,,experimental,celCCF,Endoglucanase F,target,,DB03584
"2,6-Diaminopimelic Acid",,experimental,murE,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",target,,DB03590
"2,6-Diaminopimelic Acid",,experimental,ddh,Meso-diaminopimelate D-dehydrogenase,target,,DB03590
Pterin-6-Yl-Methyl-Monophosphate,,experimental,folP,Dihydropteroate synthase,target,,DB03592
Pterin-6-Yl-Methyl-Monophosphate,,experimental,folP1,Dihydropteroate synthase 1,target,,DB03592
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,,experimental,PDE9A,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",target,,DB03597
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,,experimental,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,,DB03597
Gamma-Glutamyl[S-(2-Iodobenzyl)Cysteinyl]Glycine,,experimental,GSTM4,Glutathione S-transferase Mu 4,target,,DB03597
Decanoic Acid,Antifungal Agents,experimental,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB03600
Decanoic Acid,Antifungal Agents,experimental,FURIN,Furin,target,,DB03600
Decanoic Acid,Antifungal Agents,experimental,pab,Peptostreptococcal albumin-binding protein,target,,DB03600
Decanoic Acid,Antifungal Agents,experimental,GLTP,Glycolipid transfer protein,target,,DB03600
Decanoic Acid,Antifungal Agents,experimental,lipB,Octanoyltransferase,target,,DB03600
Decanoic Acid,Antifungal Agents,experimental,tcp14,Putative uncharacterized protein tcp14,target,,DB03600
S-Benzyl-Glutathione,,experimental,GSTA1,Glutathione S-transferase A1,target,,DB03602
S-Benzyl-Glutathione,,experimental,GLO1,Lactoylglutathione lyase,target,,DB03602
(S)-Rolipram,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB03606
(S)-Rolipram,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB03606
Diminazene,Trypanocidal Agents,experimental,PRDX5,"Peroxiredoxin-5, mitochondrial",target,,DB03608
Diminazene,Trypanocidal Agents,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB03608
Diminazene,Trypanocidal Agents,experimental,PRSS1,Trypsin-1,target,,DB03608
Diminazene,Trypanocidal Agents,experimental,ABP1,Amiloride-sensitive amine oxidase [copper-containing],target,,DB03608
4-Hydroxyphenacyl Coenzyme A,,experimental,fcbC,4-hydroxybenzoyl-CoA thioesterase,target,,DB03613
4-Hydroxyphenacyl Coenzyme A,,experimental,,4-hydroxybenzoyl-CoA thioesterase,target,,DB03613
Ribostamycin,Anti-Bacterial AgentsAminoglycosides,experimental,aac(6')-Iy,Aminoglycoside N(6')-acetyltransferase type 1,target,,DB03615
Ribostamycin,Anti-Bacterial AgentsAminoglycosides,experimental,aac,Aminoglycoside 2'-N-acetyltransferase,target,,DB03615
Ribostamycin,Anti-Bacterial AgentsAminoglycosides,experimental,P4HB,Protein disulfide-isomerase,target,,DB03615
Ribostamycin,Anti-Bacterial AgentsAminoglycosides,experimental,rpsL,30S ribosomal protein S12,target,,DB03615
Argifin,,experimental,chiB1,Chitinase,target,,DB03632
Argifin,,experimental,CHIT1,Chitotriosidase-1,target,,DB03632
Lpc-Ether,,experimental,GM2A,Ganglioside GM2 activator,target,,DB03633
Lpc-Ether,,experimental,PLA2G1B,Phospholipase A2,target,,DB03633
Ethanesulfonic Acid,,experimental,phnX,Phosphonoacetaldehyde hydrolase,target,,DB03635
Ethanesulfonic Acid,,experimental,PPBP,Platelet basic protein,target,,DB03635
CRA_1144,,experimental,PRSS1,Trypsin-1,target,,DB03643
CRA_1144,,experimental,HPN,Serine protease hepsin,target,,DB03643
L-Glucuronic Acid,,experimental,algQ1,AlgQ1,target,,DB03652
L-Glucuronic Acid,,experimental,algQ2,AlgQ2,target,,DB03652
"S,S-Propylthiocysteine",,experimental,prfA,Listeriolysin regulatory protein,target,,DB03654
"S,S-Propylthiocysteine",,experimental,nuc,Thermonuclease,target,,DB03654
Iodo-Phenylalanine,,experimental,E,Lysozyme,target,,DB03660
Iodo-Phenylalanine,,experimental,pcp,Pseudomonalisin,target,,DB03660
Iodo-Phenylalanine,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB03660
Iodo-Phenylalanine,,experimental,,Aminopeptidase S,target,,DB03660
Cysteinesulfonic Acid,,experimental,blaVIM-2,Beta-lactamase class B VIM-2,target,,DB03661
Cysteinesulfonic Acid,,experimental,TM_1080,Ribose 5-phosphate isomerase B,target,,DB03661
Cysteinesulfonic Acid,,experimental,CTSL1,Cathepsin L1,target,,DB03661
Cysteinesulfonic Acid,,experimental,,Methylaspartate ammonia-lyase,target,,DB03661
Cysteinesulfonic Acid,,experimental,prx,1-cys peroxiredoxin,target,,DB03661
Cysteinesulfonic Acid,,experimental,def,Peptide deformylase,target,,DB03661
Cysteinesulfonic Acid,,experimental,GLIPR2,Golgi-associated plant pathogenesis-related protein 1,target,,DB03661
Cysteinesulfonic Acid,,experimental,TM_1158,Glutamine amidotransferase class-I,target,,DB03661
Cysteinesulfonic Acid,,experimental,def,Peptide deformylase,target,,DB03661
Cysteinesulfonic Acid,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB03661
Cysteinesulfonic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03661
Cysteinesulfonic Acid,,experimental,,Penicillin acylase,target,,DB03661
Cysteinesulfonic Acid,,experimental,luxS,S-ribosylhomocysteine lyase,target,,DB03661
Cysteinesulfonic Acid,,experimental,1,Deoxynucleotide monophosphate kinase,target,,DB03661
Cysteinesulfonic Acid,,experimental,CDC25B,M-phase inducer phosphatase 2,target,,DB03661
3'-Azido-3'-Deoxythymidine-5'-Monophosphate,,experimental,DTYMK,Thymidylate kinase,target,,DB03666
3'-Azido-3'-Deoxythymidine-5'-Monophosphate,,experimental,tmk,Thymidylate kinase,target,,DB03666
Methyl Mercury Ion,,experimental,CA2,Carbonic anhydrase 2,target,,DB03674
Methyl Mercury Ion,,experimental,MGAT1,"Alpha-1,3-mannosyl-glycoprotein 2-beta-N-acetylglucosaminyltransferase",target,,DB03674
Methyl Mercury Ion,,experimental,HI_1034,UPF0234 protein HI_1034,target,,DB03674
Methyl Mercury Ion,,experimental,CDC25B,M-phase inducer phosphatase 2,target,,DB03674
Cystein-S-Yl Cacodylate,,experimental,Tfu_1933,"Proteinase inhibitor I4, serpin",target,,DB03676
Cystein-S-Yl Cacodylate,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03676
Tartronate,,experimental,ME2,"NAD-dependent malic enzyme, mitochondrial",target,,DB03680
Tartronate,,experimental,ME3,"NADP-dependent malic enzyme, mitochondrial",target,,DB03680
Uridine-5'-Monophosphate,,experimental,rsuA,Ribosomal small subunit pseudouridine synthase A,target,,DB03685
Uridine-5'-Monophosphate,,experimental,UCKL1,Uridine-cytidine kinase-like 1,target,,DB03685
Uridine-5'-Monophosphate,,experimental,galT,Galactose-1-phosphate uridylyltransferase,target,,DB03685
Uridine-5'-Monophosphate,,experimental,thyA,Thymidylate synthase,target,,DB03685
Uridine-5'-Monophosphate,,experimental,GLT6D1,Glycosyltransferase 6 domain-containing protein 1,target,,DB03685
Uridine-5'-Monophosphate,,experimental,LSM6,U6 snRNA-associated Sm-like protein LSm6,target,,DB03685
Uridine-5'-Monophosphate,,experimental,upp,Uracil phosphoribosyltransferase,target,,DB03685
Uridine-5'-Monophosphate,,experimental,B4GALT1,"Beta-1,4-galactosyltransferase 1",target,,DB03685
Uridine-5'-Monophosphate,,experimental,ISG20,Interferon-stimulated gene 20 kDa protein,target,,DB03685
Uridine-5'-Monophosphate,,experimental,pyrF,Orotidine 5'-phosphate decarboxylase,target,,DB03685
Uridine-5'-Monophosphate,,experimental,pyrR,Bifunctional protein PyrR,target,,DB03685
Uridine-5'-Monophosphate,,experimental,upp,Uracil phosphoribosyltransferase,target,,DB03685
Uridine-5'-Monophosphate,,experimental,arnA,Bifunctional polymyxin resistance protein ArnA,target,,DB03685
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB03687
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,,experimental,ispE,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,target,,DB03687
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol,,experimental,ispD,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,target,,DB03687
WRR-112,,experimental,,Cruzipain,target,,DB03691
WRR-112,,experimental,CTSF,Cathepsin F,target,,DB03691
S-Ethyl-N-Phenyl-Isothiourea,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03707
S-Ethyl-N-Phenyl-Isothiourea,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03707
Adenosine-5'-Phosphosulfate,,experimental,TTHA0666,ATP sulfurylase (Sulfate adenylyltransferase),target,,DB03708
Adenosine-5'-Phosphosulfate,,experimental,PAPSS1,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,target,,DB03708
Bicine,,experimental,glf,UDP-galactopyranose mutase,target,,DB03709
Bicine,,experimental,PLG,Plasminogen,target,,DB03709
Bicine,,experimental,mltB,Membrane-bound lytic murein transglycosylase B,target,,DB03709
O-Sialic Acid,,experimental,L5,Fiber,target,,DB03721
O-Sialic Acid,,experimental,SIGLEC1,Sialoadhesin,target,,DB03721
O-Sialic Acid,,experimental,AZGP1,Zinc-alpha-2-glycoprotein,target,,DB03721
O-Sialic Acid,,experimental,,Capsid protein VP1,target,,DB03721
O-Sialic Acid,,experimental,L5,Fiber,target,,DB03721
O-Sialic Acid,,experimental,CES1,Liver carboxylesterase 1,target,,DB03721
O-Sialic Acid,,experimental,tetX,Tetanus toxin,target,,DB03721
O-Sialic Acid,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB03721
O-Sialic Acid,,experimental,botB,Botulinum neurotoxin type B,target,,DB03721
O-Sialic Acid,,experimental,SELP,P-selectin,target,,DB03721
O-Sialic Acid,,experimental,MBL2,Mannose-binding protein C,target,,DB03721
O-Sialic Acid,,experimental,SELE,E-selectin,target,,DB03721
O-Sialic Acid,,experimental,REG1A,Lithostathine-1-alpha,target,,DB03721
O-Sialic Acid,,experimental,,Endo-N-acetylneuraminidase,target,,DB03721
O-Sialic Acid,,experimental,entB,Enterotoxin type B,target,,DB03721
O-Sialic Acid,,experimental,NA,Neuraminidase,target,,DB03721
O-Sialic Acid,,experimental,HN,Hemagglutinin-neuraminidase,target,,DB03721
2'-Deoxy-Thymidine-Beta-L-Rhamnose,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB03723
2'-Deoxy-Thymidine-Beta-L-Rhamnose,,experimental,rfbD,dTDP-4-dehydrorhamnose reductase,target,,DB03723
S-2-(Boronoethyl)-L-Cysteine,,experimental,ARG1,Arginase-1,target,,DB03731
S-2-(Boronoethyl)-L-Cysteine,,experimental,ARG2,"Arginase-2, mitochondrial",target,,DB03731
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,lecB,Fucose-binding lectin PA-IIL,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,env,Envelope glycoprotein gp160,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,ACE,Angiotensin-converting enzyme,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,ACHE,Acetylcholinesterase,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,GBA,Glucosylceramidase,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,pdaA,Probable polysaccharide deacetylase PdaA,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,SIGLEC7,Sialic acid-binding Ig-like lectin 7,target,,DB03740
2-(Acetylamino)-2-Deoxy-a-D-Glucopyranose,,experimental,HN,Hemagglutinin-neuraminidase,target,,DB03740
Arabinose-5-Phosphate,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB03745
Arabinose-5-Phosphate,,experimental,rpiA,Ribose-5-phosphate isomerase A,target,,DB03745
"3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol",,experimental,hex,B-N-acetylhexosaminidase,target,,DB03747
"3ar,5r,6s,7r,7ar-5-Hydroxymethyl-2-Methyl-5,6,7,7a-Tetrahydro-3ah-Pyrano[3,2-D]Thiazole-6,7-Diol",,experimental,HEXB,Beta-hexosaminidase subunit beta,target,,DB03747
Isovaleric Acid,,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB03750
Isovaleric Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB03750
Isovaleric Acid,,experimental,pcp,Pseudomonalisin,target,,DB03750
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,experimental,rmlC,"DTDP-4-dehydrorhamnose 3,5-epimerase",target,,DB03751
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,experimental,rmlB,"dTDP-glucose 4,6-dehydratase",target,,DB03751
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB03751
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,experimental,desIV,"dTDP-glucose 4,6-dehydratase",target,,DB03751
2'deoxy-Thymidine-5'-Diphospho-Alpha-D-Glucose,,experimental,rfbB,"dTDP-glucose 4,6-dehydratase",target,,DB03751
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,lytA,Autolysin,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,cc4,Cytochrome c4,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,CANT1,Soluble calcium-activated nucleotidase 1,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,nlpI,Lipoprotein NlpI,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,dps,DNA protection during starvation protein,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,HI_1317,Putative glucose-6-phosphate 1-epimerase,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,NEIL1,Endonuclease 8-like 1,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,AMD1,S-adenosylmethionine decarboxylase proenzyme,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,bioB,Biotin synthase,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,VEGFA,Vascular endothelial growth factor A,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,pgl,6-phosphogluconolactonase,target,,DB03754
Tris(Hydroxymethyl)Aminomethane,Buffers,experimental,DCN,Decorin,target,,DB03754
Radicicol,Antifungal Agents,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB03758
Radicicol,Antifungal Agents,experimental,HSP90B1,Endoplasmin,target,,DB03758
Radicicol,Antifungal Agents,experimental,DLAT,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",target,,DB03758
Radicicol,Antifungal Agents,experimental,PDK3,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",target,,DB03758
Radicicol,Antifungal Agents,experimental,phoQ,Virulence sensor histidine kinase PhoQ,target,,DB03758
Dihydrolipoic Acid,,experimental,gcvT,Aminomethyltransferase,target,,DB03760
Dihydrolipoic Acid,,experimental,GCSH,"Glycine cleavage system H protein, mitochondrial",target,,DB03760
Dihydrolipoic Acid,,experimental,DLAT,"Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex, mitochondrial",target,,DB03760
Dihydrolipoic Acid,,experimental,PDK3,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 3, mitochondrial",target,,DB03760
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,,experimental,thyA1,Thymidylate synthase 1,target,,DB03761
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,,experimental,thyA,Thymidylate synthase,target,,DB03761
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,,experimental,thyA,Thymidylate synthase,target,,DB03761
5-Fluoro-2'-Deoxyuridine-5'-Monophosphate,,experimental,thyX,Thymidylate synthase ThyX,target,,DB03761
Propanoic Acid,,experimental,cpo,Non-heme chloroperoxidase,target,,DB03766
Propanoic Acid,,experimental,GPHN,Gephyrin,target,,DB03766
Propanoic Acid,,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB03766
Propanoic Acid,,experimental,alr,Alanine racemase,target,,DB03766
6-Deoxy-Alpha-D-Glucose,,experimental,,Alpha-amylase,target,,DB03773
6-Deoxy-Alpha-D-Glucose,,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB03773
6-Deoxy-Alpha-D-Glucose,,experimental,galM,Aldose 1-epimerase,target,,DB03773
D-Dethiobiotin,Mitogens,experimental,bioB,Biotin synthase,target,,DB03775
D-Dethiobiotin,Mitogens,experimental,bioD,ATP-dependent dethiobiotin synthetase BioD 1,target,,DB03775
D-Dethiobiotin,Mitogens,experimental,bioD,ATP-dependent dethiobiotin synthetase BioD,target,,DB03775
Rbt205 Inhibitor,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB03777
Rbt205 Inhibitor,,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB03777
Rbt205 Inhibitor,,experimental,PRKCI,Protein kinase C iota type,target,,DB03777
Benzoic Acid,Food Preservatives,experimental,oxyR,Hydrogen peroxide-inducible genes activator,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,malT,HTH-type transcriptional regulator MalT,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,pptA,Tautomerase PptA,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,DAO,D-amino-acid oxidase,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,HRSP12,Ribonuclease UK114,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,clcA,"Chlorocatechol 1,2-dioxygenase",target,,DB03793
Benzoic Acid,Food Preservatives,experimental,RAB9A,Ras-related protein Rab-9A,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB03793
Benzoic Acid,Food Preservatives,experimental,cpo,Non-heme chloroperoxidase,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,chqB,"Hydroxyquinol 1,2-dioxygenase",target,,DB03793
Benzoic Acid,Food Preservatives,experimental,repA,Replication protein,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,PRDX5,"Peroxiredoxin-5, mitochondrial",target,,DB03793
Benzoic Acid,Food Preservatives,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB03793
Benzoic Acid,Food Preservatives,experimental,cocE,Cocaine esterase,target,,DB03793
Palmitic Acid,Enzyme Inhibitors,experimental,PAEP,Glycodelin,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,HNF4G,Hepatocyte nuclear factor 4-gamma,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,,Lipid binding protein,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,CYP2C8,Cytochrome P450 2C8,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,TRAPPC3,Trafficking protein particle complex subunit 3,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,TM_1468,Fatty acid-binding protein TM_1468,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,RHO,Rhodopsin,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,SEC14L2,SEC14-like protein 2,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,PPT1,Palmitoyl-protein thioesterase 1,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,PMP2,Myelin P2 protein,target,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,LALBA,Alpha-lactalbumin,target,,DB03796
2'-Deoxycytidine-5'-Monophosphate,,experimental,42,Deoxycytidylate 5-hydroxymethyltransferase,target,,DB03798
2'-Deoxycytidine-5'-Monophosphate,,experimental,thyA,Thymidylate synthase,target,,DB03798
Trifluoromethionine,,experimental,map,Methionine aminopeptidase,target,,DB03799
Trifluoromethionine,,experimental,metG,Methionine--tRNA ligase,target,,DB03799
2'-deoxyuridylic acid,,experimental,THYA,Thymidylate synthase,target,,DB03800
2'-deoxyuridylic acid,,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB03800
2'-deoxyuridylic acid,,experimental,thyA,Thymidylate synthase,target,,DB03800
2'-deoxyuridylic acid,,experimental,thyA,Thymidylate synthase,target,,DB03800
2'-deoxyuridylic acid,,experimental,TYMS,Thymidylate synthase,target,,DB03800
2'-deoxyuridylic acid,,experimental,thyX,Thymidylate synthase ThyX,target,,DB03800
2'-deoxyuridylic acid,,experimental,pol,Pol polyprotein,target,,DB03800
2'-deoxyuridylic acid,,experimental,dut,Deoxyuridine 5'-triphosphate nucleotidohydrolase,target,,DB03800
Lysine Nz-Carboxylic Acid,,experimental,hyuA,D-hydantoinase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,bla,Beta-lactamase OXA-1,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,lhyD,L-hydantoinase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,,D-hydantoinase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,,Methylmalonyl-CoA carboxyltransferase 5S subunit,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,iadA,Isoaspartyl dipeptidase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,bla,Beta-lactamase OXA-2,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,dadX,"Alanine racemase, catabolic",target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,HP_0602,Endonuclease III,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,,Hydrolase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,TM_0306,"Alpha-L-fucosidase, putative",target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,bla,Beta-lactamase OXA-10,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,alr,Alanine racemase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,murE,"UDP-N-acetylmuramoyl-L-alanyl-D-glutamate--2,6-diaminopimelate ligase",target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,opd,Parathion hydrolase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,fgs,Folylpolyglutamate synthase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,pyrC,Dihydroorotase,target,,DB03801
Lysine Nz-Carboxylic Acid,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03801
"4,4'[1,6-Hexanediylbis(Oxy)]Bisbenzenecarboximidamide",,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB03808
"4,4'[1,6-Hexanediylbis(Oxy)]Bisbenzenecarboximidamide",,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB03808
Histidinol,,experimental,hisD,Histidinol dehydrogenase,target,,DB03811
Histidinol,,experimental,hisS,Histidine--tRNA ligase,target,,DB03811
2-Decenoyl N-Acetyl Cysteamine,,experimental,fabA,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase,target,,DB03813
2-Decenoyl N-Acetyl Cysteamine,,experimental,fabA,3-hydroxydecanoyl-[acyl-carrier-protein] dehydratase,target,,DB03813
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,ACHE,Acetylcholinesterase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,glmS,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,DFR1,Dihydrofolate reductase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,nirK,Copper-containing nitrite reductase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,glmU,Bifunctional protein GlmU,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,hcp,Hydroxylamine reductase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,lysA,Diaminopimelate decarboxylase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,yicI,Alpha-xylosidase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,limA,"Limonene-1,2-epoxide hydrolase",target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,manA,"Mannan endo-1,4-beta-mannosidase",target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,B4GALT1,"Beta-1,4-galactosyltransferase 1",target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,ABL,Tyrosine-protein kinase transforming protein Abl,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,dsbC,Thiol:disulfide interchange protein DsbC,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,gapA,Glyceraldehyde-3-phosphate dehydrogenase A,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,mdlB,(S)-mandelate dehydrogenase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,nir,Dissimilatory copper-containing nitrite reductase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,hslO,33 kDa chaperonin,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,yebR,Free methionine-R-sulfoxide reductase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,PP3533,Ornithine cyclodeaminase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,QDPR,Dihydropteridine reductase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,ASL,Argininosuccinate lyase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,ymdB,O-acetyl-ADP-ribose deacetylase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,ARL3,ADP-ribosylation factor-like protein 3,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,blaB,Beta-lactamase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,HI_1679,3-deoxy-D-manno-octulosonate 8-phosphate phosphatase KdsC,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,L3MBTL1,Lethal(3)malignant brain tumor-like protein 1,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,BCHE,Cholinesterase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,rnz,Ribonuclease Z,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,PRDX6,Peroxiredoxin-6,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,mglB,Hypothetical gliding protein,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,pep,Prolyl endopeptidase Pep,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,SFTPA1,Pulmonary surfactant-associated protein A1,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,,Manganese catalase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,aroG,Chorismate mutase AroH,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,SCO1207,Putative cytochrome P450,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,IRGC,Interferon-inducible GTPase 5,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,CMA1,Chymase,target,,DB03814
2-(N-Morpholino)-Ethanesulfonic Acid,,experimental,GSTP1,Glutathione S-transferase P,target,,DB03814
Ethyl Dihydrogen Phosphate,,experimental,opd,Parathion hydrolase,target,,DB03822
Ethyl Dihydrogen Phosphate,,experimental,BCHE,Cholinesterase,target,,DB03822
Rhodamine 6g,,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB03825
Rhodamine 6g,,experimental,acrB,Acriflavine resistance protein B,target,,DB03825
Gamma-Carboxy-Glutamic Acid,,experimental,F2,Prothrombin,target,,DB03847
Gamma-Carboxy-Glutamic Acid,,experimental,BGLAP,Osteocalcin,target,,DB03847
Gamma-Carboxy-Glutamic Acid,,experimental,F10,Coagulation factor X,target,,DB03847
Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB03849
Cis-4-Cyano-4-[3-(Cyclopentyloxy)-4-Methoxyphenyl]Cyclohexanecarboxylic Acid,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB03849
"(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium",,experimental,HEXB,Beta-hexosaminidase subunit beta,target,,DB03861
"(2r,3r,4s,5r)-2-Acetamido-3,4-Dihydroxy-5-Hydroxymethyl-Piperidinium",,experimental,KCNMB2,Calcium-activated potassium channel subunit beta-2,target,,DB03861
Tetrahydrooxazine,,experimental,cel5A,Endoglucanase 5A,target,,DB03862
Tetrahydrooxazine,,experimental,bglA,Beta-glucosidase A,target,,DB03862
2-O-Methyl Fucose,,experimental,cslA,Chondroitinase-AC,target,,DB03863
2-O-Methyl Fucose,,experimental,cslB,Chondroitinase-B,target,,DB03863
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,experimental,F2,Prothrombin,target,,DB03865
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB03865
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03865
6-Chloro-2-(2-Hydroxy-Biphenyl-3-Yl)-1h-Indole-5-Carboxamidine,,experimental,HPN,Serine protease hepsin,target,,DB03865
"Thieno[2,3-B]Pyridine-2-Carboxamidine",,experimental,PRSS1,Trypsin-1,target,,DB03876
"Thieno[2,3-B]Pyridine-2-Carboxamidine",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03876
N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,,experimental,ABL,Tyrosine-protein kinase transforming protein Abl,target,,DB03878
N-[4-Methyl-3-[[4-(3-Pyridinyl)-2-Pyrimidinyl]Amino]Phenyl]-3-Pyridinecarboxamide,,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB03878
Alpha-L-Methyl-Fucose,,experimental,MBL2,Mannose-binding protein C,target,,DB03879
Alpha-L-Methyl-Fucose,,experimental,cslA,Chondroitinase-AC,target,,DB03879
Batimastat,Antineoplastic AgentsProtease Inhibitors,experimental,MMP8,Neutrophil collagenase,target,,DB03880
Batimastat,Antineoplastic AgentsProtease Inhibitors,experimental,MMP12,Macrophage metalloelastase,target,,DB03880
Batimastat,Antineoplastic AgentsProtease Inhibitors,experimental,MMP16,Matrix metalloproteinase-16,target,,DB03880
Batimastat,Antineoplastic AgentsProtease Inhibitors,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB03880
Batimastat,Antineoplastic AgentsProtease Inhibitors,experimental,ADAMTS5,A disintegrin and metalloproteinase with thrombospondin motifs 5,target,,DB03880
MT-Immucillin-H,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB03881
MT-Immucillin-H,,experimental,PFE0660c,"Purine nucleotide phosphorylase, putative",target,,DB03881
3-Phenylpyruvic Acid,,experimental,pdh,L-phenylalanine dehydrogenase,target,,DB03884
3-Phenylpyruvic Acid,,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB03884
3-Phenylpyruvic Acid,,experimental,ipdC,Indole-3-pyruvate decarboxylase,target,,DB03884
3-Phenylpyruvic Acid,,experimental,CV_3270,Putative uncharacterized protein,target,,DB03884
3-Phenylpyruvic Acid,,experimental,bacB,Bacilysin biosynthesis protein BacB,target,,DB03884
3-Phenylpyruvic Acid,,experimental,pheA,Probable chorismate mutase,target,,DB03884
Biopterin,,experimental,SPR,Sepiapterin reductase,target,,DB03886
Biopterin,,experimental,PTS,6-pyruvoyl tetrahydrobiopterin synthase,target,,DB03886
Biopterin,,experimental,DHFR,Dihydrofolate reductase,target,,DB03886
Hydroxyphenyl Propionic Acid,,experimental,tpl,Tyrosine phenol-lyase,target,,DB03897
Hydroxyphenyl Propionic Acid,,experimental,tpl,Tyrosine phenol-lyase,target,,DB03897
Hydroxyphenyl Propionic Acid,,experimental,tyrA,Prephenate dehydrogenase,target,,DB03897
2-Methyl-2-Propanol,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03900
2-Methyl-2-Propanol,,experimental,TPI1,Triosephosphate isomerase,target,,DB03900
2-Methyl-2-Propanol,,experimental,METAP2,Methionine aminopeptidase 2,target,,DB03900
2-Methyl-2-Propanol,,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB03900
2-Methyl-2-Propanol,,experimental,CALM1,Calmodulin,target,,DB03900
Urea,,experimental,ARG1,Arginase-1,target,,DB03904
Urea,,experimental,CA2,Carbonic anhydrase 2,target,,DB03904
Urea,,experimental,,Structural polyprotein,target,,DB03904
Urea,,experimental,CTNNB1,Catenin beta-1,target,,DB03904
Urea,,experimental,yedY,Sulfoxide reductase catalytic subunit YedY,target,,DB03904
Urea,,experimental,folA,Dihydrofolate reductase,target,,DB03904
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,fgs,Folylpolyglutamate synthase,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,cheA,Chemotaxis protein CheA,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,murC,UDP-N-acetylmuramate--L-alanine ligase,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,gntK,Thermoresistant gluconokinase,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,purT,Phosphoribosylglycinamide formyltransferase 2,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,INSR,Insulin receptor,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,ATP2A1,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,PDXK,Pyridoxal kinase,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,PGK1,Phosphoglycerate kinase 1,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,pknB,Serine/threonine-protein kinase PknB,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,rbsK,Ribokinase,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,STM4066,Putative sugar kinase,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,buk2,Probable butyrate kinase 2,target,,DB03909
"Adenosine-5'-[Beta, Gamma-Methylene]Triphosphate",,experimental,KIF1A,Kinesin-like protein KIF1A,target,,DB03909
4'-Phosphopantetheine,,experimental,coaD,Phosphopantetheine adenylyltransferase,target,,DB03912
4'-Phosphopantetheine,,experimental,coaD,Phosphopantetheine adenylyltransferase,target,,DB03912
4'-Phosphopantetheine,,experimental,coaD,Phosphopantetheine adenylyltransferase,target,,DB03912
4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,,experimental,zipA,Cell division protein ZipA homolog,target,,DB03916
4-{2-[4-(2-Aminoethyl)Piperazin-1-Yl]Pyridin-4-Yl}-N-(3-Chloro-4-Methylphenyl)Pyrimidin-2-Amine,,experimental,zipA,Cell division protein ZipA,target,,DB03916
ONO-6818,,experimentalinvestigational,ELANE,Neutrophil elastase,target,inhibitor,DB03925
ONO-6818,,experimentalinvestigational,CELA1,Chymotrypsin-like elastase family member 1,target,,DB03925
D-Serine,,experimental,GLRA1,Glycine receptor subunit alpha-1,target,,DB03929
D-Serine,,experimental,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,,DB03929
D-Serine,,experimental,SERPINB3,Serpin B3,target,,DB03929
D-Serine,,experimental,shp,Head decoration protein,target,,DB03929
"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",,experimental,FGF2,Fibroblast growth factor 2,target,,DB03935
"1,4-Dideoxy-O2-Sulfo-Glucuronic Acid",,experimental,ANXA5,Annexin A5,target,,DB03935
Erythose-4-Phosphate,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB03937
Erythose-4-Phosphate,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB03937
Erythose-4-Phosphate,,experimental,aroF,Phospho-2-dehydro-3-deoxyheptonate aldolase,target,,DB03937
Oxamic Acid,,experimental,,L-lactate dehydrogenase,target,,DB03940
Oxamic Acid,,experimental,ldh,L-lactate dehydrogenase,target,,DB03940
Oxamic Acid,,experimental,LDHA,L-lactate dehydrogenase A chain,target,,DB03940
Oxamic Acid,,experimental,LDHB,L-lactate dehydrogenase B chain,target,,DB03940
Oxamic Acid,,experimental,pflB,Formate acetyltransferase 1,target,,DB03940
Oxamic Acid,,experimental,,D-lactate dehydrogenase,target,,DB03940
Carboxylic PRPP,,experimental,purF,Amidophosphoribosyltransferase,target,,DB03942
Carboxylic PRPP,,experimental,purR,Pur operon repressor,target,,DB03942
Carboxylic PRPP,,experimental,gpt,Xanthine phosphoribosyltransferase,target,,DB03942
Phosphocholine,,experimental,CRP,C-reactive protein,target,,DB03945
Phosphocholine,,experimental,ELSPBP1,Epididymal sperm-binding protein 1,target,,DB03945
Phosphocholine,,experimental,hlgB,Gamma-hemolysin component B,target,,DB03945
"6-Chloropurine Riboside, 5'-Monophosphate",,experimental,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1,target,,DB03948
"6-Chloropurine Riboside, 5'-Monophosphate",,experimental,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,,DB03948
16g,,experimental,GNPDA1,Glucosamine-6-phosphate isomerase 1,target,,DB03951
16g,,experimental,nagB,Glucosamine-6-phosphate deaminase,target,,DB03951
7-methyl-guanosine-5'-triphosphate-5'-guanosine,,experimental,DCPS,m7GpppX diphosphatase,target,,DB03958
7-methyl-guanosine-5'-triphosphate-5'-guanosine,,experimental,L1,RNA-directed RNA polymerase lambda-3,target,,DB03958
"N,O6-Disulfo-Glucosamine",,experimental,FGF2,Fibroblast growth factor 2,target,,DB03959
"N,O6-Disulfo-Glucosamine",,experimental,FGF1,Fibroblast growth factor 1,target,,DB03959
"N,O6-Disulfo-Glucosamine",,experimental,HS3ST3A1,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,target,,DB03959
"N,O6-Disulfo-Glucosamine",,experimental,HGF,Hepatocyte growth factor,target,,DB03959
"N,O6-Disulfo-Glucosamine",,experimental,C3L,Complement control protein C3,target,,DB03959
"N,O6-Disulfo-Glucosamine",,experimental,ANXA5,Annexin A5,target,,DB03959
S-(Dimethylarsenic)Cysteine,,experimental,TLR2,Toll-like receptor 2,target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,UL80,Capsid scaffolding protein,target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,COPG,Coatomer subunit gamma-1,target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,,Genome polyprotein,target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,XRCC4,DNA repair protein XRCC4,target,,DB03963
S-(Dimethylarsenic)Cysteine,,experimental,msrA,Peptide methionine sulfoxide reductase MsrA,target,,DB03963
Dodecyl Sulfate,,experimental,LYZ,Lysozyme C,target,,DB03967
Dodecyl Sulfate,,experimental,crcA,Lipid A palmitoyltransferase PagP,target,,DB03967
"(6,7-Dihydro-5h-Cyclopenta[D]Imidazo[2,1-B]Thiazol-2-Yl]-4,7-Dihydro[1,4]Thiazepine-3,6-Dicarboxylic Acid",,experimental,ampC,Beta-lactamase,target,,DB03970
"(6,7-Dihydro-5h-Cyclopenta[D]Imidazo[2,1-B]Thiazol-2-Yl]-4,7-Dihydro[1,4]Thiazepine-3,6-Dicarboxylic Acid",,experimental,bla,Beta-lactamase SHV-1,target,,DB03970
"(6,7-Dihydro-5h-Cyclopenta[D]Imidazo[2,1-B]Thiazol-2-Yl]-4,7-Dihydro[1,4]Thiazepine-3,6-Dicarboxylic Acid",,experimental,bla,Beta-lactamase SHV-1,target,,DB03970
"(6,7-Dihydro-5h-Cyclopenta[D]Imidazo[2,1-B]Thiazol-2-Yl]-4,7-Dihydro[1,4]Thiazepine-3,6-Dicarboxylic Acid",,experimental,,Class C beta-lactamase,target,,DB03970
Acarbose Derived Hexasaccharide,,experimental,amyM,Maltogenic alpha-amylase,target,,DB03971
Acarbose Derived Hexasaccharide,,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB03971
Mercuribenzoic Acid,,experimental,cutA,Divalent-cation tolerance protein CutA,target,,DB03975
Mercuribenzoic Acid,,experimental,CA2,Carbonic anhydrase 2,target,,DB03975
Phosphorylisopropane,,experimental,PRSS1,Trypsin-1,target,,DB03976
Phosphorylisopropane,,experimental,PRSS2,Trypsin-2,target,,DB03976
Phosphorylisopropane,,experimental,CTRB1,Chymotrypsinogen B,target,,DB03976
N-Trimethyllysine,Mitogens,experimental,CYCS,Cytochrome c,target,,DB03977
N-Trimethyllysine,Mitogens,experimental,CALM1,Calmodulin,target,,DB03977
Tyrosinal,,experimental,tyrS,Tyrosine--tRNA ligase,target,,DB03978
Tyrosinal,,experimental,pcp,Pseudomonalisin,target,,DB03978
Tyrosinal,,experimental,YARS,"Tyrosine--tRNA ligase, cytoplasmic",target,,DB03978
Tyrosinal,,experimental,YARS,Tyrosine--tRNA ligase,target,,DB03978
"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",,experimental,ANXA5,Annexin A5,target,,DB03981
"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",,experimental,FGF2,Fibroblast growth factor 2,target,,DB03981
"1,4-Dideoxy-5-Dehydro-O2-Sulfo-Glucuronic Acid",,experimental,HS3ST3A1,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,target,,DB03981
"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",,experimental,,Dihydrofolate reductase,target,,DB03987
"2,4-Diamino-6-[N-(3',5'-Dimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",,experimental,DHFR,Dihydrofolate reductase,target,,DB03987
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",,experimental,HN,Hemagglutinin-neuraminidase,target,,DB03991
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",,experimental,nedA,Sialidase,target,,DB03991
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",,experimental,NA,Neuraminidase,target,,DB03991
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",,experimental,HN,Hemagglutinin-neuraminidase,target,,DB03991
"2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",,experimental,NEU2,Sialidase-2,target,,DB03991
Ethanolamine,,experimental,nspA,Surface protein A,target,,DB03994
Ethanolamine,,experimental,ANXA3,Annexin A3,target,,DB03994
Cyclo-Hepta-Amylose,,experimental,tvaII,Neopullulanase 2,target,,DB03995
Cyclo-Hepta-Amylose,,experimental,malE,Maltose-binding periplasmic protein,target,,DB03995
Cyclo-Hepta-Amylose,,experimental,,Maltogenic amylase,target,,DB03995
Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester,,experimental,hisC,Histidinol-phosphate aminotransferase,target,,DB03997
Phosphoric Acid Mono-[2-Amino-3-(3h-Imidazol-4-Yl)-Propyl]Ester,,experimental,hisC,Histidinol-phosphate aminotransferase,target,,DB03997
Uridine 5'-Triphosphate,,experimental,UCK2,Uridine-cytidine kinase 2,target,,DB04005
Uridine 5'-Triphosphate,,experimental,,Genome polyprotein,target,,DB04005
Uridine 5'-Triphosphate,,experimental,,Genome polyprotein,target,,DB04005
Alsterpaullone,,experimental,CDK5,Cyclin-dependent kinase 5,target,,DB04014
Alsterpaullone,,experimental,CDK1,Cyclin-dependent kinase 1,target,inhibitor,DB04014
Alsterpaullone,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB04014
Methionine Phosphinate,,experimental,metG,Methionine--tRNA ligase,target,,DB04015
Methionine Phosphinate,,experimental,map,Methionine aminopeptidase,target,,DB04015
2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,,experimental,CTSG,Cathepsin G,target,,DB04016
2-[3-({Methyl[1-(2-Naphthoyl)Piperidin-4-Yl]Amino}Carbonyl)-2-Naphthyl]-1-(1-Naphthyl)-2-Oxoethylphosphonic Acid,,experimental,CMA1,Chymase,target,,DB04016
"Guanosine-5',3'-Tetraphosphate",,experimental,xpt,Xanthine phosphoribosyltransferase,target,,DB04022
"Guanosine-5',3'-Tetraphosphate",,experimental,obg,GTPase ObgE,target,,DB04022
Phenylalanine Amide,,experimental,,Genome polyprotein,target,,DB04029
Phenylalanine Amide,,experimental,,Genome polyprotein,target,,DB04029
Phenylalanine Amide,,experimental,daaA,D-Amino acid amidase,target,,DB04029
Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate,,experimental,blaCTX-M-14,Beta-lactamase CTX-M,target,,DB04035
Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate,,experimental,ampC,Beta-lactamase,target,,DB04035
Pinacol[[2-Amino-Alpha-(1-Carboxy-1-Methylethoxyimino)-4-Thiazoleacetyl]Amino]Methaneboronate,,experimental,bla,Beta-lactamase TEM,target,,DB04035
"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",,experimental,bla,Beta-lactamase TEM,target,,DB04037
"N,N-Bis(4-Chlorobenzyl)-1h-1,2,3,4-Tetraazol-5-Amine",,experimental,bla,Beta-lactamase TEM,target,,DB04037
3-Oxo-Pentadecanoic Acid,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB04039
3-Oxo-Pentadecanoic Acid,,experimental,btuB,Vitamin B12 transporter BtuB,target,,DB04039
3-Oxo-Pentadecanoic Acid,,experimental,ceaC,Colicin-E3,target,,DB04039
[Pterin-6-Yl Methanyl]-Phosphonophosphate,,experimental,folP,Dihydropteroate synthase,target,,DB04047
[Pterin-6-Yl Methanyl]-Phosphonophosphate,,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB04047
D-[(Amino)Carbonyl]Phenylalanine,,experimental,,N-carbamoyl-D-amino acid hydrolase,target,,DB04058
D-[(Amino)Carbonyl]Phenylalanine,,experimental,CPA1,Carboxypeptidase A1,target,,DB04058
Beta-D-Fucose,,experimental,araC,Arabinose operon regulatory protein,target,,DB04062
Beta-D-Fucose,,experimental,araF,L-arabinose-binding periplasmic protein,target,,DB04062
Para-Coumaric Acid,,experimental,pph,PPH,target,,DB04066
Para-Coumaric Acid,,experimental,pyp,Photoactive yellow protein,target,,DB04066
Para-Coumaric Acid,,experimental,PTGR1,Prostaglandin reductase 1,target,,DB04066
Para-Coumaric Acid,,experimental,hutH,Histidine ammonia-lyase,target,,DB04066
4-Hydroxybenzyl Coenzyme A,,experimental,fcbC,4-hydroxybenzoyl-CoA thioesterase,target,,DB04067
4-Hydroxybenzyl Coenzyme A,,experimental,,4-hydroxybenzoyl-CoA thioesterase,target,,DB04067
Alpha-ketoisovalerate,,experimental,panB,3-methyl-2-oxobutanoate hydroxymethyltransferase,target,,DB04074
Alpha-ketoisovalerate,,experimental,cefE,Deacetoxycephalosporin C synthase,target,,DB04074
Alpha-ketoisovalerate,,experimental,leuA,2-isopropylmalate synthase,target,,DB04074
Alpha-ketoisovalerate,,experimental,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,,DB04074
N-Acetyl-L-Glutamate,,experimental,argB,Acetylglutamate kinase,target,,DB04075
N-Acetyl-L-Glutamate,,experimental,argB,Acetylglutamate kinase,target,,DB04075
Glycerol,,experimental,nrdB,Ribonucleoside-diphosphate reductase 1 subunit beta,target,,DB04077
Glycerol,,experimental,mutY,A/G-specific adenine glycosylase,target,,DB04077
Glycerol,,experimental,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,target,,DB04077
Glycerol,,experimental,glpF,Glycerol uptake facilitator protein,target,,DB04077
Glycerol,,experimental,dctD,C4-dicarboxylate transport transcriptional regulatory protein DctD,target,,DB04077
Glycerol,,experimental,ADH1B,Alcohol dehydrogenase 1B,target,,DB04077
Glycerol,,experimental,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",target,,DB04077
Glycerol,,experimental,PAEP,Glycodelin,target,,DB04077
Glycerol,,experimental,NAGA,Alpha-N-acetylgalactosaminidase,target,,DB04077
Glycerol,,experimental,cc4,Cytochrome c4,target,,DB04077
Glycerol,,experimental,bfr,Bacterioferritin,target,,DB04077
Glycerol,,experimental,TGFBR2,TGF-beta receptor type-2,target,,DB04077
Glycerol,,experimental,argG,Argininosuccinate synthase,target,,DB04077
Glycerol,,experimental,eno,Enolase,target,,DB04077
Glycerol,,experimental,ARF1,ADP-ribosylation factor 1,target,,DB04077
Glycerol,,experimental,mexA,Multidrug resistance protein MexA,target,,DB04077
Glycerol,,experimental,PAPSS1,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,target,,DB04077
Glycerol,,experimental,hisD,Histidinol dehydrogenase,target,,DB04077
Glycerol,,experimental,mutL,DNA mismatch repair protein MutL,target,,DB04077
Glycerol,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB04077
Glycerol,,experimental,celCCG,Endoglucanase G,target,,DB04077
Glycerol,,experimental,GSTP1,Glutathione S-transferase P,target,,DB04077
Glycerol,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB04077
Glycerol,,experimental,ISYNA1,Inositol-3-phosphate synthase 1,target,,DB04077
"Heptane-1,2,3-Triol",,experimental,pilE1,Fimbrial protein,target,,DB04079
"Heptane-1,2,3-Triol",,experimental,fecA,Fe(3+) dicitrate transport protein FecA,target,,DB04079
"Heptane-1,2,3-Triol",,experimental,RHO,Rhodopsin,target,,DB04079
Decyloxy-Methanol,,experimental,frr,Ribosome-recycling factor,target,,DB04082
Decyloxy-Methanol,,experimental,frr,Ribosome-recycling factor,target,,DB04082
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,,Aspartate aminotransferase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,TM_1744,L-allo-threonine aldolase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,mdeA,Methionine gamma-lyase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,metB,Cystathionine gamma-synthase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,,Tyrosine aminotransferase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,CCBL1,Kynurenine--oxoglutarate transaminase 1,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,ODC1,Ornithine decarboxylase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,bioA,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,AGXT,Serine--pyruvate aminotransferase,target,,DB04083
N'-Pyridoxyl-Lysine-5'-Monophosphate,,experimental,aspC,Aspartate aminotransferase,target,,DB04083
Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,,experimental,deoC,Deoxyribose-phosphate aldolase,target,,DB04087
Open Form of 2'-Deoxy-Ribofuranose-5'-Phosphate,,experimental,deoC,Deoxyribose-phosphate aldolase,target,,DB04087
Deamido-Nad+,,experimental,nadE,NH(3)-dependent NAD(+) synthetase,target,,DB04099
Deamido-Nad+,,experimental,NMNAT1,Nicotinamide mononucleotide adenylyltransferase 1,target,,DB04099
Deamido-Nad+,,experimental,nadD,Nicotinate-nucleotide adenylyltransferase,target,,DB04099
Deamido-Nad+,,experimental,NMNAT3,Nicotinamide mononucleotide adenylyltransferase 3,target,,DB04099
Deamido-Nad+,,experimental,nadE,NH(3)-dependent NAD(+) synthetase,target,,DB04099
Deamido-Nad+,,experimental,nadE,NH(3)-dependent NAD(+) synthetase,target,,DB04099
Hexatantalum Dodecabromide,,experimental,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,target,,DB04119
Hexatantalum Dodecabromide,,experimental,UBA1,Ubiquitin-like modifier-activating enzyme 1,target,,DB04119
"4-Methyl-1,2-Benzenediol",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB04120
"4-Methyl-1,2-Benzenediol",,experimental,catA,"Catechol 1,2-dioxygenase",target,,DB04120
N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,,experimental,CTSB,Cathepsin B,target,,DB04126
N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-2-Methyl-Butane,,experimental,CTSH,Pro-cathepsin H,target,,DB04126
S-Hexylglutathione,,experimental,GLO1,Lactoylglutathione lyase,target,,DB04132
S-Hexylglutathione,,experimental,GSTM4,Glutathione S-transferase Mu 4,target,,DB04132
S-Hexylglutathione,,experimental,GSTP1,Glutathione S-transferase P,target,,DB04132
S-Hexylglutathione,,experimental,GST,Glutathione S-transferase,target,,DB04132
S-Hexylglutathione,,experimental,GSTA1,Glutathione S-transferase A1,target,,DB04132
S-Hexylglutathione,,experimental,GSTT2,Glutathione S-transferase theta-2,target,,DB04132
Degraded Cephaloridine,,experimental,blaZ,Beta-lactamase,target,,DB04133
Degraded Cephaloridine,,experimental,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB04133
Guanosine-5'-Triphosphate,,experimental,RAB5A,Ras-related protein Rab-5A,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,engB,Probable GTP-binding protein EngB,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,P2,RNA-directed RNA polymerase,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,UCKL1,Uridine-cytidine kinase-like 1,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,HRAS,GTPase HRas,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,,Genome polyprotein,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,RND3,Rho-related GTP-binding protein RhoE,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,,Genome polyprotein,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,RHEB,GTP-binding protein Rheb,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,folE,GTP cyclohydrolase 1,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",target,,DB04137
Guanosine-5'-Triphosphate,,experimental,A103R,mRNA-capping enzyme,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,,Genome polyprotein,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,ARF1,ADP-ribosylation factor 1,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,mobA,Molybdenum cofactor guanylyltransferase,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,odcI,"Ornithine decarboxylase, inducible",target,,DB04137
Guanosine-5'-Triphosphate,,experimental,GLUD1,"Glutamate dehydrogenase 1, mitochondrial",target,,DB04137
Guanosine-5'-Triphosphate,,experimental,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB04137
Guanosine-5'-Triphosphate,,experimental,RAP2A,Ras-related protein Rap-2a,target,,DB04137
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,ABO,Histo-blood group ABO system transferase,target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,MT-CYB,Cytochrome b,target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,SDHB,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,SDHD,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,ETFDH,"Electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial",target,,DB04141
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol",,experimental,SDHC,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",target,,DB04141
Indole-3-Glycerol Phosphate,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB04143
Indole-3-Glycerol Phosphate,,experimental,trpB,Tryptophan synthase beta chain,target,,DB04143
Lauryl Dimethylamine-N-Oxide,,experimental,fecA,Fe(3+) dicitrate transport protein FecA,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,fadL,Long-chain fatty acid transport protein,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,crcA,Lipid A palmitoyltransferase PagP,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,tesB,Acyl-CoA thioesterase 2,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufL,Reaction center protein L chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufM,Reaction center protein M chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,puhA,Reaction center protein H chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,ctaDII,Cytochrome c oxidase subunit 1-beta,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,ctaC,Cytochrome c oxidase subunit 2,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,,Ig kappa chain V-I region Bi,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,,Ig heavy chain V-III region VH26,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,puhA,Reaction center protein H chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufL,Reaction center protein L chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufM,Reaction center protein M chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,puhA,H subunit of photosynthetic reaction center complex,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,DSTN,Destrin,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,RHO,Rhodopsin,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,cycA,Cytochrome c2,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,NFE2L1,Nuclear factor erythroid 2-related factor 1,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,shc,Squalene--hopene cyclase,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,btuB,Vitamin B12 transporter BtuB,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,ceaC,Colicin-E3,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,fptA,Fe(3+)-pyochelin receptor,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,PMP2,Myelin P2 protein,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,ompW,Outer membrane protein W,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,,Light-harvesting protein B-800/850 alpha chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,,Light-harvesting protein B-800/850 beta chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,tonB,Protein TonB,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,cirA,Colicin I receptor,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,cia,Colicin-Ia,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,CFL1,Cofilin-1,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,glpG,Rhomboid protease GlpG,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,ompG,Outer membrane protein G,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,papC,Outer membrane usher protein PapC,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,nanC,Probable N-acetylneuraminic acid outer membrane channel protein NanC,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,puhA,Reaction center protein H chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufL,Reaction center protein L chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pufM,Reaction center protein M chain,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,porB,Outer membrane protein II,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,mll3241,Cyclic nucleotide-gated potassium channel mll3241,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,amtB,Ammonia channel,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,pbp2,Penicillin-binding protein 2,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,traO,TraO protein,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,traF,TraF protein,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,traN,TraN protein,target,,DB04147
Lauryl Dimethylamine-N-Oxide,,experimental,PFL_1329,"Outer membrane porin, OprD family",target,,DB04147
(R)-Rolipram,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB04149
(R)-Rolipram,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB04149
"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",,experimental,zipA,Cell division protein ZipA homolog,target,,DB04154
"N-Methyl-N-[3-(6-Phenyl[1,2,4]Triazolo[4,3-B]Pyridazin-3-Yl)Phenyl]Acetamide",,experimental,zipA,Cell division protein ZipA,target,,DB04154
Aspartate Beryllium Trifluoride,,experimental,CTDSP1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,target,,DB04156
Aspartate Beryllium Trifluoride,,experimental,supH,Sugar phosphatase YbiV,target,,DB04156
Aspartate Beryllium Trifluoride,,experimental,cheY,Chemotaxis protein CheY,target,,DB04156
Diphosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB04160
Diphosphate,,experimental,nadE,NH(3)-dependent NAD(+) synthetase,target,,DB04160
Diphosphate,,experimental,tmk,Thymidylate kinase,target,,DB04160
Diphosphate,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB04160
Diphosphate,,experimental,ispA,Farnesyl diphosphate synthase,target,,DB04160
Diphosphate,,experimental,idi,Isopentenyl-diphosphate Delta-isomerase,target,,DB04160
"5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione",,experimental,ribH2,"6,7-dimethyl-8-ribityllumazine synthase 2",target,,DB04162
"5-Nitro-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB04162
"5-Phenylsulfanyl-2,4-Quinazolinediamine",,experimental,DFR1,Dihydrofolate reductase,target,,DB04163
"5-Phenylsulfanyl-2,4-Quinazolinediamine",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB04163
2-Aminobenzoic Acid,,experimental,IL4I1,L-amino-acid oxidase,target,,DB04166
2-Aminobenzoic Acid,,experimental,DAO,D-amino-acid oxidase,target,,DB04166
Fructose,,experimental,lamB,Maltoporin,target,,DB04173
Fructose,,experimental,FHIT,Bis(5'-adenosyl)-triphosphatase,target,,DB04173
Di-Stearoyl-3-Sn-Phosphatidylcholine,,experimental,BPI,Bactericidal permeability-increasing protein,target,,DB04178
Di-Stearoyl-3-Sn-Phosphatidylcholine,,experimental,SLC25A4,ADP/ATP translocase 1,target,,DB04178
Norvaline,,experimental,OTC,"Ornithine carbamoyltransferase, mitochondrial",target,,DB04185
Norvaline,,experimental,GATM,"Glycine amidinotransferase, mitochondrial",target,,DB04185
Formycin B,,experimental,HGPRTase,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB04198
Formycin B,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB04198
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,,experimental,mxiM,Lipoprotein MxiM,target,,DB04199
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,,experimental,mxiM,Lipoprotein MxiM,target,,DB04199
1-Monohexanoyl-2-Hydroxy-Sn-Glycero-3-Phosphate,,experimental,ECs4578,GrlR,target,,DB04199
Histidyl-Adenosine Monophosphate,,experimental,hisS,Histidine--tRNA ligase,target,,DB04201
Histidyl-Adenosine Monophosphate,,experimental,hisS,Histidine--tRNA ligase,target,,DB04201
"Thymidine-3',5'-Diphosphate",,experimental,topA,DNA topoisomerase 1,target,,DB04205
"Thymidine-3',5'-Diphosphate",,experimental,nuc,Thermonuclease,target,,DB04205
Dequadin,,experimental,acrB,Acriflavine resistance protein B,target,,DB04209
Dequadin,,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB04209
4-Nitrophenyl Phosphate,Chromogenic Compounds,experimental,ACP1,Low molecular weight phosphotyrosine protein phosphatase,target,,DB04214
4-Nitrophenyl Phosphate,Chromogenic Compounds,experimental,DUSP23,Dual specificity protein phosphatase 23,target,,DB04214
Quercetin,Antioxidants,experimental,HCK,Tyrosine-protein kinase HCK,target,,DB04216
Quercetin,Antioxidants,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB04216
Quercetin,Antioxidants,experimental,UGT3A1,UDP-glucuronosyltransferase 3A1,target,,DB04216
Quercetin,Antioxidants,experimental,ATP5A1,"ATP synthase subunit alpha, mitochondrial",target,,DB04216
Quercetin,Antioxidants,experimental,ATP5B,"ATP synthase subunit beta, mitochondrial",target,,DB04216
Quercetin,Antioxidants,experimental,ATP5C1,"ATP synthase subunit gamma, mitochondrial",target,,DB04216
Quercetin,Antioxidants,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB04216
Quercetin,Antioxidants,experimental,ttgR,HTH-type transcriptional regulator TtgR,target,,DB04216
Quercetin,Antioxidants,experimental,HIBCH,"3-hydroxyisobutyryl-CoA hydrolase, mitochondrial",target,,DB04216
Quercetin,Antioxidants,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB04216
Quercetin,Antioxidants,experimental,STK17B,Serine/threonine-protein kinase 17B,target,,DB04216
L-2-amino-3-butynoic acid,Anti-Bacterial Agents,experimental,CTH,Cystathionine gamma-lyase,target,,DB04217
L-2-amino-3-butynoic acid,Anti-Bacterial Agents,experimental,sufS,Cysteine desulfurase,target,,DB04217
Nitroarginine,Enzyme Inhibitors,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB04223
Nitroarginine,Enzyme Inhibitors,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB04223
Oleic Acid,,experimental,GLTP,Glycolipid transfer protein,target,,DB04224
Oleic Acid,,experimental,,14 kDa fatty acid-binding protein,target,,DB04224
Oleic Acid,,experimental,PMP2,Myelin P2 protein,target,,DB04224
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,ompX,Outer membrane protein X,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,ompA,Outer membrane protein A,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,opmA,Porin,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,ompF,Outer membrane protein F,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,fadL,Long-chain fatty acid transport protein,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,shc,Squalene--hopene cyclase,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,btuB,Vitamin B12 transporter BtuB,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,CLPS,Colipase,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,PNLIP,Pancreatic triacylglycerol lipase,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,RHO,Rhodopsin,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,sll1541,"Apocarotenoid-15,15'-oxygenase",target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,ompG,Outer membrane protein G,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,ompW,Outer membrane protein W,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,hia,Adhesin,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,oprP,Porin P,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,oprD,Porin D,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,,Porin,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,opdK,Vanillate porin OpdK,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,papC,Outer membrane usher protein PapC,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,ompC,Outer membrane porin C,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,tbuX,TbuX,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,Pput_2883,Membrane protein involved in aromatic hydrocarbon degradation,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,PA4589,Probable outer membrane protein,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,TT_C0834,Hypothetical conserved protein,target,,DB04233
(Hydroxyethyloxy)Tri(Ethyloxy)Octane,,experimental,estA,Esterase EstA,target,,DB04233
Tris(Hydroxyethyl)Aminomethane,,experimental,AMY1A,Alpha-amylase 1,target,,DB04237
Tris(Hydroxyethyl)Aminomethane,,experimental,clcA,"Chlorocatechol 1,2-dioxygenase",target,,DB04237
Tris(Hydroxyethyl)Aminomethane,,experimental,alpha-LP,Alpha-lytic protease,target,,DB04237
P-Hydroxybenzoic Acid,,experimental,fcbC,4-hydroxybenzoyl-CoA thioesterase,target,,DB04242
P-Hydroxybenzoic Acid,,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB04242
P-Hydroxybenzoic Acid,,experimental,ubiC,Chorismate--pyruvate lyase,target,,DB04242
P-Hydroxybenzoic Acid,,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB04242
Monoisopropyl Ester Phosphonic Acid Group,,experimental,BVRF2,Capsid scaffolding protein,target,,DB04251
Monoisopropyl Ester Phosphonic Acid Group,,experimental,BCHE,Cholinesterase,target,,DB04251
CB1954,,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB04253
CB1954,,experimental,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB04253
Palmitoleic Acid,,experimental,cypC,Fatty-acid peroxygenase,target,,DB04257
Palmitoleic Acid,,experimental,CYP102A1,Bifunctional P-450/NADPH-P450 reductase,target,,DB04257
Palmitoleic Acid,,experimental,lpxC,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,target,,DB04257
Beta-Sialic Acid,,experimental,nedA,Sialidase,target,,DB04265
Beta-Sialic Acid,,experimental,,Endo-N-acetylneuraminidase,target,,DB04265
Beta-Sialic Acid,,experimental,HN,Hemagglutinin-neuraminidase,target,,DB04265
Beta-Sialic Acid,,experimental,tetX,Tetanus toxin,target,,DB04265
Dipicolinic Acid,,experimental,dapB,4-hydroxy-tetrahydrodipicolinate reductase,target,,DB04267
Dipicolinic Acid,,experimental,dapB,4-hydroxy-tetrahydrodipicolinate reductase,target,,DB04267
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,eda,KHG/KDPG aldolase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,mobA,Molybdenum cofactor guanylyltransferase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,fumC,Fumarate hydratase class II,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,pgl,6-phosphogluconolactonase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,gag-pro-pol,Gag-Pro-Pol polyprotein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,IL4I1,L-amino-acid oxidase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,MIF,Macrophage migration inhibitory factor,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,CTDSP1,Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,dxr,1-deoxy-D-xylulose 5-phosphate reductoisomerase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,trpA,Tryptophan synthase alpha chain,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,nedA,Sialidase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,,Cytochrome c peroxidase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,YPTB1668,Invasin,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,ITEVIR,Intron-associated endonuclease 1,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,12,Short tail fiber protein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,MDH2,"Malate dehydrogenase, mitochondrial",target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,purE,N5-carboxyaminoimidazole ribonucleotide mutase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,rplD,50S ribosomal protein L4,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,CPB1,Carboxypeptidase B,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,PII,Hexon protein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,TM_0857,Riboflavin biosynthesis protein RibF,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,bfrA,Beta-fructosidase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,sspA,Putative stringent starvation protein A,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,cit,Citrate synthase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,rtcA,RNA 3'-terminal phosphate cyclase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,LSM6,U6 snRNA-associated Sm-like protein LSm6,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,PLEKHA1,Pleckstrin homology domain-containing family A member 1,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,fbpA,Fe(3+)-binding periplasmic protein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,TM_0570,Signal recognition particle receptor FtsY,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,nadD,Nicotinate-nucleotide adenylyltransferase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,nusB,N utilization substance protein B homolog,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,C8G,Complement component C8 gamma chain,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,nrdF,Ribonucleoside-diphosphate reductase subunit beta,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,glnA1,Glutamine synthetase 1,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,gltA,Citrate synthase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,Tb11.02.2310,Prostaglandin F synthase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,ftsZ,Cell division protein FtsZ,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,APRT,Adenine phosphoribosyltransferase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,ANG,Angiogenin,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,blm,Beta-lactamase 2,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,BC_1747,Glyoxalase family protein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,UCK2,Uridine-cytidine kinase 2,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,yfiH,Laccase domain protein YfiH,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,BHMT,Betaine--homocysteine S-methyltransferase 1,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,rpiA,Ribose-5-phosphate isomerase A,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,trpS,Tryptophan--tRNA ligase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,guaA,GMP synthase [glutamine-hydrolyzing],target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,AKR1B1,Aldose reductase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,ITPA,Inosine triphosphate pyrophosphatase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,CS,"Citrate synthase, mitochondrial",target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,17,Lysozyme,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,HS3ST3A1,Heparan sulfate glucosamine 3-O-sulfotransferase 3A1,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,TM_1436,Glycerol uptake operon antiterminator regulatory protein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,pcaB,"3-carboxy-cis,cis-muconate cycloisomerase",target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,pdc,Pyruvate decarboxylase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,RNASE1,Ribonuclease pancreatic,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,icd,Isocitrate dehydrogenase [NADP],target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,GNMT,Glycine N-methyltransferase,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,RNASE3,Eosinophil cationic protein,target,,DB04272
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,penP,Beta-lactamase,target,,DB04272
N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,,experimental,srtB,NPQTN specific sortase B,target,,DB04276
N-[N-[1-Hydroxycarboxyethyl-Carbonyl]Leucylamino-Butyl]-Guanidine,,experimental,CAPN1,Calpain-1 catalytic subunit,target,,DB04276
3-Isopropylmalic Acid,,experimental,leuB,3-isopropylmalate dehydrogenase,target,,DB04279
3-Isopropylmalic Acid,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB04279
2-Deoxy-2fluoro-Glucose,,experimental,celB,Cellulase B,target,,DB04282
2-Deoxy-2fluoro-Glucose,,experimental,bglA,Beta-glucosidase A,target,,DB04282
2-Deoxy-2fluoro-Glucose,,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB04282
2-Deoxy-2fluoro-Glucose,,experimental,cex,Exoglucanase/xylanase,target,,DB04282
beta-D-Ribopyranose,,experimental,rbsB,D-ribose-binding periplasmic protein,target,,DB04286
beta-D-Ribopyranose,,experimental,rbsD,D-ribose pyranase,target,,DB04286
"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",Antifungal Agents,experimental,HDAC8,Histone deacetylase 8,target,,DB04297
"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",Antifungal Agents,experimental,acuC1,Acetoin utilization protein,target,,DB04297
"7-[4-(Dimethylamino)Phenyl]-N-Hydroxy-4,6-Dimethyl-7-Oxo-2,4-Heptadienamide",Antifungal Agents,experimental,HDAC7,Histone deacetylase 7,target,,DB04297
Maleic Acid,,experimental,GOT1,"Aspartate aminotransferase, cytoplasmic",target,,DB04299
Maleic Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB04299
Maleic Acid,,experimental,TPR,Trypanothione reductase,target,,DB04299
Maleic Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB04299
Maleic Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB04299
"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",,experimental,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB04302
"4-Hydroxy-3,5-Dimethyl-5-(2-Methyl-Buta-1,3-Dienyl)-5h-Thiophen-2-One",,experimental,kasA,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB04302
4-O-Methyl-Alpha-D-Glucuronic Acid,,experimental,xynC,Endoxylanase,target,,DB04303
4-O-Methyl-Alpha-D-Glucuronic Acid,,experimental,aguA,Alpha-glucuronidase,target,,DB04303
"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",,experimental,DFR1,Dihydrofolate reductase,target,,DB04306
"5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB04306
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,,Peptide deformylase 2,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def1,Peptide deformylase 1,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def2,Peptide deformylase 2,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,def,Peptide deformylase,target,,DB04310
2-[(Formyl-Hydroxy-Amino)-Methyl]-Heptanoic Acid [1-(2-Hydroxymethyl-Pyrrolidine-1-Carbonyl)-2-Methyl-Propyl]-Amide,,experimental,PDF,"Peptide deformylase, mitochondrial",target,,DB04310
Guanosine-5'-Diphosphate,,experimental,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,fusA,Elongation factor G,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,TUFM,"Elongation factor Tu, mitochondrial",target,,DB04315
Guanosine-5'-Diphosphate,,experimental,der,GTPase Der,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,nudD,GDP-mannose mannosyl hydrolase,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,engB,Probable GTP-binding protein EngB,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,EIF2S3,Eukaryotic translation initiation factor 2 subunit 3,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,GNAI1,Guanine nucleotide-binding protein G(i) subunit alpha-1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ffh,Signal recognition particle protein,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,GNAT1,Guanine nucleotide-binding protein G(t) subunit alpha-1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,tufB,Elongation factor Tu-B,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAB9A,Ras-related protein Rab-9A,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RHEB,GTP-binding protein Rheb,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,CDC42,Cell division control protein 42 homolog,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,tufA,Elongation factor Tu,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARF1,ADP-ribosylation factor 1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,EEF2,Elongation factor 2,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,relA,Bifunctional (p)ppGpp synthase/hydrolase RelA,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAP2A,Ras-related protein Rap-2a,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,EFTUD1,Elongation factor Tu GTP-binding domain-containing protein 1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARL1,ADP-ribosylation factor-like protein 1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAN,GTP-binding nuclear protein Ran,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAB7A,Ras-related protein Rab-7a,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,IRGC,Interferon-inducible GTPase 5,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,GSPT1,Eukaryotic peptide chain release factor GTP-binding subunit ERF3A,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAB5A,Ras-related protein Rab-5A,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,HRAS,GTPase HRas,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,EEF1A1,Elongation factor 1-alpha 1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RHOA,Transforming protein RhoA,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARF4,ADP-ribosylation factor 4,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,TGM2,Protein-glutamine gamma-glutamyltransferase 2,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,GMDS,"GDP-mannose 4,6 dehydratase",target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAB11A,Ras-related protein Rab-11A,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RALA,Ras-related protein Ral-A,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,tuf,Elongation factor Tu,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARL5B,ADP-ribosylation factor-like protein 5B,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ftsZ,Cell division protein FtsZ,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,TGM3,Protein-glutamine gamma-glutamyltransferase E,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,rab6,GTPase (Rab6),target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAB8B,Ras-related protein Rab-8B,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARF6,ADP-ribosylation factor 6,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARL3,ADP-ribosylation factor-like protein 3,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,NME2,Nucleoside diphosphate kinase B,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,gca,"GDP-mannose 4,6-dehydratase",target,,DB04315
Guanosine-5'-Diphosphate,,experimental,RAC1,Ras-related C3 botulinum toxin substrate 1,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,rsgA,Putative ribosome biogenesis GTPase RsgA,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,SAR1B,GTP-binding protein SAR1b,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,Adss,Adenylosuccinate synthetase,target,,DB04315
Guanosine-5'-Diphosphate,,experimental,ARL5A,ADP-ribosylation factor-like protein 5A,target,,DB04315
6-Deoxyglucose,,experimental,amyA,Cyclomaltodextrin glucanotransferase,target,,DB04319
6-Deoxyglucose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB04319
Ovalicin,,experimental,METAP2,Methionine aminopeptidase 2,target,,DB04324
Ovalicin,,experimental,METAP1,Methionine aminopeptidase 1,target,,DB04324
2-Phenylethylamine,,experimental,tynA,Primary amine oxidase,target,,DB04325
2-Phenylethylamine,,experimental,PRSS2,Trypsin-2,target,,DB04325
2-Phenylethylamine,,experimental,PRSS1,Trypsin-1,target,,DB04325
"1,3-Dihydroxyacetonephosphate",,experimental,ALDOA,Fructose-bisphosphate aldolase A,target,,DB04326
"1,3-Dihydroxyacetonephosphate",,experimental,TPI1,Triosephosphate isomerase,target,,DB04326
"1,3-Dihydroxyacetonephosphate",,experimental,ALDOB,Fructose-bisphosphate aldolase B,target,,DB04326
"1,3-Dihydroxyacetonephosphate",,experimental,fucA,L-fuculose phosphate aldolase,target,,DB04326
Phosphatidylethanolamine,,experimental,alr3165,Bacteriorhodopsin,target,,DB04327
Phosphatidylethanolamine,,experimental,PROCR,Endothelial protein C receptor,target,,DB04327
Shikimate-3-Phosphate,,experimental,aroA,3-phosphoshikimate 1-carboxyvinyltransferase,target,,DB04328
Shikimate-3-Phosphate,,experimental,aroA,3-phosphoshikimate 1-carboxyvinyltransferase,target,,DB04328
6-hydroxydopa quinone,,experimental,AOC3,Membrane primary amine oxidase,target,,DB04334
6-hydroxydopa quinone,,experimental,tynA,Primary amine oxidase,target,,DB04334
6-hydroxydopa quinone,,experimental,,Phenylethylamine oxidase,target,,DB04334
Inosine,,investigational,,IAG-nucleoside hydrolase,target,,DB04335
Inosine,,investigational,PNP,Purine nucleoside phosphorylase,target,,DB04335
Inosine,,investigational,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB04335
SB220025,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB04338
SB220025,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB04338
"Glyoxalate, Glyoxylate",,experimental,glcB,Malate synthase G,target,,DB04343
"Glyoxalate, Glyoxylate",,experimental,icl,Isocitrate lyase,target,,DB04343
"Glyoxalate, Glyoxylate",,experimental,glcB,Malate synthase G,target,,DB04343
"Glyoxalate, Glyoxylate",,experimental,Rv3853,Putative regulator of ribonuclease activity,target,,DB04343
"7,8-dimethylalloxazine",,experimental,TM_0857,Riboflavin biosynthesis protein RibF,target,,DB04345
"7,8-dimethylalloxazine",,experimental,BLVRB,Flavin reductase (NADPH),target,,DB04345
3-Dehydroshikimate,,experimental,aroD,3-dehydroquinate dehydratase,target,,DB04347
3-Dehydroshikimate,,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB04347
Taurocholic Acid,,experimental,CEL,Bile salt-activated lipase,target,,DB04348
Taurocholic Acid,,experimental,FABP6,Gastrotropin,target,,DB04348
"S-1,2-Propanediol",,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB04349
"S-1,2-Propanediol",,experimental,rsbQ,Sigma factor SigB regulation protein RsbQ,target,,DB04349
Argadin,,experimental,chiB1,Chitinase,target,,DB04350
Argadin,,experimental,CHIT1,Chitotriosidase-1,target,,DB04350
Aconitate Ion,,experimental,ACO2,"Aconitate hydratase, mitochondrial",target,,DB04351
Aconitate Ion,,experimental,acnB,Aconitate hydratase 2,target,,DB04351
"[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate",,experimental,rbsD,D-ribose pyranase,target,,DB04352
"[(2r,3s,4s,5r)-3,4,5-Trihydroxytetrahydrofuran-2-Yl]Methyl Dihydrogen Phosphate",,experimental,NUDT9,"ADP-ribose pyrophosphatase, mitochondrial",target,,DB04352
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,,WbpP,target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,GYG1,Glycogenin-1,target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,GALE,UDP-glucose 4-epimerase,target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,otsA,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,galE,UDP-glucose 4-epimerase,target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,bgt,DNA beta-glucosyltransferase,target,,DB04355
Uridine-5'-Monophosphate Glucopyranosyl-Monophosphateester,,experimental,GLT6D1,Glycosyltransferase 6 domain-containing protein 1,target,,DB04355
Debromohymenialdisine,,experimental,TNK2,Activated CDC42 kinase 1,target,,DB04367
Debromohymenialdisine,,experimental,CLK1,Dual specificity protein kinase CLK1,target,,DB04367
Bb-3497,,experimental,def,Peptide deformylase,target,,DB04368
Bb-3497,,experimental,PDF,"Peptide deformylase, mitochondrial",target,inhibitor,DB04368
1-Hydroxy-2-Amino-3-Cyclohexylpropane,,experimental,REN,Renin,target,,DB04387
1-Hydroxy-2-Amino-3-Cyclohexylpropane,,experimental,SAP2,Candidapepsin-2,target,,DB04387
"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB04392
"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB04392
"Bishydroxy[2h-1-Benzopyran-2-One,1,2-Benzopyrone]",,experimental,azoR,FMN-dependent NADH-azoreductase,target,,DB04392
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,hslU,ATP-dependent protease ATPase subunit HslU,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,EPHB2,Ephrin type-B receptor 2,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,trwB,TrwB,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,CFTR,Cystic fibrosis transmembrane conductance regulator,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,VCP,Transitional endoplasmic reticulum ATPase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,TRPM7,Transient receptor potential cation channel subfamily M member 7,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,KIF1A,Kinesin-like protein KIF1A,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,CCT3,T-complex protein 1 subunit gamma,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,TM_0588,Rod shape-determining protein MreB,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,SRPK2,SRSF protein kinase 2,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,MAPK12,Mitogen-activated protein kinase 12,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,clpB,Chaperone protein ClpB,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,epsE,Type II secretion system protein E,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,phoQ,Sensor protein PhoQ,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,parE,DNA topoisomerase 4 subunit B,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,GALK1,Galactokinase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,recA,Protein RecA,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,RAD51,DNA repair protein RAD51 homolog 1,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,kdpB,Potassium-transporting ATPase B chain,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,DTYMK,Thymidylate kinase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,cheA,Chemotaxis protein CheA,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,IGF1R,Insulin-like growth factor 1 receptor,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,dhaK,Dihydroxyacetone kinase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,coaA,Pantothenate kinase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,HK1,Hexokinase-1,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,purT,Phosphoribosylglycinamide formyltransferase 2,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,EPHA2,Ephrin type-A receptor 2,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,argG,Argininosuccinate synthase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,metK,S-adenosylmethionine synthase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,murC,UDP-N-acetylmuramate--L-alanine ligase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,envZ,Osmolarity sensor protein EnvZ,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,gyrB,DNA gyrase subunit B,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,mutL,DNA mismatch repair protein MutL,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,KIF2C,Kinesin-like protein KIF2C,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,ITPKA,Inositol-trisphosphate 3-kinase A,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,TOP2B,DNA topoisomerase 2-beta,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,GSS,Glutathione synthetase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,ispE,4-diphosphocytidyl-2-C-methyl-D-erythritol kinase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,PFKFB4,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,aphA,Aminoglycoside 3'-phosphotransferase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,DAPK1,Death-associated protein kinase 1,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,arsA,Arsenical pump-driving ATPase,target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB04395
Phosphoaminophosphonic Acid-Adenylate Ester,,experimental,argB,Acetylglutamate kinase,target,,DB04395
Thiodigalactoside,,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB04396
Thiodigalactoside,,experimental,lacY,Lactose permease,target,,DB04396
Thiodigalactoside,,experimental,NCAN,Neurocan core protein,target,,DB04396
Thiodigalactoside,,experimental,LGALS1,Galectin-1,target,,DB04396
Lactic Acid,,experimental,putA,Bifunctional protein PutA,target,,DB04398
Lactic Acid,,experimental,DR_0842,NimA-related protein,target,,DB04398
"7,8-Dihydrobiopterin",,experimental,TH,Tyrosine 3-monooxygenase,target,,DB04400
"7,8-Dihydrobiopterin",,experimental,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,target,,DB04400
"7,8-Dihydrobiopterin",,experimental,PAH,Phenylalanine-4-hydroxylase,target,,DB04400
"7,8-Dihydrobiopterin",,experimental,PTR1,Pteridine reductase 1,target,,DB04400
"7,8-Dihydrobiopterin",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB04400
"7,8-Dihydrobiopterin",,experimental,folB,Dihydroneopterin aldolase,target,,DB04400
Allosamizoline,,experimental,chiB,Chitinase B,target,,DB04404
Allosamizoline,,experimental,chiA,Chitinase A,target,,DB04404
Allosamizoline,,experimental,CHIT1,Chitotriosidase-1,target,,DB04404
3-Phenylpropylamine,,experimental,PRSS2,Trypsin-2,target,,DB04410
3-Phenylpropylamine,,experimental,PRSS1,Trypsin-1,target,,DB04410
P-Nitrophenol,,experimental,SULT1A1,Sulfotransferase 1A1,target,,DB04417
P-Nitrophenol,,experimental,AMY2B,Alpha-amylase 2B,target,,DB04417
Norleucine,,experimental,PTH,Parathyroid hormone,target,,DB04419
Norleucine,,experimental,HNF1A,Hepatocyte nuclear factor 1-alpha,target,,DB04419
Norleucine,,experimental,PAH,Phenylalanine-4-hydroxylase,target,,DB04419
2-Amino-4-Mercapto-Butyric Acid,,experimental,metE,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,target,,DB04422
2-Amino-4-Mercapto-Butyric Acid,,experimental,TM_0268,5-methyltetrahydrofolate S-homocysteine methyltransferase,target,,DB04422
2-Amino-4-Mercapto-Butyric Acid,,experimental,luxS,S-ribosylhomocysteine lyase,target,,DB04422
3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,,experimental,bla,Beta-lactamase TEM,target,,DB04430
3-(4-Phenylamino-Phenylamino)-2-(1h-Tetrazol-5-Yl)-Acrylonitrile,,experimental,bla,Beta-lactamase TEM,target,,DB04430
Tetrafluoroaluminate Ion,,experimental,argB,Acetylglutamate kinase,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,GNAI1,Guanine nucleotide-binding protein G(i) subunit alpha-1,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,ATP2A1,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,GNAT1,Guanine nucleotide-binding protein G(t) subunit alpha-1,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,CMPK1,UMP-CMP kinase,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,MYH11,Myosin-11,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,MYH14,Myosin-14,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,recA,Protein RecA,target,,DB04444
Tetrafluoroaluminate Ion,,experimental,rbsK,Ribokinase,target,,DB04444
"1,4-Dithiothreitol",,experimental,paiA,Protease synthase and sporulation negative regulatory protein PAI 1,target,,DB04447
"1,4-Dithiothreitol",,experimental,acpS,Holo-[acyl-carrier-protein] synthase,target,,DB04447
"1,4-Dithiothreitol",,experimental,hisD,Histidinol dehydrogenase,target,,DB04447
"1,4-Dithiothreitol",,experimental,aroE,Shikimate dehydrogenase,target,,DB04447
"1,4-Dithiothreitol",,experimental,LGALS1,Galectin-1,target,,DB04447
"1,4-Dithiothreitol",,experimental,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,target,,DB04447
"1,4-Dithiothreitol",,experimental,rpmA,50S ribosomal protein L27,target,,DB04447
"1,4-Dithiothreitol",,experimental,ALDH1A1,Retinal dehydrogenase 1,target,,DB04447
"1,4-Dithiothreitol",,experimental,ohr,Organic hydroperoxide resistance protein,target,,DB04447
"1,4-Dithiothreitol",,experimental,pcaB,"3-carboxy-cis,cis-muconate cycloisomerase",target,,DB04447
"1,4-Dithiothreitol",,experimental,TRPM7,Transient receptor potential cation channel subfamily M member 7,target,,DB04447
"1,4-Dithiothreitol",,experimental,ugl,Unsaturated glucuronyl hydrolase,target,,DB04447
"1,4-Dithiothreitol",,experimental,moaA,Cyclic pyranopterin monophosphate synthase,target,,DB04447
"1,4-Dithiothreitol",,experimental,bca,C protein alpha-antigen,target,,DB04447
"1,4-Dithiothreitol",,experimental,MSRA,Mitochondrial peptide methionine sulfoxide reductase,target,,DB04447
"1,4-Dithiothreitol",,experimental,torD,Chaperone protein TorD,target,,DB04447
"1,4-Dithiothreitol",,experimental,AXIN1,Axin-1,target,,DB04447
"1,4-Dithiothreitol",,experimental,PPIB,Peptidyl-prolyl cis-trans isomerase B,target,,DB04447
"1,4-Dithiothreitol",,experimental,ams,Amylosucrase,target,,DB04447
"1,4-Dithiothreitol",,experimental,thyA,Thymidylate synthase,target,,DB04447
"1,4-Dithiothreitol",,experimental,TPI1,Triosephosphate isomerase,target,,DB04447
"1,4-Dithiothreitol",,experimental,GSTZ1,Maleylacetoacetate isomerase,target,,DB04447
"1,4-Dithiothreitol",,experimental,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB04447
"1,4-Dithiothreitol",,experimental,prfA,Listeriolysin regulatory protein,target,,DB04447
Heptyl 1-Thiohexopyranoside,,experimental,RHO,Rhodopsin,target,,DB04450
Heptyl 1-Thiohexopyranoside,,experimental,fpr,NADPH:ferredoxin reductase,target,,DB04450
Heptyl 1-Thiohexopyranoside,,experimental,acpP,Acyl carrier protein,target,,DB04450
Heptyl 1-Thiohexopyranoside,,experimental,bioI,Biotin biosynthesis cytochrome P450,target,,DB04450
4-Methylpiperazin-1-Yl Carbonyl Group,,experimental,SAP2,Candidapepsin-2,target,,DB04451
4-Methylpiperazin-1-Yl Carbonyl Group,,experimental,CTSL2,Cathepsin L2,target,,DB04451
Alpha-Aminobutyric Acid,,experimental,EGF,Pro-epidermal growth factor,target,,DB04454
Alpha-Aminobutyric Acid,,experimental,mrsA,Lantibiotic mersacidin,target,,DB04454
Alpha-Aminobutyric Acid,,experimental,GATM,"Glycine amidinotransferase, mitochondrial",target,,DB04454
Alpha-Aminobutyric Acid,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04454
Trimethyl Glycine,,experimental,proX,Glycine betaine-binding periplasmic protein,target,,DB04455
Trimethyl Glycine,,experimental,kaiB,Circadian clock protein KaiB,target,,DB04455
Trihydroxyarsenite(Iii),,experimental,arsA,Arsenical pump-driving ATPase,target,,DB04456
Trihydroxyarsenite(Iii),,experimental,arsC,Arsenate reductase,target,,DB04456
2'-Deoxyguanosine-5'-Monophosphate,,experimental,1,Deoxynucleotide monophosphate kinase,target,,DB04457
2'-Deoxyguanosine-5'-Monophosphate,,experimental,thyA,Thymidylate synthase,target,,DB04457
N-Formylmethionine,,experimental,gshA,Glutamate--cysteine ligase,target,,DB04464
N-Formylmethionine,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB04464
N-Formylmethionine,,experimental,CLPP,"Putative ATP-dependent Clp protease proteolytic subunit, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,RABGGTA,Geranylgeranyl transferase type-2 subunit alpha,target,,DB04464
N-Formylmethionine,,experimental,RABGGTB,Geranylgeranyl transferase type-2 subunit beta,target,,DB04464
N-Formylmethionine,,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB04464
N-Formylmethionine,,experimental,puhA,Reaction center protein H chain,target,,DB04464
N-Formylmethionine,,experimental,pufL,Reaction center protein L chain,target,,DB04464
N-Formylmethionine,,experimental,pufM,Reaction center protein M chain,target,,DB04464
N-Formylmethionine,,experimental,,Light-harvesting protein B-800/820 alpha chain,target,,DB04464
N-Formylmethionine,,experimental,,Light-harvesting protein B-800/820 beta chain,target,,DB04464
N-Formylmethionine,,experimental,,Light-harvesting protein B-800/850 alpha chain,target,,DB04464
N-Formylmethionine,,experimental,,Light-harvesting protein B-800/850 beta chain,target,,DB04464
N-Formylmethionine,,experimental,SERPINC1,Antithrombin-III,target,,DB04464
N-Formylmethionine,,experimental,B2M,Beta-2-microglobulin,target,,DB04464
N-Formylmethionine,,experimental,MT-ND1,NADH-ubiquinone oxidoreductase chain 1,target,,DB04464
N-Formylmethionine,,experimental,HLA-B,"HLA class I histocompatibility antigen, B-27 alpha chain",target,,DB04464
N-Formylmethionine,,experimental,narG,Respiratory nitrate reductase 1 alpha chain,target,,DB04464
N-Formylmethionine,,experimental,narH,Respiratory nitrate reductase 1 beta chain,target,,DB04464
N-Formylmethionine,,experimental,narI,Respiratory nitrate reductase 1 gamma chain,target,,DB04464
N-Formylmethionine,,experimental,S100G,Protein S100-G,target,,DB04464
N-Formylmethionine,,experimental,rub,Rubredoxin,target,,DB04464
N-Formylmethionine,,experimental,COX4I1,"Cytochrome c oxidase subunit 4 isoform 1, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,MT-CO1,Cytochrome c oxidase subunit 1,target,,DB04464
N-Formylmethionine,,experimental,MT-CO2,Cytochrome c oxidase subunit 2,target,,DB04464
N-Formylmethionine,,experimental,MT-CO3,Cytochrome c oxidase subunit 3,target,,DB04464
N-Formylmethionine,,experimental,COX5A,"Cytochrome c oxidase subunit 5A, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,COX6C,Cytochrome c oxidase subunit 6C,target,,DB04464
N-Formylmethionine,,experimental,COX7B,"Cytochrome c oxidase subunit 7B, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,COX7C,"Cytochrome c oxidase subunit 7C, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,COX8A,"Cytochrome c oxidase subunit 8A, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,COX6A2,"Cytochrome c oxidase subunit 6A2, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,COX6B1,Cytochrome c oxidase subunit 6B1,target,,DB04464
N-Formylmethionine,,experimental,COX7A1,"Cytochrome c oxidase subunit 7A1, mitochondrial",target,,DB04464
N-Formylmethionine,,experimental,fmt,Methionyl-tRNA formyltransferase,target,,DB04464
N-Formylmethionine,,experimental,,Streptavidin,target,,DB04464
N-Formylmethionine,,experimental,S100B,Protein S100-B,target,,DB04464
N-Formylmethionine,,experimental,hld,Delta-hemolysin,target,,DB04464
N-Formylmethionine,,experimental,UBC,Polyubiquitin-C,target,,DB04464
N-Formylmethionine,,experimental,atpH,AtpH,target,,DB04464
N-Formylmethionine,,experimental,ulaG,Probable L-ascorbate-6-phosphate lactonase UlaG,target,,DB04464
N-Formylmethionine,,experimental,spg,Immunoglobulin G-binding protein G,target,,DB04464
Lactose,,experimental,GLT6D1,Glycosyltransferase 6 domain-containing protein 1,target,,DB04465
Lactose,,experimental,GLTP,Glycolipid transfer protein,target,,DB04465
Lactose,,experimental,entB,Enterotoxin type B,target,,DB04465
Lactose,,experimental,nedA,Sialidase,target,,DB04465
Lactose,,experimental,,Hydrolase,target,,DB04465
Lactose,,experimental,xlnA,"Endo-1,4-beta-xylanase A",target,,DB04465
Lactose,,experimental,lacZ,Beta-galactosidase,target,,DB04465
Lactose,,experimental,tetX,Tetanus toxin,target,,DB04465
Pyridoxyl-Alanine-5-Phosphate,,experimental,c-des,L-cysteine/cystine lyase C-DES,target,,DB04467
Pyridoxyl-Alanine-5-Phosphate,,experimental,alr,Alanine racemase,target,,DB04467
Pyridoxyl-Alanine-5-Phosphate,,experimental,aspC,Aspartate aminotransferase,target,,DB04467
Afimoxifene,Estrogen Antagonists,investigational,ESR2,Estrogen receptor beta,target,,DB04468
Afimoxifene,Estrogen Antagonists,investigational,ESRRG,Estrogen-related receptor gamma,target,,DB04468
Afimoxifene,Estrogen Antagonists,investigational,ESR1,Estrogen receptor,target,,DB04468
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,,experimental,hheC,Halohydrin dehalogenase,target,,DB04472
(R)-1-Para-Nitro-Phenyl-2-Azido-Ethanol,,experimental,LGALS9,Galectin-9,target,,DB04472
Alpha-L-Fucose,,experimental,,Genome polyprotein,target,,DB04473
Alpha-L-Fucose,,experimental,env,Envelope glycoprotein gp160,target,,DB04473
Alpha-L-Fucose,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB04473
Alpha-L-Fucose,,experimental,,Genome polyprotein,target,,DB04473
1-Anilino-8-Naphthalene Sulfonate,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB04474
1-Anilino-8-Naphthalene Sulfonate,,experimental,S100A7,Protein S100-A7,target,,DB04474
Cmp-2-Keto-3-Deoxy-Octulosonic Acid,,experimental,kdsB,3-deoxy-manno-octulosonate cytidylyltransferase,target,,DB04482
Cmp-2-Keto-3-Deoxy-Octulosonic Acid,,experimental,kpsU,3-deoxy-manno-octulosonate cytidylyltransferase,target,,DB04482
Deoxythymidine,,experimental,TK,Thymidine kinase,target,,DB04485
Deoxythymidine,,experimental,TK2,"Thymidine kinase 2, mitochondrial",target,,DB04485
Deoxythymidine,,experimental,rmlA,Glucose-1-phosphate thymidylyltransferase,target,,DB04485
Deoxythymidine,,experimental,tsx,Nucleoside-specific channel-forming protein tsx,target,,DB04485
Deoxythymidine,,experimental,tmk,Thymidylate kinase,target,,DB04485
Deoxythymidine,,experimental,TK,Thymidine kinase,target,,DB04485
Deoxythymidine,,experimental,udp,Uridine phosphorylase,target,,DB04485
Diisopropylphosphono Group,,experimental,CFB,Complement factor B,target,,DB04491
Diisopropylphosphono Group,,experimental,estB,Esterase EstB,target,,DB04491
Diisopropylphosphono Group,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB04491
Diisopropylphosphono Group,,experimental,apr,Subtilisin BPN',target,,DB04491
Fructose-6-Phosphate,,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB04493
Fructose-6-Phosphate,,experimental,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",target,,DB04493
Fructose-6-Phosphate,,experimental,pfkA,6-phosphofructokinase,target,,DB04493
Fructose-6-Phosphate,,experimental,PFKFB4,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4",target,,DB04493
Fructose-6-Phosphate,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB04493
3-Phosphoglyceric Acid,,experimental,PGK1,Phosphoglycerate kinase 1,target,,DB04510
3-Phosphoglyceric Acid,,experimental,pgk/tpi,Bifunctional PGK/TIM,target,,DB04510
3-Phosphoglyceric Acid,,experimental,TPI,Triosephosphate isomerase,target,,DB04510
3-Phosphoglyceric Acid,,experimental,gpmI,"2,3-bisphosphoglycerate-independent phosphoglycerate mutase",target,,DB04510
3-Phosphoglyceric Acid,,experimental,PGAM2,Phosphoglycerate mutase 2,target,,DB04510
3-Phosphoglyceric Acid,,experimental,TPI1,Triosephosphate isomerase,target,,DB04510
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,,experimental,CALM1,Calmodulin,target,,DB04513
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,,experimental,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,,DB04513
N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide,,experimental,TNNI3,"Troponin I, cardiac muscle",target,,DB04513
Caprylic acid,,experimental,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB04519
Caprylic acid,,experimental,tesA,Acyl-CoA thioesterase I,target,,DB04519
"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",,experimental,chiB,Chitinase B,target,,DB04520
"(3s,8ar)-3-(4-Hydroxybenzyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",,experimental,chiB,Chitinase,target,,DB04520
Phosphonoserine,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB04522
Phosphonoserine,,experimental,spoIIAA,Anti-sigma F factor antagonist,target,,DB04522
Phosphonoserine,,experimental,pilE1,Fimbrial protein,target,,DB04522
Phosphonoserine,,experimental,phoA,Alkaline phosphatase,target,,DB04522
Phosphonoserine,,experimental,SERPINB3,Serpin B3,target,,DB04522
Phosphonoserine,,experimental,xynY,"Endo-1,4-beta-xylanase Y",target,,DB04522
Phosphonoserine,,experimental,RHO,Rhodopsin,target,,DB04522
Phosphonoserine,,experimental,TAOK2,Serine/threonine-protein kinase TAO2,target,,DB04522
Phosphonoserine,,experimental,KCNC4,Potassium voltage-gated channel subfamily C member 4,target,,DB04522
Phosphonoserine,,experimental,REG1A,Lithostathine-1-alpha,target,,DB04522
Phosphonoserine,,experimental,SMAD2,Mothers against decapentaplegic homolog 2,target,,DB04522
Phosphonoserine,,experimental,glsA1,Glutaminase 1,target,,DB04522
Phosphonoserine,,experimental,cysG,Siroheme synthase,target,,DB04522
Phosphonoserine,,experimental,ptsH,Phosphocarrier protein HPr,target,,DB04522
Phosphonoserine,,experimental,CFTR,Cystic fibrosis transmembrane conductance regulator,target,,DB04522
Phosphonoserine,,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB04522
Phosphonoserine,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB04522
Phosphonoserine,,experimental,PRKCQ,Protein kinase C theta type,target,,DB04522
Phosphonoserine,,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB04522
Phosphonoserine,,experimental,algC,Phosphomannomutase/phosphoglucomutase,target,,DB04522
Phosphonoserine,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04522
Desvancosaminyl Vancomycin,,experimental,gtfD,Glycosyltransferase GtfD,target,,DB04529
Desvancosaminyl Vancomycin,,experimental,gtfA,Glycosyltransferase GtfA,target,,DB04529
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,SERPINB5,Serpin B5,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,rmlC,"dTDP-4-dehydrorhamnose 3,5-epimerase",target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,PDE1B,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B",target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,SNX3,Sorting nexin-3,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,licT,Transcription antiterminator LicT,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,CYTH2,Cytohesin-2,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,thyA,Thymidylate synthase,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,TYMS,Thymidylate synthase,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,ARG1,Arginase-1,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,lacZ,Beta-galactosidase,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,malE,Maltose-binding periplasmic protein,target,,DB04530
"S,S-(2-Hydroxyethyl)Thiocysteine",,experimental,hemB,Delta-aminolevulinic acid dehydratase,target,,DB04530
Indole,,experimental,E,Lysozyme,target,,DB04532
Indole,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB04532
5-Nitroindazole,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB04534
5-Nitroindazole,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB04534
L-Tryptophanamide,,experimental,trpS,Tryptophan--tRNA ligase,target,,DB04537
L-Tryptophanamide,,experimental,WARS,"Tryptophan--tRNA ligase, cytoplasmic",target,,DB04537
Glyphosate,Herbicides,experimental,aroA,3-phosphoshikimate 1-carboxyvinyltransferase,target,inhibitor,DB04539
Glyphosate,Herbicides,experimental,aroA,3-phosphoshikimate 1-carboxyvinyltransferase,target,,DB04539
"(3r,4r,5r)-5-(Hydroxymethyl)Piperidine-3,4-Diol",,experimental,bglA,Beta-glucosidase A,target,,DB04545
"(3r,4r,5r)-5-(Hydroxymethyl)Piperidine-3,4-Diol",,experimental,celA1,"Possible cellulase CelA1 (Endoglucanase) (Endo-1,4-beta-glucanase) (FI-cmcase) (Carboxymethyl cellulase)",target,,DB04545
"(3r,4r,5r)-5-(Hydroxymethyl)Piperidine-3,4-Diol",,experimental,cel5A,Endoglucanase 5A,target,,DB04545
4-Deoxy-D-Glucuronic Acid,,experimental,hylB,Hyaluronate lyase,target,,DB04548
4-Deoxy-D-Glucuronic Acid,,experimental,aly,Alginate lyase,target,,DB04548
4-Deoxy-D-Glucuronic Acid,,experimental,SP_0314,Hyaluronate lyase,target,,DB04548
4-Deoxy-D-Glucuronic Acid,,experimental,cslB,Chondroitinase-B,target,,DB04548
"Fructose-1,6-Diphosphate",,experimental,glpK,Glycerol kinase,target,,DB04551
"Fructose-1,6-Diphosphate",,experimental,PKLR,Pyruvate kinase PKLR,target,,DB04551
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PLA2G1B,Phospholipase A2,target,inhibitor,DB04552
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB04552
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,CLCNKA,Chloride channel protein ClC-Ka,target,inducer,DB04552
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PTGS1,Prostaglandin G/H synthase 1,target,,DB04552
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,PLA2G4A,Cytosolic phospholipase A2,target,,DB04552
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,UGT1A9,UDP-glucuronosyltransferase 1-9,target,,DB04552
2-Oxobutanoic Acid,,experimental,,Methylmalonyl-CoA carboxyltransferase 5S subunit,target,,DB04553
2-Oxobutanoic Acid,,experimental,acdS,1-aminocyclopropane-1-carboxylate deaminase,target,,DB04553
Cytidine-5'-Diphosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB04555
Cytidine-5'-Diphosphate,,experimental,neuA,N-acylneuraminate cytidylyltransferase,target,,DB04555
Cytidine-5'-Diphosphate,,experimental,cmk,Cytidylate kinase,target,,DB04555
Cytidine-5'-Diphosphate,,experimental,rfbE,CDP-paratose 2-epimerase,target,,DB04555
Cytidine-5'-Diphosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB04555
Cytidine-5'-Diphosphate,,experimental,kpsU,3-deoxy-manno-octulosonate cytidylyltransferase,target,,DB04555
Arachidonic Acid,,experimental,,14 kDa fatty acid-binding protein,target,,DB04557
Arachidonic Acid,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB04557
"4,7-Dioxosebacic Acid",,experimental,hemB,Delta-aminolevulinic acid dehydratase,target,,DB04560
"4,7-Dioxosebacic Acid",,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB04560
"4,7-Dioxosebacic Acid",,experimental,hemB,Delta-aminolevulinic acid dehydratase,target,,DB04560
Inosinic Acid,,experimental,guaB,Inosine-5'-monophosphate dehydrogenase,target,,DB04566
Inosinic Acid,,experimental,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB04566
Inosinic Acid,,experimental,hpt,Hypoxanthine phosphoribosyltransferase,target,,DB04566
Inosinic Acid,,experimental,purA,Adenylosuccinate synthetase,target,,DB04566
Inosinic Acid,,experimental,HGPRTase,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB04566
Inosinic Acid,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04566
Inosinic Acid,,experimental,purA,Adenylosuccinate synthetase,target,,DB04566
Inosinic Acid,,experimental,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,,DB04566
Latamoxef,Anti-Bacterial AgentsCephalosporins,approved,pbpC,Penicillin-binding protein 3,target,inhibitor,DB04570
Latamoxef,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB04570
Latamoxef,Anti-Bacterial AgentsCephalosporins,approved,mrcB,Penicillin-binding protein 1B,target,inhibitor,DB04570
Latamoxef,Anti-Bacterial AgentsCephalosporins,approved,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,inhibitor,DB04570
Estriol,,approved,ESR1,Estrogen receptor,target,agonist,DB04573
Estriol,,approved,ESR2,Estrogen receptor beta,target,agonist,DB04573
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,ESR1,Estrogen receptor,target,agonist,DB04574
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,ESR2,Estrogen receptor beta,target,agonist,DB04574
Fleroxacin,Enzyme InhibitorsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsQuinolones,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB04576
Fleroxacin,Enzyme InhibitorsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsQuinolones,approved,gyrA,DNA gyrase subunit A,target,inhibitor,DB04576
Fleroxacin,Enzyme InhibitorsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsQuinolones,approved,parC,DNA topoisomerase 4 subunit A,target,inhibitor,DB04576
Aniracetam,Nootropic AgentsAntidepressive Agents,experimental,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB04599
Aniracetam,Nootropic AgentsAntidepressive Agents,experimental,DRD2,D(2) dopamine receptor,target,,DB04599
Aniracetam,Nootropic AgentsAntidepressive Agents,experimental,GRIA2,Glutamate receptor 2,target,,DB04599
Aniracetam,Nootropic AgentsAntidepressive Agents,experimental,GRIA3,Glutamate receptor 3,target,,DB04599
5-iodotubercidin,,experimental,CSNK1G2,Casein kinase I isoform gamma-2,target,,DB04604
5-iodotubercidin,,experimental,GSG2,Serine/threonine-protein kinase haspin,target,,DB04604
5-iodotubercidin,,experimental,MAPK3,Mitogen-activated protein kinase 3,target,,DB04604
Allosamidin,Enzyme InhibitorsInsecticides,experimental,chiB,Chitinase B,target,,DB04628
Allosamidin,Enzyme InhibitorsInsecticides,experimental,chiA,Chitinase A,target,,DB04628
Atpenin A5,,experimental,sdhA,Succinate dehydrogenase flavoprotein subunit,target,,DB04631
Atpenin A5,,experimental,sdhB,Succinate dehydrogenase iron-sulfur subunit,target,,DB04631
Atpenin A5,,experimental,sdhC,Succinate dehydrogenase cytochrome b556 subunit,target,,DB04631
Atpenin A5,,experimental,sdhD,Succinate dehydrogenase hydrophobic membrane anchor subunit,target,,DB04631
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,,experimental,,Genome polyprotein,target,,DB04634
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,,experimental,,Genome polyprotein,target,,DB04634
N-BENZYLOXYCARBONYL-L-SERINE-BETALACTONE,,experimental,,Genome polyprotein,target,,DB04634
Biphenylalanine,,experimental,env,Envelope glycoprotein gp160,target,,DB04639
Biphenylalanine,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB04639
"Naphthalene-2,6-disulfonic acid",,experimental,,L-lactate dehydrogenase,target,,DB04640
"Naphthalene-2,6-disulfonic acid",,experimental,XCC1738,Bacterioferritin comigratory protein,target,,DB04640
Dibromothymoquinone,,experimental,petB,Cytochrome b6,target,,DB04646
Dibromothymoquinone,,experimental,petC,Cytochrome b6-f complex iron-sulfur subunit,target,,DB04646
Dibromothymoquinone,,experimental,petD,Cytochrome b6-f complex subunit 4,target,,DB04646
Dibromothymoquinone,,experimental,petA,Apocytochrome f,target,,DB04646
Dibromothymoquinone,,experimental,petG,Cytochrome b6-f complex subunit 5,target,,DB04646
Dibromothymoquinone,,experimental,petL,Cytochrome b6-f complex subunit 6,target,,DB04646
Dibromothymoquinone,,experimental,petM,Cytochrome b6-f complex subunit 7,target,,DB04646
Dibromothymoquinone,,experimental,petN,Cytochrome b6-f complex subunit 8,target,,DB04646
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,,experimental,dacA,D-alanyl-D-alanine carboxypeptidase DacA,target,,DB04647
BOC-GAMMA-D-GLU-L-LYS(CBZ)-D-BOROALA,,experimental,dacA,D-alanyl-D-alanine carboxypeptidase DacA,target,,DB04647
"(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE",,experimental,NR3C2,Mineralocorticoid receptor,target,,DB04652
"(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB04652
"(11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB04652
4-PIPERIDIN-4-YLBUTANAL,,experimental,PRSS1,Trypsin-1,target,,DB04654
4-PIPERIDIN-4-YLBUTANAL,,experimental,TPSB2,Tryptase beta-2,target,,DB04654
"2-HYDROXY-3,5-DIIODOBENZOIC ACID",,experimental,EDNRA,Endothelin-1 receptor,target,,DB04674
"2-HYDROXY-3,5-DIIODOBENZOIC ACID",,experimental,AKR1C1,Aldo-keto reductase family 1 member C1,target,,DB04674
"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,PF11_0282,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, putative",target,,DB04685
"1-{(2S,5S)-4-FLUORO-5-[(TRITYLOXY)METHYL]TETRAHYDROFURAN-2-YL}PYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",target,,DB04685
ECGONINE METHYL ESTER,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB04688
ECGONINE METHYL ESTER,,experimental,IGKC,Ig kappa chain C region,target,,DB04688
FARNESYL THIOPYROPHOSPHATE,,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB04695
FARNESYL THIOPYROPHOSPHATE,,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB04695
FARNESYL THIOPYROPHOSPHATE,,experimental,MVK,Mevalonate kinase,target,,DB04695
FARNESYL THIOPYROPHOSPHATE,,experimental,crtM,Dehydrosqualene synthase,target,,DB04695
HYDROXYFASUDIL,,experimental,ROCK1,Rho-associated protein kinase 1,target,inhibitor,DB04707
HYDROXYFASUDIL,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB04707
HYDROXYFASUDIL,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB04707
ISOPENTENYL PYROPHOSPHATE,,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB04714
ISOPENTENYL PYROPHOSPHATE,,experimental,FDPS,Farnesyl pyrophosphate synthase,target,,DB04714
ISOPENTENYL PYROPHOSPHATE,,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB04714
ISOPENTENYL PYROPHOSPHATE,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB04714
ISOPENTENYL PYROPHOSPHATE,,experimental,uppS,Decaprenyl diphosphate synthase,target,,DB04714
ISOPENTENYL PYROPHOSPHATE,,experimental,ispH,4-hydroxy-3-methylbut-2-enyl diphosphate reductase,target,,DB04714
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",,experimental,JAK2,Tyrosine-protein kinase JAK2,target,,DB04716
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",,experimental,DAPK3,Death-associated protein kinase 3,target,,DB04716
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",,experimental,JAK1,Tyrosine-protein kinase JAK1,target,,DB04716
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",,experimental,JAK3,Tyrosine-protein kinase JAK3,target,,DB04716
"2-(1,1-DIMETHYLETHYL)9-FLUORO-3,6-DIHYDRO-7H-BENZ[H]-IMIDAZ[4,5-F]ISOQUINOLIN-7-ONE",,experimental,TYK2,Non-receptor tyrosine-protein kinase TYK2,target,,DB04716
Licofelone,,investigational,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB04725
Licofelone,,investigational,PTGS2,Prostaglandin G/H synthase 2,target,,DB04725
Licofelone,,investigational,ALOX5,Arachidonate 5-lipoxygenase,target,,DB04725
GENTAMICIN C1A,,experimental,rpsL,30S ribosomal protein S12,target,adduct,DB04729
N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,,experimental,prcA,Proteasome subunit alpha,target,,DB04732
N-(4-MORPHOLINE)CARBONYL-B-(1-NAPHTHYL)-L-ALANINE-L-LEUCINE BORONIC ACID,,experimental,prcB,Proteasome subunit beta,target,,DB04732
Nimesulide,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB04743
Nimesulide,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB04743
Nimesulide,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,LTF,Lactotransferrin,target,,DB04743
Purvalanol A,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB04751
Purvalanol A,,experimental,CSNK1G3,Casein kinase I isoform gamma-3,target,,DB04751
Purvalanol A,,experimental,RPS6KA1,Ribosomal protein S6 kinase alpha-1,target,,DB04751
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,P2RY2,P2Y purinoceptor 2,target,antagonist,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",target,inhibitor,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,FSHR,Follicle-stimulating hormone receptor,target,antagonist,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,RYR1,Ryanodine receptor 1,target,agonist,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,F2,Prothrombin,target,inhibitor,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,PLA2G2A,"Phospholipase A2, membrane associated",target,inhibitor,DB04786
Suramin,Antineoplastic AgentsAntinematodal AgentsTrypanocidal Agents,approved,C3L,Complement control protein C3,target,,DB04786
Tagetitoxin,,experimental,rpoB,DNA-directed RNA polymerase subunit beta,target,,DB04788
Tagetitoxin,,experimental,rpoC,DNA-directed RNA polymerase subunit beta',target,,DB04788
Bifonazole,Antifungal Agents,approved,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB04794
Bifonazole,Antifungal Agents,approved,CYP2B6,Cytochrome P450 2B6,target,,DB04794
Thenoyltrifluoroacetone,Chelating Agents,experimental,CES1,Liver carboxylesterase 1,target,,DB04795
Thenoyltrifluoroacetone,Chelating Agents,experimental,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",target,,DB04795
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,MT-CYB,Cytochrome b,target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB04799
"5-n-undecyl-6-hydroxy-4,7-dioxobenzothiazole",,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB04799
Nialamide,Antidepressive AgentsMonoamine Oxidase Inhibitors,withdrawn,MAOB,Amine oxidase [flavin-containing] B,target,,DB04820
Nialamide,Antidepressive AgentsMonoamine Oxidase Inhibitors,withdrawn,MAOA,Amine oxidase [flavin-containing] A,target,,DB04820
Nialamide,Antidepressive AgentsMonoamine Oxidase Inhibitors,withdrawn,COMT,Catechol O-methyltransferase,target,,DB04820
Nomifensine,Dopamine Uptake Inhibitors,withdrawn,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB04821
Nomifensine,Dopamine Uptake Inhibitors,withdrawn,SLC6A3,Sodium-dependent dopamine transporter,target,,DB04821
Nomifensine,Dopamine Uptake Inhibitors,withdrawn,MAOB,Amine oxidase [flavin-containing] B,target,,DB04821
Nomifensine,Dopamine Uptake Inhibitors,withdrawn,MAOA,Amine oxidase [flavin-containing] A,target,,DB04821
Nomifensine,Dopamine Uptake Inhibitors,withdrawn,MPO,Myeloperoxidase,target,,DB04821
Prenylamine,Adrenergic AgentsVasodilator AgentsCalcium Channel Blockers,withdrawn,CALM1,Calmodulin,target,,DB04825
Prenylamine,Adrenergic AgentsVasodilator AgentsCalcium Channel Blockers,withdrawn,,"Myosin light chain kinase 2, skeletal/cardiac muscle",target,,DB04825
Zimelidine,Serotonin Uptake Inhibitors,withdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,,DB04832
Zimelidine,Serotonin Uptake Inhibitors,withdrawn,MAOB,Amine oxidase [flavin-containing] B,target,inhibitor,DB04832
Zimelidine,Serotonin Uptake Inhibitors,withdrawn,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB04832
Amineptine,,illicitwithdrawn,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB04836
Amineptine,,illicitwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,target,,DB04836
Cyclandelate,Vasodilator Agents,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB04838
Cyclandelate,Vasodilator Agents,approved,CES1,Liver carboxylesterase 1,target,,DB04838
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,target,inhibitor,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CACNA1I,Voltage-dependent T-type calcium channel subunit alpha-1I,target,inhibitor,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB04841
Flunarizine,AnticonvulsantsVasodilator AgentsCalcium Channel BlockersHistamine H1 Antagonists,approved,CALM1,Calmodulin,target,,DB04841
Fluspirilene,Antipsychotic AgentsDopamine Antagonists,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB04842
Fluspirilene,Antipsychotic AgentsDopamine Antagonists,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB04842
Fluspirilene,Antipsychotic AgentsDopamine Antagonists,approved,CACNG1,Voltage-dependent calcium channel gamma-1 subunit,target,inhibitor,DB04842
Mepenzolate,Cholinergic Antagonists,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB04843
Mepenzolate,Cholinergic Antagonists,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB04843
Tetrabenazine,Adrenergic Uptake Inhibitors,approved,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB04844
Tetrabenazine,Adrenergic Uptake Inhibitors,approved,DRD2,D(2) dopamine receptor,target,inhibitor,DB04844
FG-4592,Anti-anemic Agents,investigational,EGLN1,Egl nine homolog 1,target,,DB04847
FG-4592,Anti-anemic Agents,investigational,EGLN2,Egl nine homolog 2,target,,DB04847
FG-4592,Anti-anemic Agents,investigational,EGLN3,Egl nine homolog 3,target,,DB04847
AZD2563,Anti-Bacterial Agents,investigational,MAOA,Amine oxidase [flavin-containing] A,target,,DB04850
Biricodar dicitrate,,investigational,ABCB5,ATP-binding cassette sub-family B member 5,target,,DB04851
Biricodar dicitrate,,investigational,ABCC1,Multidrug resistance-associated protein 1,target,,DB04851
Biricodar dicitrate,,investigational,ABCG2,ATP-binding cassette sub-family G member 2,target,,DB04851
Dronedarone,Anti-Arrhythmia Agents,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,ADRA1D,Alpha-1D adrenergic receptor,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,ADRA2A,Alpha-2A adrenergic receptor,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,ADRA2B,Alpha-2B adrenergic receptor,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,ADRA2C,Alpha-2C adrenergic receptor,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,CACNB4,Voltage-dependent L-type calcium channel subunit beta-4,target,,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB04855
Dronedarone,Anti-Arrhythmia Agents,approved,KCNK2,Potassium channel subfamily K member 2,target,inhibitor,DB04855
Nebivolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsVasodilator Agents,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB04861
Nebivolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsVasodilator Agents,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB04861
Lefradafiban,Antianginal Agents,investigational,ITGA2B,Integrin alpha-IIb,target,,DB04863
Lefradafiban,Antianginal Agents,investigational,ITGB3,Integrin beta-3,target,,DB04863
Homoharringtonine,"Antineoplastic AgentsAngiogenesis InhibitorsAntineoplastic Agents, Phytogenic",approved,,50S ribosomal protein L2,target,antagonist,DB04865
Homoharringtonine,"Antineoplastic AgentsAngiogenesis InhibitorsAntineoplastic Agents, Phytogenic",approved,RPL3,60S ribosomal protein L3,target,antagonist,DB04865
Halofuginone,Antineoplastic AgentsAngiogenesis InhibitorsProtein Synthesis InhibitorsCoccidiostats,investigational,COL1A1,Collagen alpha-1(I) chain,target,,DB04866
Halofuginone,Antineoplastic AgentsAngiogenesis InhibitorsProtein Synthesis InhibitorsCoccidiostats,investigational,MMP2,72 kDa type IV collagenase,target,,DB04866
Nilotinib,Antineoplastic Agents,approvedinvestigational,ABL1,Tyrosine-protein kinase ABL1,target,inhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,KIT,Mast/stem cell growth factor receptor Kit,target,antagonist,DB04868
Vatalanib,Antineoplastic AgentsProtein Kinase Inhibitors,investigational,FLT1,Vascular endothelial growth factor receptor 1,target,,DB04879
Vatalanib,Antineoplastic AgentsProtein Kinase Inhibitors,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB04879
Vatalanib,Antineoplastic AgentsProtein Kinase Inhibitors,investigational,FLT4,Vascular endothelial growth factor receptor 3,target,,DB04879
Dapoxetine,Serotonin Uptake Inhibitors,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB04884
Dapoxetine,Serotonin Uptake Inhibitors,investigational,HTR1B,5-hydroxytryptamine receptor 1B,target,,DB04884
Dapoxetine,Serotonin Uptake Inhibitors,investigational,HTR2C,5-hydroxytryptamine receptor 2C,target,,DB04884
Bifeprunox,,investigational,DRD2,D(2) dopamine receptor,target,,DB04888
Bifeprunox,,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB04888
Bicifadine,,investigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB04889
Bicifadine,,investigational,SLC6A4,Sodium-dependent serotonin transporter,target,,DB04889
Bicifadine,,investigational,DRD2,D(2) dopamine receptor,target,,DB04889
Phenserine,,investigational,ACHE,Acetylcholinesterase,target,,DB04892
Phenserine,,investigational,BCHE,Cholinesterase,target,inhibitor,DB04892
AZD3409,Antineoplastic Agents,investigational,FNTB,Protein farnesyltransferase subunit beta,target,,DB04893
AZD3409,Antineoplastic Agents,investigational,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB04893
Vapreotide,Antineoplastic AgentsAnalgesics,approvedinvestigational,SSTR2,Somatostatin receptor type 2,target,inducer,DB04894
Vapreotide,Antineoplastic AgentsAnalgesics,approvedinvestigational,SSTR5,Somatostatin receptor type 5,target,agonist,DB04894
Vapreotide,Antineoplastic AgentsAnalgesics,approvedinvestigational,TACR1,Substance-P receptor,target,antagonist,DB04894
Milnacipran,Serotonin Uptake InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB04896
Milnacipran,Serotonin Uptake InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB04896
Milnacipran,Serotonin Uptake InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents,approved,GRIN1,NMDA receptor,target,inhibitor,DB04896
Nesiritide,Cardiovascular AgentsNatriuretic Agents,approvedinvestigational,NPR1,Atrial natriuretic peptide receptor 1,target,binder,DB04899
Nesiritide,Cardiovascular AgentsNatriuretic Agents,approvedinvestigational,NPR2,Atrial natriuretic peptide receptor 2,target,,DB04899
Nesiritide,Cardiovascular AgentsNatriuretic Agents,approvedinvestigational,NPR3,Atrial natriuretic peptide receptor 3,target,,DB04899
Pagoclone,Hypnotics and Sedatives,investigational,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,,DB04903
Pagoclone,Hypnotics and Sedatives,investigational,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,,DB04903
Tesmilifene,Antineoplastic AgentsPlatelet Aggregation InhibitorsHistamine Antagonists,investigational,ABCB1,Multidrug resistance protein 1,target,inducer,DB04905
Tesmilifene,Antineoplastic AgentsPlatelet Aggregation InhibitorsHistamine Antagonists,investigational,HRH1,Histamine H1 receptor,target,antagonist,DB04905
ISA247,Antipsoriatic Agents,investigational,PPP3R1,Calcineurin subunit B type 1,target,,DB04906
ISA247,Antipsoriatic Agents,investigational,PPP3R2,Calcineurin subunit B type 2,target,,DB04906
Flibanserin,,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB04908
Flibanserin,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB04908
Flibanserin,,investigational,DRD4,D(4) dopamine receptor,target,,DB04908
Stannsoporfin,,investigational,HMOX1,Heme oxygenase 1,target,,DB04912
Stannsoporfin,,investigational,HMOX2,Heme oxygenase 2,target,,DB04912
Renzapride,Serotonin Receptor Agonists,investigational,HTR3A,5-hydroxytryptamine receptor 3A,target,,DB04917
Renzapride,Serotonin Receptor Agonists,investigational,HTR4,5-hydroxytryptamine receptor 4,target,,DB04917
Ceftobiprole,Anti-Bacterial AgentsCephalosporins,investigational,mecA,MecA,target,,DB04918
Ceftobiprole,Anti-Bacterial AgentsCephalosporins,investigational,pbpX,Penicillin-binding protein 2x,target,,DB04918
Ceftobiprole,Anti-Bacterial AgentsCephalosporins,investigational,ftsI,Peptidoglycan synthase FtsI,target,,DB04918
Alfimeprase,Antithrombins,investigational,FGA,Fibrinogen alpha chain,target,,DB04919
Alfimeprase,Antithrombins,investigational,FGB,Fibrinogen beta chain,target,,DB04919
Clevidipine,,approved,CACNA1F,Voltage-dependent L-type calcium channel subunit alpha-1F,target,,DB04920
Clevidipine,,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,,DB04920
Clevidipine,,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,,DB04920
Clevidipine,,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,,DB04920
XP13512,,investigational,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,,DB04922
XP13512,,investigational,CACNA2D2,Voltage-dependent calcium channel subunit alpha-2/delta-2,target,,DB04922
Itopride,,investigational,DRD2,D(2) dopamine receptor,target,,DB04924
Itopride,,investigational,CHRM3,Muscarinic acetylcholine receptor M3,target,,DB04924
Defibrotide,Antithrombins,approvedinvestigational,ADORA1,Adenosine receptor A1,target,,DB04932
Defibrotide,Antithrombins,approvedinvestigational,ADORA2A,Adenosine receptor A2a,target,,DB04932
Defibrotide,Antithrombins,approvedinvestigational,ADORA2B,Adenosine receptor A2b,target,,DB04932
E7389,Antineoplastic Agents,investigational,BCL2,Apoptosis regulator Bcl-2,target,,DB04940
E7389,Antineoplastic Agents,investigational,TUBB1,Tubulin beta-1 chain,target,,DB04940
Crofelemer,,approved,CFTR,Cystic fibrosis transmembrane conductance regulator,target,antagonist,DB04941
Crofelemer,,approved,,Anoctamin-1,target,antagonist,DB04941
Tamibarotene,Antineoplastic Agents,approvedinvestigational,RARA,Retinoic acid receptor alpha,target,agonist,DB04942
Tamibarotene,Antineoplastic Agents,approvedinvestigational,RARB,Retinoic acid receptor beta,target,agonist,DB04942
Iloperidone,,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB04946
Iloperidone,,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB04946
Iloperidone,,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB04946
Iloperidone,,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB04946
Iloperidone,,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB04946
Iloperidone,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB04946
Iloperidone,,approved,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB04946
Iloperidone,,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB04946
Iloperidone,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB04946
Iloperidone,,approved,HRH1,Histamine H1 receptor,target,antagonist,DB04946
Iloperidone,,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB04946
Ezogabine,Anticonvulsants,approved,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,target,,DB04953
Ezogabine,Anticonvulsants,approved,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,target,,DB04953
Ezogabine,Anticonvulsants,approved,KCNQ4,Potassium voltage-gated channel subfamily KQT member 4,target,,DB04953
Ezogabine,Anticonvulsants,approved,KCNQ5,Potassium voltage-gated channel subfamily KQT member 5,target,,DB04953
Azimilide,Anti-Arrhythmia Agents,investigational,KCNE1,Potassium voltage-gated channel subfamily E member 1,target,,DB04957
Azimilide,Anti-Arrhythmia Agents,investigational,KCNQ1,Potassium voltage-gated channel subfamily KQT member 1,target,,DB04957
Azimilide,Anti-Arrhythmia Agents,investigational,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,,DB04957
HspE7,Antineoplastic Agents,investigational,KRT7,"Keratin, type II cytoskeletal 7",target,,DB04959
HspE7,Antineoplastic Agents,investigational,UBR4,E3 ubiquitin-protein ligase UBR4,target,,DB04959
Lucanthone,Antineoplastic AgentsSchistosomicides,approvedinvestigational,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB04967
Lucanthone,Antineoplastic AgentsSchistosomicides,approvedinvestigational,APEX1,DNA-(apurinic or apyrimidinic site) lyase,target,inhibitor,DB04967
Lucanthone,Antineoplastic AgentsSchistosomicides,approvedinvestigational,TOP1,DNA topoisomerase 1,target,inhibitor,DB04967
Reglixane,,investigational,PPARA,Peroxisome proliferator-activated receptor alpha,target,,DB04971
Reglixane,,investigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB04971
Talampanel,Antineoplastic AgentsAnticonvulsants,investigational,GRIA1,Glutamate receptor 1,target,,DB04982
Talampanel,Antineoplastic AgentsAnticonvulsants,investigational,GRIA2,Glutamate receptor 2,target,,DB04982
Talampanel,Antineoplastic AgentsAnticonvulsants,investigational,GRIA3,Glutamate receptor 3,target,,DB04982
Talampanel,Antineoplastic AgentsAnticonvulsants,investigational,GRIA4,Glutamate receptor 4,target,,DB04982
IGN311,Antineoplastic Agents,investigational,EGFR,Epidermal growth factor receptor,target,,DB04988
IGN311,Antineoplastic Agents,investigational,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,,DB04988
Imexon,,investigational,RRM2,Ribonucleoside-diphosphate reductase subunit M2,target,,DB05003
Imexon,,investigational,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,,DB05003
AC162352,,investigational,NPY2R,Neuropeptide Y receptor type 2,target,,DB05004
AC162352,,investigational,NPY1R,Neuropeptide Y receptor type 1,target,,DB05004
AC162352,,investigational,NPY5R,Neuropeptide Y receptor type 5,target,,DB05004
AC162352,,investigational,PPYR1,Neuropeptide Y receptor type 4,target,,DB05004
XL647,,investigational,EGF,Pro-epidermal growth factor,target,,DB05007
XL647,,investigational,EPHB4,Ephrin type-B receptor 4,target,,DB05007
XL647,,investigational,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,,DB05007
SGS742,,investigational,GABBR1,Gamma-aminobutyric acid type B receptor subunit 1,target,,DB05010
SGS742,,investigational,GABBR2,Gamma-aminobutyric acid type B receptor subunit 2,target,,DB05010
Ingenol Mebutate,Antineoplastic Agents,approved,PRKCD,Protein kinase C delta type,target,ligand,DB05013
Ingenol Mebutate,Antineoplastic Agents,approved,PRKCA,Protein kinase C alpha type,target,ligand,DB05013
XL999,Antineoplastic Agents,investigational,FGFR3,Fibroblast growth factor receptor 3,target,,DB05014
XL999,Antineoplastic Agents,investigational,FGFR1,Fibroblast growth factor receptor 1,target,,DB05014
XL999,Antineoplastic Agents,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB05014
XL999,Antineoplastic Agents,investigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,,DB05014
XL999,Antineoplastic Agents,investigational,PDGFRB,Platelet-derived growth factor receptor beta,target,,DB05014
XL999,Antineoplastic Agents,investigational,RET,RET proto-oncogene,target,,DB05014
YSIL6,,investigational,TNF,Tumor necrosis factor,target,,DB05017
YSIL6,,investigational,IL6,Interleukin-6,target,,DB05017
Amonafide,,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB05022
Amonafide,,investigational,TOP2B,DNA topoisomerase 2-beta,target,,DB05022
CTA018,,investigational,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",target,,DB05024
CTA018,,investigational,VDR,Vitamin D3 receptor,target,,DB05024
XL880,,investigational,HGF,Hepatocyte growth factor,target,,DB05030
XL880,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB05030
KB2115,,investigational,THRA,Thyroid hormone receptor alpha,target,,DB05035
KB2115,,investigational,THRB,Thyroid hormone receptor beta,target,,DB05035
Grn163l,,investigational,SMG6,Telomerase-binding protein EST1A,target,,DB05036
Grn163l,,investigational,SCYL1,N-terminal kinase-like protein,target,,DB05036
Grn163l,,investigational,PTGES3,Prostaglandin E synthase 3,target,,DB05036
Grn163l,,investigational,TERT,Telomerase reverse transcriptase,target,,DB05036
AT7519,,investigational,CDK1,Cyclin-dependent kinase 1,target,,DB05037
AT7519,,investigational,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB05037
RP101,,investigational,UPP1,Uridine phosphorylase 1,target,,DB05041
RP101,,investigational,UPP2,Uridine phosphorylase 2,target,,DB05041
TM30338,,investigational,PPYR1,Neuropeptide Y receptor type 4,target,,DB05045
TM30338,,investigational,NPY2R,Neuropeptide Y receptor type 2,target,,DB05045
V1003,,investigational,OPRK1,Kappa-type opioid receptor,target,,DB05046
V1003,,investigational,OPRM1,Mu-type opioid receptor,target,,DB05046
CX717,,illicitinvestigational,GRIA4,Glutamate receptor 4,target,,DB05047
CX717,,illicitinvestigational,BDNF,Brain-derived neurotrophic factor,target,,DB05047
CX717,,illicitinvestigational,GRIA1,Glutamate receptor 1,target,,DB05047
CX717,,illicitinvestigational,GRIA2,Glutamate receptor 2,target,,DB05047
CX717,,illicitinvestigational,GRIA3,Glutamate receptor 3,target,,DB05047
AV411,,investigational,IL1B,Interleukin-1 beta,target,,DB05066
AV411,,investigational,TNF,Tumor necrosis factor,target,,DB05066
AV411,,investigational,IL6,Interleukin-6,target,,DB05066
AV411,,investigational,IL10,Interleukin-10,target,,DB05066
AV411,,investigational,NTF3,Neurotrophin-3,target,,DB05066
AV411,,investigational,GDNF,Glial cell line-derived neurotrophic factor,target,,DB05066
AV411,,investigational,NTF4,Neurotrophin-4,target,,DB05066
ATG003,,investigational,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,,DB05069
ATG003,,investigational,CHRNA9,Neuronal acetylcholine receptor subunit alpha-9,target,,DB05069
TG100801,,investigational,FLT1,Vascular endothelial growth factor receptor 1,target,,DB05075
TG100801,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB05075
TG100801,,investigational,FLT4,Vascular endothelial growth factor receptor 3,target,,DB05075
TG100801,,investigational,CSK,Tyrosine-protein kinase CSK,target,,DB05075
AER001,,investigational,IL4R,Interleukin-4 receptor subunit alpha,target,,DB05078
AER001,,investigational,IL13RA2,Interleukin-13 receptor subunit alpha-2,target,,DB05078
HY10275,,investigational,HRH1,Histamine H1 receptor,target,,DB05079
HY10275,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05079
OBE101,,investigational,HRH1,Histamine H1 receptor,target,,DB05080
OBE101,,investigational,HRH3,Histamine H3 receptor,target,,DB05080
Ganaxolone,,investigational,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,,DB05087
Ganaxolone,,investigational,GABRA2,Gamma-aminobutyric acid receptor subunit alpha-2,target,,DB05087
Ganaxolone,,investigational,GABRA3,Gamma-aminobutyric acid receptor subunit alpha-3,target,,DB05087
Ganaxolone,,investigational,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,target,,DB05087
Ganaxolone,,investigational,GABRA5,Gamma-aminobutyric acid receptor subunit alpha-5,target,,DB05087
Ganaxolone,,investigational,GABRA6,Gamma-aminobutyric acid receptor subunit alpha-6,target,,DB05087
LY2140023,,investigational,GRM2,Metabotropic glutamate receptor 2,target,,DB05096
LY2140023,,investigational,GRM3,Metabotropic glutamate receptor 3,target,,DB05096
R1295,,investigational,ITGA4,Integrin alpha-4,target,,DB05122
R1295,,investigational,ITGB4,Integrin beta-4,target,,DB05122
R1295,,investigational,ITGB7,Integrin beta-7,target,,DB05122
Elsamitrucin,,investigational,TOP1,DNA topoisomerase 1,target,,DB05129
Elsamitrucin,,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB05129
CNF1010,,investigational,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB05134
CNF1010,,investigational,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB05134
Lobeline,,investigational,CHRNA9,Neuronal acetylcholine receptor subunit alpha-9,target,,DB05137
Lobeline,,investigational,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,,DB05137
ND7001,,investigational,PDE2A,"Phosphodiesterase 2A, cGMP-stimulated",target,,DB05142
ND7001,,investigational,PDE2A,"cGMP-dependent 3',5'-cyclic phosphodiesterase",target,,DB05142
XL820,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB05146
XL820,,investigational,KIT,Mast/stem cell growth factor receptor Kit,target,,DB05146
XL820,,investigational,PDGFRA,Platelet-derived growth factor receptor alpha,target,,DB05146
XL820,,investigational,PDGFRB,Platelet-derived growth factor receptor beta,target,,DB05146
CYT997,,investigational,TUBA1A,Tubulin alpha-1A chain,target,,DB05147
CYT997,,investigational,TUBA1B,Tubulin alpha-1B chain,target,,DB05147
CYT997,,investigational,TUBA1C,Tubulin alpha-1C chain,target,,DB05147
CYT997,,investigational,TUBA4A,Tubulin alpha-4A chain,target,,DB05147
CYT997,,investigational,TUBA3C,Tubulin alpha-3C/D chain,target,,DB05147
CYT997,,investigational,TUBA3E,Tubulin alpha-3E chain,target,,DB05147
CYT997,,investigational,TUBA4B,Putative tubulin-like protein alpha-4B,target,,DB05147
CYT997,,investigational,TUBB1,Tubulin beta-1 chain,target,,DB05147
CYT997,,investigational,TUBB2A,Tubulin beta-2A chain,target,,DB05147
CYT997,,investigational,TUBB2B,Tubulin beta-2B chain,target,,DB05147
CYT997,,investigational,TUBB2C,Tubulin beta-4B chain,target,,DB05147
CYT997,,investigational,TUBB3,Tubulin beta-3 chain,target,,DB05147
CYT997,,investigational,TUBB4,Tubulin beta-4A chain,target,,DB05147
CYT997,,investigational,TUBB,Tubulin beta chain,target,,DB05147
CYT997,,investigational,TUBB6,Tubulin beta-6 chain,target,,DB05147
XL844,,investigational,CHEK2,Serine/threonine-protein kinase Chk2,target,,DB05149
XL844,,investigational,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB05149
XL184,,investigational,MET,Hepatocyte growth factor receptor,target,,DB05153
XL184,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB05153
XL184,,investigational,KIT,Mast/stem cell growth factor receptor Kit,target,,DB05153
XL184,,investigational,TEK,Angiopoietin-1 receptor,target,,DB05153
KC706,,investigational,MAPK14,Mitogen-activated protein kinase 14,target,,DB05157
KC706,,investigational,MAPK11,Mitogen-activated protein kinase 11,target,,DB05157
KC706,,investigational,MAPK12,Mitogen-activated protein kinase 12,target,,DB05157
KC706,,investigational,MAPK13,Mitogen-activated protein kinase 13,target,,DB05157
Elafin,,investigational,ELANE,Neutrophil elastase,target,,DB05161
Elafin,,investigational,PRTN3,Myeloblastin,target,,DB05161
EC145,,investigational,FOLR2,Folate receptor beta,target,,DB05168
EC145,,investigational,FOLR3,Folate receptor gamma,target,,DB05168
EC145,,investigational,FOLR1,Folate receptor alpha,target,,DB05168
AT9283,,investigational,AURKA,Aurora kinase A,target,,DB05169
AT9283,,investigational,AURKB,Aurora kinase B,target,,DB05169
E2012,,investigational,APH1A,Gamma-secretase subunit APH-1A,target,,DB05171
E2012,,investigational,PSENEN,Gamma-secretase subunit PEN-2,target,,DB05171
XL228,,investigational,IGF1R,Insulin-like growth factor 1 receptor,target,,DB05184
XL228,,investigational,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB05184
XL228,,investigational,ABL1,Tyrosine-protein kinase ABL1,target,,DB05184
XL228,,investigational,ABL2,Abelson tyrosine-protein kinase 2,target,,DB05184
GFT505,,investigational,PPARA,Peroxisome proliferator-activated receptor alpha,target,,DB05187
GFT505,,investigational,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB05187
GFT505,,investigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB05187
XL281,,investigational,BRAF,Serine/threonine-protein kinase B-raf,target,,DB05190
XL281,,investigational,RAF1,RAF proto-oncogene serine/threonine-protein kinase,target,,DB05190
KB002,,investigational,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,target,,DB05194
KB002,,investigational,CSF2,Granulocyte-macrophage colony-stimulating factor,target,,DB05194
KB002,,investigational,CSF2RA,GM-CSF receptor alpha subunit,target,,DB05194
CYC116,,investigational,AURKA,Aurora kinase A,target,,DB05198
CYC116,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB05198
ARC1779,,investigational,VWF,von Willebrand factor,target,,DB05202
ARC1779,,investigational,GP1BA,Platelet glycoprotein Ib alpha chain,target,,DB05202
SPP1148,,investigational,ACE2,Angiotensin-converting enzyme 2,target,,DB05203
SPP1148,,investigational,REN,Renin,target,,DB05203
PS433540,,investigational,AGT,Angiotensinogen,target,,DB05206
PS433540,,investigational,EDNRA,Endothelin-1 receptor,target,,DB05206
SD118,,investigational,TNF,Tumor necrosis factor,target,,DB05207
SD118,,investigational,IL1R1,Interleukin-1 receptor type 1,target,,DB05207
SF1126,Antineoplastic Agents,investigational,PIK3R1,Phosphatidylinositol 3-kinase regulatory subunit alpha,target,,DB05210
SF1126,Antineoplastic Agents,investigational,PIK3R2,Phosphatidylinositol 3-kinase regulatory subunit beta,target,,DB05210
SF1126,Antineoplastic Agents,investigational,PIK3R3,Phosphatidylinositol 3-kinase regulatory subunit gamma,target,,DB05210
SF1126,Antineoplastic Agents,investigational,PRKDC,DNA-dependent protein kinase catalytic subunit,target,,DB05210
SF1126,Antineoplastic Agents,investigational,MTOR,Serine/threonine-protein kinase mTOR,target,,DB05210
HE3286,,investigational,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,,DB05212
HE3286,,investigational,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,,DB05212
MP470,Antineoplastic Agents,investigational,KIT,Mast/stem cell growth factor receptor Kit,target,,DB05216
MP470,Antineoplastic Agents,investigational,MET,Hepatocyte growth factor receptor,target,,DB05216
MP470,Antineoplastic Agents,investigational,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,,DB05216
MP470,Antineoplastic Agents,investigational,PDGFRA,Platelet-derived growth factor receptor alpha,target,,DB05216
MP470,Antineoplastic Agents,investigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,,DB05216
MP470,Antineoplastic Agents,investigational,RAD51,DNA repair protein RAD51 homolog 1,target,,DB05216
AN2728,Antipsoriatic Agents,investigational,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,,DB05219
AN2728,Antipsoriatic Agents,investigational,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB05219
AN2728,Antipsoriatic Agents,investigational,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,,DB05219
AN2728,Antipsoriatic Agents,investigational,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB05219
SB939,Antineoplastic Agents,investigational,HDAC1,Histone deacetylase 1,target,,DB05223
SB939,Antineoplastic Agents,investigational,HDAC2,Histone deacetylase 2,target,,DB05223
SB939,Antineoplastic Agents,investigational,HDAC3,Histone deacetylase 3,target,,DB05223
SB939,Antineoplastic Agents,investigational,HDAC6,Histone deacetylase 6,target,,DB05223
Tetrodotoxin,PoisonsSodium Channel Blockers,investigational,SCN1A,Sodium channel protein type 1 subunit alpha,target,,DB05232
Tetrodotoxin,PoisonsSodium Channel Blockers,investigational,SCN2A,Sodium channel protein type 2 subunit alpha,target,,DB05232
Tetrodotoxin,PoisonsSodium Channel Blockers,investigational,SCN3A,Sodium channel protein type 3 subunit alpha,target,,DB05232
Tetrodotoxin,PoisonsSodium Channel Blockers,investigational,SCN8A,Sodium channel protein type 8 subunit alpha,target,,DB05232
NRP409,Hormone Replacement Agents,investigational,CRYM,Ketimine reductase mu-crystallin,target,,DB05235
NRP409,Hormone Replacement Agents,investigational,THRA,Thyroid hormone receptor alpha,target,,DB05235
XL765,Antineoplastic Agents,investigational,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",target,,DB05241
XL765,Antineoplastic Agents,investigational,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB05241
XL765,Antineoplastic Agents,investigational,PIK3CD,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",target,,DB05241
XL765,Antineoplastic Agents,investigational,PIK3CB,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",target,,DB05241
XL765,Antineoplastic Agents,investigational,MTOR,Serine/threonine-protein kinase mTOR,target,,DB05241
681323,,investigational,TNF,Tumor necrosis factor,target,,DB05250
681323,,investigational,IL1B,Interleukin-1 beta,target,,DB05250
681323,,investigational,IL6,Interleukin-6,target,,DB05250
Plasmin,,investigational,SERPINE1,Plasminogen activator inhibitor 1,target,,DB05254
Plasmin,,investigational,PLAU,Urokinase-type plasminogen activator,target,,DB05254
751689,,investigational,CASR,Extracellular calcium-sensing receptor,target,,DB05255
751689,,investigational,GPR110,Probable G-protein coupled receptor 110,target,,DB05255
Gallium nitrate,,approvedinvestigational,RRM2,Ribonucleoside-diphosphate reductase subunit M2,target,inhibitor,DB05260
Gallium nitrate,,approvedinvestigational,ATP6V1B2,"V-type proton ATPase subunit B, brain isoform",target,inhibitor,DB05260
Gallium nitrate,,approvedinvestigational,BGLAP,Osteocalcin,target,antagonist,DB05260
Gallium nitrate,,approvedinvestigational,PPI,Protein-tyrosine-phosphatase,target,inhibitor,DB05260
Gallium nitrate,,approvedinvestigational,IL1B,Interleukin-1 beta,target,antagonist,DB05260
Ecabet,,approvedinvestigational,NOXO1,NADPH oxidase organizer 1,target,antagonist,DB05265
Ecabet,,approvedinvestigational,ureC,Urease subunit alpha,target,inhibitor,DB05265
Ibudilast,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsBronchodilator AgentsVasodilator Agents,approvedinvestigational,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB05266
Ibudilast,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsBronchodilator AgentsVasodilator Agents,approvedinvestigational,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,inhibitor,DB05266
Ibudilast,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsBronchodilator AgentsVasodilator Agents,approvedinvestigational,PDE4C,"cAMP-specific 3',5'-cyclic phosphodiesterase 4C",target,inhibitor,DB05266
Ibudilast,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsBronchodilator AgentsVasodilator Agents,approvedinvestigational,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,inhibitor,DB05266
Ibudilast,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsBronchodilator AgentsVasodilator Agents,approvedinvestigational,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB05266
Rotigotine,Antidyskinetics,approved,DRD3,D(3) dopamine receptor,target,agonist,DB05271
Rotigotine,Antidyskinetics,approved,DRD4,D(4) dopamine receptor,target,agonist,DB05271
Rotigotine,Antidyskinetics,approved,DRD2,D(2) dopamine receptor,target,agonist,DB05271
Rotigotine,Antidyskinetics,approved,DRD5,D(1B) dopamine receptor,target,agonist,DB05271
Rotigotine,Antidyskinetics,approved,DRD1,D(1A) dopamine receptor,target,agonist,DB05271
Rotigotine,Antidyskinetics,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB05271
Rotigotine,Antidyskinetics,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB05271
SLV 308,,investigational,DRD2,D(2) dopamine receptor,target,,DB05280
SLV 308,,investigational,DRD3,D(3) dopamine receptor,target,,DB05280
SLV 308,,investigational,DRD4,D(4) dopamine receptor,target,,DB05280
SLV 308,,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB05280
S-8184,,investigational,TUBA4A,Tubulin alpha-4A chain,target,,DB05281
S-8184,,investigational,BCL2,Apoptosis regulator Bcl-2,target,,DB05281
Vandetanib,,approved,VEGFA,Vascular endothelial growth factor A,target,inhibitor,DB05294
Vandetanib,,approved,EGFR,Epidermal growth factor receptor,target,inhibitor,DB05294
Vandetanib,,approved,,Protein-tyrosine kinase 6,target,inhibitor,DB05294
Vandetanib,,approved,TEK,Angiopoietin-1 receptor,target,inhibitor,DB05294
LAX-101,,investigational,PLD1,Phospholipase D1,target,,DB05301
LAX-101,,investigational,CASP1,Caspase-1,target,,DB05301
OMS-103HP,,investigational,TNF,Tumor necrosis factor,target,,DB05303
OMS-103HP,,investigational,IL1R1,Interleukin-1 receptor type 1,target,,DB05303
WX-G250,,investigational,CA9,Carbonic anhydrase 9,target,,DB05304
WX-G250,,investigational,IL2,Interleukin-2,target,,DB05304
ACP-103,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05316
ACP-103,,investigational,DRD2,D(2) dopamine receptor,target,,DB05316
TAK-475,,investigational,FDFT1,Squalene synthase,target,,DB05317
TAK-475,,investigational,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB05317
ketoprofen transdermal patch,,investigational,PTGS2,Prostaglandin G/H synthase 2,target,,DB05335
ketoprofen transdermal patch,,investigational,PTGS1,Prostaglandin G/H synthase 1,target,,DB05335
atamestane-plus-toremifene,,investigational,CYP19A1,Cytochrome P450 19A1,target,,DB05338
atamestane-plus-toremifene,,investigational,ESR1,Estrogen receptor,target,,DB05338
SP-01A,,investigational,gag-pol,Gag-Pol polyprotein,target,,DB05342
SP-01A,,investigational,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB05342
VEC-162,,investigational,MTNR1A,Melatonin receptor type 1A,target,,DB05359
VEC-162,,investigational,MTNR1B,Melatonin receptor type 1B,target,,DB05359
SR-123781A,,investigational,SERPINC1,Antithrombin-III,target,,DB05361
SR-123781A,,investigational,F2R,Proteinase-activated receptor 1,target,,DB05361
pimagedine HCl,,investigational,AKR1B1,Aldose reductase,target,,DB05383
pimagedine HCl,,investigational,TIMP3,Metalloproteinase inhibitor 3,target,,DB05383
recombinant human GM-CSF,,investigational,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,target,,DB05386
recombinant human GM-CSF,,investigational,CSF2RA,GM-CSF receptor alpha subunit,target,,DB05386
AE-941,,investigational,MMP2,72 kDa type IV collagenase,target,,DB05387
AE-941,,investigational,,Matrix metalloproteinase-9,target,,DB05387
AE-941,,investigational,MMP12,Macrophage metalloelastase,target,,DB05387
WF10,,approvedinvestigational,MAEA,Macrophage erythroblast attacher,target,,DB05389
WF10,,approvedinvestigational,CD163,Scavenger receptor cysteine-rich type 1 protein M130,target,,DB05389
C31G,,investigational,gag-pol,Gag-Pol polyprotein,target,,DB05398
C31G,,investigational,CD9,CD9 antigen,target,,DB05398
IDN-6556,,investigational,CASP1,Caspase-1,target,,DB05408
IDN-6556,,investigational,CASP3,Caspase-3,target,,DB05408
IDN-6556,,investigational,CASP7,Caspase-7,target,,DB05408
SCIO-469,,investigational,MAPK14,Mitogen-activated protein kinase 14,target,,DB05412
SCIO-469,,investigational,TNF,Tumor necrosis factor,target,,DB05412
SCIO-469,,investigational,IL1B,Interleukin-1 beta,target,,DB05412
SCIO-469,,investigational,MT-CO2,Cytochrome c oxidase subunit 2,target,,DB05412
motexafin gadolinium,,investigational,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,,DB05428
motexafin gadolinium,,investigational,TXNRD2,"Thioredoxin reductase 2, mitochondrial",target,,DB05428
motexafin gadolinium,,investigational,RRM2,Ribonucleoside-diphosphate reductase subunit M2,target,,DB05428
ABT-510,,investigational,FGF2,Fibroblast growth factor 2,target,,DB05434
ABT-510,,investigational,HGF,Hepatocyte growth factor,target,,DB05434
ABT-510,,investigational,VEGFA,Vascular endothelial growth factor A,target,,DB05434
ABT-510,,investigational,IL8,Interleukin-8,target,,DB05434
P54,,investigational,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,,DB05451
P54,,investigational,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,,DB05451
PH-284,,investigational,AVPR1A,Vasopressin V1a receptor,target,,DB05452
PH-284,,investigational,AVPR1B,Vasopressin V1b receptor,target,,DB05452
ABT-089,,investigational,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,,DB05458
ABT-089,,investigational,CHRNB2,Neuronal acetylcholine receptor subunit beta-2,target,,DB05458
ABT-874,,investigational,IL12B,Interleukin-12 subunit beta,target,,DB05459
ABT-874,,investigational,IL23A,Interleukin-23 subunit alpha,target,,DB05459
OPC-28326,,investigational,HTR2B,5-hydroxytryptamine receptor 2B,target,,DB05461
OPC-28326,,investigational,ADRA2C,Alpha-2C adrenergic receptor,target,,DB05461
OPC-28326,,investigational,ADRA2B,Alpha-2B adrenergic receptor,target,,DB05461
NOX-700,,investigational,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,,DB05464
NOX-700,,investigational,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,,DB05464
MLN-518,,investigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,,DB05465
MLN-518,,investigational,PDGFD,Platelet-derived growth factor D,target,,DB05465
R450,,investigational,ADRA1A,Alpha-1A adrenergic receptor,target,,DB05469
R450,,investigational,ADRA1B,Alpha-1B adrenergic receptor,target,,DB05469
R450,,investigational,ADRA1D,Alpha-1D adrenergic receptor,target,,DB05469
VX-702,,investigational,MAPK14,Mitogen-activated protein kinase 14,target,,DB05470
VX-702,,investigational,TNF,Tumor necrosis factor,target,,DB05470
VX-702,,investigational,IL1B,Interleukin-1 beta,target,,DB05470
VX-702,,investigational,IL6,Interleukin-6,target,,DB05470
SGN-30,,investigational,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,,DB05471
SGN-30,,investigational,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,,DB05471
omega interferon,,investigational,IFNAR1,Interferon alpha/beta receptor 1,target,,DB05472
omega interferon,,investigational,IFNAR2,Interferon alpha/beta receptor 2,target,,DB05472
SCV-07,,investigational,TLR2,Toll-like receptor 2,target,,DB05475
SCV-07,,investigational,TLR4,Toll-like receptor 4,target,,DB05475
SCV-07,,investigational,TLR7,Toll-like receptor 7,target,,DB05475
SCV-07,,investigational,TLR9,Toll-like receptor 9,target,,DB05475
PCL-016,,investigational,UBR4,E3 ubiquitin-protein ligase UBR4,target,,DB05483
PCL-016,,investigational,ZFY,Zinc finger Y-chromosomal protein,target,,DB05483
CC-8490,,investigational,ESR1,Estrogen receptor,target,,DB05487
CC-8490,,investigational,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,,DB05487
CC-8490,,investigational,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,,DB05487
99mTc-ciprofloxacin,,investigational,gyrB,DNA gyrase subunit B,target,,DB05488
99mTc-ciprofloxacin,,investigational,TOP2B,DNA topoisomerase 2-beta,target,,DB05488
Epicept NP-1,,investigational,OPRM1,Mu-type opioid receptor,target,,DB05492
Epicept NP-1,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05492
Epicept NP-1,,investigational,HTR2B,5-hydroxytryptamine receptor 2B,target,,DB05492
Epicept NP-1,,investigational,HTR2C,5-hydroxytryptamine receptor 2C,target,,DB05492
Epicept NP-1,,investigational,ADRA1A,Alpha-1A adrenergic receptor,target,,DB05492
Epicept NP-1,,investigational,ADRA1B,Alpha-1B adrenergic receptor,target,,DB05492
Epicept NP-1,,investigational,ADRA1D,Alpha-1D adrenergic receptor,target,,DB05492
Epicept NP-1,,investigational,ADRA2A,Alpha-2A adrenergic receptor,target,,DB05492
Epicept NP-1,,investigational,ADRA2B,Alpha-2B adrenergic receptor,target,,DB05492
Epicept NP-1,,investigational,ADRA2C,Alpha-2C adrenergic receptor,target,,DB05492
Epicept NP-1,,investigational,HRH1,Histamine H1 receptor,target,,DB05492
Epicept NP-1,,investigational,OPRL1,Nociceptin receptor,target,,DB05492
AMD-070,,investigational,CXCR4,C-X-C chemokine receptor type 4,target,,DB05501
AMD-070,,investigational,CCR5,C-C chemokine receptor type 5,target,,DB05501
VX-765,,investigational,CASP1,Caspase-1,target,,DB05507
VX-765,,investigational,IL1B,Interleukin-1 beta,target,,DB05507
LI-301,,investigational,OPRM1,Mu-type opioid receptor,target,,DB05509
LI-301,,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB05509
MGCD-0103,Antineoplastic AgentsHistone Deacetylase Inhibitors,investigational,HDAC1,Histone deacetylase 1,target,,DB05651
MGCD-0103,Antineoplastic AgentsHistone Deacetylase Inhibitors,investigational,HDAC3,Histone deacetylase 3,target,,DB05651
MGCD-0103,Antineoplastic AgentsHistone Deacetylase Inhibitors,investigational,HDAC2,Histone deacetylase 2,target,,DB05651
faropenem medoxomil,Anti-Bacterial Agents,investigational,ponA,Penicillin-binding protein 1A,target,,DB05659
faropenem medoxomil,Anti-Bacterial Agents,investigational,penA,Penicillin-binding protein 2B,target,,DB05659
faropenem medoxomil,Anti-Bacterial Agents,investigational,ftsI,Peptidoglycan synthase FtsI,target,,DB05659
BL-1020,,investigational,DRD2,D(2) dopamine receptor,target,,DB05687
BL-1020,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05687
CRx-119,,investigational,SLC6A4,Sodium-dependent serotonin transporter,target,,DB05688
CRx-119,,investigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB05688
CYT006-AngQb,,investigational,AGTR1,Type-1 angiotensin II receptor,target,,DB05739
CYT006-AngQb,,investigational,AGTR2,Type-2 angiotensin II receptor,target,,DB05739
RPI-78M,,investigational,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,,DB05740
RPI-78M,,investigational,CHRNB2,Neuronal acetylcholine receptor subunit beta-2,target,,DB05740
RPI-78M,,investigational,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,,DB05740
RPI-78M,,investigational,CHRNA4,Neuronal acetylcholine receptor subunit alpha-4,target,,DB05740
RPI-78M,,investigational,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,,DB05740
RPI-78M,,investigational,CHRNA9,Neuronal acetylcholine receptor subunit alpha-9,target,,DB05740
MAP-0004,,investigational,HTR1B,5-hydroxytryptamine receptor 1B,target,,DB05743
MAP-0004,,investigational,HTR1D,5-hydroxytryptamine receptor 1D,target,,DB05743
MAP-0004,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05743
CRx-139,,investigational,TNF,Tumor necrosis factor,target,,DB05744
CRx-139,,investigational,IL6,Interleukin-6,target,,DB05744
CRx-139,,investigational,CRP,C-reactive protein,target,,DB05744
CRx-139,,investigational,IL10,Interleukin-10,target,,DB05744
CHR-2797,,investigational,NPEPPS,Puromycin-sensitive aminopeptidase,target,,DB05745
CHR-2797,,investigational,LTA4H,Leukotriene A-4 hydrolase,target,,DB05745
ALKS 27,,investigational,CHRM1,Muscarinic acetylcholine receptor M1,target,,DB05752
ALKS 27,,investigational,CHRM2,Muscarinic acetylcholine receptor M2,target,,DB05752
ALKS 27,,investigational,CHRM3,Muscarinic acetylcholine receptor M3,target,,DB05752
ALKS 27,,investigational,CHRM4,Muscarinic acetylcholine receptor M4,target,,DB05752
ALKS 27,,investigational,CHRM5,Muscarinic acetylcholine receptor M5,target,,DB05752
MK-0974,,investigational,CALCA,Calcitonin gene-related peptide 1,target,,DB05760
MK-0974,,investigational,CALCB,Calcitonin gene-related peptide 2,target,,DB05760
ABT-263,,investigational,BCL2,Apoptosis regulator Bcl-2,target,,DB05764
ABT-263,,investigational,BCL2L2,Bcl-2-like protein 2,target,,DB05764
ABT-263,,investigational,BAD,Bcl2 antagonist of cell death,target,,DB05764
ACP-104,,investigational,CHRM1,Muscarinic acetylcholine receptor M1,target,,DB05766
ACP-104,,investigational,DRD2,D(2) dopamine receptor,target,,DB05766
ACP-104,,investigational,DRD3,D(3) dopamine receptor,target,,DB05766
HMPL-004,,investigational,TNF,Tumor necrosis factor,target,,DB05767
HMPL-004,,investigational,IL1B,Interleukin-1 beta,target,,DB05767
HMPL-004,,investigational,IL6,Interleukin-6,target,,DB05767
HMPL-004,,investigational,NFKB2,Nuclear factor NF-kappa-B p100 subunit,target,,DB05767
HMPL-004,,investigational,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,,DB05767
ART-123,,approvedinvestigational,F5,Coagulation factor V,target,,DB05777
ART-123,,approvedinvestigational,F2,Prothrombin,target,,DB05777
LGD-1550,,investigational,RARA,Retinoic acid receptor alpha,target,,DB05785
LGD-1550,,investigational,RARB,Retinoic acid receptor beta,target,,DB05785
LGD-1550,,investigational,RARG,Retinoic acid receptor gamma,target,,DB05785
LGD-1550,,investigational,JUN,Transcription factor AP-1,target,,DB05785
GEM-231,,investigational,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,target,,DB05798
GEM-231,,investigational,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,target,,DB05798
MLN-02,,investigational,ITGB7,Integrin beta-7,target,,DB05802
MLN-02,,investigational,ITGA4,Integrin alpha-4,target,,DB05802
intranasal apomorphine,,investigational,DRD2,D(2) dopamine receptor,target,,DB05816
intranasal apomorphine,,investigational,DRD1,D(1A) dopamine receptor,target,,DB05816
Preotact,,approvedinvestigational,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,target,activator,DB05829
Preotact,,approvedinvestigational,,Parathyroid hormone 2 receptor,target,activator,DB05829
TC-2403-12,,investigational,CHRNB2,Neuronal acetylcholine receptor subunit beta-2,target,,DB05855
TC-2403-12,,investigational,IL8,Interleukin-8,target,,DB05855
CTI-01,,investigational,TNF,Tumor necrosis factor,target,,DB05869
CTI-01,,investigational,HMGB1,High mobility group protein B1,target,,DB05869
CHF 4227,,investigational,ESR1,Estrogen receptor,target,,DB05882
CHF 4227,,investigational,ESR2,Estrogen receptor beta,target,,DB05882
INSM-18,,investigational,IGF1R,Insulin-like growth factor 1 receptor,target,,DB05900
INSM-18,,investigational,EGFR,Epidermal growth factor receptor,target,,DB05900
OSI-930,,investigational,KIT,Mast/stem cell growth factor receptor Kit,target,,DB05913
OSI-930,,investigational,FLT1,Vascular endothelial growth factor receptor 1,target,,DB05913
ZEN-012,,investigational,TUBB,Tubulin beta chain,target,,DB06042
ZEN-012,,investigational,TUBB1,Tubulin beta-1 chain,target,,DB06042
ZEN-012,,investigational,TUBB3,Tubulin beta-3 chain,target,,DB06042
ZEN-012,,investigational,TUBB4,Tubulin beta-4A chain,target,,DB06042
ZEN-012,,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB06042
ZEN-012,,investigational,TOP2B,DNA topoisomerase 2-beta,target,,DB06042
SNX-5422,,investigational,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06070
SNX-5422,,investigational,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB06070
ABT-869,,investigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,,DB06080
ABT-869,,investigational,FLT1,Vascular endothelial growth factor receptor 1,target,,DB06080
ABT-869,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB06080
ABT-869,,investigational,FLT4,Vascular endothelial growth factor receptor 3,target,,DB06080
ABT-869,,investigational,KIT,Mast/stem cell growth factor receptor Kit,target,,DB06080
ABT-869,,investigational,CSF1R,Macrophage colony-stimulating factor 1 receptor,target,,DB06080
ICA-105665,,investigational,KCNQ1,Potassium voltage-gated channel subfamily KQT member 1,target,,DB06089
ICA-105665,,investigational,KCNQ3,Potassium voltage-gated channel subfamily KQT member 3,target,,DB06089
ICA-105665,,investigational,KCNQ4,Potassium voltage-gated channel subfamily KQT member 4,target,,DB06089
ICA-105665,,investigational,KCNQ5,Potassium voltage-gated channel subfamily KQT member 5,target,,DB06089
ICA-105665,,investigational,KCNQ2,Potassium voltage-gated channel subfamily KQT member 2,target,,DB06089
NXN-188,,investigational,NOS1,"Nitric oxide synthase, brain",target,,DB06096
NXN-188,,investigational,HTR1B,5-hydroxytryptamine receptor 1B,target,,DB06096
NXN-188,,investigational,HTR1D,5-hydroxytryptamine receptor 1D,target,,DB06096
PRLX 93936,,investigational,VDAC2,Voltage-dependent anion-selective channel protein 2,target,,DB06098
PRLX 93936,,investigational,VDAC3,Voltage-dependent anion-selective channel protein 3,target,,DB06098
IMC-1C11,,investigational,FLT1,Vascular endothelial growth factor receptor 1,target,,DB06101
IMC-1C11,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB06101
IMC-1C11,,investigational,FLT4,Vascular endothelial growth factor receptor 3,target,,DB06101
VX-148,,investigational,IMPDH1,Inosine-5'-monophosphate dehydrogenase 1,target,,DB06103
VX-148,,investigational,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,,DB06103
Sertindole,Antipsychotic Agents,approvedwithdrawn,DRD2,D(2) dopamine receptor,target,antagonist,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,KCNH2,Potassium voltage-gated channel subfamily H member 2,target,inhibitor,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,ADRA1A,Alpha-1A adrenergic receptor,target,,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,ADRA1B,Alpha-1B adrenergic receptor,target,,DB06144
Sertindole,Antipsychotic Agents,approvedwithdrawn,ADRA1D,Alpha-1D adrenergic receptor,target,,DB06144
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HRH1,Histamine H1 receptor,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HRH4,Histamine H4 receptor,target,binder,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR1A,5-hydroxytryptamine receptor 1A,target,blocker,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR2B,5-hydroxytryptamine receptor 2B,target,binder,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR1F,5-hydroxytryptamine receptor 1F,target,binder,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,DRD3,D(3) dopamine receptor,target,binder,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,SLC6A3,Sodium-dependent dopamine transporter,target,binder,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,DRD2,D(2) dopamine receptor,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,HTR6,5-hydroxytryptamine receptor 6,target,binder,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,ADRA1A,Alpha-1 adrenergic receptor,target,antagonist,DB06148
Mianserin,"Antidepressive Agents, Second-GenerationSerotonin AntagonistsHistamine H1 AntagonistsAdrenergic alpha-Antagonists",approved,DRD1,D(1) dopamine receptor,target,binder,DB06148
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,ACY1,Aminoacylase-1,target,ligand,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,CHUK,Inhibitor of nuclear factor kappa-B kinase subunit alpha,target,inhibitor,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,inhibitor,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,GSS,Glutathione synthetase,target,stimulator,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,SLC7A11,Cystine/glutamate transporter,target,activator,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",target,activator,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,activator,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,GRIN2A,"Glutamate receptor ionotropic, NMDA 2A",target,activator,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,GRIN2D,"Glutamate receptor ionotropic, NMDA 2D",target,activator,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,activator,DB06151
Icatibant,"Anti-Inflammatory Agents, Non-SteroidalAdrenergic beta-Antagonists",approved,BDKRB2,B2 bradykinin receptor,target,antagonist,DB06196
Icatibant,"Anti-Inflammatory Agents, Non-SteroidalAdrenergic beta-Antagonists",approved,ANPEP,Aminopeptidase N,target,inhibitor,DB06196
Rufinamide,,approved,GRM5,Metabotropic glutamate receptor 5,target,inhibitor,DB06201
Rufinamide,,approved,SCN9A,Sodium channel protein type 9 subunit alpha,target,modulator,DB06201
Tapentadol,,approved,OPRM1,Mu-type opioid receptor,target,agonist,DB06204
Tapentadol,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB06204
Tapentadol,,approved,OPRK1,Kappa-type opioid receptor,target,,DB06204
Tapentadol,,approved,OPRD1,Delta-type opioid receptor,target,,DB06204
Tapentadol,,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,,DB06204
Tapentadol,,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB06204
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB06207
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,ADRA1B,Alpha-1B adrenergic receptor,target,antagonist,DB06207
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,ADRA1D,Alpha-1D adrenergic receptor,target,antagonist,DB06207
Tolvaptan,Vasopressin receptor antagonists,approved,AVPR2,Vasopressin V2 receptor,target,antagonist,DB06212
Tolvaptan,Vasopressin receptor antagonists,approved,AVPR1A,Vasopressin V1a receptor,target,antagonist,DB06212
Asenapine,,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB06216
Asenapine,,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB06216
Asenapine,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB06216
Asenapine,,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,antagonist,DB06216
Asenapine,,approved,HTR2B,5-hydroxytryptamine receptor 2B,target,antagonist,DB06216
Asenapine,,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB06216
Asenapine,,approved,,5-hydroxytryptamine receptor 5A,target,antagonist,DB06216
Asenapine,,approved,HTR6,5-hydroxytryptamine receptor 6,target,antagonist,DB06216
Asenapine,,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB06216
Asenapine,,approved,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB06216
Asenapine,,approved,ADRA2B,Alpha-2B adrenergic receptor,target,antagonist,DB06216
Asenapine,,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB06216
Asenapine,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB06216
Asenapine,,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB06216
Asenapine,,approved,DRD3,D(3) dopamine receptor,target,antagonist,DB06216
Asenapine,,approved,DRD4,D(4) dopamine receptor,target,antagonist,DB06216
Asenapine,,approved,HRH1,Histamine H1 receptor,target,antagonist,DB06216
Asenapine,,approved,HRH2,Histamine H2 receptor,target,antagonist,DB06216
Asenapine,,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB06216
Asenapine,,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB06216
Lacosamide,Anticonvulsants,approved,SCN9A,Sodium channel protein type 9 subunit alpha,target,,DB06218
Lacosamide,Anticonvulsants,approved,SCN3A,Sodium channel protein type 3 subunit alpha,target,,DB06218
Lacosamide,Anticonvulsants,approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,,DB06218
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRB1,Beta-1 adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,PAH,Phenylalanine-4-hydroxylase,target,inhibitor,DB06262
Sitaxentan,,approvedinvestigational,EDNRA,Endothelin-1 receptor,target,antagonist,DB06268
Sitaxentan,,approvedinvestigational,EDNRB,Endothelin B receptor,target,antagonist,DB06268
Sulodexide,AntithrombinsFibrinolytic AgentsHypoglycemic AgentsAnticoagulantsHypolipidemic Agents,approvedinvestigational,SERPIND1,Heparin cofactor 2,target,agonist,DB06271
Sulodexide,AntithrombinsFibrinolytic AgentsHypoglycemic AgentsAnticoagulantsHypolipidemic Agents,approvedinvestigational,SERPINC1,Antithrombin-III,target,potentiator,DB06271
Alvimopan,,approved,OPRM1,Mu-type opioid receptor,target,antagonist,DB06274
Alvimopan,,approved,OPRK1,Kappa-type opioid receptor,target,antagonist,DB06274
Alvimopan,,approved,OPRD1,Delta-type opioid receptor,target,antagonist,DB06274
Amisulpride,Antipsychotic AgentsDopamine Antagonists,approvedinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB06288
Amisulpride,Antipsychotic AgentsDopamine Antagonists,approvedinvestigational,DRD3,D(3) dopamine receptor,target,antagonist,DB06288
Amisulpride,Antipsychotic AgentsDopamine Antagonists,approvedinvestigational,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB06288
Amisulpride,Antipsychotic AgentsDopamine Antagonists,approvedinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB06288
Rilonacept,Immunosuppressive Agents,approved,IL1B,Interleukin-1 beta,target,binder,DB06372
Rilonacept,Immunosuppressive Agents,approved,,Interleukin-1 alpha,target,binder,DB06372
Rilonacept,Immunosuppressive Agents,approved,,Interleukin-1 receptor antagonist protein,target,binder,DB06372
Pazopanib,,approved,FLT1,Vascular endothelial growth factor receptor 1,target,inhibitor,DB06589
Pazopanib,,approved,KDR,Vascular endothelial growth factor receptor 2,target,inhibitor,DB06589
Pazopanib,,approved,FLT4,Vascular endothelial growth factor receptor 3,target,,DB06589
Pazopanib,,approved,PDGFRA,Platelet-derived growth factor receptor alpha,target,inhibitor,DB06589
Pazopanib,,approved,PDGFRB,Platelet-derived growth factor receptor beta,target,inhibitor,DB06589
Pazopanib,,approved,KIT,Mast/stem cell growth factor receptor Kit,target,inhibitor,DB06589
Pazopanib,,approved,FGFR3,Fibroblast growth factor receptor 3,target,inhibitor,DB06589
Pazopanib,,approved,ITK,Tyrosine-protein kinase ITK/TSK,target,inhibitor,DB06589
Pazopanib,,approved,FGF1,Fibroblast growth factor 1,target,inhibitor,DB06589
Pazopanib,,approved,,SH2B adapter protein 3,target,inhibitor,DB06589
Agomelatine,Antidepressive Agents,approvedinvestigational,HTR2C,5-hydroxytryptamine receptor 2C,target,antagonist,DB06594
Agomelatine,Antidepressive Agents,approvedinvestigational,MTNR1A,Melatonin receptor type 1A,target,agonist,DB06594
Agomelatine,Antidepressive Agents,approvedinvestigational,MTNR1B,Melatonin receptor type 1B,target,agonist,DB06594
Peramivir,,investigational,NA,Neuraminidase,target,,DB06614
Peramivir,,investigational,NA,Neuraminidase,target,,DB06614
Bosutinib,,approved,,Breakpoint cluster region protein,target,inhibitor,DB06616
Bosutinib,,approved,ABL1,Tyrosine-protein kinase ABL1,target,inhibitor,DB06616
Bosutinib,,approved,LYN,Tyrosine-protein kinase Lyn,target,,DB06616
Bosutinib,,approved,HCK,Tyrosine-protein kinase HCK,target,inhibitor,DB06616
Bosutinib,,approved,SRC,Proto-oncogene tyrosine-protein kinase Src,target,inhibitor,DB06616
Bosutinib,,approved,CDK2deltaT,Cyclin-dependent kinase 2,target,inhibitor,DB06616
Bosutinib,,approved,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,inhibitor,DB06616
Bosutinib,,approved,,Dual specificity mitogen-activated protein kinase kinase 2,target,inhibitor,DB06616
Bosutinib,,approved,,Mitogen-activated protein kinase kinase kinase 2,target,inhibitor,DB06616
Bosutinib,,approved,CAMK2G,Calcium/calmodulin-dependent protein kinase type II subunit gamma,target,inhibitor,DB06616
Axitinib,,approvedinvestigational,FLT1,Vascular endothelial growth factor receptor 1,target,inhibitor,DB06626
Axitinib,,approvedinvestigational,KDR,Vascular endothelial growth factor receptor 2,target,inhibitor,DB06626
Axitinib,,approvedinvestigational,FLT4,Vascular endothelial growth factor receptor 3,target,inhibitor,DB06626
Dalfampridine,Potassium Channel Blockers,approved,KCNA1,Potassium voltage-gated channel subfamily A member 1,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily A member 2,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily A member 3,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,KCNA4,Potassium voltage-gated channel subfamily A member 4,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily A member 5,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily A member 6,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily A member 7,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily A member 10,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily B member 1,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily B member 2,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily C member 1,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily C member 2,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily C member 3,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,,Potassium voltage-gated channel subfamily D member 1,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,KCND2,Potassium voltage-gated channel subfamily D member 2,target,antagonist,DB06637
Dalfampridine,Potassium Channel Blockers,approved,KCND3,Potassium voltage-gated channel subfamily D member 3,target,antagonist,DB06637
Pasireotide,,approved,SSTR1,Somatostatin receptor type 1,target,,DB06663
Pasireotide,,approved,SSTR2,Somatostatin receptor type 2,target,,DB06663
Pasireotide,,approved,SSTR3,Somatostatin receptor type 3,target,,DB06663
Pasireotide,,approved,SSTR5,Somatostatin receptor type 5,target,,DB06663
Belatacept,Antirheumatic AgentsImmunosuppressive Agents,approved,CD86,T-lymphocyte activation antigen CD86,target,,DB06681
Belatacept,Antirheumatic AgentsImmunosuppressive Agents,approved,CD80,T-lymphocyte activation antigen CD80,target,,DB06681
Ethanolamine Oleate,Sclerosing Solutions,approved,,Coagulation factor XII,target,activator,DB06689
Aprotinin,HemostaticsSerine Proteinase InhibitorsTrypsin Inhibitors,approvedwithdrawn,PRSS1,Trypsin-1,target,,DB06692
Aprotinin,HemostaticsSerine Proteinase InhibitorsTrypsin Inhibitors,approvedwithdrawn,CTRB1,Chymotrypsinogen B,target,,DB06692
Aprotinin,HemostaticsSerine Proteinase InhibitorsTrypsin Inhibitors,approvedwithdrawn,PLG,Plasminogen,target,,DB06692
Aprotinin,HemostaticsSerine Proteinase InhibitorsTrypsin Inhibitors,approvedwithdrawn,KLK1,Kallikrein-1,target,,DB06692
Xylometazoline,Nasal Decongestants,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB06694
Xylometazoline,Nasal Decongestants,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB06694
Xylometazoline,Nasal Decongestants,approved,ADRA2B,Alpha-2B adrenergic receptor,target,agonist,DB06694
Xylometazoline,Nasal Decongestants,approved,ADRA1B,Alpha-1B adrenergic receptor,target,agonist,DB06694
Xylometazoline,Nasal Decongestants,approved,ADRA1D,Alpha-1D adrenergic receptor,target,agonist,DB06694
Xylometazoline,Nasal Decongestants,approved,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB06694
Betahistine,Antiemetics,approved,HRH1,Histamine H1 receptor,target,agonist,DB06698
Betahistine,Antiemetics,approved,HRH3,Histamine H3 receptor,target,antagonist,DB06698
Desvenlafaxine,Serotonin Uptake InhibitorsNeurotransmitter Uptake InhibitorsAntidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB06700
Desvenlafaxine,Serotonin Uptake InhibitorsNeurotransmitter Uptake InhibitorsAntidepressive Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB06700
Dexmethylphenidate,,approved,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB06701
Dexmethylphenidate,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB06701
Dexmethylphenidate,,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB06701
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB06702
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB06702
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB06702
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB06702
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB06702
Isometheptene,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB06706
Isometheptene,,approved,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB06706
Levonordefrin,,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB06707
Levonordefrin,,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB06707
Naphazoline,Sympathomimetics,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB06711
Naphazoline,Sympathomimetics,approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB06711
Nilvadipine,,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB06712
Nilvadipine,,approved,CACNA2D1,Voltage-dependent calcium channel subunit alpha-2/delta-1,target,inhibitor,DB06712
Nilvadipine,,approved,CACNB2,Voltage-dependent L-type calcium channel subunit beta-2,target,inhibitor,DB06712
Nilvadipine,,approved,CACNA1D,Voltage-dependent L-type calcium channel subunit alpha-1D,target,inhibitor,DB06712
Nilvadipine,,approved,CACNA1S,Voltage-dependent L-type calcium channel subunit alpha-1S,target,inhibitor,DB06712
Nilvadipine,,approved,CACNA2D3,Voltage-dependent calcium channel subunit alpha-2/delta-3,target,inhibitor,DB06712
Propylhexedrine,,approved,SLC18A2,Synaptic vesicular amine transporter,target,,DB06714
Propylhexedrine,,approved,TAAR1,Trace amine-associated receptor 1,target,agonist,DB06714
Fospropofol,Hypnotics and Sedatives,approvedillicit,GABRB2,Gamma-aminobutyric acid receptor subunit beta-2,target,potentiator,DB06716
Fospropofol,Hypnotics and Sedatives,approvedillicit,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,potentiator,DB06716
Buserelin,,approved,LHCGR,Lutropin-choriogonadotropic hormone receptor,target,,DB06719
Buserelin,,approved,GNRHR,Gonadotropin-releasing hormone receptor,target,,DB06719
Lornoxicam,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB06725
Lornoxicam,"Anti-Inflammatory Agents, Non-Steroidal",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB06725
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,OPRM1,Mu-type opioid receptor,target,agonist,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,OPRK1,Kappa-type opioid receptor,target,agonist,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,OPRD1,Delta-type opioid receptor,target,agonist,DB06738
Ketobemidone,"Analgesics, OpioidExcitatory Amino Acid Antagonists",approved,GRIN1,NMDA receptor,target,antagonist,DB06738
Drotaverine,AnalgesicsVasodilator AgentsParasympatholytics,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB06751
Drotaverine,AnalgesicsVasodilator AgentsParasympatholytics,approved,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,target,inhibitor,DB06751
Besifloxacin,QuinolonesAntibiotics,approved,parC,DNA topoisomerase 4 subunit A,target,antagonist,DB06771
Besifloxacin,QuinolonesAntibiotics,approved,parC,DNA topoisomerase 4 subunit A,target,antagonist,DB06771
Besifloxacin,QuinolonesAntibiotics,approved,gyrA,DNA gyrase subunit A,target,antagonist,DB06771
Besifloxacin,QuinolonesAntibiotics,approved,gyrA,DNA gyrase subunit A,target,antagonist,DB06771
Cabazitaxel,Antineoplastic Agents,approved,TUBA4A,Tubulin alpha-4A chain,target,binder,DB06772
Cabazitaxel,Antineoplastic Agents,approved,TUBB1,Tubulin beta-1 chain,target,binder,DB06772
Dalteparin,AntithrombinsFibrinolytic AgentsAnticoagulantsHeparins,approved,SERPINC1,Antithrombin-III,target,potentiator,DB06779
Dalteparin,AntithrombinsFibrinolytic AgentsAnticoagulantsHeparins,approved,VEGFA,Vascular endothelial growth factor A,target,inhibitor,DB06779
Dalteparin,AntithrombinsFibrinolytic AgentsAnticoagulantsHeparins,approved,TFPI,Tissue factor pathway inhibitor,target,inhibitor,DB06779
Dalteparin,AntithrombinsFibrinolytic AgentsAnticoagulantsHeparins,approved,SELP,P-selectin,target,inhibitor,DB06779
Methylnaltrexone,Narcotic Antagonists,approved,OPRM1,Mu-type opioid receptor,target,antagonist,DB06800
Methylnaltrexone,Narcotic Antagonists,approved,OPRK1,Kappa-type opioid receptor,target,antagonist,DB06800
Nepafenac,"Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalProdrugs",approved,PTGS1,Prostaglandin G/H synthase 1,target,inhibitor,DB06802
Nepafenac,"Anti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalProdrugs",approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB06802
Pralatrexate,,approved,DHFR,Dihydrofolate reductase,target,inhibitor,DB06813
Pralatrexate,,approved,TYMS,Thymidylate synthase,target,inhibitor,DB06813
Tinzaparin,AntithrombinsHeparins,approved,SERPINC1,Antithrombin-III,target,potentiator,DB06822
Tinzaparin,AntithrombinsHeparins,approved,ITGA4,Integrin alpha-4,target,inhibitor,DB06822
Tinzaparin,AntithrombinsHeparins,approved,CXCL12,Stromal cell-derived factor 1,target,binder,DB06822
2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB06831
2-((9H-PURIN-6-YLTHIO)METHYL)-5-CHLORO-3-(2-METHOXYPHENYL)QUINAZOLIN-4(3H)-ONE,,experimental,PIK3CD,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",target,,DB06831
"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",,experimental,ESR2,Estrogen receptor beta,target,,DB06832
"2-(3-FLUORO-4-HYDROXYPHENYL)-7-VINYL-1,3-BENZOXAZOL-5-OL",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB06832
N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE,,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB06836
N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE,,experimental,PIK3C3,Phosphatidylinositol 3-kinase catalytic subunit type 3,target,,DB06836
methyl L-phenylalaninate,,experimental,pilE1,Fimbrial protein,target,,DB06838
methyl L-phenylalaninate,,experimental,F2,Prothrombin,target,,DB06838
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,,experimental,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,,DB06842
(4R)-4-(3-butoxy-4-methoxybenzyl)imidazolidin-2-one,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB06842
"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",,experimental,GNAS,Guanine nucleotide-binding protein G(s) subunit alpha isoforms short,target,,DB06843
"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",,experimental,ADCY2,Adenylate cyclase type 2,target,,DB06843
"2',5'-DIDEOXY-ADENOSINE 3'-MONOPHOSPHATE",,experimental,ADCY5,Adenylate cyclase type 5,target,,DB06843
"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB06844
"4-[(7-OXO-7H-THIAZOLO[5,4-E]INDOL-8-YLMETHYL)-AMINO]-N-PYRIDIN-2-YL-BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB06844
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,,experimental,PRSS1,Trypsin-1,target,,DB06845
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentylamino)ethanoyl)pyrrolidine-2-carboxamide,,experimental,F2,Prothrombin,target,,DB06845
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,,experimental,PRSS1,Trypsin-1,target,,DB06850
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexylamino)ethanoyl)pyrrolidine-2-carboxamide,,experimental,F2,Prothrombin,target,,DB06850
N-(pyridin-3-ylmethyl)aniline,,experimental,ppa,Inorganic pyrophosphatase,target,,DB06851
N-(pyridin-3-ylmethyl)aniline,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB06851
N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,PRSS1,Trypsin-1,target,,DB06853
N-cycloheptylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06853
2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,experimental,F2,Prothrombin,target,,DB06854
2-(2-HYDROXY-BIPHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB06854
N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06858
N-cyclooctylglycyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,PRSS1,Trypsin-1,target,,DB06858
17-METHYL-17-ALPHA-DIHYDROEQUILENIN,,experimental,ESR1,Estrogen receptor,target,,DB06871
17-METHYL-17-ALPHA-DIHYDROEQUILENIN,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB06871
3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,,experimental,ESR2,Estrogen receptor beta,target,,DB06875
3-(3-FLUORO-4-HYDROXYPHENYL)-7-HYDROXY-1-NAPHTHONITRILE,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB06875
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB06882
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-naphthalen-1-ylurea,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB06882
4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,,experimental,ESRRG,Estrogen-related receptor gamma,target,,DB06884
4-HYDROXY-N'-(4-ISOPROPYLBENZYL)BENZOHYDRAZIDE,,experimental,NRIP1,Nuclear receptor-interacting protein 1,target,,DB06884
1-DODECANOL,,experimental,sdsA1,SDS hydrolase SdsA1,target,,DB06894
1-DODECANOL,,experimental,FAAH,Fatty-acid amide hydrolase 1,target,,DB06894
"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",,experimental,ESR1,Estrogen receptor,target,,DB06898
"4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB06898
"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",,experimental,PPP2R5C,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit gamma isoform,target,,DB06905
"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",,experimental,PPP2CA,Serine/threonine-protein phosphatase 2A catalytic subunit alpha isoform,target,,DB06905
"(2S,3S,4E,6E,8S,9S)-3-amino-9-methoxy-2,6,8-trimethyl-10-phenyldeca-4,6-dienoic acid",,experimental,PPP2R1A,Serine/threonine-protein phosphatase 2A 65 kDa regulatory subunit A alpha isoform,target,,DB06905
"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB06908
"(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB06908
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,,experimental,ESR2,Estrogen receptor beta,target,,DB06927
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB06927
[5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-YL]ACETONITRILE,,experimental,ESR1,Estrogen receptor,target,,DB06927
N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE,,experimental,CCNA2,Cyclin-A2,target,,DB06944
N-(3-CYCLOPROPYL-1H-PYRAZOL-5-YL)-2-(2-NAPHTHYL)ACETAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB06944
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,,experimental,CCNA2,Cyclin-A2,target,,DB06948
2-ANILINO-6-CYCLOHEXYLMETHOXYPURINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB06948
2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB06953
2-CHLORO-5-(3-CHLORO-PHENYL)-6-[(4-CYANO-PHENYL)-(3-METHYL-3H-IMIDAZOL-4-YL)- METHOXYMETHYL]-NICOTINONITRILE,,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB06953
(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB06959
(1S)-2-(1H-INDOL-3-YL)-1-{[(5-ISOQUINOLIN-6-YLPYRIDIN-3-YL)OXY]METHYL}ETHYLAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB06959
2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE,,experimental,LTF,Lactotransferrin,target,,DB06987
2-(4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ETHANAMIDE,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB06987
"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07009
"2-(5-HYDROXY-NAPHTHALEN-1-YL)-1,3-BENZOOXAZOL-6-OL",,experimental,ESR2,Estrogen receptor beta,target,,DB07009
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB07010
N-BENZYL-4-[4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL]-1H-PYRROLE-2-CARBOXAMIDE,,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB07010
"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",,experimental,ligA,DNA ligase,target,,DB07041
"N-[2-(2,4-diaminopyrido[2,3-d]pyrimidin-7-yl)-2-methylpropyl]-4-phenoxybenzamide",,experimental,ligA,DNA ligase,target,,DB07041
"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",,experimental,BAG1,BAG family molecular chaperone regulator 1,target,,DB07045
"(2R,3R,4S,5R)-2-[6-amino-8-[(3,4-dichlorophenyl)methylamino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",,experimental,HSPA8,Heat shock cognate 71 kDa protein,target,,DB07045
3-(INDOL-3-YL) LACTATE,,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB07060
3-(INDOL-3-YL) LACTATE,,experimental,mdlB,(S)-mandelate dehydrogenase,target,,DB07060
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",,experimental,NR1H2,Oxysterols receptor LXR-beta,target,,DB07080
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07080
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",,experimental,RXRB,Retinoic acid receptor RXR-beta,target,,DB07080
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",,experimental,NR1H3,Oxysterols receptor LXR-alpha,target,,DB07080
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07080
"N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE",,experimental,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,,DB07080
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07086
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,ESR1,Estrogen receptor,target,,DB07086
"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,ESR1,Estrogen receptor,target,,DB07087
"4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07087
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,,experimental,PRSS1,Trypsin-1,target,,DB07088
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclopentyloxy)ethanoyl)pyrrolidine-2-carboxamide,,experimental,F2,Prothrombin,target,,DB07088
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,,experimental,PRSS1,Trypsin-1,target,,DB07091
(S)-N-(4-carbamimidoylbenzyl)-1-(2-(cyclohexyloxy)ethanoyl)pyrrolidine-2-carboxamide,,experimental,F2,Prothrombin,target,,DB07091
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,,experimental,PRSS1,Trypsin-1,target,,DB07095
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclopentylpropanoyl)pyrrolidine-2-carboxamide,,experimental,F2,Prothrombin,target,,DB07095
(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07107
(1S)-2-(1H-INDOL-3-YL)-1-[({5-[(E)-2-PYRIDIN-4-YLVINYL]PYRIDIN-3-YL}OXY)METHYL]ETHYLAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07107
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07119
1-CHLORO-6-(4-HYDROXYPHENYL)-2-NAPHTHOL,,experimental,ESR2,Estrogen receptor beta,target,,DB07119
O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,,experimental,CCNA2,Cyclin-A2,target,,DB07126
O6-CYCLOHEXYLMETHOXY-2-(4'-SULPHAMOYLANILINO) PURINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07126
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,,experimental,PRSS1,Trypsin-1,target,,DB07131
(S)-N-(4-carbamimidoylbenzyl)-1-(3-cyclohexylpropanoyl)pyrrolidine-2-carboxamide,,experimental,F2,Prothrombin,target,,DB07131
(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE,,experimental,CCNA2,Cyclin-A2,target,,DB07137
(2S)-N-[(3Z)-5-CYCLOPROPYL-3H-PYRAZOL-3-YLIDENE]-2-[4-(2-OXOIMIDAZOLIDIN-1-YL)PHENYL]PROPANAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07137
"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB07140
"5-[(3R)-3-(5-methoxybiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,dfrB,Dihydrofolate reductase,target,,DB07140
"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB07142
"5-[(3R)-3-(5-methoxy-3',5'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,dfrB,Dihydrofolate reductase,target,,DB07142
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07150
4-(4-HYDROXYPHENYL)-1-NAPHTHALDEHYDE OXIME,,experimental,ESR2,Estrogen receptor beta,target,,DB07150
"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",,experimental,CCNA2,Cyclin-A2,target,,DB07164
"N-cyclopropyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07164
"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",,experimental,PTGR1,Prostaglandin reductase 1,target,,DB07177
"(5E,13E)-11-HYDROXY-9,15-DIOXOPROSTA-5,13-DIEN-1-OIC ACID",,experimental,PTGR2,Prostaglandin reductase 2,target,,DB07177
"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",,experimental,AURKA,Aurora kinase A,target,,DB07186
"4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE",,experimental,PLK1,Serine/threonine-protein kinase PLK1,target,,DB07186
"4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07191
"4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07191
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,ESR1,Estrogen receptor,target,,DB07195
"4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07195
5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,,experimental,ESR2,Estrogen receptor beta,target,,DB07198
5-HYDROXY-2-(4-HYDROXYPHENYL)-1-BENZOFURAN-7-CARBONITRILE,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07198
"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",,experimental,,Genome polyprotein,target,,DB07199
"(2S,4S,5R)-1-(4-TERT-BUTYLBENZOYL)-2-ISOBUTYL-5-(1,3-THIAZOL-2-YL)PYRROLIDINE-2,4-DICARBOXYLIC ACID",,experimental,NS5b,RNA-dependent RNA-polymerase,target,,DB07199
"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",,experimental,,Genome polyprotein,target,,DB07200
"(2S,4S,5R)-2-ISOBUTYL-5-(2-THIENYL)-1-[4-(TRIFLUOROMETHYL)BENZOYL]PYRROLIDINE-2,4-DICARBOXYLIC ACID",,experimental,NS5b,RNA-dependent RNA-polymerase,target,,DB07200
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,,experimental,CCNA2,Cyclin-A2,target,,DB07203
6-CYCLOHEXYLMETHOXY-2-(3'-CHLOROANILINO) PURINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07203
"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07204
"(1S)-1-(1H-INDOL-3-YLMETHYL)-2-(2-PYRIDIN-4-YL-[1,7]NAPHTYRIDIN-5-YLOXY)-EHYLAMINE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07204
2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,experimental,F7,Coagulation factor VII,target,,DB07207
2-(4-HYDROXY-5-PHENYL-1H-PYRAZOL-3-YL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,experimental,F3,Tissue factor,target,,DB07207
(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,,experimental,F2,Prothrombin,target,,DB07211
(2R)-2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}PROPENE-1-SULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07211
"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07215
"2-METHYL-2-(4-{[({4-METHYL-2-[4-(TRIFLUOROMETHYL)PHENYL]-1,3-THIAZOL-5-YL}CARBONYL)AMINO]METHYL}PHENOXY)PROPANOIC ACID",,experimental,PPARA,Peroxisome proliferator-activated receptor alpha,target,,DB07215
"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07216
"(11S)-8-CHLORO-11-[1-(METHYLSULFONYL)PIPERIDIN-4-YL]-6-PIPERAZIN-1-YL-11H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE",,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07216
"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",,experimental,MAPK8IP1,C-Jun-amino-terminal kinase-interacting protein 1,target,,DB07218
"6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE",,experimental,MAPK8,Mitogen-activated protein kinase 8,target,,DB07218
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07227
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07227
4-[(5-{[4-(3-CHLOROPHENYL)-3-OXOPIPERAZIN-1-YL]METHYL}-1H-IMIDAZOL-1-YL)METHYL]BENZONITRILE,,experimental,PGGT1B,Geranylgeranyl transferase type-1 subunit beta,target,,DB07227
3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,,experimental,ESR2,Estrogen receptor beta,target,,DB07230
3-BROMO-6-HYDROXY-2-(4-HYDROXYPHENYL)-1H-INDEN-1-ONE,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07230
(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB07232
(2R)-2-(7-carbamoyl-1H-benzimidazol-2-yl)-2-methylpyrrolidinium,,experimental,PARP2,Poly [ADP-ribose] polymerase 2,target,,DB07232
3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,,experimental,ESR2,Estrogen receptor beta,target,,DB07236
3-(6-HYDROXY-NAPHTHALEN-2-YL)-BENZO[D]ISOOXAZOL-6-OL,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07236
5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide,,experimental,,Genome polyprotein,target,,DB07238
5-cyclopropyl-2-(4-fluorophenyl)-6-[(2-hydroxyethyl)(methylsulfonyl)amino]-N-methyl-1-benzofuran-3-carboxamide,,experimental,,Genome polyprotein,target,,DB07238
"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",,experimental,DAPK3,Death-associated protein kinase 3,target,,DB07242
"(4R)-7,8-dichloro-1',9-dimethyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB07242
"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB07244
"5-{4-[(3,5-DIFLUOROBENZYL)AMINO]PHENYL}-6-ETHYLPYRIMIDINE-2,4-DIAMINE",,experimental,REN,Renin,target,,DB07244
"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",,experimental,F7,Coagulation factor VII,target,,DB07247
"[2'-HYDROXY-3'-(1H-PYRROLO[3,2-C]PYRIDIN-2-YL)-BIPHENYL-3-YLMETHYL]-UREA",,experimental,F3,Tissue factor,target,,DB07247
"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",,experimental,MAPK8IP1,C-Jun-amino-terminal kinase-interacting protein 1,target,,DB07272
"N-(4-AMINO-5-CYANO-6-ETHOXYPYRIDIN-2-YL)-2-(4-BROMO-2,5-DIMETHOXYPHENYL)ACETAMIDE",,experimental,MAPK8,Mitogen-activated protein kinase 8,target,,DB07272
"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",,experimental,MAPK8IP1,C-Jun-amino-terminal kinase-interacting protein 1,target,,DB07276
"5-CYANO-N-(2,5-DIMETHOXYBENZYL)-6-ETHOXYPYRIDINE-2-CARBOXAMIDE",,experimental,MAPK8,Mitogen-activated protein kinase 8,target,,DB07276
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,,experimental,F2,Prothrombin,target,,DB07277
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHANESULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07277
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,,experimental,F2,Prothrombin,target,,DB07278
2-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}ETHENESULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07278
9H-CARBAZOLE,,experimental,carAc,Ferredoxin CarAc,target,,DB07301
9H-CARBAZOLE,,experimental,carAa,Terminal oxygenase component of carbazole,target,,DB07301
"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07327
"(2-ACETYL-5-METHYLANILINO)(2,6-DIBROMOPHENYL)ACETAMIDE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07327
"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07332
"ALPHA-(2,6-DICHLOROPHENYL)-ALPHA-(2-ACETYL-5-METHYLANILINO)ACETAMIDE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07332
"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB07335
"3-[4-AMINO-1-(1-METHYLETHYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL]PHENOL",,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB07335
5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID,,experimental,hemY,Protoporphyrinogen oxidase,target,,DB07338
5-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENOXY]-2-NITROBENZOIC ACID,,experimental,hemY,Protoporphyrinogen oxidase,target,,DB07338
"N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",,experimental,AURKB,Aurora kinase B,target,,DB07340
"N~6~-cyclohexyl-N~2~-(4-morpholin-4-ylphenyl)-9H-purine-2,6-diamine",,experimental,INCENP,Inner centromere protein,target,,DB07340
4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE,,experimental,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,target,,DB07347
4-(2-AMINOETHYL)BENZENESULFONYL FLUORIDE,,experimental,ATP6V1B2,"V-type proton ATPase subunit B, brain isoform",target,,DB07347
"1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE",,experimental,CYTH2,Cytohesin-2,target,,DB07348
"1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE",,experimental,ARF1,ADP-ribosylation factor 1,target,,DB07348
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,experimental,narG,Respiratory nitrate reductase 1 alpha chain,target,,DB07349
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,experimental,narH,Respiratory nitrate reductase 1 beta chain,target,,DB07349
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,experimental,narI,Respiratory nitrate reductase 1 gamma chain,target,,DB07349
"(1S)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PENTANOYLOXY)METHYL]ETHYL OCTANOATE",,experimental,aqpZ,Aquaporin Z,target,,DB07349
"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",,experimental,CDK5,Cyclin-dependent kinase 5,target,,DB07364
"6-PHENYL[5H]PYRROLO[2,3-B]PYRAZINE",,experimental,CDK5R1,Cyclin-dependent kinase 5 activator 1,target,,DB07364
NAPHTHALEN-2-YL-3-ALANINE,,experimental,oppA,Periplasmic oligopeptide-binding protein,target,,DB07365
NAPHTHALEN-2-YL-3-ALANINE,,experimental,pol,Pol polyprotein,target,,DB07365
ANTHRACENE,,experimental,doxB,"Naphthalene 1,2-dioxygenase subunit alpha",target,,DB07372
ANTHRACENE,,experimental,doxD,"Naphthalene 1,2-dioxygenase subunit beta",target,,DB07372
ANISOMYCIN,,experimental,RPL10L,60S ribosomal protein L10-like,target,,DB07374
ANISOMYCIN,,experimental,RPL13A,60S ribosomal protein L13a,target,,DB07374
ANISOMYCIN,,experimental,RPL23,60S ribosomal protein L23,target,,DB07374
ANISOMYCIN,,experimental,RPL15,60S ribosomal protein L15,target,,DB07374
ANISOMYCIN,,experimental,RPL19,60S ribosomal protein L19,target,,DB07374
ANISOMYCIN,,experimental,RPL23A,60S ribosomal protein L23a,target,,DB07374
ANISOMYCIN,,experimental,RSL24D1,Probable ribosome biogenesis protein RLP24,target,,DB07374
ANISOMYCIN,,experimental,RPL26L1,60S ribosomal protein L26-like 1,target,,DB07374
ANISOMYCIN,,experimental,RPL8,60S ribosomal protein L8,target,,DB07374
ANISOMYCIN,,experimental,RPL37,60S ribosomal protein L37,target,,DB07374
ANISOMYCIN,,experimental,RPL3,60S ribosomal protein L3,target,,DB07374
ANISOMYCIN,,experimental,RPL11,60S ribosomal protein L11,target,,DB07374
ANISOMYCIN,,experimental,NHP2L1,NHP2-like protein 1,target,,DB07374
"5-BETA-ANDROSTANE-3,17-DIONE",,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB07375
"5-BETA-ANDROSTANE-3,17-DIONE",,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07375
"5-BETA-ANDROSTANE-3,17-DIONE",,experimental,IGKC,Ig kappa chain C region,target,,DB07375
"5-BETA-ANDROSTANE-3,17-DIONE",,experimental,,Ig kappa chain V-II region RPMI 6410,target,,DB07375
5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),,experimental,F2,Prothrombin,target,,DB07376
5-(DIMETHYLAMINO)-1-NAPHTHALENESULFONIC ACID(DANSYL ACID),,experimental,F7,Coagulation factor VII,target,,DB07376
(2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL,,experimental,CDK6,Cyclin-dependent kinase 6,target,,DB07379
(2S)-2-({6-[(3-AMINO-5-CHLOROPHENYL)AMINO]-9-ISOPROPYL-9H-PURIN-2-YL}AMINO)-3-METHYLBUTAN-1-OL,,experimental,72,Cyclin homolog,target,,DB07379
1-ACETYL-2-CARBOXYPIPERIDINE,,experimental,ATP5A1,"ATP synthase subunit alpha, mitochondrial",target,,DB07384
1-ACETYL-2-CARBOXYPIPERIDINE,,experimental,ATP5B,"ATP synthase subunit beta, mitochondrial",target,,DB07384
1-ACETYL-2-CARBOXYPIPERIDINE,,experimental,ATP5C1,"ATP synthase subunit gamma, mitochondrial",target,,DB07384
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07388
ETHYL 4-[(4-METHYLPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB07388
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB07392
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",,experimental,puhA,Reaction center protein H chain,target,,DB07392
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",,experimental,pufL,Reaction center protein L chain,target,,DB07392
"2-CHLORO-4-ISOPROPYLAMINO-6-ETHYLAMINO -1,3,5-TRIAZINE",,experimental,pufM,Reaction center protein M chain,target,,DB07392
AUROVERTIN B,,experimental,ATP5A1,"ATP synthase subunit alpha, mitochondrial",target,,DB07394
AUROVERTIN B,,experimental,ATP5B,"ATP synthase subunit beta, mitochondrial",target,,DB07394
AUROVERTIN B,,experimental,ATP5C1,"ATP synthase subunit gamma, mitochondrial",target,,DB07394
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,MT-CYB,Cytochrome b,target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB07401
METHYL (2Z)-2-(2-{[6-(2-CYANOPHENOXY)PYRIMIDIN-4-YL]OXY}PHENYL)-3-METHOXYACRYLATE,,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB07401
[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB07410
[2-(3-DIBENZOFURAN-4-YL-PHENYL)-1-HYDROXY-1-PHOSPHONO-ETHYL]-PHOSPHONIC ACID,,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB07410
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,,experimental,kcsA,pH-gated potassium channel KcsA,target,,DB07416
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,,experimental,IGKC,Ig kappa chain C region,target,,DB07416
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE,,experimental,kcsA,pH-gated potassium channel KcsA,target,,DB07416
"{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid",,experimental,,"Thyroid hormone receptor, alpha isoform 1 variant",target,,DB07425
"{4-[4-hydroxy-3-(1-methylethyl)benzyl]-3,5-dimethylphenoxy}acetic acid",,experimental,THRB,Thyroid hormone receptor beta,target,,DB07425
2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,,experimental,HBA1,Hemoglobin subunit alpha,target,,DB07427
2-[(2-methoxy-5-methylphenoxy)methyl]pyridine,,experimental,HBB,Hemoglobin subunit beta,target,,DB07427
4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,,experimental,HBA1,Hemoglobin subunit alpha,target,,DB07428
4-[(5-methoxy-2-methylphenoxy)methyl]pyridine,,experimental,HBB,Hemoglobin subunit beta,target,,DB07428
"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB07431
"(3R)-3-(aminomethyl)-9-methoxy-1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2-e][1,4]diazepin-5-one",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07431
"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",,experimental,nagZ,Beta-hexosaminidase,target,,DB07432
"[[(3R,4R,5S,6R)-3-(butanoylamino)-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-ylidene]amino] N-phenylcarbamate",,experimental,BT_4395,O-GlcNAcase BT_4395,target,,DB07432
"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",,experimental,POLK,DNA polymerase kappa,target,,DB07435
"1,2,3-TRIHYDROXY-1,2,3,4-TETRAHYDROBENZO[A]PYRENE",,experimental,polA,DNA polymerase I,target,,DB07435
"1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,udp,Uridine phosphorylase,target,,DB07437
"1-((2-HYDROXYETHOXY)METHYL)-5-BENZYLPYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,UPP1,Uridine phosphorylase 1,target,,DB07437
"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07441
"3-{[(9-CYANO-9,10-DIHYDRO-10-METHYLACRIDIN-9-YL)CARBONYL]AMINO}PROPANOIC ACID",,experimental,IGKC,Ig kappa chain C region,target,,DB07441
"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB07471
"5-[5,6-BIS(METHYLOXY)-1H-BENZIMIDAZOL-1-YL]-3-{[1-(2-CHLOROPHENYL)ETHYL]OXY}-2-THIOPHENECARBOXAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07471
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA1,Proteasome subunit alpha type-1,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA2,Proteasome subunit alpha type-2,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA3,Proteasome subunit alpha type-3,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA4,Proteasome subunit alpha type-4,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA5,Proteasome subunit alpha type-5,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA6,Proteasome subunit alpha type-6,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMA7,Proteasome subunit alpha type-7,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB1,Proteasome subunit beta type-1,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB2,Proteasome subunit beta type-2,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB3,Proteasome subunit beta type-3,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB4,Proteasome subunit beta type-4,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB5,Proteasome subunit beta type-5,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB6,Proteasome subunit beta type-6,target,,DB07475
N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE,,experimental,PSMB7,Proteasome subunit beta type-7,target,,DB07475
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,experimental,frdA,Fumarate reductase flavoprotein subunit,target,,DB07490
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,experimental,frdB,Fumarate reductase iron-sulfur subunit,target,,DB07490
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,experimental,frdC,Fumarate reductase subunit C,target,,DB07490
"2-[1-(4-CHLORO-PHENYL)-ETHYL]-4,6-DINITRO-PHENOL",,experimental,frdD,Fumarate reductase subunit D,target,,DB07490
"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",,experimental,yngHB,Biotin/lipoyl attachment protein,target,,DB07497
"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",,experimental,PC,"Pyruvate carboxylase, mitochondrial",target,,DB07497
"5-(HEXAHYDRO-2-OXO-1H-THIENO[3,4-D]IMIDAZOL-6-YL)PENTANAL",,experimental,pycA,Pyruvate carboxylase,target,,DB07497
L-BENZYLSUCCINIC ACID,,experimental,CPA1,Carboxypeptidase A1,target,,DB07506
L-BENZYLSUCCINIC ACID,,experimental,npr,Thermolysin,target,,DB07506
L-BENZYLSUCCINIC ACID,,experimental,SCPEP1,Retinoid-inducible serine carboxypeptidase,target,,DB07506
"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07530
"(1R,3R)-5-[(2E)-3-{(1S,3R)-2,2,3-trimethyl-3-[6,6,6-trifluoro-5-hydroxy-5-(trifluoromethyl)hex-3-yn-1-yl]cyclopentyl}prop-2-en-1-ylidene]cyclohexane-1,3-diol",,experimental,VDR,Vitamin D3 receptor,target,,DB07530
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB07533
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]-2-FURYL}-N-METHYLBENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07533
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB07534
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07534
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB07538
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}-2-(TRIFLUOROMETHYL)BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07538
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",,experimental,CCNA2,Cyclin-A2,target,,DB07539
"4-{5-[(Z)-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZOIC ACID",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07539
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,,experimental,E,Lysozyme,target,,DB07543
(2S)-1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol,,experimental,ADRB2,Beta-2 adrenergic receptor,target,,DB07543
"2-CHLORO-4-ETHYLAMINO-6-(S(-)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB07551
"2-CHLORO-4-ETHYLAMINO-6-(S(-)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,puhA,Reaction center protein H chain,target,,DB07551
"2-CHLORO-4-ETHYLAMINO-6-(S(-)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,pufL,Reaction center protein L chain,target,,DB07551
"2-CHLORO-4-ETHYLAMINO-6-(S(-)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,pufM,Reaction center protein M chain,target,,DB07551
"2-CHLORO-4-ETHYLAMINO-6-(R(+)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB07552
"2-CHLORO-4-ETHYLAMINO-6-(R(+)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,puhA,Reaction center protein H chain,target,,DB07552
"2-CHLORO-4-ETHYLAMINO-6-(R(+)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,pufL,Reaction center protein L chain,target,,DB07552
"2-CHLORO-4-ETHYLAMINO-6-(R(+)-2'-CYANO-4-BUTYLAMINO)-1,3,5-TRIAZINE",,experimental,pufM,Reaction center protein M chain,target,,DB07552
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,,experimental,MMP12,Macrophage metalloelastase,target,,DB07556
N-HYDROXY-2(R)-[[(4-METHOXYPHENYL)SULFONYL](3-PICOLYL)AMINO]-3-METHYLBUTANAMIDE HYDROCHLORIDE,,experimental,MMP1,Interstitial collagenase,target,,DB07556
"(5BETA)-PREGNANE-3,20-DIONE",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07557
"(5BETA)-PREGNANE-3,20-DIONE",,experimental,RXRA,Retinoic acid receptor RXR-alpha,target,,DB07557
"(5BETA)-PREGNANE-3,20-DIONE",,experimental,NR1I3,Nuclear receptor subfamily 1 group I member 3,target,,DB07557
"(5BETA)-PREGNANE-3,20-DIONE",,experimental,AKR1D1,3-oxo-5-beta-steroid 4-dehydrogenase,target,,DB07557
"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07562
"N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE",,experimental,CCNA2,Cyclin-A2,target,,DB07562
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,experimental,STMN4,Stathmin-4,target,,DB07574
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,experimental,TUBB2B,Tubulin beta-2B chain,target,,DB07574
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,experimental,TUBA1A,Tubulin alpha-1A chain,target,,DB07574
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,experimental,TUBA1C,Tubulin alpha-1C chain,target,,DB07574
"2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE",,experimental,TUBA1B,Tubulin alpha-1B chain,target,,DB07574
"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",,experimental,,Genome polyprotein,target,,DB07582
"N-[(2R,3S)-1-((2S)-2-{[(CYCLOPENTYLAMINO)CARBONYL]AMINO}-3-METHYLBUTANOYL)-2-(1-FORMYL-1-CYCLOBUTYL)PYRROLIDINYL]CYCLOPROPANECARBOXAMIDE",,experimental,,NS3 protease,target,,DB07582
"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07583
"(4R,2S)-5'-(4-(4-CHLOROBENZYLOXY)PYRROLIDIN-2-YLMETHANESULFONYL)ISOQUINOLINE",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07583
"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",,experimental,AKT1,RAC-alpha serine/threonine-protein kinase,target,,DB07584
"N-[2-(5-methyl-4H-1,2,4-triazol-3-yl)phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07584
"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",,experimental,AKT1,RAC-alpha serine/threonine-protein kinase,target,,DB07585
"5-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07585
"4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB07594
"4-[4-(2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)-3-METHYL-1H-PYRAZOL-5-YL]-6-ETHYLBENZENE-1,3-DIOL",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07594
"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",,experimental,rep,Replicase polyprotein 1ab,target,,DB07620
"2-[(2,4-DICHLORO-5-METHYLPHENYL)SULFONYL]-1,3-DINITRO-5-(TRIFLUOROMETHYL)BENZENE",,experimental,1a,Replicase polyprotein 1a,target,,DB07620
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",,experimental,MT-CYB,Cytochrome b,target,,DB07636
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB07636
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB07636
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB07636
"5-HEPTYL-6-HYDROXY-1,3-BENZOTHIAZOLE-4,7-DIONE",,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB07636
"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,experimental,ESR1,Estrogen receptor,target,,DB07638
"(3AS,4R,9BR)-2,2-DIFLUORO-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,experimental,ESR2,Estrogen receptor beta,target,,DB07638
"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",,experimental,sqr,Sulfide-quinone reductase,target,,DB07640
"2-decyl-5,6-dimethoxy-3-methylcyclohexa-2,5-diene-1,4-dione",,experimental,AFE_1792,"Sulfide-quinone reductase, putative",target,,DB07640
SEBACIC ACID,,experimental,HBA1,Hemoglobin subunit alpha,target,,DB07645
SEBACIC ACID,,experimental,HBB,Hemoglobin subunit beta,target,,DB07645
"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",,experimental,B1,Light-harvesting protein B-800/850 beta 1 chain,target,,DB07646
"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",,experimental,A1,Light-harvesting protein B-800/850 alpha chain,target,,DB07646
"UNDECYLAMINE-N,N-DIMETHYL-N-OXIDE",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07646
"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",,experimental,POLK,DNA polymerase kappa,target,,DB07652
"1-[2-DEOXYRIBOFURANOSYL]-2,4-DIFLUORO-5-METHYL-BENZENE-5'MONOPHOSPHATE",,experimental,rnhA,Ribonuclease H,target,,DB07652
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB07662
N-[4-(3-BROMO-PHENYLAMINO)-QUINAZOLIN-6-YL]-ACRYLAMIDE,,experimental,EGFR,Epidermal growth factor receptor,target,,DB07662
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",,experimental,CSNK1G3,Casein kinase I isoform gamma-3,target,,DB07664
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",,experimental,SLK,STE20-like serine/threonine-protein kinase,target,,DB07664
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",,experimental,CAMK4,Calcium/calmodulin-dependent protein kinase type IV,target,,DB07664
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",,experimental,CLK3,Dual specificity protein kinase CLK3,target,,DB07664
"5-AMINO-3-{[4-(AMINOSULFONYL)PHENYL]AMINO}-N-(2,6-DIFLUOROPHENYL)-1H-1,2,4-TRIAZOLE-1-CARBOTHIOAMIDE",,experimental,ABL2,Abelson tyrosine-protein kinase 2,target,,DB07664
"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",,experimental,frdA,Fumarate reductase flavoprotein subunit,target,,DB07669
"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",,experimental,frdB,Fumarate reductase iron-sulfur subunit,target,,DB07669
"2,3-DIMETHYL-1,4-NAPHTHOQUINONE",,experimental,frdC,Fumarate reductase cytochrome b subunit,target,,DB07669
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,experimental,sdhA,Succinate dehydrogenase flavoprotein subunit,target,,DB07671
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,experimental,sdhB,Succinate dehydrogenase iron-sulfur subunit,target,,DB07671
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,experimental,sdhC,Succinate dehydrogenase cytochrome b556 subunit,target,,DB07671
"2-[1-METHYLHEXYL]-4,6-DINITROPHENOL",,experimental,sdhD,Succinate dehydrogenase hydrophobic membrane anchor subunit,target,,DB07671
"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07676
"3-({[(3S)-3,4-dihydroxybutyl]oxy}amino)-1H,2'H-2,3'-biindol-2'-one",,experimental,CAMK4,Calcium/calmodulin-dependent protein kinase type IV,target,,DB07676
"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",,experimental,ESR1,Estrogen receptor,target,,DB07678
"(9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07678
"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07688
"4-{[5-(CYCLOHEXYLOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB07688
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,ksi,Steroid Delta-isomerase,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,ppcA,PpcA,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,EFTUD1,Elongation factor Tu GTP-binding domain-containing protein 1,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,cbh,Choloylglycine hydrolase,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,aldA,Lactaldehyde dehydrogenase,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,acrB,Acriflavine resistance protein B,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,ctaD,Cytochrome c oxidase subunit 1,target,,DB07690
"(3ALPHA,5BETA,12ALPHA)-3,12-DIHYDROXYCHOLAN-24-OIC ACID",,experimental,ctaC,Cytochrome c oxidase subunit 2,target,,DB07690
"(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL",,experimental,NCOA5,Nuclear receptor coactivator 5,target,,DB07702
"(16ALPHA,17ALPHA)-ESTRA-1,3,5(10)-TRIENE-3,16,17-TRIOL",,experimental,ESR2,Estrogen receptor beta,target,,DB07702
"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",,experimental,cyp130,Cytochrome P450 130,target,,DB07705
"1-[(2S)-2-[(4-CHLOROBENZYL)OXY]-2-(2,4-DICHLOROPHENYL)ETHYL]-1H-IMIDAZOLE",,experimental,CYP51A1,Lanosterol 14-alpha demethylase,target,,DB07705
"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",,experimental,ESR1,Estrogen receptor,target,,DB07707
"(9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07707
3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,experimental,ESR1,Estrogen receptor,target,,DB07708
3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07708
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,experimental,ESR1,Estrogen receptor,target,,DB07712
3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07712
"3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB07715
"3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE",,experimental,actIII,Putative ketoacyl reductase,target,,DB07715
"3-METHYL-1,6,8-TRIHYDROXYANTHRAQUINONE",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB07715
3-(4-HYDROXY-PHENYL)PYRUVIC ACID,,experimental,F2,Prothrombin,target,,DB07718
3-(4-HYDROXY-PHENYL)PYRUVIC ACID,,experimental,MIF,Macrophage migration inhibitory factor,target,,DB07718
3-(4-HYDROXY-PHENYL)PYRUVIC ACID,,experimental,tyrA,Prephenate dehydrogenase,target,,DB07718
3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB07724
3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,,experimental,PPARA,Peroxisome proliferator-activated receptor alpha,target,,DB07724
3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,,experimental,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB07724
3-{5-methoxy-1-[(4-methoxyphenyl)sulfonyl]-1H-indol-3-yl}propanoic acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07724
"2-tert-butylbenzene-1,4-diol",,experimental,,Hemagglutinin,target,,DB07726
"2-tert-butylbenzene-1,4-diol",,experimental,HA,Hemagglutinin,target,,DB07726
"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB07728
"2-[2-(2-FLUOROPHENYL)PYRIDIN-4-YL]-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,experimental,MAPKAPK3,MAP kinase-activated protein kinase 3,target,,DB07728
2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07732
2-[(2-NAPHTHYLSULFONYL)AMINO]ETHYL DIHYDROGEN PHOSPHATE,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07732
"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",,experimental,rep,Replicase polyprotein 1ab,target,,DB07743
"S-[5-(TRIFLUOROMETHYL)-4H-1,2,4-TRIAZOL-3-YL] 5-(PHENYLETHYNYL)FURAN-2-CARBOTHIOATE",,experimental,1a,Replicase polyprotein 1a,target,,DB07743
2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07745
2-{[4-(TRIFLUOROMETHOXY)BENZOYL]AMINO}ETHYL DIHYDROGEN PHOSPHATE,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07745
2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07748
2-({[4-(TRIFLUOROMETHOXY)PHENYL]SULFONYL}AMINO)ETHYL DIHYDROGEN PHOSPHATE,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07748
FARNESYL,,experimental,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,target,,DB07752
FARNESYL,,experimental,GNB1,Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1,target,,DB07752
FARNESYL,,experimental,PDC,Phosducin,target,,DB07752
FARNESYL,,experimental,KRAS,GTPase KRas,target,,DB07752
FARNESYL,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07752
FARNESYL,,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07752
FARNESYL,,experimental,RABGGTA,Geranylgeranyl transferase type-2 subunit alpha,target,,DB07752
FARNESYL,,experimental,RABGGTB,Geranylgeranyl transferase type-2 subunit beta,target,,DB07752
FARNESYL,,experimental,CHM,Rab proteins geranylgeranyltransferase component A 1,target,,DB07752
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,MT-CYB,Cytochrome b,target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB07763
"(5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE",,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB07763
"(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}",,experimental,CAMK2A,Calcium/calmodulin-dependent protein kinase type II subunit alpha,target,,DB07766
"(2Z,3E)-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE 3-{O-[(3R)-3,4-DIHYDROXYBUTYL]OXIME}",,experimental,CDK16,Cyclin-dependent kinase 16,target,,DB07766
3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID,,experimental,xynY,"Endo-1,4-beta-xylanase Y",target,,DB07767
3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID,,experimental,xynZ,"Endo-1,4-beta-xylanase Z",target,,DB07767
3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID,,experimental,,Est1e,target,,DB07767
3-(4-HYDROXY-3-METHOXYPHENYL)-2-PROPENOIC ACID,,experimental,slr0095,O-methyltransferase,target,,DB07767
"(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE",,experimental,AKR1C1,Aldo-keto reductase family 1 member C1,target,,DB07768
"(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE",,experimental,AKR1C2,Aldo-keto reductase family 1 member C2,target,,DB07768
"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",,experimental,KRAS,GTPase KRas,target,,DB07771
"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07771
"[(3,7,11-TRIMETHYL-DODECA-2,6,10-TRIENYLOXYCARBAMOYL)-METHYL]-PHOSPHONIC ACID",,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07771
5-FLUOROINDOLE PROPANOL PHOSPHATE,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07773
5-FLUOROINDOLE PROPANOL PHOSPHATE,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07773
FAMOXADONE,,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB07778
FAMOXADONE,,experimental,MT-CYB,Cytochrome b,target,,DB07778
FAMOXADONE,,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB07778
FAMOXADONE,,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB07778
FAMOXADONE,,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB07778
FAMOXADONE,,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB07778
FAMOXADONE,,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB07778
FAMOXADONE,,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB07778
FAMOXADONE,,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB07778
FAMOXADONE,,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB07778
FARNESYL DIPHOSPHATE,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,KRAS,GTPase KRas,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,FDPS,Farnesyl pyrophosphate synthase,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,nisZ,Lantibiotic nisin-Z,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,Rv1086,"(2Z,6E)-farnesyl diphosphate synthase",target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,RABGGTA,Geranylgeranyl transferase type-2 subunit alpha,target,,DB07780
FARNESYL DIPHOSPHATE,,experimental,RABGGTB,Geranylgeranyl transferase type-2 subunit beta,target,,DB07780
"3,7,3',4'-TETRAHYDROXYFLAVONE",,experimental,72,Cyclin homolog,target,,DB07795
"3,7,3',4'-TETRAHYDROXYFLAVONE",,experimental,CDK6,Cyclin-dependent kinase 6,target,,DB07795
"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",,experimental,AKT2,RAC-beta serine/threonine-protein kinase,target,,DB07812
"N-[(1S)-2-amino-1-phenylethyl]-5-(1H-pyrrolo[2,3-b]pyridin-4-yl)thiophene-2-carboxamide",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07812
"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",,experimental,pheS,Phenylalanine--tRNA ligase alpha subunit,target,,DB07817
"1-{3-[(4-pyridin-2-ylpiperazin-1-yl)sulfonyl]phenyl}-3-(1,3-thiazol-2-yl)urea",,experimental,pheT,Phenylalanine--tRNA ligase beta subunit,target,,DB07817
"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",,experimental,botA,Botulinum neurotoxin type A,target,,DB07818
"(2E)-3-(2,4-DICHLOROPHENYL)-N-HYDROXYACRYLAMIDE",,experimental,bont/a,BoNT/A,target,,DB07818
(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,,experimental,botA,Botulinum neurotoxin type A,target,,DB07819
(2E)-3-(4-CHLOROPHENYL)-N-HYDROXYACRYLAMIDE,,experimental,bont/a,BoNT/A,target,,DB07819
"(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE",,experimental,CES1,Liver carboxylesterase 1,target,,DB07821
"(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE",,experimental,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit gamma,target,,DB07821
"(1R)-1,2,2-TRIMETHYLPROPYL (R)-METHYLPHOSPHINATE",,experimental,PLA2G7,Platelet-activating factor acetylhydrolase,target,,DB07821
"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB07823
"(2S)-2-[(3aR,4R,7S,7aS)-1,3-dioxooctahydro-2H-4,7-methanoisoindol-2-yl]propanoic acid",,experimental,ampC,Beta-lactamase,target,,DB07823
"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB07824
"4-ethyl-5-methyl-2-(1H-tetrazol-5-yl)-1,2-dihydro-3H-pyrazol-3-one",,experimental,ampC,Beta-lactamase,target,,DB07824
GERANYLGERANYL DIPHOSPHATE,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07841
GERANYLGERANYL DIPHOSPHATE,,experimental,PGGT1B,Geranylgeranyl transferase type-1 subunit beta,target,,DB07841
GERANYLGERANYL DIPHOSPHATE,,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07841
GERANYLGERANYL DIPHOSPHATE,,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB07841
GERANYLGERANYL DIPHOSPHATE,,experimental,FDPS,Farnesyl pyrophosphate synthase,target,,DB07841
GERANYLGERANYL DIPHOSPHATE,,experimental,RABGGTA,Geranylgeranyl transferase type-2 subunit alpha,target,,DB07841
GERANYLGERANYL DIPHOSPHATE,,experimental,RABGGTB,Geranylgeranyl transferase type-2 subunit beta,target,,DB07841
"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",,experimental,CCNA2,Cyclin-A2,target,,DB07852
"1-(3,5-DICHLOROPHENYL)-5-METHYL-1H-1,2,4-TRIAZOLE-3-CARBOXYLIC ACID",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07852
"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",,experimental,SLK,STE20-like serine/threonine-protein kinase,target,,DB07853
"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",,experimental,CAMK2D,Calcium/calmodulin-dependent protein kinase type II subunit delta,target,,DB07853
"[4-({4-[(5-CYCLOPROPYL-1H-PYRAZOL-3-YL)AMINO]QUINAZOLIN-2-YL}IMINO)CYCLOHEXA-2,5-DIEN-1-YL]ACETONITRILE",,experimental,MST4,Serine/threonine-protein kinase MST4,target,,DB07853
N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07854
N-METHYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07854
(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07855
(S)-1-PHENYL-1-[4-(9H-PURIN-6-YL)PHENYL]METHANAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07855
6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07856
6-{4-[4-(4-CHLOROPHENYL)PIPERIDIN-4-YL]PHENYL}-9H-PURINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07856
(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07857
(2R)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07857
(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07858
(2S)-2-(4-CHLOROPHENYL)-2-[4-(1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07858
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07859
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07859
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,experimental,AKT2,RAC-beta serine/threonine-protein kinase,target,,DB07859
4-(4-CHLOROPHENYL)-4-[4-(1H-PYRAZOL-4-YL)PHENYL]PIPERIDINE,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07859
(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07860
(2R)-2-(4-CHLOROPHENYL)-2-PHENYLETHANAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07860
2-chloro-5-nitro-N-phenylbenzamide,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07863
2-chloro-5-nitro-N-phenylbenzamide,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07863
2-chloro-5-nitro-N-phenylbenzamide,,experimental,RXRA,Retinoic acid receptor RXR-alpha,target,,DB07863
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07876
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07876
(S)-2-METHYL-1-[(4-METHYL-5-ISOQUINOLINE)SULFONYL]-HOMOPIPERAZINE,,experimental,ROCK1,Rho-associated protein kinase 1,target,,DB07876
"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB07877
"8-(6-BROMO-BENZO[1,3]DIOXOL-5-YLSULFANYL)-9-(3-ISOPROPYLAMINO-PROPYL)-ADENINE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07877
4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07890
4-(2-HYDROXYPHENYLTHIO)-1-BUTENYLPHOSPHONIC ACID,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07890
4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07894
4-(2-HYDROXY-4-FLUOROPHENYLTHIO)-BUTYLPHOSPHONIC ACID,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07894
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB07895
ALPHA-HYDROXYFARNESYLPHOSPHONIC ACID,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB07895
(2S)-2-HYDROXYOCTANOIC ACID,,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB07907
(2S)-2-HYDROXYOCTANOIC ACID,,experimental,mdlB,(S)-mandelate dehydrogenase,target,,DB07907
"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",,experimental,,Uncharacterized protein,target,,DB07909
"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07909
"(1S,2S,5S)2-(4-GLUTARIDYLBENZYL)-5-PHENYL-1-CYCLOHEXANOL",,experimental,IGKC,Ig kappa chain C region,target,,DB07909
PHENYLALANINDIOL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07910
PHENYLALANINDIOL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07910
PHENYLALANINDIOL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07910
"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",,experimental,bphD,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",target,,DB07911
"(3E)-2,6-DIOXO-6-PHENYLHEX-3-ENOATE",,experimental,hsaD,"4,5:9,10-diseco-3-hydroxy-5,9,17-trioxoandrosta-1(10),2-diene-4-oate hydrolase",target,,DB07911
"(2Z,4E)-2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOIC ACID",,experimental,bphK,Glutathione S-transferase,target,,DB07914
"(2Z,4E)-2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOIC ACID",,experimental,RHA1_ro03865,"Catechol 2,3-dioxygenase",target,,DB07914
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,frdA,Fumarate reductase flavoprotein subunit,target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,frdB,Fumarate reductase iron-sulfur subunit,target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,frdC,Fumarate reductase subunit C,target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,frdD,Fumarate reductase subunit D,target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,fdnG,"Formate dehydrogenase, nitrate-inducible, major subunit",target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,fdnH,"Formate dehydrogenase, nitrate-inducible, iron-sulfur subunit",target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,fdnI,"Formate dehydrogenase, nitrate-inducible, cytochrome b556(fdn) subunit",target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,DVU_0624,NapC/NirT cytochrome c family protein,target,,DB07918
2-HEPTYL-4-HYDROXY QUINOLINE N-OXIDE,,experimental,DVU_0625,"Cytochrome c nitrite reductase, catalytic subunit NfrA, putative",target,,DB07918
4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07925
4-(2-HYDROXYPHENYLSULFINYL)-BUTYLPHOSPHONIC ACID,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07925
"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",,experimental,NR1H3,Oxysterols receptor LXR-alpha,target,,DB07929
"N-(TERT-BUTYL)-3,5-DIMETHYL-N'-[(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN-6-YL)CARBONYL]BENZOHYDRAZIDE",,experimental,RXRB,Retinoic acid receptor RXR-beta,target,,DB07929
"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",,experimental,ESR1,Estrogen receptor,target,,DB07932
"dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB07932
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,experimental,ESR2,Estrogen receptor beta,target,,DB07933
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,experimental,ESR1,Estrogen receptor,target,,DB07933
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07947
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07947
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,experimental,AKT2,RAC-beta serine/threonine-protein kinase,target,,DB07947
ISOQUINOLINE-5-SULFONIC ACID (2-(2-(4-CHLOROBENZYLOXY)ETHYLAMINO)ETHYL)AMIDE,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07947
1H-INDOL-3-YLACETIC ACID,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB07950
1H-INDOL-3-YLACETIC ACID,,experimental,SKP1,S-phase kinase-associated protein 1,target,,DB07950
1H-INDOL-3-YLACETIC ACID,,experimental,CCBL1,Kynurenine--oxoglutarate transaminase 1,target,,DB07950
N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07951
N-[1H-INDOL-3-YL-ACETYL]ASPARTIC ACID,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07951
N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07952
N-[1H-INDOL-3-YL-ACETYL]GLYCINE ACID,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07952
N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,,experimental,trpA,Tryptophan synthase alpha chain,target,,DB07953
N-[1H-INDOL-3-YL-ACETYL]VALINE ACID,,experimental,trpB,Tryptophan synthase beta chain,target,,DB07953
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE3B,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE7A,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE9A,"High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE8A,"High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE2A,"cGMP-dependent 3',5'-cyclic phosphodiesterase",target,,DB07954
3-ISOBUTYL-1-METHYLXANTHINE,,experimental,PDE6G,"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma",target,,DB07954
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07995
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07995
N-[2-(4-BROMOCINNAMYLAMINO)ETHYL]-5-ISOQUINOLINE SULFONAMIDE,,experimental,GSG2,Serine/threonine-protein kinase haspin,target,,DB07995
1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07996
1-(5-ISOQUINOLINESULFONYL)-2-METHYLPIPERAZINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07996
N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07997
N-[2-(METHYLAMINO)ETHYL]-5-ISOQUINOLINESULFONAMIDE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB07997
(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,,experimental,,Genome polyprotein,target,,DB08012
(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE,,experimental,,Genome polyprotein,target,,DB08012
(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,,experimental,,Genome polyprotein,target,,DB08013
(METHYLPYRIDAZINE PIPERIDINE PROPYLOXYPHENYL)ETHYLACETATE,,experimental,,Genome polyprotein,target,,DB08013
(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,,experimental,,Genome polyprotein,target,,DB08014
(METHYLPYRIDAZINE PIPERIDINE BUTYLOXYPHENYL)ETHYLACETATE,,experimental,,Genome polyprotein,target,,DB08014
3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,,experimental,,Genome polyprotein,target,,DB08017
3-METHOXY-6-[4-(3-METHYLPHENYL)-1-PIPERAZINYL]PYRIDAZINE,,experimental,,Genome polyprotein,target,,DB08017
"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB08018
"N-{(3S,4S)-4-[(6-AMINO-4-METHYLPYRIDIN-2-YL)METHYL]PYRROLIDIN-3-YL}-N'-(4-CHLOROBENZYL)ETHANE-1,2-DIAMINE",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB08018
"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB08019
"N-{(3R,4S)-4-[(6-amino-4-methylpyridin-2-yl)methyl]pyrrolidin-3-yl}-N'-(3-chlorobenzyl)ethane-1,2-diamine",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB08019
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,experimental,ESR2,Estrogen receptor beta,target,,DB08020
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-6-(METHOXYMETHYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-8-OL",,experimental,ESR1,Estrogen receptor,target,,DB08020
"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",,experimental,CALM1,Calmodulin,target,,DB08039
"(3Z)-N,N-DIMETHYL-2-OXO-3-(4,5,6,7-TETRAHYDRO-1H-INDOL-2-YLMETHYLIDENE)-2,3-DIHYDRO-1H-INDOLE-5-SULFONAMIDE",,experimental,CAMK2D,Calcium/calmodulin-dependent protein kinase type II subunit delta,target,,DB08039
"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",,experimental,ESR1,Estrogen receptor,target,,DB08047
"4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08047
"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",,experimental,ESR1,Estrogen receptor,target,,DB08048
"4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08048
"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB08059
"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",,experimental,PLK1,Serine/threonine-protein kinase PLK1,target,,DB08059
"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",,experimental,PIK3R1,Phosphatidylinositol 3-kinase regulatory subunit alpha,target,,DB08059
"(1S,6BR,9AS,11R,11BR)-9A,11B-DIMETHYL-1-[(METHYLOXY)METHYL]-3,6,9-TRIOXO-1,6,6B,7,8,9,9A,10,11,11B-DECAHYDRO-3H-FURO[4,3,2-DE]INDENO[4,5-H][2]BENZOPYRAN-11-YL ACETATE",,experimental,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",target,,DB08059
"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",,experimental,RXRA,Retinoic acid receptor RXR-alpha,target,,DB08063
"1-BENZYL-3-(4-METHOXYPHENYLAMINO)-4-PHENYLPYRROLE-2,5-DIONE",,experimental,NR1H3,Oxysterols receptor LXR-alpha,target,,DB08063
N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,,experimental,AURKA,Aurora kinase A,target,,DB08066
N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08066
2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08070
2-[4-(3-METHYL-1H-PYRAZOL-4-YL)PHENYL]ETHANAMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08070
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,experimental,AKT2,RAC-beta serine/threonine-protein kinase,target,,DB08073
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB08073
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08073
(2S)-1-(1H-INDOL-3-YL)-3-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08073
"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",,experimental,HBA1,Hemoglobin subunit alpha,target,,DB08077
"2-[4-({[(3,5-DICHLOROPHENYL)AMINO]CARBONYL}AMINO)PHENOXY]-2-METHYLPROPANOIC ACID",,experimental,HBB,Hemoglobin subunit beta,target,,DB08077
LATRUNCULIN B,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB08080
LATRUNCULIN B,,experimental,MKL1,MKL/myocardin-like protein 1,target,,DB08080
LATRUNCULIN B,,experimental,SPIRE2,Protein spire homolog 2,target,,DB08080
3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,,experimental,traR,Transcriptional activator protein TraR,target,,DB08081
3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,,experimental,traR,Probable transcriptional activator protein TraR,target,,DB08081
3-OXO-OCTANOIC ACID (2-OXO-TETRAHYDRO-FURAN-3-YL)-AMIDE,,experimental,traM,Probable transcriptional repressor TraM,target,,DB08081
3-pyridin-4-yl-1H-indazole,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08113
3-pyridin-4-yl-1H-indazole,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08113
"5-benzyl-1,3-thiazol-2-amine",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08114
"5-benzyl-1,3-thiazol-2-amine",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08114
"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08148
"1-[4-(4-chlorophenyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08148
"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08149
"1-[4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-yl]methanamine",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08149
"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08150
"4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-aminium",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08150
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,,experimental,CA1,Carbonic anhydrase 1,target,,DB08155
N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE,,experimental,CA2,Carbonic anhydrase 2,target,,DB08155
3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,,experimental,CA1,Carbonic anhydrase 1,target,,DB08156
3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID,,experimental,CA2,Carbonic anhydrase 2,target,,DB08156
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,,experimental,CA1,Carbonic anhydrase 1,target,,DB08157
ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE,,experimental,CA2,Carbonic anhydrase 2,target,,DB08157
"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08162
"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08162
"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",,experimental,ROCK1,Rho-associated protein kinase 1,target,,DB08162
"5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE",,experimental,ROCK2,Rho-associated protein kinase 2,target,,DB08162
"3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM",,experimental,ACHE,Acetylcholinesterase,target,,DB08167
"3,7-BIS(DIMETHYLAMINO)PHENOTHIAZIN-5-IUM",,experimental,Cgl2612,"Bacterial regulatory protein, TetR family",target,,DB08167
7-AMINO-4-METHYL-CHROMEN-2-ONE,,experimental,ppiA,Peptidyl-prolyl cis-trans isomerase A,target,,DB08168
7-AMINO-4-METHYL-CHROMEN-2-ONE,,experimental,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",target,,DB08168
7-AMINO-4-METHYL-CHROMEN-2-ONE,,experimental,HDAC8,Histone deacetylase 8,target,,DB08168
"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08175
"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",,experimental,RXRB,Retinoic acid receptor RXR-beta,target,,DB08175
"(2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID",,experimental,NR1H3,Oxysterols receptor LXR-alpha,target,,DB08175
"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08178
"4-(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,experimental,CCNA2,Cyclin-A2,target,,DB08178
2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB08180
2-[METHYL-(5-GERANYL-4-METHYL-PENT-3-ENYL)-AMINO]-ETHYL-DIPHOSPHATE,,experimental,PGGT1B,Geranylgeranyl transferase type-1 subunit beta,target,,DB08180
"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08182
"4-(4-propoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-2-amine",,experimental,CCNA2,Cyclin-A2,target,,DB08182
"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",,experimental,JAK1,Tyrosine-protein kinase JAK1,target,,DB08183
"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",,experimental,JAK2,Tyrosine-protein kinase JAK2,target,,DB08183
"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",,experimental,JAK3,Tyrosine-protein kinase JAK3,target,,DB08183
"3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile",,experimental,TYK2,Non-receptor tyrosine-protein kinase TYK2,target,,DB08183
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,tuf,Elongation factor Tu,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsL,30S ribosomal protein S12,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsJ,30S ribosomal protein S10,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsK,30S ribosomal protein S11,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsM,30S ribosomal protein S13,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsZ,30S ribosomal protein S14 type Z,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsO,30S ribosomal protein S15,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsP,30S ribosomal protein S16,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsQ,30S ribosomal protein S17,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsR,30S ribosomal protein S18,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsS,30S ribosomal protein S19,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsT,30S ribosomal protein S20,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsD,30S ribosomal protein S4,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsE,30S ribosomal protein S5,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsF,30S ribosomal protein S6,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsG,30S ribosomal protein S7,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsH,30S ribosomal protein S8,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsI,30S ribosomal protein S9,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsU,30S ribosomal protein Thx,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsQ,30S ribosomal protein S17,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsT,30S ribosomal protein S20,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsB,30S ribosomal protein S2,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsC,30S ribosomal protein S3,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsI,30S ribosomal protein S9,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsS,30S ribosomal protein S19,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsB,30S ribosomal protein S2,target,,DB08185
2-METHYLTHIO-N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,rpsC,30S ribosomal protein S3,target,,DB08185
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB08215
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,puhA,Reaction center protein H chain,target,,DB08215
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,pufL,Reaction center protein L chain,target,,DB08215
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,pufM,Reaction center protein M chain,target,,DB08215
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,pufL,Reaction center protein L chain,target,,DB08215
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,pufM,Reaction center protein M chain,target,,DB08215
2-T-BUTYLAMINO-4-ETHYLAMINO-6-METHYLTHIO-S-TRIAZINE,,experimental,puhA,Reaction center protein H chain,target,,DB08215
"2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL",,experimental,EIF4E,Eukaryotic translation initiation factor 4E,target,,DB08217
"2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL",,experimental,MT1810,Uncharacterized protein,target,,DB08217
"2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL",,experimental,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,target,,DB08217
"2,2,5,5-TETRAMETHYL-3-(SULFANYLMETHYL)-2,5-DIHYDRO-1H-PYRROL-1-OL",,experimental,afaE3,Afimbrial adhesin AFA-III,target,,DB08217
"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",,experimental,CCNA2,Cyclin-A2,target,,DB08218
"HYDROXY(OXO)(3-{[(2Z)-4-[3-(1H-1,2,4-TRIAZOL-1-YLMETHYL)PHENYL]PYRIMIDIN-2(5H)-YLIDENE]AMINO}PHENYL)AMMONIUM",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08218
"4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE",,experimental,CCNA2,Cyclin-A2,target,,DB08219
"4-METHYL-5-{(2E)-2-[(4-MORPHOLIN-4-YLPHENYL)IMINO]-2,5-DIHYDROPYRIMIDIN-4-YL}-1,3-THIAZOL-2-AMINE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08219
"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB08220
"(8alpha,10alpha,13alpha,17beta)-17-[(4-hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid",,experimental,NR1H4,Bile acid receptor,target,,DB08220
METHOXYUNDECYLPHOSPHINIC ACID,,experimental,CLPS,Colipase,target,,DB08222
METHOXYUNDECYLPHOSPHINIC ACID,,experimental,PNLIP,Pancreatic triacylglycerol lipase,target,,DB08222
Myxopyronin B,,experimental,rpoA,DNA-directed RNA polymerase subunit alpha,target,,DB08226
Myxopyronin B,,experimental,rpoB,DNA-directed RNA polymerase subunit beta,target,,DB08226
Myxopyronin B,,experimental,rpoC,DNA-directed RNA polymerase subunit beta',target,,DB08226
Myxopyronin B,,experimental,rpoZ,DNA-directed RNA polymerase subunit omega,target,,DB08226
Myxopyronin B,,experimental,TTHA0532,RNA polymerase sigma factor,target,,DB08226
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08231
MYRISTIC ACID,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,fadR,Fatty acid metabolism regulator protein,target,,DB08231
MYRISTIC ACID,,experimental,PECI,"Enoyl-CoA delta isomerase 2, mitochondrial",target,,DB08231
MYRISTIC ACID,,experimental,RCVRN,Recoverin,target,,DB08231
MYRISTIC ACID,,experimental,CALM1,Calmodulin,target,,DB08231
MYRISTIC ACID,,experimental,luxF,Non-fluorescent flavoprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB08231
MYRISTIC ACID,,experimental,lpxC,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,HNF4A,Hepatocyte nuclear factor 4-alpha,target,,DB08231
MYRISTIC ACID,,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB08231
MYRISTIC ACID,,experimental,nef,Protein Nef,target,,DB08231
MYRISTIC ACID,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB08231
MYRISTIC ACID,,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB08231
MYRISTIC ACID,,experimental,PPP3R1,Calcineurin subunit B type 1,target,,DB08231
MYRISTIC ACID,,experimental,PPP3CA,Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform,target,,DB08231
MYRISTIC ACID,,experimental,MT1417,Alpha-pyrone synthesis polyketide synthase-like Pks18,target,,DB08231
MYRISTIC ACID,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,TRAPPC3,Trafficking protein particle complex subunit 3,target,,DB08231
MYRISTIC ACID,,experimental,INS,Insulin,target,,DB08231
MYRISTIC ACID,,experimental,,Genome polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,,Polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,GM2A,Ganglioside GM2 activator,target,,DB08231
MYRISTIC ACID,,experimental,ARF6,ADP-ribosylation factor 6,target,,DB08231
MYRISTIC ACID,,experimental,LY96,Lymphocyte antigen 96,target,,DB08231
MYRISTIC ACID,,experimental,tonB,Protein TonB,target,,DB08231
MYRISTIC ACID,,experimental,gag,Gag polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08231
MYRISTIC ACID,,experimental,ARF1,ADP-ribosylation factor 1,target,,DB08231
MYRISTIC ACID,,experimental,GUCA1A,Guanylyl cyclase-activating protein 1,target,,DB08231
MYRISTIC ACID,,experimental,Rv0233,R2-like ligand binding oxidase,target,,DB08231
MYRISTIC ACID,,experimental,PVR,Poliovirus receptor,target,,DB08231
MYRISTIC ACID,,experimental,TLR4,Toll-like receptor 4,target,,DB08231
"{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID",,experimental,F7,Coagulation factor VII,target,,DB08232
"{5-(5-AMINO-1H-PYRROLO[3,2-B]PYRIDIN-2-YL)-6-HYDROXY-3'-NITRO-BIPHENYL-3-YL]-ACETIC ACID",,experimental,F3,Tissue factor,target,,DB08232
6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,,experimental,CCNA2,Cyclin-A2,target,,DB08233
6-CYCLOHEXYLMETHYLOXY-2-(4'-HYDROXYANILINO)PURINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08233
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,experimental,dfrA,Dihydrofolate reductase,target,,DB08234
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB08234
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,experimental,dfrB,Dihydrofolate reductase,target,,DB08234
"5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine",,experimental,folA,Dihydrofolate reductase,target,,DB08234
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ARPC1B,Actin-related protein 2/3 complex subunit 1B,target,,DB08235
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ACTR2,Actin-related protein 2,target,,DB08235
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ACTR3,Actin-related protein 3,target,,DB08235
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ARPC2,Actin-related protein 2/3 complex subunit 2,target,,DB08235
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ARPC3,Actin-related protein 2/3 complex subunit 3,target,,DB08235
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ARPC4,Actin-related protein 2/3 complex subunit 4,target,,DB08235
N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide,,experimental,ARPC5,Actin-related protein 2/3 complex subunit 5,target,,DB08235
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ARPC1B,Actin-related protein 2/3 complex subunit 1B,target,,DB08236
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ACTR2,Actin-related protein 2,target,,DB08236
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ACTR3,Actin-related protein 3,target,,DB08236
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ARPC2,Actin-related protein 2/3 complex subunit 2,target,,DB08236
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ARPC3,Actin-related protein 2/3 complex subunit 3,target,,DB08236
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ARPC4,Actin-related protein 2/3 complex subunit 4,target,,DB08236
"(2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one",,experimental,ARPC5,Actin-related protein 2/3 complex subunit 5,target,,DB08236
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,,experimental,CCNA2,Cyclin-A2,target,,DB08241
4-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)--BENZAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08241
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,,experimental,CCNA2,Cyclin-A2,target,,DB08248
3-(6-CYCLOHEXYLMETHOXY-9H-PURIN-2-YLAMINO)-BENZENESULFONAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08248
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB08249
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,experimental,fadB,Fatty acid oxidation complex subunit alpha,target,,DB08249
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,experimental,fadA,3-ketoacyl-CoA thiolase,target,,DB08249
"3,6,9,12,15-PENTAOXATRICOSAN-1-OL",,experimental,fpvA,Ferripyoverdine receptor,target,,DB08249
2-NAPHTHALENESULFONIC ACID,,experimental,F2,Prothrombin,target,,DB08254
2-NAPHTHALENESULFONIC ACID,,experimental,PRSS1,Trypsin-1,target,,DB08254
"2,6-DICARBOXYNAPHTHALENE",,experimental,HBA1,Hemoglobin subunit alpha,target,,DB08262
"2,6-DICARBOXYNAPHTHALENE",,experimental,HBB,Hemoglobin subunit beta,target,,DB08262
"(1R, 2S)-CIS 1,2 DIHYDROXY-1,2-DIHYDRONAPHTHALENE",,experimental,ndoB,"Naphthalene 1,2-dioxygenase subunit alpha",target,,DB08264
"(1R, 2S)-CIS 1,2 DIHYDROXY-1,2-DIHYDRONAPHTHALENE",,experimental,ndoC,"Naphthalene 1,2-dioxygenase subunit beta",target,,DB08264
"methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,experimental,rpoA,DNA-directed RNA polymerase subunit alpha,target,,DB08266
"methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,experimental,rpoB,DNA-directed RNA polymerase subunit beta,target,,DB08266
"methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,experimental,rpoC,DNA-directed RNA polymerase subunit beta',target,,DB08266
"methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,experimental,rpoZ,DNA-directed RNA polymerase subunit omega,target,,DB08266
"methyl [(1E,5R)-5-{(3S)-3-[(2E,4E)-2,5-dimethylocta-2,4-dienoyl]-2,4-dioxo-3,4-dihydro-2H-pyran-6-yl}hexylidene]carbamate",,experimental,TTHA0532,RNA polymerase sigma factor,target,,DB08266
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,experimental,MMP10,Stromelysin-2,target,,DB08271
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,experimental,MMP12,Macrophage metalloelastase,target,,DB08271
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,experimental,MMP3,Stromelysin-1,target,,DB08271
N-ISOBUTYL-N-[4-METHOXYPHENYLSULFONYL]GLYCYL HYDROXAMIC ACID,,experimental,MMP20,Matrix metalloproteinase-20,target,,DB08271
4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,experimental,,Ig heavy chain V-I region ND,target,,DB08273
4-HYDROXY-5-IODO-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,experimental,,Ig lambda chain V region 4A,target,,DB08273
"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08285
"(2R)-2-{[4-(benzylamino)-8-(1-methylethyl)pyrazolo[1,5-a][1,3,5]triazin-2-yl]amino}butan-1-ol",,experimental,CCNA2,Cyclin-A2,target,,DB08285
NAPHTHYLOXYACETIC ACID,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08286
NAPHTHYLOXYACETIC ACID,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08286
2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,,experimental,,Ig heavy chain V-I region ND,target,,DB08294
2-(4-HYDROXY-3-NITROPHENYL)ACETIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08294
4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,experimental,,Ig heavy chain V-I region ND,target,,DB08295
4-HYDROXY-3-NITROPHENYLACETYL-EPSILON-AMINOCAPROIC ACID ANION,,experimental,,Ig lambda chain V region 4A,target,,DB08295
"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",,experimental,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,,DB08299
"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB08299
"4-[8-(3-nitrophenyl)-1,7-naphthyridin-6-yl]benzoic acid",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB08299
3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08309
3-({2-[(4-{[6-(CYCLOHEXYLMETHOXY)-9H-PURIN-2-YL]AMINO}PHENYL)SULFONYL]ETHYL}AMINO)PROPAN-1-OL,,experimental,CCNA2,Cyclin-A2,target,,DB08309
"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",,experimental,ESR1,Estrogen receptor,target,,DB08320
"DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08320
2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,,experimental,CSNK1G1,Casein kinase I isoform gamma-1,target,,DB08325
2-(2-HYDROXYETHYLAMINO)-6-(3-CHLOROANILINO)-9-ISOPROPYLPURINE,,experimental,MERTK,Tyrosine-protein kinase Mer,target,,DB08325
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,MT-CYB,Cytochrome b,target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB08330
METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE,,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB08330
S-PALMITOYL-L-CYSTEINE,,experimental,TRAPPC6A,Trafficking protein particle complex subunit 6A,target,,DB08342
S-PALMITOYL-L-CYSTEINE,,experimental,TRAPPC3,Trafficking protein particle complex subunit 3,target,,DB08342
S-PALMITOYL-L-CYSTEINE,,experimental,TRAPPC6B,Trafficking protein particle complex subunit 6B,target,,DB08342
S-PALMITOYL-L-CYSTEINE,,experimental,TRAPPC5,Trafficking protein particle complex subunit 5,target,,DB08342
S-PALMITOYL-L-CYSTEINE,,experimental,TRAPPC4,Trafficking protein particle complex subunit 4,target,,DB08342
S-PALMITOYL-L-CYSTEINE,,experimental,TRAPPC1,Trafficking protein particle complex subunit 1,target,,DB08342
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,experimental,eta,Exotoxin A,target,,DB08348
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,experimental,EEF2,Elongation factor 2,target,,DB08348
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,experimental,toxA,Cholix toxin,target,,DB08348
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,experimental,PARP3,Poly [ADP-ribose] polymerase 3,target,,DB08348
"N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTHRIDIN-2-YL)GLYCINAMIDE",,experimental,PARP15,Poly [ADP-ribose] polymerase 15,target,,DB08348
"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",,experimental,CCNA2,Cyclin-A2,target,,DB08355
"1-methyl-8-(phenylamino)-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxylic acid",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08355
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,,experimental,ACHE,Acetylcholinesterase,target,,DB08357
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,,experimental,ybbD,Uncharacterized lipoprotein YbbD,target,,DB08357
1-ETHOXY-2-(2-ETHOXYETHOXY)ETHANE,,experimental,ptsP,Phosphoenolpyruvate-protein phosphotransferase,target,,DB08357
"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB08358
"2-(2-QUINOLIN-3-YLPYRIDIN-4-YL)-1,5,6,7-TETRAHYDRO-4H-PYRROLO[3,2-C]PYRIDIN-4-ONE",,experimental,MAPKAPK3,MAP kinase-activated protein kinase 3,target,,DB08358
PARA-(BENZOYL)-PHENYLALANINE,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08371
PARA-(BENZOYL)-PHENYLALANINE,,experimental,YARS,"Tyrosine--tRNA ligase, cytoplasmic",target,,DB08371
1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08372
1-[2-(4-ETHOXY-3-FLUOROPYRIDIN-2-YL)ETHYL]-3-(5-METHYLPYRIDIN-2-YL)THIOUREA,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08372
PCNOTAXIME GROUP,,experimental,pbpA,Penicillin-binding protein 1A,target,,DB08375
PCNOTAXIME GROUP,,experimental,bla,Beta-lactamase Toho-1,target,,DB08375
PCNOTAXIME GROUP,,experimental,ampC,Beta-lactamase,target,,DB08375
"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",,experimental,MYL6B,Myosin light chain 6B,target,,DB08378
"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",,experimental,MYL12A,Myosin regulatory light chain 12A,target,,DB08378
"4-[4-(2,5-DIOXO-PYRROLIDIN-1-YL)-PHENYLAMINO]-4-HYDROXY-BUTYRIC ACID",,experimental,MYH7,Myosin-7,target,,DB08378
PHENANTHRENE,,experimental,doxB,"Naphthalene 1,2-dioxygenase subunit alpha",target,,DB08381
PHENANTHRENE,,experimental,doxD,"Naphthalene 1,2-dioxygenase subunit beta",target,,DB08381
"2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE",,experimental,ESR1,Estrogen receptor,target,,DB08398
"2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08398
PICEATANNOL,,experimental,ATP5A1,"ATP synthase subunit alpha, mitochondrial",target,,DB08399
PICEATANNOL,,experimental,ATP5B,"ATP synthase subunit beta, mitochondrial",target,,DB08399
PICEATANNOL,,experimental,ATP5C1,"ATP synthase subunit gamma, mitochondrial",target,,DB08399
"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB08402
"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08402
"2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID",,experimental,RXRA,Retinoic acid receptor RXR-alpha,target,,DB08402
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,,experimental,MMP1,Interstitial collagenase,target,,DB08403
METHYLAMINO-PHENYLALANYL-LEUCYL-HYDROXAMIC ACID,,experimental,MMP8,Neutrophil collagenase,target,,DB08403
4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08409
4-NITRO-BENZYLPHOSPHONOBUTANOYL-GLYCINE,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB08409
METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,,experimental,IGKC,Ig kappa chain C region,target,,DB08413
METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER,,experimental,ALPP,"Alkaline phosphatase, placental type",target,,DB08413
3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08425
3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08425
3(S)-AMINO-4-PHENYL-BUTAN-2(R)-OL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08425
3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08428
3(S)-AMINO-4-PHENYL-BUTAN-2(S)-OL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08428
PUROMYCIN,,experimental,RPL10L,60S ribosomal protein L10-like,target,,DB08437
PUROMYCIN,,experimental,RPL13A,60S ribosomal protein L13a,target,,DB08437
PUROMYCIN,,experimental,RPL23,60S ribosomal protein L23,target,,DB08437
PUROMYCIN,,experimental,RPL15,60S ribosomal protein L15,target,,DB08437
PUROMYCIN,,experimental,RPL19,60S ribosomal protein L19,target,,DB08437
PUROMYCIN,,experimental,RPL23A,60S ribosomal protein L23a,target,,DB08437
PUROMYCIN,,experimental,RSL24D1,Probable ribosome biogenesis protein RLP24,target,,DB08437
PUROMYCIN,,experimental,RPL26L1,60S ribosomal protein L26-like 1,target,,DB08437
PUROMYCIN,,experimental,RPL8,60S ribosomal protein L8,target,,DB08437
PUROMYCIN,,experimental,RPL37,60S ribosomal protein L37,target,,DB08437
PUROMYCIN,,experimental,RPL3,60S ribosomal protein L3,target,,DB08437
PUROMYCIN,,experimental,RPL11,60S ribosomal protein L11,target,,DB08437
PUROMYCIN,,experimental,NHP2L1,NHP2-like protein 1,target,,DB08437
PUROMYCIN,,experimental,aat,Leucyl/phenylalanyl-tRNA--protein transferase,target,,DB08437
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,MT-CYB,Cytochrome b,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petB,Cytochrome b6,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petA,Apocytochrome f,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petC,Cytochrome b6-f complex iron-sulfur subunit,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petD,Cytochrome b6-f complex subunit 4,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petG,Cytochrome b6-f complex subunit 5,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petL,Cytochrome b6-f complex subunit 6,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petM,Cytochrome b6-f complex subunit 7,target,,DB08453
2-NONYL-4-HYDROXYQUINOLINE N-OXIDE,,experimental,petN,Cytochrome b6-f complex subunit 8,target,,DB08453
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08463
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol,,experimental,CCNA2,Cyclin-A2,target,,DB08463
"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08464
"METHYL 3-CHLORO-2-{3-[(2,5-DIHYDROXY-4-METHOXYPHENYL)AMINO]-3-OXOPROPYL}-4,6-DIHYDROXYBENZOATE",,experimental,HSP90B1,Endoplasmin,target,,DB08464
"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08465
"2-(3-AMINO-2,5,6-TRIMETHOXYPHENYL)ETHYL 5-CHLORO-2,4-DIHYDROXYBENZOATE",,experimental,HSP90B1,Endoplasmin,target,,DB08465
"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID",,experimental,HBA1,Hemoglobin subunit alpha,target,,DB08486
"2-{4-[(3,5-DIMETHYLANILINO)-CARBONYL-METHYL]-PHENOXY}-2-METHYLPROPIONIC ACID",,experimental,HBB,Hemoglobin subunit beta,target,,DB08486
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB08513
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,,experimental,INSR,Insulin receptor,target,,DB08513
[4-({5-(AMINOCARBONYL)-4-[(3-METHYLPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENYL]ACETIC ACID,,experimental,IRS1,Insulin receptor substrate 1,target,,DB08513
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA1,Proteasome subunit alpha type-1,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA2,Proteasome subunit alpha type-2,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA3,Proteasome subunit alpha type-3,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA4,Proteasome subunit alpha type-4,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA5,Proteasome subunit alpha type-5,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA6,Proteasome subunit alpha type-6,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMA7,Proteasome subunit alpha type-7,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB1,Proteasome subunit beta type-1,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB2,Proteasome subunit beta type-2,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB3,Proteasome subunit beta type-3,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB4,Proteasome subunit beta type-4,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB5,Proteasome subunit beta type-5,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB6,Proteasome subunit beta type-6,target,,DB08515
"(3AR,6R,6AS)-6-((S)-((S)-CYCLOHEX-2-ENYL)(HYDROXY)METHYL)-6A-METHYL-4-OXO-HEXAHYDRO-2H-FURO[3,2-C]PYRROLE-6-CARBALDEHYDE",,experimental,PSMB7,Proteasome subunit beta type-7,target,,DB08515
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08521
4-[5-(4-FLUORO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-3H-IMIDAZOL-4-YL]-PYRIDINE,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB08521
[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,,experimental,def,Peptide deformylase,target,,DB08523
[HYDROXY(3-PHENYLPROPYL)AMINO]METHANOL,,experimental,def,Peptide deformylase,target,,DB08523
"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",,experimental,CCNA2,Cyclin-A2,target,,DB08527
"1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08527
(1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID,,experimental,ampC,Beta-lactamase,target,,DB08551
(1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID,,experimental,bla,Beta-lactamase TEM,target,,DB08551
(1R)-1-(2-THIENYLACETYLAMINO)-1-(3-CARBOXYPHENYL)METHYLBORONIC ACID,,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB08551
N-(3-CARBOXYPROPANOYL)-L-NORVALINE,,experimental,BF0439,Putative ornithine carbamoyltransferase,target,,DB08554
N-(3-CARBOXYPROPANOYL)-L-NORVALINE,,experimental,argF',N-acetylornithine carbamoyltransferase,target,,DB08554
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,experimental,lpxA,Acyl-[acyl-carrier-protein]--UDP-N-acetylglucosamine O-acyltransferase,target,,DB08558
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,experimental,fbpC,Diacylglycerol acyltransferase/mycolyltransferase Ag85C,target,,DB08558
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,experimental,ADRB1,Beta-1 adrenergic receptor,target,,DB08558
"2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL",,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB08558
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,,experimental,IGKC,Ig kappa chain C region,target,,DB08562
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08562
4-(4-STYRYL-PHENYLCARBAMOYL)-BUTYRIC ACID,,experimental,,Ig kappa chain V-II region TEW,target,,DB08562
(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08568
(2S)-1-{[5-(3-METHYL-1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-PHENYLPROPAN-2-AMINE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08568
"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08569
"3-PYRIDIN-4-YL-2,4-DIHYDRO-INDENO[1,2-.C.] PYRAZOLE",,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08569
4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,,experimental,NA,Neuraminidase,target,,DB08570
4-(ACETYLAMINO)-3-HYDROXY-5-NITROBENZOIC ACID,,experimental,NA,Neuraminidase,target,,DB08570
4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,,experimental,CCNA2,Cyclin-A2,target,,DB08572
4-{[4-AMINO-6-(CYCLOHEXYLMETHOXY)-5-NITROSOPYRIMIDIN-2-YL]AMINO}BENZAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08572
"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,ESR1,Estrogen receptor,target,,DB08595
"4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL",,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08595
"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",,experimental,ACVR1,Activin receptor type-1,target,,DB08597
"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-pyridin-4-ylpyrazolo[1,5-a]pyrimidine",,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB08597
"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08598
"4-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08598
tributylstannanyl,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08601
tributylstannanyl,,experimental,RXRA,Retinoic acid receptor RXR-alpha,target,,DB08601
Triclosan,,approved,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB08604
Triclosan,,approved,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB08604
Triclosan,,approved,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB08604
Triclosan,,approved,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB08604
Triclosan,,approved,fabI,Enoyl-[acyl-carrier-protein] reductase [NADPH] FabI,target,,DB08604
"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",,experimental,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",target,,DB08605
"6-METHYL-2(PROPANE-1-SULFONYL)-2H-THIENO[3,2-D][1,2,3]DIAZABORININ-1-OL",,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB08605
"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",,experimental,ATP5A1,"ATP synthase subunit alpha, mitochondrial",target,,DB08629
"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",,experimental,ATP5B,"ATP synthase subunit beta, mitochondrial",target,,DB08629
"N1-(2-AMINO-4-METHYLPENTYL)OCTAHYDRO-PYRROLO[1,2-A] PYRIMIDINE",,experimental,ATP5C1,"ATP synthase subunit gamma, mitochondrial",target,,DB08629
"1,3,5-BENZENETRICARBOXYLIC ACID",,experimental,HBA1,Hemoglobin subunit alpha,target,,DB08632
"1,3,5-BENZENETRICARBOXYLIC ACID",,experimental,HBB,Hemoglobin subunit beta,target,,DB08632
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,mauC,Amicyanin,target,,DB08646
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,mauB,Methylamine dehydrogenase heavy chain,target,,DB08646
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,mauA,Methylamine dehydrogenase light chain,target,,DB08646
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,moxG,Cytochrome c-L,target,,DB08646
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,qhnDH,Quinohemoprotein amine dehydrogenase subunit gamma,target,,DB08646
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,,Quinohemoprotein amine dehydrogenase 60 kDa subunit,target,,DB08646
TRW3-(2-AMINO-3-HYDROXY-PROPYL)-6-(N'-CYCLOHEXYL-HYDRAZINO)OCTAHYDRO-INDOL-7-OL,,experimental,,Quinohemoprotein amine dehydrogenase 40 kDa subunit,target,,DB08646
"8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID",,experimental,pheA,P-protein,target,,DB08648
"8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID",,experimental,aroH,Chorismate mutase AroH,target,,DB08648
"8-HYDROXY-2-OXA-BICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID",,experimental,MT1933,Secreted chorismate mutase,target,,DB08648
(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,,experimental,aauA,Aralkylamine dehydrogenase light chain,target,,DB08649
(1S)-1-AMINO-2-(1H-INDOL-3-YL)ETHANOL,,experimental,aauB,Aralkylamine dehydrogenase heavy chain,target,,DB08649
"(1R,3S,5S,8R)-8-HYDROXY-2-OXABICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID",,experimental,Rv0948c,Intracellular chorismate mutase,target,,DB08650
"(1R,3S,5S,8R)-8-HYDROXY-2-OXABICYCLO[3.3.1]NON-6-ENE-3,5-DICARBOXYLIC ACID",,experimental,aroG,Phospho-2-dehydro-3-deoxyheptonate aldolase AroG,target,,DB08650
3'-THIO-THYMIDINE-5'-PHOSPHATE,,experimental,ecoRVR,Type-2 restriction enzyme EcoRV,target,,DB08651
3'-THIO-THYMIDINE-5'-PHOSPHATE,,experimental,TOP2B,DNA topoisomerase 2-beta,target,,DB08651
2-(1H-INDOL-3-YL)ACETAMIDE,,experimental,aauA,Aralkylamine dehydrogenase light chain,target,,DB08652
2-(1H-INDOL-3-YL)ACETAMIDE,,experimental,aauB,Aralkylamine dehydrogenase heavy chain,target,,DB08652
2-(1H-INDOL-3-YL)ETHANAMINE,,experimental,aauA,Aralkylamine dehydrogenase light chain,target,,DB08653
2-(1H-INDOL-3-YL)ETHANAMINE,,experimental,aauB,Aralkylamine dehydrogenase heavy chain,target,,DB08653
"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB08674
"(20S)-19,20,21,22-TETRAHYDRO-19-OXO-5H-18,20-ETHANO-12,14-ETHENO-6,10-METHENO-18H-BENZ[D]IMIDAZO[4,3-K][1,6,9,12]OXATRIAZA-CYCLOOCTADECOSINE-9-CARBONITRILE",,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB08674
"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",,experimental,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,target,,DB08676
"(20S)-19,20,22,23-TETRAHYDRO-19-OXO-5H,21H-18,20-ETHANO-12,14-ETHENO-6,10-METHENOBENZ[D]IMIDAZO[4,3-L][1,6,9,13]OXATRIAZACYCLONOADECOSINE-9-CARBONITRILE",,experimental,FNTB,Protein farnesyltransferase subunit beta,target,,DB08676
N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE,,experimental,EGLN1,Egl nine homolog 1,target,,DB08687
N-[(1-CHLORO-4-HYDROXYISOQUINOLIN-3-YL)CARBONYL]GLYCINE,,experimental,HIF1A,Hypoxia-inducible factor 1-alpha,target,,DB08687
UBIQUINONE-1,,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB08689
UBIQUINONE-1,,experimental,puhA,Reaction center protein H chain,target,,DB08689
UBIQUINONE-1,,experimental,pufL,Reaction center protein L chain,target,,DB08689
UBIQUINONE-1,,experimental,pufM,Reaction center protein M chain,target,,DB08689
UBIQUINONE-1,,experimental,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",target,,DB08689
UBIQUINONE-1,,experimental,SDHB,"Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial",target,,DB08689
UBIQUINONE-1,,experimental,SDHD,"Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial",target,,DB08689
UBIQUINONE-1,,experimental,SDHC,"Succinate dehydrogenase cytochrome b560 subunit, mitochondrial",target,,DB08689
UBIQUINONE-1,,experimental,dsbA,Thiol:disulfide interchange protein DsbA,target,,DB08689
UBIQUINONE-1,,experimental,dsbB,Disulfide bond formation protein B,target,,DB08689
UBIQUINONE-1,,experimental,nrfC,NrfC protein,target,,DB08689
UBIQUINONE-1,,experimental,TT_C0155,Thiosulfate reductase,target,,DB08689
UBIQUINONE-1,,experimental,TT_C0153,Hypothetical membrane spanning protein,target,,DB08689
UBIQUINONE-2,,experimental,sdhA,Succinate dehydrogenase flavoprotein subunit,target,,DB08690
UBIQUINONE-2,,experimental,sdhB,Succinate dehydrogenase iron-sulfur subunit,target,,DB08690
UBIQUINONE-2,,experimental,sdhC,Succinate dehydrogenase cytochrome b556 subunit,target,,DB08690
UBIQUINONE-2,,experimental,sdhD,Succinate dehydrogenase hydrophobic membrane anchor subunit,target,,DB08690
UBIQUINONE-2,,experimental,CYC1,"Cytochrome c1, heme protein, mitochondrial",target,,DB08690
UBIQUINONE-2,,experimental,MT-CYB,Cytochrome b,target,,DB08690
UBIQUINONE-2,,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB08690
UBIQUINONE-2,,experimental,UQCRC2,"Cytochrome b-c1 complex subunit 2, mitochondrial",target,,DB08690
UBIQUINONE-2,,experimental,UQCRH,"Cytochrome b-c1 complex subunit 6, mitochondrial",target,,DB08690
UBIQUINONE-2,,experimental,UQCRQ,Cytochrome b-c1 complex subunit 8,target,,DB08690
UBIQUINONE-2,,experimental,UQCRFS1,"Cytochrome b-c1 complex subunit Rieske, mitochondrial",target,,DB08690
UBIQUINONE-2,,experimental,UQCR11,Cytochrome b-c1 complex subunit 10,target,,DB08690
UBIQUINONE-2,,experimental,UQCRB,Cytochrome b-c1 complex subunit 7,target,,DB08690
UBIQUINONE-2,,experimental,UQCR10,Cytochrome b-c1 complex subunit 9,target,,DB08690
UBIQUINONE-2,,experimental,pufC,Photosynthetic reaction center cytochrome c subunit,target,,DB08690
UBIQUINONE-2,,experimental,puhA,Reaction center protein H chain,target,,DB08690
UBIQUINONE-2,,experimental,pufL,Reaction center protein L chain,target,,DB08690
UBIQUINONE-2,,experimental,pufM,Reaction center protein M chain,target,,DB08690
UBIQUINONE-2,,experimental,dsbB,Disulfide bond formation protein B,target,,DB08690
UBIQUINONE-2,,experimental,petB,Cytochrome b,target,,DB08690
UBIQUINONE-2,,experimental,petA,Ubiquinol-cytochrome c reductase iron-sulfur subunit,target,,DB08690
UBIQUINONE-2,,experimental,petC,Cytochrome c1,target,,DB08690
UBIQUINONE-2,,experimental,pufL,Reaction center protein L chain,target,,DB08690
UBIQUINONE-2,,experimental,pufM,Reaction center protein M chain,target,,DB08690
UBIQUINONE-2,,experimental,puhA,Reaction center protein H chain,target,,DB08690
"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",,experimental,CLK1,Dual specificity protein kinase CLK1,target,,DB08691
"ethyl 3-[(E)-2-amino-1-cyanoethenyl]-6,7-dichloro-1-methyl-1H-indole-2-carboxylate",,experimental,CLK3,Dual specificity protein kinase CLK3,target,,DB08691
"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08694
"9-amino-5-(2-aminopyrimidin-4-yl)pyrido[3',2':4,5]pyrrolo[1,2-c]pyrimidin-4-ol",,experimental,CCNA2,Cyclin-A2,target,,DB08694
"5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL",,experimental,MED1,Mediator of RNA polymerase II transcription subunit 1,target,,DB08696
"5-{2-[1-(1-METHYL-PROPYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL",,experimental,VDR,Vitamin D3 receptor,target,,DB08696
"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",,experimental,,Genome polyprotein,target,,DB08701
"2-(3-BROMOPHENYL)-6-[(2-HYDROXYETHYL)AMINO]-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE",,experimental,,Genome polyprotein,target,,DB08701
"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08723
"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08723
"5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08726
"5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08726
"5-(7-(4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08726
"5-(3-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PROPYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08728
"5-(3-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PROPYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08728
NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,,experimental,rep,Replicase polyprotein 1ab,target,,DB08732
NALPHA-[(BENZYLOXY)CARBONYL]-N-[(1R)-4-HYDROXY-1-METHYL-2-OXOBUTYL]-L-PHENYLALANINAMIDE,,experimental,1a,Replicase polyprotein 1a,target,,DB08732
"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",,experimental,NCOA1,Nuclear receptor coactivator 1,target,,DB08742
"1,3-CYCLOHEXANEDIOL, 4-METHYLENE-5-[(2E)-[(1S,3AS,7AS)-OCTAHYDRO-1-(5-HYDROXY-5-METHYL-1,3-HEXADIYNYL)-7A-METHYL-4H-INDEN-4-YLIDENE]ETHYLIDENE]-, (1R,3S,5Z)",,experimental,VDR,Vitamin D3 receptor,target,,DB08742
4-(DIMETHYLAMINO)BENZOIC ACID,,experimental,rep,Replicase polyprotein 1ab,target,,DB08748
4-(DIMETHYLAMINO)BENZOIC ACID,,experimental,orf1ab,Orf1a polyprotein,target,,DB08748
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB08756
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,,experimental,PKIA,cAMP-dependent protein kinase inhibitor alpha,target,,DB08756
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,,experimental,ROCK1,Rho-associated protein kinase 1,target,,DB08756
(R)-TRANS-4-(1-AMINOETHYL)-N-(4-PYRIDYL) CYCLOHEXANECARBOXAMIDE,,experimental,ROCK2,Rho-associated protein kinase 2,target,,DB08756
"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",,experimental,CA2,Carbonic anhydrase 2,target,,DB08765
"6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE",,experimental,MIF,Macrophage migration inhibitory factor,target,,DB08765
2-(4-METHOXYPHENYL)ACETAMIDE,,experimental,aauA,Aralkylamine dehydrogenase light chain,target,,DB08767
2-(4-METHOXYPHENYL)ACETAMIDE,,experimental,aauB,Aralkylamine dehydrogenase heavy chain,target,,DB08767
"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",,experimental,AKR1B10,Aldo-keto reductase family 1 member B10,target,,DB08772
"3,4-DIHYDRO-4-OXO-3-((5-TRIFLUOROMETHYL-2-BENZOTHIAZOLYL)METHYL)-1-PHTHALAZINE ACETIC ACID",,experimental,AKR1B1,Aldose reductase,target,,DB08772
RALOXIFENE CORE,,experimental,ESR1,Estrogen receptor,target,,DB08773
RALOXIFENE CORE,,experimental,NCOA2,Nuclear receptor coactivator 2,target,,DB08773
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,pbp2a,Penicillin-binding protein 2a,target,inhibitor,DB08795
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,pbp1b,Penicillin-binding protein 1b,target,inhibitor,DB08795
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB08795
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB08795
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB08795
Dimetindene,Anti-Allergic AgentsAntipruriticsHistamine H1 AntagonistsCholinergic AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB08801
Dimetindene,Anti-Allergic AgentsAntipruriticsHistamine H1 AntagonistsCholinergic AntagonistsHistamine Antagonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB08801
Bopindolol,,approved,ADRB1,Beta-1 adrenergic receptor,target,partial agonist,DB08807
Bopindolol,,approved,ADRB2,Beta-2 adrenergic receptor,target,partial agonist,DB08807
Bopindolol,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB08807
Bopindolol,,approved,HTR1B,5-hydroxytryptamine receptor 1B,target,,DB08807
Bopindolol,,approved,ADRB3,Beta-3 adrenergic receptor,target,,DB08807
Bupranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB08808
Bupranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB2,Beta-2 adrenergic receptor,target,antagonist,DB08808
Bupranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ADRB3,Beta-3 adrenergic receptor,target,antagonist,DB08808
Cinitapride,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB08810
Cinitapride,,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB08810
Cinitapride,,approved,HTR4,5-hydroxytryptamine receptor 4,target,agonist,DB08810
Tofisopam,Antidepressive AgentsBenzodiazepines,approved,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,inhibitor,DB08811
Tofisopam,Antidepressive AgentsBenzodiazepines,approved,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,inhibitor,DB08811
Tofisopam,Antidepressive AgentsBenzodiazepines,approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB08811
Tofisopam,Antidepressive AgentsBenzodiazepines,approved,PDE2A,"cGMP-dependent 3',5'-cyclic phosphodiesterase",target,inhibitor,DB08811
Nadroparin,Antithrombins,approved,SERPINC1,Antithrombin-III,target,potentiator,DB08813
Nadroparin,Antithrombins,approved,SELP,P-selectin,target,inhibitor,DB08813
Nadroparin,Antithrombins,approved,FOS,Proto-oncogene c-Fos,target,inhibitor,DB08813
Nadroparin,Antithrombins,approved,,Myc proto-oncogene protein,target,inhibitor,DB08813
Triflusal,AntithrombinsPlatelet Aggregation Inhibitors,approved,PTGS1,Prostaglandin G/H synthase 1,target,antagonist,DB08814
Triflusal,AntithrombinsPlatelet Aggregation Inhibitors,approved,NFKB1,Nuclear factor NF-kappa-B p105 subunit,target,antagonist,DB08814
Triflusal,AntithrombinsPlatelet Aggregation Inhibitors,approved,NOS2,"Nitric oxide synthase, inducible",target,agonist,DB08814
Triflusal,AntithrombinsPlatelet Aggregation Inhibitors,approved,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,antagonist,DB08814
Lurasidone,,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB08815
Lurasidone,,approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB08815
Lurasidone,,approved,HTR7,5-hydroxytryptamine receptor 7,target,antagonist,DB08815
Lurasidone,,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB08815
Lurasidone,,approved,ADRA2C,Alpha-2C adrenergic receptor,target,antagonist,DB08815
Lurasidone,,approved,ADRA2A,Alpha-2A adrenergic receptor,target,,DB08815
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,CD44,CD44 antigen,target,,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,ICAM1,Intercellular adhesion molecule 1,target,,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Hyaluronan mediated motility receptor,target,,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,NCAN,Neurocan core protein,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,VCAN,Versican core protein,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,"Complement component 1 Q subcomponent-binding protein, mitochondrial",target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Hyaluronan and proteoglycan link protein 1,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Hyaluronan and proteoglycan link protein 3,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Hyaluronan and proteoglycan link protein 4,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Hyaluronan-binding protein 2,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Layilin,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Stabilin-2,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Tumor necrosis factor-inducible gene 6 protein,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Interphotoreceptor matrix proteoglycan 2,target,binder,DB08818
Hyaluronan,"Adjuvants, ImmunologicViscosupplements",approved,,Intracellular hyaluronan-binding protein 4,target,binder,DB08818
Tetraethylammonium,Potassium Channel Blockers,experimental,kcsA,pH-gated potassium channel KcsA,target,inhibitor,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,CHRNA9,Neuronal acetylcholine receptor subunit alpha-9,target,agonistinhibitor,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,,Calcium-activated potassium channel subunit alpha-1,target,inhibitor,DB08837
Agmatine,,experimentalinvestigational,ADRA2C,Alpha-2C adrenergic receptor,target,agonist,DB08838
Agmatine,,experimentalinvestigational,NISCH,Nischarin,target,agonist,DB08838
Agmatine,,experimentalinvestigational,CHRNA1,Acetylcholine receptor subunit alpha,target,antagonist,DB08838
Agmatine,,experimentalinvestigational,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,antagonist,DB08838
Agmatine,,experimentalinvestigational,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,antagonist,DB08838
Agmatine,,experimentalinvestigational,CACNA1B,Voltage-dependent N-type calcium channel subunit alpha-1B,target,antagonist,DB08838
Agmatine,,experimentalinvestigational,,Acid-sensing ion channel 3,target,agonist,DB08838
Ellagic Acid,Antineoplastic Agents,investigational,CA1,Carbonic anhydrase 1,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA2,Carbonic anhydrase 2,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA3,Carbonic anhydrase 3,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA4,Carbonic anhydrase 4,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA5A,"Carbonic anhydrase 5A, mitochondrial",target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA5B,"Carbonic anhydrase 5B, mitochondrial",target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA6,Carbonic anhydrase 6,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA7,Carbonic anhydrase 7,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA9,Carbonic anhydrase 9,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA12,Carbonic anhydrase 12,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CA14,Carbonic anhydrase 14,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,CSNK2A1,Casein kinase II subunit alpha,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,"inhibitor, competitive",DB08846
Ellagic Acid,Antineoplastic Agents,investigational,PRKCA,Protein kinase C alpha type,target,"inhibitor, competitive",DB08846
Ellagic Acid,Antineoplastic Agents,investigational,PRKCB,Protein kinase C beta type,target,"inhibitor, competitive",DB08846
Ellagic Acid,Antineoplastic Agents,investigational,SYK,Tyrosine-protein kinase SYK,target,inhibitor,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,SQLE,Squalene monooxygenase,target,inhibitor,DB08846
Guvacine,,experimental,,Sodium- and chloride-dependent GABA transporter 2,target,inhibitor,DB08848
Guvacine,,experimental,SLC6A1,Sodium- and chloride-dependent GABA transporter 1,target,inhibitor,DB08848
Guvacine,,experimental,,Sodium- and chloride-dependent GABA transporter 3,target,inhibitor,DB08848
Guvacine,,experimental,,Sodium- and chloride-dependent betaine transporter,target,inhibitor,DB08848
Rilpivirine,,approved,pol,Reverse Transcriptase,target,inhibitor,DB08864
Rilpivirine,,approved,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,agonist,DB08864
Crizotinib,Protein Kinase Inhibitors,approved,,ALK tyrosine kinase receptor,target,inhibitor,DB08865
Crizotinib,Protein Kinase Inhibitors,approved,MET,Hepatocyte growth factor receptor,target,inhibitor,DB08865
Cabozantinib,,approved,MET,Hepatocyte growth factor receptor,target,antagonist,DB08875
Cabozantinib,,approved,KDR,Vascular endothelial growth factor receptor 2,target,antagonist,DB08875
Cabozantinib,,approved,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,antagonist,DB08875
Ruxolitinib,,approved,JAK1,Tyrosine-protein kinase JAK1,target,inhibitor,DB08877
Ruxolitinib,,approved,JAK2,Tyrosine-protein kinase JAK2,target,inhibitor,DB08877
Aflibercept,Antineoplastic AgentsOphthalmics,approved,VEGFA,Vascular endothelial growth factor A,target,binder,DB08885
Aflibercept,Antineoplastic AgentsOphthalmics,approved,PGF,Placenta growth factor,target,binder,DB08885
Aflibercept,Antineoplastic AgentsOphthalmics,approved,,Vascular endothelial growth factor B,target,binder,DB08885
Ocriplasmin,Ophthalmics,approved,FN1,Fibronectin,target,cleavage,DB08888
Ocriplasmin,Ophthalmics,approved,A2M,Alpha-2-macroglobulin,target,ligand,DB08888
Ocriplasmin,Ophthalmics,approved,SERPINF2,Alpha-2-antiplasmin,target,ligand,DB08888
Carfilzomib,Antineoplastic Agents,approved,PSMB5,Proteasome subunit beta type-5,target,inhibitor,DB08889
Carfilzomib,Antineoplastic Agents,approved,,Proteasome subunit beta type-8,target,inhibitor,DB08889
Carfilzomib,Antineoplastic Agents,approved,PSMB1,Proteasome subunit beta type-1,target,inhibitor,DB08889
Carfilzomib,Antineoplastic Agents,approved,,Proteasome subunit beta type-9,target,inhibitor,DB08889
Carfilzomib,Antineoplastic Agents,approved,PSMB2,Proteasome subunit beta type-2,target,inhibitor,DB08889
Carfilzomib,Antineoplastic Agents,approved,,Proteasome subunit beta type-10,target,inhibitor,DB08889
Arbaclofen,,investigational,GABBR1,Gamma-aminobutyric acid type B receptor subunit 1,target,agonist,DB08891
Arbaclofen,,investigational,GABBR2,Gamma-aminobutyric acid type B receptor subunit 2,target,agonist,DB08891
Arbaclofen Placarbil,,investigational,GABBR1,Gamma-aminobutyric acid type B receptor subunit 1,target,agonist,DB08892
Arbaclofen Placarbil,,investigational,GABBR2,Gamma-aminobutyric acid type B receptor subunit 2,target,agonist,DB08892
Tofacitinib,,approved,JAK2,Tyrosine-protein kinase JAK2,target,inhibitor,DB08895
Tofacitinib,,approved,JAK1,Tyrosine-protein kinase JAK1,target,inhibitor,DB08895
Tofacitinib,,approved,JAK3,Tyrosine-protein kinase JAK3,target,inhibitor,DB08895
Regorafenib,Antineoplastic Agents,approved,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,FLT1,Vascular endothelial growth factor receptor 1,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,KDR,Vascular endothelial growth factor receptor 2,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,FLT4,Vascular endothelial growth factor receptor 3,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,KIT,Mast/stem cell growth factor receptor Kit,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,PDGFRA,Platelet-derived growth factor receptor alpha,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,PDGFRB,Platelet-derived growth factor receptor beta,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,FGFR1,Fibroblast growth factor receptor 1,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,FGFR2,Fibroblast growth factor receptor 2,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,TEK,Angiopoietin-1 receptor,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,,Discoidin domain-containing receptor 2,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,NTRK1,High affinity nerve growth factor receptor,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,EPHA2,Ephrin type-A receptor 2,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,RAF1,RAF proto-oncogene serine/threonine-protein kinase,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,BRAF,Serine/threonine-protein kinase B-raf,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,MAPK11,Mitogen-activated protein kinase 11,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,,Tyrosine-protein kinase FRK,target,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,ABL1,Tyrosine-protein kinase ABL1,target,inhibitor,DB08896
Aclidinium,Muscarinic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB08897
Aclidinium,Muscarinic AntagonistsAntispasmodics,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,antagonist,DB08897
Aclidinium,Muscarinic AntagonistsAntispasmodics,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB08897
Aclidinium,Muscarinic AntagonistsAntispasmodics,approved,CHRM4,Muscarinic acetylcholine receptor M4,target,antagonist,DB08897
Aclidinium,Muscarinic AntagonistsAntispasmodics,approved,CHRM5,Muscarinic acetylcholine receptor M5,target,antagonist,DB08897
Ponatinib,,approved,ABL1,Tyrosine-protein kinase ABL1,target,inhibitor,DB08901
Ponatinib,,approved,,Breakpoint cluster region protein,target,inhibitor,DB08901
Ponatinib,,approved,KIT,Mast/stem cell growth factor receptor Kit,target,inhibitor,DB08901
Ponatinib,,approved,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,inhibitor,DB08901
Ponatinib,,approved,TEK,Angiopoietin-1 receptor,target,inhibitor,DB08901
Ponatinib,,approved,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,inhibitor,DB08901
Ponatinib,,approved,FGFR1,Fibroblast growth factor receptor 1,target,inhibitor,DB08901
Ponatinib,,approved,FGFR2,Fibroblast growth factor receptor 2,target,inhibitor,DB08901
Ponatinib,,approved,FGFR3,Fibroblast growth factor receptor 3,target,inhibitor,DB08901
Ponatinib,,approved,FGFR4,Fibroblast growth factor receptor 4,target,inhibitor,DB08901
Ponatinib,,approved,LCK,Tyrosine-protein kinase Lck,target,inhibitor,DB08901
Ponatinib,,approved,SRC,Proto-oncogene tyrosine-protein kinase Src,target,inhibitor,DB08901
Ponatinib,,approved,LYN,Tyrosine-protein kinase Lyn,target,inhibitor,DB08901
Ponatinib,,approved,KDR,Vascular endothelial growth factor receptor 2,target,inhibitor,DB08901
Ponatinib,,approved,PDGFRA,Platelet-derived growth factor receptor alpha,target,inhibitor,DB08901
Canagliflozin,Antidiabetic Agents,approved,,Sodium/glucose cotransporter 2,target,inhibitor,DB08907
Canagliflozin,Antidiabetic Agents,approved,,Sodium/glucose cotransporter 1,target,inhibitor,DB08907
Pomalidomide,Immunosuppressive Agents,approved,,Protein cereblon,target,inhibitor,DB08910
Pomalidomide,Immunosuppressive Agents,approved,TNF,Tumor necrosis factor,target,inhibitor,DB08910
Pomalidomide,Immunosuppressive Agents,approved,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB08910
Trametinib,,approved,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,inhibitor,DB08911
Trametinib,,approved,,Dual specificity mitogen-activated protein kinase kinase 2,target,inhibitor,DB08911
Dabrafenib,,approved,BRAF,Serine/threonine-protein kinase B-raf,target,inhibitor,DB08912
Dabrafenib,,approved,RAF1,RAF proto-oncogene serine/threonine-protein kinase,target,inhibitor,DB08912
Dabrafenib,,approved,,Serine/threonine-protein kinase SIK1,target,inhibitor,DB08912
Dabrafenib,,approved,,Serine/threonine-protein kinase Nek11,target,inhibitor,DB08912
Dabrafenib,,approved,,LIM domain kinase 1,target,inhibitor,DB08912
Aleglitazar,,investigational,PPARA,Peroxisome proliferator-activated receptor alpha,target,agonist,DB08915
Aleglitazar,,investigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB08915
Aleglitazar,,investigational,NCOA1,Nuclear receptor coactivator 1,target,,DB08915
Afatinib,,approved,EGFR,Epidermal growth factor receptor,target,inhibitor,DB08916
Afatinib,,approved,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,inhibitor,DB08916
Afatinib,,approved,,Receptor tyrosine-protein kinase erbB-4,target,inhibitor,DB08916
Levomilnacipran,Serotonin Uptake Inhibitors,approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB08918
Levomilnacipran,Serotonin Uptake Inhibitors,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB08918
Zuclopenthixol acetate,,experimentalinvestigational,DRD1,D(1A) dopamine receptor,target,antagonist,DB08919
Zuclopenthixol acetate,,experimentalinvestigational,DRD5,D(1B) dopamine receptor,target,antagonist,DB08919
Zuclopenthixol acetate,,experimentalinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB08919
Zuclopenthixol acetate,,experimentalinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB08919
Zuclopenthixol acetate,,experimentalinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB08919
Zuclopenthixol acetate,,experimentalinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB08919
Zuclopenthixol acetate,,experimentalinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB08919
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,DRD1,D(1A) dopamine receptor,target,antagonist,DB08920
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,DRD5,D(1B) dopamine receptor,target,antagonist,DB08920
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,antagonist,DB08920
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB08920
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB08920
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,antagonist,DB08920
Zuclopenthixol decanoate,Antipsychotic AgentsDopamine Antagonists,experimentalinvestigational,DRD2,D(2) dopamine receptor,target,antagonist,DB08920
MACITENTAN,Vasodilator Agents,approved,EDNRA,Endothelin-1 receptor,target,antagonist,DB08932
MACITENTAN,Vasodilator Agents,approved,EDNRB,Endothelin B receptor,target,antagonist,DB08932
Lepirudin,AntithrombinsFibrinolytic Agents,approved,F2,Prothrombin,target,inhibitor,DB00001
Bivalirudin,Antithrombins,approvedinvestigational,F2,Prothrombin,target,inhibitor,DB00006
Leuprolide,"Antineoplastic Agents, HormonalFertility Agents, FemaleEstrogen Antagonists",approvedinvestigational,GNRHR,Gonadotropin-releasing hormone receptor,target,agonist,DB00007
Sermorelin,Hormone Replacement Agents,approvedwithdrawn,GHRHR,Growth hormone-releasing hormone receptor,target,agonist,DB00010
Darbepoetin alfa,HematinicsAnti-anemic Agents,approvedinvestigational,EPOR,Erythropoietin receptor,target,agonist,DB00012
Epoetin alfa,HematinicsAnti-anemic Agents,approved,EPOR,Erythropoietin receptor,target,agonist,DB00016
Salmon Calcitonin,Bone Density Conservation AgentsAntihypercalcemic AgentsAnti-Osteporotic Agents,approvedinvestigational,CALCR,Calcitonin receptor,target,agonist,DB00017
Secretin,Diagnostic Agents,approvedinvestigational,SCTR,Secretin receptor,target,agonist,DB00021
Thyrotropin Alfa,Diagnostic Agents,approved,TSHR,Thyrotropin receptor,target,agonist,DB00024
Anakinra,Antirheumatic AgentsImmunosuppressive Agents,approved,IL1R1,Interleukin-1 receptor type 1,target,antagonist,DB00026
Oprelvekin,Antineoplastic AgentsCoagulantsThrombotic Agents,approvedinvestigational,IL11RA,Interleukin-11 receptor subunit alpha,target,agonist,DB00038
Lutropin alfa,Fertility Agents,approved,LHCGR,Lutropin-choriogonadotropic hormone receptor,target,agonist,DB00044
OspA lipoprotein,Vaccines,approvedwithdrawn,TLR2,Toll-like receptor 2,target,other/unknown,DB00045
Alpha-1-proteinase inhibitor,Serine Proteinase InhibitorsTrypsin InhibitorsEnzyme Replacement Agents,approved,ELANE,Neutrophil elastase,target,inhibitor,DB00058
Eptifibatide,Platelet Aggregation Inhibitors,approvedinvestigational,ITGB3,Integrin beta-3,target,,DB00063
Infliximab,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalDermatologic AgentsGastrointestinal AgentsImmunosuppressive Agents",approved,TNF,Tumor necrosis factor,target,inhibitor,DB00065
Follitropin beta,Fertility Agents,approved,FSHR,Follicle-stimulating hormone receptor,target,agonist,DB00066
Pegvisomant,Hormone Replacement Agents,approved,GHR,Growth hormone receptor,target,antagonist,DB00082
Capromab,Indicators and ReagentsDiagnostic Agents,approved,FOLH1,Glutamate carboxypeptidase 2,target,other/unknown,DB00089
Felypressin,Vasoconstrictor AgentsRenal Agents,approved,AVPR1A,Vasopressin V1a receptor,target,agonist,DB00093
Urofollitropin,Fertility Agents,approved,FSHR,Follicle-stimulating hormone receptor,target,agonist,DB00094
Abarelix,Anti-Testosterone Agents,approvedinvestigationalwithdrawn,GNRHR,Gonadotropin-releasing hormone receptor,target,antagonist,DB00106
Enfuvirtide,HIV Fusion Inhibitors,approvedinvestigational,gp41,Envelope glycoprotein,target,,DB00109
Arcitumomab,Diagnostic Agents,approvedinvestigational,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,target,other/unknown,DB00113
Calcitriol,Bone Density Conservation AgentsVitaminsCalcium Channel AgonistsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,VDR,Vitamin D3 receptor,target,antagonist,DB00136
Calcidiol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,VDR,Vitamin D3 receptor,target,agonist,DB00146
Pyridoxal,Vitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,PDXK,Pyridoxal kinase,target,,DB00147
Ergocalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,VDR,Vitamin D3 receptor,target,agonist,DB00153
Pyridoxine,Vitamin B ComplexVitamins,approvednutraceutical,PDXK,Pyridoxal kinase,target,ligand,DB00165
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,VDR,Vitamin D3 receptor,target,agonist,DB00169
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB00175
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00176
Valsartan,Angiotensin Receptor Antagonists,approvedinvestigational,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB00177
Ramipril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00178
Masoprocol,Antineoplastic AgentsAntioxidantsCyclooxygenase InhibitorsLipoxygenase Inhibitors,approved,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00179
Flunisolide,,approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB00180
Pentagastrin,Diagnostic Agents,approved,CCKBR,Gastrin/cholecystokinin type B receptor,target,agonist,DB00183
Esmolol,,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB00187
Ethchlorvynol,Hypnotics and Sedatives,approvedillicitwithdrawn,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00189
Carbidopa,Enzyme InhibitorsDopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,DDC,Aromatic-L-amino-acid decarboxylase,target,inhibitor,DB00190
Indecainide,Anti-Arrhythmia AgentsSodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00192
Fluconazole,Antifungal Agents,approved,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB00196
Ticlopidine,,approved,P2RY12,P2Y purinoceptor 12,target,antagonist,DB00208
Trospium,,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00209
Remikiren,,approved,REN,Renin,target,inhibitor,DB00212
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,ATP4A,Potassium-transporting ATPase alpha chain 1,target,inhibitor,DB00213
Torasemide,Antihypertensive AgentsDiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00214
Oxyphenonium,,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00219
Nelfinavir,,approved,HIV-1 protease,HIV-1 protease,target,inhibitor,DB00220
Diflorasone,Anti-Inflammatory AgentsGlucocorticoids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00223
Indinavir,,approved,,Protease,target,inhibitor,DB00224
Guanadrel,Antihypertensive Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,partial agonist,DB00226
Cefotiam,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inducer,DB00229
Pregabalin,AnalgesicsAnticonvulsants,approvedillicitinvestigational,CACNA1A,Voltage-dependent P/Q-type calcium channel subunit alpha-1A,target,inhibitor,DB00230
Reboxetine,,approvedinvestigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,inhibitor,DB00234
Milrinone,Platelet Aggregation InhibitorsCardiotonic AgentsPhosphodiesterase 3 InhibitorsVasodilator Agents,approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB00235
Nevirapine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approved,pol,Reverse Transcriptase,target,inhibitor,DB00238
Alclometasone,AntipruriticsCorticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00240
Terconazole,Antifungal Agents,approved,ERG11,Lanosterol 14-alpha demethylase,target,antagonist,DB00251
Medrysone,Anti-Inflammatory Agents,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00253
Sulfanilamide,Anti-Bacterial AgentsSulfonamidesHomeopathic Agents,approved,folP,Dihydropteroate synthase,target,inhibitor,DB00259
Anagrelide,Antithrombins,approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB00261
Sulfisoxazole,Anti-Infective AgentsSulfonamides,approved,folP,Dihydropteroate synthase,target,inhibitor,DB00263
Chlorotrianisene,"Antineoplastic Agents, HormonalEstrogens, Non-Steroidal",withdrawn,ESR1,Estrogen receptor,target,agonist,DB00269
Betazole,Gastrointestinal AgentsHistamine AgonistsDiagnostic Agents,approved,HRH2,Histamine H2 receptor,target,agonist,DB00272
Olmesartan,Angiotensin II Type 1 Receptor Blockers,approvedinvestigational,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB00275
Argatroban,,approvedinvestigational,F2,Prothrombin,target,inhibitor,DB00278
Clemastine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00283
Conjugated Estrogens,Estrogens,approved,ESR1,Estrogen receptor,target,agonist,DB00286
Travoprost,"Prostaglandins, SyntheticAnti-glaucoma AgentsOphthalmics",approved,PTGFR,Prostaglandin F2-alpha receptor,target,agonist,DB00287
Ropivacaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00296
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,pol,Reverse Transcriptase,target,inhibitor,DB00300
Flucloxacillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB00301
Tranexamic Acid,Antifibrinolytic Agents,approved,PLG,Plasminogen,target,inhibitor,DB00302
Vindesine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,TUBB1,Tubulin beta-1 chain,target,inhibitor,DB00309
Chlorthalidone,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB00310
Gefitinib,,approvedinvestigational,EGFR,Epidermal growth factor receptor,target,antagonist,DB00317
Floxuridine,"Antineoplastic AgentsAntimetabolites, Antineoplastic",approved,TYMS,Thymidylate synthase,target,,DB00322
Tolcapone,Antidyskinetics,approvedwithdrawn,COMT,Catechol O-methyltransferase,target,inhibitor,DB00323
Fluorometholone,Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00324
Nitroprusside,,approved,NPR1,Atrial natriuretic peptide receptor 1,target,agonist,DB00325
Metformin,Antidiabetic Agents,approved,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,target,inducer,DB00331
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,ATP4A,Potassium-transporting ATPase alpha chain 1,target,inhibitor,DB00338
Cetirizine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00341
Diltiazem,,approved,CACNG1,Voltage-dependent calcium channel gamma-1 subunit,target,inhibitor,DB00343
Trimethadione,Anticonvulsants,approved,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB00347
Nitisinone,,approvedinvestigational,HPD,4-hydroxyphenylpyruvate dioxygenase,target,inhibitor,DB00348
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00349
Methylergometrine,Oxytocics,approved,DRD1,D(1A) dopamine receptor,target,antagonist,DB00353
Chlorzoxazone,"Muscle Relaxants, Central",approved,KCNMA1,Calcium-activated potassium channel subunit alpha-1,target,,DB00356
Sulfadiazine,Antiprotozoal AgentsAnti-Infective AgentsCoccidiostats,approved,,Dihydropteroate synthetase,target,inhibitor,DB00359
Vinorelbine,"Antineoplastic Agents, Phytogenic",approvedinvestigational,TUBB,Tubulin beta chain,target,inhibitor,DB00361
Anidulafungin,Antifungal Agents,approvedinvestigational,fksA,"1,3-beta-glucan synthase component FKS1",target,inhibitor,DB00362
Cidofovir,Antineoplastic AgentsAntiviral AgentsAnti-HIV AgentsRadiation-Sensitizing Agents,approved,UL54,DNA polymerase catalytic subunit,target,inhibitor,DB00369
Palonosetron,,approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00377
Dydrogesterone,ProgestinsProgesterones,approvedwithdrawn,PGR,Progesterone receptor,target,agonist,DB00378
Alseroxylon,,withdrawn,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB00386
Carbimazole,Antithyroid Agents,approved,TPO,Thyroid peroxidase,target,inhibitor,DB00389
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,,DB00390
Beclomethasone,Anti-Arrhythmia AgentsCorticosteroids,approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB00394
Ceruletide,Diagnostic Agents,approved,CCKAR,Cholecystokinin receptor type A,target,inducer,DB00403
Alprazolam,Anti-Anxiety AgentsHypnotics and SedativesGABA ModulatorsBenzodiazepines,approvedillicitinvestigational,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00404
Dexbrompheniramine,Histamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00405
Mupirocin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntibiotics,approvedinvestigational,ileS,Isoleucine--tRNA ligase,target,inhibitor,DB00410
Acetohexamide,Hypoglycemic AgentsAntidiabetic Agents,withdrawn,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inhibitor,DB00414
Metocurine Iodide,,withdrawn,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB00416
Miglustat,Enzyme Inhibitors,approved,UGCG,Ceramide glucosyltransferase,target,inhibitor,DB00419
Methocarbamol,"Muscle Relaxants, Central",approved,CA1,Carbonic anhydrase 1,target,inhibitor,DB00423
Triprolidine,,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00427
Carboprost Tromethamine,,approved,PTGER1,Prostaglandin E2 receptor EP1 subtype,target,agonist,DB00429
Prochlorperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB00433
Nitric Oxide,Bronchodilator AgentsEndothelium-Dependent Relaxing FactorsFree Radical ScavengersNeurotransmitter Agents,approved,GUCY1A2,Guanylate cyclase soluble subunit alpha-2,target,inducer,DB00435
Allopurinol,Gout SuppressantsEnzyme InhibitorsAntimetabolitesFree Radical Scavengers,approved,XDH,Xanthine dehydrogenase/oxidase,target,inhibitor,DB00437
Cerivastatin,Hypolipidemic Agents,withdrawn,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB00439
Betamethasone,Anti-Asthmatic AgentsAnti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00443
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,TOP2A,DNA topoisomerase 2-alpha,target,inhibitor,DB00444
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,ATP4A,Potassium-transporting ATPase alpha chain 1,target,inhibitor,DB00448
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00455
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,SLC6A4,Sodium-dependent serotonin transporter,target,inhibitor,DB00472
Methohexital,"Anesthetics, IntravenousBarbiturates",approved,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,antagonist,DB00474
Chlordiazepoxide,"Anti-Anxiety AgentsHypnotics and SedativesAdjuvants, AnesthesiaGABA ModulatorsBenzodiazepines",approvedillicit,GABRA1,GABA-A receptor (anion channel),target,positive allosteric modulator,DB00475
Rimantadine,,approved,M,Matrix protein 2,target,other/unknown,DB00478
Fosinopril,,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00492
Entacapone,Enzyme InhibitorsAntiparkinson AgentsAntidyskinetics,approvedinvestigational,COMT,Catechol O-methyltransferase,target,inhibitor,DB00494
Phenindione,Anticoagulants,approved,VKORC1,Vitamin K epoxide reductase complex subunit 1,target,inhibitor,DB00498
Cimetidine,Adjuvants,approved,HRH2,Histamine H2 receptor,target,antagonist,DB00501
Ritonavir,,approvedinvestigational,,Protease,target,inhibitor,DB00503
Levallorphan,Narcotic AntagonistsAntidotes,approved,OPRM1,Mu-type opioid receptor,target,partial agonist,DB00504
Nitazoxanide,Antiparasitic Agents,approvedinvestigational,por,Pyruvate-flavodoxin oxidoreductase,target,inhibitor,DB00507
Acetyldigitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB00511
Trandolapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00519
Caspofungin,Antifungal Agents,approved,fksA,"1,3-beta-glucan synthase component FKS1",target,inhibitor,DB00520
Bentiromide,Indicators and ReagentsDiagnostic Agents,withdrawn,HPN,Serine protease hepsin,target,ligand,DB00522
Metolazone,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB00524
Tolnaftate,Antifungal Agents,approved,ERG1,Squalene monooxygenase,target,inhibitor,DB00525
Lercanidipine,Antihypertensive AgentsCalcium Channel Blockers,approvedinvestigational,CACNG1,Voltage-dependent calcium channel gamma-1 subunit,target,inhibitor,DB00528
Mephenytoin,Anticonvulsants,investigationalwithdrawn,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00532
Toremifene,"Antineoplastic Agents, HormonalBone Density Conservation AgentsSelective Estrogen Receptor Modulators",approvedinvestigational,ESR1,Estrogen receptor,target,modulator,DB00539
Benazepril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00542
Desoximetasone,,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00547
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,CYSLTR1,Cysteinyl leukotriene receptor 1,target,antagonist,DB00549
Propylthiouracil,AntimetabolitesAntithyroid Agents,approved,TPO,Thyroid peroxidase,target,inhibitor,DB00550
Pentostatin,Antineoplastic AgentsAdenosine Deaminase InhibitorsAntibiotics,approvedinvestigational,ADA,Adenosine deaminase,target,inhibitor,DB00552
Lamotrigine,AnticonvulsantsCalcium Channel BlockersAntidepressive Agents,approvedinvestigational,SCN2A,Sodium channel protein type 2 subunit alpha,target,inhibitor,DB00555
Hydroxyzine,Hypnotics and SedativesAntipruriticsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00557
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,DHFR,Dihydrofolate reductase,target,inhibitor,DB00563
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00564
Cisatracurium Besylate,Neuromuscular Blocking Agents,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,inhibitor,DB00565
Sulfamethizole,Anti-Infective Agents,approved,folP,Dihydropteroate synthase,target,inhibitor,DB00576
Valdecoxib,"Anti-Inflammatory Agents, Non-Steroidal",investigationalwithdrawn,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB00580
Lactulose,Gastrointestinal Agents,approved,ebgA,Evolved beta-galactosidase subunit alpha,target,other,DB00581
Voriconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ERG11,Lanosterol 14-alpha demethylase,target,antagonistinhibitor,DB00582
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00584
Nizatidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,HRH2,Histamine H2 receptor,target,antagonist,DB00585
Cinalukast,Anti-Arrhythmia Agents,approved,CYSLTR1,Cysteinyl leukotriene receptor 1,target,antagonist,DB00587
Fluocinolone Acetonide,Anti-Inflammatory AgentsGlucocorticoids,approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB00591
Piperazine,Antinematodal Agents,approved,GABRB3,Gamma-aminobutyric acid receptor subunit beta-3,target,agonist,DB00592
Ethosuximide,AnticonvulsantsSuccinimides,approved,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB00593
Halobetasol Propionate,,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00596
Monobenzone,Dermatologic Agents,approved,TYR,Tyrosinase,target,inhibitor,DB00600
Metaraminol,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approvedinvestigational,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00610
Paramethadione,,approved,CACNA1I,Voltage-dependent T-type calcium channel subunit alpha-1I,target,suppressor,DB00617
Triamcinolone,Anti-Inflammatory AgentsGlucocorticoids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00620
Oxandrolone,Anabolic AgentsAndrogens,approvedinvestigational,AR,Androgen receptor,target,agonist,DB00621
Testosterone,Androgens,approvedinvestigational,AR,Androgen receptor,target,agonist,DB00624
Efavirenz,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,pol,Reverse Transcriptase,target,inhibitor,DB00625
Dexmedetomidine,"Hypnotics and SedativesAnalgesics, Non-NarcoticAdrenergic alpha-2 Receptor Agonists",approved,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB00633
Clofibrate,Anticholesteremic AgentsHypolipidemic Agents,approved,PPARA,Peroxisome proliferator-activated receptor alpha,target,agonist,DB00636
Inulin,Diagnostic Agents,approvednutraceutical,cft,Cycloinulo-oligosaccharide fructanotransferase,target,binder,DB00638
Dyclonine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00645
Stavudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approvedinvestigational,pol,Reverse Transcriptase,target,inhibitor,DB00649
Leucovorin,"Vitamin B ComplexVitaminsAntidotesAnti-anemic AgentsAntineoplastics, Adjuncts",approved,TYMS,Thymidylate synthase,target,inhibitor,DB00650
Latanoprost,,approvedinvestigational,PTGFR,Prostaglandin F2-alpha receptor,target,agonist,DB00654
Estrone,EstrogensAnti-menopausal Agents,approved,ESR1,Estrogen receptor,target,agonist,DB00655
Mecamylamine,,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,inhibitor,DB00657
Flumethasone Pivalate,,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00663
Sulfametopyrazine,"AntimalarialsAnti-Infective AgentsAnti-Infective Agents, Urinary",approvedwithdrawn,,Dihydropteroate synthetase,target,inhibitor,DB00664
Nilutamide,Antineoplastic AgentsAndrogen Antagonists,approved,AR,Androgen receptor,target,antagonist,DB00665
Pirenzepine,Anti-Ulcer AgentsMuscarinic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00670
Cefixime,Anti-Bacterial AgentsCephalosporins,approved,mrdA,Penicillin-binding protein 2,target,inhibitor,DB00671
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,ABCC8,ATP-binding cassette sub-family C member 8,target,inhibitor,DB00672
Aprepitant,,approvedinvestigational,TACR1,Substance-P receptor,target,antagonist,DB00673
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB00678
Moricizine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approvedwithdrawn,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00680
Warfarin,AnticoagulantsRodenticides,approved,VKORC1,Vitamin K epoxide reductase complex subunit 1,target,inhibitor,DB00682
Cephaloglycin,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 2A,target,antagonist,DB00689
Nicergoline,Nootropic AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB00699
Eplerenone,Mineralocorticoid Receptor Antagonists,approved,NR3C2,Mineralocorticoid receptor,target,antagonist,DB00700
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,,Protease,target,inhibitor,DB00701
Delavirdine,Reverse Transcriptase Inhibitors,approved,pol,Reverse Transcriptase,target,inhibitor,DB00705
Norethindrone,"Contraceptives, Oral, Synthetic",approved,PGR,Progesterone receptor,target,agonist,DB00717
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,P,Protein P,target,other,DB00718
Azatadine,Histamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00719
Nitroglycerin,Vasodilator AgentsExplosive Agents,approvedinvestigational,NPR1,Atrial natriuretic peptide receptor 1,target,agonist,DB00727
Diphemanil Methylsulfate,,approvedwithdrawn,CHRM3,Muscarinic acetylcholine receptor M3,target,antagonist,DB00729
Thiabendazole,Anthelmintics,approved,frdA,Fumarate reductase flavoprotein subunit,target,inhibitor,DB00730
Atracurium,,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,inhibitor,DB00732
Naftifine,,approved,SQLE,Squalene monooxygenase,target,inhibitor,DB00735
Esomeprazole,Proton Pump InhibitorsHistamine Antagonists,approvedinvestigational,ATP4A,Potassium-transporting ATPase alpha chain 1,target,inhibitor,DB00736
Meclizine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine AntagonistsAntiemetics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00737
Zileuton,"Anti-Inflammatory Agents, Non-SteroidalLipoxygenase InhibitorsLeukotriene Antagonists",approvedinvestigationalwithdrawn,ALOX5,Arachidonate 5-lipoxygenase,target,inhibitor,DB00744
Carbinoxamine,Histamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00748
Prilocaine,"Anesthetics, Local",approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00750
Ethotoin,Anticonvulsants,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00754
Dolasetron,Serotonin AntagonistsAntiemetics,approved,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00757
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,P2RY12,P2Y purinoceptor 12,target,antagonist,DB00758
Meropenem,Anti-Bacterial Agents,approvedinvestigational,dacB,D-alanyl-D-alanine carboxypeptidase DacB,target,inhibitor,DB00760
Methimazole,Antithyroid Agents,approved,TPO,Thyroid peroxidase,target,inhibitor,DB00763
Mometasone,,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00764
Metyrosine,Enzyme Inhibitors,approved,TH,Tyrosine 3-monooxygenase,target,binder,DB00765
Clavulanate,Enzyme InhibitorsAnti-Bacterial Agents,approved,blaZ,Beta-lactamase,target,inhibitor,DB00766
Hydrocortamate,Anti-Inflammatory AgentsCorticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00769
Clidinium,Anti-Arrhythmia AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00771
Malathion,Cholinesterase InhibitorsInsecticides,approvedinvestigational,BCHE,Cholinesterase,target,inhibitor,DB00772
Oxcarbazepine,Anticonvulsants,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB00776
Propantheline,Anti-Ulcer AgentsMuscarinic AntagonistsAntispasmodics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00782
Gadopentetate dimeglumine,Contrast Media,approved,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",target,inhibitor,DB00789
Perindopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00790
Tripelennamine,Anti-Allergic AgentsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00792
Candesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB00796
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB00802
Proparacaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00807
Orciprenaline,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00816
Fosfomycin,Anti-Bacterial Agents,approved,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,inhibitor,DB00828
Clocortolone,Corticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00838
Tolazamide,,approved,KCNJ1,ATP-sensitive inward rectifier potassium channel 1,target,inhibitor,DB00839
Flurandrenolide,Anti-Inflammatory AgentsGlucocorticoids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00846
Aminolevulinic acid,Photosensitizing Agents,approved,ALAD,Delta-aminolevulinic acid dehydratase,target,inducer,DB00855
Terbinafine,Antifungal Agents,approvedinvestigational,SQLE,Squalene monooxygenase,target,inhibitor,DB00857
Drostanolone,,approvedillicit,AR,Androgen receptor,target,agonist,DB00858
Prednisolone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00860
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,HRH2,Histamine H2 receptor,target,antagonist,DB00863
Tacrolimus,,approvedinvestigational,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,inhibitor,DB00864
Ritodrine,SympathomimeticsAdrenergic beta-2 Receptor AgonistsTocolytic Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00867
Benzonatate,Antitussive Agents,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,antagonist,DB00868
Terbutaline,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator AgentsTocolytic Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00871
Loteprednol,Anti-Allergic Agents,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00873
Eprosartan,,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB00876
Emtricitabine,,approvedinvestigational,pol,Reverse Transcriptase,target,inhibitor,DB00879
Quinapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,ACE,Angiotensin-converting enzyme,target,inhibitor,DB00881
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,ESR1,Estrogen receptor,target,antagonistagonist,DB00882
Isosorbide Dinitrate,Vasodilator AgentsNitric Oxide Donors,approved,NPR1,Atrial natriuretic peptide receptor 1,target,agonist,DB00883
Granisetron,Serotonin AntagonistsAntiemetics,approvedinvestigational,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00889
Dienestrol,"Estrogens, Non-Steroidal",approved,ESR1,Estrogen receptor,target,agonist,DB00890
Sulfapyridine,Dermatologic AgentsAnti-Infective AgentsSulfonamides,approved,sulI,Dihydropteroate synthase type-1,target,inhibitor,DB00891
Oxybuprocaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00892
Testolactone,"Antineoplastic Agents, Hormonal",approved,CYP19A1,Cytochrome P450 19A1,target,inhibitor,DB00894
Rimexolone,Corticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00896
Bitolterol,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,withdrawn,ADRB2,Beta-2 adrenergic receptor,target,,DB00901
Methdilazine,Histamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00902
Tiagabine,AnticonvulsantsNeurotransmitter Uptake InhibitorsGABA Agonists,approved,SLC6A1,Sodium- and chloride-dependent GABA transporter 1,target,inhibitor,DB00906
Paricalcitol,,approvedinvestigational,VDR,Vitamin D3 receptor,target,agonist,DB00910
Anileridine,,approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB00913
Spectinomycin,Anti-Bacterial AgentsAminoglycosides,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB00919
Ceforanide,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 2,target,inhibitor,DB00923
Cyclobenzaprine,"Tranquilizing AgentsNeuromuscular AgentsMuscle relaxant, Skeletal",approved,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB00924
Famotidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,HRH2,Histamine H2 receptor,target,antagonist,DB00927
Tipranavir,Anti-HIV Agents,approvedinvestigational,,Protease,target,inhibitor,DB00932
Salmeterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00938
Hexafluronium,Neuromuscular Agents,approved,BCHE,Cholinesterase,target,inhibitor,DB00941
Cycrimine,Antidyskinetics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00942
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,pol,Reverse Transcriptase,target,inhibitor,DB00943
Phenprocoumon,Anticoagulants,approved,VKORC1,Vitamin K epoxide reductase complex subunit 1,target,inhibitor,DB00946
Fulvestrant,"Antineoplastic AgentsAntineoplastic Agents, HormonalEstrogen Antagonists",approvedinvestigational,ESR1,Estrogen receptor,target,antagonist,DB00947
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00950
Methylprednisolone,Anti-Inflammatory AgentsGlucocorticoidsNeuroprotective AgentsAntiemetics,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB00959
Mepivacaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB00961
Desloratadine,"Cholinergic AntagonistsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approvedinvestigational,HRH1,Histamine H1 receptor,target,antagonist,DB00967
Alosetron,,approvedwithdrawn,HTR3A,5-hydroxytryptamine receptor 3A,target,antagonist,DB00969
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,HRH1,Histamine H1 receptor,target,antagonist,DB00972
Cyclopentolate,Muscarinic AntagonistsParasympatholyticsMydriatics,approved,CHRM1,Muscarinic acetylcholine receptor M1,target,antagonist,DB00979
Physostigmine,Cholinesterase InhibitorsMiotics,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB00981
Isotretinoin,Anti-acne preparationsSkin and Mucous Membrane Agents,approved,RARA,Retinoic acid receptor alpha,target,other/unknown,DB00982
Formoterol,SympathomimeticsAdrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB00983
Nandrolone phenpropionate,Anabolic Agents,approvedillicit,AR,Androgen receptor,target,agonist,DB00984
Dimenhydrinate,Histamine H1 AntagonistsAntiemetics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB00985
Exemestane,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,target,inhibitor,DB00990
Methyl aminolevulinate,,approved,FCGR1A,High affinity immunoglobulin gamma Fc receptor I,target,antibody,DB00992
Azathioprine,"Antirheumatic AgentsImmunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,target,inhibitor,DB00993
Levobupivacaine,,approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB01002
Hydroxyurea,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis InhibitorsAntisickling Agents,approved,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,inhibitor,DB01005
Letrozole,Antineoplastic AgentsAromatase Inhibitors,approvedinvestigational,CYP19A1,Cytochrome P450 19A1,target,antagonist,DB01006
Cinacalcet,Calcimimetics,approved,CASR,Extracellular calcium-sensing receptor,target,agonist,DB01012
Clobetasol propionate,Anti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB01013
Bethanechol,ParasympathomimeticsMuscarinic Agonists,approved,CHRM2,Muscarinic acetylcholine receptor M2,target,agonist,DB01019
Isosorbide Mononitrate,Vasodilator AgentsNitric Oxide Donors,approved,GUCY1A2,Guanylate cyclase soluble subunit alpha-2,target,inducer,DB01020
Lubiprostone,Laxatives,approvedinvestigational,CLCN2,Chloride channel protein 2,target,inducer,DB01046
Abacavir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,pol,Reverse Transcriptase,target,inhibitor,DB01048
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01053
Tocainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersSodium Channel Blockers,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01056
Echothiophate,Cholinesterase InhibitorsParasympathomimeticsMiotics,approved,BCHE,Cholinesterase,target,inhibitor,DB01057
Amoxicillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01060
Azlocillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01061
Dihydrotachysterol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approved,VDR,Vitamin D3 receptor,target,agonist,DB01070
Mequitazine,Histamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01071
Atazanavir,Anti-HIV AgentsHIV Protease Inhibitors,approvedinvestigational,,Protease,target,inhibitor,DB01072
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,HRH1,Histamine H1 receptor,target,antagonist,DB01075
Deslanoside,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB01078
Emedastine,Anti-Allergic AgentsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01084
Benzocaine,"Anesthetics, Local",approved,SCN10A,Sodium channel protein type 10 subunit alpha,target,inhibitor,DB01086
Deserpidine,,approved,SLC18A2,Synaptic vesicular amine transporter,target,inhibitor,DB01089
Butenafine,Antifungal Agents,approved,SQLE,Squalene monooxygenase,target,inhibitor,DB01091
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB01092
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB01095
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB01098
Cefuroxime,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01112
Trimethaphan,"Antihypertensive AgentsAdjuvants, AnesthesiaNicotinic AntagonistsGanglionic Blockers",approved,CHRNA10,Neuronal acetylcholine receptor subunit alpha-10,target,antagonist,DB01116
Phenacemide,,approved,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB01121
Ambenonium,Anti-Arrhythmia AgentsAntimyasthenic Agents,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB01122
Anisindione,,approved,GGCX,Vitamin K-dependent gamma-carboxylase,target,inhibitor,DB01125
Econazole,,approved,ERG11,Lanosterol 14-alpha demethylase,target,antagonist,DB01127
Bicalutamide,,approved,AR,Androgen receptor,target,antagonist,DB01128
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,ATP4A,Potassium-transporting ATPase alpha chain 1,target,inhibitor,DB01129
Prednicarbate,Anti-Inflammatory AgentsCorticosteroidsSteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB01130
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,agonist,DB01132
Desoxycorticosterone Pivalate,,experimental,NR3C2,Mineralocorticoid receptor,target,agonist,DB01134
Cefapirin,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01139
Micafungin,Antifungal Agents,approvedinvestigational,fksA,"1,3-beta-glucan synthase component FKS1",target,inhibitor,DB01141
Sulfoxone,Anti-Infective AgentsSulfonamides,approved,,Dihydropteroate synthetase,target,inhibitor,DB01145
Sertaconazole,Antifungal Agents,approved,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB01153
Trimetrexate,"Antifungal AgentsAntiprotozoal AgentsFolic Acid AntagonistsAntimetabolites, AntineoplasticAntibiotics",approvedinvestigational,DHFR,Dihydrofolate reductase,target,inhibitor,DB01157
Bretylium,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic Antagonists,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB01158
Cilostazol,Fibrinolytic AgentsPlatelet Aggregation InhibitorsBronchodilator AgentsPhosphodiesterase 3 InhibitorsVasodilator AgentsNeuroprotective Agents,approved,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB01166
Guanethidine,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inducer,DB01170
Moclobemide,Antidepressive AgentsMonoamine Oxidase Inhibitors,approved,MAOA,Amine oxidase [flavin-containing] A,target,inhibitor,DB01171
Chlormezanone,"Anti-Anxiety AgentsAntipsychotic AgentsMuscle Relaxants, CentralBenzodiazepines",approvedwithdrawn,TSPO,Translocator protein,target,agonist,DB01178
Rescinnamine,,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB01180
Ciclopirox,Antifungal Agents,approvedinvestigational,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,binder,DB01188
Rifapentine,"Leprostatic AgentsAntibiotics, AntitubercularAntimycobacterials",approved,rpoC,DNA-directed RNA polymerase subunit beta',target,inhibitor,DB01201
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,rplJ,50S ribosomal protein L10,target,inhibitor,DB01211
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,penA,Penicillin-binding protein 2B,target,inhibitor,DB01212
Anastrozole,"Antineoplastic Agents, HormonalAromatase Inhibitors",approvedinvestigational,CYP19A1,Cytochrome P450 19A1,target,inhibitor,DB01217
Dantrolene,"Muscle Relaxants, Central",approved,RYR1,Ryanodine receptor 1,target,antagonist,DB01219
Budesonide,Corticosteroids,approved,NR3C1,Glucocorticoid receptor,target,antagonist,DB01222
Encainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersSodium Channel Blockers,approvedwithdrawn,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01228
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,,Protease,target,inhibitor,DB01232
Bromodiphenhydramine,Histamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01237
Gemfibrozil,Hypolipidemic Agents,approved,PPARA,Peroxisome proliferator-activated receptor alpha,target,agonist,DB01241
Alimemazine,Antipruritics,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01246
Ergonovine,Oxytocics,approved,ADRA1A,Alpha-1A adrenergic receptor,target,agonist,DB01253
Retapamulin,Anti-Bacterial Agents,approved,rplC,50S ribosomal protein L3,target,inhibitor,DB01256
Eculizumab,,approvedinvestigational,C5,Complement C5,target,antibody,DB01257
Aliskiren,,approvedinvestigational,REN,Renin,target,inhibitor,DB01258
Desonide,,approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB01260
Sitagliptin,Dipeptidyl-Peptidase IV Inhibitors,approvedinvestigational,DPP4,Dipeptidyl peptidase 4,target,inhibitor,DB01261
Posaconazole,Antifungal Agents,approvedinvestigational,ERG11,Lanosterol 14-alpha demethylase,target,antagonist,DB01263
Darunavir,HIV Protease Inhibitors,approved,,Protease,target,inhibitor,DB01264
Panitumumab,,approvedinvestigational,EGFR,Epidermal growth factor receptor,target,suppressor,DB01269
Ranibizumab,Ophthalmics,approved,VEGFA,Vascular endothelial growth factor A,target,,DB01270
Arformoterol,Adrenergic beta-2 Receptor AgonistsBronchodilator Agents,approvedinvestigational,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01274
Exenatide,Hypoglycemic Agents,approvedinvestigational,GLP1R,Glucagon-like peptide 1 receptor,target,agonist,DB01276
Carbetocin,OxytocicsDelayed-Action PreparationsAnti-tocolytic AgentsLabor Induction Agents,approved,OXTR,Oxytocin receptor,target,agonist,DB01282
Cosyntropin,HormonesDiagnostic Agents,approved,MC2R,Adrenocorticotropic hormone receptor,target,antagonist,DB01284
Glisoxepide,,approved,KCNJ8,ATP-sensitive inward rectifier potassium channel 8,target,inhibitor,DB01289
Practolol,Adrenergic beta-1 Receptor AntagonistsAnti-Arrhythmia Agents,approved,ADRB1,Beta-1 adrenergic receptor,target,antagonist,DB01297
Sulfacytine,Sulfonamides,approved,folP,Dihydropteroate synthase,target,inhibitor,DB01298
Insulin Aspart,Hypoglycemic AgentsAntidiabetic Agents,approved,INSR,Insulin receptor,target,agonist,DB01306
Insulin Detemir,Antidiabetic Agents,approved,INSR,Insulin receptor,target,agonist,DB01307
Insulin Glulisine,Antidiabetic Agents,approved,INSR,Insulin receptor,target,agonist,DB01309
Fosamprenavir,Prodrugs,approved,,Protease,target,inhibitor,DB01319
Fosphenytoin,Anticonvulsants,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01320
Josamycin,Anti-Bacterial AgentsMacrolides,approved,rplD,50S ribosomal protein L4,target,inhibitor,DB01321
Polythiazide,,approved,SLC12A3,Solute carrier family 12 member 3,target,inhibitor,DB01324
Cefamandole,Anti-Bacterial AgentsCephalosporins,approved,pbpA,Penicillin-binding protein 2,target,inhibitor,DB01326
Cefotetan,Anti-Bacterial AgentsCephalosporins,approved,pbp3,Penicillin-binding protein 3,target,inhibitor,DB01330
Cefradine,Anti-Bacterial AgentsCephalosporins,approved,mrcA,Penicillin-binding protein 1A,target,inhibitor,DB01333
Vecuronium,,approved,CHRNA2,Neuronal acetylcholine receptor subunit alpha-2,target,antagonist,DB01339
Cilazapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB01340
Dihydroquinidine barbiturate,,experimental,GABRA1,Gamma-aminobutyric acid receptor subunit alpha-1,target,potentiator,DB01341
Forasartan,Angiotensin Receptor Antagonists,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB01342
Potassium,,experimental,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,,DB01345
Saprisartan,,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB01347
Spirapril,,approved,ACE,Angiotensin-converting enzyme,target,inhibitor,DB01348
Mestranol,,approved,ESR1,Estrogen receptor,target,agonist,DB01357
Procaterol,,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01366
Magnesium,,nutraceutical,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,,DB01378
Cortisone acetate,Corticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB01380
Paramethasone,,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB01384
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,inhibitor,DB01396
Neostigmine,,approved,ACHE,Acetylcholinesterase,target,inhibitor,DB01400
Bambuterol,,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB01408
Ciclesonide,,approvedinvestigational,NR3C1,Glucocorticoid receptor,target,agonist,DB01410
Cefpodoxime,Anti-Bacterial AgentsCephalosporins,approved,ftsI,Peptidoglycan synthase FtsI,target,inhibitor,DB01416
Acenocoumarol,Anticoagulants,approved,VKORC1,Vitamin K epoxide reductase complex subunit 1,target,inhibitor,DB01418
Testosterone Propionate,,approved,AR,Androgen receptor,target,agonist,DB01420
Alizapride,AntiemeticsProkinetic Agents,approved,DRD2,D(2) dopamine receptor,target,antagonist,DB01425
Ajmaline,Anti-Arrhythmia Agents,approved,SCN5A,Sodium channel protein type 5 subunit alpha,target,inhibitor,DB01426
Almitrine,Respiratory System Agents,approved,ATP1A1,Sodium/potassium-transporting ATPase subunit alpha-1,target,binder,DB01430
Methadyl Acetate,"Analgesics, OpioidNarcotics",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01433
Phenazopyridine,,approved,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB01438
Fencamfamine,Central Nervous System StimulantsAntipsychotic Agents,approvedillicitwithdrawn,SLC6A3,Sodium-dependent dopamine transporter,target,inhibitor,DB01463
Ethylmorphine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,OPRM1,Mu-type opioid receptor,target,agonist,DB01466
Delta1-dihydrotestosterone,,experimentalillicit,AR,Androgen receptor,target,agonist,DB01481
Boldenone,Anabolic Agents,experimentalillicit,AR,Androgen receptor,target,agonist,DB01541
Calusterone,,experimentalillicit,AR,Androgen receptor,target,,DB01564
Sulfamerazine,Sulfonamides,approved,folP,Dihydropteroate synthase,target,inhibitor,DB01581
Sulfamethazine,Sulfonamides,approved,folP,Dihydropteroate synthase,target,inhibitor,DB01582
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,AKR1C2,Aldo-keto reductase family 1 member C2,target,inducer,DB01586
Everolimus,Immunosuppressive Agents,approved,MTOR,Serine/threonine-protein kinase mTOR,target,inhibitor,DB01590
Cilastatin,,approved,DPEP1,Dipeptidase 1,target,inhibitor,DB01597
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,,Protease,target,inhibitor,DB01601
Bacampicillin,Penicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01602
Pivampicillin,Anti-Bacterial AgentsPenicillins,approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01604
Pivmecillinam,"Anti-Bacterial AgentsAnti-Infective Agents, UrinaryPenicillins",approved,pbpA,Penicillin-binding protein 1A,target,inhibitor,DB01605
Ticarcillin,Anti-Bacterial AgentsPenicillins,approved,mecA,Penicillin binding protein 2a,target,inhibitor,DB01607
Amyl Nitrite,Vasodilator Agents,approved,NPR1,Atrial natriuretic peptide receptor 1,target,agonist,DB01612
Aceprometazine,Hypnotics and SedativesHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01615
Alverine,ParasympatholyticsAntispasmodics,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,antagonist,DB01616
Phenindamine,Histamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01619
Pheniramine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB01620
Lincomycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntibiotics,approved,rplJ,50S ribosomal protein L10,target,inhibitor,DB01627
Etoricoxib,,approvedinvestigational,PTGS2,Prostaglandin G/H synthase 2,target,inhibitor,DB01628
5-Fluorouridine,,experimental,udp,Uridine phosphorylase,target,,DB01629
SC-74020,,experimental,MMP2,72 kDa type IV collagenase,target,,DB01630
Deoxy-2-Fluoro-B-D-Cellotrioside,,experimental,cel5A,Endoglucanase 5A,target,,DB01633
2-Oxy-4-Hydroxy-5-(2-Hydrazinopyridine)Phenylalanine,,experimental,tynA,Primary amine oxidase,target,,DB01634
N-Methyl-Pyridoxal-5'-Phosphate,,experimental,aspC,Aspartate aminotransferase,target,,DB01639
"(5r)-6-(4-{[2-(3-Iodobenzyl)-3-Oxocyclohex-1-En-1-Yl]Amino}Phenyl)-5-Methyl-4,5-Dihydropyridazin-3(2h)-One",,experimental,PDE3B,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",target,,DB01640
"3,6-Dihydroxy-Xanthene-9-Propionic Acid",,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB01644
(R)-Mesopram,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB01647
trans-2-hydroxycinnamic acid,,experimental,,Major NAD(P)H-flavin oxidoreductase,target,,DB01650
"Methyl 4,6-O-[(1r)-1-Carboxyethylidene]-Beta-D-Galactopyranoside",,experimental,APCS,Serum amyloid P-component,target,,DB01651
L-Guluronic Acid 6-Phosphate,,experimental,ulaD,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,target,,DB01655
"2-Amino-3-[4-Hydroxy-6-Oxo-3-(2-Phenyl-Cyclopropylimino)-Cyclohexa-1,4-Dienyl]-Propionic Acid",,experimental,tynA,Primary amine oxidase,target,,DB01657
Phosphoribosyl Atp,,experimental,hisG,ATP phosphoribosyltransferase,target,,DB01661
Trans-O-Hydroxy-Alpha-Methyl Cinnamate,,experimental,CTRB1,Chymotrypsinogen B,target,,DB01662
"Lambda-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (Ii)",,experimental,camC,Camphor 5-monooxygenase,target,,DB01663
(S)-Des-Me-Ampa,,experimental,GRIA2,Glutamate receptor 2,target,,DB01664
ZK-800270,,experimental,PRSS1,Trypsin-1,target,,DB01665
8-azaguanine,"Antimetabolites, Antineoplastic",experimental,PNP,Purine nucleoside phosphorylase,target,,DB01667
Nanaomycin D,,experimental,actVA 6,ActVA 6 protein,target,,DB01668
Virginiamycin M1,Anti-Bacterial Agents,experimental,vatD,Streptogramin A acetyltransferase,target,,DB01669
Propyl Acetate,,experimental,est,Carboxylesterase,target,,DB01670
4-(Hydroxymercury)Benzoic Acid,,experimental,CA2,Carbonic anhydrase 2,target,,DB01671
Methacrylyl-Coenzyme A,,experimental,ACAD8,"Isobutyryl-CoA dehydrogenase, mitochondrial",target,,DB01675
Trinitrotoluene,Explosive Agents,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB01676
RU84687,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB01678
Benzene Hexacarboxylic Acid,,experimental,PGAM2,Phosphoglycerate mutase 2,target,,DB01681
Chymostatin,,experimental,pam,Peptide amidase,target,,DB01683
1-Hydroxy-1-Thio-Glycerol,,experimental,PREP,Prolyl endopeptidase,target,,DB01684
"4-[5-Pyridin-4-Yl-1h-[1,2,4]Triazol-3-Yl]-Pyridine-2-Carbonitrile",,experimental,XDH,Xanthine dehydrogenase/oxidase,target,,DB01685
P-Cresol,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB01688
Inhibitor Idd 384,,experimental,AKR1B1,Aldose reductase,target,,DB01689
Bis(Adenosine)-5'-Triphosphate,,experimental,coaE,Dephospho-CoA kinase,target,,DB01690
Indole Naphthyridinone,,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB01691
N-Hydroxy-4-Phosphono-Butanamide,,experimental,TPI1,Triosephosphate isomerase,target,,DB01695
"7,9-Dihydro-1h-Purine-2,6,8(3h)-Trione",,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB01696
Rutin,,experimental,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB01698
(4e)-4-Aminohex-4-Enoic Acid,,experimental,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,,DB01699
Aicar,,experimental,ATIC,Bifunctional purine biosynthesis protein PURH,target,,DB01700
"1,2-Dichloro-Propane",,experimental,linB,Haloalkane dehalogenase,target,,DB01701
N-(2-Ferrocenylethyl)Maleimide,,experimental,camC,Camphor 5-monooxygenase,target,,DB01703
"2,4-Dihydroxy-Trans Cinnamic Acid",,experimental,CTRB1,Chymotrypsinogen B,target,,DB01704
Porphyrin Fe(Iii),,experimental,MB,Myoglobin,target,,DB01710
"2,3,4,5,6-Pentafluorobenzyl Alcohol",,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB01711
"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Phenylalanine Ethyl Ester",,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB01712
Udp-Alpha-D-Xylopyranose,,experimental,hasB,UDP-glucose 6-dehydrogenase,target,,DB01713
"7,8-Diamino-Nonanoic Acid",,experimental,bioD,ATP-dependent dethiobiotin synthetase BioD 1,target,,DB01715
Thio-Maltopentaose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB01719
(2z)-2-(Benzoylamino)-3-[4-(2-Bromophenoxy)Phenyl]-2-Propenoic Acid,,experimental,,Genome polyprotein,target,,DB01720
Analogue of Indinavir Drug,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB01721
Ethylbenzene,,experimental,E,Lysozyme,target,,DB01722
"{3-[3-(3,4-Dimethoxy-Phenyl)-1-(1-{1-[2-(3,4,5-Trimethoxy-Phenyl)-Butyryl]-Piperidin-2yl}-Vinyloxy)-Propyl]-Phenoxy}-Acetic Acid",,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB01723
CRA_7806,,experimental,PRSS1,Trypsin-1,target,,DB01725
2-Aminophenol,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB01726
"3-[Aminoethylphosphoryl]-[1,2-Di-Palmitoyl]-Sn-Glycerol",,experimental,RHO,Rhodopsin,target,,DB01728
(S)-Wiskostatin,,experimental,WAS,Wiskott-Aldrich syndrome protein,target,,DB01731
"(4r,5s,6s,7r)-1,3-Dibenzyl-4,7-Bis(Phenoxymethyl)-5,6-Dihydroxy-1,3 Diazepan-2-One",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB01732
L-Phospholactate,,experimental,PKM2,Pyruvate kinase PKM,target,,DB01733
3-(Oxalyl-Amino)-Naphthalene-2-Carboxylic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB01734
3-Chloroalaninate,,experimental,acdS,1-aminocyclopropane-1-carboxylate deaminase,target,,DB01735
[3-(Dodecanoylamino)Propyl](Hydroxy)Dimethylammonium,,experimental,SLC25A4,ADP/ATP translocase 1,target,,DB01736
"Nalpha-(2-Naphthylsulfonylglycyl)-3-Amidino-D,L-Phenylalanine-Isopropylester",,experimental,PRSS1,Trypsin-1,target,,DB01737
O-Phosphoethanolamine,,experimental,PRKCB,Protein kinase C beta type,target,,DB01738
CRA_17693,,experimental,PRSS1,Trypsin-1,target,,DB01741
(3r)-1-Acetyl-3-Methylpiperidine,,experimental,PPIA,Peptidyl-prolyl cis-trans isomerase A,target,,DB01742
Pyoverdine-Chromophore,,experimental,fpvA,Ferripyoverdine receptor,target,,DB01743
Camphor,,experimental,camC,Camphor 5-monooxygenase,target,,DB01744
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)Isopipecolinic Acid Methyl Ester,,experimental,PRSS1,Trypsin-1,target,,DB01745
Coprogen,,experimental,fhuD,Iron(3+)-hydroxamate-binding protein FhuD,target,,DB01747
N-Benzyl-4-Sulfamoyl-Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB01748
Naphthalen-1-Yl-Acetic Acid,,experimental,SKP1,S-phase kinase-associated protein 1,target,,DB01750
4-Oxo-Nicotinamide-Adenine Dinucleotide Phosphate,,experimental,fprA,NADPH-ferredoxin reductase FprA,target,,DB01753
"3,4-Dihydroxy-1-Methylquinolin-2(1h)-One",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB01754
N-[Isoleucinyl]-N'-[Adenosyl]-Diaminosufone,,experimental,ileS,Isoleucine--tRNA ligase,target,,DB01755
D-4-Phosphoerythronic Acid,,experimental,RPIA,Ribose-5-phosphate isomerase,target,,DB01756
3-Iodo-Tyrosine,,experimental,tyrS,Tyrosine--tRNA ligase,target,,DB01758
2-Methoxy-3-Isopropylpyrazine,,experimental,LCN9,Epididymal-specific lipocalin-9,target,,DB01760
4-[5-[2-(1-Phenyl-Ethylamino)-Pyrimidin-4-Yl]-1-Methyl-4-(3-Trifluoromethylphenyl)-1h-Imidazol-2-Yl]-Piperidine,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB01761
Acetoacetic Acid,,experimental,FAH,Fumarylacetoacetase,target,,DB01762
Tatp,,experimental,NNT,"NAD(P) transhydrogenase, mitochondrial",target,,DB01763
Dalfopristin,Anti-Bacterial Agents,approved,vatD,Streptogramin A acetyltransferase,target,inhibitor,DB01764
"(5-Oxo-5,6-Dihydro-Indolo[1,2-a]Quinazolin-7-Yl)-Acetic Acid",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB01765
Methylumbelliferyl Sialic Acid,,experimental,,Trans-sialidase,target,,DB01768
CRA_10991,,experimental,PRSS1,Trypsin-1,target,,DB01771
"3-[3-(2,3-Dihydroxy-Propylamino)-Phenyl]-4-(5-Fluoro-1-Methyl-1h-Indol-3-Yl)-Pyrrole-2,5-Dione",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB01772
4-[3-Carboxymethyl-3-(4-Phosphonooxy-Benzyl)-Ureido]-4-[(3-Cyclohexyl-Propyl)-Methyl-Carbamoyl]Butyric Acid,,experimental,V-SRC,Tyrosine-protein kinase transforming protein Src,target,,DB01773
Adenosine-5'-Monophosphate Glucopyranosyl-Monophosphate Ester,,experimental,hldD,ADP-L-glycero-D-manno-heptose-6-epimerase,target,,DB01774
Dihydroxyacetone,,experimental,dhaK,Dihydroxyacetone kinase,target,,DB01775
M-Cresol,,experimental,INS,Insulin,target,,DB01776
Coa-S-Trimethylene-Acetyl-Tryptamine,,experimental,AANAT,Serotonin N-acetyltransferase,target,,DB01777
"8-Amino-1,3-Dimethyl-3,7-Dihydropurine-2,6-Dione",,experimental,folB,Dihydroneopterin aldolase,target,,DB01778
Glycerol-2-Phosphate,,experimental,TPI,Triosephosphate isomerase,target,,DB01779
Fusicoccin,,experimental,YWHAE,14-3-3 protein epsilon,target,,DB01780
Pantothenic acid,Vitamin B Complex,nutraceutical,coaA,Pantothenate kinase,target,,DB01783
4-Flourobenzenesulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB01784
4-Imino-5-Methidyl-2-Methylpyrimidine,,experimental,thiE,Thiamine-phosphate synthase,target,,DB01788
"1-Amino-2,3-Dihydroxy-5-Hydroxymethyl Cyclohex-5-Ene",,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB01789
"Sp-Adenosine-3',5'-Cyclic-Monophosphorothioate",,experimental,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,target,,DB01790
Adenylyl-3'-5'-Phospho-Uridine-3'-Monophosphate,,experimental,,Diphtheria toxin,target,,DB01792
I-5,,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB01793
Phenyl Boronic Acid,,experimental,cocE,Cocaine esterase,target,,DB01795
4-Hydroxy-3-Methyl Butyl Diphosphate,,experimental,idi,Isopentenyl-diphosphate Delta-isomerase,target,,DB01799
2-(Trimethylammonium)Ethyl Thiol,,experimental,srtB,NPQTN specific sortase B,target,,DB01803
"2-Ammoniobut-3-Enoate, 2-Amino-3-Butenoate",,experimental,acdS,1-aminocyclopropane-1-carboxylate deaminase,target,,DB01804
"10-{4-Dimethylamino-5-[4-Hydroxy-6-Methyl-5-(6-Methyl-5-Oxo-Tetrahydro-Pyran-2-Yloxy)-Tetrahydro-Pyrane-2-Yloxy]-6-Methyl-Tetrahydro-Pyran-2-Yloxy}-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",,experimental,rdmC,RdmC,target,,DB01806
"N-[(3z)-5-Tert-Butyl-2-Phenyl-1,2-Dihydro-3h-Pyrazol-3-Ylidene]-N'-(4-Chlorophenyl)Urea",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB01807
Thiarsahydroxy-Cysteine,,experimental,arsC,Arsenate reductase,target,,DB01808
"3h-Indole-5,6-Diol",,experimental,LTF,Lactotransferrin,target,,DB01811
2-Tridecanoyloxy-Pentadecanoic Acid,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB01814
Nz-(Dicarboxymethyl)Lysine,,experimental,talB,Transaldolase B,target,,DB01815
"(1s,6s,7r,8r,8ar)-1,6,7,8-Tetrahydroxyindolizidine",,experimental,XOG1,"Glucan 1,3-beta-glucosidase",target,,DB01816
Threonine-Aspartic Ester,,experimental,ansB,L-asparaginase 2,target,,DB01817
O3-Sulfonylgalactose,,experimental,MBL2,Mannose-binding protein C,target,,DB01818
"Compound 12, N-Acetyl-4-[(Carboxycarbonyl)(2-Carboxyphenyl)Amino]-N-Pentyl-1-Napthylalaniamide",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB01820
Dithiane Diol,,experimental,,Penicillin acylase,target,,DB01822
Beta-D-Glucopyranose Spirohydantoin,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB01823
"(3s)-Tetrahydrofuran-3-Yl (1r,2s)-3-[4-((1r)-2-{[(S)-Amino(Hydroxy)Methyl]Oxy}-2,3-Dihydro-1h-Inden-1-Yl)-2-Benzyl-3-Oxopyrrolidin-2-Yl]-1-Benzyl-2-Hydroxypropylcarbamate",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB01824
2-Amino-8-Methylquinazolin-4(3h)-One,,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB01825
"2,3,5,6-Tetrafluoro-4-Methoxy-Benzamide",,experimental,LGALS3,Galectin-3,target,,DB01827
Methylamine,,experimental,amtB,Ammonia channel,target,,DB01828
Desulfo-Coenzyme A,,experimental,cat,Chloramphenicol acetyltransferase,target,,DB01829
"{4-[2-Acetylamino-2-(3-Carbamoyl-2-Cyclohexylmethoxy-6,7,8,9-Tetrahydro-5h-Benzocyclohepten-5ylcarbamoyl)-Ethyl]-2-Phosphono-Phenyl}-Phosphonic Acid",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB01830
4-[Hydroxy-[Methyl-Phosphinoyl]]-3-Oxo-Butanoic Acid,,experimental,FAH,Fumarylacetoacetase,target,,DB01832
L-2-Amino-4-(Guanidinooxy)Butyric Acid,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB01833
4r-Fluoro-N6-Ethanimidoyl-L-Lysine,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB01835
"[4-(6-Chloro-Naphthalene-2-Sulfonyl)-Piperazin-1-Yl]-(3,4,5,6-Tetrahydro-2h-[1,4']Bipyridinyl-4-Yl)-Methanone",,experimental,PRSS1,Trypsin-1,target,,DB01836
O-Acetylserine,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB01837
2-Deoxy-D-Glucitol 6-(E)-Vinylhomophosphonate,,experimental,ISYNA1,Inositol-3-phosphate synthase 1,target,,DB01840
"3-Amino-8,9,10-Trihydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB01843
N-Butylbenzene,,experimental,E,Lysozyme,target,,DB01845
N-Carbamyl-D-Valine,,experimental,,N-carbamoyl-D-amino acid hydrolase,target,,DB01847
Isocitrate Calcium Complex,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB01848
Kaempherol,,experimental,UGT3A1,UDP-glucuronosyltransferase 3A1,target,,DB01852
5-Bromonicotinamide,,experimental,ART1,GPI-linked NAD(P)(+)--arginine ADP-ribosyltransferase 1,target,,DB01854
Pimelic Acid,,experimental,dapD,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",target,,DB01856
[1-(4-Fluorobenzyl)Cyclobutyl]Methyl (1s)-1-[Oxo(1h-Pyrazol-5-Ylamino)Acetyl]Pentylcarbamate,,experimental,CTSK,Cathepsin K,target,,DB01858
4-Diphosphocytidyl-2-C-Methyl-D-Erythritol 2-Phosphate,,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB01859
Cordycepin Triphosphate,,experimental,PAPOLA,Poly(A) polymerase alpha,target,,DB01860
3-(6-Aminopyridin-3-Yl)-N-Methyl-N-[(1-Methyl-1h-Indol-2-Yl)Methyl]Acrylamide,,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB01865
RU79256,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB01866
Glycyl-L-a-Aminopimelyl-E-(D-2-Aminoethyl)Phosphonate,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB01868
"1,4-Dithio-Alpha-D-Mannose",,experimental,AMY2B,Alpha-amylase 2B,target,,DB01870
8-Azaxanthine,,experimental,uao,Uric acid degradation bifunctional protein,target,,DB01875
Bis(5-Amidino-2-Benzimidazolyl)Methanone,,experimental,PRSS1,Trypsin-1,target,,DB01876
"N-Hydroxy 1n(4-Methoxyphenyl)Sulfonyl-4-(Z,E-N-Methoxyimino)Pyrrolidine-2r-Carboxamide",,experimental,MMP3,Stromelysin-1,target,,DB01877
(S)-2-{Methyl-[2-(Naphthalene-2-Sulfonylamino)-5-(Naphthalene-2-Sulfonyloxy)-Benzoyl]-Amino}-Succinicacid,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB01879
"2-Methylpentane-1,2,4-Triol",,experimental,xylA,Xylose isomerase,target,,DB01881
N-(Sulfanylacetyl)Tyrosylprolylmethioninamide,,experimental,lef,Lethal factor,target,,DB01883
2-Amino-3-Methyl-1-Pyrrolidin-1-Yl-Butan-1-One,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB01884
D-Galctopyranosyl-1-On,,experimental,lacZ,Beta-galactosidase,target,,DB01885
"4-[5-(Trans-4-Aminocyclohexylamino)-3-Isopropylpyrazolo[1,5-a]Pyrimidin-7-Ylamino]-N,N-Dimethylbenzenesulfonamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB01888
"16,17-Androstene-3-Ol",,experimental,NR1I3,Nuclear receptor subfamily 1 group I member 3,target,,DB01889
N6-Benzyl Adenosine-5'-Diphosphate,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB01893
5-N-Acetyl-Alpha-D-Neuraminic Acid,,experimental,tetX,Tetanus toxin,target,,DB01894
Aspartyl-Adenosine-5'-Monophosphate,,experimental,aspS,Aspartate--tRNA ligase,target,,DB01895
M-Aminophenylboronic Acid,,experimental,ampC,Beta-lactamase,target,,DB01896
2-(2f-Benzothiazolyl)-5-Styryl-3-(4f-Phthalhydrazidyl)Tetrazolium Chloride,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB01897
Nd1-Phosphonohistidine,,experimental,ptsH,Phosphocarrier protein HPr,target,,DB01899
Sucrose Octasulfate,,experimental,FGF1,Fibroblast growth factor 1,target,,DB01901
5-Bromo-2'-Deoxyuridine-5'-Monophosphate,,experimental,thyX,Thymidylate synthase ThyX,target,,DB01903
"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-Benzoic Acid",,experimental,folB,Dihydroneopterin aldolase,target,,DB01906
RU85493,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB01908
Alpha-Cyclodextrin (Cyclohexa-Amylose),,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB01909
N-Methylmesoporphyrin,,experimental,hemH,Ferrochelatase,target,,DB01911
[Methyltelluro]Acetate,,experimental,soxA,Monomeric sarcosine oxidase,target,,DB01918
Pentanal,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB01919
1-O-[O-Nitrophenyl]-Beta-D-Galactopyranose,,experimental,lacZ,Beta-galactosidase,target,,DB01920
Xylose-Derived Lactam Oxime,,experimental,cex,Exoglucanase/xylanase,target,,DB01921
"Maltosyl-Alpha (1,4)-D-Gluconhydroximo-1,5-Lactam",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB01922
L-Xylulose 5-Phosphate,,experimental,ulaD,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,target,,DB01923
"2'-Chloro-Biphenyl-2,3-Diol",,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB01925
Carboxymycobactin S,,experimental,LCN2,Neutrophil gelatinase-associated lipocalin,target,,DB01926
Duroquinone,,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB01927
Huperaine A,,experimental,ACHE,Acetylcholinesterase,target,,DB01928
"2,4-Dihydroxy-3,3-Dimethyl-Butyrate",,experimental,panC,Pantothenate synthetase,target,,DB01930
"Dcka, 5,7-Dichlorokynurenic Acid",,experimental,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,,DB01931
5-Methylpyrrole,,experimental,E,Lysozyme,target,,DB01932
7-Hydroxystaurosporine,,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB01933
"N-Methyl-N-(10-Methylundecanoyl)-D-Seryl-L-Alanyl-N~1~-[(7s,10s,13s)-13-Carboxy-3,18-Dihydroxy-10-Methyl-8,11-Dioxo-9,12-Diazatricyclo[13.3.1.1~2,6~]Icosa-1(19),2(20),3,5,15,17-Hexaen-7-Yl]-N~1~-Methylglycinamide",,experimental,lepB,Signal peptidase I,target,,DB01934
Ribose,,experimental,rbsK,Ribokinase,target,,DB01936
Guanosine-2'-Monophosphate,,experimental,rnaSA,Guanyl-specific ribonuclease Sa,target,,DB01937
L-Histidine Beta Naphthylamide,,experimental,hutP,Hut operon positive regulatory protein,target,,DB01938
5-Amidino-Benzimidazole,,experimental,PRSS1,Trypsin-1,target,,DB01939
Balanol Analog 2,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB01940
"6-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-Tetrahydronaphthalen-2-Yl)Cyclopropyl]Pyridine-3-Carboxylic Acid",,experimental,RXRB,Retinoic acid receptor RXR-beta,target,,DB01941
(S)-blebbistatin,,experimental,MYH14,Myosin-14,target,,DB01944
RU78262,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB01947
"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperidin-4-Yl-3,4-Dihydroquinolin-2(1h)-One",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB01948
"2-Amino-N,3,3-Trimethylbutanamide",,experimental,,Matrix metalloproteinase-9,target,,DB01949
"N-(4-Methoxybenzyl)-N'-(5-Nitro-1,3-Thiazol-2-Yl)Urea",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB01950
Gpi-1046,,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB01951
"1,N6-Ethenoadenine",,experimental,HP_0602,Endonuclease III,target,,DB01952
Inhibitor of P38 Kinase,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB01953
3-Chlorophenol,,experimental,E,Lysozyme,target,,DB01957
Cytidine-3'-Monophosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB01961
Phenylethane Boronic Acid,,experimental,CTRB1,Chymotrypsinogen B,target,,DB01963
AL5424,,experimental,CA2,Carbonic anhydrase 2,target,,DB01964
Di-Stearoyl-3-Sn-Phosphatidylethanolamine,,experimental,PSAP,Proactivator polypeptide,target,,DB01966
2-Thioethenamine,,experimental,mrsA,Lantibiotic mersacidin,target,,DB01968
Trifluoroacetonyl Coenzyme A,,experimental,CS,"Citrate synthase, mitochondrial",target,,DB01969
"Hg9a-9, Nonanoyl-N-Hydroxyethylglucamide",,experimental,PDE3B,"cGMP-inhibited 3',5'-cyclic phosphodiesterase B",target,,DB01970
trans-urocanic acid,,experimental,hutU,Urocanate hydratase,target,,DB01971
6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB01977
"7,9-Dimethylguanine",,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB01978
Methyl alpha-D-mannoside,,experimental,MBL2,Mannose-binding protein C,target,,DB01979
Para-Iodo-D-Phenylalanine Hydroxamic Acid,,experimental,,Bacterial leucyl aminopeptidase,target,,DB01980
"3,6-Anhydro-D-Galactose-2-Sulfate",,experimental,cgiA,Iota-carrageenase,target,,DB01981
2(S)-Amino-6-Boronohexanoic Acid,,experimental,ARG1,Arginase-1,target,,DB01983
N-Alpha-L-Acetyl-Arginine,,experimental,cs1,Clavaminate synthase 1,target,,DB01985
3-Fluoro-2-Methyl-Aniline,,experimental,E,Lysozyme,target,,DB01986
6((S)-3-Benzylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)Pyrazine,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB01988
Carbobenzoxy-Pro-Lys-Phe-Y(Po2)-Ala-Pro-Ome,,experimental,TLL2,Tolloid-like protein 2,target,,DB01989
Cholesterol-Sulfate,,experimental,RORA,Nuclear receptor ROR-alpha,target,,DB01990
Tu-514,,experimental,lpxC,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,target,,DB01991
N-(5'-Phosphopyridoxyl)-D-Alanine,,experimental,alr,Alanine racemase,target,,DB01993
"2-[3,4-Dihydroxy-2-Hydroxymethyl-5-(2-Hydroxy-Nonyl)-Tetrahydro-Furan-2-Yloxy]-6-Hydroxymethyl-Tetra Hydro-Pyran-3,4,5-Triol",,experimental,SERPINA1,Alpha-1-antitrypsin,target,,DB01998
"Delta-Bis(2,2'-Bipyridine)Imidazole Ruthenium (Ii)",,experimental,azu,Azurin,target,,DB02003
"5-(Aminomethyl)-6-(2,4-Dichlorophenyl)-2-(3,5-Dimethoxyphenyl)Pyrimidin-4-Amine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB02004
2-Oxo-3-Pentenoic Acid,,experimental,xylH,2-hydroxymuconate tautomerase,target,,DB02005
1-(2-Fluorobenzyl)-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,,experimental,PCK1,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",target,,DB02008
"L-756,423",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02009
N-(Phosphonoacetyl)-L-Ornithine,,experimental,OTC,"Ornithine carbamoyltransferase, mitochondrial",target,,DB02011
Compound 9,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02014
R048-8071,,experimental,LSS,Lanosterol synthase,target,,DB02016
Imidazole-Derived Cellobiose,,experimental,cel5A,Endoglucanase 5A,target,,DB02017
Amido Phenyl Pyruvic Acid,,experimental,TPSB2,Tryptase beta-2,target,,DB02018
Acetyl Dithranol,,experimental,actVA 6,ActVA 6 protein,target,,DB02019
Alrestatin,,experimental,AKR1B1,Aldose reductase,target,,DB02020
Fidarestat,,experimental,AKR1B1,Aldose reductase,target,inhibitor,DB02021
8-Oxo-2'-Deoxy-Guanosine-5'-Monophosphate,,experimental,mutT,8-oxo-dGTP diphosphatase,target,,DB02023
"Furo[2,3d]Pyrimidine Antifolate",,experimental,,Dihydrofolate reductase,target,,DB02026
"L-Alpha-Glycerophospho-D-Myo-Inositol-4,5-Bis-Phosphate",,experimental,TUB,Tubby protein homolog,target,,DB02028
N-Cyclohexyl-N'-(4-Iodophenyl)Urea,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB02029
Alpha-Ribazole-5'-Phosphate,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02030
"N-(3-Cyclopropyl(5,6,7,8,9,10-Hexahydro-2-Oxo-2h-Cycloocta[B]Pyran-3-Yl)Methyl)Phenylbenzensulfonamide",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02033
Swainsonine,,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB02034
1-Hexadecylsulfonyl Fluoride,,experimental,PPT1,Palmitoyl-protein thioesterase 1,target,,DB02035
"2-(3,4-Dihydro-3-Oxo-2h-Benzo[B][1,4]Thiazin-2-Yl)-N-Hydroxyacetamide",,experimental,def,Peptide deformylase,target,,DB02036
"D-Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate",,experimental,dgdA,"2,2-dialkylglycine decarboxylase",target,,DB02038
4-Aminophthalhydrazide,Luminescent Agents,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB02041
"1,2-Dipalmitoyl-Phosphatidyl-Glycerole",,experimental,ntpK,V-type sodium ATPase subunit K,target,,DB02043
Amylamine,,experimental,PRSS1,Trypsin-1,target,,DB02045
N-[(Furan-2-Yl)Carbonyl]-(S)-Leucyl-(R)-[1-Amino-2(1h-Indol-3-Yl)Ethyl]-Phosphonic Acid,,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB02046
"2-(1,1'-Biphenyl-4-Yl)Propanoic Acid",,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB02047
"1,2,4-Triazole-Carboxamidine",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02048
2-{4-[4-(4-Chloro-Phenoxy)-Benzenesulfonyl]-Tetrahydro-Pyran-4-Yl}-N-Hydroxy-Acetamide,,experimental,MMP13,Collagenase 3,target,,DB02049
3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid 4-Nitro-Phenyl Ester,,experimental,,Cruzipain,target,,DB02051
"(5e,13e)-9,15-Dihydroxy-11-Oxoprosta-5,13-Dien-1-Oicacid",,experimental,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB02056
AMPA,,experimental,GRIA2,Glutamate receptor 2,target,,DB02057
Cyclohexanone,,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB02060
CRA_16847,,experimental,PRSS1,Trypsin-1,target,,DB02063
4-Deoxylactose,,experimental,lgtC,Glycosyl transferase,target,,DB02065
N7-Methyl-Formycin A,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB02066
Triglu-5-Formyl-Tetrahydrofolate,,experimental,SHMT1,"Serine hydroxymethyltransferase, cytosolic",target,,DB02067
N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB02069
WAY-151693,,experimental,MMP13,Collagenase 3,target,,DB02071
"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Thiopyran-3-Carboxylic Acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02072
"(1s)-1(9-Deazahypoxanthin-9yl)1,4-Dideoxy-1,4-Imino-D-Ribitol-5-Phosphate",,experimental,LACZ,Hypoxanthine-guanine-xanthine phosphoribosyltransferase,target,,DB02075
(Aminooxy)Acetic Acid,,experimental,AGXT,Serine--pyruvate aminotransferase,target,,DB02079
Bis-Benzamidine,,experimental,PRSS1,Trypsin-1,target,,DB02081
Phosphoaminophosphonic Acid Guanylate Ester,,experimental,RAB8B,Ras-related protein Rab-8B,target,,DB02082
Dimethylglycine,,experimental,soxA,Monomeric sarcosine oxidase,target,,DB02083
CRA_17312,,experimental,PRSS1,Trypsin-1,target,,DB02084
1-Aminocyclopropanecarboxylic Acid,,experimental,acdS,1-aminocyclopropane-1-carboxylate deaminase,target,,DB02085
"(3,4-Dihydroxy-Phenyl)-Triphenyl-Arsonium",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02086
"3,5-Difluorobenzenesulfonamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB02087
Norleucine Phosphonate,,experimental,map,Methionine aminopeptidase,target,,DB02088
CP-526423,,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB02089
A Disubstituted Succinyl Caprolactam Hydroxymate Mmp3inhibitor,,experimental,MMP3,Stromelysin-1,target,,DB02090
Cholesteryl Linoleate,,experimental,LIP3,Lipase 3,target,,DB02092
5-Phospho-D-Arabinohydroxamic Acid,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB02093
N-2-Thiophen-2-Yl-Acetamide Boronic Acid,,experimental,ampC,Beta-lactamase,target,,DB02094
Isatin,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB02095
FR221647,,experimental,ADA,Adenosine deaminase,target,,DB02096
Cytidine,,experimental,UCK2,Uridine-cytidine kinase 2,target,,DB02097
Fidarestat(Stereoisomer),,experimental,AKR1B1,Aldose reductase,target,,DB02101
DMP450,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02102
2-Chlorodideoxyadenosine,,experimental,HSP90B1,Endoplasmin,target,,DB02103
"2,4-Diamino-5-Methyl-6-[(3,4,5-Trimethoxy-N-Methylanilino)Methyl]Pyrido[2,3-D]Pyrimidine",,experimental,DHFR,Dihydrofolate reductase,target,,DB02104
"3,5-Dinitrocatechol",,experimental,COMT,Catechol O-methyltransferase,target,,DB02105
"[3,5-Dibromo-4-(4-Hydroxy-3-Phenethylcarbamoyl-Phenoxy)-Phenyl]-Acetic Acid",,experimental,THRB,Thyroid hormone receptor beta,target,,DB02106
Leucine - Reduced Carbonyl,,experimental,SPINK6,Serine protease inhibitor Kazal-type 6,target,,DB02107
2-Aminoethanimidic Acid,,experimental,CTSB,Cathepsin B,target,,DB02108
3-Hydroxyisoxazole-4-Carboxylic Acid,,experimental,,L-lactate dehydrogenase,target,,DB02111
Zk-806450,,experimental,PRSS1,Trypsin-1,target,,DB02112
6-Methylpurine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB02113
Para-Isopropylaniline,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB02114
Daidzin,Enzyme InhibitorsAlcohol Deterrents,experimental,ALDH2,"Aldehyde dehydrogenase, mitochondrial",target,,DB02115
CP-271485,,experimental,MMP12,Macrophage metalloelastase,target,,DB02118
Butyramide,,experimental,amiC,Aliphatic amidase expression-regulating protein,target,,DB02121
Glycochenodeoxycholic Acid,,experimental,hdhA,7-alpha-hydroxysteroid dehydrogenase,target,,DB02123
"(2s,3s)-Trans-2,3-Dihydro-3-Hydroxyanthranilic Acid",,experimental,phzF,"Trans-2,3-dihydro-3-hydroxyanthranilate isomerase",target,,DB02124
Adamantanone,,experimental,camC,Camphor 5-monooxygenase,target,,DB02125
[1-(3-Hydroxy-2-Oxo-1-Phenethyl-Propylcarbamoyl)2-Phenyl-Ethyl]-Carbamic Acid Pyridin-4-Ylmethyl Ester,,experimental,,Cruzipain,target,,DB02128
Dihydroorotic Acid,,experimental,pyrC,Dihydroorotase,target,,DB02129
4-Hydroxy-3-Methoxybenzoate,,experimental,ubiC,Chorismate--pyruvate lyase,target,,DB02130
N-1-Methylheptylformamide,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02131
"[3-(4-Bromo-2-Fluoro-Benzyl)-7-Chloro-2,4-Dioxo-3,4-Dihydro-2h-Quinazolin-1-Yl]-Acetic Acid",,experimental,AKR1B1,Aldose reductase,target,,DB02132
"4-{2,6,8-Trioxo-9-[(2r,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB02135
Cephalosporin Analog,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB02136
Molybdenum Cofactor,,experimental,mop,Aldehyde oxidoreductase,target,,DB02137
(2e)-N-Allyl-4-{[3-(4-Bromophenyl)-5-Fluoro-1-Methyl-1h-Indazol-6-Yl]Oxy}-N-Methyl-2-Buten-1-Amine,,experimental,shc,Squalene--hopene cyclase,target,,DB02139
N1-(1-Dimethylcarbamoyl-2-Phenyl-Ethyl)-2-Oxo-N4-(2-Pyridin-2-Yl-Ethyl)-Succinamide,,experimental,CTSH,Pro-cathepsin H,target,,DB02140
"S,S'-(1,4-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02141
N-Isopropyl-N'-Hydroxyguanidine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02143
"1,2-Diacyl-Sn-Glycero-3-Phosphoinositol",,experimental,PITPNA,Phosphatidylinositol transfer protein alpha isoform,target,,DB02144
Butan-1-Ol,,experimental,linB,Haloalkane dehalogenase,target,,DB02145
Cyclo-Tetrametavanadate,,experimental,C3,Mono-ADP-ribosyltransferase C3,target,,DB02147
3-Amino-4-Oxybenzyl-2-Butanone,,experimental,CTSB,Cathepsin B,target,,DB02148
Balanol Analog 8,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB02155
"R-1,2-Propanediol",,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB02159
S-Butyryl-Cystein,,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB02160
Hydroxy-Phenyl-Acetic Acid 8-Methyl-8-Aza-Bicyclo[3.2.1]Oct-3-Yl Ester,,experimental,CES1,Liver carboxylesterase 1,target,,DB02161
5'-O-(N-Ethyl-Sulfamoyl)Adenosine,,experimental,HINT1,Histidine triad nucleotide-binding protein 1,target,,DB02162
"2,5-Xylidine",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02163
N-Sulfo-Flavin Mononucleotide,,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB02164
Zinc Trihydroxide,,experimental,GSTM1,Glutathione S-transferase Mu 1,target,,DB02165
Propidium,,experimental,ACHE,Acetylcholinesterase,target,,DB02166
Bromopurine,,experimental,ptd,Nucleoside deoxyribosyltransferase-I,target,,DB02168
"9,10-Deepithio-9,10-Didehydroacanthifolicin",Ionophores,experimental,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,target,,DB02169
"1,8-Di-Hydroxy-4-Nitro-Xanthen-9-One",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB02170
D-Fructose-6-Phosphate (Open Form),,experimental,nagB,Glucosamine-6-phosphate deaminase,target,,DB02171
"2,5-Dideoxy-2,5-Imino-D-Glucitol",,experimental,xylA,Xylose isomerase,target,,DB02172
D-Glutamine,,experimental,murI,Glutamate racemase,target,,DB02174
1-Acetyl-4-(4-{4-[(2-Ethoxyphenyl)Thio]-3-Nitrophenyl}Pyridin-2-Yl)Piperazine,,experimental,ITGAL,Integrin alpha-L,target,,DB02177
Phenylacetaldehyde,,experimental,tynA,Primary amine oxidase,target,,DB02178
Hybrid Between B and C Type Hemes (Protoporphyrin Ixcontaining Fe),,experimental,cybC,Soluble cytochrome b562,target,,DB02182
Adenosine-5'-Ditungstate,,experimental,HINT1,Histidine triad nucleotide-binding protein 1,target,,DB02183
"(2s,3s)-1,4-Dimercaptobutane-2,3-Diol",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB02184
"2,4-Dihydroxy-7-(Methyloxy)-2h-1,4-Benzoxazin-3(4h)-One",,experimental,LCTL,Lactase-like protein,target,,DB02185
Equilin,,approved,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB02187
N-Methylmesoporphyrin Containing Copper,,experimental,hemH,Ferrochelatase,target,,DB02188
"2',3'-Dideoxyadenosine-5'-Triphosphate",,experimental,DNTT,DNA nucleotidylexotransferase,target,,DB02189
2-Oxalosuccinic Acid,,experimental,icd,Isocitrate dehydrogenase [NADP],target,,DB02190
2-Phenyl-Ethanol,,experimental,opd,Parathion hydrolase,target,,DB02192
"3-(4-Fluorophenyl)-1-Hydroxy-2-(Pyridin-4-Yl)-1h-Pyrrolo[3,2-B]Pyridine",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB02195
"4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02197
2-Bromoacetyl Group,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB02198
3-[N-[Benzyloxycarbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonylmethylbenzene,,experimental,,Cruzipain,target,,DB02200
N-Methyl-N-Propargyl-1(R)-Aminoindan,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB02211
"6,7-Dioxo-5h-8-Ribitylaminolumazine",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB02214
Furoyl-Leucine,,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB02215
Dpb-T,,experimental,NT5M,"5'(3')-deoxyribonucleotidase, mitochondrial",target,,DB02217
Al7089a,,experimental,CA2,Carbonic anhydrase 2,target,,DB02220
"4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB02221
"2,6-Diamino-(S)-9-[2-(Phosphonomethoxy)Propyl]Purine",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02222
Ly231514 Tetra Glu,,experimental,thyA,Thymidylate synthase,target,,DB02223
"1,2-Di-N-Pentanoyl-Sn-Glycero-3-Dithiophosphocholine",,experimental,plc,Phospholipase C,target,,DB02225
"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-4-Yl]Hexyl]-Phenanthridinium",,experimental,ACHE,Acetylcholinesterase,target,,DB02226
"4,5-Dihydroxy-Tetrahydro-Pyran-2-Carboxylic Acid",,experimental,,Chondroitinase (Chondroitin lyase),target,,DB02227
2-Fluoro-2-Deoxy-Beta-D-Galactopyranose,,experimental,lacZ,Beta-galactosidase,target,,DB02228
5'-O-[(L-Methionyl)-Sulphamoyl]Adenosine,,experimental,metG,Methionine--tRNA ligase,target,,DB02229
Immucillin-G,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02230
6-Hydroxy-D-Norleucine,,experimental,ansB,L-asparaginase,target,,DB02233
4-(Methylsulfanyl)-2-Oxobutanoic Acid,,experimental,,Aminotransferase,target,,DB02238
Laevulinic Acid,,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB02239
N-{(1s)-4-[Bis(2-Chloroethyl)Amino]-1-Methylbutyl}-N-(6-Chloro-2-Methoxy-9-Acridinyl)Amine,,experimental,TPR,Trypanothione reductase,target,,DB02240
Cyclohexane Propionic Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB02242
4-Morpholin-4-Yl-Piperidine-1-Carboxylic Acid [1-(3-Benzenesulfonyl-1-Propyl-Allylcarbamoyl)-2-Phenylethyl]-Amide,,experimental,CTSF,Cathepsin F,target,,DB02243
Hydrolyzed Cephalothin,,experimental,ampC,Beta-lactamase,target,,DB02247
2-Ethoxyethanol,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02249
Cu-Bicyclam,,experimental,LYZ,Lysozyme C,target,,DB02250
Iodophenyl,,experimental,celCCF,Endoglucanase F,target,,DB02252
"(1r)-4-[(1e,3e,5e,7z,9e,11z,13e,15e)-17-Hydroxy-3,7,12,16-Tetramethylheptadeca-1,3,5,7,9,11,13,15-Octaen-1-Yl]-3,5,5-Trimethylcyclohex-3-En-1-Ol",,experimental,sll1541,"Apocarotenoid-15,15'-oxygenase",target,,DB02253
Trifluoro-thiamin phosphate,,experimental,thiE,Thiamine-phosphate synthase,target,,DB02254
N-Bromoacetyl-Aminoethyl Phosphate,,experimental,pgiB,Glucose-6-phosphate isomerase B,target,,DB02257
SR11254,,experimental,RARG,Retinoic acid receptor gamma,target,,DB02258
"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid (4-Sulfamoyl-Phenyl)-Amide",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02259
Platelet Activating Factor,,experimental,GM2A,Ganglioside GM2 activator,target,,DB02261
Ethyl-Trimethyl-Silane,,experimental,tetX,Tetanus toxin,target,,DB02265
4-(Acetylamino)-3-Amino Benzoic Acid,,experimental,NA,Neuraminidase,target,,DB02268
[4-({[5-Benzyloxy-1-(3-Carbamimidoyl-Benzyl)-1h-Indole-2-Carbonyl]-Amino}-Methyl)-Phenyl]-Trimethyl-Ammonium,,experimental,PRSS1,Trypsin-1,target,,DB02269
S-(2-Oxo)Pentadecylcoa,,experimental,NMT2,Glycylpeptide N-tetradecanoyltransferase 2,target,,DB02271
Porphobilinogen,,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB02272
7-Keto-8-Aminopelargonic Acid,,experimental,bioA,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,target,,DB02274
(S)-2-(Phosphonoxy)Caproyl-L-Leucyl-P-Nitroanilide,,experimental,def,Peptide deformylase,target,,DB02276
1-(5-Tert-Butyl-2-Methyl-2h-Pyrazol-3-Yl)-3-(4-Chloro-Phenyl)-Urea,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB02277
"7,8-Dihydro-7,7-Dimethyl-6-Hydroxypterin",,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB02278
Benzoylformic Acid,,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB02279
2-Phenylamino-Ethanesulfonic Acid,,experimental,ccpA,Catabolite control protein A,target,,DB02283
Protoporphyrin Ix,,experimental,FTL,Ferritin light chain,target,,DB02285
2-(2-Hydroxy-Phenyl)-3h-Benzoimidazole-5-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB02287
CRA_9334,,experimental,PRSS1,Trypsin-1,target,,DB02288
2-Aminopropanedioic Acid,,experimental,atsA,Arylsulfatase,target,,DB02289
"3-{2,6,8-Trioxo-9-[(2s,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB02290
"6-Oxo-8,9,10,11-Tetrahydro-7h-Cyclohepta[C][1]Benzopyran-3-O-Sulfamate",,experimental,CA2,Carbonic anhydrase 2,target,,DB02292
"(5r,6s,7s,8s)-5-Hydroxymethyl-6,7,8-Trihydroxy-Tetrazolo[1,5-a]Piperidine",,experimental,lacZ,Beta-galactosidase,target,,DB02294
1-Hydroxy-3-Methylbutane,,experimental,REN,Renin,target,,DB02296
2-Amino-6-Chloropyrazine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02297
Arginineamide,,experimental,KCNA4,Potassium voltage-gated channel subfamily A member 4,target,,DB02299
Calcipotriol,Dermatologic AgentsAntipsoriatic Agents,approved,VDR,Vitamin D3 receptor,target,antagonist,DB02300
"N3, N4-Dimethylarginine",,experimental,linB,Haloalkane dehalogenase,target,,DB02302
"(5s)-5-Iododihydro-2,4(1h,3h)-Pyrimidinedione",,experimental,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB02303
"4,5-Dehydro-D-Glucuronic Acid",,experimental,cslA,Chondroitinase-AC,target,,DB02305
Palmitoyl-Linoleoyl Phosphatidylcholine,,experimental,PCTP,Phosphatidylcholine transfer protein,target,,DB02306
N-(1-Carboxy-3-Phenylpropyl)Phenylalanyl-Alpha-Asparagine,,experimental,lasB,Pseudolysin,target,,DB02307
"4-(1,3,2-Dioxaborolan-2-Yloxy)Butan-1-Aminium",,experimental,PRSS3,Trypsin-3,target,,DB02308
"3,5,6,8-Tetramethyl-N-Methyl Phenanthrolinium",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB02310
Methyl Methylsulfinylmethyl Sulfide,,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB02311
Beta-Galactose-6-Phosphate,,experimental,lacG,6-phospho-beta-galactosidase,target,,DB02312
4-{2-(4-Fluoro-Benzyl)-6-Methyl-5-[(5-Methyl-Isoxazole-3-Carbonyl)-Amino]-4-Oxo-Heptanoylamino}-5-(2-Oxo-Pyrrolidin-3-Yl)-Pentanoic Acid Ethyl Ester,,experimental,,Genome polyprotein,target,,DB02313
"1-(5-Carboxypentyl)-5-[(2,6-Dichlorobenzyl)Oxy]-1 H-Indole-2-Carboxylic Acid",,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB02316
Alpha-D-Galactose-1-Phosphate,,experimental,pgmB,Beta-phosphoglucomutase,target,,DB02317
2-Deoxy-2-Fluoro-Alpha-D-Mannosyl Fluoride,,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB02318
"5,6-Dihydroxy-Nadp",,experimental,yqhD,Alcohol dehydrogenase YqhD,target,,DB02319
"5-(3-Amino-4,4-Dihyroxy-Butylsulfanylmethyl)-Tetrahydro-Furan-2,3,4-Triol",,experimental,luxS,S-ribosylhomocysteine lyase,target,,DB02321
Heparin Disaccharide I-S,,experimental,CCL5,C-C motif chemokine 5,target,,DB02322
EM-1745,,experimental,HSD17B1,Estradiol 17-beta-dehydrogenase 1,target,,DB02323
5-Iodo-2'-Deoxyuridine-5'-Monophosphate,,experimental,TK,Thymidine kinase,target,,DB02324
1-Hydroxyamine-2-Isobutylmalonic Acid,,experimental,MMP8,Neutrophil collagenase,target,,DB02326
2-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Imino]-5-Phosphono-Pent-3-Enoic Acid,,experimental,CTH,Cystathionine gamma-lyase,target,,DB02328
"(2s)-2-[(5-Benzofuran-2-Yl-Thiophen-2-Ylmethyl)-(2,4-Dichloro-Benzoyl)-Amino]-3-Phenyl-Propionic Acid",,experimental,,Genome polyprotein,target,,DB02331
Flavin-N7 Protonated-Adenine Dinucleotide,,experimental,choA,Cholesterol oxidase,target,,DB02332
(R)-2-Hydroxy-3-Sulfopropanoic Acid,,experimental,comB,Probable 2-phosphosulfolactate phosphatase,target,,DB02334
2-Aminothiazoline,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02335
RU83876,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB02336
S-(D-Carboxybutyl)-L-Homocysteine,,experimental,BHMT,Betaine--homocysteine S-methyltransferase 1,target,,DB02337
Allyl-{6-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-Hexyl-}-Methyl-Amin,,experimental,shc,Squalene--hopene cyclase,target,,DB02339
N-Acetyl-Serine,,experimental,F13A1,Coagulation factor XIII A chain,target,,DB02340
O-Sialic Acid (Chair Conformation),,experimental,kpsU,3-deoxy-manno-octulosonate cytidylyltransferase,target,,DB02344
3'-O-N-Octanoyl-a-D-Glucopyranosyl-B-D-Fructofuranoside,,experimental,csd,Probable cysteine desulfurase,target,,DB02346
2-Amino-3-(5-Tert-Butyl-3-(Phosphonomethoxy)-4-Isoxazolyl)Propionic Acid,,experimental,GRIA2,Glutamate receptor 2,target,,DB02347
Fluoro-Phosphite Ion,Cariostatic Agents,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02348
"N-Hydroxy-4-[(4-Methoxylphenyl)Sulfonyl]-2,2-Dimethyl-Hexahydro-1,4-Thiazepine-3(S)-Carboxamide",,experimental,MMP3,Stromelysin-1,target,,DB02350
Hirulog,Antithrombins,experimental,F2,Prothrombin,target,inhibitor,DB02351
Heparin Disaccharide Iii-S,,experimental,CCL5,C-C motif chemokine 5,target,,DB02353
4-{[1-Methyl-5-(2-Methyl-Benzoimidazol-1-Ylmethyl)-1h-Benzoimidazol-2-Ylmethyl]-Amino}-Benzamidine,,experimental,PRSS1,Trypsin-1,target,,DB02354
Adenosine-5'-Rp-Alpha-Thio-Triphosphate,,experimental,cyaC,Adenylate cyclase,target,,DB02355
LY374571,,experimental,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic",target,,DB02358
"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB02359
Bis-Napthyl Beta-Ketophosphonic Acid,,experimental,CTSG,Cathepsin G,target,,DB02360
S-Methyl Thiocysteine Group,,experimental,celCCG,Endoglucanase G,target,,DB02361
2-Amino-3-(Diethoxy-Phosphoryloxy)-Propionic Acid,,experimental,tesA,Acyl-CoA thioesterase I,target,,DB02364
CRA_10762,,experimental,PRSS1,Trypsin-1,target,,DB02366
(1n)-4-N-Butoxyphenylsulfonyl-(2r)-N-Hydroxycarboxamido-(4s)-Methanesulfonylamino-Pyrrolidine,,experimental,MMP3,Stromelysin-1,target,,DB02367
N-Acetyl-L-Citrulline,,experimental,argF',N-acetylornithine carbamoyltransferase,target,,DB02368
Nz-(1-Carboxyethyl)-Lysine,,experimental,dapA,4-hydroxy-tetrahydrodipicolinate synthase,target,,DB02370
"2-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Ethanesulfonic Acid",,experimental,C1S,Complement C1s subcomponent,target,,DB02371
Adenosine Monotungstate,,experimental,FHIT,Bis(5'-adenosyl)-triphosphatase,target,,DB02373
Xylose-Derived Imidazole,,experimental,cex,Exoglucanase/xylanase,target,,DB02374
Myricetin,,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB02375
"D-Gluconhydroximo-1,5-Lactam",,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB02376
MMI-175,,experimental,BACE1,Beta-secretase 1,target,,DB02378
Nor-N-Omega-Hydroxy-L-Arginine,,experimental,ARG1,Arginase-1,target,,DB02381
(E)-2-Fluoro-P-Hydroxycinnamate,,experimental,pptA,Tautomerase PptA,target,,DB02384
"Cyclohexyl-{4-[5-(3,4-Dichlorophenyl)-2-Piperidin-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB02388
"2-Amino-7-[2-(2-Hydroxy-1-Hydroxymethyl-Ethylamino)-Ethyl]-1,7-Dihydro-Purin-6-One",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02391
"D-Gluco-2,5-Anhydro-1-Deoxy-1-Phosphonohexitol-6-Phosphate",,experimental,PFKFB1,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 1",target,,DB02393
Oxiranpseudoglucose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB02394
"3-Hydroxymethyl-5-Aziridinyl-1methyl-2-[1h-Indole-4,7-Dione]-Propanol",,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB02395
Methylethylamine,,experimental,MB,Myoglobin,target,,DB02396
6-[N-(4-(Aminomethyl)Phenyl)Carbamyl]-2-Naphthalenecarboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB02398
L-Rhamnitol,,experimental,rhaA,L-rhamnose isomerase,target,,DB02399
"5-Methoxy-1,2-Dimethyl-3-(4-Nitrophenoxymethyl)Indole-4,7-Dione",,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB02400
2-Fluoroaniline,,experimental,E,Lysozyme,target,,DB02403
1-Deoxy-1-Thio-Heptaethylene Glycol,,experimental,ACHE,Acetylcholinesterase,target,,DB02404
12-Bromododecanoic Acid,,experimental,PAEP,Glycodelin,target,,DB02405
N-Valeric Acid,,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB02406
"2-Acetyl-3-[(4-Amino-2-Methyl-5-Pyrimidinyl)Methyl]-4-Methyl-5-(4,6,6-Trihydroxy-3,5-Dioxa-4,6-Diphosphahex-1-Yl)Thiazolium Inner Salt P,P'-Dioxide",,experimental,por,Pyruvate-flavodoxin oxidoreductase,target,,DB02410
"2-(11-{2-[Benzenesulfonyl-(3-Methyl-Butyl)-Amino]-1-Hydroxy-Ethyl}-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-8-Yl)-Acetamide, Inhibitor 2",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02411
Hydroxyethylcysteine,,experimental,gag-pro-pol,Gag-Pro-Pol polyprotein,target,,DB02413
"(3s,8ar)-3-(1h-Imidazol-5-Ylmethyl)Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",,experimental,chiB,Chitinase B,target,,DB02414
"(R,R)-2,3-Butanediol",,experimental,UBE2D2,Ubiquitin-conjugating enzyme E2 D2,target,,DB02418
Ethyl Oxo(Piperidin-1-Yl)Acetate,,experimental,PPIA,Peptidyl-prolyl cis-trans isomerase A,target,,DB02419
"[[4-(Aminomethyl)Phenyl]Amino]Oxo-Acetic Acid,",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02420
Uridine-5'-Diphosphate-Mannose,,experimental,galE,UDP-glucose 4-epimerase,target,,DB02421
Methyl-2-S-(Alpha-D-Mannopyranosyl)-2-Thio-Alpha-D-Mannopyranoside,,experimental,MAN1B1,"Endoplasmic reticulum mannosyl-oligosaccharide 1,2-alpha-mannosidase",target,,DB02422
Hexadecyl Octanoate,,experimental,ethR,HTH-type transcriptional regulator EthR,target,,DB02425
Carboxyatractyloside,,experimental,SLC25A4,ADP/ATP translocase 1,target,,DB02426
Quinaldic Acid,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02428
4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB02429
Trehalose-6-Phosphate,,experimental,treR,HTH-type transcriptional regulator TreR,target,,DB02430
RU90395,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB02432
4-(2-Thienyl)Butyric Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB02434
2-{4-[(2s)-2-[({[(1s)-1-Carboxy-2-Phenylethyl]Amino}Carbonyl)Amino]-3-Oxo-3-(Pentylamino)Propyl]Phenoxy}Malonic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02436
3-O-Methylfructose in Linear Form,,experimental,xylA,Xylose isomerase,target,,DB02438
"2-Butyl-5,6-Dihydro-1h-Imidazo[4,5-D]Pyridazine-4,7-Dione",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB02441
Dioxyselenocysteine,,experimental,apr,Subtilisin BPN',target,,DB02442
Methicillin Acyl-Serine,,experimental,pbp,Beta-lactam-inducible penicillin-binding protein,target,,DB02443
Glutamine Hydroxamate,,experimental,glmS,Glutamine--fructose-6-phosphate aminotransferase [isomerizing],target,,DB02446
"3,8,9,10-Tetrahydroxy-7-Hydroxymethyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02447
3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid,,experimental,MMP3,Stromelysin-1,target,,DB02449
Trihydroxyantimonite(Iii),,experimental,arsA,Arsenical pump-driving ATPase,target,,DB02453
Cytosine Arabinose-5'-Phosphate,,experimental,cmk,Cytidylate kinase,target,,DB02456
Undecyl-Phosphinic Acid Butyl Ester,,experimental,LIPF,Gastric triacylglycerol lipase,target,,DB02457
4-Guanidinobenzoic Acid,,experimental,CFB,Complement factor B,target,,DB02459
Hydrogenobyrinic Acid,,experimental,cobH,Precorrin-8X methylmutase,target,,DB02460
S-Methyl Phosphocysteine,,experimental,cheY,Chemotaxis protein CheY,target,,DB02461
Thiocoumarin,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02462
2-(2-Hydroxy-Phenyl)-1h-Indole-5-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB02463
Methoxy arachidonyl fluorophosphonate,,experimental,FAAH,Fatty-acid amide hydrolase 1,target,,DB02465
"4-[3-Oxo-3-(5,5,8,8-Tetramethyl-5,6,7,8-Tetrahydro-Naphthalen-2-Yl)-Propenyl]-Benzoic Acid",,experimental,RARG,Retinoic acid receptor gamma,target,,DB02466
12-Phenylheme,,experimental,HMOX1,Heme oxygenase 1,target,,DB02468
"4,6-Dideoxy-4-Amino-Beta-D-Glucopyranoside",,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB02469
D-Glycero-D-Mannopyranose-7-Phosphate,,experimental,gmhA,Phosphoheptose isomerase,target,,DB02470
"6-Hydroxy-7,8-Dihydro Purine Nucleoside",,experimental,ADA,Adenosine deaminase,target,,DB02472
"6-[N-(1-Isopropyl-3,4-Dihydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB02473
Bmsc-0013,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02474
Deoxyguanidinoproclavaminic acid,,experimental,cs1,Clavaminate synthase 1,target,,DB02475
[Cyclohexylethyl]-[[[[4-[2-Methyl-1-Imidazolyl-Butyl]Phenyl]Acetyl]-Seryl]-Lysinyl]-Amine,,experimental,NMT1,Glycylpeptide N-tetradecanoyltransferase,target,,DB02477
(R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB02479
(S)-4-Bromo-3-Hydroxy-3-Methylbutyl Diphosphate,,experimental,idi,Isopentenyl-diphosphate Delta-isomerase,target,,DB02480
N-Benzylformamide,,experimental,ADH1B,Alcohol dehydrogenase 1B,target,,DB02481
Cytidine 5'-Diphosphoglycerol,,experimental,tagD,Glycerol-3-phosphate cytidylyltransferase,target,,DB02484
Cytidine-5'-Monophosphate-5-N-Acetylneuraminic Acid,,experimental,CMAS,N-acylneuraminate cytidylyltransferase,target,,DB02485
9-Methylguanine,,experimental,folB,Dihydroneopterin aldolase,target,,DB02489
(Diaminomethyl-Methyl-Amino)-Acetic Acid,,experimental,CKM,Creatine kinase M-type,target,,DB02490
4-[4-(1-Amino-1-Methylethyl)Phenyl]-5-Chloro-N-[4-(2-Morpholin-4-Ylethyl)Phenyl]Pyrimidin-2-Amine,,experimental,FGFR2,Fibroblast growth factor receptor 2,target,,DB02491
Ghavamiol,,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB02492
Hydantocidin-5'-Phosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB02493
9-(4-Hydroxybutyl)-N2-Phenylguanine,,experimental,TK,Thymidine kinase,target,,DB02495
L-Alpha-Glycerophosphorylserine,,experimental,ANXA5,Annexin A5,target,,DB02497
Carba-Nicotinamide-Adenine-Dinucleotide,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB02498
Dinor-N(Omega)-Hydroxy-L-Arginine,,experimental,ARG1,Arginase-1,target,,DB02499
6-(Dihydroxy-Isobutyl)-Thymine,,experimental,TK,Thymidine kinase,target,,DB02500
N~2~-Succinylarginine,,experimental,astB,N-succinylarginine dihydrolase,target,,DB02501
4-(Carboxyvin-2-Yl)Phenylboronic Acid,,experimental,ampC,Beta-lactamase,target,,DB02503
[3-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Propyl-]-Phosphonic Acid,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB02504
N-(R-Carboxy-Ethyl)-Alpha-(S)-(2-Phenylethyl),,experimental,,Plasmepsin-2,target,,DB02505
4-Hydroxy-3-[(1s)-3-Oxo-1-Phenylbutyl]-2h-Chromen-2-One,,experimental,CYP2C9,Cytochrome P450 2C9,target,,DB02507
Farnesol,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB02509
5'-O-(N-(L-Prolyl)-Sulfamoyl)Adenosine,,experimental,EPRS,Bifunctional glutamate/proline--tRNA ligase,target,,DB02510
2-Hydroxy-5-({1-[(2-Naphthyloxy)Methyl]-3-Oxoprop-1-Enyl}Amino)Tyrosine,,experimental,,Phenylethylamine oxidase,target,,DB02511
(2z)-3-{[Oxido(Oxo)Phosphino]Oxy}-2-Phenylacrylate,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB02514
"O5'-(4-(3-{2-[2-((R)-3-Hydroxy-4-(Trimethylammonio)-1-Oxo-Butyl)Sulfanyl-Ethylcarbamoyl]-Ethylcarbamoyl}-(R)-3-Hydroxy-2,2-Dimethyl-Propyl)-1-Hydroxy-3-Oxido-1,3-Dioxo-2,4-Dioxa-1,3-Diphosphabut-1-Yl) 3'-Phospho-Adenosine",,experimental,caiB,Crotonobetainyl-CoA:carnitine CoA-transferase,target,,DB02516
D-Glutamic Acid,,experimental,nprS,Thermolysin,target,,DB02517
N-Acetylalanine,,experimental,AKR1B1,Aldose reductase,target,,DB02518
Phosphonopyruvate,,experimental,ppdK,"Pyruvate, phosphate dikinase",target,,DB02522
"Spiro(2,4,6-Trinitrobenzene[1,2a]-2o',3o'-Methylene-Adenine-Triphosphate",,experimental,cheA,Chemotaxis protein CheA,target,,DB02524
Tetrazolyl Histidine,,experimental,MB,Myoglobin,target,,DB02528
"5-N-Acetyl-4-Amino-6-Diethylcarboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",,experimental,NA,Neuraminidase,target,,DB02529
Gamma(Amino)-Butyric Acid,,experimental,GATM,"Glycine amidinotransferase, mitochondrial",target,,DB02530
Isobutyric Acid,,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB02531
Aminoguanidine,,experimental,NOS2,"Nitric oxide synthase, inducible",target,inhibitor,DB02533
2-Allylphenol,,experimental,E,Lysozyme,target,,DB02534
Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB02535
2-Hydroxy-5-({1-[(4-Methylphenoxy)Methyl]-3-Oxoprop-1-Enyl}Amino)-L-Tyrosine,,experimental,,Phenylethylamine oxidase,target,,DB02537
"N-[4-(2-Methylimidazo[1,2-a]Pyridin-3-Yl)-2-Pyrimidinyl]Acetamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02538
S-Ethylisothiourea,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB02539
"(10S)-10-Formyl-5,8,10-Trideazafolic Acid",,experimental,purN,Phosphoribosylglycinamide formyltransferase,target,,DB02540
4-Hydroxybutan-1-Aminium,,experimental,PRSS3,Trypsin-3,target,,DB02541
(4s)-5-Fluoro-L-Leucine,,experimental,UBB,Polyubiquitin-B,target,,DB02542
Pyrrole-2-Carboxylate,,experimental,soxA,Monomeric sarcosine oxidase,target,,DB02543
"N-(6-{[3-(4-Bromophenyl)-1,2-Benzisothiazol-6-Yl]Oxy}Hexyl)-N-Methylprop-2-En-1-Amine",,experimental,shc,Squalene--hopene cyclase,target,,DB02544
Fexaramine,,experimental,NR1H4,Bile acid receptor,target,,DB02545
Guanosine-5'-Diphosphate-Rhamnose,,experimental,GMDS,"GDP-mannose 4,6 dehydratase",target,,DB02547
Sorbitol 6-phosphate,,experimental,GPI,Glucose-6-phosphate isomerase,target,,DB02548
3'-O-Acetylthymidine-5'-Diphosphate,,experimental,rfbC,"dTDP-4-dehydrorhamnose 3,5-epimerase",target,,DB02549
"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB02550
"6-[N-(4-Ethyl-1,2,3,4-Tetrahydro-6-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB02551
Glutathionylspermidine Disulfide,,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB02553
SP4160,,experimental,IL2,Interleukin-2,target,,DB02555
Phosphoramidon,,experimental,MME,Neprilysin,target,inhibitor,DB02557
N-(3-Phenyl-2-Sulfanylpropanoyl)Phenylalanylalanine,,experimental,MME,Neprilysin,target,,DB02558
D-Para-Chlorophenyl-1-Acteamidoboronic Acid Alanine,,experimental,apr,Subtilisin Carlsberg,target,,DB02560
Beta-D-Fructopyranose,,experimental,lecB,Fucose-binding lectin PA-IIL,target,,DB02561
"Quinonoid 7,8-Tetrahydrobiopterin",,experimental,PAH,Phenylalanine-4-hydroxylase,target,,DB02562
Hexanoyl-Coenzyme A,,experimental,ECHS1,"Enoyl-CoA hydratase, mitochondrial",target,,DB02563
4-Dimethylamino-N-(6-Hydroxycarbamoyethyl)Benzamide-N-Hydroxy-7-(4-Dimethyla Minobenzoyl)Aminoheptanamide,,experimental,HDAC8,Histone deacetylase 8,target,,DB02565
PD173955,,experimental,ABL,Tyrosine-protein kinase transforming protein Abl,target,,DB02567
Peldesine,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02568
"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate",,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB02569
PD150606,,experimental,CAPNS1,Calpain small subunit 1,target,,DB02570
2-Amino-6-Oxo-Hexanoic Acid,,experimental,ansB,Glutaminase-asparaginase,target,,DB02571
BV4,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02572
"2'-Deoxycytidine-2'-Deoxyadenosine-3',5'-Monophosphate",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB02573
BV2,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02574
F-Loop of Vitamin B12,,experimental,mamA,Methylaspartate mutase S chain,target,,DB02576
Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanyl-D-Alanine,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB02578
Acrylic Acid,Tissue Adhesives,experimental,bla,Beta-lactamase SHV-1,target,,DB02579
"5-[2,3-Dichloro-4-(5-{1-[2-(2-Guanidino-4-Methyl-Pentanoylamino)-Acetyl]-Piperidin-4-Yl}-1-Methyl-1h-Pyrazol-3-Yl)-Phenoxymethyl]-Furan-2-Carboxylic Acid",,experimental,IL2,Interleukin-2,target,,DB02581
"N6-(2,5-Dimethoxy-Benzyl)-N6-Methyl-Pyrido[2,3-D]Pyrimidine-2,4,6-Triamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB02583
4-(Hydroxymethyl)Benzamidine,,experimental,PRSS3,Trypsin-3,target,,DB02585
"4,7-Dimethyl-[1,10]Phenanthroline",,experimental,azu,Azurin,target,,DB02586
Moxalactam Derivative,,experimental,ampC,Beta-lactamase,target,,DB02588
Se-Ethyl-Isoselenourea,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02589
Abequose,,experimental,9,Bifunctional tail protein,target,,DB02590
"5,6-Dimethylbenzimidazole",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02591
Carbaphosphonate,,experimental,aroB,3-dehydroquinate synthase,target,,DB02592
"7,8-Dihydroxy-1-Methoxy-3-Methyl-10-Oxo-4,10-Dihydro-1h,3h-Pyrano[4,3-B]Chromene-9-Carboxylic Acid",,experimental,ccrA,Beta-lactamase type II,target,,DB02593
"N-Alpha-Acetyl-3,5-Diiodotyrosylglycine",,experimental,PAM,Peptidyl-glycine alpha-amidating monooxygenase,target,,DB02598
"2,6-Diamino-8-Propylsulfanylmethyl-3h-Quinazoline-4-One",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB02599
5-N-Acetyl-3-(1-Ethylpropyl)-1-Cyclohexene-1-Carboxylic Acid,,experimental,NA,Neuraminidase,target,,DB02600
AL7182,,experimental,CA2,Carbonic anhydrase 2,target,,DB02602
1-Amino-6-Cyclohex-3-Enylmethyloxypurine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02603
2-Deoxy-Glucose-6-Phosphate,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02604
2-Butanol,,experimental,adh,NADP-dependent isopropanol dehydrogenase,target,,DB02606
Adenosine Phosphonoacetic Acid,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB02607
N-Acetyl-P-Nitrophenylserinol,,experimental,,Chloramphenicol 3-O phosphotransferase,target,,DB02608
4-Hydroxy-L-Threonine-5-Monophosphate,,experimental,pdxA,4-hydroxythreonine-4-phosphate dehydrogenase,target,,DB02609
"N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB02610
Balanol Analog 1,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB02611
FR117016,,experimental,ADA,Adenosine deaminase,target,,DB02616
"1-(N-Imidazolyl)-2-Hydroxy-2-(2,3-Dichlorophenyl)Octane",,experimental,camC,Camphor 5-monooxygenase,target,,DB02617
Sp7343-Sp7964,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02620
2-(Oxalyl-Amino)-Benzoic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02622
Aminophosphonic Acid-Guanylate Ester,,experimental,CDC42,Cell division control protein 42 homolog,target,,DB02623
Homoserine Lactone,,experimental,SLC9A1,Sodium/hydrogen exchanger 1,target,,DB02624
(2r)-2-{[Formyl(Hydroxy)Amino]Methyl}Hexanoic Acid,,experimental,PFI0380c,"Formylmethionine deformylase, putative",target,,DB02625
Phenylferricrocin-Iron,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02626
"4,4'-Biphenyldiboronic Acid",,experimental,ampC,Beta-lactamase,target,,DB02627
"1-[3,3-Dimethyl-2-(2-Methylamino-Propionylamino)-Butyryl]-Pyrrolidine-2-Carboxylic Acid(1,2,3,4-Tetrahydro-Naphthalen-1-Yl)-Amide",,experimental,XIAP,E3 ubiquitin-protein ligase XIAP,target,,DB02628
Inhibitor Bea403,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02629
L-Xylitol 5-Phosphate,,experimental,ulaD,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,target,,DB02630
"5-Chloro-6-[(2-Iminopyrrolidin-1-Yl)Methyl]Pyrimidine-2,4(1h,3h)-Dione",,experimental,TYMP,Thymidine phosphorylase,target,,DB02631
N-[O-Phosphono-Pyridoxyl]-Isoleucine,,experimental,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",target,,DB02635
"9-Hydroxy-8-Methoxy-6-Nitro-Phenanthrol[3,4-D][1,3]Dioxole-5-Carboxylic Acid",,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB02636
Fumagillin,,experimental,METAP2,Methionine aminopeptidase 2,target,ligand,DB02640
Heptanamide,,experimental,limA,"Limonene-1,2-epoxide hydrolase",target,,DB02641
"3,4-Epoxybutyl-Alpha-D-Glucopyranoside",,experimental,spoII,Beta-amylase,target,,DB02645
Nitrosoethane,,experimental,MB,Myoglobin,target,,DB02646
N-(5-Cyclopropyl-1h-Pyrazol-3-Yl)Benzamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02647
3-Amino-3-Oxopropanoic Acid,,experimental,,Malonamidase E2,target,,DB02649
"{[2-(1h-1,2,3-Benzotriazol-1-Yl)-2-(3,4-Difluorophenyl)Propane-1,3-Diyl]Bis[4,1-Phenylene(Difluoromethylene)]}Bis(Phosphonic Acid)",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02651
L-[(N-Hydroxyamino)Carbonyl]Phenylalanine,,experimental,CPA1,Carboxypeptidase A1,target,,DB02652
"Delta-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C2-Adamantane Ruthenium (Ii)",,experimental,camC,Camphor 5-monooxygenase,target,,DB02653
"2,4-Dinitrophenyl 2-Deoxy-2-Fluoro-Beta-D-Allopyranoside",,experimental,bglA,Beta-glucosidase A,target,,DB02658
Filaminast,,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB02660
"Adenosine-5'-Diphosphate-2',3'-Vanadate",,experimental,PAPSS1,Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1,target,,DB02661
Novo Nordisk a/S Compound,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02662
2-Amino-4-(Hydroxymethyl-Phosphinyl)Butanoic Acid,Herbicides,experimental,glnA,Glutamine synthetase,target,,DB02663
1-Butane Boronic Acid,,experimental,,Bacterial leucyl aminopeptidase,target,,DB02664
Trans-2-Phenylcyclopropylamine,,experimental,PRSS1,Trypsin-1,target,,DB02665
(C8-R)-Hydantocidin 5'-Phosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB02666
Factor IIIm,,experimental,Moth_1208,5-methyltetrahydrofolate--homocysteine S-methyltransferase,target,,DB02667
"Je-2147, Ag1776, Kni-764",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02668
"(4ar,6s,8ar)-11-[8-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Octyl]-6-Hydroxy-3-Methoxy-5,6,9,10-Tetrahydro-4ah-[1]Benzofuro[3a,3,2-Ef][2]Benzazepin-11-Ium",,experimental,ACHE,Acetylcholinesterase,target,,DB02673
"4-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Butyricacid",,experimental,,Streptavidin,target,,DB02674
"2-[3-(2-Hydroxy-1,1-Dihydroxymethyl-Ethylamino)-Propylamino]-2-Hydroxymethyl-Propane-1,3-Diol",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB02676
D-Naphthyl-1-Acetamido Boronic Acid Alanine,,experimental,apr,Subtilisin Carlsberg,target,,DB02677
2-Deoxy-2-Aminogalactose,,experimental,LGALS7,Galectin-7,target,,DB02678
Cyanamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB02679
Dinitrophenylene,,experimental,manA,"Mannan endo-1,4-beta-mannosidase",target,,DB02680
2-Deamino-6-Deoxy-6thiophosphite-5'-Phosphate Guanosine,,experimental,purA,Adenylosuccinate synthetase,target,,DB02682
Inhibitor Bea428,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02683
5'-O-(N-(L-Cysteinyl)-Sulfamoyl)Adenosine,,experimental,EPRS,Bifunctional glutamate/proline--tRNA ligase,target,,DB02684
3-Methylphenylalanine,,experimental,CTSB,Cathepsin B,target,,DB02685
Undecyl-Beta-D-Maltopyranoside,,experimental,ntpK,V-type sodium ATPase subunit K,target,,DB02686
"2,3-Didehydroalanine",,experimental,mrsA,Lantibiotic mersacidin,target,,DB02688
S-{2-[Amino(Dihydroxy)-Lambda~4~-Sulfanyl]Ethyl}-D-Cysteine,,experimental,ARG1,Arginase-1,target,,DB02689
NU1025,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB02690
N-Cholylglycine,,experimental,FABP6,Gastrotropin,target,,DB02691
"(4s,5s)-1,2-Dithiane-4,5-Diol",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB02693
Pantoyl Adenylate,,experimental,panC,Pantothenate synthetase,target,,DB02694
O1-Pentyl-Mannose,,experimental,,Cyanovirin-N,target,,DB02695
"6-Aminohexyl-Uridine-C1,5'-Diphosphate",,experimental,B4GALT1,"Beta-1,4-galactosyltransferase 1",target,,DB02696
3-Deoxy-D-Glucosamine,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02700
XV638,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02702
"(2r,3r,4r,5r)-3,4-Dihydroxy-N,N'-Bis[(1s,2r)-2-Hydroxy-2,3-Dihydro-1h-Inden-1-Yl]-2,5-Bis(2-Phenylethyl)Hexanediamide",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02704
"6-[N-(1-Isopropyl-1,2,3,4-Tetrahydro-7-Isoquinolinyl)Carbamyl]-2-Naphthalenecarboxamidine",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB02705
Mercaptocarboxylate Inhibitor,,experimental,,Beta-lactamase IMP-1,target,,DB02706
"2,3,-Dihydroxybenzoylserine",,experimental,LCN2,Neutrophil gelatinase-associated lipocalin,target,,DB02710
"4-{2,6,8-Trioxo-9-[(2s,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Butyl Dihydrogen Phosphate",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB02711
Sorbinil,Angiogenesis Inhibitors,experimental,AKR1B1,Aldose reductase,target,inhibitor,DB02712
Acetylamino-Acetic Acid,,experimental,thiO,Glycine oxidase,target,,DB02713
3'-Uridinemonophosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB02714
Compound 18,,experimental,ESR1,Estrogen receptor,target,,DB02715
7-Methyl-Guanosine-5'-Triphosphate,,experimental,EIF4E,Eukaryotic translation initiation factor 4E,target,,DB02716
Cellotetraose,,experimental,cbhA,"Cellulose 1,4-beta-cellobiosidase",target,,DB02717
C-(1-Hydrogyl-Beta-D-Glucopyranosyl) Formamide,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02719
Alpha-D-Glucopyranosyl-2-Carboxylic Acid Amide,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02720
4-O-Methyl-Beta-D-Glucuronic Acid,,experimental,aguA,Alpha-glucuronidase,target,,DB02722
"4-Oxo-2-Phenylmethanesulfonyl-Octahydro-Pyrrolo[1,2-a]Pyrazine-6-Carboxylic Acid [1-(N-Hydroxycarbamimidoyl)-Piperidin-4-Ylmethyl]-Amide",,experimental,F2,Prothrombin,target,,DB02723
"2-Amino-4-(4-Amino-Cyclohexa-2,5-Dienyl)-Butyric Acid",,experimental,bioA,Adenosylmethionine-8-amino-7-oxononanoate aminotransferase,target,,DB02725
N-Butyl-N'-Hydroxyguanidine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02727
7-Hydroxy-2-Oxo-Chromene-3-Carboxylic Acid Ethyl Ester,,experimental,MIF,Macrophage migration inhibitory factor,target,,DB02728
SD146,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02729
4-Methylthio-Alpha-D-Mannose,,experimental,AMY2B,Alpha-amylase 2B,target,,DB02730
2-Amino-3-Oxo-4-Sulfo-Butyric Acid,,experimental,STS,Steryl-sulfatase,target,,DB02735
Acetamide,,experimental,amiC,Aliphatic amidase expression-regulating protein,target,,DB02736
Adenosine-5'-Pentaphosphate,,experimental,ndx1,Diadenosine hexaphosphate hydrolase,target,,DB02738
CD564,,experimental,RARG,Retinoic acid receptor gamma,target,,DB02741
"Beta-1,4-Galactobioside",,experimental,ganB,"Arabinogalactan endo-1,4-beta-galactosidase",target,,DB02743
RPR131247,,experimental,PRSS1,Trypsin-1,target,,DB02744
Phthalic Acid,,experimental,nadC,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,,DB02746
Pyromellitic Acid,,experimental,fumC,Fumarate hydratase class II,target,,DB02749
S-(Methylmercury)-L-Cysteine,,experimental,EFTUD1,Elongation factor Tu GTP-binding domain-containing protein 1,target,,DB02750
N-[Amino(Imino)Methyl]Glycine,Affinity Labels,experimental,GAMT,Guanidinoacetate N-methyltransferase,target,,DB02751
Tosyl-D-Proline,,experimental,thyA,Thymidylate synthase,target,,DB02752
Selenoinosine,,experimental,ptd,Nucleoside deoxyribosyltransferase-I,target,,DB02753
1-3 Sugar Ring of Pentamannosyl 6-Phosphate,,experimental,M6PR,Cation-dependent mannose-6-phosphate receptor,target,,DB02755
Pyrazole,Enzyme Inhibitors,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02757
4-Methylumbelliferyl Chitobiose,,experimental,LYZ,Lysozyme C,target,,DB02759
RU79072,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB02762
"9-Hydroxypropyladenine, R-Isomer",,experimental,TK,Thymidine kinase,target,,DB02765
(3r)-3-{[(Benzyloxy)Carbonyl]Amino}-2-Oxo-4-Phenylbutane-1-Diazonium,,experimental,speB,Streptopain,target,,DB02766
Tert-Butyloxycarbonyl Group,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02768
7-Alpha-D-Ribofuranosyl-2-Aminopurine-5'-Phosphate,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02770
Dodecane,,experimental,ompC,Outer membrane protein C,target,,DB02771
(3-Chloro-4-Propoxy-Phenyl)-Acetic Acid,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB02773
"2,5-Anhydroglucitol-1,6-Biphosphate",,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB02778
Dodecane-Trimethylamine,,experimental,PTPN11,Tyrosine-protein phosphatase non-receptor type 11,target,,DB02779
Beta-3-Cysteine,,experimental,env,Envelope glycoprotein gp160,target,,DB02780
N-[4-(2-{2-[3-(2-Bromo-Acetylamino)-Propionylamino]-3-Hydroxy-Propionylamino}-Ethyl)-Phenyl]-Oxalamic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02784
N-[2(S)-Cyclopentyl-1(R)-Hydroxy-3(R)Methyl]-5-[(2(S)-Tertiary-Butylamino-Carbonyl)-4-(N1-(2)-(N-Methylpiperazinyl)-3-Chloro-Pyrazinyl-5-Carbonyl)-Piperazino]-4(S)-Hydroxy-2(R)-Phenylmethyl-Pentanamide,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02785
2-Anhydro-3-Fluoro-Quinic Acid,,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB02786
N-Acetylmannosaminitol,,experimental,synC,Capsule biosynthesis protein,target,,DB02787
Pregnenolone,,experimental,SULT2B1,Sulfotransferase family cytosolic 2B member 1,target,,DB02789
Phenyl-Uridine-5'-Diphosphate,,experimental,galE,UDP-glucose 4-epimerase,target,,DB02790
Tetraphenylphosphonium,,experimental,bmrR,Multidrug-efflux transporter 1 regulator,target,,DB02791
Isochorismic Acid,,experimental,phzD1,Phenazine biosynthesis protein PhzD,target,,DB02793
N-[5'-O-Phosphono-Ribofuranosyl]-2-[2-Hydroxy-2-[4-[Glutamic Acid]-N-Carbonylphenyl]-3-[2-Amino-4-Hydroxy-Quinazolin-6-Yl]-Propanylamino]-Acetamide,,experimental,purN,Phosphoribosylglycinamide formyltransferase,target,,DB02794
9-Deazainosine,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB02796
3-Nitrophenylboronic Acid,,experimental,ampC,Beta-lactamase,target,,DB02797
Alpha-Methylene Adenosine Monophosphate,,experimental,prs,Ribose-phosphate pyrophosphokinase,target,,DB02798
N-[2-(1-Maleimidyl)Ethyl]-7-Diethylaminocoumarin-3-Carboxamide,,experimental,pstS,Phosphate-binding protein PstS,target,,DB02799
5-Aminocarbonyl-3-Nitrophenyl-Alpha-D-Galactopyranose,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02802
"3-Phenyl-1,2-Propandiol",,experimental,REN,Renin,target,,DB02803
A-98881,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02804
"1-(3-O-Phosphono-Beta-L-Arabinofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB02805
"Brodimoprim-4,6-Dicarboxylate",,experimental,folA,Dihydrofolate reductase,target,,DB02809
N-(2-Acetamido)Iminodiacetic Acid,,experimental,def,Peptide deformylase,target,,DB02810
"(2s,4r)-1-Acetyl-N-[(1s)-4-[(Aminoiminomethyl)Amino]-1-(2-Benzothiazolylcarbonyl)Butyl]-4-Hydroxy-2-Pyrrolidinecarboxamide",,experimental,PRSS1,Trypsin-1,target,,DB02812
Indene,,experimental,E,Lysozyme,target,,DB02815
"7-(1-Methyl-1,2,3-Triazol-4-Yl)-6-Formyl-2,7-Dihydro-[1,4]Thiazepine-3-Carboxylic Acid, Brl42715, C6-(N1-Methyl-1,2,3-Triazolylmethylene)Penem",,experimental,ampC,Beta-lactamase,target,,DB02816
5-Exo-Hydroxycamphor,,experimental,camC,Camphor 5-monooxygenase,target,,DB02817
Iodo-Willardiine,,experimental,GRIA2,Glutamate receptor 2,target,,DB02818
"Mono-[3,4-Dihydroxy-5-(5-Methyl-Benzoimidazol-1-Yl)-Tetrahydor-Furan-2-Ylmethyl] Ester",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02819
"1-Azepan-1-Yl-2-Phenyl-2-(4-Thioxo-1,4-Dihydro-Pyrazolo[3,4-D]Pyrimidin-5-Yl)Ethanone Adduct",,experimental,HSD17B10,3-hydroxyacyl-CoA dehydrogenase type-2,target,,DB02820
Canaline,,experimental,OAT,"Ornithine aminotransferase, mitochondrial",target,inhibitor,DB02821
Para-Bromobenzyl Alcohol,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02822
Phosphonoacetic Acid,,experimental,phoA,Alkaline phosphatase,target,,DB02823
Methylphosphonic Acid Ester Group,,experimental,ACHE,Acetylcholinesterase,target,,DB02825
"7-(1,1-Dioxo-1h-Benzo[D]Isothiazol-3-Yloxymethyl)-2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02827
5-Fluorolevulinic Acid,,experimental,hemB,Delta-aminolevulinic acid dehydratase,target,,DB02828
4-(Acetylamino)-3-[(Aminoacetyl)Amino]Benzoic Acid,,experimental,NA,Neuraminidase,target,,DB02829
FR236913,,experimental,ADA,Adenosine deaminase,target,,DB02830
Siroheme,,experimental,cysI,Sulfite reductase [NADPH] hemoprotein beta-component,target,,DB02832
IDD552,,experimental,AKR1B1,Aldose reductase,target,,DB02834
O4-Sulfonylgalactose,,experimental,MBL2,Mannose-binding protein C,target,,DB02837
"3,4-Dihydro-2h-Pyrrolium-5-Carboxylate",,experimental,DAO,D-amino-acid oxidase,target,,DB02838
"4-(1,3-Benzodioxol-5-Yl)-5-(5-Ethyl-2,4-Dihydroxyphenyl)-2h-Pyrazole-3-Carboxylic Acid",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB02840
"S-Adenosyl-1,8-Diamino-3-Thiooctane",,experimental,speE,Spermidine synthase,target,,DB02844
Thioproline,,experimental,ANXA5,Annexin A5,target,,DB02846
"{4-[3-(6,7-Diethoxy-Quinazolin-4-Ylamino)-Phenyl]-Thiazol-2-Yl}-Methanol",,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB02848
N-Pyridoxyl-1-Amino-Cyclopropanecarboxylic Acid-5-Monophosphate,,experimental,dgdA,"2,2-dialkylglycine decarboxylase",target,,DB02849
(1-Tert-Butyl-5-Hydroxy-1h-Pyrazol-4-Yl)-(6-Methanesulfonyl-4'-Methoxy-2-Methyl-Biphenyl-3-Yl)-Methanone,,experimental,HPD,4-hydroxyphenylpyruvate dioxygenase,target,,DB02850
Thiocamphor,,experimental,camC,Camphor 5-monooxygenase,target,,DB02851
Domoic Acid,,experimental,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,,DB02852
N-(3-Propylcarbamoyloxirane-2-Carbonyl)-Isoleucyl-Proline,Neuroprotective AgentsCysteine Proteinase Inhibitors,experimental,CTSB,Cathepsin B,target,,DB02855
Methyl-Carbamic Acid Ethyl Ester,,experimental,stxB,Shiga-like toxin 1 subunit B,target,,DB02856
3-(4-Benzenesulfonyl-Thiophene-2-Sulfonylamino)-Phenylboronic Acid,,experimental,ampC,Beta-lactamase,target,,DB02858
Soraphen A,,experimental,ACACB,Acetyl-CoA carboxylase 2,target,,DB02859
Calyculin A,,experimental,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,target,,DB02860
"4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB02861
Alpha Chlorophyll A,,experimental,blm,Beta-lactamase 2,target,,DB02863
Glucosamine 4-Phosphate,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02865
Dansylamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB02866
D-Mannose 1-Phosphate,,experimental,algC,Phosphomannomutase/phosphoglucomutase,target,,DB02867
"3''-(Beta-Chloroethyl)-2'',4''-Dioxo-3, 5''-Spiro-Oxazolidino-4-Deacetoxy-Vinblastine",,experimental,CALM1,Calmodulin,target,,DB02868
N-Allyl-Aniline,,experimental,E,Lysozyme,target,,DB02870
3-Butylthiolane 1-Oxide,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB02871
"Cis-[4,5-Bis-(4-Bromophenyl)-2-(2-Ethoxy-4-Methoxyphenyl)-4,5-Dihydroimidazol-1-Yl]-[4-(2-Hydroxyethyl)Piperazin-1-Yl]Methanone",,experimental,MDM2,E3 ubiquitin-protein ligase Mdm2,target,,DB02872
"1-(2,6-Dichlorophenyl)-5-(2,4-Difluorophenyl)-7-Piperazin-1-Yl-3,4-Dihydroquinazolin-2(1h)-One",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB02873
CRA_1802,,experimental,PRSS1,Trypsin-1,target,,DB02875
"3-(4-Carbamoyl-1-Carboxy-2-Methylsulfonyl-Buta-1,3-Dienylamino)-Indolizine-2-Carboxylic Acid",,experimental,ampC,Beta-lactamase,target,,DB02876
TTNPB,Antineoplastic Agents,experimental,RARB,Retinoic acid receptor beta,target,,DB02877
3-(2-Aminoethyl)-4-(Aminomethyl)Heptanedioic Acid,,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB02878
"2,3-Di-O-Sulfo-Alpha-D-Glucopyranose",,experimental,TP_0574,47 kDa membrane antigen,target,,DB02879
"2',3'-Dideoxycytidine-5'-Monophosphate",,experimental,cmk,Cytidylate kinase,target,,DB02883
Beta-Cyclohexyl-Alanine,,experimental,ZFY,Zinc finger Y-chromosomal protein,target,,DB02884
4-Imino-5-Methidyl-2-Trifluoromethylpyrimidine,,experimental,thiE,Thiamine-phosphate synthase,target,,DB02885
"2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate",,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB02887
FKB-001,,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB02888
"4-O-(4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Beta-D-Lyxo-Hexopyranosyl)-Alpha-D-Erythro-Hexopyranose",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB02889
L-2-Amino-6-Methylene-Pimelic Acid,,experimental,ddh,Meso-diaminopimelate D-dehydrogenase,target,,DB02892
"Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester",,experimental,CA2,Carbonic anhydrase 2,target,,DB02894
3-(Prop-2-Ene-1-Sulfinyl)-Propene-1-Thiol,,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB02895
Methylthioinosine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB02896
5-{[(2-Amino-9h-Purin-6-Yl)Oxy]Methyl}-2-Pyrrolidinone,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02898
3'-Phosphate-Adenosine-5'-Phosphate Sulfate,,experimental,SULT1E1,Estrogen sulfotransferase,target,,DB02902
BV3,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB02903
Beta-3-Serine,,experimental,env,Envelope glycoprotein gp160,target,,DB02904
"Phosphoric Acid Mono-[3,4-Dihydroxy-5-(5-Hydroxy-Benzoimidazol-1-Yl)Tetrahydro-Furan-2-Ylmethyl] Ester",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02905
"(2s,4s)-Alpha-Campholinic Acid",,experimental,camK,6-oxocamphor hydrolase,target,,DB02906
2-Amino-Vinyl-Phosphate,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB02907
RU78783,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB02908
"2,4-Diamino-6-Phenyl-5,6,7,8,-Tetrahydropteridine",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02911
Propionyl Coenzyme A,,experimental,pccB,Propionyl-CoA carboxylase complex B subunit,target,,DB02912
N-Hydroxy-4-(Methyl{[5-(2-Pyridinyl)-2-Thienyl]Sulfonyl}Amino)Benzamide,,experimental,HDAC8,Histone deacetylase 8,target,,DB02917
6-(4-Difluoromethoxy-3-Methoxy-Phenyl)-2h-Pyridazin-3-One,,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB02918
"2,4-Diamino-6-[N-(3',4',5'-Trimethoxybenzyl)-N-Methylamino]Pyrido[2,3-D]Pyrimidine",,experimental,DHFR,Dihydrofolate reductase,target,,DB02919
(South)-Methanocarba-Thymidine,,experimental,TK,Thymidine kinase,target,,DB02921
"D-Limonene 1,2-Epoxide",,experimental,LCN9,Epididymal-specific lipocalin-9,target,,DB02924
Piretanide,,experimental,SLC12A1,Solute carrier family 12 member 1,target,inhibitor,DB02925
"Mixed Carbamic Phosphoric Acid Anhydride of 7,8-Diaminononanic Acid",,experimental,bioD,ATP-dependent dethiobiotin synthetase BioD 1,target,,DB02927
3-Amino-6-Hydroxy-Tyrosine,,experimental,tynA,Primary amine oxidase,target,,DB02928
K201,,experimental,ANXA5,Annexin A5,target,,DB02929
Coa-S-Acetyl Tryptamine,,experimental,AANAT,Serotonin N-acetyltransferase,target,,DB02931
(2r)-N-[4-Cyano-3-(Trifluoromethyl)Phenyl]-3-[(4-Fluorophenyl)Sulfonyl]-2-Hydroxy-2-Methylpropanamide,,experimental,AR,Androgen receptor,target,,DB02932
9-(6-Deoxy-Alpha-L-Talofuranosyl)-6-Methylpurine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB02934
1-Methoxy-2-(2-Methoxyethoxy)Ethane,,experimental,HSP90B1,Endoplasmin,target,,DB02935
4-(1-Benzyl-3-Carbamoylmethyl-2-Methyl-1h-Indol-5-Yloxy)-Butyric Acid,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB02936
Heptanoic Acid,,experimental,PLA2G1B,Phospholipase A2,target,,DB02938
[(1e)-4-Phenylbut-1-Enyl]Benzene,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB02939
3-(1-Aminoethyl)Nonanedioic Acid,,experimental,bioD,ATP-dependent dethiobiotin synthetase BioD 1,target,,DB02941
"Inositol 1,3-Bisphosphate",,experimental,EEA1,Early endosome antigen 1,target,,DB02942
N-(4-Aminobutanoyl)-S-(4-Methoxybenzyl)-L-Cysteinylglycine,,experimental,GSTA1,Glutathione S-transferase A1,target,,DB02943
L-Iduronic Acid,,experimental,cslA,Chondroitinase-AC,target,,DB02945
2-Fluoro-2'-Deoxyadenosine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB02947
Fosmidomycin,,experimental,dxr,1-deoxy-D-xylulose 5-phosphate reductoisomerase,target,,DB02948
2-Acetyl-Protoporphyrin Ix,,experimental,cycA,Cytochrome c-552,target,,DB02949
2-Thiomethyl-3-Phenylpropanoic Acid,,experimental,MMP8,Neutrophil collagenase,target,,DB02953
Pentasulfide-Sulfur,,experimental,sud,Sulfide dehydrogenase,target,,DB02956
Oxitriptan,"Antidepressive Agents, Second-Generation",approvednutraceutical,trpS2,Tryptophan--tRNA ligase 2,target,,DB02959
L-Rhamnose,,experimental,rhaA,L-rhamnose isomerase,target,,DB02961
Benzimidazole,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB02962
"(5-Chloropyrazolo[1,5-a]Pyrimidin-7-Yl)-(4-Methanesulfonylphenyl)Amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02963
"8,9,10-Trihydroxy-7-Hydroxymethyl-2-Thioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Decan-4-One",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB02964
Ndelta-(N'-Sulphodiaminophosphinyl)-L-Ornithine,,experimental,argI,Ornithine carbamoyltransferase chain I,target,,DB02965
Fluoro-Willardiine,,experimental,GRIA2,Glutamate receptor 2,target,,DB02966
N-Ethylmaleimide,,experimental,CLC,Galectin-10,target,,DB02967
4-Methyl-5-Hydroxyethylthiazole,,experimental,thiM,Hydroxyethylthiazole kinase,target,,DB02969
2-Propyl-Aniline,,experimental,E,Lysozyme,target,,DB02970
1-Benzyl-(R)-Propylamine,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB02972
4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB02973
4-(4-Chlorophenyl)Imidazole,,experimental,CYP2B6,Cytochrome P450 2B6,target,,DB02974
Ge2270a,,experimental,tufA,Elongation factor Tu,target,,DB02975
PNU177836,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB02977
"N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB02979
Thymidine-5'-(Dithio)Phosphate,,experimental,,Nuclease P1,target,,DB02980
Vitamin B6 Complexed with 2-Amino-Hexanoic Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB02981
"4-[3-Methylsulfanylanilino]-6,7-Dimethoxyquinazoline",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB02984
8-Iodo-Guanine,,experimental,punA,Purine nucleoside phosphorylase,target,,DB02985
"N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB02986
Imino-Tryptophan,,experimental,DAO,D-amino-acid oxidase,target,,DB02988
CRA_10972,,experimental,PRSS1,Trypsin-1,target,,DB02989
C16-Fatty-Acyl-Substrate-Mimic,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB02990
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB02991
1-Deoxy-6-O-Phosphono-1-[(Phosphonomethyl)Amino]-L-Threo-Hexitol,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB02992
Cyclohexylammonium Ion,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB02995
2-(Thiomethylene)-4-Methylpentanoic Acid,,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB02996
"9-Hydroxypropyladenine, S-Isomer",,experimental,TK,Thymidine kinase,target,,DB03000
"3,8-Diamino-6-Phenyl-5-[6-[1-[2-[(1,2,3,4-Tetrahydro-9-Acridinyl)Amino]Ethyl]-1h-1,2,3-Triazol-5-Yl]Hexyl]-Phenanthridinium",,experimental,ACHE,Acetylcholinesterase,target,,DB03005
4-Aminophenylarsonic Acid,,experimental,LYZ,Lysozyme C,target,,DB03006
5-Fluoro-Beta-L-Gulosyl Fluoride,,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB03008
Adenosine-5'-(Dithio)Phosphate,,experimental,,Nuclease P1,target,,DB03011
Phenylalanine-N-Sulfonamide,,experimental,CPA1,Carboxypeptidase A1,target,,DB03012
"6-Hydroxy-1,6-Dihydro Purine Nucleoside",,experimental,ADA,Adenosine deaminase,target,,DB03015
CRA_1801,,experimental,PRSS1,Trypsin-1,target,,DB03016
"3,4-Dimethylaniline",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03018
"4-(2,5-Dichloro-Thiophen-3-Yl)-Pyrimidin-2-Ylamine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03019
5-Beta-D-Ribofuranosylnicotinamide Adenine Dinucleotide,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB03020
Ulapualide A,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB03021
"3-{2,6,8-Trioxo-9-[(2r,3s,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB03022
2-Methyl-3-(2-Aminothiazolo)Propanal,,experimental,REN,Renin,target,,DB03024
1h-Benoximidazole-2-Carboxylic Acid,,experimental,CTSD,Cathepsin D,target,,DB03028
Ortho-Xylene,,experimental,E,Lysozyme,target,,DB03029
4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole,,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB03030
Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide,,experimental,camC,Camphor 5-monooxygenase,target,,DB03031
S-Octylglutathione,,experimental,GSTM4,Glutathione S-transferase Mu 4,target,,DB03032
Dextrofloxacine,,experimental,lytA,Autolysin,target,,DB03034
"1,8-Di-Hydroxy-4-Nitro-Anthraquinone",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB03035
Oxidized Acetyl Dithranol,,experimental,actVA 6,ActVA 6 protein,target,,DB03037
LY341770,,experimental,thyA,Thymidylate synthase,target,,DB03038
"4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB03039
Nitrilotriacetic Acid,,experimental,LTF,Lactotransferrin,target,,DB03040
1-(5-Tert-Butyl-2-P-Tolyl-2h-Pyrazol-3-Yl)-3-[4-(2-Morpholin-4-Yl-Ethoxy)-Naphthalen-1-Yl]-Urea,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB03044
Pantothenyl-Aminoethanol-Acetate Pivalic Acid,,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB03045
7-Methoxy-8-[1-(Methylsulfonyl)-1h-Pyrazol-4-Yl]Naphthalene-2-Carboximidamide,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03046
6-Carboxymethyluracil,,experimental,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB03048
S-Selanyl Cysteine,,experimental,sufS,Cysteine desulfurase,target,,DB03049
Geran-8-Yl Geran,,experimental,GDI1,Rab GDP dissociation inhibitor alpha,target,,DB03050
Dazoxiben,AntithrombinsEnzyme Inhibitors,experimental,TBXAS1,Thromboxane-A synthase,target,inhibitor,DB03052
1-Aminocyclopropylphosphonate,,experimental,acdS,1-aminocyclopropane-1-carboxylate deaminase,target,,DB03053
4-Piperidino-Piperidine,,experimental,CES1,Liver carboxylesterase 1,target,,DB03056
Malonaldehyde,,experimental,bla,Beta-lactamase SHV-1,target,,DB03057
Isatoic Anhydride,,experimental,CFD,Complement factor D,target,,DB03058
Sri-9662,,experimental,DHFR,Dihydrofolate reductase,target,,DB03060
(R)-N-(1-Methyl-Hexyl)-Formamide,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB03061
"N-(1-Benzyl-3-{[3-(1,3-Dioxo-1,3-Dihydro-Isoindol-2-Yl)-Propionyl]-[2-(Hexahydro-Benzo[1,3]Dioxol-5-Yl)-Ethyl]-Amino}-2-Hydroxy-Propyl)-4-Benzyloxy-3,5-Dimethoxy-Benzamide",,experimental,,Plasmepsin-2,target,,DB03063
"3-Decyl-2,5-Dioxo-4-Hydroxy-3-Pyrroline",,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB03064
7-Nitroindazole-2-Carboxamidine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03065
D-Lactic Acid,,experimental,,(S)-2-haloacid dehalogenase,target,,DB03066
"4-{2,4-Bis[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03067
Zebularine,,experimental,cdd,Cytidine deaminase,target,,DB03068
Cytidine-5'-Diphospho-Beta-D-Xylose,,experimental,rfbG,"CDP-glucose 4,6-dehydratase",target,,DB03069
Selenazole-4-Carboxyamide-Adenine Dinucleotide,,experimental,IMPDH2,Inosine-5'-monophosphate dehydrogenase 2,target,,DB03070
"2-{3-[4-(4-Fluorophenyl)-3,6-Dihydro-1(2h)-Pyridinyl]Propyl}-8-Methyl-4(3h)-Quinazolinone",,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB03072
3-Methoxybenzamide,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB03073
7-Deaza-7-Cyano-Guanine,,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB03074
(Diphosphono)Aminophosphonic Acid,,experimental,metK,S-adenosylmethionine synthase,target,,DB03075
AHA047,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03076
PASBN,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03078
Alpha-Ribazole-5'-Phosphate Derivative,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03079
17-Dmag,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03080
Crc200 (Chiron-Behring),,experimental,PRSS1,Trypsin-1,target,,DB03081
6-[(Z)-Amino(Imino)Methyl]-N-[4-(Aminomethyl)Phenyl]-4-(Pyrimidin-2-Ylamino)-2-Naphthamide,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03082
IC261,,experimental,CSNK1G2,Casein kinase I isoform gamma-2,target,,DB03083
"Cyclopropyl-{4-[5-(3,4-Dichlorophenyl)-2-[(1-Methyl)-Piperidin]-4-Yl-3-Propyl-3h-Imidazol-4-Yl]-Pyrimidin-2-Yl}Amine",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB03084
"N'-(2s,3r)-3-Amino-4-Cyclohexyl-2-Hydroxy-Butano-N-(4-Methylphenyl)Hydrazide",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB03086
2-(Sec-Butyl)Thiazole,,experimental,LCN9,Epididymal-specific lipocalin-9,target,,DB03087
L-Iso-Aspartate,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB03089
Ethylaminobenzylmethylcarbonyl Group,,experimental,SAP2,Candidapepsin-2,target,,DB03090
4-Amido-4-Carbamoyl-Butyric Acid,,experimental,atpF,ATP synthase subunit b,target,,DB03091
"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03093
Tetramethylammonium Ion,,experimental,GALE,UDP-glucose 4-epimerase,target,,DB03095
N-Aminoethylmorpholine,,experimental,CTSD,Cathepsin D,target,,DB03096
"Pmp-Hydroxyisoxazole, Pyridoxamine-5-Phosphate-Hydroxyisoxazole",,experimental,alr,Alanine racemase,target,,DB03097
[Methylseleno]Acetate,,experimental,soxA,Monomeric sarcosine oxidase,target,,DB03098
"2-(Oxalyl-Amino)-4,7-Dihydro-5h-Thieno[2,3-C]Pyran-3-Carboxylic Acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03102
Thymidine-5'- Diphosphate,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB03103
RU82129,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03104
Beta-Alanine,,experimental,panC,Pantothenate synthetase,target,,DB03107
4-Phospho-D-Erythronate,,experimental,rpiB,Ribose-5-phosphate isomerase B,target,,DB03108
2-Chlorophenol,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB03110
Glucosamine 1-Phosphate,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB03111
"6-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Hexanoic Acid",,experimental,,Streptavidin,target,,DB03112
3-Fluoro-2-(Phosphonooxy)Propanoic Acid,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB03113
PAS219,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03114
"5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide",,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB03115
5-(1-Carboxy-1-Phosphonooxy-Ethoxyl)-Shikimate-3-Phosphate,,experimental,aroA,3-phosphoshikimate 1-carboxyvinyltransferase,target,,DB03116
2-Carboxypropyl-Coenzyme A,,experimental,mmcD,Methylmalonyl-CoA decarboxylase,target,,DB03117
1-(5-Chloroindol-3-Yl)-3-Hydroxy-3-(2h-Tetrazol-5-Yl)-Propenone,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03118
1-Benzyl-5-Methoxy-2-Methyl-1h-Indol-3-Yl)-Acetic Acid,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB03121
5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid,,experimental,CASP3,Caspase-3,target,,DB03124
Mant-Adp,,experimental,MYH14,Myosin-14,target,,DB03126
Acetylcholine,Vasodilator AgentsCholinergic AgonistsCholinergic Agents,experimental,ACHE,Acetylcholinesterase,target,,DB03128
"[3-(1,3,2-Dioxaborolan-2-Yloxy)Propyl]Guanidine",,experimental,PRSS3,Trypsin-3,target,,DB03129
S-P-Nitrobenzyloxycarbonylglutathione,,experimental,GLO1,Lactoylglutathione lyase,target,,DB03130
"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,2,3-Benzimidazole",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03133
2-Aminopimelic Acid,,experimental,dapD,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",target,,DB03134
[2(Formyl-Hydroxy-Amino)-Ethyl]-Phosphonic Acid,,experimental,TPI1,Triosephosphate isomerase,target,,DB03135
"8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9-Pent-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03137
Perchlorate Ion,,experimental,arsC,Protein ArsC,target,,DB03138
"6-[5-(2-Oxo-Hexahydro-Thieno[3,4-D]Imidazol-4-Yl)-Pentanoylamino]-Hexanoic Acid",,experimental,,Streptavidin,target,,DB03139
4-Carboxyphenylboronic Acid,,experimental,ampC,Beta-lactamase,target,,DB03140
Nonan-1-Ol,,experimental,atpE,"ATP synthase subunit c, sodium ion specific",target,,DB03143
4-Methyl-5-Hydroxyethylthiazole Phosphate,,experimental,thiE,Thiamine-phosphate synthase,target,,DB03145
2-Deazo-6-Thiophosphate Guanosine-5'-Monophosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB03146
"2',3'-Dideoxythymidine-5'-Monophosphate",,experimental,DTYMK,Thymidylate kinase,target,,DB03150
"3h-Pyrazolo[4,3-D]Pyrimidin-7-Ol",,experimental,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB03153
{[7-(Difluoro-Phosphono-Methyl)-Naphthalen-2-Yl]-Difluoro-Methyl}-Phosphonic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03154
"1-(2-Deoxy-2-Fluoro-3-O-Phosphono-Beta-L-Ribofuranosyl)Pyrimidine-2,4(1h,3h)-Dione",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03155
"N,O-Didansyl-L-Tyrosine",,experimental,thyA,Thymidylate synthase,target,,DB03157
"D-Myo-Inositol-1,4-Bisphosphate",,experimental,INPP5B,"Type II inositol 1,4,5-trisphosphate 5-phosphatase",target,,DB03158
N-Pyridoxyl-7-Keto-8-Aminopelargonic Acid-5'-Monophosphate,,experimental,bioF,8-amino-7-oxononanoate synthase,target,,DB03160
"4-Hydroxy-1,2,5-Thiadiazole-3-Carboxylic Acid",,experimental,,L-lactate dehydrogenase,target,,DB03162
(2-[2-Ketopropylthio]Ethanesulfonate,,experimental,xecC,"2-oxopropyl-CoM reductase, carboxylating",target,,DB03163
6-Amino-1-Methylpurine,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB03164
2-Dimethylamino-Ethyl-Diphosphate,,experimental,idi,Isopentenyl-diphosphate Delta-isomerase,target,,DB03165
Dephospho Coenzyme A,,experimental,coaD,Phosphopantetheine adenylyltransferase,target,,DB03170
Tubercidin,"Antibiotics, AntineoplasticAntimetabolites, Antineoplastic",experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB03172
CRA_10433,,experimental,PRSS1,Trypsin-1,target,,DB03173
Phosphonoacetaldehyde,,experimental,phnX,Phosphonoacetaldehyde hydrolase,target,,DB03174
1-Proponol,,experimental,LYZ,Lysozyme C,target,,DB03175
5-methylbenzimidazole,Anti-Bacterial Agents,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03177
"Guanosine-2',3'-Cyclophosphorothioate",,experimental,rnaSA,Guanyl-specific ribonuclease Sa,target,,DB03178
Sinapoyl Coenzyme A,,experimental,COMTD1,Catechol O-methyltransferase domain-containing protein 1,target,,DB03179
"4,5-Dimethyl-1,2-Phenylenediamine",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03180
"2-[4-(4-Hydroxy-3-Isopropyl-Phenoxy)-3,5-Dimethyl-Phenyl]-2h-[1,2,4]Triazine-3,5-Dione",,experimental,THRB,Thyroid hormone receptor beta,target,,DB03181
Alpha-Fluoro-Carboxymethyldethia Coenzyme a Complex,,experimental,CS,"Citrate synthase, mitochondrial",target,,DB03182
"1-(4-Aminophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB03183
"1-Beta-Ribofuranosyl-1,3-Diazepinone",,experimental,CDA,Cytidine deaminase,target,,DB03185
U-Pi-a-Pi,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03186
6-(Hydroxyethyldithio)-8-(Aminomethylthio)Octanoic Acid,,experimental,GCSH,"Glycine cleavage system H protein, mitochondrial",target,,DB03187
4-Thio-Beta-D-Glucopyranose,,experimental,celCCG,Endoglucanase G,target,,DB03188
Cu-Cyclam,,experimental,LYZ,Lysozyme C,target,,DB03189
"N-Octanoyl-B-D-Fructofuranosyl-a-D-Glucopyranoside,Sucrose Monocaproylate",,experimental,pbpX,Penicillin-binding protein 2X,target,,DB03190
3-Oxiran-2ylalanine,,experimental,MAT1A,S-adenosylmethionine synthase isoform type-1,target,,DB03191
3r-Hydroxydecanoyl-Coa,,experimental,HSD17B4,Peroxisomal multifunctional enzyme type 2,target,,DB03192
Stearic acid,Pharmaceutic Aids,experimental,PLA2G2D,Group IID secretory phospholipase A2,target,,DB03193
Beta-L-Methyl-Fucose,,experimental,MBL2,Mannose-binding protein C,target,,DB03194
"Phosphoric Acid Mono-[3-Fluoro-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahyro-Furan-2-Ylmethyl] Ester",,experimental,DTYMK,Thymidylate kinase,target,,DB03195
4-Nitrophenyl-Ara,,experimental,abfA,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,target,,DB03196
6-Hydroxymethylpterin,,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB03197
Thio-Maltohexaose,,experimental,,Cyclomaltodextrin glucanotransferase,target,,DB03198
4-Methoxy-E-Rhodomycin T,,experimental,dnrK,Carminomycin 4-O-methyltransferase,target,,DB03199
7-Alpha-D-Ribofuranosyl-Purine-5'-Phosphate,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03200
D-Cysteine,,experimental,CPA1,Carboxypeptidase A1,target,,DB03201
"2-[5-Methanesulfonylamino-2-(4-Aminophenyl)-6-Oxo-1,6-Dihydro-1-Pyrimidinyl]-N-(3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl)Acetamide",,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB03202
"2-(Biphenyl-4-Sulfonyl)-1,2,3,4-Tetrahydro-Isoquinoline-3-Carboxylic Acid",,experimental,MMP8,Neutrophil collagenase,target,,DB03207
4-Aminohydrocinnamic Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB03210
(3-Formyl-but-3-Enyl)-Phosphonic Acid,,experimental,,"Glyceraldehyde-3-phosphate dehydrogenase, glycosomal",target,,DB03211
4-Deoxyglucarate,,experimental,gudD,Glucarate dehydratase,target,,DB03212
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone,,experimental,PRSS1,Trypsin-1,target,,DB03213
"(2s,5s)-5-Carboxymethylproline",,experimental,carA,Carbapenam-3-carboxylate synthase,target,,DB03215
"(1'r,2's)-9-(2-Hydroxy-3'-Keto-Cyclopenten-1-Yl)Adenine",,experimental,AHCY,Adenosylhomocysteinase,target,,DB03216
DPI59,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03217
N-Acetyl-N'-Beta-D-Glucopyranosyl Urea,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03218
11-Deoxy-Beta-Rhodomycin,,experimental,rdmB,RdmB,target,,DB03219
FR233623,,experimental,ADA,Adenosine deaminase,target,,DB03220
AL7099A,,experimental,CA2,Carbonic anhydrase 2,target,,DB03221
Diphthamide,,experimental,EEF2,Elongation factor 2,target,,DB03223
2-Formyl-Protoporphryn Ix,,experimental,cycA,Cytochrome c-552,target,,DB03224
D-Tryptophan,,experimental,DAO,D-amino-acid oxidase,target,,DB03225
"5-[Bis-2(Chloro-Ethyl)-Amino]-2,4-Dintro-Benzamide",,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB03228
Adenosine-5'-Propylphosphate,,experimental,acs,Acetyl-coenzyme A synthetase,target,,DB03230
"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-[2-(2-(Hydroxymethyl-Phenylsulfanyl)-Benzyl]-Benzamide",,experimental,folB,Dihydroneopterin aldolase,target,,DB03231
"2-[(2e,6e,10e,14e,18e,22e,26e)-3,7,11,15,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-Octaenyl]Phenol",,experimental,yceI,Protein YceI,target,,DB03232
"Phosphoric Acid Mono-[3-Amino-5-(5-Methyl-2,4-Dioxo-3,4-Dihydro-2h-Pyrimidin-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",,experimental,DTYMK,Thymidylate kinase,target,,DB03233
"(4'-{[Allyl(Methyl)Amino]Methyl}-1,1'-Biphenyl-4-Yl)(4-Bromophenyl)Methanone",,experimental,shc,Squalene--hopene cyclase,target,,DB03234
N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-Nitro-5-(Galactopyranosyl)-Alpha-Benzamide,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB03235
"2,3-Dihydroxy-5-Oxo-Hexanedioate",,experimental,gudD,Glucarate dehydratase,target,,DB03237
"3,5-Difluoroaniline",,experimental,E,Lysozyme,target,,DB03238
"(S)-2-Amino-3-(1,3,5,7-Pentahydro-2,4-Dioxo-Cyclopenta[E]Pyrimidin-1-Yl) Proionic Acid",,experimental,GRIA2,Glutamate receptor 2,target,,DB03240
1-Amino-1-Carbonyl Pentane,,experimental,SAP2,Candidapepsin-2,target,,DB03241
P-Aminophenyl-Alpha-D-Galactopyranoside,,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB03242
4-Fluorobenzylamine,,experimental,PRSS1,Trypsin-1,target,,DB03243
S-4-Nitrobutyryl-Coa,,experimental,GCDH,"Glutaryl-CoA dehydrogenase, mitochondrial",target,,DB03245
Beta-L-Arabinose,,experimental,araF,L-arabinose-binding periplasmic protein,target,,DB03246
2-(Phosphonooxy)Butanoic Acid,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB03248
"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Benzothiazole",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03250
RWJ-51084,,experimental,PRSS1,Trypsin-1,target,,DB03251
(2s)-Pyrrolidin-2-Ylmethylamine,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB03253
4-Phenyl-1h-Imidazole,,experimental,SCO1207,Putative cytochrome P450,target,,DB03254
"5-[1-(Acetylamino)-3-Methylbutyl]-2,5-Anhydro-3,4-Dideoxy-4-(Methoxycarbonyl)Pentonic Acid",,experimental,NA,Neuraminidase,target,,DB03257
"2',6'-Dichloro-Biphenyl-2,6-Diol",,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB03259
"1,6-Diaminohexane",,experimental,DR_A0149,"Agmatinase, putative",target,,DB03260
"Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",,experimental,CA2,Carbonic anhydrase 2,target,,DB03262
1-Allyl-3-Butyl-8-(N-Acetyl-4-Aminobenzyl)-Xanthine,,experimental,PCK1,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",target,,DB03267
RU82197,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03268
"2,6-Difluorobenzenesulfonamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB03270
3'-Oxo-Adenosine,,experimental,AHCY,Adenosylhomocysteinase,target,,DB03273
2'-5'dideoxyuridine,,experimental,thyA,Thymidylate synthase,target,,DB03274
"4-[(10s,14s,18s)-18-(2-Amino-2-Oxoethyl)-14-(1-Naphthylmethyl)-8,17,20-Trioxo-7,16,19-Triazaspiro[5.14]Icos-11-En-10-Yl]Benzylphosphonic Acid",,experimental,GRB2,Growth factor receptor-bound protein 2,target,,DB03276
D-Treitol,,experimental,pflB,Formate acetyltransferase 1,target,,DB03278
Dodecyl-Alpha-D-Maltoside,,experimental,RARG,Retinoic acid receptor gamma,target,,DB03279
"2,6-Anhydro-3-Deoxy-D-Erythro-Hex-2-Enonic Acid",,experimental,,Chondroitinase (Chondroitin lyase),target,,DB03284
C-(1-Azido-Alpha-D-Glucopyranosyl) Formamide,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03286
5-Chloro-1h-Indole-2-Carboxylic Acid{[Cyclopentyl-(2-Hydroxy-Ethyl)-Carbamoyl]-Methyl}-Amide,,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB03288
Thiarsa Dihydroxy Cysteine,,experimental,arsC,Arsenate reductase,target,,DB03289
L-Naphthyl-1-Acetamido Boronic Acid Alanine,,experimental,apr,Subtilisin Carlsberg,target,,DB03290
D-2-Amino-3-Phosphono-Propionic Acid,,experimental,PSPH,Phosphoserine phosphatase,target,,DB03292
"1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide",,experimental,CA2,Carbonic anhydrase 2,target,,DB03294
Lactose Sialic Acid,,experimental,,Trans-sialidase,target,,DB03296
Phenylphosphate,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03298
N-Succinyl Phenylglycine,,experimental,Aaar,N-acylamino acid racemase,target,,DB03299
Pterin Cytosine Dinucleotide,,experimental,MOD,Aldehyde oxidoreductase,target,,DB03300
2-Allyl-6-Methyl-Phenol,,experimental,E,Lysozyme,target,,DB03301
7-Deaza-7-Aminomethyl-Guanine,,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB03304
N5-Iminoethyl-L-Ornithine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03305
RU78300,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03306
4-[(6-Amino-4-Pyrimidinyl)Amino]Benzenesulfonamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03307
L-Leucyl-Hydroxylamine,,experimental,nprS,Thermolysin,target,,DB03308
"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid [4-(Thiazol-2-Ylsulfamoyl)-Phenyl]-Amide",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03311
5-Bromovinyldeoxyuridine,,experimental,TK,Thymidine kinase,target,,DB03312
(S)-ATPA,,experimental,GRIA2,Glutamate receptor 2,target,,DB03319
3-Amino-Alanine,,experimental,env,Envelope glycoprotein gp160,target,,DB03320
"4-Amino-2-Deoxy-2,3-Dehydro-N-Neuraminic Acid",,experimental,NA,Neuraminidase,target,,DB03321
Tyrosyladenylate,,experimental,tyrS,Tyrosine--tRNA ligase,target,,DB03325
"deoxycytidylyl-3',5'-guanosine",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03326
{1-[(3-Hydroxy-Methyl-5-Phosphonooxy-Methyl-Pyridin-4-Ylmethyl)-Amino]-Ethyl}-Phosphonic Acid,,experimental,alr,Alanine racemase,target,,DB03327
dioxothiomolybdenum(VI) ion,,experimental,XDH,Xanthine dehydrogenase/oxidase,target,,DB03328
2-Pyridinethiol,Cathepsin B,experimental,CTSB,Cathepsin B,target,,DB03329
S-(N-Hydroxy-N-Iodophenylcarbamoyl)Glutathione,,experimental,GLO1,Lactoylglutathione lyase,target,,DB03330
"N-Naphthalen-1-Ylmethyl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",,experimental,GAPDHS,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",target,,DB03331
"5,6-Cyclic-Tetrahydropteridine",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03332
(4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester,,experimental,CA2,Carbonic anhydrase 2,target,,DB03333
1-Bromopropane-2-Ol,,experimental,linB,Haloalkane dehalogenase,target,,DB03335
BIA,,experimental,COMT,Catechol O-methyltransferase,target,,DB03336
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea,,experimental,PRSS1,Trypsin-1,target,,DB03337
3-[(1-Amino-2-Carboxy-Ethyl)-Hydroxy-Phosphinoyl]-2-Methyl-Propionic Acid,,experimental,pepV,Beta-Ala-Xaa dipeptidase,target,,DB03340
Coa-S-Acetyl 5-Bromotryptamine,,experimental,AANAT,Serotonin N-acetyltransferase,target,,DB03341
4-(Acetylamino)-3-Guanidinobenzoic Acid,,experimental,NA,Neuraminidase,target,,DB03342
Malate Like Intermediate,,experimental,fccA,Fumarate reductase flavoprotein subunit,target,,DB03343
"Inositol-(1,3,4,5,6)-Pentakisphosphate",,experimental,CYTH3,Cytohesin-3,target,,DB03344
"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",,experimental,SULT1E1,Estrogen sulfotransferase,target,,DB03346
Huperzine B,,investigational,ACHE,Acetylcholinesterase,target,,DB03348
Sri-9439,,experimental,DHFR,Dihydrofolate reductase,target,,DB03351
2-Iminobiotin,,experimental,,Streptavidin,target,,DB03353
"2-(Beta-D-Glucopyranosyl)-5-Methyl-1,3,4-Oxadiazole",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03354
(S)-Mandelic Acid,,experimental,mdlA,Mandelate racemase,target,,DB03357
7n-Methyl-8-Hydroguanosine-5'-Triphosphate,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB03358
"M-(N,N,N-Trimethylammonio)-2,2,2-Trifluoro-1,1-Dihydroxyethylbenzene",,experimental,ACHE,Acetylcholinesterase,target,,DB03359
N-Acetylproline,,experimental,carC,(5R)-carbapenem-3-carboxylate synthase,target,,DB03360
"2-{(9as)-9a-[(1s)-1-Hydroxyethyl]-2,7-Dimethyl-9a,10-Dihydro-5h-Pyrimido[4,5-D][1,3]Thiazolo[3,2-a]Pyrimidin-8-Yl}Ethyl Trihydrogen Diphosphate",,experimental,budB,"Acetolactate synthase, catabolic",target,,DB03361
N-Carbamyl-D-Methionine,,experimental,,N-carbamoyl-D-amino acid hydrolase,target,,DB03364
"4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03365
PF-00356231,,experimental,MMP12,Macrophage metalloelastase,target,,DB03367
"5-Methyl-5-(4-Phenoxy-Phenyl)-Pyrimidine-2,4,6-Trione",,experimental,MMP3,Stromelysin-1,target,,DB03368
9-Aminophenanthrene,,experimental,eryF,6-deoxyerythronolide B hydroxylase,target,,DB03369
FR239087,,experimental,ADA,Adenosine deaminase,target,,DB03370
Modified Ribosylated Glutamyl Ester,,experimental,ptd,Nucleoside deoxyribosyltransferase-I,target,,DB03371
"3-Mercapto-1-(1,3,4,9-Tetrahydro-B-Carbolin-2-Yl)-Propan-1-One",,experimental,IL2,Interleukin-2,target,,DB03372
ZK-806711,,experimental,PRSS1,Trypsin-1,target,,DB03373
5'-O-(N-(L-Alanyl)-Sulfamoyl)Adenosine,,experimental,EPRS,Bifunctional glutamate/proline--tRNA ligase,target,,DB03376
2-Carboxyethylphosphonic Acid,,experimental,TPI1,Triosephosphate isomerase,target,,DB03379
5-Chloro-1h-Indole-2-Carboxylic Acid [1-(4-Fluorobenzyl)-2-(4-Hydroxypiperidin-1yl)-2-Oxoethyl]Amide,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03383
Fica,,experimental,CASP7,Caspase-7,target,,DB03384
"3-[(2,4-Dichlorobenzoyl)(Isopropyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid",,experimental,,Genome polyprotein,target,,DB03388
N-Propyl-Tartramic Acid,,experimental,ACPP,Prostatic acid phosphatase,target,,DB03390
"(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yl)-Phosphoramidic Acid Dimethyl Ester",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03392
"(3s,6s,9r,10r,11s,12s,13e,15e,18s,21s)-18-{(1e,3e,7s,8s)-9-[(2s,3r,4s,5s,6r,9s,11s)-9-Ethyl-4-Hydroxy-3,5,11-Trimethyl-8-Oxo-1-Oxa-7-Azaspiro[5.5]Undec-2-Yl]-8-Hydroxy-1,7-Dimethylnona-1,3-Dienyl}-10,12-Dihydroxy-3-(3-Hydroxybenzyl)-6-Isopropyl-11-Methyl-",,experimental,PPIA,Peptidyl-prolyl cis-trans isomerase A,target,,DB03393
Enalkiren,,experimental,REN,Renin,target,inhibitor,DB03395
"(E)-(2r,3r,4s,5r)-3,4,5-Trihydroxy-2-Methoxy-8,8-Dimethyl-Non-6-Enoic Acid ((3s,6r)-6-Hydroxy-2-Oxo-Azepan-3-Yl)-Amide",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB03396
Ethyl Isocyanide,,experimental,MB,Myoglobin,target,,DB03399
3-(P-Tolyl)Propionic Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB03400
"6,7-Dicarboxyl-1,2,3,4,5,8-Hexamethylhemin",,experimental,MB,Myoglobin,target,,DB03404
1-[N[(Phenylmethoxy)Carbonyl]-L-Leucyl-4-[[N/N-[(Phenylmethoxy)Carbonyl]-/Nl-Leucyl]Amino]-3-Pyrrolidinone/N,,experimental,CTSK,Cathepsin K,target,,DB03405
Gamma-Glutamylcysteine,,experimental,GSS,Glutathione synthetase,target,,DB03408
4-hydroxycoumarin,,experimental,,Major NAD(P)H-flavin oxidoreductase,target,,DB03410
"2-Hydroxymethyl-Pyrrolidine-3,4-Diol",,experimental,punA,Purine nucleoside phosphorylase,target,,DB03411
6-Hydroxy-L-Norleucine,,experimental,ansB,L-asparaginase,target,,DB03412
5-Thio-a/B-D-Mannopyranosylamine,,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB03414
3-Thiaoctanoyl-Coenzyme A,,experimental,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",target,,DB03415
Thiamin Phosphate,,experimental,thiE,Thiamine-phosphate synthase,target,,DB03416
1-(4-Tert-Butylcarbamoyl-Piperazine-1-Carbonyl)-3-(3-Guanidino-Propyl)-4-Oxo-Azetidine-2-Carboxylic Acid,,experimental,PRSS1,Trypsin-1,target,,DB03417
"2,4-Deoxy-4-Guanidino-5-N-Acetyl-Neuraminic Acid",,experimental,NA,Neuraminidase,target,,DB03420
"2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione",,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB03421
S-Adenosyl-L-Homoselenocysteine,,experimental,cmoA,tRNA (cmo5U34)-methyltransferase,target,,DB03423
"2s,4r-4-Methylglutamate",,experimental,GRIK2,"Glutamate receptor ionotropic, kainate 2",target,,DB03425
Cardiolipin,,experimental,SLC25A4,ADP/ATP translocase 1,target,,DB03429
(2s)-Hydroxy(4-Hydroxyphenyl)Ethanenitrile,,experimental,LCTL,Lactase-like protein,target,,DB03430
{3-[(3-Hydroxy-2-Methyl-5-Phosphonooxymethyl-Pyridin-4-Ylmethyl)-Amino]-2-Methyl-Propyl}-Phosphonic Acid,,experimental,cobD,Threonine-phosphate decarboxylase,target,,DB03433
Gallichrome,,experimental,fhuD,Iron(3+)-hydroxamate-binding protein FhuD,target,antagonist,DB03436
"2-{1-[2-(2-Amino-Thiazol-4-Yl)-2-Methoxyimino-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",,experimental,ampC,Beta-lactamase,target,,DB03437
N-Hexadecanoylglycine,,experimental,CYP102A1,Bifunctional P-450/NADPH-P450 reductase,target,,DB03440
2-Benzyl-3-Iodopropanoic Acid,,experimental,CPA1,Carboxypeptidase A1,target,,DB03441
2-[5-Hydroxy-3-Methyl-1-(2-Methyl-4-Sulfo-Phenyl)-1h-Pyrazol-4-Ylazo]-4-Sulfo-Benzoic Acid,,experimental,ATIC,Bifunctional purine biosynthesis protein PURH,target,,DB03442
Bis(5-Amidino-Benzimidazolyl)Methanone Zinc,,experimental,PRSS1,Trypsin-1,target,,DB03443
"(3e)-6'-Bromo-2,3'-Biindole-2',3(1h,1'h)-Dione 3-Oxime",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB03444
Tazobactam Trans-Enamine Intermediate,,experimental,bla,Beta-lactamase SHV-1,target,,DB03445
3-Benzylaminocarbonylphenyl-Alpha-D-Galactoside,,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB03446
Uridylyl-2'-5'-Phospho-Adenosine,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03447
"1alpha,25-Dihydroxyl-20-Epi-22-Oxa-24,26,27-Trihomovitamin D3",,experimental,VDR,Vitamin D3 receptor,target,,DB03451
3-Trimethylsilylsuccinic Acid,,experimental,fumC,Fumarate hydratase class II,target,,DB03452
(R)-N-[2-[1-(Aminoiminomethyl)-3-Piperidinyl]-1-Oxoethyl]-4-(Phenylethynyl)-L-Phenylalanine Methylester,,experimental,IL2,Interleukin-2,target,,DB03453
"3-Methyl-Benzene-1,2-Diol",,experimental,bphC,"Biphenyl-2,3-diol 1,2-dioxygenase",target,,DB03454
(1h-Indol-3-Yl)-(2-Mercapto-Ethoxyimino)-Acetic Acid,,experimental,IL2,Interleukin-2,target,,DB03455
N2-[(Benzyloxy)Carbonyl]-N1-[(3s)-1-Cyanopyrrolidin-3-Yl]-L-Leucinamide,,experimental,CTSK,Cathepsin K,target,,DB03456
Para-Xylene,,experimental,E,Lysozyme,target,,DB03463
Formycin-5'-Monophosphate,,experimental,amn,AMP nucleosidase,target,,DB03464
2-Phospho-D-Glyceric Acid,,experimental,ENO3,Beta-enolase,target,,DB03465
BMS184394,,experimental,RARG,Retinoic acid receptor gamma,target,,DB03466
Naringenin,,experimental,ttgR,HTH-type transcriptional regulator TtgR,target,,DB03467
"1,2,3,4-Tetrahydro-Isoquinoline-7-Sulfonic Acid Amide",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB03468
Trypanothione,,experimental,TPR,Trypanothione reductase,target,,DB03470
6-Phenyl-4(R)-(7-Phenyl-Heptanoylamino)-Hexanoic Acid,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB03471
N5-Methylglutamine,,experimental,TM_0488,Release factor glutamine methyltransferase,target,,DB03473
"1-[4-Carboxy-2-(3-Pentylamino)Phenyl]-5,5'-Di(Hydroxymethyl)Pyrrolidin-2-One",,experimental,NA,Neuraminidase,target,,DB03475
Trans-6-(2-Phenylcyclopropyl)-Naphthalene-2-Carboxamidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03476
1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole,,experimental,PTGS2,Prostaglandin G/H synthase 2,target,,DB03477
2'-O-Acetyl Adenosine-5-Diphosphoribose,,experimental,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",target,,DB03478
"8,9,10-Trihydroxy-7-Hydroxymethyl-3-Methyl-6-Oxa-1,3-Diaza-Spiro[4.5]Decane-2,4-Dione",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03479
Brequinar Analog,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB03480
"5,10-Dimethylene Tetrahydromethanopterin",,experimental,fae,Formaldehyde-activating enzyme,target,,DB03481
8-Demethyl-8-Dimethylamino-Flavin-Adenine-Dinucleotide,,experimental,pobA,p-hydroxybenzoate hydroxylase,target,,DB03482
4-Benzoylamino-4-{1-{1-Carbamoyl-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethylcarbamoyl}-Butyric Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03483
L-Alpha-Glycerophosphorylethanolamine,,experimental,ANXA5,Annexin A5,target,,DB03484
Phosphomethylphosphonic Acid Guanosyl Ester,,experimental,CANT1,Soluble calcium-activated nucleotidase 1,target,,DB03486
Uridine-5'-Diphosphate-2-Deoxy-2-Fluoro-Alpha-D-Galactose,,experimental,otsA,"Alpha,alpha-trehalose-phosphate synthase [UDP-forming]",target,,DB03488
2-Keto-3-Deoxygluconate,,experimental,TT_P0036,2-keto-3-deoxy-gluconate kinase,target,,DB03489
"3-Pyridin-4-Yl-2,4-Dihydro-Indeno[1,2-.C.]Pyrazole",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03490
2'-Deoxyguanosine-5'-Diphosphate,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB03491
"Lambda-Bis(2,2'-Bipyridine)Imidazole Osmium (Ii)",,experimental,azu,Azurin,target,,DB03492
7-Methylguanosine,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB03493
CRA_10950,,experimental,PRSS1,Trypsin-1,target,,DB03494
"4,6-Dideoxy-4-{[4,5,6-Trihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}-Alpha-D-Lyxo-Hexopyranosyl-(1->4)-Alpha-D-Threo-Hexopyranosyl-(1->6)-Alpha-L-Threo-Hexopyranose",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB03495
Mercaptomethyl Phosphonate,,experimental,phoA,Alkaline phosphatase,target,,DB03498
Tricosanoic Acid,,experimental,LIP3,Lipase 3,target,,DB03500
(4s)-4-{[(2s)-2-Amino-3-Oxopropyl]Sulfanyl}-L-Homoserinate,,experimental,asd,Aspartate-semialdehyde dehydrogenase,target,,DB03502
"4-Acetyl-4-Guanidino-6-Methyl(Propyl)Carboxamide-4,5-Dihydro-2h-Pyran-2-Carboxylic Acid",,experimental,NA,Neuraminidase,target,,DB03503
"9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03504
"2,6-Diaminoquinazolin-4(3h)-One",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB03505
9-Deazaadenine,,experimental,APRT,Adenine phosphoribosyltransferase,target,,DB03506
"6-[3-(4-Morpholinyl)Propyl]-2-(3-Nitrophenyl)-5-Thioxo-5,6,-Dihydro-7h-Thienol[2',3':4,5]Pyrrolo[1,2-C]Imidazol-7-One",,experimental,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,target,,DB03507
2-(4-Chlorophenyl)-5-Quinoxalinecarboxamide,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB03509
"Uridine-2',3'-Vanadate",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03512
[Methylthio]Acetate,,experimental,soxA,Monomeric sarcosine oxidase,target,,DB03517
(R)-Mevalonate,,experimental,mvaA,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB03518
2-Amino-Pentanoic Acid,,experimental,OTC,"Ornithine carbamoyltransferase, mitochondrial",target,,DB03519
Aspartic Acid-4-Carboxymethyl Ester,,experimental,dhlB,(S)-2-haloacid dehalogenase,target,,DB03522
"6-Fluoro-2-(2'-Fluoro-1,1'-Biphenyl-4-Yl)-3-Methylquinoline-4-Carboxylic Acid",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB03523
"N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-(2-Thiophen-2-Yl-Acetylamino)-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB03524
RU79073,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03525
AL5927,,experimental,CA2,Carbonic anhydrase 2,target,,DB03526
9-Beta-D-Xylofuranosyl-Adenine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB03528
Flavin-Adenine Dinucleotide-N5-Isobutyl Ketone,,experimental,DAO,D-amino-acid oxidase,target,,DB03531
Phosphomethylphosphonic Acid Guanylate Ester,,experimental,ftsZ,Cell division protein FtsZ,target,,DB03532
Glycoluril,,experimental,,Streptavidin,target,,DB03533
3-[(Acetyl-Methyl-Amino)-Methyl]-4-Amino-N-Methyl-N-(1-Methyl-1h-Indol-2-Ylmethyl)-Benzamide,,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB03534
2-(Acetylamino)-2-Deoxy-6-O-Methyl-Alpha-D-Allopyranose,,experimental,CHIT1,Chitotriosidase-1,target,,DB03539
Norcamphor,,experimental,camC,Camphor 5-monooxygenase,target,,DB03540
L-Myo-Inositol-1-Phosphate,,experimental,IMPA1,Inositol monophosphatase 1,target,,DB03542
10-CF3C(OH)2-DDACTHF,,experimental,GART,Trifunctional purine biosynthetic protein adenosine-3,target,,DB03546
3-Deoxy-D-Manno-Oct-2-Ulosonic Acid,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB03548
Biotinyl P-Nitroaniline,,experimental,,Streptavidin,target,,DB03549
Meta-Tyrosine,,experimental,TH,Tyrosine 3-monooxygenase,target,,DB03552
5-Iodouracil,,experimental,DPYD,Dihydropyrimidine dehydrogenase [NADP(+)],target,,DB03554
CRA_11092,,experimental,PRSS1,Trypsin-1,target,,DB03555
N-{1-[5-(1-Carbamoyl-2-Mercapto-Ethylcarbamoyl)-Pentylcarbamoyl]-2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Ethyl}-3-{2-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Acetylamino}-Succinamic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03557
Sp-876,,experimental,thyA,Thymidylate synthase,target,,DB03558
Cyclohexane,,experimental,PRSS1,Trypsin-1,target,,DB03561
Tetrahydrodeoxyuridine,,experimental,cdd,Cytidine deaminase,target,,DB03562
Tetradecane,,experimental,LSS,Lanosterol synthase,target,,DB03563
1-O-Octyl-2-Heptylphosphonyl-Sn-Glycero-3-Phosphoethanolamine,,experimental,PLA2G1B,Phospholipase A2,target,,DB03565
"4,5-Dehydro-L-Iduronic Acid",,experimental,cslA,Chondroitinase-AC,target,,DB03569
"3-(5-Amino-7-Hydroxy-[1,2,3]Triazolo[4,5-D]Pyrimidin-2-Yl)-N-(3,5-Dichlorobenzyl)-Benzamide",,experimental,folB,Dihydroneopterin aldolase,target,,DB03571
FR230513,,experimental,ADA,Adenosine deaminase,target,,DB03572
Ferricrocin-Iron,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB03574
N-Pyridoxyl-Threonine-5-Monophosphate,,experimental,TM_1744,L-allo-threonine aldolase,target,,DB03576
Alpha-Benzyl-Aminobenzyl-Phosphonic Acid,,experimental,ACPP,Prostatic acid phosphatase,target,,DB03577
N~2~-Succinylornithine,,experimental,astB,N-succinylarginine dihydrolase,target,,DB03582
"(2e,3s)-3-Hydroxy-5'-[(4-Hydroxypiperidin-1-Yl)Sulfonyl]-3-Methyl-1,3-Dihydro-2,3'-Biindol-2'(1'h)-One",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03583
Oxyphenbutazone,"Anti-Inflammatory Agents, Non-Steroidal",experimentalwithdrawn,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB03585
5(R)-5-Fluoro-Beta-D-Xylopyranosyl-Enzyme Intermediate,,experimental,yicI,Alpha-xylosidase,target,,DB03586
Pyruvoyl Group,,experimental,PLA2G1B,Phospholipase A2,target,,DB03587
Diphenylacetic Acid,,experimental,CTSB,Cathepsin B,target,,DB03588
Alpha-Ketomalonic Acid,,experimental,ME2,"NAD-dependent malic enzyme, mitochondrial",target,,DB03589
RU82209,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03591
N7-Methyl-Guanosine-5'-Monophosphate,,experimental,DCPS,m7GpppX diphosphatase,target,,DB03593
"1,2,4-Triazole",,experimental,CA2,Carbonic anhydrase 2,target,,DB03594
CRA_9785,,experimental,PRSS1,Trypsin-1,target,,DB03595
N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB03596
"Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]",,experimental,CA2,Carbonic anhydrase 2,target,,DB03598
4-Thio-D-Glucose,,experimental,celCCF,Endoglucanase F,target,,DB03599
Glucarate,,experimental,gudD,Glucarate dehydratase,target,,DB03603
"[4-(4-Hydroxy-3-Iodo-Phenoxy)-3,5-Diiodo-Phenyl]-Acetic Acid",,experimental,THRB,Thyroid hormone receptor beta,target,,DB03604
"(2s)-2-[(2,4-Dichloro-Benzoyl)-(3-Trifluoromethyl-Benzyl)-Amino]-3-Phenyl-Propionic Acid",,experimental,,Genome polyprotein,target,,DB03605
D-Para-Chlorophenyl-1-Acetamidoboronic Acid Alanine,,experimental,apr,Subtilisin Carlsberg,target,,DB03607
3-Deoxyguanosine,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB03609
L-2-Amino-4-Methoxy-Cis-but-3-Enoic Acid,,experimental,MAT1A,S-adenosylmethionine synthase isoform type-1,target,,DB03611
3-Hydroxybutyryl-Coenzyme A,,experimental,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",target,,DB03612
Co-Methylcobalamin,,experimental,metH,Methionine synthase,target,,DB03614
Kabiramide C,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB03616
"L-709,587",,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB03621
"2-Hydroxy-5-[4-(2-Hydroxy-Ethyl)-Piperidin-1-Yl]-5-Phenyl-1h-Pyrimidine-4,6-Dione",,experimental,MMP8,Neutrophil collagenase,target,,DB03622
"9-(4-Hydroxyphenyl)-2,7-Phenanthroline",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB03623
7-(Carboxyamino)-8-Amino-Nonanoic Acid,,experimental,bioD,ATP-dependent dethiobiotin synthetase BioD 1,target,,DB03624
"5,10-Dideazatetrahydrofolic Acid",,experimental,folA,Dihydrofolate reductase,target,,DB03625
"5-Methoxy-1,2-Dimethyl-3-(Phenoxymethyl)Indole-4,7-Dione",,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB03626
Adamantane,,experimental,camC,Camphor 5-monooxygenase,target,,DB03627
ISO24,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03628
Pyridoxal-5'-Phosphate-N-Oxide,,experimental,aspC,Aspartate aminotransferase,target,,DB03629
"3-(4-Hydroxy-3-Imino-6-Oxo-Cyclohexa-1,4-Dienyl)-Alanine",,experimental,tynA,Primary amine oxidase,target,,DB03631
Glycinamid,,experimental,MMP8,Neutrophil collagenase,target,,DB03636
Guanidine-3-Propanol,,experimental,PRSS3,Trypsin-3,target,,DB03637
1-Guanidinium-7-Aminoheptane,,experimental,DHPS,Deoxyhypusine synthase,target,inhibitor,DB03639
Beta-Hydroxyaspartic Acid,,experimental,bla,Beta-lactamase TEM,target,,DB03640
"2'-deoxyuridine 5'-alpha,beta-imido-diphosphate",,experimental,dut,DUTPase,target,,DB03641
Benzofuran-2-Carboxylic Acid {(S)-3-Methyl-1-[3-Oxo-1-(Pyridin-2-Ylsulfonyl)Azepan-4-Ylcarbamoyl]Butyl}Amide,,experimental,CTSK,Cathepsin K,target,,DB03642
3-Hydroxyanthranilic Acid,Free Radical Scavengers,experimental,phzF,"Trans-2,3-dihydro-3-hydroxyanthranilate isomerase",target,,DB03644
Phosphonoacetohydroxamic Acid,,experimental,ENO3,Beta-enolase,target,,DB03645
3-[Isopropyl(4-Methylbenzoyl)Amino]-5-Phenylthiophene-2-Carboxylic Acid,,experimental,,Genome polyprotein,target,,DB03647
2-{N'-[2-(5-Amino-1-Phenylcarbamoyl-Pentylcarbamoyl)-Hexyl]-Hydrazinomethyl}-Hexanoic Acid(5-Amino-1-Phenylcarbamoyl-Pentyl)-Amide,,experimental,PFI0380c,"Formylmethionine deformylase, putative",target,,DB03648
"[{(5-Chloro-2-Pyridinyl)Amino} Methylene]-1,1-Bisphosphonate",,experimental,dxr,1-deoxy-D-xylulose 5-phosphate reductoisomerase,target,,DB03649
(3e)-3-[(4-Hydroxyphenyl)Imino]-1h-Indol-2(3h)-One,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB03650
"2,4,6-Trinitrophenol",,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB03651
Bcx-1812,,experimental,NA,Neuraminidase,target,,DB03655
1-Deoxy-1-Methoxycarbamido-Beta-D-Glucopyranose,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03657
"2-{1-[2-Amino-2-(4-Hydroxy-Phenyl)-Acetylamino]-2-Oxo-Ethyl}-5,5-Dimethyl-Thiazolidine-4-Carboxylic Acid",,experimental,ampC,Beta-lactamase,target,,DB03658
Butylamine,,experimental,SAP2,Candidapepsin-2,target,,DB03659
Vitamin B6 Complexed with 2-Amino-Pentanoic Acid,,experimental,aspC,Aspartate aminotransferase,target,,DB03662
"1-[(2-Amino-6,9-Dihydro-1h-Purin-6-Yl)Oxy]-3-Methyl-2-Butanol",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03663
P1-(Adenosine-5'-P5-(Uridine-5')Pentaphosphate,,experimental,CMPK1,UMP-CMP kinase,target,,DB03664
Acetic Acid Salicyloyl-Amino-Ester,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB03667
1-(5'-Phospho-Beta-D-Ribofuranosyl)Barbituric Acid,,experimental,pyrF,Orotidine 5'-phosphate decarboxylase,target,,DB03668
4-Fluorophenethyl Alcohol,,experimental,E,Lysozyme,target,,DB03669
"2-(Oxalyl-Amino)-4,5,6,7-Tetrahydro-Thieno[2,3-C]Pyridine-3-Carboxylic Acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03670
9-N-Phenylmethylamino-Tacrine,,experimental,BCHE,Cholinesterase,target,,DB03672
Beta(2-Thienyl)Alanine,,experimental,PAH,Phenylalanine-4-hydroxylase,target,,DB03673
N-Cyclohexyl-N'-Decylurea,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB03677
2-Hydroxy-Tryptophan,,experimental,qheDH,Quinohemoprotein ethanol dehydrogenase type-1,target,,DB03679
2-{[Formyl(Hydroxy)Amino]Methyl}-4-Methylpentanoic Acid,,experimental,,Matrix metalloproteinase-9,target,,DB03683
S-(P-Nitrobenzyl)Glutathione,,experimental,GSTP1,Glutathione S-transferase P,target,,DB03686
3-Hydroxy-Propanoic Acid,,experimental,bioH,Pimelyl-[acyl-carrier protein] methyl ester esterase,target,,DB03688
"(Z,Z)-4-Hydroxy-N,N,N-Trimethyl-10-Oxo-7-[(1-Oxo-9-Octadecenyl)Oxy]-3,5,9-Trioxa-4-Phosphaheptacos-18-En-1-Aminium-4-Oxide",,experimental,PITPNA,Phosphatidylinositol transfer protein alpha isoform,target,,DB03690
1-Hexadecanosulfonyl-O-L-Serine,,experimental,pldA,Phospholipase A1,target,,DB03692
N-(2-Aminoethyl)-5-Chloroisoquinoline-8-Sulfonamide,,experimental,CSNK1G2,Casein kinase I isoform gamma-2,target,,DB03693
"6-(2,5-Dimethoxy-Benzyl)-5-Methyl-Pyrido[2,3-D]Pyrimidine-2,4-Diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB03695
Lanosterol,,experimental,LSS,Lanosterol synthase,target,,DB03696
4-Sulfonamide-[1-(4-Aminobutane)]Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB03697
5-Mercaptoethanol-2-Decenoyl-Coenzyme A,,experimental,fadH,"2,4-dienoyl-CoA reductase [NADPH]",target,,DB03698
Succinyl-Coenzyme A,,experimental,dapD,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",target,,DB03699
D-Threonine,,experimental,nprS,Thermolysin,target,,DB03700
"2-[4-[[(S)-1-[[(S)-2-[[(Rs)-3,3,3-Trifluoro-1-Isopropyl-2-Oxopropyl]Aminocarbonyl]Pyrrolidin-1-Yl-]Carbonyl]-2-Methylpropyl]Aminocarbonyl]Benzoylamino]Acetic Acid",,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB03702
Cyclohexanol,,experimental,ADH1B,Alcohol dehydrogenase 1B,target,,DB03703
12-Hydroxydodecanoic Acid,,experimental,ADH5,Alcohol dehydrogenase class-3,target,,DB03704
6-Methylamino-5-Nitroisocytosine,,experimental,folP,Dihydropteroate synthase,target,,DB03705
1-Hydroxy-2-S-Glutathionyl-3-Para-Nitrophenoxy-Propane,,experimental,GSTM4,Glutathione S-transferase Mu 4,target,,DB03706
N5-(1-Imino-3-Butenyl)-L-Ornithine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03710
6-Hydroxy-6-Methyl-Heptan-3-One,,experimental,LCN9,Epididymal-specific lipocalin-9,target,,DB03711
RU85053,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03712
4-Carbamoyl-4-{[6-(Difluoro-Phosphono-Methyl)-Naphthalene-2-Carbonyl]-Amino}-Butyric Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03714
Pentadecane,,experimental,clcA,H(+)/Cl(-) exchange transporter ClcA,target,,DB03715
5'-Fluoro-5'-Deoxyadenosine,,experimental,flA,5'-fluoro-5'-deoxy-adenosine synthase,target,,DB03716
"3-Hydroxy-4-(3,4,5-Trihydroxy-Tetrahydro-Pyran-2-Yloxy)-Piperidin-2-One",,experimental,cex,Exoglucanase/xylanase,target,,DB03717
N-Ethyl-5'-Carboxamido Adenosine,,experimental,HSP90B1,Endoplasmin,target,,DB03719
"3,4-Dihydro-5-Methyl-Isoquinolinone",,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB03722
Phosphomethylphosphonic Acid-Guanylate Ester,,experimental,PCK1,"Phosphoenolpyruvate carboxykinase, cytosolic [GTP]",target,,DB03725
Purine Riboside-5'-Monophosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03726
Coproporphyrin I,,experimental,UROD,Uroporphyrinogen decarboxylase,target,,DB03727
4-Chlorobenzoic Acid,,experimental,,4-chlorobenzoyl CoA ligase,target,,DB03728
2-Amino-5-Hydroxy-Benzimidazole,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03729
"3,9-Dimethyladenine",,experimental,HP_0602,Endonuclease III,target,,DB03730
Etheno-Nadp,,experimental,BST1,ADP-ribosyl cyclase 2,target,,DB03732
Ethylene Dichloride,,experimental,linB,Haloalkane dehalogenase,target,,DB03733
Xylarohydroxamate,,experimental,gudD,Glucarate dehydratase,target,,DB03734
9-(2-Deoxy-Beta-D-Ribofuranosyl)-6-Methylpurine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB03735
2-Cyclopropylmethylenepropanal,,experimental,REN,Renin,target,,DB03736
"4-((3r,4s,5r)-4-Amino-3,5-Dihydroxy-Hex-1-Ynyl)-5-Fluoro-3-[1-(3-Methoxy-1h-Pyrrol-2-Yl)-Meth-(Z)-Ylidene]-1,3-Dihydro-Indol-2-One",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB03737
Pantothenoylaminoethenethiol,,experimental,PPCDC,Phosphopantothenoylcysteine decarboxylase,target,,DB03738
3-Hydroxyimino Quinic Acid,,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB03739
2-Methylbutanoic Acid,,experimental,cumD,"2-hydroxy-6-oxo-7-methylocta-2,4-dienoate hydrolase",target,,DB03741
Compound 4-D,,experimental,ESR1,Estrogen receptor,target,,DB03742
"Cp403700, (S)-1-{2-[(5-Chloro-1h-Indole-2-Carbonyl)-Amino]-3-Phenyl-Propionyl}-Azetidine-3-Carboxylate",,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB03744
"3-Amino-4,5-Dihydroxy-Cyclohex-1-Enecarboxylate",,experimental,aroD,3-dehydroquinate dehydratase,target,,DB03746
Methyl-[4-(4-Piperidine-1-Ylmethyl-Phenyl)-Cyclohexyl]-Carbaminic Acid-(4-Chlorophenyl)-Ester,,experimental,shc,Squalene--hopene cyclase,target,,DB03748
"4-(1h-Imidazol-4-Yl)-3-(5-Ethyl-2,4-Dihydroxy-Phenyl)-1h-Pyrazole",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03749
P-(2'-Iodo-5'-Thenoyl)Hydrotropic Acid,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB03752
Flurbiprofen Methyl Ester,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB03753
"Adenosine-5'-[Beta, Gamma-Methylene]Tetraphosphate",,experimental,fgs,Folylpolyglutamate synthase,target,,DB03755
(Tert-Butyloxycarbonyl)-Alanyl-Alanyl-Amine,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB03757
Dnqx,,experimental,GRIA2,Glutamate receptor 2,target,,DB03759
5-Methyl-2'-Deoxypseudouridine,,experimental,ntd,Nucleoside deoxyribosyltransferase,target,,DB03763
Cytidine-2'-Monophosphate,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03765
Morpholine-4-Carboxylic Acid [1s-(2-Benzyloxy-1r-Cyano-Ethylcarbamoyl)-3-Methyl-Butyl]Amide,,experimental,CTSS,Cathepsin S,target,,DB03767
"N-[2-Hydroxy-2-(8-Isopropyl-6,9-Dioxo-2-Oxa-7,10-Diaza-Bicyclo[11.2.2]Heptadeca-1(16),13(17),14-Trien-11-Yl)-Ethyl]-N-(3-Methyl-Butyl)-Benzenesulfonamide,Inhibitor 3",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03768
D-Eritadenine,,experimental,AHCY,Adenosylhomocysteinase,target,,DB03769
Allyl-{4-[3-(4-Bromo-Phenyl)-Benzofuran-6-Yloxy]-but-2-Enyl}-Methyl-Amine,,experimental,shc,Squalene--hopene cyclase,target,,DB03771
"2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,5-Diol",,experimental,ABO,Histo-blood group ABO system transferase,target,,DB03772
Glucosaminyl-(Alpha-6)-D-Myo-Inositol,,experimental,,1-phosphatidylinositol phosphodiesterase,target,,DB03779
2-Aminoquinazolin-4(3h)-One,,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB03780
"2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid",,experimental,ACACB,Acetyl-CoA carboxylase 2,target,,DB03781
N-(1-Adamantyl)-N'-(4-Guanidinobenzyl)Urea,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB03782
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,PTGS1,Prostaglandin G/H synthase 1,target,,DB03783
Elaidoylamide,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB03784
"(3r,5r)-7-((1r,2r,6s,8r,8as)-2,6-Dimethyl-8-{[(2r)-2-Methylbutanoyl]Oxy}-1,2,6,7,8,8a-Hexahydronaphthalen-1-Yl)-3,5-Dihydroxyheptanoic Acid",,experimental,mvaA,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB03785
"L-Pyridoxyl-N,O-Cycloserylamide-5-Monophosphate",,experimental,dgdA,"2,2-dialkylglycine decarboxylase",target,,DB03787
GC-24,,experimental,THRB,Thyroid hormone receptor beta,target,,DB03788
S-Dioxymethionine,,experimental,katA,Catalase,target,,DB03790
"(3-{3-[[2-Chloro-3-(Trifluoromethyl)Benzyl](2,2-Diphenylethyl)Amino]Propoxy}Phenyl)Acetic Acid",,experimental,NR1H2,Oxysterols receptor LXR-beta,target,,DB03791
"5-Amino-1h-Pyrimidine-2,4-Dione",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB03792
2-Dehydropantoate,,experimental,panB,3-methyl-2-oxobutanoate hydroxymethyltransferase,target,,DB03795
"1-[4-(Octahydro-Pyrido[1,2-a]Pyrazin-2-Yl)-Phenyl]-2-Phenyl-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",,experimental,ESR1,Estrogen receptor,target,,DB03802
Inhibitor Msa367,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03803
5-Bromothienyldeoxyuridine,,experimental,TK,Thymidine kinase,target,,DB03804
Antiproliferative Agent A771726,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB03805
"1-(2-Chlorophenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB03807
9-Butyl-8-(3-Methoxybenzyl)-9h-Purin-6-Amine,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03809
"3-{2,6,8-Trioxo-9-[(2s,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB03812
Fucitol,,experimental,fucI,L-fucose isomerase,target,,DB03815
Difluoromethionine,,experimental,metG,Methionine--tRNA ligase,target,,DB03816
"2,4-Diaminobutyric Acid",,experimental,env,Envelope glycoprotein gp160,target,,DB03817
N-[Tosyl-D-Prolinyl]Amino-Ethanethiol,,experimental,thyA,Thymidylate synthase,target,,DB03818
"(2s,5r,6r)-6-{[(6r)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-3,3-Dimethyl-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptane-2-Carboxylate",,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB03820
2-Amino-3-Hydroxy-3-Phosphonooxy-Propionic Acid,,experimental,ARSA,Arylsulfatase A,target,,DB03821
"7-Iodo-1,2,3,4-Tetrahydro-Isoquinoline",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB03824
"(3s)-3,4-Di-N-Hexanoyloxybutyl-1-Phosphocholine",,experimental,plc,Phospholipase C,target,,DB03827
RU78299,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03828
Phosphorylated Dihydropteroate,,experimental,folC,Bifunctional protein FolC,target,,DB03830
"3-Carboxy-N,N,N-Trimethyl-2-(Octanoyloxy)Propan-1-Aminium",,experimental,CROT,Peroxisomal carnitine O-octanoyltransferase,target,,DB03832
"2-Prolyl-5-Tert-Butyl-[1,3,4]Oxadiazole",,experimental,pip,Proline iminopeptidase,target,,DB03833
Tazobactam Intermediate,,experimental,bla,Beta-lactamase SHV-1,target,,DB03834
"N-(8,9,10-Trihydroxy-7-Hydroxymethyl-2,4-Dioxo-6-Oxa-1,3-Diaza-Spiro[4.5]Dec-3-Yl-Acetamide",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB03835
"1,3,5-Trichloro-Benzene",,experimental,camC,Camphor 5-monooxygenase,target,,DB03836
Morpholine-4-Carboxylic Acid (1-(3-Benzenesulfonyl-1-Phenethylallylcarbamoyl)-3-Methylbutyl)-Amide,,experimental,CTSS,Cathepsin S,target,,DB03837
Tetra(Imidazole)Diaquacopper (Ii),,experimental,azu,Azurin,target,,DB03840
Y-700,,experimental,XDH,Xanthine dehydrogenase/oxidase,target,,DB03841
2-Chloro-6-Methyl-Aniline,,experimental,E,Lysozyme,target,,DB03842
Formaldehyde,DisinfectantsFixatives,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB03843
"N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB03844
P1-(5'-Adenosyl)P5-(5'-(3'azido-3'-Deoxythymidyl))Pentaphosphate,,experimental,DTYMK,Thymidylate kinase,target,,DB03845
5-Hydroxymethyluridine-2'-Deoxy-5'-Monophosphate,,experimental,tmk,Thymidylate kinase,target,,DB03846
Benzenesulfonyl,,experimental,NR1H2,Oxysterols receptor LXR-beta,target,,DB03848
Jaspisamide A,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB03850
"Pentane-1,5-Diamine",,experimental,ispD,2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase,target,,DB03854
L-Threonohydroxamate 4-Phosphate,,experimental,ulaD,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,target,,DB03855
Alpha-Difluoromethylornithine,,experimental,ODC1,Ornithine decarboxylase,target,,DB03856
"1,4-Deoxy-1,4-Dithio-Beta-D-Glucopyranose",,experimental,celCCF,Endoglucanase F,target,,DB03857
1-Thio-Beta-D-Glucopyranose,,experimental,celCCG,Endoglucanase G,target,,DB03859
"N-Butyl-11-[(7r,8r,9s,13s,14s,17s)-3,17-Dihydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-Decahydro-6h-Cyclopenta[a]Phenanthren-7-Yl]-N-Methylundecanamide",,experimental,ESR2,Estrogen receptor beta,target,,DB03860
Monothioglycerol,,experimental,PREP,Prolyl endopeptidase,target,,DB03864
Prostaglandin G2,,experimental,PTGS2,Prostaglandin G/H synthase 2,target,,DB03866
Meta-Nitro-Tyrosine,,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB03867
3-Dehydroquinic Acid,,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB03868
5'-O-(N-(L-Seryl)-Sulfamoyl)Adenosine,,experimental,thrS,Threonine--tRNA ligase,target,,DB03869
"Ara-Alpha(1,3)-Xyl",,experimental,abfA,Intracellular exo-alpha-(1->5)-L-arabinofuranosidase,target,,DB03870
"Lambda-Bis(2,2'-Bipyridine)Imidazole Ruthenium (Ii)",,experimental,azu,Azurin,target,,DB03871
"(4e,8e,12z,16z)-N,N,4,8,13,17,21-Heptamethyldocosa-4,8,12,16,20-Pentaen-1-Amine",,experimental,shc,Squalene--hopene cyclase,target,,DB03874
"Delta-Bis(2,2'-Bipyridine)-(5-Methyl-2-2'-Bipyridine)-C9-Adamantane Ruthenium (Ii)",,experimental,camC,Camphor 5-monooxygenase,target,,DB03875
AL4623,,experimental,CA2,Carbonic anhydrase 2,target,,DB03877
"5-Alpha-Androstane-3-Beta,17beta-Diol",,experimental,ESR2,Estrogen receptor beta,target,agonist,DB03882
Alpha-Adenosine Monophosphate,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB03887
Allyl-{6-[3-(4-Bromo-Phenyl)-1-Methyl-1h-Indazol-6-Yl]Oxy}Hexyl)-N-Methylamine,,experimental,shc,Squalene--hopene cyclase,target,,DB03888
S-(N-Hydroxy-N-Bromophenylcarbamoyl)Glutathione,,experimental,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",target,,DB03889
N-[2-(1-Formyl-2-Methyl-Propyl)-1-(4-Piperidin-1-Yl-but-2-Enoyl)-Pyrrolidin-3-Yl]-Methanesulfonamide,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB03890
"1,5-Bis(N-Benzyloxycarbonyl-L-Leucinyl)Carbohydrazide",,experimental,CTSK,Cathepsin K,target,,DB03891
5-N-Allyl-Arginine,,experimental,NOS1,"Nitric oxide synthase, brain",target,,DB03892
Thionicotinamide-Adenine-Dinucleotide,,experimental,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,target,,DB03893
N-Propargyl-1(S)-Aminoindan,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB03894
Malachite Green,,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB03895
Triphospate,,experimental,PAPOLA,Poly(A) polymerase alpha,target,,DB03896
9-Butyl-8-(4-Methoxybenzyl)-9h-Purin-6-Amine,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB03899
5-Oxo-Pyrrolidine-2-Carbaldehyde,,experimental,,Acidic cytochrome c3,target,,DB03901
Oxalic Acid,Reducing Agents,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB03902
Tmr,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB03903
Succinamide-Coa,,experimental,dapD,"2,3,4,5-tetrahydropyridine-2,6-dicarboxylate N-succinyltransferase",target,,DB03905
2-Phenylheme,,experimental,HMOX1,Heme oxygenase 1,target,,DB03906
"N-{3-[5-(6-Amino-Purin-9-Yl)-3,4-Dihydroxy-Tetrahydro-Furan-2-Yl]-Allyl}-2,3-Dihydroxy-5-Nitro-Benzamide",,experimental,COMT,Catechol O-methyltransferase,target,,DB03907
Inhibitor Bea322,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB03908
"S,S'-(1,3-Phenylene-Bis(1,2-Ethanediyl))Bis-Isothiourea",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03910
L-Xylopyranose,,experimental,xylA,Xylose isomerase,target,,DB03911
2-Amino-3-Ketobutyric Acid,,experimental,kbl,2-amino-3-ketobutyrate coenzyme A ligase,target,,DB03915
"6s-5,6,7,8-Tetrahydrobiopterin",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03918
Ethyl-Carbamic Acid Methyl Ester,,experimental,stxB,Shiga-like toxin 1 subunit B,target,,DB03919
4-(3-Pyridin-2-Yl-1h-Pyrazol-4-Yl)Quinoline,,experimental,TGFBR1,TGF-beta receptor type-1,target,,DB03921
Feruloyl Coenzyme A,,experimental,COMTD1,Catechol O-methyltransferase domain-containing protein 1,target,,DB03923
"5,8-Di-Amino-1,4-Dihydroxy-Anthraquinone",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB03924
Glycyl-L-Alpha-Amino-Epsilon-Pimelyl-D-Alanine,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB03927
"Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol",,experimental,CTH,Cystathionine gamma-lyase,target,,DB03928
Diguanosine-5'-Triphosphate,,experimental,A103R,mRNA-capping enzyme,target,,DB03931
LFA703,,experimental,ITGAL,Integrin alpha-L,target,,DB03932
C-1027 Aromatized Chromophore,,experimental,cagA,Antitumor antibiotic C-1027 apoprotein,target,,DB03933
Protoporphyrin Ix Containing Zn,,experimental,CYCS,Cytochrome c,target,,DB03934
1-Deoxy-Ribofuranose-5'-Phosphate,,experimental,kdsA,2-dehydro-3-deoxyphosphooctonate aldolase,target,,DB03936
Deacetoxycephalosporin-C,,experimental,cefE,Deacetoxycephalosporin C synthase,target,,DB03938
"4-Hydroxy-3,4-Dihydro-1h-Pyrimidin-2-One",,experimental,codA,Cytosine deaminase,target,,DB03939
"5-[1-(3,4-Dimethoxy-Benzoyl)-1,2,3,4-Tetrahydro-Quinolin-6-Yl]-6-Methyl-3,6-Dihydro-[1,3,4]Thiadiazin-2-One",,experimental,TNNC1,"Troponin C, slow skeletal and cardiac muscles",target,,DB03944
D-Xylulose,,experimental,xylA,Xylose isomerase,target,,DB03947
(2-Sulfanyl-3-Phenylpropanoyl)-Phe-Tyr,,experimental,nprS,Thermolysin,target,,DB03949
(S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB03950
9-(6-Deoxy-Beta-D-Allofuranosyl)-6-Methylpurine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB03952
L-Thiocitrulline,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB03953
"1,5-Dideoxy-1,5-Imino-D-Mannitol",,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB03955
"D-Myo-Inositol-2,4,5-Trisphosphate",,experimental,PLCD1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase delta-1",target,,DB03956
SP2456,,experimental,IL2,Interleukin-2,target,,DB03957
"2c-Methyl-D-Erythritol 2,4-Cyclodiphosphate",,experimental,ispF,"2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase",target,,DB03961
Nicotinamide 8-Bromo-Adenine Dinucleotide Phosphate,,experimental,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",target,,DB03962
4-Hydroxy-Aconitate Ion,,experimental,ACO2,"Aconitate hydratase, mitochondrial",target,,DB03964
Clorobiocin,Anti-Bacterial Agents,experimental,gyrB,DNA gyrase subunit B,target,,DB03966
"1-Methyl-2-Oxy-5,5-Dimethyl Pyrrolidine",,experimental,REN,Renin,target,,DB03968
3-Acetyl Pyridine Adenine Dinucleotide,,experimental,dapB,4-hydroxy-tetrahydrodipicolinate reductase,target,,DB03969
"3-{2,6,8-Trioxo-9-[(2r,3r,4r)-2,3,4,5-Tetrahydroxypentyl]-1,2,3,6,8,9-Hexahydro-7h-Purin-7-Yl}Propyl Dihydrogen Phosphate",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB03973
L-Homoarginine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB03974
1-[Glycerolylphosphonyl]-2-[8-(2-Hexyl-Cyclopropyl)-Octanal-1-Yl]-3-[Hexadecanal-1-Yl]-Glycerol,,experimental,hmp,Flavohemoprotein,target,,DB03979
4-(Fluorophenyl)-1-Cyclopropylmethyl-5-(2-Amino-4-Pyrimidinyl)Imidazole,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB03980
"Compound 5, 2-(Naphthalen-1-Yl-Oxalyl-Amino)-Benzoicacid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB03982
"(Molybdopterin-S,S)-Dioxo-Thio-Molybdenum(V)",,experimental,SUOX,"Sulfite oxidase, mitochondrial",target,,DB03983
Morpholine-4-Carboxylic Acid [1-(2-Benzylsulfanyl-1-Formyl-Ethylcarbamoyl)-2-Phenyl-Ethyl]-Amide,,experimental,CTSS,Cathepsin S,target,,DB03984
6-Methyl-Formycin A,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB03986
"2,6-Diamino-Hexanoic Acid Amide",,experimental,ADCYAP1,Pituitary adenylate cyclase-activating polypeptide,target,,DB03988
D-Allopyranose,,experimental,alsB,D-allose-binding periplasmic protein,target,,DB03989
4-Methyl Valeric Acid,,experimental,ilvE,Branched-chain-amino-acid aminotransferase,target,,DB03993
"3-[(5s)-1-Acetyl-3-(2-Chlorophenyl)-4,5-Dihydro-1h-Pyrazol-5-Yl]Phenol",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB03996
Butylphosphonate,,experimental,lip,Lipase,target,,DB03999
Bromo-Willardiine,,experimental,GRIA2,Glutamate receptor 2,target,,DB04000
6-(Oxalyl-Amino)-1h-Indole-5-Carboxylic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04001
4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB04002
(4-{2-Acetylamino-2-[1-(3-Carbamoyl-4-Cyclohexylmethoxy-Phenyl)-Ethylcarbamoyl}-Ethyl}-2-Phosphono-Phenoxy)-Acetic Acid,,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB04003
"2,6-Diamino-8-(2-Dimethylaminoethylsulfanylmethyl)-3h-Quinazolin-4-One",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB04004
"[2-Amino-6-(2,6-Difluoro-Benzoyl)-Imidazo[1,2-a]Pyridin-3-Yl]-Phenyl-Methanone",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04006
Bromo-WR99210,,experimental,folA,Dihydrofolate reductase,target,,DB04007
Bis(5-Amidino-Benzimidazolyl)Methane Zinc,,experimental,PRSS1,Trypsin-1,target,,DB04008
Dimethyl Propionate Ester Heme,,experimental,CYB5A,Cytochrome b5,target,,DB04009
2-(3'-Methoxyphenyl) Benzimidazole-4-Carboxamide,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB04010
"(3r)-4-(P-Toluenesulfonyl)-1,4-Thiazane-3-Carboxylicacid-L-Leucine",,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB04012
1-Deoxy-1-Methoxycarbamido-Beta-D-Gluco-2-Heptulopyranosonamide,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04013
"N-Methyl-N-Propargyl-3-(2,4-Dichlorophenoxy)Propylamine",,experimental,MAOA,Amine oxidase [flavin-containing] A,target,,DB04017
S-Isopropyl-Isothiourea,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB04018
"4-(2-{[4-{[3-(4-Chlorophenyl)Propyl]Sulfanyl}-6-(1-Piperazinyl)-1,3,5-Triazin-2-Yl]Amino}Ethyl)Phenol",,experimental,ESR2,Estrogen receptor beta,target,,DB04020
MF268,,experimental,ACHE,Acetylcholinesterase,target,,DB04021
"Guanosine 5'-(Trihydrogen Diphosphate), P'-D-Mannopyranosyl Ester",,experimental,algD,GDP-mannose 6-dehydrogenase,target,,DB04023
N'-L-Seryl-3'-Amino-(3'-Deoxy)-Adenosine,,experimental,thrS,Threonine--tRNA ligase,target,,DB04024
D-Arginine,,experimental,CKM,Creatine kinase M-type,target,,DB04027
Tyvelose,,experimental,9,Bifunctional tail protein,target,,DB04028
"1,3,4,9-Tetrahydro-2-(Hydroxybenzoyl)-9-[(4-Hydroxyphenyl)Methyl]-6-Methoxy-2h-Pyrido[3,4-B]Indole",,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB04030
Serine Vanadate,,experimental,phoA,Alkaline phosphatase,target,,DB04031
Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide,,experimental,camC,Camphor 5-monooxygenase,target,,DB04032
Z-Ala Prolinal,,experimental,pep,Prolyl endopeptidase Pep,target,,DB04033
Ribulose-5-Phosphate,,experimental,ulaD,3-keto-L-gulonate-6-phosphate decarboxylase UlaD,target,,DB04034
Coenzyme a Persulfide,,experimental,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",target,,DB04036
"N-(2-Morpholin-4-Yl-1-Morpholin-4-Ylmethyl-Ethyl)-3-Nitro-5-(3,4,5-Trihydroxy-6-Hydroxymethyl-Tetrahydro-Pyran-2-Yloxy)-Benzamide",,experimental,eltB,Heat-labile enterotoxin B chain,target,,DB04040
Nitrocefin Acyl-Serine,,experimental,pbp,Beta-lactam-inducible penicillin-binding protein,target,,DB04041
"2-[4-(Hydroxy-Methoxy-Methyl)-Benzyl]-7-(4-Hydroxymethyl-Benzyl)-1,1-Dioxo-3,6-Bis-Phenoxymethyl-1lambda6-[1,2,7]Thiadiazepane-4,5-Diol",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04042
Carboxymycobactin T,,experimental,LCN2,Neutrophil gelatinase-associated lipocalin,target,,DB04043
4-{2-[(3-Nitrobenzoyl)Amino]Phenoxy}Phthalic Acid,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04044
Methylmalonyl-Coenzyme A,,experimental,,Methylmalonyl-CoA carboxyltransferase 12S subunit,target,,DB04045
N-Carbamoyl-Alanine,,experimental,PRDX2,Peroxiredoxin-2,target,,DB04048
N-Propyl Isocyanide,,experimental,MB,Myoglobin,target,,DB04050
5-Phenylvaleric Acid,,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB04051
"3,4-Dimethylphenol",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB04052
Hypophosphite,,experimental,rhdA,Thiosulfate sulfurtransferase,target,,DB04053
"9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB04054
"2,3-Dicarboxy-4-(2-Chloro-Phenyl)-1-Ethyl-5-Isopropoxycarbonyl-6-Methyl-Pyridinium",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04055
"Beta-Dadf, Msa, Multisubstrate Adduct Inhibitor",,experimental,ATIC,Bifunctional purine biosynthesis protein PURH,target,,DB04057
8-(Pyrimidin-2-Ylamino)Naphthalene-2-Carboximidamide,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB04059
2-Methylleucine,,experimental,ilvE,Branched-chain-amino-acid aminotransferase,target,,DB04063
Nogalaviketone,,experimental,snoaL,Nogalonic acid methyl ester cyclase,target,,DB04064
N-Cyclopentyl-N-Cyclobutylformamide,,experimental,ADH1A,Alcohol dehydrogenase 1A,target,,DB04065
Fudp,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB04068
"5,6-Dihydro-Benzo[H]Cinnolin-3-Ylamine",,experimental,DAPK1,Death-associated protein kinase 1,target,,DB04069
6-Deoxyerythronolide B,,experimental,eryF,6-deoxyerythronolide B hydroxylase,target,,DB04070
Cpad,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB04071
Alpha-Methylisocitric Acid,,experimental,ACO2,"Aconitate hydratase, mitochondrial",target,,DB04072
N-{3-[4-(3-Amino-Propyl)-Piperazin-1-Yl]-Propyl}-3-Nitro-5-(Galactopyranosyl)-Beta-Benzamide,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB04073
Hypoxanthine,,experimental,PNP,Purine nucleoside phosphorylase,target,,DB04076
Isobutylbenzene,,experimental,E,Lysozyme,target,,DB04078
RU78191,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB04080
"(4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide",,experimental,CA2,Carbonic anhydrase 2,target,,DB04081
2-Deoxy-2-Fluoro-Alpha-D-Mannose,,experimental,manA,"Mannan endo-1,4-beta-mannosidase",target,,DB04084
"1-[Pyrrol-1-Yl-2,5-Dione-Methoxymethyl]-Pyrrole-2,5-Dione",,experimental,azu,Azurin,target,,DB04085
"2',4'-Dinitrophenyl-2deoxy-2-Fluro-B-D-Cellobioside",,experimental,cel5A,Endoglucanase 5A,target,,DB04086
N-(Allyloxycarbonyl)-4-[N-(Carboxy-Formyl)-2-(Benzoic Acid)-Amino]-L-Phenylalaninyl-Amino-Butyloxy-(6-Hydroxy-Benzoic Acid Methyl Ester),,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04088
AL5300,,experimental,CA2,Carbonic anhydrase 2,target,,DB04089
"2,5-Diaziridin-1-Yl-3-(Hydroxymethyl)-6-Methylcyclohexa-2,5-Diene-1,4-Dione",,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB04090
Alpha-L-1-Methyl-Fucose,,experimental,MBL2,Mannose-binding protein C,target,,DB04091
Apstatin,,experimental,pepP,Xaa-Pro aminopeptidase,target,,DB04092
4-Hydroxy-2-Butanone,,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB04094
9-Deazahypoxanthine,,experimental,punA,Purine nucleoside phosphorylase,target,,DB04095
Uridine-5'-Diphosphate-4-Deoxy-4-Fluoro-Alpha-D-Galactose,,experimental,galE,UDP-glucose 4-epimerase,target,,DB04097
Balanol,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB04098
"(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)",,experimental,azu,Azurin,target,,DB04100
"N-[4-(2,4-Dimethyl-1,3-Thiazol-5-Yl)Pyrimidin-2-Yl]-N'-Hydroxyimidoformamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04101
3-Methylcytosine,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB04103
3-Methyladenine,,experimental,tag,DNA-3-methyladenine glycosylase 1,target,,DB04104
N-Heptylformamide,,experimental,ADH1B,Alcohol dehydrogenase 1B,target,,DB04105
Fotemustine,Antineoplastic Agents,experimental,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,,DB04106
[(1-{2[(4-Carbamimidoyl-Phenylamino)-Methyl]-1-Methyl-1h-Benzoimidazol-5-Yl}-Cyclopropyl)-Pyridin-2-Yl-Methyleneaminooxy]-Acetic Acid Ethyl Ester,,experimental,PRSS1,Trypsin-1,target,,DB04107
"(2s,3r)-3-Amino-2-Hydroxy-5-(Ethylsulfanyl)Pentanoyl-((S)-(-)-(1-Naphthyl)Ethyl)Amide",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB04108
"[4-(1,3,2-Dioxaborolan-2-Yloxy)Methyl]Benzamidine",,experimental,PRSS3,Trypsin-3,target,,DB04109
1-Octadecyl-2-Acetamido-2-Deoxy-Sn-Glycerol-3-Phosphoethylmethyl Sulfide,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB04112
N-Formylpiperidine,,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB04113
"3-Chloro-9-Ethyl-6,7,8,9,10,11-Hexahydro-7,11-Methanocycloocta[B]Quinolin-12-Amine",,experimental,ACHE,Acetylcholinesterase,target,,DB04114
Berberine,,experimental,qacR,HTH-type transcriptional regulator QacR,target,,DB04115
Allolactose,,experimental,lacZ,Beta-galactosidase,target,,DB04116
"4-(N,N-Dimethylamino)Cinnamoyl-Coa",,experimental,ECHS1,"Enoyl-CoA hydratase, mitochondrial",target,,DB04117
Guanosine-3'-Monophosphate-5'-Diphosphate,,experimental,ARF1,ADP-ribosylation factor 1,target,,DB04121
Beta-D-Glucose-6-Phosphate,,experimental,zwf,Glucose-6-phosphate 1-dehydrogenase,target,,DB04122
(P-Iodophenylacetylamino)Methylphosphinic Acid,,experimental,ampC,Beta-lactamase,target,,DB04123
Aurodox,Anti-Bacterial Agents,experimental,tufB,Elongation factor Tu-B,target,,DB04124
N-Alpha-(2-Naphthylsulfonyl)-N(3-Amidino-L-Phenylalaninyl)-4-Acetyl-Piperazine,,experimental,PRSS1,Trypsin-1,target,,DB04125
Beta-D-Arabinofuranose-5'-Phosphate,,experimental,rpiA,Ribose-5-phosphate isomerase A,target,,DB04127
"5-Nitroso-6-Ribityl-Amino-2,4(1h,3h)-Pyrimidinedione",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB04128
Willardiine,,experimental,GRIA2,Glutamate receptor 2,target,,DB04129
5-Methoxybenzimidazole,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB04130
"10-(4-Dimethylamino-5-Hydroxy-6-Methyl-Tetrahydro-Pyran-2-Yloxy)-8-Ethyl-1,8,11-Trihydroxy-7,8,9,10-Tetrahydro-Naphthacene-5,12-Dione",,experimental,rdmC,RdmC,target,,DB04131
"5-Fluoro-4-(S)-Hydroxy-3,4-Dihydropyrimidine",,experimental,codA,Cytosine deaminase,target,,DB04135
Lysophosphotidylserine,,experimental,F2,Prothrombin,target,,DB04136
"2,4-Dinitro,5-[Bis(2-Bromoethyl)Amino]-N-(2',3'-Dioxopropyl)Benzamide",,experimental,nfnB,Oxygen-insensitive NAD(P)H nitroreductase,target,,DB04138
6-Hydroxypropylthymine,,experimental,TK,Thymidine kinase,target,,DB04139
1-Benzyl-3-(4-Methoxy-Benzenesulfonyl)-6-Oxo-Hexahydro-Pyrimidine-4-Carboxylic Acid Hydroxyamide,,experimental,MMP3,Stromelysin-1,target,,DB04140
"3-(3,5-Dibromo-4-Hydroxy-Benzoyl)-2-Ethyl-Benzofuran-6-Sulfonic Acid Dimethylamide",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04142
"Cis-[4,5-Bis-(4-Chlorophenyl)-2-(2-Isopropoxy-4-Methoxyphenyl)-4,5-Dihyd Roimidazol-1-Yl]-Piperazin-1-Yl-Methanone",,experimental,MDM2,E3 ubiquitin-protein ligase Mdm2,target,,DB04144
Threonine Derivative,,experimental,PAM,Peptidyl-glycine alpha-amidating monooxygenase,target,,DB04150
4-Methyl-Histidine,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB04151
"2-Amino-3-(3-Hydroxy-7,8-Dihydro-6h-Cyclohepta[D]-4-Isoxazolyl)Propionic Acid",,experimental,GRIA2,Glutamate receptor 2,target,,DB04152
S-Hydroxymethyl Glutathione,,experimental,ADH5,Alcohol dehydrogenase class-3,target,,DB04153
2-Fluoro-2-Deoxy-Beta-D-Galactopyranosyl-Beta-D-Glucopyranose,,experimental,lacZ,Beta-galactosidase,target,,DB04155
N-[(Aminooxy)Carbonyl]Aniline,,experimental,chiB,Chitinase B,target,,DB04157
"6-(Adenosine Tetraphosphate-Methyl)-7,8-Dihydropterin",,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB04158
"1,4-Deoxy-4-((5-Hydroxymethyl-2,3,4-Trihydroxycyclohex-5-Enyl)Amino)Fructose",,experimental,amy,Alpha-amylase,target,,DB04164
Valpromide,,experimental,limA,"Limonene-1,2-epoxide hydrolase",target,,DB04165
N-Acetyl-L-Glutamine,,experimental,DR_0044,N-acylamino acid racemase,target,,DB04167
2-Amino-5-Bromo-6-Phenylpyrimidin-4-Ol,,experimental,folB,Dihydroneopterin aldolase,target,,DB04168
"3,5-Diaminophthalhydrazide",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB04169
4-Bromo-3-Hydroxy-3-Methyl Butyl Diphosphate,,experimental,idi,Isopentenyl-diphosphate Delta-isomerase,target,,DB04170
"[2,4,6-Triisopropyl-Phenylsulfonyl-L-[3-Amidino-Phenylalanine]]-Piperazine-N'-Beta-Alanine",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB04172
3'-1-Carboxy-1-Phosphonooxy-Ethoxy-Uridine-Diphosphate-N-Acetylglucosamine,,experimental,murA,UDP-N-acetylglucosamine 1-carboxyvinyltransferase,target,,DB04174
Mdl-29951,,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB04175
"Phosporic Acid Mono-[3,4-Dihydroxy-5-(5-Methoxy-Benzoimidazol-1-Yl)-Tetrahydro-Furan-2-Ylmethyl] Ester",,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB04176
Benzofuran,,experimental,E,Lysozyme,target,,DB04179
"4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB04180
Cefotaxime Group,,experimental,bla,Beta-lactamase Toho-1,target,,DB04181
"(S)-2-Amino-4-[(2s,3r)-2,3,5-Trihydroxy-4-Oxo-Pentyl]Mercapto-Butyric Acid",,experimental,luxS,S-ribosylhomocysteine lyase,target,,DB04182
Methylmalonic Acid,,experimental,,Methylmalonyl-CoA carboxyltransferase 12S subunit,target,,DB04183
"N'-(Pyrrolidino[2,1-B]Isoindolin-4-On-8-Yl)-N-(Pyridin-2-Yl)Urea",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04186
"(9s,10s)-9-(S-Glutathionyl)-10-Hydroxy-9,10-Dihydrophenanthrene",,experimental,GSTM1,Glutathione S-transferase Mu 1,target,,DB04187
Inhibitor Bea425,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04190
Skf 107457,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04191
Chitotriose,,experimental,LYZ,Lysozyme C,target,,DB04194
Heptulose-2-Phosphate,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04195
Pteroic Acid,,experimental,folP,Dihydropteroate synthase,target,,DB04196
Descarboxy-nor-N(Omega)-Hydroxy-L-Arginine,,experimental,ARG1,Arginase-1,target,,DB04197
Matairesinol,,experimental,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,target,,DB04200
3-Mercuri-4-Aminobenzenesulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB04203
[(4-{4-[4-(Difluoro-Phosphono-Methyl)-Phenyl]-Butyl}-Phenyl)-Difluoro-Methyl]-Phosphonic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04204
Nz2-Tryptophan,,experimental,R,Lysozyme,target,,DB04206
N-(5-Amino-5-Carboxypentyl)Glutamic Acid,,experimental,AASS,"Alpha-aminoadipic semialdehyde synthase, mitochondrial",target,,DB04207
"3-(3,4-Dimethoxyphenyl)Propionic Acid",,experimental,tyrB,Aromatic-amino-acid aminotransferase,target,,DB04208
BV1,,experimental,ctxB,Cholera enterotoxin subunit B,target,,DB04210
2-Iminiopropanoate,,experimental,acdS,1-aminocyclopropane-1-carboxylate deaminase,target,,DB04212
N-Cyclohexyl-N'-(Propyl)Phenyl Urea,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB04213
CRA_9076,,experimental,PRSS1,Trypsin-1,target,,DB04215
1-Deaza-Adenosine,,experimental,ADA,Adenosine deaminase,target,,DB04218
Rifamycin Cgp 4832,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB04220
Didecyl-Dimethyl-Ammonium,,experimental,cmaA2,Cyclopropane mycolic acid synthase 2,target,,DB04221
"9-Amino-2-Deoxy-2,3-Dehydro-N-Acetyl-Neuraminic Acid",,experimental,NA,Neuraminidase,target,,DB04227
"7,10,13-Tri(Carboxymethyl)-5,15-Dioxo-4,7,10,13,16-Pentaaza-1,19-Dithianonadecane",,experimental,,Pseudoazurin,target,,DB04229
Nitromethyldethia Coenzyme A,,experimental,CS,"Citrate synthase, mitochondrial",target,,DB04230
Tetra(Imidazole)Diaquacopper (I),,experimental,azu,Azurin,target,,DB04231
N-Hydroxy-1-(4-Methoxyphenyl)Sulfonyl-4-Benzyloxycarbonyl-Piperazine-2-Carboxamide,,experimental,MMP3,Stromelysin-1,target,,DB04232
N2-({[(4-Bromophenyl)Methyl]Oxy}Carbonyl)-N1-[(1s)-1-Formylpentyl]-L-Leucinamide,,experimental,CTSK,Cathepsin K,target,,DB04234
4-Amino Hexanoic Acid,,experimental,ABAT,"4-aminobutyrate aminotransferase, mitochondrial",target,,DB04235
N-Alpha-(2-Naphthylsulfonyl)-N-(3-Amidino-L-Phenylalaninyl)-D-Pipecolinic Acid,,experimental,PRSS1,Trypsin-1,target,,DB04238
2-Amino-6-Aminomethyl-8-Phenylsulfanylmethyl-3h-Quinazolin-4-One,,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB04239
N-Pyridoxyl-2-Methylalanine-5-Phosphate,,experimental,dgdA,"2,2-dialkylglycine decarboxylase",target,,DB04241
5-Methyluridine 5'-Monophosphate,,experimental,ssb,Single-stranded DNA-binding protein,target,,DB04243
1-[2-(3-Biphenyl)-4-Methylvaleryl)]Amino-3-(2-Pyridylsulfonyl)Amino-2-Propanone,,experimental,CTSK,Cathepsin K,target,,DB04244
2-Hydroxy-3-Amino-4-Phenyl Butane,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04245
CRA_23653,,experimental,PRSS1,Trypsin-1,target,,DB04246
"Beta-1,4-Galactotrioside",,experimental,ganB,"Arabinogalactan endo-1,4-beta-galactosidase",target,,DB04248
Zinc Substituted Heme C,,experimental,CYCS,Cytochrome c,target,,DB04249
Butyrylthiocholine,,experimental,BCHE,Cholinesterase,target,,DB04250
N-Carbamoyl-L-Aspartate,,experimental,pyrC,Dihydroorotase,target,,DB04252
"8-Benzo[1,3]Dioxol-,5-Ylmethyl-9-Butyl-2-Fluoro-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB04254
Inhibitor Bea388,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04255
4-(1-Amino-1-Carboxy-Ethyl)-Benzoic Acid,,experimental,GRM1,Metabotropic glutamate receptor 1,target,,DB04256
Seocalcitol,Antineoplastic AgentsImmunosuppressive Agents,experimental,VDR,Vitamin D3 receptor,target,,DB04258
"9-(5,5-Difluoro-5-Phosphonopentyl)Guanine",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB04260
Carbamic Acid,,experimental,penP,Beta-lactamase,target,,DB04261
3-(7-Hydroxy-8-Ribityllumazine-6-Yl) Propionic Acid,,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB04262
G418,,experimental,ODC1,Ornithine decarboxylase,target,,DB04263
"(10R)-10-Formyl-5,8,10-Trideazafolic Acid",,experimental,purN,Phosphoribosylglycinamide formyltransferase,target,,DB04264
Methylumbelliferyl Chitotriose,,experimental,LYZ,Lysozyme C,target,,DB04268
Cyclotheonamide A,,experimental,PRSS1,Trypsin-1,target,,DB04269
(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB04270
"3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB04271
"8,9-Dichloro-2,3,4,5-Tetrahydro-1h-Benzo[C]Azepine",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB04273
N-Acetyl Serotonin,,experimental,SPR,Sepiapterin reductase,target,,DB04275
Fructose -6-Phosphate,,experimental,nagB,Glucosamine-6-phosphate deaminase 1,target,,DB04277
2-[2-(2-Cyclohexyl-2-Guanidino-Acetylamino)-Acetylamino]-N-(3-Mercapto-Propyl)-Propionamide,,experimental,IL2,Interleukin-2,target,,DB04278
"((2r,3s,5r)-3-Hydroxy-5-(4-Hydroxy-2-Oxo-3,4-Dihydropyrimidin-1(2h)-Yl)-Tetrahydrofuran-2-Yl)Methyldihydrogen Phosphate",,experimental,CD,Deoxycytidylate deaminase,target,,DB04280
"2-[4-(4-Chlorophenyl)Cyclohexylidene]-3,4-Dihydroxy-1(2h)-Naphthalenone",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB04281
Proline Betaine,,experimental,proX,Glycine betaine-binding periplasmic protein,target,,DB04284
"{4-[(2s,4e)-2-(1,3-Benzothiazol-2-Yl)-2-(1h-1,2,3-Benzotriazol-1-Yl)-5-Phenylpent-4-Enyl]Phenyl}(Difluoro)Methylphosphonic Acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04285
(S)-5-(4-Benzyloxy-Phenyl)-4-(7-Phenyl-Heptanoylamino)-Pentanoic Acid,,experimental,PLA2G2A,"Phospholipase A2, membrane associated",target,,DB04287
2-[Trans-(4-Aminocyclohexyl)Amino]-6-(Benzyl-Amino)-9-Cyclopentylpurine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04288
Genz-10850,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB04289
[2-Cytidylate-O'-Phosphonyloxyl]-Ethyl-Trimethyl-Ammonium,,experimental,licC,LicC protein,target,,DB04290
7-(2-Amino-2-Phenyl-Acetylamino)-3-Chloro-8-Oxo-1-Aza-Bicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,experimental,ampC,Beta-lactamase,target,,DB04293
5-Phosphoribosyl-1-(Beta-Methylene) Pyrophosphate,,experimental,nadC,Nicotinate-nucleotide pyrophosphorylase [carboxylating],target,,DB04294
N-Benzoyl-N'-Beta-D-Glucopyranosyl Urea,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04295
5-Oxo-L-Norleucine,,experimental,purF,Amidophosphoribosyltransferase,target,,DB04296
"3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One",,experimental,,Genome polyprotein,target,,DB04298
Bis(5-Amidino-2-Benzimidazolyl)Methane Ketone Hydrate,,experimental,PRSS1,Trypsin-1,target,,DB04301
Gluconic Acid,,experimental,bglA,Beta-glucosidase A,target,,DB04304
5-Hydroxy-N-Propargyl-1(R)-Aminoindan,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB04307
4-Phenylbutylamine,,experimental,PRSS1,Trypsin-1,target,,DB04311
"2,3-Difluorobenzyl Alcohol",,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB04312
1-Methylcytosine,,experimental,PAPS,Cap-specific mRNA (nucleoside-2'-O-)-methyltransferase,target,,DB04314
D-[(N-Hydroxyamino)Carbonyl]Phenylalanine,,experimental,CPA1,Carboxypeptidase A1,target,,DB04316
"3,3-Dichloro-2-Phosphonomethyl-Acrylic Acid",,experimental,ppc,Phosphoenolpyruvate carboxylase,target,,DB04317
1-Benzyloxycarbonylamino-2-Phenyl-Ethyl)-{2-[1-Carbamoyl-2-(1h-Indol-3-Yl)-Ethylcarbamoyl]-5-Phenyl-Pentyl}-Phosphinic Acid,,experimental,MMP11,Stromelysin-3,target,,DB04318
2-Bromo-2-Propene-1-Ol,,experimental,linB,Haloalkane dehalogenase,target,,DB04320
LY249543,,experimental,MTHFD1,"C-1-tetrahydrofolate synthase, cytoplasmic",target,,DB04322
Bilh 434,,experimental,E2,Regulatory protein E2,target,,DB04330
Monastrol,,experimental,KIF11,Kinesin-like protein KIF11,target,,DB04331
1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea,,experimental,PRSS1,Trypsin-1,target,,DB04336
Methyl Isocyanide,,experimental,MB,Myoglobin,target,,DB04337
Carboxymethylenecysteine,,experimental,GSTP1,Glutathione S-transferase P,target,,DB04339
2-[(Dioxidophosphino)Oxy]Benzoate,,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB04340
7-((Carboxy(4-Hydroxyphenyl)Acetyl)Amino)-7-Methoxy-(3-((1-Methyl-1h-Tetrazol-5-Yl)Thio)Methyl)-8-Oxo-5-Oxa-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid,,experimental,bla,Beta-lactamase OXA-10,target,,DB04342
"(2r,4s)-2-Methyl-2,3,3,4-Tetrahydroxytetrahydrofuran",,experimental,lsrB,Autoinducer 2-binding protein LsrB,target,,DB04346
{(1s)-1-Benzyl-4-[3-Carbamoyl-1-(1-Carbamoyl-2-Phenyl-Ethylcarbamoyl)-(S)-Propylcarbamoyl]-2-Oxo-5-Phenyl-Pentyl}-Carbamic Acid Tert-Butyl Ester,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04353
9-Deazaguanine,,experimental,HPRT1,Hypoxanthine-guanine phosphoribosyltransferase,target,,DB04356
Vinylsulphonic Acid,,experimental,phnX,Phosphonoacetaldehyde hydrolase,target,,DB04359
Benzo[B]Thiophene-2-Boronic Acid,,experimental,ampC,Beta-lactamase,target,,DB04360
Methylhydrazine,,experimental,gdhB,Quinoprotein glucose dehydrogenase B,target,,DB04361
Mesobiliverdin Iv Alpha,,experimental,BLVRB,Flavin reductase (NADPH),target,,DB04363
Arecoline,Nootropic Agents,experimental,CHRM1,Muscarinic acetylcholine receptor M1,target,,DB04365
3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB04366
"1,3,2-Dioxaborolan-2-Ol",,experimental,PRSS3,Trypsin-3,target,,DB04369
AL6528,,experimental,CA2,Carbonic anhydrase 2,target,,DB04371
Di-Linoleoyl-3-Sn-Phosphatidylcholine,,experimental,PCTP,Phosphatidylcholine transfer protein,target,,DB04372
"4-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",,experimental,,Plasmepsin-2,target,,DB04373
"4-Carboxy-5-(1-Pentyl)Hexylsulfanyl-1,2,3-Triazole",,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB04374
"5-Methyl-5,6,7,8-Tetrahydrofolic Acid",,experimental,metE,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,target,,DB04375
13-Acetylphorbol,Protein Kinase C-delta,experimental,PRKCD,Protein kinase C delta type,target,,DB04376
3-Hydroxy-3-Methyl-Glutaric Acid,Hypolipidemic Agents,experimental,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB04377
"3-Amino-N-{4-[2-(2,6-Dimethyl-Phenoxy)-Acetylamino]-3-Hydroxy-1-Isobutyl-5-Phenyl-Pentyl}-Benzamide",,experimental,,Plasmepsin-2,target,,DB04378
N-Methyl-N-(Methylbenzyl)Formamide,,experimental,REN,Renin,target,,DB04379
Diureido-Acetate,,experimental,allC,Allantoate amidohydrolase,target,,DB04380
Crotonaldehyde,,experimental,ALDH2,"Aldehyde dehydrogenase, mitochondrial",target,,DB04381
2-Deoxy-Beta-D-Galactose,,experimental,lacZ,Beta-galactosidase,target,,DB04382
3-Deazacytidine,,experimental,cdd,Cytidine deaminase,target,,DB04385
"4,6-O-(1-Carboxyethylidene)-Beta-D-Glucose",,experimental,xly,Xanthan lyase,target,,DB04386
4-Carboxy-4-Aminobutanal,,experimental,ansB,Glutaminase-asparaginase,target,,DB04388
Ado-P-Ch2-P-Ps-Ado,,experimental,FHIT,Bis(5'-adenosyl)-triphosphatase,target,,DB04389
Aeruginosin 98-B,,experimental,PRSS1,Trypsin-1,target,,DB04391
Diclosan,,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB04393
3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB04394
Alpha-D-Glucose-1-Phosphate-6-Vanadate,,experimental,PGM1,Phosphoglucomutase-1,target,,DB04397
"[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde",,experimental,prr,Gamma-aminobutyraldehyde dehydrogenase,target,,DB04401
"2-[2-(1,3-Dioxo-1,3-Dihydro-2h-Isoindol-2-Yl)Ethyl]-4-(4'-Ethoxy-1,1'-Biphenyl-4-Yl)-4-Oxobutanoic Acid",,experimental,MMP12,Macrophage metalloelastase,target,,DB04405
4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04407
Ncs-Chromophore,,experimental,ncsA,Neocarzinostatin,target,,DB04408
Naphthalene Trisulfonate,,experimental,FGF1,Fibroblast growth factor 1,target,,DB04409
Alpha-N-Dichloroacetyl-P-Aminophenylserinol,,experimental,,Chloramphenicol 3-O phosphotransferase,target,,DB04411
Heptamolybdate,,experimental,citA,Sensor histidine kinase CitA,target,,DB04414
"R-2-{[4'-Methoxy-(1,1'-Biphenyl)-4-Yl]-Sulfonyl}-Amino-6-Methoxy-Hex-4-Ynoic Acid",,experimental,MMP3,Stromelysin-1,target,,DB04416
Adenylosuccinic Acid,,experimental,ADSSL1,Adenylosuccinate synthetase isozyme 1,target,,DB04418
RPR128515,,experimental,PRSS1,Trypsin-1,target,,DB04424
"7,8-Dihydroneopterin",,experimental,folB,Dihydroneopterin aldolase,target,,DB04425
Alpha-Methyl-N-Acetyl-D-Glucosamine,,experimental,MBL2,Mannose-binding protein C,target,,DB04426
3-[[N-[4-Methyl-Piperazinyl]Carbonyl]-Phenylalaninyl-Amino]-5-Phenyl-Pentane-1-Sulfonic Acid Benzyloxy-Amide,,experimental,,Cruzipain,target,,DB04427
ZK-805623,,experimental,PRSS1,Trypsin-1,target,,DB04432
"N''-{3-[(3s,8ar)-1,4-Dioxooctahydropyrrolo[1,2-a]Pyrazin-3-Yl]Propyl}Guanidine",,experimental,chiB,Chitinase B,target,,DB04433
Naphthyridine Inhibitor,,experimental,TGFBR1,TGF-beta receptor type-1,target,,DB04434
Tetraphenyl-Arsonium,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04435
3-Fluorotyrosine,Central Nervous System Stimulants,experimental,SOD2,"Superoxide dismutase [Mn], mitochondrial",target,,DB04436
BVDU-MP,,experimental,ORF36,Thymidine kinase,target,,DB04438
Modified Acarbose Pentasaccharide,,experimental,mgtA,4-alpha-glucanotransferase,target,,DB04439
Purine Riboside,,experimental,ADA,Adenosine deaminase,target,,DB04440
2-Fluoroadenosine,,experimental,deoD,Purine nucleoside phosphorylase DeoD-type,target,,DB04441
"2-(2-Oxo-1,2-Dihydro-Pyridin-3-Yl)-1h-Benzoimidazole-5-Carboxamidine",,experimental,PRSS1,Trypsin-1,target,,DB04442
Mercury Diiodide,,experimental,SULT2A1,Bile salt sulfotransferase,target,,DB04445
Benzo[B]Thiophene-2-Carboxamidine,,experimental,PRSS1,Trypsin-1,target,,DB04446
"2,4-Difluorobenzyl Alcohol 2,4-Difluoro-1-(Hydroxymethyl)Benzene",,experimental,ADH1C,Alcohol dehydrogenase 1C,target,,DB04448
"N,N'-Bis(4-Amino-2-Methylquinolin-6-Yl)Urea",,experimental,lef,Lethal factor,target,,DB04452
"4-O-(4,6-Dideoxy-4-{[4-[(4-O-Hexopyranosylhexopyranosyl)Oxy]-5,6-Dihydroxy-3-(Hydroxymethyl)Cyclohex-2-En-1-Yl]Amino}Hexopyranosyl)Hexopyranose",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB04453
"3,4-Dichloroisocoumarin",,experimental,CFD,Complement factor D,target,,DB04459
(C8-S)-Hydantocidin 5'-Phosphate,,experimental,purA,Adenylosuccinate synthetase,target,,DB04460
Coproporphyrin Iii,,experimental,UROD,Uroporphyrinogen decarboxylase,target,,DB04461
Tetrabromo-2-Benzotriazole,,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB04462
"3-(4-Amino-1-Tert-Butyl-1h-Pyrazolo[3,4-D]Pyrimidin-3-Yl)Phenol",,experimental,CBR1,Carbonyl reductase [NADPH] 1,target,,DB04463
SR12813,,experimental,NR1I2,Nuclear receptor subfamily 1 group I member 2,target,,DB04466
"1-(4-Methoxyphenyl)-3,5-Dimethyl-1h-Pyrazole-4-Carboxylic Acid Ethyl Ester",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB04469
CRA_10656,,experimental,PRSS1,Trypsin-1,target,,DB04470
"2-Phenyl-1-[4-(2-Piperidin-1-Yl-Ethoxy)-Phenyl]-1,2,3,4-Tetrahydro-Isoquinolin-6-Ol",,experimental,ESR1,Estrogen receptor,target,,DB04471
"Trencam-3,2-Hopo",,experimental,LCN2,Neutrophil gelatinase-associated lipocalin,target,,DB04476
"N-1,2,3,4-Tetrahydronaphth-1-Yl-2'-[3,5-Dimethoxybenzamido]-2'-Deoxy-Adenosine",,experimental,GAPDHS,"Glyceraldehyde-3-phosphate dehydrogenase, testis-specific",target,,DB04477
"Cp-166572, 2-Hydroxymethyl-4-(4-N,N-Dimethylaminosulfonyl-1-Piperazino)-Pyrimidine",,experimental,SORD,Sorbitol dehydrogenase,target,,DB04478
"3-(4-Fluorophenyl)-2-(6-Methylpyridin-2-Yl)-5,6-Dihydro-4h-Pyrrolo[1,2-B]Pyrazole",,experimental,TGFBR1,TGF-beta receptor type-1,target,,DB04480
Meso-Erythritol,,experimental,metE,5-methyltetrahydropteroyltriglutamate--homocysteine methyltransferase,target,,DB04481
2-Deoxy-2-Fluoro-Beta-D-Mannose,,experimental,manA,"Mannan endo-1,4-beta-mannosidase",target,,DB04483
N-Methylleucine,,experimental,CXCL10,C-X-C motif chemokine 10,target,,DB04487
"(6r,7r)-3-[(Acetyloxy)Methyl]-7-{[(6s)-6-(Glycylamino)-7-Oxido-7-Oxoheptanoyl]Amino}-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Octane-2-Carboxylate",,experimental,,D-alanyl-D-alanine carboxypeptidase,target,,DB04488
Guanidinoethylmercaptosuccinic acid,,experimental,CPD,Carboxypeptidase D,target,,DB04489
3-(Mercaptomethylene)Pyridine,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04490
2-(Acetylamino)-2-Deoxy-4-O-Sulfo-Alpha-D-Galactopyranose,,experimental,cslB,Chondroitinase-B,target,,DB04492
Mo(Vi)(=O)(Oh)2 Cluster,,experimental,citA,Sensor histidine kinase CitA,target,,DB04494
RU81843,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB04495
4-Phospho-D-Erythronohydroxamic Acid,,experimental,rpiB,Ribose-5-phosphate isomerase B,target,,DB04496
Aspartate Semialdehyde,,experimental,asd,Aspartate-semialdehyde dehydrogenase,target,,DB04498
R-Styrene Oxide,,experimental,hheC,Halohydrin dehalogenase,target,,DB04499
Camphane,,experimental,camC,Camphor 5-monooxygenase,target,,DB04501
WRR-204,,experimental,,Cruzipain,target,,DB04502
Sp-722,,experimental,thyA,Thymidylate synthase,target,,DB04503
"8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB04505
"Methyl(6s)-1-Thio-L-Manno-Hexodialdo-6,2-Pyranoside",,experimental,HN,Hemagglutinin-neuraminidase,target,,DB04508
N-Methylnaloxonium,,experimental,CES1,Liver carboxylesterase 1,target,,DB04509
N-Succinyl Methionine,,experimental,Aaar,N-acylamino acid racemase,target,,DB04511
2-Isobutyl-3-Methoxypyrazine,,experimental,LCN9,Epididymal-specific lipocalin-9,target,,DB04512
Phosphoric Acid-2'-[2'-Deoxy-Uridine]Ester-5'-Guanosine Ester,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB04514
6-Deoxy-2-O-Methyl-Alpha-L-Galactopyranose,,experimental,cslB,Chondroitinase-B,target,,DB04515
2-Deoxy-Glucitol-6-Phosphate,,experimental,ISYNA1,Inositol-3-phosphate synthase 1,target,,DB04516
Dipyrromethane Cofactor,,experimental,hemC,Porphobilinogen deaminase,target,,DB04517
"3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamino]-Phenol",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04518
GSHNA,,experimental,GSTA3,Glutathione S-transferase A3,target,,DB04521
Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate,,experimental,CTSK,Cathepsin K,target,,DB04523
Malonyl-Coenzyme A,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB04524
2-(Carboxymethoxy)-5-[(2s)-2-({(2s)-2-[(3-Carboxypropanoyl)Amino] -3-Phenylpropanoyl}Amino)-3-Oxo-3-(Pentylamino)Propyl]Benzoic Acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04525
L-Glycero-D-Manno-Heptopyranose,,experimental,fhuA,Ferrichrome-iron receptor,target,,DB04526
Beta-Hydroxyasparagine,,experimental,MASP2,Mannan-binding lectin serine protease 2,target,,DB04527
"2,4-Dinitrophenol",,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB04528
Benzylcysteine,,experimental,MGMT,Methylated-DNA--protein-cysteine methyltransferase,target,,DB04531
2-Amino-P-Cresol,,experimental,cobT,Nicotinate-nucleotide--dimethylbenzimidazole phosphoribosyltransferase,target,,DB04533
"2s,3s-3-Methylaspartic Acid",,experimental,,3-methylaspartate ammonia-lyase,target,,DB04538
Cholesterol,,experimental,RORA,Nuclear receptor ROR-alpha,target,,DB04540
"(8ar)-Hexahydropyrrolo[1,2-a]Pyrazine-1,4-Dione",,experimental,chiB,Chitinase B,target,,DB04541
3'-Azido-3'-Deoxythymidine-5'-Diphosphate,,experimental,NME1,Nucleoside diphosphate kinase A,target,,DB04542
"2,6-Diamino-8-(1h-Imidazol-2-Ylsulfanylmethyl)-3h-Quinazoline-4-One",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB04543
1-Deoxy-1-Acetylamino-Beta-D-Gluco-2-Heptulopyranosonamide,,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04544
3-Deaza-Adenosine,,experimental,,IAG-nucleoside hydrolase,target,,DB04546
Inhibitor Bea409,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04547
"4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB04549
"Delta-Bis(2,2'-Bipyridine)Imidazole Osmium (Ii)",,experimental,azu,Azurin,target,,DB04550
8-Bromoadenosine-5'-Diphosphate,,experimental,metK,S-adenosylmethionine synthase,target,,DB04554
3-[(1s)-1-(Dimethylamino)Ethyl]Phenol,,experimental,ACHE,Acetylcholinesterase,target,,DB04556
Phenylmercury,,experimental,F5,Coagulation factor V,target,,DB04558
N-(Chlorophenyl)-N'-Hydroxyguanidine,,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB04559
"4-Acetamido-2,4-Didexoy-D-Glycero-Beta-D-Galacto-Octopyranosylphosphonic Acid",,experimental,nanH,Sialidase,target,,DB04561
Tricarballylic Acid,,experimental,ACO2,"Aconitate hydratase, mitochondrial",target,,DB04562
CRA_9678,,experimental,PRSS1,Trypsin-1,target,,DB04563
Gluconolactone,,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB04564
4-(Acetylamino)-3-[(Hydroxyacetyl)Amino]Benzoic Acid,,experimental,NA,Neuraminidase,target,,DB04565
5-Aminoimidazole Ribonucleoside,,experimental,STM4066,Putative sugar kinase,target,,DB04568
Formic Acid Benzyl Ester,,experimental,nprS,Thermolysin,target,,DB04569
Quinestrol,EstrogensHormone Replacement Agents,approved,ESR1,Estrogen receptor,target,agonistmodulator,DB04575
1-(1-phenylcyclopentyl)methylamine,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB04577
"(S)-2-[(R)-3-amino-4-(2-fluorophenyl)butyryl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB04578
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-",,experimental,CTSB,Cathepsin B,target,,DB04579
1-Methyl-2-quinolone,,experimental,Tb927.5.1360,Putative uncharacterized protein,target,,DB04580
1-benzylimidazole,Adrenergic alpha-Antagonists,experimental,QPCT,Glutaminyl-peptide cyclotransferase,target,,DB04581
"5-(AMINOCARBONYL)-1,1':4',1''-TERPHENYL-3-CARBOXYLICACID",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB04583
DEHYDRO-2(S)-AMINO-6-BORONOHEXANOIC ACID,,experimental,ARG1,Arginase-1,target,,DB04585
2-bromophenol,,experimental,thyA,Thymidylate synthase,target,,DB04586
"N-[4-(AMINOSULFONYL)BENZYL]-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB04588
(2R)-({4-[AMINO(IMINO)METHYL]PHENYL}AMINO){5-ETHOXY-2-FLUORO-3-[(3R)-TETRAHYDROFURAN-3-YLOXY]PHENYL}ACETICACID,,experimental,F7,Coagulation factor VII,target,,DB04590
"N-{2,2-DIFLUORO-2-[(2R)-PIPERIDIN-2-YL]ETHYL}-2-[2-(1H-1,2,4-TRIAZOL-1-YL)BENZYL][1,3]OXAZOLO[4,5-C]PYRIDIN-4-AMINE",,experimental,F2,Prothrombin,target,,DB04591
3-Bromo-3-buten-1-ol,,experimental,mmoX,Methane monooxygenase component A alpha chain,target,,DB04592
3-({1-[3-CARBAMIMIDOYL-1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-PROPYLCARBAMOYL]-2-METHYL-BUTYLSULFAMOYL}-METHYL)-BENZOIC ACID,,experimental,F7,Coagulation factor VII,target,,DB04593
3-hydroxyglutaric acid,,experimental,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",target,,DB04594
"4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE-(1->4)-BETA-D-GLUCURONIC ACID",,experimental,xly,Xanthan lyase,target,,DB04596
"[4,6-O-(1-CARBOXYETHYLIDENE)-BETA-D-MANNOSE]",,experimental,xly,Xanthan lyase,target,,DB04597
2-AMINO-4-CHLORO-3-HYDROXYBENZOIC ACID,,experimental,Rmet_5193,"3-hydroxyanthranilate 3,4-dioxygenase",target,,DB04598
"4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",,experimental,CA2,Carbonic anhydrase 2,target,,DB04600
"4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE",,experimental,CA2,Carbonic anhydrase 2,target,,DB04601
PUROMYCIN AMINONUCLEOSIDE-5'-MONOPHOSPHATE,,experimental,RPL37,60S ribosomal protein L37,target,,DB04602
5-Aminoisoquinoline,,experimental,Tb927.5.1360,Putative uncharacterized protein,target,,DB04605
2-[2-ETHANESULFONYLAMINO-3-(5-PROPOXY-1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIMIDOYL-BENZYLAMIDE),,experimental,F7,Coagulation factor VII,target,,DB04606
"PHENYLAMINOIMIDAZO(1,2-ALPHA)PYRIDINE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04607
"9-HYDROXY-4-PHENYL-6H-PYRROLO[3,4-C]CARBAZOLE-1,3-DIONE",,experimental,WEE1,Wee1-like protein kinase,target,,DB04608
INHIBITOR Q8467 OF DUPONT MERCK,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB04609
"7,8-dihydro-6-hydroxymethyl-7-methyl-7-[2-phenylethyl]-pterin",,experimental,folK,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,target,,DB04610
"N-METHYLALANYL-3-METHYLVALYL-4-PHENOXY-N-(1,2,3,4-TETRAHYDRONAPHTHALEN-1-YL)PROLINAMIDE",,experimental,XIAP,E3 ubiquitin-protein ligase XIAP,target,,DB04612
(R)-tacrine(10)-hupyridone,,experimental,ACHE,Acetylcholinesterase,target,,DB04614
(S)-tacrine(10)-hupyridone,,experimental,ACHE,Acetylcholinesterase,target,,DB04615
TACRINE(8)-4-AMINOQUINOLINE,,experimental,ACHE,Acetylcholinesterase,target,,DB04616
"(9S)-9-[(8-AMMONIOOCTYL)AMINO]-1,2,3,4,9,10-HEXAHYDROACRIDINIUM",,experimental,ACHE,Acetylcholinesterase,target,,DB04617
"4,6-DIDEOXY-4-{[4-[(4-O-HEXOPYRANOSYLHEXOPYRANOSYL)OXY]-5,6-DIHYDROXY-3-(HYDROXYMETHYL)CYCLOHEX-2-EN-1-YL]AMINO}HEXOPYRANOSYL-(1->4)HEXOPYRANOSYL-(1->4)HEXOPYRANOSE",,experimental,AMY2A,Pancreatic alpha-amylase,target,,DB04618
ACETOPHENONE,,experimental,radh,R-specific alcohol dehydrogenase,target,,DB04619
Cycloleucine,,experimental,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,,DB04620
N-ACETYLHISTAMINE,,experimental,QPCT,Glutaminyl-peptide cyclotransferase,target,,DB04622
"2-ETHOXYETHYL (2S,3S)-4-((S)-2-BENZYL-3-OXO-4-((3AR,8R,8AS)-2-OXO-3,3A,8,8A-TETRAHYDRO-2H-INDENO[1,2-D]OXAZOL-8-YL)-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE",,experimental,pol,Pol protein,target,,DB04623
DERIVATIVE OF AKLANONIC ACID METHYL ESTER (AAME),,experimental,acma,Aklanonic acid methyl ester cyclase,target,,DB04624
Cyclouridine,,experimental,udp,Uridine phosphorylase,target,,DB04627
Aplyronine A,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB04629
Aldosterone,,experimental,NR3C2,Mineralocorticoid receptor,target,,DB04630
4-(2-HYDROXYBENZYLAMINO)-N-(3-(4-FLUOROPHENOXY)PHENYL)PIPERIDINE-1-SULFONAMIDE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB04632
"N-ethyl-N-[3-(propylamino)propyl]propane-1,3-diamine",,experimental,SAT1,Diamine acetyltransferase 1,target,,DB04633
Glutamine t-butyl ester,,experimental,QPCT,Glutaminyl-peptide cyclotransferase,target,,DB04636
6-Bromo-1-hexanol,,experimental,mmoX,Methane monooxygenase component A alpha chain,target,,DB04637
"2,5-DI-(TERT-BUTYL)-1,4,BENZOHYDROQUINONE",,experimental,ATP2A1,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,target,,DB04638
"3,7-DIHYDROXYNAPHTHALENE-2-CARBOXYLIC ACID",,experimental,,L-lactate dehydrogenase,target,,DB04641
"7-{2,6-DICHLORO-4-[3-(2-CHLORO-BENZOYL)-UREIDO]-PHENOXY}-HEPTANOIC ACID",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04642
"4-{3-CHLORO-4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-PHENOXY}-BUTYRIC ACID",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04643
"4-{4-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2,3-DIMETHYL-PHENOXY}-BUTYRIC ACID",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04644
"5-{3-[3-(2,4-DICHLORO-BENZOYL)-UREIDO]-2-METHYL-PHENOXY}-PENTANOIC ACID",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB04645
S-propylamine-L-cysteine,,experimental,ARG1,Arginase-1,target,,DB04648
TETRAHEDRAL INTERMEDIATE OF BLASTICIDIN S,,experimental,bsd,Blasticidin-S deaminase,target,,DB04649
"5-[(3AS,4R,6AR)-2-OXOHEXAHYDRO-1H-THIENO[3,4-D]IMIDAZOL-4-YL]PENTANOIC ACID",,experimental,,Streptavidin,target,,DB04650
BIOTINOL-5-AMP,,experimental,birA,Bifunctional protein BirA,target,,DB04651
CBZ-LEU-LEU-TYR-CH2F,,experimental,CAPN1,Calpain-1 catalytic subunit,target,,DB04653
"METOPRINE, METHODICHLOROPHEN",,experimental,HNMT,Histamine N-methyltransferase,target,,DB04655
"1,3,4-TRIHYDROXY-5-(3-PHENOXYPROPYL)-CYCLOHEXANE-1-CARBOXYLIC A CID",,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB04656
Carboxin,"Fungicides, Industrial",experimental,SDHA,"Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",target,,DB04657
"(1S,2R,3S,4R,5S)-8-AZABICYCLO[3.2.1]OCTANE-1,2,3,4-TETROL",,experimental,bglA,Beta-glucosidase A,target,,DB04658
"(1S,2S,3R,4S,5S)-2,3,4-TRIHYDROXY-5-(HYDROXYMETHYL)CYCLOHEXYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE",,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB04659
Glycerylphosphorylcholine,,experimental,GM2A,Ganglioside GM2 activator,target,,DB04660
Cis-tetracosenoyl sulfatide,,experimental,CD1D,Antigen-presenting glycoprotein CD1d,target,,DB04661
OLOMOUCINE II,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04662
Cyclohexyl-pentyl-maltoside,,experimental,CYP2B6,Cytochrome P450 2B6,target,,DB04664
2H-1-BENZOPYRAN-2-ONE,,experimental,CYP2A6,Cytochrome P450 2A6,target,,DB04665
TRIAZOLOPYRIMIDINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB04669
L-CYSTEIN-S-1-(IMINOMETHYL)-L-ORNITHINE,,experimental,arcA,Arginine deiminase,target,,DB04671
"cyclic 3',5'-thymidine monophosphate",,experimental,NT5M,"5'(3')-deoxyribonucleotidase, mitochondrial",target,,DB04672
4-[(5-CHLOROINDOL-2-YL)SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL)PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE,,experimental,F10,Coagulation factor X,target,,DB04673
"(2S,5R,8S,11R,12S,15S,18S,19S,E)-8-ISOBUTYL-18-((5S,6S)-6-METHOXY-3,5-DIMETHYL-7-PHENYLHEPTYL)-1,2,5,12,15,19-HEXAMETHYL-3,6,9,13,16,20,25-HEPTAOXO-1,4,7,10,14,17,21-HEPTAAZACYCLOPENTACOS-21-ENE-11,22-DICARBOXYLIC ACID",,experimental,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,target,,DB04675
Dansyllysine,,experimental,IGHA2,Ig alpha-2 chain C region,target,,DB04676
N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB04677
H TYPE II TRISACCHARIDE,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB04678
H TYPE I TRISACCHARIDE,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB04679
GALACTOSE GREASE,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB04680
BETA-METHYLLACTOSIDE,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB04681
Octylphenoxy polyethoxyethanol,Surface-Active AgentsAntifoaming AgentsDetergentsExcipientsSpermatocidal Agents,experimental,TNNC2,"Troponin C, skeletal muscle",target,,DB04682
"(2R)-3-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-2-[(9E)-HEXADEC-9-ENOYLOXY]PROPYL (9E)-OCTADEC-9-ENOATE",,experimental,NR5A1,Steroidogenic factor 1,target,,DB04683
DIMETHYL THIOPHOSPHATE,,experimental,opdA,Phosphotriesterase,target,,DB04687
2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB04689
Camptothecin,"Antineoplastic Agents, PhytogenicTopoisomerase I Inhibitors",experimental,TOP1,DNA topoisomerase 1,target,,DB04690
"(13S)-13-METHYLDODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-3,17(2H,4H)-DIONE",,experimental,ksi,Steroid Delta-isomerase,target,,DB04693
"4-CHLORO-3',3''-DIBROMOPHENOL-1,8-NAPHTHALEIN",,experimental,thyA,Thymidylate synthase,target,,DB04696
TRANS-4-(GUANIDINOMETHYL)-CYCLOHEXANE-L-YL-D-3-CYCLOHEXYLALANYL-L-AZETIDINE-2-YL-D-TYROSINYL-L-HOMOARGININAMIDE,,experimental,F2,Prothrombin,target,,DB04697
"N-(1,4-DIHYDRO-5H-TETRAZOL-5-YLIDENE)-9-OXO-9H-XANTHENE-2-SULFONAMIDE",,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB04698
4-Butyrolactone,Solvents,experimental,nagJ,O-GlcNAcase NagJ,target,,DB04699
GLUTATHIONE SULFINATE,,experimental,GSTK1,Glutathione S-transferase kappa 1,target,,DB04700
S-METHYL-GLUTATHIONE,,experimental,GSTM2,Glutathione S-transferase Mu 2,target,,DB04701
"S-[(2E)-3,7-DIMETHYLOCTA-2,6-DIENYL] TRIHYDROGENTHIODIPHOSPHATE",,experimental,,Prenyltransferase,target,,DB04702
HESPERIDIN,,experimental,AURKB,Aurora kinase B,target,,DB04703
"(3AALPHA,4ALPHA,7ALPHA,7AALPHA)- 3A,4,7,7A-TETRAHYDRO-2-(4-NITRO-1-NAPHTHALENYL)-4,7-ETHANO-1H-ISOINDOLE-1,3(2H)-DIONE",,experimental,AR,Androgen receptor,target,,DB04709
4-IODOPHENYLALANINE,,experimental,,Aminopeptidase S,target,,DB04713
IMIDAZOPYRIDAZIN 1,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB04715
"DIMETHYL-(4,5,6,7-TETRABROMO-1H-BENZOIMIDAZOL-2-YL)-AMINE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB04719
"S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB04720
"N1,N2-ETHYLENE-2-METHYLAMINO-4,5,6,7-TETRABROMO-BENZIMIDAZOLE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB04721
"2-(3-CHLORO-6-{[2,2-DIFLUORO-2-(1-OXIDOPYRIDIN-2-YL)ETHYL]AMINO}-1-OXIDOPYRIDIN-2-YL)-N-[1-(3-CHLOROPHENYL)ETHYL]ACETAMIDE",,experimental,F2,Prothrombin,target,,DB04722
2-(3-GUANIDINOPHENYL)-3-MERCAPTOPROPANOIC ACID,,experimental,CPB1,Carboxypeptidase B,target,,DB04723
"(S)-2-((S)-3-ISOBUTYL-2,5-DIOXO-4-QUINOLIN-3-YLMETHYL-[1,4]DIAZEPAN-1YL)-N-METHYL-3-NAPHTALEN-2-YL-PROPIONAMIDE",,experimental,ITGAL,Integrin alpha-L,target,,DB04724
"N-(4-{4-AMINO-6-[4-(METHYLOXY)PHENYL]FURO[2,3-D]PYRIMIDIN-5-YL}PHENYL)-N'-[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]UREA",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB04727
1-ACETYL-2-LYSO-SN-GLYCERO-3-PHOSPHOETHANOLAMINE,,experimental,cinA,Lantibiotic cinnamycin,target,,DB04731
"1,6-DI-O-PHOSPHONO-D-MANNITOL",,experimental,ALDOA,Fructose-bisphosphate aldolase A,target,,DB04733
Citraconic acid,,experimental,fccA,Fumarate reductase flavoprotein subunit,target,,DB04734
MONOGALACTOSYL-DIACYLGLYCEROL,,experimental,psbA1,Photosystem Q(B) protein 1,target,,DB04735
"2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE(BETA1-4)-2-ACETAMIDO-1,6-ANHYDRO-3-O-[(R)-1-CARBOXYETHYL]-2-DEOXY-BETA-D-GLUCOPYRANOSE-L-ALANYL-GAMMA-D-GLUTAMYL-MESO-DIAMINOPIMELYL-D-ALANINE",,experimental,PGLYRP3,Peptidoglycan recognition protein 3,target,,DB04736
Motuporin,,experimental,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,target,,DB04738
4-[(4-METHYL-1-PIPERAZINYL)METHYL]-N-[3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]PHENYL]-BENZAMIDE,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB04739
MOXALACTAM (HYDROLYZED),,experimental,,Metallo-beta-lactamase L1,target,,DB04740
Myxothiazol,Antifungal AgentsAnti-Bacterial Agents,experimental,UQCRC1,"Cytochrome b-c1 complex subunit 1, mitochondrial",target,,DB04741
NITROCEFIN,,experimental,dac,D-alanyl-D-alanine carboxypeptidase,target,,DB04742
2-OXOQUINOLINE,,experimental,oxoO,"2-oxo-1,2-dihydroquinoline 8-monooxygenase, oxygenase component",target,,DB04745
"(10E,12Z)-octadeca-10,12-dienoic acid",,experimental,PPA1039,Putative aminooxidase,target,,DB04746
11-TRANS-13-TRANS-15-CIS-OCTADECATRIENOIC ACID,,experimental,PPA1039,Putative aminooxidase,target,,DB04747
2-(3-OXO-PROPYLSULFANYLCARBONYL)-ETHANETHIOLATE,,experimental,,Beta-lactamase IMP-1,target,,DB04749
Phosphatidyl ethanol,,experimental,NR5A1,Steroidogenic factor 1,target,,DB04752
"9-DEAZAINOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB04753
"GUANOSINE-2',3'-O-ETHYLIDENEPHOSPHONATE",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB04754
"GUANOSINE-2',3'-O-METHYLIDENEPHOSPHONATE",,experimental,PNP,Purine nucleoside phosphorylase,target,,DB04757
2-[2-ETHANESULFONYLAMINO-3-(1H-INDOL-3-YL)-PROPIONYLAMINO]-PENTANEDIOIC ACID 5-AMIDE 1-(4-CARBAMIM IDOYL-BENZYLAMIDE),,experimental,F7,Coagulation factor VII,target,,DB04758
"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(3-METHYL-BENZYLAMIDE)",,experimental,MMP13,Collagenase 3,target,,DB04759
"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-(4-FLUORO-3-METHYL-BENZYLAMIDE)",,experimental,MMP13,Collagenase 3,target,,DB04760
"PYRIMIDINE-4,6-DICARBOXYLIC ACID BIS-[(PYRIDIN-3-YLMETHYL)-AMIDE]",,experimental,MMP13,Collagenase 3,target,,DB04761
N-PYRIDOXYL-D-GLUTAMIC ACID-5'-MONOPHOSPHATE,,experimental,aspC,Aspartate aminotransferase,target,,DB04762
"1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM",,experimental,CA2,Carbonic anhydrase 2,target,,DB04763
[4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL]-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE,,experimental,TPSB2,Tryptase beta-2,target,,DB04764
N-PYRIDOXYL-2-METHYL-L-GLUTAMIC ACID-5'-MONOPHOSPHATE,,experimental,aspC,Aspartate aminotransferase,target,,DB04765
N-[1-(4-CARBAMIMIDOYL-BENZYLCARBAMOYL)-3-METHYLSULFANYL-PROPYL]-3-HYDROXY-2-PROPOXYAMINO-BUTYRAMID,,experimental,F7,Coagulation factor VII,target,,DB04767
Pyrithiamine Pyrophosphate,,experimental,TPK1,Thiamin pyrophosphokinase 1,target,,DB04768
"5-QUINOXALIN-6-YLMETHYLENE-THIAZOLIDINE-2,4-DIONE",,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB04769
"O6-(R)-ROSCOVITINE, R-2-(6-BENZYLOXY-9-ISOPROPYL-9H-PURIN-2-YLAMINO)-BUTAN-1-OL",,experimental,PDXK,Pyridoxal kinase,target,,DB04770
1-GUANIDINO-4-(N-NITRO-BENZOYLAMINO-L-LEUCYL-L-PROLYLAMINO)BUTANE,,experimental,F2,Prothrombin,target,,DB04771
1-GUANIDINO-4-(N-PHENYLMETHANESULFONYL-L-LEUCYL-L-PROLYLAMINO)BUTANE,,experimental,F2,Prothrombin,target,,DB04772
METHYL (3R)-3-{[(3R)-3-{[(3R)-3-HYDROXYBUTANOYL]OXY}BUTANOYL]OXY}BUTANOATE,,experimental,AFUA_4G03560,"Polyhydroxybutyrate depolymerase, putative",target,,DB04773
Reidispongiolide A,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB04774
Reidispongiolide C,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB04775
"N6-METHYL-(R)-ROSCOVITINE, R-2-[6-(BENZYL-METHYL-AMINO)-9-ISOPROPYL-9H-PURIN-2-YLAMINO]-BUTAN-1-OL",,experimental,PDXK,Pyridoxal kinase,target,,DB04776
(R)-4-Nitrostyrene oxide,,experimental,hheC,Halohydrin dehalogenase,target,,DB04777
ETHYL (1E)-2-PHENYL-N-(SULFOOXY)ETHANIMIDOTHIOATE,,experimental,LCT,Lactase-phlorizin hydrolase,target,,DB04779
5-hydroxyvaleric acid,,experimental,ALAD,Delta-aminolevulinic acid dehydratase,target,,DB04781
(S)-4-Nitrostyrene oxide,,experimental,dehB,"2,3-dichloro-1-propanol dehalogenase",target,,DB04782
Sphinxolide B,,experimental,ACTA1,"Actin, alpha skeletal muscle",target,,DB04783
Methylphenyl carbinol,,experimental,radh,R-specific alcohol dehydrogenase,target,,DB04784
Tanaproget,,experimental,PGR,Progesterone receptor,target,,DB04787
5-methyltetrahydrofolate,,experimental,AMT,"Aminomethyltransferase, mitochondrial",target,,DB04789
"2,5-bis-o-{3-[amino(imino)methyl]phenyl}-1,4:3,6-dianhydro-d-glucitol",,experimental,PRSS1,Trypsin-1,target,,DB04790
"2-O-(4'-AMIDINOPHENYL)-5-O-(3''-AMIDINOPHENYL)-1,4:3,6-DIANHYDRO-D-SORBITOL",,experimental,PRSS1,Trypsin-1,target,,DB04791
"2,5-O,O-BIS-{4',4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",,experimental,PRSS1,Trypsin-1,target,,DB04792
"2-O-(3'-AMIDINOPHENYL)-5-O-(4''-AMIDINOPHENYL}-1,4:3,6-DIANHYDRO-D-SORBITOL",,experimental,PRSS1,Trypsin-1,target,,DB04793
Inecalcitol,,experimental,VDR,Vitamin D3 receptor,target,,DB04796
Triazolopyridine,Anti-Bacterial Agents,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB04797
THIO-ATPA,,experimental,GRIA2,Glutamate receptor 2,target,,DB04798
1-METHYL-3-PHENYL-1H-PYRAZOL-5-YLSULFAMIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB04800
(11E)-OCTADEC-11-ENOIC ACID,,experimental,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB04801
Verdoheme,,experimental,HMOX1,Heme oxygenase 1,target,,DB04803
Virginiamycin factor S1,Anti-Bacterial Agents,experimental,RPL37,60S ribosomal protein L37,target,,DB04805
4-NITROPHENYL-(6-S-ALPHA-D-XYLOPYRANOSYL)-BETA-D-GLUCOPYRANOSIDE,,experimental,yicI,Alpha-xylosidase,target,,DB04807
SALOPHEN-10-PROPIONATE IRON CHELATE,,experimental,,Heme oxygenase,target,,DB04809
Salophen-10-carboxylate iron chelate,,experimental,,Heme oxygenase,target,,DB04810
Salophen iron chelate,,experimental,,Heme oxygenase,target,,DB04811
Metamizole,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,PTGS1,Prostaglandin G/H synthase 1,target,,DB04817
Phenolphthalein,Indicators and Reagents,withdrawn,UGT1A9,UDP-glucuronosyltransferase 1-9,target,,DB04824
Zomepirac,"Anti-Inflammatory Agents, Non-Steroidal",withdrawn,GPR44,Prostaglandin D2 receptor 2,target,,DB04828
Lysergic Acid Diethylamide,Serotonin AntagonistsHallucinogensSerotonin Receptor Agonists,illicitwithdrawn,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB04829
Maraviroc,,approvedinvestigational,CCR5,C-C chemokine receptor type 5,target,antagonist,DB04835
Clofedanol,Histamine Antagonists,approvedwithdrawn,HRH1,Histamine H1 receptor,target,antagonist,DB04837
Cyproterone acetate,,approvedinvestigational,AR,Androgen receptor,target,antagonist,DB04839
Debrisoquin,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,SLC6A2,Sodium-dependent noradrenaline transporter,target,inducer,DB04840
Ixabepilone,,approvedinvestigational,TUBB3,Tubulin beta-3 chain,target,inhibitor,DB04845
AZD2171,,investigational,KDR,Vascular endothelial growth factor receptor 2,target,,DB04849
Implitapide,,investigational,MTTP,Microsomal triglyceride transfer protein large subunit,target,,DB04852
Binodenoson,Diagnostic Agents,investigational,ADORA2A,Adenosine receptor A2a,target,,DB04853
Dexloxiglumide,,investigational,CCKAR,Cholecystokinin receptor type A,target,,DB04856
Brasofensine,,investigational,DRD2,D(2) dopamine receptor,target,,DB04857
Zanapezil,,investigational,ACHE,Acetylcholinesterase,target,,DB04859
Isatoribine,,investigational,TLR7,Toll-like receptor 7,target,,DB04860
Merimepodib,,investigational,guaB,Inosine-5'-monophosphate dehydrogenase,target,,DB04862
Huperzine A,Neuroprotective AgentsCholinesterase Inhibitors,investigational,ACHE,Acetylcholinesterase,target,,DB04864
Lintitript,Antineoplastic AgentsAnti-Obesity Agents,investigational,CCKAR,Cholecystokinin receptor type A,target,,DB04867
Olcegepant,Anti-migraine Agents,investigational,CALCA,Calcitonin gene-related peptide 1,target,,DB04869
Lorcaserin,,approved,HTR2C,5-hydroxytryptamine receptor 2C,target,,DB04871
Osanetant,,investigational,TACR3,Neuromedin-K receptor,target,,DB04872
Piboserod,,investigational,HTR4,5-hydroxytryptamine receptor 4,target,,DB04873
Pralnacasan,,investigational,CASP1,Caspase-1,target,,DB04875
Vildagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approvedinvestigational,DPP4,Dipeptidyl peptidase 4,target,inhibitor,DB04876
Voacamine,Antimalarials,approvedinvestigational,ABCB1,Multidrug resistance protein 1,target,"inhibitor, competitive",DB04877
Voglibose,,approvedinvestigational,MGAM,"Maltase-glucoamylase, intestinal",target,inhibitor,DB04878
Enoximone,,approvedinvestigational,PDE3A,"cGMP-inhibited 3',5'-cyclic phosphodiesterase A",target,inhibitor,DB04880
Elacridar,"Antineoplastics, Adjuncts",investigational,ABCB1,Multidrug resistance protein 1,target,,DB04881
Edotecarin,Antineoplastic Agents,investigational,TOP1,DNA topoisomerase 1,target,,DB04882
Darusentan,,investigational,EDNRA,Endothelin-1 receptor,target,,DB04883
Cilansetron,,investigational,HTR3A,5-hydroxytryptamine receptor 3A,target,,DB04885
Calanolide A,Anti-HIV AgentsReverse Transcriptase Inhibitors,investigational,gag-pol,Gag-Pol polyprotein,target,,DB04886
Brecanavir,,investigational,,Protease,target,,DB04887
Bepotastine,Mast Cell Stabilizers,approved,HRH1,Histamine H1 receptor,target,antagonist,DB04890
Pegaptanib,,approvedinvestigational,NRP1,Neuropilin-1,target,,DB04895
Ximelagatran,Antithrombins,approvedinvestigationalwithdrawn,F2,Prothrombin,target,inhibitor,DB04898
Galiximab,Antipsoriatic Agents,investigational,CD80,T-lymphocyte activation antigen CD80,target,,DB04901
AZD6140,,investigational,P2RY12,P2Y purinoceptor 12,target,,DB04902
Oxibendazole,Anthelmintics,investigational,TUBB2C,Tubulin beta-4B chain,target,,DB04910
Phenoxodiol,Antineoplastic Agents,investigational,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,target,,DB04915
Desmoteplase,Fibrinolytic Agents,investigational,PLG,Plasminogen,target,,DB04925
Neramexane,,investigational,GRIN3A,"Glutamate receptor ionotropic, NMDA 3A",target,,DB04926
NM100060,,investigational,SQLE,Squalene monooxygenase,target,,DB04927
DG031,,investigational,ALOX5AP,Arachidonate 5-lipoxygenase-activating protein,target,,DB04929
Permethrin,,approvedinvestigational,SCN1A,Sodium channel protein type 1 subunit alpha,target,inhibitor,DB04930
EPT1647,Affinity Labels,investigational,MC1R,Melanocyte-stimulating hormone receptor,target,,DB04931
Eritoran,,investigational,TLR4,Toll-like receptor 4,target,,DB04933
Benzoxazinorifamycin,"Anti-Bacterial AgentsLeprostatic AgentsAntibiotics, Antitubercular",investigational,rpoB,DNA-directed RNA polymerase subunit beta,target,,DB04934
GV1001,Antineoplastic AgentsVaccines,investigational,TERT,Telomerase reverse transcriptase,target,,DB04937
Ospemifene,Estrogen Antagonists,approved,ESR1,Estrogen receptor,target,antagonistagonist,DB04938
Altropane,Diagnostic Agents,investigational,SLC6A3,Sodium-dependent dopamine transporter,target,,DB04947
Lofexidine,Antihypertensive AgentsAdrenergic alpha-2 Receptor AgonistsNarcotic Antagonists,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,agonist,DB04948
Pirfenidone,,investigational,FURIN,Furin,target,,DB04951
Tecadenoson,Anti-Arrhythmia Agents,investigational,ADORA1,Adenosine receptor A1,target,,DB04954
Afelimomab,,investigational,TNF,Tumor necrosis factor,target,,DB04956
Epratuzumab,,investigational,CD22,B-cell receptor CD22,target,,DB04958
R115777,Antineoplastic Agents,investigational,FNTB,Protein farnesyltransferase subunit beta,target,,DB04960
Oregovomab,Antineoplastic Agents,investigational,MUC16,Mucin-16,target,,DB04964
Lesopitron,,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB04970
Canfosfamide,Antineoplastic Agents,investigational,GSTP1,Glutathione S-transferase P,target,,DB04972
LErafAON,Antineoplastic Agents,investigational,RAF1,RAF proto-oncogene serine/threonine-protein kinase,target,,DB04973
AP1903,,investigational,MTOR,Serine/threonine-protein kinase mTOR,target,,DB04974
Banoxantrone,Antineoplastic Agents,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB04975
SP1049C,Antineoplastic Agents,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB04978
Denufosol,,investigational,P2RY2,P2Y purinoceptor 2,target,,DB04983
PCK3145,Antineoplastic Agents,investigational,RPSA,40S ribosomal protein SA,target,,DB04985
XL784,,investigational,ADAM10,Disintegrin and metalloproteinase domain-containing protein 10,target,,DB04991
ATL1102,,investigational,ITGA4,Integrin alpha-4,target,,DB04997
AGRO100,,investigational,IKBKG,NF-kappa-B essential modulator,target,,DB04998
PSN9301,,investigational,DPP4,Dipeptidyl peptidase 4,target,,DB05001
CCX282,,investigational,CCR9,C-C chemokine receptor type 9,target,,DB05005
BMS068645,,investigational,ADORA2A,Adenosine receptor A2a,target,,DB05009
XEN2174,,investigational,SLC6A2,Sodium-dependent noradrenaline transporter,target,,DB05012
Migalastat,,investigational,GLA,Alpha-galactosidase A,target,,DB05018
ANA380,,investigational,,DNA polymerase,target,,DB05020
ATL1101,,investigational,IGF1R,Insulin-like growth factor 1 receptor,target,,DB05023
Arimoclomol,,investigational,SOD1,Superoxide dismutase [Cu-Zn],target,,DB05025
APD125,,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05026
REV131,,investigational,HRH4,Histamine H4 receptor,target,,DB05032
INCB7839,,investigational,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,target,,DB05033
Ularitide,,investigational,NPR1,Atrial natriuretic peptide receptor 1,target,,DB05034
Indacaterol,,approved,ADRB2,Beta-2 adrenergic receptor,target,agonist,DB05039
SGS518,,investigational,HTR6,5-hydroxytryptamine receptor 6,target,,DB05042
PSN357,,investigational,PYGL,"Glycogen phosphorylase, liver form",target,,DB05044
DDP733,,investigational,HTR3A,5-hydroxytryptamine receptor 3A,target,,DB05049
ADL5859,,investigational,OPRD1,Delta-type opioid receptor,target,,DB05050
MF101,,investigational,ESR2,Estrogen receptor beta,target,,DB05052
MB07803,,investigational,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB05053
AN2690,,investigational,CDC60,Cytosolic leucyl-tRNA synthetase,target,,DB05058
R1626,,investigational,NS5b,RNA-dependent RNA-polymerase,target,,DB05060
INCB9471,,investigational,CCR5,C-C chemokine receptor type 5,target,,DB05062
INCB13739,,investigational,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB05064
PHX1149,,investigational,DPP4,Dipeptidyl peptidase 4,target,,DB05065
ADX10059,,investigational,GRM5,Metabotropic glutamate receptor 5,target,,DB05070
AV608,,investigational,TACR1,Substance-P receptor,target,,DB05072
SRT501,,investigational,SIRT1,NAD-dependent protein deacetylase sirtuin-1,target,,DB05073
SLV319,,investigational,CNR1,Cannabinoid receptor 1,target,,DB05077
M0002,,investigational,AVPR2,Vasopressin V2 receptor,target,,DB05091
CDP323,,investigational,ITGA4,Integrin alpha-4,target,,DB05092
MDV3100,,investigational,AR,Androgen receptor,target,,DB05094
Cimicoxib,,investigational,PTGS2,Prostaglandin G/H synthase 2,target,,DB05095
Labetuzumab,,investigational,,Carcinoembryonic antigen,target,,DB05097
Leptin,,investigational,LEPR,Leptin receptor,target,,DB05098
Ancrod,,investigational,FGA,Fibrinogen alpha chain,target,,DB05099
Matuzumab,,investigational,EGFR,Epidermal growth factor receptor,target,,DB05101
AG7088,,investigational,,Genome polyprotein,target,,DB05102
Asimadoline,,investigational,OPRK1,Kappa-type opioid receptor,target,,DB05104
Pleconaril,,investigational,,Polyprotein,target,,DB05105
HE2000,,investigational,G6PD,Glucose-6-phosphate 1-dehydrogenase,target,,DB05107
VIR201,,investigational,IFNG,Interferon gamma,target,,DB05110
Fontolizumab,,investigational,IFNG,Interferon gamma,target,,DB05111
NN344,,investigational,INSR,Insulin receptor,target,,DB05115
NB1011,,investigational,TYMS,Thymidylate synthase,target,,DB05116
AT1391,,investigational,INSR,Insulin receptor,target,,DB05120
SC12267,,investigational,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB05125
ANA971,,investigational,TLR7,Toll-like receptor 7,target,,DB05127
INCB3284,,investigational,CCR2,C-C chemokine receptor type 2,target,,DB05130
TTP889,,investigational,F9,Coagulation factor IX,target,,DB05131
VP025,,investigational,IL1B,Interleukin-1 beta,target,,DB05133
CR002,,investigational,PDGFD,Platelet-derived growth factor D,target,,DB05139
LY2181308,,investigational,BIRC5,Baculoviral IAP repeat-containing protein 5,target,,DB05141
CAD106,,investigational,APP,Amyloid beta A4 protein,target,,DB05150
NGX267,,investigational,CHRM1,Muscarinic acetylcholine receptor M1,target,,DB05152
CR665,,investigational,OPRK1,Kappa-type opioid receptor,target,,DB05155
CCX915,,investigational,CCR2,C-C chemokine receptor type 2,target,,DB05159
GSK716155,,investigational,GLP1R,Glucagon-like peptide 1 receptor,target,,DB05162
CMLVAX100,,investigational,BCR/ABL fusion,BCR/ABL p210 fusion protein,target,,DB05164
LY2275796,,investigational,EIF4E,Eukaryotic translation initiation factor 4E,target,,DB05165
APD668,,investigational,GPR119,Glucose-dependent insulinotropic receptor,target,,DB05166
DG051,,investigational,LTA4H,Leukotriene A-4 hydrolase,target,,DB05177
MLN0415,,investigational,IKBKB,Inhibitor of nuclear factor kappa-B kinase subunit beta,target,,DB05183
KD3010,,investigational,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB05188
Atl146e,,investigational,ADORA2A,Adenosine receptor A2a,target,,DB05191
MB07811,,investigational,THRB,Thyroid hormone receptor beta,target,,DB05192
LX1031,,investigational,TPH1,Tryptophan 5-hydroxylase 1,target,,DB05199
AT2220,,investigational,GAA,Lysosomal alpha-glucosidase,target,,DB05200
V24343,,investigational,CNR1,Cannabinoid receptor 1,target,,DB05201
XL418,,investigational,BTK,Tyrosine-protein kinase BTK,target,,DB05204
CX157,,investigational,MAOA,Amine oxidase [flavin-containing] A,target,,DB05205
SYM001,,investigational,RHD,Rhesus blood group D antigen,target,,DB05209
AC220,Antineoplastic Agents,investigational,FLT3,Receptor-type tyrosine-protein kinase FLT3,target,,DB05213
KD7040,,investigational,NOS2,"Nitric oxide synthase, inducible",target,,DB05214
RHIIP,,investigational,INSR,Insulin receptor,target,,DB05215
GMX1777,Antineoplastic Agents,investigational,NAMPT,Nicotinamide phosphoribosyltransferase,target,,DB05217
PN0621,Immunosuppressive Agents,investigational,TNF,Tumor necrosis factor,target,,DB05218
MLN8237,Antineoplastic Agents,investigational,AURKA,Aurora kinase A,target,,DB05220
KB001,Anti-Bacterial Agents,investigational,pcrV,PcrV,target,,DB05222
REP8839,Anti-Bacterial Agents,investigational,metG,Methionine--tRNA ligase,target,,DB05224
AM103,,investigational,ALOX5AP,Arachidonate 5-lipoxygenase-activating protein,target,,DB05225
BTA9881,,investigational,F,Fusion glycoprotein F0,target,,DB05226
APD791,Antithrombins,investigational,HTR2A,5-hydroxytryptamine receptor 2A,target,,DB05227
RDEA806,Reverse Transcriptase Inhibitors,investigational,gag-pol,Gag-Pol polyprotein,target,,DB05228
Beraprost,,investigational,PTGIR,Prostacyclin receptor,target,,DB05229
AP1081,Contraceptive Agents,investigational,ESR1,Estrogen receptor,target,,DB05233
LGD2941,,investigational,AR,Androgen receptor,target,,DB05234
PLX4032,Antineoplastic Agents,investigational,BRAF,Serine/threonine-protein kinase B-raf,target,,DB05238
XL518,Antineoplastic Agents,investigational,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB05239
XL147,Antineoplastic Agents,investigational,PIK3CA,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",target,,DB05240
XL019,Antineoplastic Agents,investigational,JAK2,Tyrosine-protein kinase JAK2,target,,DB05243
Methsuximide,AnticonvulsantsSuccinimides,approved,CACNA1G,Voltage-dependent T-type calcium channel subunit alpha-1G,target,inhibitor,DB05246
FavId,,investigational,CSF3R,Granulocyte colony-stimulating factor receptor,target,,DB05249
ACCLAIM,,investigational,NOS2,"Nitric oxide synthase, inducible",target,,DB05252
Proellex,,investigational,PGR,Progesterone receptor,target,,DB05253
659032,,investigational,PLA2G7,Platelet-activating factor acetylhydrolase,target,,DB05256
Natural alpha interferon,Antineoplastic Agents,approvedinvestigational,IFNAR1,Interferon alpha/beta receptor 1,target,,DB05258
Glatiramer Acetate,"Adjuvants, ImmunologicImmunosuppressive Agents",approvedinvestigational,HLA-DRB1,"HLA class II histocompatibility antigen, DRB1-1 beta chain",target,binder,DB05259
Oxypurinol,Enzyme Inhibitors,investigational,XDH,Xanthine dehydrogenase/oxidase,target,,DB05262
NPI 32101,,investigational,CSF2RB,Cytokine receptor common subunit beta,target,,DB05264
iCo-007,,investigational,RAF1,RAF proto-oncogene serine/threonine-protein kinase,target,,DB05268
AST-120,,approvedinvestigational,LPL,Lipoprotein lipase,target,,DB05269
hepatitis B immune globulin,,approvedinvestigational,S gene,HBsAg,target,,DB05276
inhaled insulin,,approvedinvestigational,CRP,C-reactive protein,target,,DB05278
MCC,,investigational,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",target,,DB05282
CA4P,,investigational,TUBB,Tubulin beta chain,target,,DB05284
FTY 720,,investigational,S1PR5,Sphingosine 1-phosphate receptor 5,target,,DB05286
MPC-7869,,investigational,IKBKG,NF-kappa-B essential modulator,target,,DB05289
SPP 301,,investigational,EDNRA,Endothelin-1 receptor,target,,DB05290
lidocaine patch,,investigational,CYP1A2,Cytochrome P450 1A2,target,,DB05291
ED-71,,investigational,VDR,Vitamin D3 receptor,target,,DB05295
DHA-paclitaxel,,investigational,BCL2,Apoptosis regulator Bcl-2,target,,DB05297
OPC-6535,,investigational,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB05298
keyhole limpet hemocyanin,,investigational,IL2,Interleukin-2,target,,DB05299
Cintredekin Besudotox,Antineoplastic Agents,investigational,IL13,Interleukin-13,target,,DB05305
CHF-1512,,investigational,DDC,Aromatic-L-amino-acid decarboxylase,target,,DB05307
ANX-510,,investigational,TYMS,Thymidylate synthase,target,,DB05308
TP-508,,investigational,FGF4,Fibroblast growth factor 4,target,,DB05309
DX-88,,investigational,KLKB1,Plasma kallikrein,target,,DB05311
DN-101,,investigational,CDA,Cytidine deaminase,target,,DB05314
NGX-4010,Sensory System Agents,investigational,pkn3,Putative serine/threonine protein kinase,target,,DB05318
oportuzumab monatox,,investigational,EPCAM,Epithelial cell adhesion molecule,target,,DB05319
PEG-uricase,,investigational,uao,Uric acid degradation bifunctional protein,target,,DB05321
HuMax-EGFr,,investigational,EGFR,Epidermal growth factor receptor,target,,DB05324
AS-3201,,investigational,AKR1B1,Aldose reductase,target,,DB05327
VGV-1,,investigational,gag-pol,Gag-Pol polyprotein,target,,DB05328
Romiplostim,Colony-Stimulating FactorsThrombopoietic Agents,approved,MPL,Thrombopoietin receptor,target,agonist,DB05332
SOT-107,,investigational,GLIPR1,Glioma pathogenesis-related protein 1,target,,DB05337
MN-305,,investigational,HTR1A,5-hydroxytryptamine receptor 1A,target,,DB05339
C1-INH,,investigational,SERPING1,Plasma protease C1 inhibitor,target,,DB05341
ONO-2506,,investigational,S100B,Protein S100-B,target,,DB05343
SO-101,,investigational,HRH1,Histamine H1 receptor,target,,DB05345
iontophoretic acyclovir,,investigational,ORF1,DNA polymerase,target,,DB05347
TAK-390MR,Enzyme InhibitorsAnti-Ulcer AgentsAnti-Infective Agents,investigational,ATP4A,Potassium-transporting ATPase alpha chain 1,target,,DB05351
TAK-491,,investigational,ACE2,Angiotensin-converting enzyme 2,target,,DB05358
KW-3902,,investigational,ADORA1,Adenosine receptor A1,target,,DB05360
SSR-126517E,,investigational,F10,Coagulation factor X,target,,DB05362
ROX-888,,investigational,CCL3,C-C motif chemokine 3,target,,DB05364
CDB-2914,,investigational,PGR,Progesterone receptor,target,,DB05366
Actelion-1,,investigational,EDNRA,Endothelin-1 receptor,target,,DB05367
HZT-501,,investigational,HRH2,Histamine H2 receptor,target,,DB05369
CP-945598,,investigational,CNR1,Cannabinoid receptor 1,target,,DB05372
CDX-110,,investigational,EGFR,Epidermal growth factor receptor,target,,DB05374
histamine dihydrochloride,,investigational,HRH2,Histamine H2 receptor,target,,DB05381
molecular iodine,Trace Elements,investigational,MT-ND5,NADH-ubiquinone oxidoreductase chain 5,target,,DB05382
INS 316,,investigational,P2RY2,P2Y purinoceptor 2,target,,DB05390
liposomal prostaglandin E1,,investigational,GP1BA,Platelet glycoprotein Ib alpha chain,target,,DB05391
SR 58611,Adrenergic beta-Agonists,investigational,ADRB3,Beta-3 adrenergic receptor,target,,DB05395
AGI-1067,,investigational,VCAM1,Vascular cell adhesion protein 1,target,,DB05399
CEP-1347,,investigational,MAPK12,Mitogen-activated protein kinase 12,target,,DB05403
AZD 3355,,investigational,TP53,Cellular tumor antigen p53,target,,DB05404
TBC-3711,,investigational,EDN1,Endothelin-1,target,,DB05407
T-1249,,investigational,SERPINA5,Plasma serine protease inhibitor,target,,DB05413
ERA-923,,investigational,NE1940,"Integrase, catalytic core",target,,DB05414
OSI-461,,investigational,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,,DB05415
GW 468816,,investigational,GLRA1,Glycine receptor subunit alpha-1,target,,DB05417
GW 597599,,investigational,TACR1,Substance-P receptor,target,,DB05418
ADX-10061,,investigational,CALY,Neuron-specific vesicular protein calcyon,target,,DB05419
gallium maltolate,,investigational,RRM1,Ribonucleoside-diphosphate reductase large subunit,target,,DB05420
CP-122721,,investigational,TACR1,Substance-P receptor,target,,DB05421
OPC-14523,,investigational,SLC6A4,Sodium-dependent serotonin transporter,target,,DB05422
ORG-34517,,investigational,NR3C1,Glucocorticoid receptor,target,,DB05423
CI-1033,,investigational,EGFR,Epidermal growth factor receptor,target,,DB05424
CAT-213,,investigational,CCL11,Eotaxin,target,,DB05429
MLN-977,,investigational,ALOX5,Arachidonate 5-lipoxygenase,target,,DB05431
DAS-431 IV,,investigational,CALY,Neuron-specific vesicular protein calcyon,target,,DB05432
TNX-355,,investigational,GPR120,Free fatty acid receptor 4,target,,DB05435
BNP-166,,investigational,IL1B,Interleukin-1 beta,target,,DB05442
ADL 10-0101,,investigational,OPRK1,Kappa-type opioid receptor,target,,DB05443
LJP 1082,,investigational,APOH,Beta-2-glycoprotein 1,target,,DB05446
AVI-4557,,investigational,HNF4A,Hepatocyte nuclear factor 4-alpha,target,,DB05447
PX-12,,investigational,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",target,,DB05448
FM-VP4,,investigational,ABCB1,Multidrug resistance protein 1,target,,DB05449
SR 121463,,investigational,AVPR1B,Vasopressin V1b receptor,target,,DB05455
OSI-7904L,,investigational,TYMS,Thymidylate synthase,target,,DB05457
TLK-199,,investigational,GSTP1,Glutathione S-transferase P,target,,DB05460
ISS-1018,,investigational,TLR9,Toll-like receptor 9,target,,DB05463
R673,,investigational,TACR1,Substance-P receptor,target,,DB05466
R667,,investigational,RARG,Retinoic acid receptor gamma,target,,DB05467
R411,,investigational,ITGA4,Integrin alpha-4,target,,DB05468
WX-UK1,,investigational,PLAUR,Urokinase plasminogen activator surface receptor,target,,DB05476
pradefovir mesylate,,investigational,CYP3A4,Cytochrome P450 3A4,target,,DB05478
CZEN 002,,investigational,MC1R,Melanocyte-stimulating hormone receptor,target,,DB05479
Recombinant alpha 1-antitrypsin,,investigational,SERPINA1,Alpha-1-antitrypsin,target,,DB05481
LE-SN38,,investigational,TOP1,DNA topoisomerase 1,target,,DB05482
MDX-018,,investigational,IL8,Interleukin-8,target,,DB05484
MLN-1202,,investigational,CCR2,C-C chemokine receptor type 2,target,,DB05486
ACA 125,,investigational,ABL,Tyrosine-protein kinase transforming protein Abl,target,,DB05489
T131,,investigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB05490
CP-4055,,investigational,DCK,Deoxycytidine kinase,target,,DB05494
PG-530742,,investigational,,Matrix metalloproteinase-9,target,,DB05495
NM-702,,investigational,TBXAS1,Thromboxane-A synthase,target,,DB05505
ISIS 113715,,investigational,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB05506
PTI-901,,investigational,OPRS1,"HCG20471, isoform CRA_c",target,,DB05508
Huperzine-A,,investigational,ACHE,Acetylcholinesterase,target,,DB05510
CF-101,,investigational,ADORA3,Adenosine receptor A3,target,,DB05511
Telaprevir,,approved,,NS3/4A protein,target,inhibitor,DB05521
Sodium stibogluconate,Antineoplastic Agents,approvedinvestigational,TOP1,DNA topoisomerase 1,target,inhibitor,DB05630
TD-5108,,investigational,HTR4,5-hydroxytryptamine receptor 4,target,,DB05655
TZP-101,,investigational,GHSR,Growth hormone secretagogue receptor type 1,target,,DB05657
SPL-7013,,investigational,env,Envelope glycoprotein gp160,target,,DB05658
NP-50301,,investigational,ESR1,Estrogen receptor,target,,DB05662
EP-2104R,Contrast MediaDiagnostic Agents,investigational,FGA,Fibrinogen alpha chain,target,,DB05675
CNTO 1275,,investigational,IL12B,Interleukin-12 subunit beta,target,,DB05679
FX06,,investigational,CDH5,Cadherin-5,target,,DB05685
SCH-530348,Platelet Aggregation Inhibitors,investigational,F2R,Proteinase-activated receptor 1,target,,DB05692
NBI-56418,,investigational,GNRHR,Gonadotropin-releasing hormone receptor,target,,DB05694
GTS-21,Nicotinic Agonists,investigational,CHRNA7,Neuronal acetylcholine receptor subunit alpha-7,target,,DB05708
AZD-9684,Antithrombins,investigational,CPB2,Carboxypeptidase B2,target,,DB05712
LY-517717,Antithrombins,investigational,F10,Coagulation factor X,target,,DB05713
Genz-112638,,investigational,UGCG,Ceramide glucosyltransferase,target,,DB05715
MIV-701,,investigational,CTSK,Cathepsin K,target,,DB05736
MPI-674,,investigational,CYP19A1,Cytochrome P450 19A1,target,,DB05749
AVE-1625,,investigational,CNR1,Cannabinoid receptor 1,target,,DB05750
CYT007-TNFQb,,investigational,TNF,Tumor necrosis factor,target,,DB05758
IMC-A12,,investigational,IGF1R,Insulin-like growth factor 1 receptor,target,,DB05759
LLL-3348,,investigational,IL10,Interleukin-10,target,,DB05771
ado-trastuzumab emtansine,Antineoplastic AgentsTubulin ModulatorsMonoclonal antibodies,approved,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,antibody,DB05773
IMC-11F8,,investigational,EGFR,Epidermal growth factor receptor,target,,DB05774
MGI-114,,investigational,FUBP1,Far upstream element-binding protein 1,target,,DB05786
LM-609,,investigational,ITGB3,Integrin beta-3,target,,DB05787
LYM-2,,investigational,CD74,HLA class II histocompatibility antigen gamma chain,target,,DB05788
SR 140333,,investigational,TACR1,Substance-P receptor,target,,DB05790
SR 31747,,investigational,OPRS1,"HCG20471, isoform CRA_c",target,,DB05792
PRO-542,,investigational,GPR120,Free fatty acid receptor 4,target,,DB05793
SLV 306,,investigational,MME,Neprilysin,target,,DB05796
TNX-901,,investigational,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,target,,DB05797
GTI 2040,,investigational,RRM2,Ribonucleoside-diphosphate reductase subunit M2,target,,DB05801
BNP 1350,,investigational,TOP1,DNA topoisomerase 1,target,,DB05806
Abiraterone,,approved,CYP17A1,"Steroid 17-alpha-hydroxylase/17,20 lyase",target,inhibitor,DB05812
GPI-1485,,investigational,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB05814
NCX 4016,,investigational,PTGS1,Prostaglandin G/H synthase 1,target,,DB05822
CNS-5161,,investigational,GRIN1,"Glutamate receptor ionotropic, NMDA 1",target,,DB05824
ING-1,,investigational,EPCAM,Epithelial cell adhesion molecule,target,,DB05831
OPC-51803,,investigational,AVPR2,Vasopressin V2 receptor,target,,DB05838
Mito-4509,,investigational,APP,Amyloid beta A4 protein,target,,DB05846
humanized SMART Anti-IL-12 Antibody,,investigational,IL12B,Interleukin-12 subunit beta,target,,DB05848
NCX 950,,investigational,ADRB2,Beta-2 adrenergic receptor,target,,DB05849
CLX-0921,,investigational,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB05854
PPI-2458,,investigational,METAP2,Methionine aminopeptidase 2,target,,DB05864
99mTc-14 F7 Mab,,investigational,ST3GAL5,"Lactosylceramide alpha-2,3-sialyltransferase",target,,DB05867
BILN 2061,,investigational,,Genome polyprotein,target,,DB05868
UC-781,,investigational,gag-pol,Gag-Pol polyprotein,target,,DB05871
PDE4,,investigational,PDE4A,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",target,,DB05876
AME-527,,investigational,TNF,Tumor necrosis factor,target,,DB05879
ABX-PTH,,investigational,PTH,Parathyroid hormone,target,,DB05883
MEM 1414,,investigational,PDE4,CAMP phosphodiesterase,target,,DB05888
VEGF-AS,,investigational,VEGFA,Vascular endothelial growth factor A,target,,DB05890
RI 624,,investigational,NGF,Beta-nerve growth factor,target,,DB05892
HGS-TR2J,,investigational,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,target,,DB05895
rhIGFBP-3,,investigational,IGF1R,Insulin-like growth factor 1 receptor,target,,DB05897
TD-2749,,investigational,HTR4,5-hydroxytryptamine receptor 4,target,,DB05905
MYO-029,,investigational,MSTN,Growth/differentiation factor 8,target,,DB05915
CT-011,,investigational,PDCD1,Programmed cell death protein 1,target,,DB05916
RTA 744,,investigational,TOP2A,DNA topoisomerase 2-alpha,target,,DB05920
CRA-024781,,investigational,HDAC1,Histone deacetylase 1,target,,DB05921
SB-559448,,investigational,MPL,Thrombopoietin receptor,target,,DB05930
ITMN-191,,investigational,,Genome polyprotein,target,,DB06038
PA-1050040,,investigational,gag,Gag polyprotein,target,,DB06039
XTL-6865,,investigational,,Genome polyprotein,target,,DB06058
ADX-48621,,investigational,GRM5,Metabotropic glutamate receptor 5,target,,DB06060
AZD-8330,,investigational,MAP3K1,Mitogen-activated protein kinase kinase kinase 1,target,,DB06061
XOMA 052,,investigational,IL1B,Interleukin-1 beta,target,,DB06062
KAI-1455,,investigational,PRKCE,Protein kinase C epsilon type,target,,DB06064
XMT-1001,,investigational,TOP1,DNA topoisomerase 1,target,,DB06069
CTS-21166,,investigational,BACE1,Beta-secretase 1,target,inhibitor,DB06073
TC-5619,,investigational,CHRFAM7A,Alpha-7 nicotinic cholinergic receptor subunit,target,,DB06090
OGX-427,,investigational,HSPB1,Heat shock protein beta-1,target,,DB06094
GSK-923295,,investigational,CENPE,Centromere-associated protein E,target,,DB06097
KRP-104,,investigational,DPP4,Dipeptidyl peptidase 4,target,,DB06127
Sulfathiazole,Anti-Infective Agents,approved,,Dihydropteroate synthetase,target,inhibitor,DB06147
Rimonabant,,approvedinvestigational,CNR1,Cannabinoid receptor 1,target,antagonist,DB06155
Canakinumab,Anti-Inflammatory AgentsMonoclonal antibodies,approvedinvestigational,IL1B,Interleukin-1 beta,target,binder,DB06168
Ipilimumab,Antineoplastic AgentsMonoclonal antibodies,approved,CTLA4,Cytotoxic T-lymphocyte protein 4,target,,DB06186
Alogliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,DPP4,Dipeptidyl peptidase 4,target,inhibitor,DB06203
Prasugrel,Platelet Aggregation Inhibitors,approved,P2RY12,P2Y purinoceptor 12,target,antagonist,DB06209
Eltrombopag,Thrombopoietic Agents,approved,MPL,Thrombopoietin receptor,target,agonist,DB06210
Regadenoson,Diagnostic Agents,approved,ADORA2A,Adenosine receptor A2a,target,agonist,DB06213
Rivaroxaban,,approved,F10,Coagulation factor X,target,antagonist,DB06228
Avanafil,,approved,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB06237
Udenafil,,approvedinvestigational,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,inhibitor,DB06267
Tocilizumab,,approved,IL6R,Interleukin-6 receptor subunit alpha,target,antibody,DB06273
Teriparatide,Bone Density Conservation Agents,approvedinvestigational,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,target,binder,DB06285
Temsirolimus,,approved,MTOR,Serine/threonine-protein kinase mTOR,target,inhibitor,DB06287
SIMEPREVIR,Protease Inhibitors,approved,,NS3 protease,target,inhibitor,DB06290
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,,Sodium/glucose cotransporter 2,target,"antagonistinhibitor, competitive",DB06292
Saxagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,DPP4,Dipeptidyl peptidase 4,target,inhibitor,DB06335
Pertuzumab,Monoclonal antibodies,approved,ERBB2,Receptor tyrosine-protein kinase erbB-2,target,antibody,DB06366
Tyloxapol,Surface-Active AgentsDetergents,approvedinvestigational,LPL,Lipoprotein lipase,target,inhibitor,DB06439
Bevirimat,,investigational,gag-pol,Gag-Pol polyprotein,target,,DB06581
Apixaban,,approved,F10,Coagulation factor X,target,inhibitor,DB06605
Flupirtine,,approvedinvestigational,ADRA2A,Alpha-2A adrenergic receptor,target,,DB06623
Denosumab,Bone Density Conservation AgentsMonoclonal antibodies,approved,TNFSF11,Tumor necrosis factor ligand superfamily member 11,target,antibody,DB06643
Liraglutide,,approved,GLP1R,Glucagon-like peptide 1 receptor,target,agonist,DB06655
golimumab,Antipsoriatic AgentsMonoclonal antibodiesTNF inhibitor,approved,TNF,Tumor necrosis factor,target,antibody,DB06674
Vilazodone,Serotonin Uptake InhibitorsSerotonin Receptor AgonistsAntidepressive Agents,approved,HTR1A,5-hydroxytryptamine receptor 1A,target,agonist,DB06684
Mepyramine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB06691
Mevastatin,Antifungal AgentsAnti-Bacterial AgentsAnticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,experimental,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB06693
Dabigatran etexilate,Antithrombins,approved,F2,Prothrombin,target,inhibitor,DB06695
Arbekacin,Anti-Infective AgentsAminoglycosidesAntibiotics,approved,rpsL,30S ribosomal protein S12,target,inhibitor,DB06696
Degarelix,Gonadotropin-releasing hormone antagonist,approved,GNRHR,Gonadotropin-releasing hormone receptor,target,antagonist,DB06699
Methacholine,,approved,CHRM3,Muscarinic acetylcholine receptor M3,target,agonist,DB06709
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,AR,Androgen receptor,target,agonist,DB06710
Norelgestromin,"Contraceptive AgentsContraceptives, Oral, Combined",approved,PGR,Progesterone receptor,target,agonist,DB06713
Velaglucerase alfa,Enzymes,approvedinvestigational,GBA,Glucosylceramidase,target,,DB06720
Bufuralol,Adrenergic beta-Antagonists,experimentalinvestigational,ADRB1,Beta adrenergic receptor,target,antagonist,DB06726
Sulfaphenazole,Anti-Bacterial AgentsAnti-Infective AgentsSulfonamides,approved,folP,Dihydropteroate synthase,target,inhibitor,DB06729
Bafilomycin A1,,experimental,ATP6V1A,V-type proton ATPase catalytic subunit A,target,inhibitor,DB06733
Bafilomycin B1,,experimental,ATP6V1A,V-type proton ATPase catalytic subunit A,target,inhibitor,DB06734
Gavestinel,,investigational,GRIN1,Glutamate (NMDA) receptor,target,antagonist,DB06741
Alcaftadine,Anti-Inflammatory AgentsHistamine H1 Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB06766
Carglumic Acid,,approved,CPS1,"Carbamoyl-phosphate synthase [ammonia], mitochondrial",target,allosteric modulator,DB06775
Chenodeoxycholic acid,Gastrointestinal AgentsCathartics,approved,NR1H4,Bile acid receptor,target,other,DB06777
Difluprednate,Anti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB06781
Mafenide,,approved,CA6,Carbonic anhydrase 6,target,antagonist,DB06795
Plerixafor,Anti-HIV AgentsHematopoietic Agents,approved,CXCR4,C-X-C chemokine receptor type 4,target,antagonist,DB06809
Raltegravir,Anti-HIV Agents,approved,,Integrase,target,inhibitor,DB06817
5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB06828
4-BROMO-3-(CARBOXYMETHOXY)-5-[3-(CYCLOHEXYLAMINO)PHENYL]THIOPHENE-2-CARBOXYLIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB06829
"(1-HYDROXYHEPTANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB06830
1-CYCLOHEXYL-N-{[1-(4-METHYLPHENYL)-1H-INDOL-3-YL]METHYL}METHANAMINE,,experimental,ESRRA,Steroid hormone receptor ERR1,target,,DB06833
"N-(2-hydroxy-1,1-dimethylethyl)-1-methyl-3-(1H-pyrrolo[2,3-b]pyridin-2-yl)-1H-indole-5-carboxamide",,experimental,SYK,Tyrosine-protein kinase SYK,target,,DB06834
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(S)-HYDROXY[(1R)-2-METHYL-1-{[(2-PHENYLETHYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,,experimental,CPB1,Carboxypeptidase B,target,,DB06835
"(2R)-N~4~-hydroxy-2-(3-hydroxybenzyl)-N~1~-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]butanediamide",,experimental,ADAMTS5,A disintegrin and metalloproteinase with thrombospondin motifs 5,target,,DB06837
"diethyl [(1R)-1,5-diaminopentyl]boronate",,experimental,PRSS1,Trypsin-1,target,,DB06840
D-phenylalanyl-N-[(1S)-4-{[amino(iminio)methyl]amino}-1-(chloroacetyl)butyl]-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06841
"7-[3-(4-FLUORO-PHENYL)-1-ISOPROPYL-1H-INDOL-2-YL]-3,5-DIHYDROXY-HEPTANOIC ACID",,experimental,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,,DB06846
"5-[(3S)-3-(2-methoxybiphenyl-4-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,dfrB,Dihydrofolate reductase,target,,DB06847
"1-(1'-{[3-(methylsulfanyl)-2-benzothiophen-1-yl]carbonyl}spiro[1-benzofuran-3,4'-piperidin]-5-yl)methanamine",,experimental,TPSAB1,Tryptase alpha/beta-1,target,,DB06848
"1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine",,experimental,TPSAB1,Tryptase alpha/beta-1,target,,DB06849
4-[(3S)-1-AZABICYCLO[2.2.2]OCT-3-YLAMINO]-3-(1H-BENZIMIDAZOL-2-YL)-6-CHLOROQUINOLIN-2(1H)-ONE,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB06852
6-FLUORO-2-(2-HYDROXY-3-ISOBUTOXY-PHENYL)-1H-BENZOIMIDAZOLE-5-CARBOXAMIDINE,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB06855
6-FLUORO-2-[2-HYDROXY-3-(2-METHYL-CYCLOHEXYLOXY)-PHENYL]-1H-INDOLE-5-CARBOXAMIDINE,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB06856
N-(4-CARBAMIMIDOYL-3-CHORO-PHENYL)-2-HYDROXY-3-IODO-5-METHYL-BENZAMIDE,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB06857
N-ALLYL-5-AMIDINOAMINOOXY-PROPYLOXY-3-CHLORO-N-CYCLOPENTYLBENZAMIDE,,experimental,F2,Prothrombin,target,,DB06859
"2-(2-chloropyridin-4-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",,experimental,thyA,Thymidylate synthase,target,,DB06860
6-(2-HYDROXY-CYCLOPENTYL)-7-OXO-HEPTANAMIDINE,,experimental,F2,Prothrombin,target,,DB06861
2-HYDROXY-5-(2-MERCAPTO-ETHYLSULFAMOYL)-BENZOIC ACID,,experimental,CASP3,Caspase-3,target,,DB06862
"2-(3-CARBOXYPROPIONYL)-6-HYDROXY-CYCLOHEXA-2,4-DIENE CARBOXYLIC ACID",,experimental,menC,o-succinylbenzoate synthase,target,,DB06864
6-CARBAMIMIDOYL-2-[2-HYDROXY-6-(4-HYDROXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,,experimental,F2,Prothrombin,target,,DB06865
6-CARBAMIMIDOYL-2-[2-HYDROXY-5-(3-METHOXY-PHENYL)-INDAN-1-YL]-HEXANOIC ACID,,experimental,F2,Prothrombin,target,,DB06866
"3,6,9,12,15,18-HEXAOXAICOSANE",,experimental,PIN1,Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1,target,,DB06867
N-(3-chlorobenzyl)-1-(4-methylpentanoyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06868
1-[2-AMINO-2-CYCLOHEXYL-ACETYL]-PYRROLIDINE-3-CARBOXYLIC ACID 5-CHLORO-2-(2-ETHYLCARBAMOYL-ETHOXY)-BENZYLAMIDE,,experimental,F2,Prothrombin,target,,DB06869
"17-HYDROXY-18A-HOMO-19-NOR-17ALPHA-PREGNA-4,9,11-TRIEN-3-ONE",,experimental,AR,Androgen receptor,target,,DB06870
"1-((2-HYDROXYETHOXY)METHYL)-5-(PHENYLTHIO)PYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,udp,Uridine phosphorylase,target,,DB06872
"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)PYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,udp,Uridine phosphorylase,target,,DB06873
"(6-[4-(AMINOMETHYL)-2,6-DIMETHYLPHENOXY]-2-{[4-(AMINOMETHYL)PHENYL]AMINO}-5-BROMOPYRIMIDIN-4-YL)METHANOL",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB06874
"N-{5-[4-(4-METHYLPIPERAZIN-1-YL)PHENYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL}NICOTINAMIDE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB06876
"N,N-DIMETHYL-4-(4-PHENYL-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE",,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB06877
1-[(2R)-2-aminobutanoyl]-N-(3-chlorobenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06878
"5-(4'-AMINO-1'-ETHYL-5',8'-DIFLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLINE]-1-YLCARBONYL)PICOLINONITRILE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB06879
"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-PROP-1-YN-1-YLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB06880
(1Z)-2-HYDROXY-3-OXOHEX-1-EN-1-YL DIHYDROGEN PHOSPHATE,,experimental,mtnW,"2,3-diketo-5-methylthiopentyl-1-phosphate enolase",target,,DB06881
1-[1-(3-aminophenyl)-3-tert-butyl-1H-pyrazol-5-yl]-3-phenylurea,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB06883
N-BENZYLOXYCARBONYL-ALA-PRO-3-AMINO-4-PHENYL-BUTAN-2-OL,,experimental,apr,Subtilisin DY,target,,DB06886
"3(S)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB06887
"(13R,15S)-13-METHYL-16-OXA-8,9,12,22,24-PENTAAZAHEXACYCLO[15.6.2.16,9.1,12,15.0,2,7.0,21,25]HEPTACOSA-1(24),2,4,6,17(25),18,20-HEPTAENE-23,26-DIONE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB06888
"3-(1H-tetrazol-5-ylmethyl)-5,6,7,8-tetrahydro[1]benzothieno[2,3-d]pyrimidin-4(3H)-one",,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB06889
(2R)-2-PHENYL-N-PYRIDIN-4-YLBUTANAMIDE,,experimental,cyp51,Lanosterol 14-alpha demethylase,target,,DB06890
"5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE",,experimental,CA2,Carbonic anhydrase 2,target,,DB06891
"(5S)-4,5-difluoro-6-[(2-fluoro-4-iodophenyl)imino]-N-(2-hydroxyethoxy)cyclohexa-1,3-diene-1-carboxamide",,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB06892
1-DECANE-SULFONIC-ACID,,experimental,sdsA1,SDS hydrolase SdsA1,target,,DB06893
"1-(4-fluorophenyl)-N-[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]-2-oxo-1,2-dihydropyridine-3-carboxamide",,experimental,MET,Hepatocyte growth factor receptor,target,,DB06896
"3-[3-chloro-5-(5-{[(1S)-1-phenylethyl]amino}isoxazolo[5,4-c]pyridin-3-yl)phenyl]propan-1-ol",,experimental,PLK1,Serine/threonine-protein kinase PLK1,target,,DB06897
"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOTHIAZIN-4-YL]ETHYL}ACETAMIDE",,experimental,REN,Renin,target,,DB06899
1-[4-(hydroxymethyl)phenyl]guanidine,,experimental,PRSS8,Prostasin,target,,DB06900
2-(2-HYDROXY-CYCLOPENTYL)-PENT-4-ENAL,,experimental,CELA2A,Chymotrypsin-like elastase family member 2A,target,,DB06901
4-(1-methyl-1-phenylethyl)phenol,,experimental,ESRRG,Estrogen-related receptor gamma,target,,DB06902
"(1S,3aS,5aR,8aS)-1,7,7-trimethyl-1,2,3,3a,5a,6,7,8-octahydrocyclopenta[c]pentalene-4-carboxylic acid",,experimental,ptlH,1-deoxypentalenic acid 11-beta-hydroxylase,target,,DB06903
"(5S,6S)-6-[(R)ACETOXYETH-2-YL]-PENEM-3-CARBOXYLATEPROPANE",,experimental,lepB,Signal peptidase I,target,,DB06904
2-AMINO-4-HYDROXYPYRIMIDINE-5-CARBOXYLIC ACID ETHYL ESTER,,experimental,folB,Dihydroneopterin aldolase,target,,DB06906
"1-ethyl-N-(phenylmethyl)-4-(tetrahydro-2H-pyran-4-ylamino)-1H-pyrazolo[3,4-b]pyridine-5-carboxamide",,experimental,PDE4B,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",target,,DB06909
"[4-R-(4-ALPHA,6-BETA,7-BETA]-HEXAHYDRO-5,6-DI(HYDROXY)-1,3-DI(ALLYL)-4,7-BISPHENYLMETHYL)-2H-1,3-DIAZEPINONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB06910
D-leucyl-N-(3-chlorobenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06911
"UNDECA-3,7-DIENE-1,3,7,11-TETRACARBALDEHYDE",,experimental,LYZ,Lysozyme C,target,,DB06912
"(2R,3R)-3-{[3,5-BIS(TRIFLUOROMETHYL)PHENYL]AMINO}-2-CYANO-3-THIOXOPROPANAMIDE",,experimental,,Genome polyprotein,target,,DB06913
"1-({2-[2-(4-CHLOROPHENYL)ETHYL]-1,3-DIOXOLAN-2-YL}METHYL)-1H-IMIDAZOLE",,experimental,HMOX1,Heme oxygenase 1,target,,DB06914
"N-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-1-[2-(1H-IMIDAZOL-1-YL)-6-METHYLPYRIMIDIN-4-YL]-D-PROLINAMIDE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB06916
(4-fluorophenyl)(pyridin-4-yl)methanone,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB06917
2-(2-METHYLPHENYL)-1H-INDOLE-6-CARBOXIMIDAMIDE,,experimental,PRSS1,Trypsin-1,target,,DB06918
D-phenylalanyl-N-(3-chlorobenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06919
"(2R,4R)-N~1~-(4-CHLOROPHENYL)-N~2~-[2-FLUORO-4-(2-OXOPYRIDIN-1(2H)-YL)PHENYL]-4-METHOXYPYRROLIDINE-1,2-DICARBOXAMIDE",,experimental,F10,Coagulation factor X,target,,DB06920
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-HYDROXY{(1R)-2-METHYL-1-[(PHENYLSULFONYL)AMINO]PROPYL}PHOSPHORYL]PROPANOIC ACID,,experimental,CPB1,Carboxypeptidase B,target,,DB06921
"2-[(1R)-1-carboxy-2-naphthalen-1-ylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",,experimental,ampC,Beta-lactamase,target,,DB06922
2-(3-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,,experimental,PRSS1,Trypsin-1,target,,DB06923
(2R)-2-benzyl-3-nitropropanoic acid,,experimental,CPA1,Carboxypeptidase A1,target,,DB06924
3-(2-AMINOQUINAZOLIN-6-YL)-4-METHYL-N-[3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE,,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB06925
"(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB06926
(2S)-2-{[HYDROXY(4-IODOBENZYL)PHOSPHORYL]METHYL}PENTANEDIOIC ACID,,experimental,FOLH1,Glutamate carboxypeptidase 2,target,,DB06928
1-butanoyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06929
"N-[amino(imino)methyl]-2-(2,5-diphenyl-1H-pyrrol-1-yl)acetamide",,experimental,BACE1,Beta-secretase 1,target,,DB06930
"(1-HYDROXYNONANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB06931
"10,11-dimethoxy-4-methyldibenzo[c,f]-2,7-naphthyridine-3,6-diamine",,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB06932
N-(tert-butyl)-4-[5-(pyridin-2-ylamino)quinolin-3-yl]benzenesulfonamide,,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB06933
(1R)-3-chloro-1-phenylpropan-1-ol,,experimental,E,Lysozyme,target,,DB06934
N-(4-carbamimidoylbenzyl)-1-(4-methylpentanoyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06936
"4-(6-HYDROXY-BENZO[D]ISOXAZOL-3-YL)BENZENE-1,3-DIOL",,experimental,ESR2,Estrogen receptor beta,target,,DB06937
4-[[2-[[4-chloro-3-(trifluoromethyl)phenyl]amino]-3H-benzimidazol-5-yl]oxy]-N-methyl-pyridine-2-carboxamide,,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB06938
"N-(TRANS-4-{(1S,2S)-2-AMINO-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-1-METHYL-3-OXOPROPYL}CYCLOHEXYL)-N-METHYLACETAMIDE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB06939
"N-ethyl-4-{[5-(methoxycarbamoyl)-2-methylphenyl]amino}-5-methylpyrrolo[2,1-f][1,2,4]triazine-6-carboxamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB06940
(Z)-2-[2-(4-methylpiperazin-1-yl)benzyl]diazenecarbothioamide,,experimental,S100B,Protein S100-B,target,,DB06941
N-(4-carbamimidoylbenzyl)-1-(3-phenylpropanoyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06942
(3S)-1-{[4-(BUT-2-YN-1-YLOXY)PHENYL]SULFONYL}PYRROLIDINE-3-THIOL,,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB06943
N-hydroxy-4-({4-[4-(trifluoromethyl)phenoxy]phenyl}sulfonyl)tetrahydro-2H-pyran-4-carboxamide,,experimental,ADAMTS5,A disintegrin and metalloproteinase with thrombospondin motifs 5,target,,DB06945
"(2S,3S)-3-(4-fluorophenyl)-2,3-dihydroxypropanoic acid",,experimental,,"MIO-dependent tyrosine 2,3-aminomutase",target,,DB06946
1-[(2R)-2-aminobutanoyl]-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06947
"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]naphthalene-2-carbohydrazide",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB06949
"4-chloro-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB06950
(3R)-3-ethyl-N-[(4-methylphenyl)sulfonyl]-L-aspartic acid,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB06951
(2S)-2-HYDROXY-2H-CHROMENE-2-CARBOXYLIC ACID,,experimental,nahD,2-hydroxychromene-2-carboxylate isomerase,target,,DB06952
"2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate",,experimental,CA2,Carbonic anhydrase 2,target,,DB06954
"3,4-bis(7-chloro-1H-indol-3-yl)-1H-pyrrole-2,5-dicarboxylic acid",,experimental,staP,Cytochrome P450,target,,DB06955
"N-(4-ACETYLPHENYL)-5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-1H-PYRAZOLE-4-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06956
"4-CHLORO-6-(4-{4-[4-(METHYLSULFONYL)BENZYL]PIPERAZIN-1-YL}-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06957
"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-PIPERAZIN-1-YL-1H-PYRAZOLE-3-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06958
"N-[(1R,2R,3E)-2-hydroxy-1-(hydroxymethyl)heptadec-3-en-1-yl]acetamide",,experimental,PA0845,Neutral ceramidase,target,,DB06960
"5-(5-chloro-2,4-dihydroxyphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]isoxazole-3-carboxamide",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06961
"(5-(aminomethyl)-2H-spiro[benzofuran-3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan-2-yl)methanone",,experimental,TPSB2,Tryptase beta-2,target,,DB06962
"3-[3-(3-methyl-6-{[(1S)-1-phenylethyl]amino}-1H-pyrazolo[4,3-c]pyridin-1-yl)phenyl]propanamide",,experimental,PLK1,Serine/threonine-protein kinase PLK1,target,,DB06963
"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)ISOXAZOLE-3-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06964
HEXYLPHOSPHONIC ACID (R)-2-METHYL-3-PHENYLPROPYL ESTER,,experimental,lipA,Lipase,target,,DB06965
HEXYLPHOSPHONIC ACID (S)-2-METHYL-3-PHENYLPROPYL ESTER,,experimental,lipA,Lipase,target,,DB06966
"6-ETHYL-5-[9-(3-METHOXYPROPYL)-9H-CARBAZOL-2-YL]PYRIMIDINE-2,4-DIAMINE",,experimental,REN,Renin,target,,DB06967
"1,1'-HEXANE-1,6-DIYLBIS(1H-IMIDAZOLE)",,experimental,azu,Azurin,target,,DB06968
"2-amino-4-[2,4-dichloro-5-(2-pyrrolidin-1-ylethoxy)phenyl]-N-ethylthieno[2,3-d]pyrimidine-6-carboxamide",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB06969
"2-CHLORO-N-(3-CYANO-5,6-DIHYDRO-4H-CYCLOPENTA[B]THIOPHEN-2-YL)-5-DIETHYLSULFAMOYL-BENZAMIDE",,experimental,murF,UDP-N-acetylmuramoyl-tripeptide--D-alanyl-D-alanine ligase,target,,DB06970
"N-{2-[(4'-CYANO-1,1'-BIPHENYL-4-YL)OXY]ETHYL}-N'-HYDROXY-N-METHYLUREA",,experimental,MMP8,Neutrophil collagenase,target,,DB06971
"7A-[(4-cyanophenyl)methyl]-6-(3,5-dichlorophenyl)-5-oxo-2,3,5,7A-tetrahydro-1H-pyrrolo[1,2-A]pyrrole-7-carbonitrile",,experimental,ITGAL,Integrin alpha-L,target,,DB06972
"4,4'-PROPANE-2,2-DIYLDIPHENOL",,experimental,ESRRG,Estrogen-related receptor gamma,target,,DB06973
"5-hydroxy-4-(7-methoxy-1,1-dioxido-2H-1,2,4-benzothiadiazin-3-yl)-2-(3-methylbutyl)-6-phenylpyridazin-3(2H)-one",,experimental,,Genome polyprotein,target,,DB06974
"1-(5-OXO-2,3,5,9B-TETRAHYDRO-1H-PYRROLO[2,1-A]ISOINDOL-9-YL)-3-(5-PYRROLIDIN-2-YL-1H-PYRAZOL-3-YL)-UREA",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB06976
(2S)-1-{[5-(1H-INDAZOL-5-YL)PYRIDIN-3-YL]OXY}-3-[(7AS)-7AH-INDOL-3-YL]PROPAN-2-AMINE,,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB06977
"N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-4-methoxybenzohydrazide",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB06978
"5-(dodecylthio)-1H-1,2,3-triazole-4-carboxylic acid",,experimental,HAO1,Hydroxyacid oxidase 1,target,,DB06979
(2S)-2-(1H-indol-3-yl)hexanoic acid,,experimental,SKP1,S-phase kinase-associated protein 1,target,,DB06980
(2S)-2-(1H-indol-3-yl)pentanoic acid,,experimental,SKP1,S-phase kinase-associated protein 1,target,,DB06981
(2S)-8-[(tert-butoxycarbonyl)amino]-2-(1H-indol-3-yl)octanoic acid,,experimental,SKP1,S-phase kinase-associated protein 1,target,,DB06982
"(5-phenyl-7-(pyridin-3-ylmethylamino)pyrazolo[1,5-a]pyrimidin-3-yl)methanol",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB06983
"(1R,2R,3R,4S,5R)-4-(BENZYLAMINO)-5-(METHYLTHIO)CYCLOPENTANE-1,2,3-TRIOL",,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB06984
"2-CHLORO-N-[(1R,2R)-1-HYDROXY-2,3-DIHYDRO-1H-INDEN-2-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB06986
2-HYDROXY-5-{[(1E)-2-PHENYLETHYLIDENE]AMINO}-L-TYROSINE,,experimental,,Phenylethylamine oxidase,target,,DB06988
{4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID,,experimental,PTPRB,Receptor-type tyrosine-protein phosphatase beta,target,,DB06989
"4-[(1E,7E)-8-(2,6-DIOXO-1,2,3,6-TETRAHYDROPYRIMIDIN-4-YL)-3,6-DIOXA-2,7-DIAZAOCTA-1,7-DIEN-1-YL]BENZOIC ACID",,experimental,UNG,Uracil-DNA glycosylase,target,,DB06990
"N-[2-methyl-5-(methylcarbamoyl)phenyl]-2-{[(1R)-1-methylpropyl]amino}-1,3-thiazole-5-carboxamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB06991
"(3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB06992
"(2S,3S)-4-cyclopropyl-3-{(3R,5R)-3-[2-fluoro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazolidin-5-yl}-1-[(3S)-3-fluoropyrrolidin-1-yl]-1-oxobutan-2-amine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB06993
"(2S,3S)-3-{3-[2-chloro-4-(methylsulfonyl)phenyl]-1,2,4-oxadiazol-5-yl}-1-cyclopentylidene-4-cyclopropyl-1-fluorobutan-2-amine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB06994
N-({4-[(2-aminopyridin-4-yl)oxy]-3-fluorophenyl}carbamoyl)-2-(4-fluorophenyl)acetamide,,experimental,MET,Hepatocyte growth factor receptor,target,,DB06995
D-leucyl-N-(4-carbamimidoylbenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB06996
"2-(4-fluorophenyl)-N-{[3-fluoro-4-(1H-pyrrolo[2,3-b]pyridin-4-yloxy)phenyl]carbamoyl}acetamide",,experimental,MET,Hepatocyte growth factor receptor,target,,DB06997
"[(5R)-5-(2,3-dibromo-5-ethoxy-4-hydroxybenzyl)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]acetic acid",,experimental,dnaN,DNA polymerase III subunit beta,target,,DB06998
"N-{3-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide",,experimental,BRAF,Serine/threonine-protein kinase B-raf,target,,DB06999
"N-{2,4-difluoro-3-[(5-pyridin-3-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)carbonyl]phenyl}ethanesulfonamide",,experimental,BRAF,Serine/threonine-protein kinase B-raf,target,,DB07000
"(3S,5E)-3-propyl-3,4-dihydrothieno[2,3-f][1,4]oxazepin-5(2H)-imine",,experimental,NOS3,"Nitric oxide synthase, endothelial",target,,DB07001
4-({4-[(4-methoxypyridin-2-yl)amino]piperidin-1-yl}carbonyl)benzonitrile,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07002
"(2S)-2-methyl-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07003
2-[(5-hex-1-yn-1-ylfuran-2-yl)carbonyl]-N-methylhydrazinecarbothioamide,,experimental,S100B,Protein S100-B,target,,DB07004
D-phenylalanyl-N-{4-[amino(iminio)methyl]benzyl}-L-prolinamide,,experimental,F2,Prothrombin,target,,DB07005
"9-HYDROXY-6-(3-HYDROXYPROPYL)-4-(2-METHOXYPHENYL)PYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",,experimental,WEE1,Wee1-like protein kinase,target,,DB07006
"(3R)-3-[(1,2,3,4-tetrahydroisoquinolin-7-yloxy)methyl]-2,3-dihydrothieno[2,3-f][1,4]oxazepin-5-amine",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07007
"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PYRIMIDINE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07008
"(3S)-1-(1,3-BENZODIOXOL-5-YLMETHYL)-3-[4-(1H-IMIDAZOL-1-YL)PHENOXY]PIPERIDINE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07011
"6-AMINO-3,7-DIHYDRO-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB07012
TERT-BUTYL 4-({[4-(BUT-2-YN-1-YLAMINO)PHENYL]SULFONYL}METHYL)-4-[(HYDROXYAMINO)CARBONYL]PIPERIDINE-1-CARBOXYLATE,,experimental,MMP13,Collagenase 3,target,,DB07013
"2-(1,3-benzodioxol-5-yl)-5-[(3-fluoro-4-methoxybenzyl)sulfanyl]-1,3,4-oxadiazole",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07014
"(3R,4R)-4-(pyrrolidin-1-ylcarbonyl)-1-(quinoxalin-2-ylcarbonyl)pyrrolidin-3-amine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07015
"(3R)-8-(dioxidosulfanyl)-3-methyl-1,2,3,4-tetrahydroquinoline",,experimental,F2,Prothrombin,target,,DB07016
"(5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07017
5-ETHYL-3-[(2-METHOXYETHYL)METHYLAMINO]-6-METHYL-4-(3-METHYLBENZYL)PYRIDIN-2(1H)-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07018
"N-[(5R,14R)-5-AMINO-5,14-DIMETHYL-4-OXO-3-OXA-18-AZATRICYCLO[15.3.1.1~7,11~]DOCOSA-1(21),7(22),8,10,17,19-HEXAEN-19-YL]-N-METHYLMETHANESULFONAMIDE",,experimental,BACE1,Beta-secretase 1,target,,DB07019
"N-{3-[5-(1H-1,2,4-triazol-3-yl)-1H-indazol-3-yl]phenyl}furan-2-carboxamide",,experimental,MAPK9,Mitogen-activated protein kinase 9,target,,DB07020
"(7R,8R)-8-(2,4,5-trifluorophenyl)-6,7,8,9-tetrahydroimidazo[1,2-a:4,5-c']dipyridin-7-amine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07021
3-HYDROXYPROPYL 3-[({7-[AMINO(IMINO)METHYL]-1-NAPHTHYL}AMINO)CARBONYL]BENZENESULFONATE,,experimental,F11,Coagulation factor XI,target,,DB07022
"(1R)-2-{[AMINO(IMINO)METHYL]AMINO}-1-{4-[(4R)-4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL]PHENYL}ETHYL NICOTINATE",,experimental,F11,Coagulation factor XI,target,,DB07023
"2-(3,4-DIHYDROXYPHENYL)-8-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-3-HYDROXY-6-METHYL-4H-CHROMEN-4-ONE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07024
3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)QUINOLIN-2(1H)-ONE,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07025
"(1S,5S,7R)-N~7~-(BIPHENYL-4-YLMETHYL)-N~3~-HYDROXY-6,8-DIOXA-3-AZABICYCLO[3.2.1]OCTANE-3,7-DICARBOXAMIDE",,experimental,MMP12,Macrophage metalloelastase,target,,DB07026
D-phenylalanyl-N-(3-fluorobenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB07027
(2-{[(4-BROMO-2-FLUOROBENZYL)AMINO]CARBONYL}-5-CHLOROPHENOXY)ACETIC ACID,,experimental,AKR1B1,Aldose reductase,target,,DB07028
"4-(1,3-BENZODIOXOL-5-YLOXY)-2-[4-(1H-IMIDAZOL-1-YL)PHENOXY]-6-METHYLPYRIMIDINE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07029
(5-CHLORO-2-{[(3-NITROBENZYL)AMINO]CARBONYL}PHENOXY)ACETIC ACID,,experimental,AKR1B1,Aldose reductase,target,,DB07030
"R-3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID",,experimental,RARG,Retinoic acid receptor gamma,target,,DB07031
2-(4-HYDROXY-PHENYL)BENZOFURAN-5-OL,,experimental,ESR2,Estrogen receptor beta,target,,DB07032
5-HYDROXY-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-2-ONE,,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB07033
"2,2'-{[9-(HYDROXYIMINO)-9H-FLUORENE-2,7-DIYL]BIS(OXY)}DIACETIC ACID",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07034
"(2E)-3-{3-[(5-ETHYL-3-IODO-6-METHYL-2-OXO-1,2-DIHYDROPYRIDIN-4-YL)OXY]PHENYL}ACRYLONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07035
"(3aS,4R,9bR)-2,2-difluoro-4-(4-hydroxyphenyl)-6-(methoxymethyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol",,experimental,ESR2,Estrogen receptor beta,target,,DB07036
(2S)-1-AMINO-3-[(5-NITROQUINOLIN-8-YL)AMINO]PROPAN-2-OL,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07037
2-(cyclohexylamino)benzoic acid,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07038
(2S)-N-(4-cyano-3-iodophenyl)-3-(4-cyanophenoxy)-2-hydroxy-2-methylpropanamide,,experimental,AR,Androgen receptor,target,,DB07039
"2-amino-7-fluoro-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxamide",,experimental,ligA,DNA ligase,target,,DB07040
"7-amino-2-tert-butyl-4-{[2-(1H-imidazol-4-yl)ethyl]amino}pyrido[2,3-d]pyrimidine-6-carboxamide",,experimental,ligA,DNA ligase,target,,DB07042
"7-amino-2-tert-butyl-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrido[2,3-d]pyrimidine-6-carboxamide",,experimental,ligA,DNA ligase,target,,DB07043
"3-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB07044
"2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide",,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB07046
"N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB07048
(2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine,,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07049
"5-[(phenylsulfonyl)amino]-1,3,4-thiadiazole-2-sulfonamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB07050
"3,5-DIMETHYL-1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID ETHYL ESTER",,experimental,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",target,,DB07051
5'-S-ethyl-5'-thioadenosine,,experimental,ahcY,Adenosylhomocysteinase,target,,DB07052
2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07053
(2R)-1-(DIMETHYLAMINO)-3-{4-[(6-{[2-FLUORO-5-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENOXY}PROPAN-2-OL,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07054
"2-[2-(1H-tetrazol-5-yl)ethyl]-1H-isoindole-1,3(2H)-dione",,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB07055
"2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07056
(3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine-3-carboxylic acid,,experimental,ampC,Beta-lactamase,target,,DB07057
"5-[1-(4-methoxyphenyl)-1H-benzimidazol-6-yl]-1,3,4-oxadiazole-2(3H)-thione",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07058
"N-{2-[6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-1,4-BENZOXAZIN-4-YL]ETHYL}ACETAMIDE",,experimental,REN,Renin,target,,DB07059
"1-(CYCLOHEXYLAMINO)-3-(6-METHYL-3,4-DIHYDRO-1H-CARBAZOL-9(2H)-YL)PROPAN-2-OL",,experimental,NMT2,Glycylpeptide N-tetradecanoyltransferase 2,target,,DB07061
"N-{3-[4-hydroxy-1-(3-methylbutyl)-2-oxo-1,2-dihydropyrrolo[1,2-b]pyridazin-3-yl]-1,1-dioxido-2H-1,2,4-benzothiadiazin-7-yl}methanesulfonamide",,experimental,,Genome polyprotein,target,,DB07062
"{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID",,experimental,AKR1B1,Aldose reductase,target,,DB07063
"(4R)-4-(3-HYDROXYPHENYL)-N,N,7,8-TETRAMETHYL-3,4-DIHYDROISOQUINOLINE-2(1H)-CARBOXAMIDE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB07064
"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)-3-thiocyanatopyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07065
"2-CHLORO-N-[(3R)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB07066
"(2S,3S)-3-{3-[4-(METHYLSULFONYL)PHENYL]-1,2,4-OXADIAZOL-5-YL}-1-OXO-1-PYRROLIDIN-1-YLBUTAN-2-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07067
"(4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID",,experimental,PTPRB,Receptor-type tyrosine-protein phosphatase beta,target,,DB07068
3-Hydroxyhippuric acid,,experimental,KYNU,Kynureninase,target,,DB07069
(2S)-2-{3-[({[2-fluoro-4-(trifluoromethyl)phenyl]carbonyl}amino)methyl]-4-methoxybenzyl}butanoic acid,,experimental,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB07070
"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE",,experimental,F11,Coagulation factor XI,target,,DB07071
"(1S,2R,5S)-5-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-2-(2,4,5-TRIFLUOROPHENYL)CYCLOHEXANAMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07072
"5,5-dimethyl-2-morpholin-4-yl-5,6-dihydro-1,3-benzothiazol-7(4H)-one",,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB07073
6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER,,experimental,F11,Coagulation factor XI,target,,DB07074
3-(5-{[4-(AMINOMETHYL)PIPERIDIN-1-YL]METHYL}-1H-INDOL-2-YL)-1H-INDAZOLE-6-CARBONITRILE,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07075
6-[(Z)-AMINO(IMINO)METHYL]-N-[3-(CYCLOPENTYLOXY)PHENYL]-2-NAPHTHAMIDE,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB07076
"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE",,experimental,F11,Coagulation factor XI,target,,DB07077
"(3Z)-6-(4-HYDROXY-3-METHOXYPHENYL)-3-(1H-PYRROL-2-YLMETHYLENE)-1,3-DIHYDRO-2H-INDOL-2-ONE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07078
3-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}propane-1-thiol,,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07079
"(2R)-4-[(8R)-8-METHYL-2-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[1,5-A]PYRAZIN-7(8H)-YL]-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07081
"1,1,1,3,3,3-HEXAFLUORO-2-{4-[(2,2,2-TRIFLUOROETHYL)AMINO]PHENYL}PROPAN-2-OL",,experimental,NR1H2,Oxysterols receptor LXR-beta,target,,DB07082
beta-phenyl-D-phenylalanyl-N-propyl-L-prolinamide,,experimental,F2,Prothrombin,target,,DB07083
"N-(6,7,9,10,17,18,20,21-octahydrodibenzo[b,k][1,4,7,10,13,16]hexaoxacyclooctadecin-2-yl)acetamide",,experimental,ompF,Outer membrane protein F,target,,DB07084
2-{[N-(2-ACETYL-5-CHLORO-4-FLUOROPHENYL)GLYCYL]AMINO}BENZOIC ACID,,experimental,,Genome polyprotein,target,,DB07085
N-[amino(imino)methyl]-2-[2-(2-chlorophenyl)-4-(4-propoxyphenyl)-3-thienyl]acetamide,,experimental,BACE1,Beta-secretase 1,target,,DB07089
(3S)-N-(3-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07090
"(2S,3S)-3-AMINO-4-(3,3-DIFLUOROPYRROLIDIN-1-YL)-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-6-YLCYCLOHEXYL)BUTANAMIDE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07092
"{3-[(5-CHLORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-2,4-DIOXO-3,4-DIHYDROPYRIMIDIN-1(2H)-YL}ACETIC ACID",,experimental,AKR1B1,Aldose reductase,target,,DB07093
"1-(2,2'-bithiophen-5-yl)methanamine",,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07094
"6-AMINO-BENZO[DE]ISOQUINOLINE-1,3-DIONE",,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB07096
"4-tert-butyl-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB07097
"4-bromo-N'-[(1E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]benzohydrazide",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB07098
N-[4-(benzyloxy)phenyl]glycinamide,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07099
"4-CHLORO-6-(4-PIPERAZIN-1-YL-1H-PYRAZOL-5-YL)BENZENE-1,3-DIOL",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07100
"N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide",,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB07101
(2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07102
2-(4-METHYLPHENOXY)ETHYLPHOSPHINATE,,experimental,npr,Thermolysin,target,,DB07103
4-amino-N-[4-(benzyloxy)phenyl]butanamide,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07104
2-[2-(4-CHLORO-PHENYLSULFANYL)-ACETYLAMINO]-3-(4-GUANIDINO-PHENYL)-PROPIONAMIDE,,experimental,F2,Prothrombin,target,,DB07105
4-(DIMETHYLAMINO)BUTYL IMIDOTHIOCARBAMATE,,experimental,HNMT,Histamine N-methyltransferase,target,,DB07106
"4'-FLUORO-1,1'-BIPHENYL-4-CARBOXYLIC ACID",,experimental,BCL2L1,Bcl-2-like protein 1,target,,DB07108
(2E)-3-(3-hydroxy-4-methoxyphenyl)prop-2-enoic acid,,experimental,slr0095,O-methyltransferase,target,,DB07109
4-(4-FLUOROBENZYL)PIPERIDINE,,experimental,BACE1,Beta-secretase 1,target,,DB07110
"(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07111
N-[(4-HYDROXY-8-IODOISOQUINOLIN-3-YL)CARBONYL]GLYCINE,,experimental,EGLN1,Egl nine homolog 1,target,,DB07112
"(2S)-6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-2-(3,5-DIFLUOROPHENYL)-4-(3-METHOXYPROPYL)-2H-1,4-BENZOXAZIN-3(4H)-ONE",,experimental,REN,Renin,target,,DB07113
4-[(METHYLSULFONYL)AMINO]BENZOIC ACID,,experimental,ampC,Beta-lactamase,target,,DB07114
"N-(4-chlorobenzyl)-N-methylbenzene-1,4-disulfonamide",,experimental,CA13,Carbonic anhydrase 13,target,,DB07115
1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-4-METHYL-1H-INDOLE,,experimental,UNG,Uracil-DNA glycosylase,target,,DB07116
"5-(4-PHENOXYPHENYL)-5-(4-PYRIMIDIN-2-YLPIPERAZIN-1-YL)PYRIMIDINE-2,4,6(2H,3H)-TRIONE",,experimental,,Matrix metalloproteinase-9,target,,DB07117
7-hydroxy-4-methyl-2H-chromen-2-one,,experimental,assT,Arylsulfate sulfotransferase,target,,DB07118
"N4-(N,N-DIPHENYLCARBAMOYL)-AMINOGUANIDINE",,experimental,F2,Prothrombin,target,,DB07120
"4-({4-[(4-AMINOBUT-2-YNYL)OXY]PHENYL}SULFONYL)-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07121
1-[4-(2-oxo-2-phenylethyl)phenyl]guanidine,,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB07122
N-(4-METHYLBENZOYL)-4-BENZYLPIPERIDINE,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07123
"(2S)-1-(6H-INDOL-3-YL)-3-{[5-(7H-PYRAZOLO[3,4-C]PYRIDIN-5-YL)PYRIDIN-3-YL]OXY}PROPAN-2-AMINE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07124
"4-(6-{[(1R)-1-(hydroxymethyl)propyl]amino}imidazo[1,2-b]pyridazin-3-yl)benzoic acid",,experimental,DAPK3,Death-associated protein kinase 3,target,,DB07125
"{4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID",,experimental,PTPRB,Receptor-type tyrosine-protein phosphatase beta,target,,DB07127
"N7-BUTYL-N2-(5-CHLORO-2-METHYLPHENYL)-5-METHYL[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-2,7-DIAMINE",,experimental,F2,Prothrombin,target,,DB07128
"(2R)-1-(2,6-dimethylphenoxy)propan-2-amine",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB07129
4-BROMO-3-(CARBOXYMETHOXY)-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07130
1-{2-OXO-3-[(1R)-1-(1H-PYRROL-2-YL)ETHYL]-2H-INDOL-5-YL}UREA,,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB07132
D-phenylalanyl-N-(3-methylbenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB07133
"5-(4-CHLORO-5-PHENYL-3-THIENYL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07134
"(2S,3S)-3-AMINO-4-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-N,N-DIMETHYL-4-OXO-2-(TRANS-4-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-5-YLCYCLOHEXYL)BUTANAMIDE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07135
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-{(R)-HYDROXY[(1R)-2-METHYL-1-{[(3-PHENYLPROPYL)SULFONYL]AMINO}PROPYL]PHOSPHORYL}PROPANOIC ACID,,experimental,CPB1,Carboxypeptidase B,target,,DB07136
"5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-b]pyridazin-6-one",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07138
3-[5-(3-nitrophenyl)thiophen-2-yl]propanoic acid,,experimental,AKR1B1,Aldose reductase,target,,DB07139
"5-[(3R)-3-(5-methoxy-4'-methylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB07141
D-phenylalanyl-N-benzyl-L-prolinamide,,experimental,F2,Prothrombin,target,,DB07143
"5-[(3R)-3-(5-methoxy-2',6'-dimethylbiphenyl-3-yl)but-1-yn-1-yl]-6-methylpyrimidine-2,4-diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB07144
(2R)-N-HYDROXY-2-[(3S)-3-METHYL-3-{4-[(2-METHYLQUINOLIN-4-YL)METHOXY]PHENYL}-2-OXOPYRROLIDIN-1-YL]PROPANAMIDE,,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07145
"2,3-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-B]PYRIDIN-4-AMINE",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB07146
"methyl (1R,2S)-2-(hydroxycarbamoyl)-1-{4-[(2-methylquinolin-4-yl)methoxy]benzyl}cyclopropanecarboxylate",,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07147
"(6S)-1-chloro-3-[(4-fluorobenzyl)oxy]-6-(pyrrolidin-1-ylcarbonyl)pyrrolo[1,2-a]pyrazin-4(6H)-one",,experimental,PREP,Prolyl endopeptidase,target,,DB07148
"(7S)-2-(2-aminopyrimidin-4-yl)-7-(2-fluoroethyl)-1,5,6,7-tetrahydro-4H-pyrrolo[3,2-c]pyridin-4-one",,experimental,GSK3B,Glycogen synthase kinase-3 beta,target,,DB07149
4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one,,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB07151
N-[4-(5-fluoro-6-methylpyridin-2-yl)-5-quinoxalin-6-yl-1H-imidazol-2-yl]acetamide,,experimental,TGFBR1,TGF-beta receptor type-1,target,,DB07152
"6-methyl-5-[3-methyl-3-(3,4,5-trimethoxyphenyl)but-1-yn-1-yl]pyrimidine-2,4-diamine",,experimental,dfrB,Dihydrofolate reductase,target,,DB07153
"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-METHYL-1,4-DIAZEPAN-2-ONE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07154
(3S)-1-CYCLOHEXYL-5-OXO-N-PHENYLPYRROLIDINE-3-CARBOXAMIDE,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07155
"(4Z)-6-bromo-4-({[4-(pyrrolidin-1-ylmethyl)phenyl]amino}methylidene)isoquinoline-1,3(2H,4H)-dione",,experimental,IGF1R,Insulin-like growth factor 1 receptor,target,,DB07156
"(5R,6S,8S)-8-[3-(AMINOMETHYL)PHENYL]-6-HYDROXY-5-ISOPROPYL-3-OXO-1-PHENYL-2,7-DIOXA-4-AZA-6-PHOSPHANONAN-9-OIC ACID 6-OXIDE",,experimental,CPB1,Carboxypeptidase B,target,,DB07157
"5-ETHYL-3-METHYL-1,5-DIHYDRO-4H-PYRAZOLO[4,3-C]QUINOLIN-4-ONE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07158
"6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one",,experimental,SYK,Tyrosine-protein kinase SYK,target,,DB07159
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCINE",,experimental,CTSB,Cathepsin B,target,,DB07160
5-phenyl-1H-indazol-3-amine,,experimental,JAK2,Tyrosine-protein kinase JAK2,target,,DB07161
4-(3-amino-1H-indazol-5-yl)-N-tert-butylbenzenesulfonamide,,experimental,JAK2,Tyrosine-protein kinase JAK2,target,,DB07162
5-[(2-AMINOETHYL)AMINO]-6-FLUORO-3-(1H-PYRROL-2-YL)BENZO[CD]INDOL-2(1H)-ONE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07163
N-(5-CHLORO-BENZO[B]THIOPHEN-3-YLMETHYL)-2-[6-CHLORO-OXO-3-(2-PYRIDIN-2-YL-ETHYLAMINO)-2H-PYRAZIN-1-YL]-ACETAMIDE,,experimental,F2,Prothrombin,target,,DB07165
5-CYANO-FURAN-2-CARBOXYLIC ACID [5-HYDROXYMETHYL-2-(4-METHYL-PIPERIDIN-1-YL)-PHENYL]-AMIDE,,experimental,CSF1R,Macrophage colony-stimulating factor 1 receptor,target,,DB07167
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]-6-(methylamino)pyrimidin-2-yl}amino)phenyl]acetonitrile,,experimental,CAMK2B,Calcium/calmodulin-dependent protein kinase type II subunit beta,target,,DB07168
"5R-(3,4-DICHLOROPHENYLMETHYL)-3-(2-THIOPHENESULFONYLAMINO)-4-OXO-2-THIONOTHIAZOLIDINE",,experimental,,Genome polyprotein,target,,DB07169
"5'-FLUORO-2',5'-DIDEOXYADENOSINE",,experimental,flA,5'-fluoro-5'-deoxy-adenosine synthase,target,,DB07170
"5-(2-hydroxyethyl)nonane-1,9-diol",,experimental,ECE1,Endothelin-converting enzyme 1,target,,DB07171
"(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07172
"7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE",,experimental,ADK,Adenosine kinase,target,,DB07173
"6-(2,4-DIAMINO-6-ETHYLPYRIMIDIN-5-YL)-4-(3-METHOXYPROPYL)-2,2-DIMETHYL-2H-1,4-BENZOXAZIN-3(4H)-ONE",,experimental,REN,Renin,target,,DB07174
N-{2-methyl-5-[(6-phenylpyrimidin-4-yl)amino]phenyl}methanesulfonamide,,experimental,BACE1,Beta-secretase 1,target,,DB07175
5-PENTYL-2-PHENOXYPHENOL,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07178
"3-((3-bromo-5-o-tolylpyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07179
"5-[(Z)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",,experimental,NEK2,Serine/threonine-protein kinase Nek2,target,,DB07180
"4'-[(1R)-1-amino-2-(2,5-difluorophenyl)ethyl]biphenyl-3-carboxamide",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07181
(2S)-2-(3-{[AMINO(IMINO)METHYL]AMINO}PHENYL)-3-[(S)-HYDROXY(3-PHENYLPROPYL)PHOSPHORYL]PROPANOIC ACID,,experimental,CPB1,Carboxypeptidase B,target,,DB07182
N-(4-phenoxyphenyl)-2-[(pyridin-4-ylmethyl)amino]nicotinamide,,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07183
"6-(cyclohexylsulfanyl)-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07184
2-{[(4-CHLOROPHENOXY)ACETYL]AMINO}BENZOIC ACID,,experimental,,Genome polyprotein,target,,DB07185
6-[(5-CHLORO-3-METHYL-1-BENZOFURAN-2-YL)SULFONYL]PYRIDAZIN-3(2H)-ONE,,experimental,AKR1B1,Aldose reductase,target,,DB07187
"(3S)-1-CYCLOHEXYL-N-(3,5-DICHLOROPHENYL)-5-OXOPYRROLIDINE-3-CARBOXAMIDE",,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07188
"(1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid",,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07189
3-cyclohexyl-D-alanyl-N-(3-chlorobenzyl)-L-prolinamide,,experimental,F2,Prothrombin,target,,DB07190
(3S)-N-(3-BROMOPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07192
"(2R,3R)-7-(methylsulfonyl)-3-(2,4,5-trifluorophenyl)-1,2,3,4-tetrahydropyrido[1,2-a]benzimidazol-2-amine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07193
"2-{2-[(3,5-dimethylphenyl)amino]pyrimidin-4-yl}-N-[(1S)-2-hydroxy-1-methylethyl]-4-methyl-1,3-thiazole-5-carboxamide",,experimental,SYK,Tyrosine-protein kinase SYK,target,,DB07194
N-methyl-1-(2-thiophen-2-ylphenyl)methanamine,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07196
4-BROMO-3-(CARBOXYMETHOXY)-5-(4-HYDROXYPHENYL)THIOPHENE-2-CARBOXYLIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07197
6-CHLORO-3-(3-METHYLISOXAZOL-5-YL)-4-PHENYLQUINOLIN-2(1H)-ONE,,experimental,CSF1R,Macrophage colony-stimulating factor 1 receptor,target,,DB07202
N6-ISOPENTENYL-ADENOSINE-5'-MONOPHOSPHATE,,experimental,YARS,"Tyrosine--tRNA ligase, cytoplasmic",target,,DB07205
6-[2-(1H-INDOL-6-YL)ETHYL]PYRIDIN-2-AMINE,,experimental,BACE1,Beta-secretase 1,target,,DB07206
"(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07208
"(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07209
"3-bromo-5-phenyl-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07210
N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE,,experimental,F11,Coagulation factor XI,target,,DB07212
"(5-{3-[5-(PIPERIDIN-1-YLMETHYL)-1H-INDOL-2-YL]-1H-INDAZOL-6-YL}-2H-1,2,3-TRIAZOL-4-YL)METHANOL",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07213
"N-(3-cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)-2-fluorobenzamide",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB07217
"BENZYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",,experimental,CTSB,Cathepsin B,target,,DB07219
"N-[5-(1,1-DIOXIDOISOTHIAZOLIDIN-2-YL)-1H-INDAZOL-3-YL]-2-(4-PIPERIDIN-1-YLPHENYL)ACETAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07220
"(2,2-DIPHOSPHONOETHYL)(DODECYL)DIMETHYLPHOSPHONIUM",,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB07221
(3S)-N-(5-CHLORO-2-METHYLPHENYL)-1-CYCLOHEXYL-5-OXOPYRROLIDINE-3-CARBOXAMIDE,,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07222
"METHYL N-({(2S,3S)-3-[(PROPYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINATE",,experimental,CTSB,Cathepsin B,target,,DB07223
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ALANINE",,experimental,CTSB,Cathepsin B,target,,DB07224
"N-{[(2S,3S)-3-(ETHOXYCARBONYL)OXIRAN-2-YL]CARBONYL}-L-ISOLEUCYL-L-ISOLEUCINE",,experimental,CTSB,Cathepsin B,target,,DB07225
"N-[4-(2-CHLOROPHENYL)-1,3-DIOXO-1,2,3,6-TETRAHYDROPYRROLO[3,4-C]CARBAZOL-9-YL]FORMAMIDE",,experimental,WEE1,Wee1-like protein kinase,target,,DB07226
1-(5-CHLORO-2-METHOXYPHENYL)-3-{6-[2-(DIMETHYLAMINO)-1-METHYLETHOXY]PYRAZIN-2-YL}UREA,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07228
"3-{5-[AMINO(IMINIO)METHYL]-1H-INDOL-2-YL}-5-METHOXY-1,1'-BIPHENYL-2-OLATE",,experimental,PRSS1,Trypsin-1,target,,DB07229
"N-({(2S,3S)-3-[(BENZYLAMINO)CARBONYL]OXIRAN-2-YL}CARBONYL)-L-ISOLEUCYL-L-PROLINE",,experimental,CTSB,Cathepsin B,target,,DB07231
N-{[4-(but-2-yn-1-yloxy)phenyl]sulfonyl}-5-methyl-D-tryptophan,,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07233
"3-{[(1R)-1-phenylethyl]amino}-4-(pyridin-4-ylamino)cyclobut-3-ene-1,2-dione",,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB07234
"N-[(1S)-2-AMINO-1-(2,4-DICHLOROBENZYL)ETHYL]-5-[2-(METHYLAMINO)PYRIMIDIN-4-YL]THIOPHENE-2-CARBOXAMIDE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07235
{4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphenyl)methanone,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07237
7-(aminomethyl)-6-(2-chlorophenyl)-1-methyl-1H-benzimidazole-5-carbonitrile,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07239
"7-carboxy-5-hydroxy-12,13-dihydro-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole",,experimental,rbmD,Putative FAD-monooxygenase,target,,DB07241
"(3-ENDO)-8-METHYL-8-AZABICYCLO[3.2.1]OCT-3-YL 1H-PYRROLO[2,3-B]PYRIDINE-3-CARBOXYLATE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07243
6-[2-(3'-METHOXYBIPHENYL-3-YL)ETHYL]PYRIDIN-2-AMINE,,experimental,BACE1,Beta-secretase 1,target,,DB07245
"(2R)-2-AMINO-3,3,3-TRIFLUORO-N-HYDROXY-2-{[(4-PHENOXYPHENYL)SULFONYL]METHYL}PROPANAMIDE",,experimental,,Matrix metalloproteinase-9,target,,DB07246
"7-PYRIDIN-2-YL-N-(3,4,5-TRIMETHOXYPHENYL)-7H-PYRROLO[2,3-D]PYRIMIDIN-2-AMINE",,experimental,PTK2,Focal adhesion kinase 1,target,,DB07248
"N-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07249
"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3,4,5- TRIMETHOXYPHENYL)PYRIMIDINE-2,4-DIAMINE",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07250
"N'-(3-CHLORO-4-METHOXY-PHENYL)-N-(3,4,5-TRIMETHOXYPHENYL)-1,3,5-TRIAZINE-2,4-DIAMINE",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07251
"3-({4-[(5-chloro-1,3-benzodioxol-4-yl)amino]pyrimidin-2-yl}amino)benzenesulfonamide",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07252
"N'-(5-chloro-1,3-benzodioxol-4-yl)-N-(3-methylsulfonylphenyl)pyrimidine-2,4-diamine",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07253
"N-[3-[[4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL]AMINO]PHENYL]METHANESULFONAMIDE",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07254
"N'-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-N-(3-MORPHOLIN-4-YLPHENYL)PYRIMIDINE-2,4-DIAMINE",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07255
"3-({4-[(5-CHLORO-1,3-BENZODIOXOL-4-YL)AMINO]PYRIMIDIN-2-YL}AMINO)BENZAMIDE",,experimental,EPHB4,Ephrin type-B receptor 4,target,,DB07256
"4-(2-chlorophenyl)-8-(2-hydroxyethyl)-6-methylpyrrolo[3,4-e]indole-1,3(2H,6H)-dione",,experimental,WEE1,Wee1-like protein kinase,target,,DB07257
(R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07258
1-(4-thiophen-2-ylphenyl)methanamine,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07259
N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07260
"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [1-(1-AMINO-ISOQUINOLIN-7-YLMETHYL)-2-OXO-PYRROLDIN-3-YL]-AMIDE",,experimental,F10,Coagulation factor X,target,,DB07261
1-{[N-(1-IMINO-GUANIDINO-METHYL)]SULFANYLMETHYL}-3-TRIFLUOROMETHYL-BENZENE,,experimental,folA,Dihydrofolate reductase,target,,DB07262
"[{2-bromo-4-[(2R)-3-oxo-2,3-diphenylpropyl]phenyl}(difluoro)methyl]phosphonic acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07263
(S)-N-(1-(3-CHLORO-4-FLUOROPHENYL)-2-HYDROXYETHYL)-4-(4-(3-CHLOROPHENYL)-1H-PYRAZOL-3-YL)-1H-PYRROLE-2-CARBOXAMIDE,,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB07264
"3-(9-HYDROXY-1,3-DIOXO-4-PHENYL-2,3-DIHYDROPYRROLO[3,4-C]CARBAZOL-6(1H)-YL)PROPANOIC ACID",,experimental,WEE1,Wee1-like protein kinase,target,,DB07265
"8-ethyl-3,10,10-trimethyl-4,5,6,8,10,12-hexahydropyrazolo[4',3':6,7]cyclohepta[1,2-b]pyrrolo[2,3-f]indol-9(1H)-one",,experimental,AURKA,Aurora kinase A,target,,DB07266
2-(6-methylpyridin-2-yl)-N-pyridin-4-ylquinazolin-4-amine,,experimental,TGFBR1,TGF-beta receptor type-1,target,,DB07267
2-({2-[(3-HYDROXYPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)BENZAMIDE,,experimental,MAPK8,Mitogen-activated protein kinase 8,target,,DB07268
(2S)-2-[3-(AMINOMETHYL)PHENYL]-3-[(R)-[(1R)-1-{[(BENZYLOXY)CARBONYL]AMINO}-2-METHYLPROPYL](HYDROXY)PHOSPHORYL]PROPANOIC ACID,,experimental,CPB1,Carboxypeptidase B,target,,DB07269
"N-[7-(3-AMINOPHENYL)-5-METHOXY-1,3-BENZOXAZOL-2-YL]-2,5-DICHLOROBENZENESULFONAMIDE",,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB07270
"(3R)-4-[(3R)-3-AMINO-4-(2,4,5-TRIFLUOROPHENYL)BUTANOYL]-3-(2,2,2-TRIFLUOROETHYL)-1,4-DIAZEPAN-2-ONE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07271
1-[(2-AMINO-4-CHLORO-5-METHYLPHENYL)SULFONYL]-L-PROLINE,,experimental,,Genome polyprotein,target,,DB07273
"N-cyclopropyl-6-[(6,7-dimethoxyquinolin-4-yl)oxy]naphthalene-1-carboxamide",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07274
"3-(1,1-dioxido-4H-1,2,4-benzothiadiazin-3-yl)-4-hydroxy-1-(3-methylbutyl)quinolin-2(1H)-one",,experimental,,Genome polyprotein,target,,DB07275
N-ETHYL-N-ISOPROPYL-3-METHYL-5-{[(2S)-2-(PYRIDIN-4-YLAMINO)PROPYL]OXY}BENZAMIDE,,experimental,F2,Prothrombin,target,,DB07279
5-[4-(DIMETHYLAMINO)PHENYL]-6-[(6-MORPHOLIN-4-YLPYRIDIN-3-YL)ETHYNYL]PYRIMIDIN-4-AMINE,,experimental,ADK,Adenosine kinase,target,,DB07280
"N~3~-BENZYLPYRIDINE-2,3-DIAMINE",,experimental,BACE1,Beta-secretase 1,target,,DB07281
"N~3~-(3-PYRIDIN-3-YLBENZYL)PYRIDINE-2,3-DIAMINE",,experimental,BACE1,Beta-secretase 1,target,,DB07284
"(3R)-4,4-DIFLUORO-3-[(4-METHOXYPHENYL)SULFONYL]BUTANOIC ACID",,experimental,,Matrix metalloproteinase-9,target,,DB07285
"2-CHLORO-4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-3-METHYLBENZONITRILE",,experimental,AR,Androgen receptor,target,,DB07286
"2-(2,4-DICHLOROPHENOXY)-5-(PYRIDIN-2-YLMETHYL)PHENOL",,experimental,inhA,Enoyl-[acyl-carrier-protein] reductase [NADH],target,,DB07287
N-(4-chlorophenyl)-2-[(pyridin-4-ylmethyl)amino]benzamide,,experimental,FLT1,Vascular endothelial growth factor receptor 1,target,,DB07288
5-[3-(BENZYLAMINO)PHENYL]-4-BROMO-3-(CARBOXYMETHOXY)THIOPHENE-2-CARBOXYLIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07289
(2R)-2-{[(4-FLUORO-3-METHYLPHENYL)SULFONYL]AMINO}-N-HYDROXY-2-TETRAHYDRO-2H-PYRAN-4-YLACETAMIDE,,experimental,lef,Lethal factor,target,,DB07290
5-amino-1-(4-chlorophenyl)-1H-pyrazole-4-carbonitrile,,experimental,ppa,Inorganic pyrophosphatase,target,,DB07291
"4-(2-amino-1,3-thiazol-4-yl)phenol",,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB07292
benzyl (2-oxopropyl)carbamate,,experimental,rep,Replicase polyprotein 1ab,target,,DB07293
"3-FLUORO-4-[2-HYDROXY-2-(5,5,8,8-TETRAMETHYL-5,6,7,8,-TETRAHYDRO-NAPHTALEN-2-YL)-ACETYLAMINO]-BENZOIC ACID",,experimental,RARG,Retinoic acid receptor gamma,target,,DB07294
2-[(7-HYDROXY-NAPHTHALEN-1-YL)-OXALYL-AMINO]-BENZOIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07295
(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE,,experimental,murB,UDP-N-acetylenolpyruvoylglucosamine reductase,target,,DB07296
"5,6-DIPHENYL-N-(2-PIPERAZIN-1-YLETHYL)FURO[2,3-D]PYRIMIDIN-4-AMINE",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB07297
"3-(CARBOXYMETHOXY)THIENO[2,3-B]PYRIDINE-2-CARBOXYLIC ACID",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07298
4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE,,experimental,F11,Coagulation factor XI,target,,DB07299
"2-(1H-imidazol-1-yl)-9-methoxy-8-(2-methoxyethoxy)benzo[c][2,7]naphthyridin-4-amine",,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB07300
"(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07302
"N~3~-[3-(5-METHOXYPYRIDIN-3-YL)BENZYL]PYRIDINE-2,3-DIAMINE",,experimental,BACE1,Beta-secretase 1,target,,DB07303
5-[2-(TRIFLUOROMETHOXY)PHENYL]-2-FUROIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB07304
5-(2-CHLORO-4-NITROPHENYL)-2-FUROIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB07305
ETHYL 4-[(4-CHLOROPYRIDIN-2-YL)AMINO]PIPERIDINE-1-CARBOXYLATE,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07306
N-cyclopropyl-4-methyl-3-[1-(2-methylphenyl)phthalazin-6-yl]benzamide,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07307
5-(2-CHLOROBENZYL)-2-FUROIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB07308
5-BROMO-2-{[(4-CHLOROPHENYL)SULFONYL]AMINO}BENZOIC ACID,,experimental,METAP2,Methionine aminopeptidase 2,target,,DB07309
"(5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07310
"18-CHLORO-11,12,13,14-TETRAHYDRO-1H,10H-8,4-(AZENO)-9,15,1,3,6-BENZODIOXATRIAZACYCLOHEPTADECIN-2-ONE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07311
"2,5-DICHLORO-N-(5-CHLORO-1,3-BENZOXAZOL-2-YL)BENZENESULFONAMIDE",,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB07312
5-METHYL-2-[(PHENYLSULFONYL)AMINO]BENZOIC ACID,,experimental,METAP2,Methionine aminopeptidase 2,target,,DB07313
"1-(5-CHLORO-2,4-DIMETHOXYPHENYL)-3-(5-CYANOPYRAZIN-2-YL)UREA",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07314
"5-chloro-N-{4-[(1R)-1,2-dihydroxyethyl]phenyl}-1H-indole-2-carboxamide",,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB07315
"N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07316
(3E)-3-[(phenylamino)methylidene]dihydrofuran-2(3H)-one,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07317
"N-[2-(4-AMINO-5,8-DIFLUORO-1,2-DIHYDROQUINAZOLIN-2-YL)ETHYL]-3-FURAMIDE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07318
"6-(3-BROMO-2-NAPHTHYL)-1,3,5-TRIAZINE-2,4-DIAMINE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07319
"4-(6-{[(4-METHYLCYCLOHEXYL)AMINO]METHYL}-1,4-DIHYDROINDENO[1,2-C]PYRAZOL-3-YL)BENZOIC ACID",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07320
"2,5-DICHLORO-N-[5-METHOXY-7-(6-METHOXYPYRIDIN-3-YL)-1,3-BENZOXAZOL-2-YL]BENZENESULFONAMIDE",,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB07321
"2-[(PHENYLSULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB07322
"2-[({2-[(1Z)-3-(DIMETHYLAMINO)PROP-1-ENYL]-4-FLUOROPHENYL}SULFONYL)AMINO]-5,6,7,8-TETRAHYDRONAPHTHALENE-1-CARBOXYLIC ACID",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB07323
"3-({2-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)ETHYNYL]BENZYL}AMINO)-1,3-OXAZOL-2(3H)-ONE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07324
N-[(2-AMINO-6-METHYLPYRIMIDIN-4-YL)METHYL]-3-{[(E)-(2-OXODIHYDROFURAN-3(2H)-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07325
"6-chloro-N-pyrimidin-5-yl-3-{[3-(trifluoromethyl)phenyl]amino}-1,2-benzisoxazole-7-carboxamide",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07326
"METHYL 4-{[({[(2R,5S)-5-{[(2S)-2-(AMINOMETHYL)PYRROLIDIN-1-YL]CARBONYL}PYRROLIDIN-2-YL]METHYL}AMINO)CARBONYL]AMINO}BENZOATE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07328
1-[N-4'-NITROBENZYL-N-4'-CARBOXYBUTYLAMINO]METHYLPHOSPHONIC ACID,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB07329
trans-4-(7-carbamoyl-1H-benzimidazol-2-yl)-1-propylpiperidinium,,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB07330
2-(4-NITROPHENYL)ACETIC ACID,,experimental,pac,Penicillin G acylase,target,,DB07331
"N-(CYCLOPROPYLMETHYL)-4-(METHYLOXY)-3-({5-[3-(3-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-YL}AMINO)BENZENESULFONAMIDE",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07333
"N-[5-(ETHYLSULFONYL)-2-METHOXYPHENYL]-5-[3-(2-PYRIDINYL)PHENYL]-1,3-OXAZOL-2-AMINE",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07334
4-[3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOL-6-YL]-2-METHOXYPHENOL,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07336
"4-[4-AMINO-6-(5-CHLORO-1H-INDOL-4-YLMETHYL)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07337
"(3S)-3-hydroxy-1-methyl-2,3-dihydro-1H-indole-5,6-dione",,experimental,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB07339
"octyl 3-amino-3-deoxy-2-O-(2,6-dideoxy-alpha-L-lyxo-hexopyranosyl)-beta-D-galactopyranoside",,experimental,ABO,Histo-blood group ABO system transferase,target,,DB07341
1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone,,experimental,HMOX1,Heme oxygenase 1,target,,DB07342
"4-[4-AMINO-6-(2,6-DICHLORO-PHENOXY)-[1,3,5]TRIAZIN-2-YLAMINO]-BENZONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07343
"3,6,9,12,15-PENTAOXAHEPTADECAN-1-OL",,experimental,MCAT,"Malonyl-CoA-acyl carrier protein transacylase, mitochondrial",target,,DB07344
4-(2-aminoethyl)-2-cyclohexylphenol,,experimental,BACE1,Beta-secretase 1,target,,DB07345
4-(2-aminoethyl)-2-ethylphenol,,experimental,BACE1,Beta-secretase 1,target,,DB07346
(2E)-N-hydroxy-3-[1-methyl-4-(phenylacetyl)-1H-pyrrol-2-yl]prop-2-enamide,,experimental,HDAC8,Histone deacetylase 8,target,,DB07350
O-(((1R)-((N-(PHENYL-METHOXY-CARBONYL)-ALANYL)-AMINO)METHYL)HYDROXYPHOSPHINYL)3-L-PHENYLLACTATE,,experimental,CPA1,Carboxypeptidase A1,target,,DB07351
"5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB07352
"4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL",,experimental,F2,Prothrombin,target,,DB07353
"2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM",,experimental,TOP1,DNA topoisomerase 1,target,,DB07354
3-(heptyloxy)benzoic acid,,experimental,lpxC,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,target,,DB07355
"(1S)-2-[(2S,5R)-2-(AMINOMETHYL)-5-ETHYNYLPYRROLIDIN-1-YL]-1-CYCLOPENTYL-2-OXOETHANAMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07356
"4-AMINO-2-HEXYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",,experimental,ABO,Histo-blood group ABO system transferase,target,,DB07357
"2-amino-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",,experimental,GCK,Glucokinase,target,,DB07358
"3-[(4-fluorophenyl)sulfanyl]-N-(4-methyl-1,3-thiazol-2-yl)-6-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]pyridine-2-carboxamide",,experimental,GCK,Glucokinase,target,,DB07359
"1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea",,experimental,AURKA,Aurora kinase A,target,,DB07360
"1-(3-chlorophenyl)-3-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}urea",,experimental,AURKA,Aurora kinase A,target,,DB07361
"1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea",,experimental,AURKA,Aurora kinase A,target,,DB07362
"THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE)",,experimental,CA2,Carbonic anhydrase 2,target,,DB07363
2-[N'-(4-AMINO-BUTYL)-HYDRAZINOCARBONYL]-PYRROLIDINE-1-CARBOXYLIC ACID BENZYL ESTER,,experimental,F2,Prothrombin,target,,DB07366
"(3Z,5S,6R,7S,8S,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",,experimental,bglA,Beta-glucosidase A,target,,DB07367
4-(METHYLSULFONYL)BENZENECARBOXIMIDAMIDE,,experimental,PRSS1,Trypsin-1,target,,DB07368
"N-(3-chlorophenyl)-N-methyl-2-oxo-3-[(3,4,5-trimethyl-1H-pyrrol-2-yl)methyl]-2H-indole-5-sulfonamide",,experimental,MET,Hepatocyte growth factor receptor,target,,DB07369
"(3Z,5S,6R,7S,8R,8aS)-3-(octylimino)hexahydro[1,3]thiazolo[3,4-a]pyridine-5,6,7,8-tetrol",,experimental,bglA,Beta-glucosidase A,target,,DB07370
3-(10-METHYL-ANTHRACEN-9-YL)-PROPIONIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07371
"ANDROSTA-1,4-DIENE-3,17-DIONE",,experimental,onr,Pentaerythritol tetranitrate reductase,target,,DB07373
"N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB07377
"4-AMINO-2-OCTYLOXY-6-HYDROXYMETHYL-TETRAHYDRO-PYRAN-3,5-DIOL",,experimental,ABO,Histo-blood group ABO system transferase,target,,DB07378
"1,1,1-TRIFLUORO-3-ACETAMIDO-4-PHENYL BUTAN-2-ONE(N-ACETYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",,experimental,CTRB1,Chymotrypsinogen B,target,,DB07380
S-Atrolactic Acid,,experimental,mdlA,Mandelate racemase,target,,DB07381
"N~2~-1H-benzimidazol-5-yl-N~4~-(3-cyclopropyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine",,experimental,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,target,,DB07382
"N-(1-BENZYL-3,3,3-TRIFLUORO-2,2-DIHYDROXY-PROPYL)-ACETAMIDE",,experimental,CTRB1,Chymotrypsinogen B,target,,DB07383
"3-(HYDROXYMETHYL)-1-METHYL-5-(2-METHYLAZIRIDIN-1-YL)-2-PHENYL-1H-INDOLE-4,7-DIONE",,experimental,NQO1,NAD(P)H dehydrogenase [quinone] 1,target,,DB07385
3-(BUTYLSULPHONYL)-PROPANOIC ACID,,experimental,TPI1,Triosephosphate isomerase,target,,DB07387
N-[2-(6-AMINO-4-METHYLPYRIDIN-2-YL)ETHYL]-4-CYANOBENZAMIDE,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07389
"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YL)-UREIDO]-N-METHYL-3-PHENYL-PROPIONAMIDE",,experimental,MMP3,Stromelysin-1,target,,DB07390
"(2S)-2-AMINO-1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)PROPAN-1-ONE",,experimental,pip,Proline iminopeptidase,target,,DB07391
"2-(2-PHENYL-3-PYRIDIN-2-YL-4,5,6,7-TETRAHYDRO-2H-ISOPHOSPHINDOL-1-YL)PYRIDINE",,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB07393
"4-[3-(2-Chloro-4,5-difluoro-benzoyl)ureido]-3-trifluoromethoxybenzoic acid",,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB07395
"1-{2-[3-(2-Chloro-4,5-difluoro-benzoyl)-ureido]-4-fluoro-phenyl}-piperidine-4-carboxylic acid",,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB07396
"(5S)-5-(2-amino-2-oxoethyl)-4-oxo-N-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)methyl]-3,4,5,6,7,8-hexahydro[1]benzothieno[2,3-d]pyrimidine-2-carboxamide",,experimental,MMP8,Neutrophil collagenase,target,,DB07397
"2-[(CYCLOPROPYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",,experimental,pknG,Serine/threonine-protein kinase PknG,target,,DB07398
1-ETHOXYCARBONYL-D-PHE-PRO-2(4-AMINOBUTYL)HYDRAZINE,,experimental,F2,Prothrombin,target,,DB07400
"4-[(3-CHLORO-4-{[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]AMINO}PHENYL)SULFONYL]-N,N-DIMETHYLBENZAMIDE",,experimental,PDK1,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",target,,DB07403
"(1-HYDROXY-1-PHOSPHONO-2-[1,1';3',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB07404
"1-(6-CYANO-3-PYRIDYLCARBONYL)-5',8'-DIFLUOROSPIRO[PIPERIDINE-4,2'(1'H)-QUINAZOLINE]-4'-AMINE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB07405
"(4R)-N-[4-({[2-(DIMETHYLAMINO)ETHYL]AMINO}CARBONYL)-1,3-THIAZOL-2-YL]-4-METHYL-1-OXO-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE-6-CARBOXAMIDE",,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB07406
5-(2-METHOXYPHENYL)-2-FUROIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB07407
5-(2-NITROPHENYL)-2-FUROIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB07408
"(1-HYDROXY-1-PHOSPHONO-2-[1,1';4',1'']TERPHENYL-3-YL-ETHYL)-PHOSPHONIC ACID",,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB07409
PHENYLALANINE BORONIC ACID,,experimental,alpha-LP,Alpha-lytic protease,target,,DB07411
1-biphenyl-2-ylmethanamine,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07412
5'-S-[2-(decylamino)ethyl]-5'-thioadenosine,,experimental,mmaA4,Hydroxymycolate synthase MmaA4,target,,DB07413
"(5S)-1-benzyl-3-(1,1-dioxido-1,2-benzisothiazol-3-yl)-4-hydroxy-5-(1-methylethyl)-1,5-dihydro-2H-pyrrol-2-one",,experimental,,Genome polyprotein,target,,DB07414
4-[(1S)-1-(3-fluoro-4-methoxyphenyl)-2-(2-methoxy-5-nitrophenyl)ethyl]-1H-imidazol-2-amine,,experimental,BACE1,Beta-secretase 1,target,,DB07415
bis(4-nitrophenyl) hydrogen phosphate,,experimental,PA1000,Uncharacterized protein PA1000,target,,DB07418
(2S)-3-(4-chloro-3-fluorophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide,,experimental,AR,Androgen receptor,target,,DB07419
(1R)-4-(3-phenoxyphenyl)-1-phosphonobutane-1-sulfonic acid,,experimental,crtM,Dehydrosqualene synthase,target,,DB07420
"4-{[(1R,2S)-1,2-dihydroxy-2-methyl-3-(4-nitrophenoxy)propyl]amino}-2-(trifluoromethyl)benzonitrile",,experimental,AR,Androgen receptor,target,,DB07421
(2S)-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-3-(pentafluorophenoxy)propanamide,,experimental,AR,Androgen receptor,target,,DB07422
(2S)-3-[4-(acetylamino)phenoxy]-2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,,experimental,AR,Androgen receptor,target,,DB07423
tripotassium (1R)-4-biphenyl-4-yl-1-phosphonatobutane-1-sulfonate,,experimental,crtM,Dehydrosqualene synthase,target,,DB07424
"[1-HYDROXY-2-(1,1':3',1''-TERPHENYL-3-YLOXY)ETHANE-1,1-DIYL]BIS(PHOSPHONIC ACID)",,experimental,uppS,"Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific)",target,,DB07426
2-({[4-bromo-3-(diethylsulfamoyl)phenyl]carbonyl}amino)benzoic acid,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB07429
"(10R)-10-methyl-3-(6-methylpyridin-3-yl)-9,10,11,12-tetrahydro-8H-[1,4]diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one",,experimental,MAPKAPK2,MAP kinase-activated protein kinase 2,target,,DB07430
(TERT-BUTYLOXYCARBONYL)-ALANYL-AMINO ETHYL-FORMAMIDE,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB07433
HONH-BENZYLMALONYL-L-ALANYLGLYCINE-P-NITROANILIDE,,experimental,npr,Thermolysin,target,,DB07434
N-(1-PHENYL-PROPYL)-FORMAMIDE,,experimental,UL80,Capsid scaffolding protein,target,,DB07436
"1-((2-HYDROXYETHOXY)METHYL)-5-(3-(BENZYLOXY)BENZYL)-6-HYDROXYPYRIMIDINE-2,4(1H,3H)-DIONE",,experimental,udp,Uridine phosphorylase,target,,DB07439
4-TERT-BUTYLBENZENESULFONIC ACID,,experimental,F2,Prothrombin,target,,DB07440
(2Z)-N-biphenyl-4-yl-2-cyano-3-hydroxybut-2-enamide,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07443
"6-(3-AMINOPROPYL)-4,9-DIMETHYLPYRROLO[3,4-C]CARBAZOLE-1,3(2H,6H)-DIONE",,experimental,DAPK1,Death-associated protein kinase 1,target,,DB07444
"N'-[(1E)-(3,5-DIBROMO-2,4-DIHYDROXYPHENYL)METHYLENE]NICOTINOHYDRAZIDE",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB07445
N-(biphenyl-4-ylsulfonyl)-D-leucine,,experimental,MMP12,Macrophage metalloelastase,target,,DB07446
5-beta-DIHYDROTESTOSTERONE,,experimental,AKR1D1,3-oxo-5-beta-steroid 4-dehydrogenase,target,,DB07447
(2S)-3-[(R)-[(1S)-1-amino-3-phenylpropyl](hydroxy)phosphoryl]-2-benzylpropanoic acid,,experimental,LAP3,Cytosol aminopeptidase,target,,DB07448
N-[(1S)-1-(AMINOCARBONYL)-4-(ETHANIMIDOYLAMINO)BUTYL]BENZAMIDE,,experimental,PADI4,Protein-arginine deiminase type-4,target,,DB07449
"2[4-BROMO-2-FLUOROPHENYL)METHYL]-6-FLUOROSPIRO[ISOQUINOLINE-4-(1H),3'-PYRROLIDINE]-1,2',3,5'(2H)-TETRONE",,experimental,AKR1B1,Aldose reductase,target,,DB07450
1-(5-BROMO-PYRIDIN-2-YL)-3-[2-(6-FLUORO-2-HYDROXY-3-PROPIONYL-PHENYL)-CYCLOPROPYL]-UREA,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07451
"2,6-diamino-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB07452
2-PHENYL-4H-BENZO[H]CHROMEN-4-ONE,,experimental,CYP1A2,Cytochrome P450 1A2,target,,DB07453
(R)-3-BROMO-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,,experimental,AR,Androgen receptor,target,,DB07454
"N,N'-[biphenyl-4,4'-diyldi(2R)propane-2,1-diyl]dimethanesulfonamide",,experimental,GRIA2,Glutamate receptor 2,target,,DB07455
"3-(1H-INDOL-3-YL)-4-(1-{2-[(2S)-1-METHYLPYRROLIDINYL]ETHYL}-1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB07456
"3-[1-(3-AMINOPROPYL)-1H-INDOL-3-YL]-4-(1H-INDOL-3-YL)-1H-PYRROLE-2,5-DIONE",,experimental,PDPK1,3-phosphoinositide-dependent protein kinase 1,target,,DB07457
"3-(1H-INDOL-3-YL)-4-{1-[2-(1-METHYLPYRROLIDIN-2-YL)ETHYL]-1H-INDOL-3-YL}-1H-PYRROLE-2,5-DIONE",,experimental,PRKACA,cAMP-dependent protein kinase catalytic subunit alpha,target,,DB07458
4-PHENOXY-N-(PYRIDIN-2-YLMETHYL)BENZAMIDE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07459
2-({5-CHLORO-2-[(2-METHOXY-4-MORPHOLIN-4-YLPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)-N-METHYLBENZAMIDE,,experimental,PTK2,Focal adhesion kinase 1,target,,DB07460
"3-AMINO-3-BENZYL-9-CARBOXAMIDE[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",,experimental,F2,Prothrombin,target,,DB07461
"(3,4-DIHYDROXY-2-NITROPHENYL)(PHENYL)METHANONE",,experimental,COMT,Catechol O-methyltransferase,target,,DB07462
"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(butylsulfanyl)methyl]pyrrolidin-3-ol",,experimental,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB07463
1(R)-1-ACETAMIDO-2-(3-CARBOXY-2-HYDROXYPHENYL)ETHYL BORONIC ACID,,experimental,bla,Beta-lactamase TEM,target,,DB07464
"(1S,3S,5S)-2-{(2S)-2-amino-2-[(1R,3S,5R,7S)-3-hydroxytricyclo[3.3.1.1~3,7~]dec-1-yl]acetyl}-2-azabicyclo[3.1.0]hexane-3-carbonitrile",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07465
(1R)-2-PHENYLACETAMIDO-2-(3-CARBOXYPHENYL)ETHYL BORONIC ACID,,experimental,bla,Beta-lactamase TEM,target,,DB07466
"4-chloro-N-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-3-sulfamoylbenzamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB07467
"(3aS)-3a-hydroxy-5-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",,experimental,MYH14,Myosin-14,target,,DB07468
"(3aS)-3a-hydroxy-7-methyl-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",,experimental,MYH14,Myosin-14,target,,DB07469
"(3aS)-3a-hydroxy-1-phenyl-1,2,3,3a-tetrahydro-4H-pyrrolo[2,3-b]quinolin-4-one",,experimental,MYH14,Myosin-14,target,,DB07470
"(R)-(+)9B-(3-METHYL)PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-5(9BH)-ONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07472
"(R)-(+) 5(9BH)-OXO-9B-PHENYL-2,3-DIHYDROTHIAZOLO[2,3-A]ISOINDOL-3-CARBOXYLIC ACID METHYL ESTER",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07473
3-[5-(1H-IMIDAZOL-1-YL)-7-METHYL-1H-BENZIMIDAZOL-2-YL]-4-[(PYRIDIN-2-YLMETHYL)AMINO]PYRIDIN-2(1H)-ONE,,experimental,IGF1R,Insulin-like growth factor 1 receptor,target,,DB07474
N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE,,experimental,CA2,Carbonic anhydrase 2,target,,DB07476
BIPHENYL-4-YL-ACETALDEHYDE,,experimental,CTSL1,Cathepsin L1,target,,DB07477
"1,1'-BIPHENYL-3,4-DIOL",,experimental,doxG,"1,2-dihydroxynaphthalene dioxygenase",target,,DB07478
"(1S)-1,2,3,4-TETRAHYDRO-BENZO[C]PHENANTHRENE-2,3,4-TRIOL",,experimental,POLB,DNA polymerase beta,target,,DB07479
4-PHOSPHONOOXY-PHENYL-METHYL-[4-PHOSPHONOOXY]BENZEN,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07480
"tert-butyl [(2-amino-4-oxo-4,7-dihydro-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methyl]carbamate",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB07481
(2R)-N-[(2R)-2-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-N-[(5R)-5-(DIHYDROXYBORYL)-1-L-PROLYLPYRROLIDIN-2-YL]-L-PROLINAMIDE,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07482
"1,1'-BIPHENYL-2-SULFINIC ACID",,experimental,soxB,2'-hydroxybiphenyl-2-sulfinate desulfinase,target,,DB07483
"(2R)-4,4-dihydroxy-5-nitro-2-(phenylmethyl)pentanoic acid",,experimental,CPA1,Carboxypeptidase A1,target,,DB07484
"4,4'-cyclohexane-1,1-diyldiphenol",,experimental,ESRRG,Estrogen-related receptor gamma,target,,DB07485
"3-({4-[(1E)-3-morpholin-4-yl-3-oxoprop-1-en-1-yl]-2,3-bis(trifluoromethyl)phenyl}sulfanyl)aniline",,experimental,ITGAL,Integrin alpha-L,target,,DB07486
"(6-METHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL)METHYLPHOSPHINATE",,experimental,npr,Thermolysin,target,,DB07487
"{(2Z)-4-AMINO-2-[(4-METHOXYPHENYL)IMINO]-2,3-DIHYDRO-1,3-THIAZOL-5-YL}(4-METHOXYPHENYL)METHANONE",,experimental,CSNK1G3,Casein kinase I isoform gamma-3,target,,DB07488
"{[4-AMINO-2-(3-CHLOROANILINO)-1,3-THIAZOL-5-YL](4-FLUOROPHENYL)METHANONE",,experimental,CSNK1G3,Casein kinase I isoform gamma-3,target,,DB07489
"5-amino-2,4,6-tribromobenzene-1,3-dicarboxylic acid",,experimental,PRSS1,Trypsin-1,target,,DB07491
BROMAMPHENICOL,,experimental,draA,Dr hemagglutinin structural subunit,target,,DB07492
"(2Z)-5'-BROMO-2,3'-BIINDOLE-2',3(1H,1'H)-DIONE AMMONIATE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07493
"(3-EXO)-3-(10,11-DIHYDRO-5H-DIBENZO[A,D][7]ANNULEN-5-YLOXY)-8,8-DIMETHYL-8-AZONIABICYCLO[3.2.1]OCTANE",,experimental,CHRFAM7A,CHRNA7-FAM7A fusion protein,target,,DB07494
"5-(5-CHLORO-2,4-DIHYDROXYPHENYL)-N-ETHYL-4-(4-METHOXYPHENYL)-1H-PYRAZOLE-3-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07495
"1,3-DIPHENYLUREA",,experimental,ephB,Epoxide hydrolase,target,,DB07496
"4-[3-(3-NITROPHENYL)-1,2,4-OXADIAZOL-5-YL]BUTANOIC ACID",,experimental,AKR1B1,Aldose reductase,target,,DB07498
"N-(4-{[amino(imino)methyl]amino}butyl)-2,4'-bi-1,3-thiazole-4-carboxamide",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07499
(2E)-1-[2-hydroxy-4-methoxy-5-(3-methylbut-2-en-1-yl)phenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB07500
(2S)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07501
"4-bromo-6-(6-hydroxy-1,2-benzisoxazol-3-yl)benzene-1,3-diol",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07502
"(5E)-5-[(2,2-DIFLUORO-1,3-BENZODIOXOL-5-YL)METHYLENE]-1,3-THIAZOLIDINE-2,4-DIONE",,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB07503
(2R)-1-{4-[(4-ANILINO-5-BROMOPYRIMIDIN-2-YL)AMINO]PHENOXY}-3-(DIMETHYLAMINO)PROPAN-2-OL,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07504
"N-({(3R,4R)-4-[(benzyloxy)methyl]pyrrolidin-3-yl}methyl)-N-(2-methylpropyl)benzenesulfonamide",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07505
"2-(4-hydroxybiphenyl-3-yl)-4-methyl-1H-isoindole-1,3(2H)-dione",,experimental,thyA,Thymidylate synthase,target,,DB07507
4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE,,experimental,F2,Prothrombin,target,,DB07508
difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07509
"3-fluoro-6-(4-fluorophenyl)-2-hydroxy-6-oxohexa-2,4-dienoic acid",,experimental,bphD,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",target,,DB07510
"4-(4-methyl-1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)benzonitrile",,experimental,thyA,Thymidylate synthase,target,,DB07511
7-[(3-CHLOROBENZYL)OXY]-2-OXO-2H-CHROMENE-4-CARBALDEHYDE,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB07512
7-[(3-CHLOROBENZYL)OXY]-4-[(METHYLAMINO)METHYL]-2H-CHROMEN-2-ONE,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB07513
"3-(2-aminoquinazolin-6-yl)-1-(3,3-dimethylindolin-6-yl)-4-methylpyridin-2(1H)-one",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07514
"1-(2-{[(6-AMINO-2-METHYLPYRIDIN-3-YL)METHYL]AMINO}ETHYL)-6-CHLORO-3-[(2,2-DIFLUORO-2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL",,experimental,F2,Prothrombin,target,,DB07515
"(2Z,4E)-3-chloro-2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid",,experimental,bphD,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",target,,DB07516
(2R)-2-ETHYL-1-HEXANESULFONIC ACID,,experimental,atsK,Putative alkylsulfatase,target,,DB07518
"(6R)-2-amino-6-[2-(3'-methoxybiphenyl-3-yl)ethyl]-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",,experimental,BACE1,Beta-secretase 1,target,,DB07519
"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(MORPHOLIN-4-YLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",,experimental,CTSS,Cathepsin S,target,,DB07520
"6-CHLORO-1-(2-{[(5-CHLORO-1-BENZOTHIEN-3-YL)METHYL]AMINO}ETHYL)-3-[(2-PYRIDIN-2-YLETHYL)AMINO]-1,4-DIHYDROPYRAZIN-2-OL",,experimental,F2,Prothrombin,target,,DB07521
"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]NAPHTHALENE-2-SULFONAMIDE",,experimental,F2,Prothrombin,target,,DB07522
"N-phenyl-1H-pyrrolo[2,3-b]pyridin-3-amine",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB07524
"3-(3-methoxybenzyl)-1H-pyrrolo[2,3-b]pyridine",,experimental,FGFR1,Fibroblast growth factor receptor 1,target,,DB07525
N-[4-({[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}AMINO)BUTYL]-3-SULFANYLPROPANAMIDE,,experimental,,Beta-lactamase IMP-1,target,,DB07526
"N-[(2R,3S)-3-AMINO-2-HYDROXY-4-PHENYLBUTYL]-4-METHOXY-2,3,6-TRIMETHYLBENZENESULFONAMIDE",,experimental,F2,Prothrombin,target,,DB07527
3-(2-aminoquinazolin-6-yl)-4-methyl-1-[3-(trifluoromethyl)phenyl]pyridin-2(1H)-one,,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07528
"2-IMINO-5-(1-PYRIDIN-2-YL-METH-(E)-YLIDENE)-1,3-THIAZOLIDIN-4-ONE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07529
"4-{5-[(Z)-(2,4-DIOXO-1,3-THIAZOLIDIN-5-YLIDENE)METHYL]FURAN-2-YL}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07531
2-amino-6-[2-(1H-indol-6-yl)ethyl]pyrimidin-4(3H)-one,,experimental,BACE1,Beta-secretase 1,target,,DB07535
"N-{(1S,2R)-2-hydroxy-1-[(hydroxyamino)carbonyl]propyl}-4-{[4-(morpholin-4-ylmethyl)phenyl]ethynyl}benzamide",,experimental,lpxC,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,target,,DB07536
"N'-(6-aminopyridin-3-yl)-N-(2-cyclopentylethyl)-4-methyl-benzene-1,3-dicarboxamide",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB07537
"4-{5-[(1Z)-1-(2-IMINO-4-OXO-1,3-THIAZOLIDIN-5-YLIDENE)ETHYL]-2-FURYL}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07540
4-(dihydroxyboranyl)-2-({[4-(phenylsulfonyl)thiophen-2-yl]sulfonyl}amino)benzoic acid,,experimental,ampC,Beta-lactamase,target,,DB07541
5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOBUTYL-HEXANOIC ACID,,experimental,CTSD,Cathepsin D,target,,DB07542
N'-(5-CHLOROBENZOFURAN-2-CARBONYL)-2-(TRIFLUOROMETHYL)BENZENESULFONOHYDRAZIDE,,experimental,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",target,,DB07544
N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE,,experimental,AURKA,Aurora kinase A,target,,DB07545
[1-(6-{6-[(1-methylethyl)amino]-1H-indazol-1-yl}pyrazin-2-yl)-1H-pyrrol-3-yl]acetic acid,,experimental,CSNK2A2,Casein kinase II subunit alpha',target,,DB07546
5-(4-CYANOPHENYL)-3-{[(2-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,,experimental,,Genome polyprotein,target,,DB07547
"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-6-PYRIDINYL)METHYL]ACETAMIDE",,experimental,F2,Prothrombin,target,,DB07548
"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUORO-3-METHYL-6-PYRIDINYL)METHYL]ACETAMIDE",,experimental,F2,Prothrombin,target,,DB07549
"2-(6-CHLORO-3-{[2,2-DIFLUORO-2-(1-OXIDO-2-PYRIDINYL)ETHYL]AMINO}-2-OXO-1(2H)-PYRAZINYL)-N-[(2-FLUOROPHENYL)METHYL]ACETAMIDE",,experimental,F2,Prothrombin,target,,DB07550
"9,9,9-TRIFLUORO-8-OXO-N-PHENYLNONANAMIDE",,experimental,hdaH,Histone deacetylase-like amidohydrolase,target,,DB07553
"1-(2-nitrophenyl)-2,2,2-trifluoroethyl]-arsenocholine",,experimental,ACHE,Acetylcholinesterase,target,,DB07555
2-ACETYLAMINO-4-METHYL-PENTANOIC ACID [1-(1-FORMYL-PENTYLCARBAMOYL)-3-METHYL-BUTYL]-AMIDE,,experimental,PSMA7,Proteasome subunit alpha type-7,target,,DB07558
"(2Z)-2-cyano-N-(2,2'-dichlorobiphenyl-4-yl)-3-hydroxybut-2-enamide",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07559
N-[(1S)-2-methyl-1-(pyridin-4-ylcarbamoyl)propyl]cyclohexanecarboxamide,,experimental,cyp51,Lanosterol 14-alpha demethylase,target,,DB07560
(2Z)-2-cyano-N-(3'-ethoxybiphenyl-4-yl)-3-hydroxybut-2-enamide,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07561
"1-{7-cyclohexyl-6-[4-(4-methylpiperazin-1-yl)benzyl]-7H-pyrrolo[2,3-d]pyrimidin-2-yl}methanamine",,experimental,CTSK,Cathepsin K,target,,DB07563
"6-amino-2-[(2-morpholin-4-ylethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB07564
CHLORAMPHENICOL SUCCINATE,,experimental,draA,Dr hemagglutinin structural subunit,target,,DB07565
"(2R,3R,4S)-3-(4-HYDROXYPHENYL)-4-METHYL-2-[4-(2-PYRROLIDIN-1-YLETHOXY)PHENYL]CHROMAN-6-OL",,experimental,ESR1,Estrogen receptor,target,,DB07567
"(2S)-2-[(2,1,3-BENZOTHIADIAZOL-4-YLSULFONYL)AMINO]-2-PHENYL-N-PYRIDIN-4-YLACETAMIDE",,experimental,cyp51,Lanosterol 14-alpha demethylase,target,,DB07568
CIS-4-METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE,,experimental,cyp51,Lanosterol 14-alpha demethylase,target,,DB07569
3-CYCLOHEXYL-1-(2-MORPHOLIN-4-YL-2-OXOETHYL)-2-PHENYL-1H-INDOLE-6-CARBOXYLIC ACID,,experimental,,Genome polyprotein,target,,DB07570
"N~2~-[(BENZYLOXY)CARBONYL]-N-[(1S,2S)-2-HYDROXY-1-(4-HYDROXYBENZYL)PROPYL]-L-LEUCINAMIDE",,experimental,clpP,ATP-dependent Clp protease proteolytic subunit,target,,DB07571
3-{[(4-methylphenyl)sulfonyl]amino}propyl pyridin-4-ylcarbamate,,experimental,cyp51,Lanosterol 14-alpha demethylase,target,,DB07572
"(2S)-1-(2,5-dimethylphenoxy)-3-morpholin-4-ylpropan-2-ol",,experimental,BACE1,Beta-secretase 1,target,,DB07573
"2,4-DIAMINO-1,5-DIPHENYL-3-HYDROXYPENTANE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07575
"6-ETHYL-5-PHENYLPYRIMIDINE-2,4-DIAMINE",,experimental,TYMS,Thymidylate synthase,target,,DB07577
"3-[4-(2-METHYL-IMIDAZO[4,5-C]PYRIDIN-1-YL)BENZYL]-3H-BENZOTHIAZOL-2-ONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07578
"BIS-1,2-{[(Z)-2-CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBAMOYL}-ETHANE",,experimental,APCS,Serum amyloid P-component,target,,DB07579
"BIS-1,2-{[(Z)-2CARBOXY-2-METHYL-1,3-DIOXANE]-5-YLOXYCARBONYL}-PIPERAZINE",,experimental,APCS,Serum amyloid P-component,target,,DB07580
5-AMINO-6-CYCLOHEXYL-4-HYDROXY-2-ISOPROPYL-HEXANOIC ACID,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07581
"5-(4-METHYL-BENZOYLAMINO)-BIPHENYL-3,4'-DICARBOXYLIC ACID 3-DIMETHYLAMIDE-4'-HYDROXYAMIDE",,experimental,HDAC8,Histone deacetylase 8,target,,DB07586
"N-(1-CYANOCYCLOPROPYL)-3-({[(2S)-5-OXOPYRROLIDIN-2-YL]METHYL}SULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-FLUOROPHENYL)ETHYL]-L-ALANINAMIDE",,experimental,CTSS,Cathepsin S,target,,DB07587
"3,4-DI-1H-INDOL-3-YL-1H-PYRROLE-2,5-DICARBOXYLIC ACID",,experimental,staP,Cytochrome P450,target,,DB07588
"N-[1-(AMINOMETHYL)CYCLOPROPYL]-3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2-TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]-L-ALANINAMIDE",,experimental,CTSS,Cathepsin S,target,,DB07589
"S-[3-(3,4-DICHLOROPHENYL)-3-OXOPROPYL]-L-CYSTEINE",,experimental,srtB,Sortase B,target,,DB07590
N1-CYCLOPENTYL-N2-(THIAZOL-2-YL)OXALAMIDE,,experimental,map,Methionine aminopeptidase,target,,DB07591
(1R)-2-METHYL-1-(PHENYLMETHYL)PROPYL[(1S)-1-FORMYLPENTYL]CARBAMATE,,experimental,CTSK,Cathepsin K,target,,DB07592
1-(PHENYLMETHYL)CYCLOPENTYL[(1S)-1-FORMYLPENTYL]CARBAMATE,,experimental,CTSK,Cathepsin K,target,,DB07593
"(5Z)-5-(3-BROMOCYCLOHEXA-2,5-DIEN-1-YLIDENE)-N-(PYRIDIN-4-YLMETHYL)-1,5-DIHYDROPYRAZOLO[1,5-A]PYRIMIDIN-7-AMINE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07595
"(17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate",,experimental,CA2,Carbonic anhydrase 2,target,,DB07596
"CIS-(1R,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB07597
"2,3,6A,7,8,9-HEXAHYDRO-11H-[1,4]DIOXINO[2,3-G]PYRROLO[2,1-B][1,3]BENZOXAZIN-11-ONE",,experimental,GRIA2,Glutamate receptor 2,target,,DB07598
[(2-AMINO-ALPHA-METHOXYIMINO-4-THIAZOLYLACETYL)AMINO]METHYLBORONIC ACID,,experimental,bla,Beta-lactamase TEM,target,,DB07599
"4-chloro-6-{5-[(2-morpholin-4-ylethyl)amino]-1,2-benzisoxazol-3-yl}benzene-1,3-diol",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB07601
S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE,,experimental,EGFR,Epidermal growth factor receptor,target,,DB07602
"(6AR,11AS,11BR)-10-ACETYL-9-HYDROXY-7,7-DIMETHYL-2,6,6A,7,11A,11B-HEXAHYDRO-11H-PYRROLO[1',2':2,3]ISOINDOLO[4,5,6-CD]INDOL-11-ONE",,experimental,ATP2A1,Sarcoplasmic/endoplasmic reticulum calcium ATPase 1,target,,DB07604
"2-({4-[(5-CHLORO-1H-INDOL-2-YL)SULFONYL]PIPERAZIN-1-YL}CARBONYL)THIENO[3,2-B]PYRIDINE 4-OXIDE",,experimental,F10,Coagulation factor X,target,,DB07605
"6-(3,4-DIHYDROXYBENZYL)-3-ETHYL-1-(2,4,6-TRICHLOROPHENYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4(5H)-ONE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07606
4-[5-(3-IODO-PHENYL)-2-(4-METHANESULFINYL-PHENYL)-1H-IMIDAZOL-4-YL]-PYRIDINE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07607
N-(5-{[(2S)-4-amino-2-(3-chlorophenyl)butanoyl]amino}-1H-indazol-3-yl)benzamide,,experimental,DYRK1A,Dual specificity tyrosine-phosphorylation-regulated kinase 1A,target,,DB07608
"N,N-DIMETHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE",,experimental,CYP2A6,Cytochrome P450 2A6,target,,DB07609
"NAPHTHALENE-1,2-DIOL",,experimental,doxG,"1,2-dihydroxynaphthalene dioxygenase",target,,DB07610
DECANE-1-THIOL,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB07611
6-(3-AMINOPHENYL)-N-(TERT-BUTYL)-2-(TRIFLUOROMETHYL)QUINAZOLIN-4-AMINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07612
3-phenyl-5-(1H-pyrazol-3-yl)isoxazole,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB07613
"PHENYL-5-(1H-PYRAZOL-3-YL)-1,3-THIAZOLE",,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB07614
"2-{[(2E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]amino}benzoic acid",,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB07615
"4-{[4-(4-fluoro-3-methylphenyl)-1,3-thiazol-2-yl]amino}-2-hydroxybenzoic acid",,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB07616
N-METHYL(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,,experimental,CYP2A6,Cytochrome P450 2A6,target,,DB07617
"2-(4-(AMINOMETHYL)PIPERIDIN-1-YL)-N-(3_CYCLOHEXYL-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)ACETAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07618
"N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07619
(5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE,,experimental,CYP2A6,Cytochrome P450 2A6,target,,DB07621
"1-(3-(2,4-DIMETHYLTHIAZOL-5-YL)-4-OXO-2,4-DIHYDROINDENO[1,2-C]PYRAZOL-5-YL)-3-(4-METHYLPIPERAZIN-1-YL)UREA",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07622
"4,4'-DIPYRIDYL DISULFIDE",,experimental,CYP2A6,Cytochrome P450 2A6,target,,DB07623
"1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07624
"4-(2-aminoethoxy)-N-(2,5-diethoxyphenyl)-3,5-dimethylbenzamide",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB07625
"4-(2-aminoethoxy)-N-(3-chloro-2-ethoxy-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB07626
(2S)-4-METHYL-2-(3-PHENYLTHIOUREIDO)-N-((3S)-TETRAHYDRO-2-HYDROXY-3-FURANYL)PENTANAMIDE,,experimental,CAPN1,Calpain-1 catalytic subunit,target,,DB07627
"6-(2-fluorobenzyl)-2,4-dimethyl-4,6-dihydro-5H-thieno[2',3':4,5]pyrrolo[2,3-d]pyridazin-5-one",,experimental,PKM2,Pyruvate kinase PKM,target,,DB07628
"N-((1R,2S)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",,experimental,F10,Coagulation factor X,target,,DB07629
"N-((1R,2R)-2-(5-CHLORO-1H-INDOLE-2-CARBOXAMIDO)CYCLOHEXYL)-5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDINE-2-CARBOXAMIDE",,experimental,F10,Coagulation factor X,target,,DB07630
"N-DODECYL-N,N-DIMETHYLGLYCINATE",,experimental,appA,AppA protein,target,,DB07631
"5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB07632
octyl 3-deoxy-2-O-(6-deoxy-alpha-L-galactopyranosyl)-beta-D-xylo-hexopyranoside,,experimental,ABO,Histo-blood group ABO system transferase,target,,DB07633
"(2,6-DIMETHYL-PHENOXY)-ACETIC ACID",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07634
bis(4-hydroxyphenyl)methanone,,experimental,cyp51,Lanosterol 14-alpha demethylase,target,,DB07635
"3,5 DIBROMOTYROSINE",,experimental,EPOR,Erythropoietin receptor,target,,DB07637
3-(7-DIAMINOMETHYL-NAPHTHALEN-2-YL)-PROPIONIC ACID ETHYL ESTER,,experimental,F2,Prothrombin,target,,DB07639
DECYL(DIMETHYL)PHOSPHINE OXIDE,,experimental,MAOA,Amine oxidase [flavin-containing] A,target,,DB07641
"5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",,experimental,DCPS,m7GpppX diphosphatase,target,,DB07642
"5-{[1-(2,3-dichlorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine",,experimental,DCPS,m7GpppX diphosphatase,target,,DB07643
"5-[(1S)-1-(3-chlorophenyl)ethoxy]quinazoline-2,4-diamine",,experimental,DCPS,m7GpppX diphosphatase,target,,DB07644
"(2R)-1-[(5,6-DIPHENYL-7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO]PROPAN-2-OL",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07647
"(2R)-3-{[(4Z)-5,6-DIPHENYL-6,7-DIHYDRO-4H-PYRROLO[2,3-D]PYRIMIDIN-4-YLIDENE]AMINO}PROPANE-1,2-DIOL",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07648
"(3R,4S)-1-[(4-amino-5H-pyrrolo[3,2-d]pyrimidin-7-yl)methyl]-4-[(benzylsulfanyl)methyl]pyrrolidin-3-ol",,experimental,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB07649
DECYL FORMATE,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB07650
N-ACETYL-L-PHENYLALANYL-4-[DIFLUORO(PHOSPHONO)METHYL]-L-PHENYLALANINAMIDE,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07651
"N-(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)GLYCINE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07653
"(5,6-DIPHENYL-FURO[2,3-D]PYRIMIDIN-4-YLAMINO)-ACETIC",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07654
"3-AMINO-3-BENZYL-[4.3.0]BICYCLO-1,6-DIAZANONAN-2-ONE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07655
N-[4-(1-BENZOYLPIPERIDIN-4-YL)BUTYL]-3-PYRIDIN-3-YLPROPANAMIDE,,experimental,NAMPT,Nicotinamide phosphoribosyltransferase,target,,DB07656
PHOSPHONIC ACID 2-DODECANOYLAMINO-HEXYL ESTER PROPYL ESTER,,experimental,PLA2G1B,Phospholipase A2,target,,DB07657
AC-(D)PHE-PRO-BOROLYS-OH,,experimental,F2,Prothrombin,target,,DB07658
AC-(D)PHE-PRO-BOROHOMOLYS-OH,,experimental,F2,Prothrombin,target,,DB07659
AC-(D)PHE-PRO-BOROHOMOORNITHINE-OH,,experimental,F2,Prothrombin,target,,DB07660
"1,6-DIHYDROXY NAPHTHALENE",,experimental,,Prenyltransferase,target,,DB07661
"2-[(1R)-1-CARBOXY-2-(4-HYDROXYPHENYL)ETHYL]-1,3-DIOXOISOINDOLINE-5-CARBOXYLIC ACID",,experimental,ampC,Beta-lactamase,target,,DB07663
"N-[2-(carbamimidamidooxy)ethyl]-2-{6-cyano-3-[(2,2-difluoro-2-pyridin-2-ylethyl)amino]-2-fluorophenyl}acetamide",,experimental,F2,Prothrombin,target,,DB07665
"(3R,4S)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07666
"2-((3',5'-DIMETHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",,experimental,,Streptavidin,target,,DB07667
3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)-2-METHYL-PROPIONIC ACID,,experimental,CTRB1,Chymotrypsinogen B,target,,DB07668
4-METHYL-N-METHYL-N-(2-PHENYL-2H-PYRAZOL-3-YL)BENZENESULFONAMIDE,,experimental,CYP2C18,Cytochrome P450 2C18,target,,DB07670
TRANS-2-(DIMETHYLPHENYLSILYL)-PIPERIDINE-N-OXIDE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07672
DEAMINO-METHYL-PHENYLALANINE,,experimental,npr,Thermolysin,target,,DB07673
"O,O-DIETHYL HYDROGEN THIOPHOSPHATE",,experimental,opdA,Phosphotriesterase,target,,DB07674
(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07675
"2-methyl-3,5,7,8-tetrahydro-4H-thiopyrano[4,3-d]pyrimidin-4-one",,experimental,PARP3,Poly [ADP-ribose] polymerase 3,target,,DB07677
"(9S,12S)-9-(1-methylethyl)-7,10-dioxo-2-oxa-8,11-diazabicyclo[12.2.2]octadeca-1(16),14,17-triene-12-carboxylic acid",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07679
[(1S)-1-(5-CHLORO-1-BENZOTHIEN-3-YL)-2-(2-NAPHTHYLAMINO)-2-OXOETHYL]PHOSPHONIC ACID,,experimental,CMA1,Chymase,target,,DB07680
DODECANESULFONATE ION,,experimental,BCHE,Cholinesterase,target,,DB07681
"N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine",,experimental,MMP12,Macrophage metalloelastase,target,,DB07683
5-(DIMETHYLAMINO)-2-NAPHTHALENESULFONIC ACID,,experimental,PLAT,Tissue-type plasminogen activator,target,,DB07684
"4-{[5-(CYCLOHEXYLMETHOXY)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07685
"4-{[5-(CYCLOHEXYLAMINO)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL]AMINO}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07686
"4-({5-[(4-AMINOCYCLOHEXYL)AMINO][1,2,4]TRIAZOLO[1,5-A]PYRIMIDIN-7-YL}AMINO)BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07687
"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL]AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",,experimental,DHRS4L1,Putative dehydrogenase/reductase SDR family member 4-like 2,target,,DB07689
"2-({[3-(3,4-dihydroisoquinolin-2(1H)-ylsulfonyl)phenyl]carbonyl}amino)benzoic acid",,experimental,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB07691
"1-[(2,6-difluorophenyl)sulfonyl]-4-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)piperazine",,experimental,PKM2,Pyruvate kinase PKM,target,,DB07692
methyl (3S)-3-[(tert-butoxycarbonyl)amino]-4-oxopentanoate,,experimental,CASP3,Caspase-3,target,,DB07696
"1-(2,3-dihydro-1,4-benzodioxin-6-ylsulfonyl)-4-[(4-methoxyphenyl)sulfonyl]piperazine",,experimental,PKM2,Pyruvate kinase PKM,target,,DB07697
"3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine",,experimental,GSG2,Serine/threonine-protein kinase haspin,target,,DB07698
"3-CARBOXAMIDO-1,3,5(10)-ESTRATRIEN-17(R)-SPIRO-2'(5',5'-DIMETHYL-6'OXO)TETRAHYDROPYRAN",,experimental,AKR1C3,Aldo-keto reductase family 1 member C3,target,,DB07700
"1-BENZYL-4-[(5,6-DIMETHOXY-1-INDANON-2-YL)METHYL]PIPERIDINE",,experimental,ACHE,Acetylcholinesterase,target,,DB07701
"(3R,4S,5S,7R,9E,11R,12R)-12-ETHYL-4-HYDROXY-3,5,7,11-TETRAMETHYLOXACYCLODODEC-9-ENE-2,8-DIONE",,experimental,pikAIV,Type I polyketide synthase PikAIV,target,,DB07703
"6-AMINO-4-[2-(4-METHOXYPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB07704
"2,3,17BETA-TRIHYDROXY-1,3,5(10)-ESTRATRIENE",,experimental,cyaC,Adenylate cyclase,target,,DB07706
PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE,,experimental,CA2,Carbonic anhydrase 2,target,,DB07710
"(2S,3R)-3-(6-amino-9H-purin-9-yl)nonan-2-ol",,experimental,ADA,Adenosine deaminase,target,,DB07711
"(1S)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID",,experimental,MMP8,Neutrophil collagenase,target,,DB07713
"6-(3-METHYL-1,4-DIOXO-1,4-DIHYDRONAPHTHALEN-2-YL)HEXANOIC ACID",,experimental,GSR,"Glutathione reductase, mitochondrial",target,,DB07714
"(4Z)-2,8:7,12:11,15:14,18:17,22-PENTAANHYDRO-4,5,6,9,10,13,19,20,21-NONADEOXY-D-ARABINO-D-ALLO-D-ALLO-DOCOSA-4,9,20-TRIENITOL",,experimental,IGKC,Ig kappa chain C region,target,,DB07716
"(5S,8R,9S,10S,13R,14S,17S)-13-{2-[(3,5-DIFLUOROBENZYL)OXY]ETHYL}-17-HYDROXY-10-METHYLHEXADECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-3-ONE",,experimental,AR,Androgen receptor,target,,DB07717
"3(R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07719
EPIBATIDINE,,experimental,CHRFAM7A,CHRNA7-FAM7A fusion protein,target,,DB07720
DIETHYL 4-METHOXYPHENYL PHOSPHATE,,experimental,opdA,Phosphotriesterase,target,,DB07721
3-(4-NITRO-PHENOXY)-PROPAN-1-OL,,experimental,,Pol polyprotein,target,,DB07722
3-(5-methoxy-1H-indol-3-yl)propanoic acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07723
3-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzamide,,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB07729
"5-(3-HYDROXYPHENYL)ISOTHIAZOL-3(2H)-ONE 1,1-DIOXIDE",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB07730
"4-[(E)-(3,5-DIAMINO-1H-PYRAZOL-4-YL)DIAZENYL]PHENOL",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07731
"1-METHYL-3-TRIFLUOROMETHYL-1H-THIENO[2,3-C]PYRAZOLE-5-CARBOXYLIC ACID (2-MERCAPTO-ETHYL)-AMIDE",,experimental,CASP1,Caspase-1,target,,DB07733
N-(1-benzylpiperidin-4-yl)-4-sulfanylbutanamide,,experimental,BACE1,Beta-secretase 1,target,,DB07734
"N-[1-(2,6-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",,experimental,BACE1,Beta-secretase 1,target,,DB07735
(2S)-4-(4-fluorobenzyl)-N-(2-sulfanylethyl)piperazine-2-carboxamide,,experimental,BACE1,Beta-secretase 1,target,,DB07736
(2S)-4-(4-fluorobenzyl)-N-(3-sulfanylpropyl)piperazine-2-carboxamide,,experimental,BACE1,Beta-secretase 1,target,,DB07737
"N-[1-(5-bromo-2,3-dimethoxybenzyl)piperidin-4-yl]-4-sulfanylbutanamide",,experimental,BACE1,Beta-secretase 1,target,,DB07738
"(3R)-3-(FLUOROMETHYL)-7-(THIOMORPHOLIN-4-YLSULFONYL)-1,2,3,4-TETRAHYDROISOQUINOLINE",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB07739
"(3R,5S,7R,12S,13R)-13-FORMYL-12,14-DIHYDROXY-3,5,7-TRIMETHYLTETRADECANOIC ACID",,experimental,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",target,,DB07740
"4-(1R,3AS,4R,8AS,8BR)-[1-DIFLUOROMETHYL-2-(4-FLUOROBENZYL)-3-OXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZAMIDINE",,experimental,F2,Prothrombin,target,,DB07741
"N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE",,experimental,CA2,Carbonic anhydrase 2,target,,DB07742
3-[2-(2-BENZYLOXYCARBONYLAMINO-3-METHYL-BUTYRYLAMINO)-PROPIONYLAMINO]-4-OXO-PENTANOIC ACID,,experimental,CASP1,Caspase-1,target,,DB07744
3-ETHYL-6-{[(4-FLUOROPHENYL)SULFONYL]AMINO}-2-METHYLBENZOIC ACID,,experimental,METAP2,Methionine aminopeptidase 2,target,,DB07746
"(3R)-N-(4-CHLOROPHENYL)-3-(HYDROXYMETHYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB07747
2-ACETYLAMINO-4-METHYL-PENTANOIC ACID (1-FORMYL-2-PHENYL-ETHYL)-AMIDE,,experimental,CTRB1,Chymotrypsinogen B,target,,DB07749
"(2R)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07750
"(2S)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07751
N-({(1R)-1-carboxy-2-[(4-fluorobenzyl)sulfanyl]ethyl}carbamoyl)-L-glutamic acid,,experimental,FOLH1,Glutamate carboxypeptidase 2,target,,DB07754
"(2S)-1-[4-({4-[(2,5-DICHLOROPHENYL)AMINO]PYRIMIDIN-2-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07755
"1-[3-({[(4-AMINO-5-FLUORO-2-METHYLQUINOLIN-3-YL)METHYL]THIO}METHYL)PHENYL]-2,2,2-TRIFLUOROETHANE-1,1-DIOL",,experimental,ACHE,Acetylcholinesterase,target,,DB07756
"(9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one",,experimental,ESR2,Estrogen receptor beta,target,,DB07757
"5-(2,5-DICHLOROPHENYL)-2-FUROIC ACID",,experimental,map,Methionine aminopeptidase,target,,DB07758
5-[2-(TRIFLUOROMETHYL)PHENYL]-2-FUROIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB07759
"3-[(1E,7E)-8-(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl]benzoic acid",,experimental,UNG,Uracil-DNA glycosylase,target,,DB07760
"(2R)-1-[4-({6-[(2,6-DIFLUOROPHENYL)AMINO]PYRIMIDIN-4-YL}AMINO)PHENOXY]-3-(DIMETHYLAMINO)PROPAN-2-OL",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07761
4-(N-ACETYLAMINO)-3-[N-(2-ETHYLBUTANOYLAMINO)]BENZOIC ACID,,experimental,NA,Neuraminidase,target,,DB07762
FLUORESCIN,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07764
"METHYL 1-(4-{[(2,4-DIAMINOPTERIDIN-6-YL)METHYL](METHYL)AMINO}BENZOYL)PIPERIDINE-4-CARBOXYLATE",,experimental,DHRS4L1,Putative dehydrogenase/reductase SDR family member 4-like 2,target,,DB07765
S-3-(4-FLUOROPHENOXY)-2-HYDROXY-2-METHYL-N-[4-NITRO-3-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE,,experimental,AR,Androgen receptor,target,,DB07769
5-(4-FLUOROPHENYL)-3-{[(4-METHYLPHENYL)SULFONYL]AMINO}THIOPHENE-2-CARBOXYLIC ACID,,experimental,,Genome polyprotein,target,,DB07770
"(1R)-1-{[(4'-METHOXY-1,1'-BIPHENYL-4-YL)SULFONYL]AMINO}-2-METHYLPROPYLPHOSPHONIC ACID",,experimental,MMP8,Neutrophil collagenase,target,,DB07772
2-PHENYL-4H-CHROMEN-4-ONE,,experimental,ncsA,Neocarzinostatin,target,,DB07776
N-({(2S)-1-[(3R)-3-AMINO-4-(2-FLUOROPHENYL)BUTANOYL]PYRROLIDIN-2-YL}METHYL)BENZAMIDE,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07779
N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-NITRILOMETHYL-PYRIDYL]-THIOUREA,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07781
4-AMINO-2-TRIFLUOROMETHYL-5-HYDROXYMETHYLPYRIMIDINE PYROPHOSPHATE,,experimental,thiE,Thiamine-phosphate synthase,target,,DB07782
1-((1R)-1-(HYDROXYMETHYL)-3-{6-[(3-PHENYLPROPANOYL)AMINO]-1H-INDOL-1-YL}PROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE,,experimental,ADA,Adenosine deaminase,target,,DB07783
"[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID",,experimental,IGKC,Ig kappa chain C region,target,,DB07784
"1-{(1R,2S)-2-HYDROXY-1-[2-(2-NAPHTHYLOXY)ETHYL]PROPYL}-1H-IMIDAZONE-4-CARBOXAMIDE",,experimental,ADA,Adenosine deaminase,target,,DB07785
"1-((1R,2S)-1-{2-[2-(4-CHLOROPHENYL)-1,3-BENZOXAZOL-7-YL]ETHYL}-2-HYDROXYPROPYL)-1H-IMIDAZOLE-4-CARBOXAMIDE",,experimental,ADA,Adenosine deaminase,target,,DB07786
"5-FLUORO-1-[4-(4-PHENYL-3,6-DIHYDROPYRIDIN-1(2H)-YL)BUTYL]QUINAZOLINE-2,4(1H,3H)-DIONE",,experimental,PARP1,Poly [ADP-ribose] polymerase 1,target,,DB07787
"(3R,5Z,8S,9S,11E)-8,9,16-TRIHYDROXY-14-METHOXY-3-METHYL-3,4,9,10-TETRAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,7(8H)-DIONE",,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB07788
"1-[5-methyl-2-(trifluoromethyl)furan-3-yl]-3-[(2Z)-5-(2-{[6-(1H-1,2,4-triazol-3-ylamino)pyrimidin-4-yl]amino}ethyl)-1,3-thiazol-2(3H)-ylidene]urea",,experimental,PLK1,Serine/threonine-protein kinase PLK1,target,,DB07789
N-(2-METHOXYETHYL)-4-({4-[2-METHYL-1-(1-METHYLETHYL)-1H-IMIDAZOL-5-YL]PYRIMIDIN-2-YL}AMINO)BENZENESULFONAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07790
4-{[4-(1-CYCLOPROPYL-2-METHYL-1H-IMIDAZOL-5-YL)PYRIMIDIN-2-YL]AMINO}-N-METHYLBENZENESULFONAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07791
"(S)-2-CHLORO-N-(1-(2-(2-HYDROXYETHYLAMINO)-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL)-6H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB07792
"(2S)-N-[(3S)-1-(2-AMINO-2-OXOETHYL)-2-OXO-1,2,3,4-TETRAHYDROQUINOLIN-3-YL]-2-CHLORO-2H-THIENO[2,3-B]PYRROLE-5-CARBOXAMIDE",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB07793
"5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H-PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE",,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB07794
"(3ASR,4RS,8ASR,8BRS)-4-(2-(4-FLUOROBENZYL)-1,3-DIOXODEACAHYDROPYRROLO[3,4-A] PYRROLIZIN-4-YL)BENZAMIDINE",,experimental,F2,Prothrombin,target,,DB07796
N-[[3-FLUORO-4-ETHOXY-PYRID-2-YL]ETHYL]-N'-[5-CHLORO-PYRIDYL]-THIOUREA,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07797
"(3R)-3-(FLUOROMETHYL)-N-(3,3,3-TRIFLUOROPROPYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB07798
N-(2-(((5-CHLORO-2-PYRIDINYL)AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE,,experimental,F10,Coagulation factor X,target,,DB07800
N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide,,experimental,AURKA,Aurora kinase A,target,,DB07801
"3,8-DIBROMO-7-HYDROXY-4-METHYL-2H-CHROMEN-2-ONE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB07802
2-phenyl-1H-imidazole-4-carboxylic acid,,experimental,ampC,Beta-lactamase,target,,DB07803
"5-(5-CHLORO-2-THIENYL)-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1H-1,2,4-TRIAZOLE-3-SULFONAMIDE",,experimental,F10,Coagulation factor X,target,,DB07804
"3-CHLORO-2,2-DIMETHYL-N-[4-(TRIFLUOROMETHYL)PHENYL]PROPANAMIDE",,experimental,ddl,D-alanine--D-alanine ligase,target,,DB07805
"(2R,4S)-2-[(R)-BENZYLCARBAMOYL-PHENYLACETYL-METHYL]-5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07806
"(3R,4R,5R)-5-(HYDROXYMETHYL)-1-(3-PHENYLPROPYL)PIPERIDINE-3,4-DIOL",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB07807
"(1S,2R)-2-[(2,5-difluorophenyl)carbamoyl]cyclopropanecarboxylic acid",,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB07808
4-({[4-(3-METHYLBENZOYL)PYRIDIN-2-YL]AMINO}METHYL)BENZENECARBOXIMIDAMIDE,,experimental,F2,Prothrombin,target,,DB07809
"3-(4-HYDROXYPHENYL)-1-(2,4,6-TRIHYDROXYPHENYL)PROPAN-1-ONE",,experimental,ttgR,HTH-type transcriptional regulator TtgR,target,,DB07810
"N-cyclopropyl-2',6-dimethyl-4'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-3-carboxamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07811
GLYCYLALANYL-N-2-NAPHTHYL-L-PROLINEAMIDE,,experimental,ptpA,Prolyl tripeptidyl peptidase,target,,DB07813
GIBBERELLIN A3,,experimental,AADACL2,Arylacetamide deacetylase-like 2,target,,DB07814
GIBBERELLIN A4,,experimental,AADACL2,Arylacetamide deacetylase-like 2,target,,DB07815
N-(P-CYANOPHENYL)-N'-DIPHENYLMETHYL-GUANIDINE-ACETIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07816
"6-(3',5'-DIMETHYLBENZYL)-1-ETHOXYMETHYL-5-ISOPROPYLURACIL",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07820
"(1R)-1,2,2-TRIMETHYLPROPYL (S)-METHYLPHOSPHINATE",,experimental,ACHE,Acetylcholinesterase,target,,DB07822
(3S)-1-(4-acetylphenyl)-5-oxopyrrolidine-3-carboxylic acid,,experimental,ampC,Beta-lactamase,target,,DB07825
2-[4-chloro-2-(phenylcarbonyl)phenoxy]-N-phenylacetamide,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07826
"4-{[1-METHYL-2,4-DIOXO-6-(3-PHENYLPROP-1-YN-1-YL)-1,4-DIHYDROQUINAZOLIN-3(2H)-YL]METHYL}BENZOIC ACID",,experimental,MMP13,Collagenase 3,target,,DB07827
4-[3-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL]PYRIDINE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07829
"(4R,5R)-5-AMINO-1-[2-(1,3-BENZODIOXOL-5-YL)ETHYL]-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-2-ONE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07830
"2-{[(6-OXO-1,6-DIHYDROPYRIDIN-3-YL)METHYL]AMINO}-N-[4-PROPYL-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE",,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB07831
"4-{4-[(5-hydroxy-2-methylphenyl)amino]quinolin-7-yl}-1,3-thiazole-2-carbaldehyde",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07832
"N-(3-cyanophenyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)-4-biphenylcarboxamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07833
"N-(cyclopropylmethyl)-2'-methyl-5'-(5-methyl-1,3,4-oxadiazol-2-yl)biphenyl-4-carboxamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07834
"N~3~-cyclopropyl-N~4~'-(cyclopropylmethyl)-6-methylbiphenyl-3,4'-dicarboxamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07835
1-DECYL-3-TRIFLUORO ETHYL-SN-GLYCERO-2-PHOSPHOMETHANOL,,experimental,PLA2G1B,Phospholipase A2,target,,DB07836
"[4-(5-naphthalen-2-yl-1H-pyrrolo[2,3-b]pyridin-3-yl)phenyl]acetic acid",,experimental,SGK1,Serine/threonine-protein kinase Sgk1,target,,DB07837
(Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)-2-THIOXOTHIAZOLIDIN-4-ONE,,experimental,NMT2,Glycylpeptide N-tetradecanoyltransferase 2,target,,DB07838
"N~2~-1,3-BENZOXAZOL-2-YL-3-CYCLOHEXYL-N-{2-[(4-METHOXYPHENYL)AMINO]ETHYL}-L-ALANINAMIDE",,experimental,CTSS,Cathepsin S,target,,DB07839
"(E)-[4-(3,5-difluorophenyl)-3H-pyrrolo[2,3-b]pyridin-3-ylidene](3-methoxyphenyl)methanol",,experimental,FGFR1,Fibroblast growth factor receptor 1,target,,DB07840
(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB07842
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07843
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-OXOETHYL]-2-OXOPYRROLIDIN-3-YL}-1-BENZOTHIOPHENE-2-SULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07844
"2-fluoro-6-{[2-({2-methoxy-4-[(methylsulfonyl)methyl]phenyl}amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}benzamide",,experimental,MAPK8,Mitogen-activated protein kinase 8,target,,DB07845
"1S,3AS,8AS-TRIMETHYL-1-OXIDO-1,2,3,3A,8,8A-HEXAHYDROPYRROLO[2,3-B]INDOL-5-YL 2-ETHYLPHENYLCARBAMATE",,experimental,ACHE,Acetylcholinesterase,target,,DB07846
6-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-(4-MORPHOLINYL)-2-OXO ETHYL]-2-OXO-3-PYRROLIDINYL}-2-NAPHTHALENESULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07847
5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-5-CHLORO-N-{(3S)-1-[(1S)-1-METHYL-2-MORPHOLIN-4-YL-2-SULFONAMIDE,,experimental,F10,Coagulation factor X,target,,DB07848
S-NONYL-CYSTEINE,,experimental,GSTP1,Glutathione S-transferase P,target,,DB07849
"(1R,2S)-2-(5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)cyclohexanecarboxylic acid",,experimental,ampC,Beta-lactamase,target,,DB07850
"(3R,4S)-1-(3,4-DIMETHOXYPHENYL)-3-(3-METHYLPHENYL)PIPERIDIN-4-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB07851
(2R)-N-hydroxy-3-naphthalen-2-yl-2-[(naphthalen-2-ylsulfonyl)amino]propanamide,,experimental,lpxC,UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase,target,,DB07861
"7-(1-ETHYL-PROPYL)-7H-PYRROLO-[3,2-F]QUINAZOLINE-1,3-DIAMINE",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB07862
4-[(CYCLOPROPYLETHYNYL)OXY]-6-FLUORO-3-ISOPROPYLQUINOLIN-2(1H)-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07864
3-(1H-tetrazol-5-ylamino)cyclohex-2-en-1-one,,experimental,blaCTX-M-9a,Beta-lactamase,target,,DB07865
"(5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB07866
6-CHLORO-4-(CYCLOHEXYLOXY)-3-PROPYLQUINOLIN-2(1H)-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07867
6-CHLORO-4-(CYCLOHEXYLSULFANYL)-3-PROPYLQUINOLIN-2(1H)-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07868
6-CHLORO-4-(CYCLOHEXYLSULFINYL)-3-PROPYLQUINOLIN-2(1H)-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07869
(2S)-2-(4-{[3-CHLORO-5-(TRIFLUOROMETHYL)PYRIDIN-2-YL]OXY}PHENOXY)PROPANOIC ACID,,experimental,ACACB,Acetyl-CoA carboxylase 2,target,,DB07870
6-CHLORO-4-(CYCLOHEXYLOXY)-3-ISOPROPYLQUINOLIN-2(1H)-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07871
5-chloro-N-[(3R)-1-(2-{[2-fluoro-4-(2-oxopyridin-1(2H)-yl)phenyl]amino}-2-oxoethyl)pyrrolidin-3-yl]thiophene-2-carboxamide,,experimental,F10,Coagulation factor X,target,,DB07872
"(1-HYDROXYDODECANE-1,1-DIYL)BIS(PHOSPHONIC ACID)",,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB07873
"(6S)-2-amino-6-(3'-methoxybiphenyl-3-yl)-3,6-dimethyl-5,6-dihydropyrimidin-4(3H)-one",,experimental,BACE1,Beta-secretase 1,target,,DB07874
"5-Chloro-thiophene-2-carboxylic acid ((3S,4S)-1-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenylcarbamoyl]-methyl}-4-hydroxy-pyrrolidin-3-yl)-amide",,experimental,F10,Coagulation factor X,target,,DB07875
"N-[(1S)-1-{1-[(1R,3E)-1-ACETYLPENT-3-EN-1-YL]-1H-1,2,3-TRIAZOL-4-YL}-1,2-DIMETHYLPROPYL]BENZAMIDE",,experimental,CTSS,Cathepsin S,target,,DB07878
"N-hydroxy-5-[(3-phenyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)carbonyl]thiophene-2-carboxamide",,experimental,HDAC4,Histone deacetylase 4,target,,DB07879
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID,,experimental,,Streptavidin,target,,DB07880
N-{[2-({[1-(4-CARBOXYBUTANOYL)AMINO]-2-PHENYLETHYL}-HYDROXYPHOSPHINYL)OXY]ACETYL}-2-PHENYLETHYLAMINE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07881
"4-{4-[2-(1A,7A-DIMETHYL-4-OXY-OCTAHYDRO-1-OXA-4-AZA-CYCLOPROPA[A]NAPHTHALEN-4-YL) -ACETYLAMINO]-PHENYLCARBAMOYL}-BUTYRIC ACID",,experimental,IGKC,Ig kappa chain C region,target,,DB07882
(2-AMINO-3-PHENYL-BICYCLO[2.2.1]HEPT-2-YL)-PHENYL-METHANONE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB07883
"ISOPROPYL (2S)-2-ETHYL-7-FLUORO-3-OXO-3,4-DIHYDROQUINOXALINE-1(2H)-CARBOXYLATE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07884
"(S)-4-ISOPROPOXYCARBONYL-6-METHOXY-3-METHYLTHIOMETHYL-3,4-DIHYDROQUINOXALIN-2(1H)-THIONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07885
"(R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)BENZYL)GUANIDINE",,experimental,F11,Coagulation factor XI,target,,DB07887
"3-(4-HYDROXYPHENYL)-4,5-DIHYDRO-5-ISOXAZOLE-ACETIC ACID METHYL ESTER",,experimental,MIF,Macrophage migration inhibitory factor,target,,DB07888
"1-(DIMETHYLAMINO)-3-(4-{{4-(2-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO}PHENOXY)PROPAN-2-OL",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07889
1-(2-HYDROXYETHYLOXYMETHYL)-6-PHENYL THIOTHYMINE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07892
PHENYL[1-(N-SUCCINYLAMINO)PENTYL]PHOSPHONATE,,experimental,IGKC,Ig kappa chain C region,target,,DB07893
(2S)-hydroxy(4-hydroxyphenyl)ethanoic acid,,experimental,,4-hydroxymandelate synthase,target,,DB07896
1-(HYDROXYMETHYLENEAMINO)-8-HYDROXY-OCTANE,,experimental,F2,Prothrombin,target,,DB07897
2-(BUTYRYLOXY)-1-{[(TETRAHYDROXYPHOSPHORANYL)OXY]METHYL}ETHYL BUTYRATE,,experimental,,Phospholipase D,target,,DB07898
(2S) N-ACETYL-L-ALANYL-ALPHAL-PHENYLALANYL-CHLOROETHYLKETONE,,experimental,CTRB1,Chymotrypsinogen B,target,,DB07899
3-FORMYL-2-HYDROXY-5-METHYL-HEXANOIC ACID HYDROXYAMIDE,,experimental,MMP8,Neutrophil collagenase,target,,DB07900
5-CHLORO-6-METHYL-N-(2-PHENYLETHYL)-2-PYRIDIN-2-YLPYRIMIDIN-4-AMINE,,experimental,METAP1,Methionine aminopeptidase 1,target,,DB07901
"TERT-BUTYL {2-[(1,3-THIAZOL-2-YLAMINO)CARBONYL]PYRIDIN-3-YL}CARBAMATE",,experimental,METAP1,Methionine aminopeptidase 1,target,,DB07902
"3-[(2,2-DIMETHYLPROPANOYL)AMINO]-N-1,3-THIAZOL-2-YLPYRIDINE-2-CARBOXAMIDE",,experimental,METAP1,Methionine aminopeptidase 1,target,,DB07903
"(1aR,8S,13S,14S,15aR)-5,13,14-trihydroxy-3-methoxy-8-methyl-8,9,13,14,15,15a-hexahydro-6H-oxireno[k][2]benzoxacyclotetradecine-6,12(1aH)-dione",,experimental,MAPK1,Mitogen-activated protein kinase 1,target,,DB07905
"[(3R)-7-NITRO-1,2,3,4-TETRAHYDROISOQUINOLIN-3-YL]METHANOL",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB07906
7-HYDROXY-4-METHYL-3-(2-HYDROXY-ETHYL)COUMARIN,,experimental,PFN1,Profilin-1,target,,DB07908
2-OXOHEPTYLPHOSPHONIC ACID,,experimental,ENOPH1,Enolase-phosphatase E1,target,,DB07912
HOMOPHENYLALANINYLMETHANE,,experimental,CTSF,Cathepsin F,target,,DB07913
"(2E,4E)-2-HYDROXY-6-OXO-6-PHENYLHEXA-2,4-DIENOIC ACID",,experimental,bphD,"2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoate hydrolase",target,,DB07915
3-{6-[(8-HYDROXY-QUINOLINE-2-CARBONYL)-AMINO]-2-THIOPHEN-2-YL-HEXANOYLAMINO}-4-OXO-BUTYRI ACID,,experimental,CASP1,Caspase-1,target,,DB07916
4-(BENZHYDRYLOXY)-1-[3-(1H-TETRAAZOL-5-YL)PROPYL]PIPERIDINE,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB07917
7-METHOXY-1-METHYL-9H-BETA-CARBOLINE,,experimental,MAOA,Amine oxidase [flavin-containing] A,target,,DB07919
N-oxo-2-[(4-phenylphenyl)sulfonylamino]ethanamide,,experimental,MMP12,Macrophage metalloelastase,target,,DB07920
2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide,,experimental,MMP12,Macrophage metalloelastase,target,,DB07921
N-oxo-2-(phenylsulfonylamino)ethanamide,,experimental,MMP12,Macrophage metalloelastase,target,,DB07922
octyl alpha-L-altropyranoside,,experimental,aqpZ,Aquaporin Z,target,,DB07923
octyl beta-D-galactopyranoside,,experimental,aqpZ,Aquaporin Z,target,,DB07924
N-[3-(N'-HYDROXYCARBOXAMIDO)-2-(2-METHYLPROPYL)-PROPANOYL]-O-TYROSINE-N-METHYLAMIDE,,experimental,MMP1,Interstitial collagenase,target,,DB07926
3-{[(4-CARBOXY-2-HYDROXYANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID,,experimental,ampC,Beta-lactamase,target,,DB07927
N-(2-OXOTETRAHYDROFURAN-3-YL)OCTANAMIDE,,experimental,sdiA,Regulatory protein SdiA,target,,DB07928
(3R)-3-HYDROXYDODECANOIC ACID,,experimental,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,target,,DB07930
"4-[(1R,2S)-1-ethyl-2-(4-hydroxyphenyl)butyl]phenol",,experimental,AKR1C1,Aldo-keto reductase family 1 member C1,target,,DB07931
[[CYCLOHEXANESULFONYL-GLYCYL]-3[PYRIDIN-4-YL-AMINOMETHYL]ALANYL]PIPERIDINE,,experimental,F2,Prothrombin,target,,DB07934
"5-[(5-fluoro-3-methyl-1H-indazol-4-yl)oxy]benzene-1,3-dicarbonitrile",,experimental,pol,Reverse transcriptase/RNaseH,target,,DB07935
N-(4-{[(3S)-3-(dimethylamino)pyrrolidin-1-yl]carbonyl}phenyl)-5-fluoro-4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-amine,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07936
"2-butoxy-9-(2,6-difluorobenzyl)-N-(2-morpholin-4-ylethyl)-9H-purin-6-amine",,experimental,murI,Glutamate racemase,target,,DB07937
"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-chroman-5-yl]methyl]pyrimidine-2,4-diamine",,experimental,folA,Dihydrofolate reductase,target,,DB07938
N-(3-MERCAPTOPROPANOYL)-D-ALANINE,,experimental,,Metallo-beta-lactamase L1,target,,DB07939
"9-(3-IODOBENZYLAMINO)-1,2,3,4-TETRAHYDROACRIDINE",,experimental,BCHE,Cholinesterase,target,,DB07940
"3-{3-bromo-4-[(2,4-difluorobenzyl)oxy]-6-methyl-2-oxopyridin-1(2H)-yl}-N,4-dimethylbenzamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07941
2-fluoro-4-[4-(4-fluorophenyl)-1H-pyrazol-3-yl]pyridine,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07942
2-{4-[5-(4-chlorophenyl)-4-pyrimidin-4-yl-1H-pyrazol-3-yl]piperidin-1-yl}-2-oxoethanol,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB07943
N-{3-METHYL-5-[2-(PYRIDIN-4-YLAMINO)-ETHOXY]-PHENYL}-BENZENESULFONAMIDE,,experimental,F2,Prothrombin,target,,DB07944
"N-[2-({[amino(imino)methyl]amino}oxy)ethyl]-2-{6-chloro-3-[(2,2-difluoro-2-phenylethyl)amino]-2-fluorophenyl}acetamide",,experimental,F2,Prothrombin,target,,DB07946
"({[(3E)-2'-OXO-2',7'-DIHYDRO-2,3'-BIINDOL-3(7H)-YLIDENE]AMINO}OXY)ACETIC ACID",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB07949
(2-BROMOETHYL)(2-'FORMYL-4'-AMINOPHENYL) ACETATE,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB07955
[1-(3-CHLORO-2-FORMYL-PHENYLCARBAMOYL)-2-METHYL-PROPYL]-CARBAMIC ACID TERT-BUTYL ESTER,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB07956
METHYL(2-ACETOXY-2-(2-CARBOXY-4-AMINO-PHENYL))ACETATE,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB07957
(2-CARBAMOYLMETHYL-5-PROPYL-OCTAHYDRO-INDOL-7-YL)ACETIC ACID,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB07958
3-(1H-BENZIMIDAZOL-2-YL)-1H-INDAZOLE,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB07959
"5-ACETAMIDO-5,6-DIHYDRO-4-HYDROXY-6-ISOBUTOXY-4H-PYRAN-2-CARBOXYLIC ACID",,experimental,NEU2,Sialidase-2,target,,DB07960
"1-(4-CYANO-PHENYL)-3-[2-(2,6-DICHLORO-PHENYL)-1-IMINO-ETHYL]-THIOUREA",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB07961
"(3S)-4-{[4-(BUT-2-YNYLOXY)PHENYL]SULFONYL}-N-HYDROXY-2,2-DIMETHYLTHIOMORPHOLINE-3-CARBOXAMIDE",,experimental,ADAM17,Disintegrin and metalloproteinase domain-containing protein 17,target,,DB07964
6-(CYCLOHEXYLAMINO)-9-[2-(4-METHYLPIPERAZIN-1-YL)-ETHYL]-9H-PURINE-2-CARBONITRILE,,experimental,CTSK,Cathepsin K,target,,DB07965
[4-({4-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl}amino)phenyl]acetonitrile,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB07966
9-CYCLOPENTYL-6-[2-(3-IMIDAZOL-1-YL-PROPOXY)-PHENYLAMINO]-9H-PURINE-2-CARBONITRILE,,experimental,CTSK,Cathepsin K,target,,DB07967
N-(2-CHLORO-4-FLUOROBENZOYL)-N'-(5-HYDROXY-2-METHOXYPHENYL)UREA,,experimental,PYGL,"Glycogen phosphorylase, liver form",target,,DB07968
3-[3-(4-methylpiperazin-1-yl)-7-(trifluoromethyl)quinoxalin-5-yl]phenol,,experimental,MET,Hepatocyte growth factor receptor,target,,DB07969
5-[(2-methyl-5-{[3-(trifluoromethyl)phenyl]carbamoyl}phenyl)amino]pyridine-3-carboxamide,,experimental,EPHA7,Ephrin type-A receptor 7,target,,DB07970
"5-AMINO-2-{4-[(4-AMINOPHENYL)SULFANYL]PHENYL}-1H-ISOINDOLE-1,3(2H)-DIONE",,experimental,cyp130,Cytochrome P450 130,target,,DB07971
1-(3-METHYLPHENYL)-1H-BENZIMIDAZOL-5-AMINE,,experimental,cyp130,Cytochrome P450 130,target,,DB07972
N-(1-ISOPROPYLPIPERIDIN-4-YL)-1-(3-METHOXYBENZYL)-1H-INDOLE-2-CARBOXAMIDE,,experimental,F10,Coagulation factor X,target,,DB07973
1-{2-[(4-CHLOROPHENYL)AMINO]-2-OXOETHYL}-N-(1-ISOPROPYLPIPERIDIN-4-YL)-1H-INDOLE-2-CARBOXAMIDE,,experimental,F10,Coagulation factor X,target,,DB07974
"2-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07975
3-{[(3-FLUORO-3'-METHOXYBIPHENYL-4-YL)AMINO]CARBONYL}THIOPHENE-2-CARBOXYLIC ACID,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07976
"3-({[3,5-DIFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)THIOPHENE-2-CARBOXYLIC ACID",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07977
"2-({[2,3,5,6-TETRAFLUORO-3'-(TRIFLUOROMETHOXY)BIPHENYL-4-YL]AMINO}CARBONYL)CYCLOPENTA-1,3-DIENE-1-CARBOXYLIC ACID",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB07978
"(2E)-3-(3,4-DIHYDROXYPHENYL)-2-IMINOPROPANOIC ACID",,experimental,DAO,D-amino-acid oxidase,target,,DB07979
(2E)-1-[(6-chloropyridin-3-yl)methyl]-N-nitroimidazolidin-2-imine,,experimental,CHRFAM7A,CHRNA7-FAM7A fusion protein,target,,DB07980
2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1R)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB07981
2-{4-[4-({4-[2-methyl-1-(1-methylethyl)-1H-imidazol-5-yl]pyrimidin-2-yl}amino)phenyl]piperazin-1-yl}-2-oxoethanol,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB07982
1-(4-IODOBENZOYL)-5-METHOXY-2-METHYL INDOLE-3-ACETIC ACID,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB07983
2-[1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL]-N-[(1S)-1-(HYDROXYMETHYL)PROPYL]ACETAMIDE,,experimental,PTGS1,Prostaglandin G/H synthase 1,target,,DB07984
+/-METHYL 4-(AMINOIMINOMETHYL)-BETA-[3- INH (AMINOIMINO)PHENYL]BENZENE PENTANOATE,,experimental,PRSS1,Trypsin-1,target,,DB07985
[4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID,,experimental,MMP3,Stromelysin-1,target,,DB07986
"[2-(5-MERCAPTO-[1,3,4]THIADIAZOL-2-YLCARBAMOYL)-1-PHENYL-ETHYL]-CARBAMIC ACID BENZYL ESTER",,experimental,MMP3,Stromelysin-1,target,,DB07987
"2-[3-(5-MERCAPTO-[1,3,4]THIADIAZOL-2YL)-UREIDO]-N-METHYL-3-PENTAFLUOROPHENYL-PROPIONAMIDE",,experimental,MMP3,Stromelysin-1,target,,DB07988
2-(ACETYL-HYDROXY-AMINO)-4-METHYL-PENTANOIC ACID METHYL ESTER,,experimental,npr,Thermolysin,target,,DB07989
"(RP,SP)-O-(2R)-(1-PHENOXYBUT-2-YL)-METHYLPHOSPHONIC ACID CHLORIDE",,experimental,lipA,Lipase,target,,DB07990
N-[(1R)-3-(4-HYDROXYPHENYL)-1-METHYLPROPYL]-2-(2-PHENYL-1H-INDOL-3-YL)ACETAMIDE,,experimental,ESR1,Estrogen receptor,target,,DB07991
"N~3~-[3-(1H-INDOL-6-YL)BENZYL]PYRIDINE-2,3-DIAMINE",,experimental,BACE1,Beta-secretase 1,target,,DB07993
"N~3~-[5-(1H-INDOL-6-YL)-2-(PYRIDIN-2-YLMETHOXY)BENZYL]PYRIDINE-2,3-DIAMINE",,experimental,BACE1,Beta-secretase 1,target,,DB07994
"{4-[(CARBOXYMETHOXY)CARBONYL]-3,3-DIOXIDO-1-OXONAPHTHO[1,2-D]ISOTHIAZOL-2(1H)-YL}ACETIC ACID",,experimental,AKR1B1,Aldose reductase,target,,DB07999
"2-(CARBOXYMETHYL)-1-OXO-1,2-DIHYDRONAPHTHO[1,2-D]ISOTHIAZOLE-4-CARBOXYLIC ACID 3,3-DIOXIDE",,experimental,AKR1B1,Aldose reductase,target,,DB08000
5-(3-{3-[3-HYDROXY-2-(METHOXYCARBONYL)PHENOXY]PROPENYL}PHENYL)-4-(HYDROXYMETHYL)ISOXAZOLE-3-CARBOXYLIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08001
ISOTHIAZOLIDINONE ANALOG,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08003
"(2S)-2-{[3-(3-aminophenyl)imidazo[1,2-b]pyridazin-6-yl]amino}-3-methylbutan-1-ol",,experimental,GSG2,Serine/threonine-protein kinase haspin,target,,DB08004
4-{[5-chloro-4-(1H-indol-3-yl)pyrimidin-2-yl]amino}-N-ethylpiperidine-1-carboxamide,,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08005
"N-anthracen-2-yl-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-amine",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB08006
(2R)-3-{[(BENZYLAMINO)CARBONYL]AMINO}-2-HYDROXYPROPANOIC ACID,,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB08007
"5-methyl-N-[4-(trifluoromethyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine",,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB08008
"5-[(E)-(5-CHLORO-2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]-N-[2-(DIETHYLAMINO)ETHYL]-2,4-DIMETHYL-1H-PYRROLE-3-CARBOXAMIDE",,experimental,CAMK1G,Calcium/calmodulin-dependent protein kinase type 1G,target,,DB08009
"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-[(E)-2-phenylethenyl]-1H-indole-2,3-dione 3-oxime",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08010
"(3E)-5-fluoro-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-1H-indole-2,3-dione 3-oxime",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08011
"(3Z)-1-[(6-fluoro-4H-1,3-benzodioxin-8-yl)methyl]-4-phenyl-1H-indole-2,3-dione 3-oxime",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08015
"4-(6-CHLORO-2,4-DIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL) BUTYL PHOSPHATE",,experimental,ribH,"6,7-dimethyl-8-ribityllumazine synthase",target,,DB08016
5-bromo-N-(3-chloro-2-(4-(prop-2-ynyl)piperazin-1-yl)phenyl)furan-2-carboxamide,,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08021
"(2S)-1,3-benzothiazol-2-yl{2-[(2-pyridin-3-ylethyl)amino]pyrimidin-4-yl}ethanenitrile",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08022
"N-cyclohexyl-4-imidazo[1,2-a]pyridin-3-yl-N-methylpyrimidin-2-amine",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08023
1-[2-(S)-AMINO-3-BIPHENYL-4-YL-PROPIONYL]-PYRROLIDINE-2-(S)-CARBONITRILE,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08024
"N-{2'-[(4-FLUOROPHENYL)AMINO]-4,4'-BIPYRIDIN-2-YL}-4-METHOXYCYCLOHEXANECARBOXAMIDE",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08025
"2-{4-[(4-imidazo[1,2-a]pyridin-3-ylpyrimidin-2-yl)amino]piperidin-1-yl}-N-methylacetamide",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08026
1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08027
"BUT-3-ENYL-[5-(4-CHLORO-PHENYL)-3,6-DIHYDRO-[1,3,4]THIADIAZIN-2-YLIDENE]-AMINE",,experimental,MMP8,Neutrophil collagenase,target,,DB08028
N~2~-(biphenyl-4-ylsulfonyl)-N-hydroxy-N~2~-(2-hydroxyethyl)glycinamide,,experimental,MMP3,Stromelysin-1,target,,DB08029
3-[(4'-cyanobiphenyl-4-yl)oxy]-N-hydroxypropanamide,,experimental,MMP3,Stromelysin-1,target,,DB08030
"N-[(13-CYCLOHEXYL-6,7-DIHYDROINDOLO[1,2-D][1,4]BENZOXAZEPIN-10-YL)CARBONYL]-2-METHYL-L-ALANINE",,experimental,,Genome polyprotein,target,,DB08031
"N,N-DIETHYL-2-[(2-THIENYLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08032
"(5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2-YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1-BENZOTHIOPHENE-3-CARBOXAMIDE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08033
"(E)-3,4-DIHYDROXY-N'-[(2-METHOXYNAPHTHALEN-1-YL)METHYLENE]BENZOHYDRAZIDE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08034
"1-TERT-BUTYL-3-(2,5-DIMETHYLBENZYL)-1H-PYRAZOLO[3,4-D]PYRIMIDIN-4-AMINE",,experimental,AR,Androgen receptor,target,,DB08035
"6,7,12,13-tetrahydro-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazol-5-one",,experimental,rbmD,Putative FAD-monooxygenase,target,,DB08036
"(2S)-4-(2,5-difluorophenyl)-N-[(3R,4S)-3-fluoro-1-methylpiperidin-4-yl]-2-(hydroxymethyl)-N-methyl-2-phenyl-2,5-dihydro-1H-pyrrole-1-carboxamide",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08037
"L-alanyl-N-[(1S,2R)-1-benzyl-2-hydroxypropyl]-L-alaninamide",,experimental,KLK7,Kallikrein-7,target,,DB08038
N-[(2R)-2-benzyl-4-(hydroxyamino)-4-oxobutanoyl]-L-alanine,,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB08040
3-BENZYLOXYCARBONYLAMINO-2-HYDROXY-4-PHENYL-BUTYRIC ACID,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08041
"N~4~-methyl-N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB08042
1-[4-(PYRIDIN-4-YLOXY)PHENYL]-3-[3-(TRIFLUOROMETHYL)PHENYL]UREA,,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB08043
"(1S,6R)-3-{[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]CARBONYL}-6-(2,4,5-TRIFLUOROPHENYL)CYCLOHEX-3-EN-1-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08044
"4-{4-[4-(3-AMINOPROPOXY)PHENYL]-1H-PYRAZOL-5-YL}-6-CHLOROBENZENE-1,3-DIOL",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08045
2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB08046
"7,8-dihydroxy-4-phenyl-2H-chromen-2-one",,experimental,COMT,Catechol O-methyltransferase,target,,DB08049
5-PHENYL-2-KETO-VALERIC ACID,,experimental,ipdC,Indole-3-pyruvate decarboxylase,target,,DB08050
"(2R)-4-(2-BENZOYL-1,2-DIAZEPAN-1-YL)-4-OXO-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08051
"1-cyclopentyl-3-(1H-pyrrolo[2,3-b]pyridin-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB08052
"1-cyclobutyl-3-(3,4-dimethoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB08053
"1-(1-methylethyl)-3-quinolin-6-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB08054
"N-(2-chlorophenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB08055
"N-(2,6-dimethylphenyl)-5-phenylimidazo[1,5-a]pyrazin-8-amine",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB08056
"N-(2-chloro-6-methylphenyl)-8-[(3S)-3-methylpiperazin-1-yl]imidazo[1,5-a]quinoxalin-4-amine",,experimental,LCK,Tyrosine-protein kinase Lck,target,,DB08057
"4-[3-(1,4-diazepan-1-ylcarbonyl)-4-fluorobenzyl]phthalazin-1(2H)-one",,experimental,PARP3,Poly [ADP-ribose] polymerase 3,target,,DB08058
4-(2-AMINOPHENYL)-4-OXOBUTANOIC ACID,,experimental,AGXT,Serine--pyruvate aminotransferase,target,,DB08060
4-[3-(4-CHLOROPHENYL)-1H-PYRAZOL-5-YL]PIPERIDINE,,experimental,F2,Prothrombin,target,,DB08061
"3-(4-CHLOROPHENYL)-5-(METHYLTHIO)-4H-1,2,4-TRIAZOLE",,experimental,F2,Prothrombin,target,,DB08062
N-(3-TERT-BUTYL-1H-PYRAZOL-5-YL)-N'-{4-CHLORO-3-[(PYRIDIN-3-YLOXY)METHYL]PHENYL}UREA,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08064
2-(1H-pyrazol-3-yl)-1H-benzimidazole,,experimental,AURKA,Aurora kinase A,target,,DB08065
4-[(2-{4-[(CYCLOPROPYLCARBAMOYL)AMINO]-1H-PYRAZOL-3-YL}-1H-BENZIMIDAZOL-6-YL)METHYL]MORPHOLIN-4-IUM,,experimental,JAK2,Tyrosine-protein kinase JAK2,target,,DB08067
N-[4-CHLORO-3-(PYRIDIN-3-YLOXYMETHYL)-PHENYL]-3-FLUORO-,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08068
"4-AMINO-5-(2-METHYLPHENYL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOLE-3-THIONE",,experimental,,Metallo-beta-lactamase L1,target,,DB08069
"(2S)-1-methyl-2-[(2S,4R)-2-methyl-4-phenylpentyl]piperidine",,experimental,lat,Probable L-lysine-epsilon aminotransferase,target,,DB08071
"4-(2-AMINOETHOXY)-3,5-DICHLORO-N-[3-(1-METHYLETHOXY)PHENYL]BENZAMIDE",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB08072
3-(3-methylbut-2-en-1-yl)-3H-purin-6-amine,,experimental,accC,Biotin carboxylase,target,,DB08074
"4-(2-amino-1,3-thiazol-4-yl)pyrimidin-2-amine",,experimental,accC,Biotin carboxylase,target,,DB08075
"4-[1-(2,6-dichlorobenzyl)-2-methyl-1H-imidazol-4-yl]pyrimidin-2-amine",,experimental,accC,Biotin carboxylase,target,,DB08076
{4-[3-(4-acetyl-3-hydroxy-2-propylphenoxy)propoxy]phenoxy}acetic acid,,experimental,PPARD,Peroxisome proliferator-activated receptor delta,target,,DB08078
"7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline",,experimental,,Met proto-oncogene variant,target,,DB08079
N-(2-AMINOETHYL)-P-CHLOROBENZAMIDE,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB08082
"2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide",,experimental,CA2,Carbonic anhydrase 2,target,,DB08083
IDD594,,experimental,AKR1B1,Aldose reductase,target,,DB08084
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE,,experimental,THRB,Thyroid hormone receptor beta,target,,DB08085
N-[12-(1H-imidazol-1-yl)dodecanoyl]-L-leucine,,experimental,CYP102A1,Bifunctional P-450/NADPH-P450 reductase,target,,DB08086
"4-[(7R,7AS)-7-HYDROXY-1,3-DIOXOTETRAHYDRO-1H-PYRROLO[1,2-C]IMIDAZOL-2(3H)-YL]-1-NAPHTHONITRILE",,experimental,AR,Androgen receptor,target,,DB08087
"2-chloro-4-{[(1R,3Z,7S,7aS)-7-hydroxy-1-(trifluoromethyl)tetrahydro-1H-pyrrolo[1,2-c][1,3]oxazol-3-ylidene]amino}-3-methylbenzonitrile",,experimental,AR,Androgen receptor,target,,DB08088
"6-[BIS(2,2,2-TRIFLUOROETHYL)AMINO]-4-(TRIFLUOROMETHYL)QUINOLIN-2(1H)-ONE",,experimental,AR,Androgen receptor,target,,DB08089
"(3Z,5S,6R,7S,8R,8aR)-3-(octylimino)hexahydro[1,3]oxazolo[3,4-a]pyridine-5,6,7,8-tetrol",,experimental,bglA,Beta-glucosidase A,target,,DB08090
3-FLUORO-5-MORPHOLIN-4-YL-N-[3-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-5-YL]BENZAMIDE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08091
3-FLUORO-N-1H-INDOL-5-YL-5-MORPHOLIN-4-YLBENZAMIDE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08092
3-(1-NAPHTHYLMETHOXY)PYRIDIN-2-AMINE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08093
"(4-AMINO-2-{[1-(METHYLSULFONYL)PIPERIDIN-4-YL]AMINO}PYRIMIDIN-5-YL)(2,3-DIFLUORO-6-METHOXYPHENYL)METHANONE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08094
"3-(2-CHLOROPHENYL)-1-(2-{[(1S)-2-HYDROXY-1,2-DIMETHYLPROPYL]AMINO}PYRIMIDIN-4-YL)-1-(4-METHOXYPHENYL)UREA",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08095
"8-(2-CHLOROPHENYLAMINO)-2-(2,6-DIFLUOROPHENYLAMINO)-9-ETHYL-9H-PURINE-1,7-DIIUM",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08096
"2-(2,6-DIFLUOROPHENOXY)-N-(2-FLUOROPHENYL)-9-ISOPROPYL-9H-PURIN-8-AMINE",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08097
"{[5-(5-NITRO-2-FURYL)-1,3,4-OXADIAZOL-2-YL]THIO}ACETIC ACID",,experimental,AKR1B1,Aldose reductase,target,,DB08098
"6-ETHYL-5-[(2S)-1-(3-METHOXYPROPYL)-2-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-7-YL]PYRIMIDINE-2,4-DIAMINE",,experimental,REN,Renin,target,,DB08099
N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-L-GLUTAMIC ACID,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB08105
N-[(6-BUTOXYNAPHTHALEN-2-YL)SULFONYL]-D-GLUTAMIC ACID,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB08106
N-{[6-(PENTYLOXY)NAPHTHALEN-2-YL]SULFONYL}-D-GLUTAMIC ACID,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB08107
N-({6-[(4-CYANOBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB08108
"(1S,4R,7AR)-4-BUTOXY-1-[(1R)-1-FORMYLPROPYL]-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",,experimental,ampC,Beta-lactamase,target,,DB08109
"(1R,4S,7AS)-1-(1-FORMYLPROP-1-EN-1-YL)-4-METHOXY-2,4,5,6,7,7A-HEXAHYDRO-1H-ISOINDOLE-3-CARBOXYLIC ACID",,experimental,ampC,Beta-lactamase,target,,DB08110
"4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl]phenol",,experimental,,Met proto-oncogene variant,target,,DB08111
N-({6-[(4-CYANO-2-FLUOROBENZYL)OXY]NAPHTHALEN-2-YL}SULFONYL)-D-GLUTAMIC ACID,,experimental,murD,UDP-N-acetylmuramoylalanine--D-glutamate ligase,target,,DB08112
2-aminoethyl naphthalen-1-ylacetate,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08115
"(3R)-4-{[(3,4-dihydroxyphenyl)acetyl]oxy}-N-(2-formylindolizin-3-yl)-3-sulfino-D-valine",,experimental,bla,Beta-lactamase SHV-1,target,,DB08116
"2-(methylamino)-N-(4-methyl-1,3-thiazol-2-yl)-5-[(4-methyl-4H-1,2,4-triazol-3-yl)sulfanyl]benzamide",,experimental,GCK,Glucokinase,target,,DB08118
"1,1,1-TRIFLUORO-3-((N-ACETYL)-L-LEUCYLAMIDO)-4-PHENYL-BUTAN-2-ONE(N-ACETYL-L-LEUCYL-L-PHENYLALANYL TRIFLUOROMETHYL KETONE)",,experimental,CTRB1,Chymotrypsinogen B,target,,DB08119
"6,8-DIMERCAPTO-OCTANOIC ACID AMIDE",,experimental,,Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex,target,,DB08120
(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB08121
"N-METHYL-4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08122
"N-METHYL-{4-[2-(7-OXO-6,7-DIHYDRO-8H-[1,3]THIAZOLO[5,4-E]INDOL-8-YLIDENE)HYDRAZINO]PHENYL}METHANESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08123
"3-{[(2,2-DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08124
"4-{[(2-OXO-1,2-DIHYDRO-3H-INDOL-3-YLIDENE)METHYL]AMINO}-N-(1,3-THIAZOL-2-YL)BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08125
"3-{[4-([AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08126
"(1S,4R,9S)-5-(trifluoromethyl)-1,2,3,4-tetrahydro-1,4-methanonaphthalen-9-amine",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB08128
(1R)-2-amino-1-[3-(trifluoromethyl)phenyl]ethanol,,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB08129
"N-(5-{3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]phenyl}-1,3,4-oxadiazol-2-yl)ethane-1,2-diamine",,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB08130
"2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-3-METHYL-BUTYRIC ACID",,experimental,thyA,Thymidylate synthase,target,,DB08131
5-hydroxynaphthalene-1-sulfonamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08132
N-(4-sulfamoylphenyl)-1H-indazole-3-carboxamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08133
4-[(6-chloropyrazin-2-yl)amino]benzenesulfonamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08134
N-phenyl-1H-pyrazole-3-carboxamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08135
4-(acetylamino)-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08136
(4E)-N-(4-fluorophenyl)-4-[(phenylcarbonyl)imino]-4H-pyrazole-3-carboxamide,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08137
"{[(2,6-difluorophenyl)carbonyl]amino}-N-(4-fluorophenyl)-1H-pyrazole-3-carboxamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08138
"5-chloro-7-[(1-methylethyl)amino]pyrazolo[1,5-a]pyrimidine-3-carbonitrile",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08139
"5-[(4-AMINOCYCLOHEXYL)AMINO]-7-(PROPAN-2-YLAMINO)PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBONITRILE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08140
"4-{[(2,6-difluorophenyl)carbonyl]amino}-N-[(3S)-piperidin-3-yl]-1H-pyrazole-3-carboxamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08141
"4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08142
"5-CHLORO-THIOPHENE-2-CARBOXYLIC ACID ((3S,4S)-4-FLUORO- 1-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYLCARBAMOYL]-METHYL}-PYRROLIDIN-3-YL)-AMIDE",,experimental,F10,Coagulation factor X,target,,DB08143
"6-(2,6-dibromophenyl)pyrido[2,3-d]pyrimidine-2,7-diamine",,experimental,accC,Biotin carboxylase,target,,DB08144
"6-(2,6-DIMETHOXYPHENYL)PYRIDO[2,3-D]PYRIMIDINE-2,7-DIAMINE",,experimental,accC,Biotin carboxylase,target,,DB08145
"7-(2,5-dihydropyrrol-1-yl)-6-phenyl-pyrido[6,5-d]pyrimidin-2-amine",,experimental,accC,Biotin carboxylase,target,,DB08146
"4-[3-(dibenzylamino)phenyl]-2,4-dioxobutanoic acid",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08147
"(5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-phenyl-1,6-dioxa-2-azaspiro[4.5]dec-2-ene-8,9,10-triol",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB08151
{(2S)-1-[N-(tert-butoxycarbonyl)glycyl]pyrrolidin-2-yl}methyl (3-chlorophenyl)acetate,,experimental,F2,Prothrombin,target,,DB08152
"(5E)-14-CHLORO-15,17-DIHYDROXY-4,7,8,9,10,11-HEXAHYDRO-2-BENZOXACYCLOPENTADECINE-1,12(3H,13H)-DIONE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08153
3-chloro-5-[2-chloro-5-(1H-indazol-3-ylmethoxy)phenoxy]benzonitrile,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08154
"2,4-DINITROPHENYL 2-DEOXY-2-FLUORO-BETA-D-MANNOPYRANOSIDE",,experimental,BT_0458,Beta-mannosidase,target,,DB08158
"4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE",,experimental,TOP1,DNA topoisomerase 1,target,,DB08159
"(2S)-2-AMINO-4-(METHYLSULFANYL)-1-(1,3-THIAZOL-2-YL)BUTANE-1,1-DIOL",,experimental,map,Methionine aminopeptidase,target,,DB08160
(S)-2-(MERCAPTOMETHYL)-5-PHENYLPENTANOIC ACID,,experimental,VIM-2,Class B carbapenemase VIM-2,target,,DB08161
5'-{[4-(aminooxy)butyl](methyl)amino}-5'-deoxy-8-ethenyladenosine,,experimental,AMD1,S-adenosylmethionine decarboxylase proenzyme,target,,DB08163
"(3R,4R)-1-{6-[3-(METHYLSULFONYL)PHENYL]PYRIMIDIN-4-YL}-4-(2,4,5-TRIFLUOROPHENYL)PIPERIDIN-3-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08164
indane-5-sulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB08165
"(4R)-7-chloro-9-methyl-1-oxo-1,2,4,9-tetrahydrospiro[beta-carboline-3,4'-piperidine]-4-carbonitrile",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08166
(2Z)-N-biphenyl-4-yl-2-cyano-3-cyclopropyl-3-hydroxyprop-2-enamide,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB08169
"(1R)-N,6-DIHYDROXY-7-METHOXY-2-[(4-METHOXYPHENYL)SULFONYL]-1,2,3,4-TETRAHYDROISOQUINOLINE-1-CARBOXAMIDE",,experimental,MMP7,Matrilysin,target,,DB08170
11-MERCAPTOUNDECANOIC ACID,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB08171
(2Z)-N-(3-chloro-2'-methoxybiphenyl-4-yl)-2-cyano-3-hydroxybut-2-enamide,,experimental,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,,DB08172
5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE,,experimental,F10,Coagulation factor X,target,,DB08173
"5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL)THIOPHENE-2-CARBOXAMIDE",,experimental,F10,Coagulation factor X,target,,DB08174
(1Z)-4-(4-FLUOROPHENYL)-2-METHYLIDENEBUTAN-1-IMINE,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB08176
(E)-3-(5((5-(4-CHLOROPHENYL)FURAN-2-YL)METHYLENE)-4-OXO-2-THIOXOTHIAZOLIDIN-3-YL)PROPANOIC ACID,,experimental,lef,Lethal factor,target,,DB08177
"methyl 4-(2,3-dihydroxy-5-methylphenoxy)-2-hydroxy-6-methylbenzoate",,experimental,GLO1,Lactoylglutathione lyase,target,,DB08179
2-((3'-METHYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,,experimental,,Streptavidin,target,,DB08181
2-(2-METHYLPHENYL)-1H-INDOLE-5-CARBOXIMIDAMIDE,,experimental,PRSS1,Trypsin-1,target,,DB08184
(3E)-4-(1-METHYL-1H-INDOL-3-YL)BUT-3-EN-2-ONE,,experimental,KAT2B,Histone acetyltransferase KAT2B,target,,DB08186
METHYL-PHE-PRO-AMINO-CYCLOHEXYLGLYCINE,,experimental,F2,Prothrombin,target,,DB08187
6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08188
N-[2-(2-iodo-5-methoxy-1H-indol-3-yl)ethyl]acetamide,,experimental,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB08190
"4-(5-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)benzoic acid",,experimental,SGK1,Serine/threonine-protein kinase Sgk1,target,,DB08191
2-(4-CARCOXY-5-ISOPROPYLTHIAZOLYL)BENZOPIPERIDINE,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB08192
2-(3-NITROPHENYL)ACETIC ACID,,experimental,pac,Penicillin G acylase,target,,DB08193
"4-methyl-7,8-dihydro-5H-thiopyrano[4,3-d]pyrimidin-2-amine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08194
(1R)-2-[(CYANOMETHYL)AMINO]-1-({[2-(DIFLUOROMETHOXY)BENZYL]SULFONYL}METHYL)-2-OXOETHYL MORPHOLINE-4-CARBOXYLATE,,experimental,CTSS,Cathepsin S,target,,DB08195
"2-((3',5'-DIMETHOXY-4'-HYDROXYPHENYL)AZO)BENZOIC ACID",,experimental,,Streptavidin,target,,DB08196
"(5E,7S)-2-amino-7-(4-fluoro-2-pyridin-3-ylphenyl)-4-methyl-7,8-dihydroquinazolin-5(6H)-one oxime",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08197
"[(4R)-4-(3-HYDROXYPHENYL)-1,6-DIMETHYL-2-THIOXO-1,2,3,4-TETRAHYDROPYRIMIDIN-5-YL](PHENYL)METHANONE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08198
N-[(BENZYLOXY)CARBONYL]-L-CYSTEINYLGLYCINE,,experimental,,Metallo-beta-lactamase L1,target,,DB08199
(1R)-MENTHYL HEXYL PHOSPHONATE GROUP,,experimental,BCHE,Cholinesterase,target,,DB08200
(1S)-MENTHYL HEXYL PHOSPHONATE GROUP,,experimental,BCHE,Cholinesterase,target,,DB08201
4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE,,experimental,CA2,Carbonic anhydrase 2,target,,DB08202
"7-[2-METHOXY-1-(METHOXYMETHYL)ETHYL]-7H-PYRROLO[3,2-F] QUINAZOLINE-1,3-DIAMINE",,experimental,DHFRL1,"Dihydrofolate reductase, mitochondrial",target,,DB08203
3-DIPHENOL-6-NITRO-3H-BENZO[DE]ISOCHROMEN-1-ONE,,experimental,thyA,Thymidylate synthase,target,,DB08204
"2-[(4-ETHYNYL-2-FLUOROPHENYL)AMINO]-3,4-DIFLUORO-N-(2-HYDROXYETHOXY)BENZAMIDE",,experimental,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,target,,DB08208
2-(4-DIMETHYLAMINOPHENYL)DIAZENYLBENZOIC ACID,,experimental,azoR1,FMN-dependent NADH-azoreductase 1,target,,DB08209
"2-AMINO-4-FLUORO-5-[(1-METHYL-1H-IMIDAZOL-2-YL)SULFANYL]-N-(1,3-THIAZOL-2-YL)BENZAMIDE",,experimental,GCK,Glucokinase,target,,DB08210
5-bromo-3-(pyrrolidin-1-ylsulfonyl)-1H-indole-2-carboxamide,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08211
1-[2-(3-ACETYL-2-HYDROXY-6-METHOXY-PHENYL)-CYCLOPROPYL]-3-(5-CYANO-PYRIDIN-2-YL)-THIOUREA,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08212
"1-METHYL-5-(2-PHENOXYMETHYL-PYRROLIDINE-1-SULFONYL)-1H-INDOLE-2,3-DIONE",,experimental,CASP3,Caspase-3,target,,DB08213
4-(1H-IMIDAZOL-1-YL)PHENOL,,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB08214
2-((3'-TERTBUTYL-4'-HYDROXYPHENYL)AZO)BENZOIC ACID,,experimental,,Streptavidin,target,,DB08216
N-{4-METHYL-3-[(3-PYRIMIDIN-4-YLPYRIDIN-2-YL)AMINO]PHENYL}-3-(TRIFLUOROMETHYL)BENZAMIDE,,experimental,TEK,Angiopoietin-1 receptor,target,,DB08221
"(1S,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-7-METHYL-8-[2-[(2R,4R)-TETRAHYDRO-4-HY DROXY-6-OXO-2H-PYRAN-2-YL]ETHYL]-1-NAPHTHALENOL",,experimental,CES1,Liver carboxylesterase 1,target,,DB08224
"1-(1-HYDROXY-2,2,6,6-TETRAMETHYLPIPERIDIN-4-YL)PYRROLIDINE-2,5-DIONE",,experimental,malE,Maltose-binding periplasmic protein,target,,DB08227
"5,8-dimethoxy-1,4-dimethylquinolin-2(1H)-one",,experimental,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB08228
[N-(3-DIBENZYLCARBAMOYL-OXIRANECARBONYL)-HYDRAZINO]-ACETIC ACID,,experimental,CASP3,Caspase-3,target,,DB08229
"5,7-DIHYDROXY-2-(3,4,5-TRIHYDROXYPHENYL)-4H-CHROMEN-4-ONE",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08230
2'-deoxy-N-(naphthalen-1-ylmethyl)guanosine 5'-(dihydrogen phosphate),,experimental,POLK,DNA polymerase kappa,target,,DB08237
5-AMINO-NAPHTALENE-2-MONOSULFONATE,,experimental,FGF1,Fibroblast growth factor 1,target,,DB08238
"(2S)-4-(2,5-DIFLUOROPHENYL)-N-METHYL-2-PHENYL-N-PIPERIDIN-4-YL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08239
N-(4-CHLOROPHENYL)-3-(PHOSPHONOOXY)NAPHTHALENE-2-CARBOXAMIDE,,experimental,ALDOA,Fructose-bisphosphate aldolase A,target,,DB08240
"N,4-dimethyl-3-[(1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl)amino]benzamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08242
"(1S)-1-CYCLOPROPYL-2-[(2S)-4-(2,5-DIFLUOROPHENYL)-2-PHENYL-2,5-DIHYDRO-1H-PYRROL-1-YL]-2-OXOETHANAMINE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08244
1-(2-DEOXY-5-O-PHOSPHONO-BETA-D-ERYTHRO-PENTOFURANOSYL)-5-NITRO-1H-INDOLE,,experimental,43,DNA polymerase,target,,DB08245
"(2S)-4-(2,5-DIFLUOROPHENYL)-N,N-DIMETHYL-2-PHENYL-2,5-DIHYDRO-1H-PYRROLE-1-CARBOXAMIDE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08246
6-(CYCLOHEXYLMETHOXY)-8-ISOPROPYL-9H-PURIN-2-AMINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08247
"(5S)-5-(3-AMINOPROPYL)-3-(2,5-DIFLUOROPHENYL)-N-ETHYL-5-PHENYL-4,5-DIHYDRO-1H-PYRAZOLE-1-CARBOXAMIDE",,experimental,KIF11,Kinesin-like protein KIF11,target,,DB08250
4-[5-(2-CARBOXY-1-FORMYL-ETHYLCARBAMOYL)-PYRIDIN-3-YL]-BENZOIC ACID,,experimental,CASP3,Caspase-3,target,,DB08251
2-((4'-HYDROXYNAPHTHYL)-AZO)BENZOIC ACID,,experimental,,Streptavidin,target,,DB08252
NAM NAPTHYLAMINOALANINE,,experimental,pol,Pol polyprotein,target,,DB08253
"(3AR,5R,6S,7R,7AR)-5-(HYDROXYMETHYL)-2-PROPYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D][1,3]THIAZOLE-6,7-DIOL",,experimental,BT_4395,O-GlcNAcase BT_4395,target,,DB08255
N-[(CYCLOHEXYLAMINO)CARBONYL]GLYCINE,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB08256
4-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}BUTANOIC ACID,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB08257
6-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEXANOIC ACID,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB08258
7-{[(CYCLOHEXYLAMINO)CARBONYL]AMINO}HEPTANOIC ACID,,experimental,EPHX2,Bifunctional epoxide hydrolase 2,target,,DB08259
"(1S,2R,3S,4R,5R)-2,3,4-trihydroxy-N-octyl-6-oxa-8-azabicyclo[3.2.1]octane-8-carbothioamide",,experimental,bglA,Beta-glucosidase A,target,,DB08260
"2-HYDROXY-7-METHOXY-5-METHYL-NAPHTHALENE-1-CARBOXYLIC ACID MESO-2,5-DIHYDROXY-CYCLOPENT-3-ENYL ESTER",,experimental,ncsA,Neocarzinostatin,target,,DB08261
N-(CARBOXYCARBONYL)-D-PHENYLALANINE,,experimental,HIF1AN,Hypoxia-inducible factor 1-alpha inhibitor,target,,DB08263
"2-(TOLUENE-4-SULFONYL)-2H-BENZO[D][1,2,3]DIAZABORININ-1-OL",,experimental,fabI,Enoyl-[acyl-carrier-protein] reductase [NADH] FabI,target,,DB08265
"6-AMINO-4-(2-PHENYLETHYL)-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB08267
"6-AMINO-4-[2-(4-METHYLPHENYL)ETHYL]-1,7-DIHYDRO-8H-IMIDAZO[4,5-G]QUINAZOLIN-8-ONE",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB08268
"N-(2-AMINOETHYL)-N~2~-{(1S)-1-[4'-(AMINOSULFONYL)BIPHENYL-4-YL]-2,2,2-TRIFLUOROETHYL}-L-LEUCINAMIDE",,experimental,CTSK,Cathepsin K,target,,DB08270
(4S)-4-(2-NAPHTHYLMETHYL)-D-GLUTAMIC ACID,,experimental,murI,Glutamate racemase,target,,DB08272
"6,7,8,9-TETRAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOHEPTA[B]PYRAN-2-ONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08274
N-DODECANOYL-L-TYROSINE,,experimental,feeM,Long-chain N-acyl amino acid synthase,target,,DB08275
N-METHYL O-NITROPHENYL AMINOETHYLDIPHOSPHATE BERYLLIUM TRIFLUORIDE,,experimental,MYH14,Myosin-14,target,,DB08276
"2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB08277
"1-(2-CYCLOPROPYLETHYL)-3-(1,1-DIOXIDO-2H-1,2,4-BENZOTHIADIAZIN-3-YL)-6-FLUORO-4-HYDROXYQUINOLIN-2(1H)-ONE",,experimental,,Genome polyprotein,target,,DB08278
3-{ISOPROPYL[(TRANS-4-METHYLCYCLOHEXYL)CARBONYL]AMINO}-5-PHENYLTHIOPHENE-2-CARBOXYLIC ACID,,experimental,,Genome polyprotein,target,,DB08279
"(1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB08280
"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-bromophenyl)thiocarbamate",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08281
"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-chlorophenyl)thiocarbamate",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08282
"(2R,3R,4R,5S)-2-(HYDROXYMETHYL)-1-NONYLPIPERIDINE-3,4,5-TRIOL",,experimental,GBA,Glucosylceramidase,target,,DB08283
"O-[2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)ethyl] (4-iodophenyl)thiocarbamate",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08284
"(1R,2R)-N-(2-AMINOETHYL)-2-{[(4-METHOXYPHENYL)SULFONYL]METHYL}CYCLOHEXANECARBOXAMIDE",,experimental,CTSK,Cathepsin K,target,,DB08287
N-(PARA-GLUTARAMIDOPHENYL-ETHYL)-PIPERIDINIUM-N-OXIDE,,experimental,IGKC,Ig kappa chain C region,target,,DB08289
N-(3-AMINOPROPYL)-2-NITROBENZENAMINE,,experimental,KAT2B,Histone acetyltransferase KAT2B,target,,DB08291
"(5Z)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08292
"(5E)-12-CHLORO-13,15-DIHYDROXY-4,7,8,9-TETRAHYDRO-2-BENZOXACYCLOTRIDECINE-1,10(3H,11H)-DIONE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08293
5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08296
ORTHONITROPHENYL-BETA-D-FUCOPYRANOSIDE,,experimental,lacI,Lactose operon repressor,target,,DB08297
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,,experimental,pab,Peptostreptococcal albumin-binding protein,target,,DB08298
"1-methyl-3-naphthalen-2-yl-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,experimental,PIK3CG,"Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",target,,DB08300
N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE,,experimental,CA2,Carbonic anhydrase 2,target,,DB08301
3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB08302
"(3S)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide",,experimental,GRIA2,Glutamate receptor 2,target,,DB08303
"(3R)-3-cyclopentyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",,experimental,GRIA2,Glutamate receptor 2,target,,DB08304
"(3R)-3-cyclopentyl-6-methyl-7-[(4-methylpiperazin-1-yl)sulfonyl]-3,4-dihydro-2H-1,2-benzothiazine 1,1-dioxide",,experimental,GRIA2,Glutamate receptor 2,target,,DB08305
3-{[(3-NITROANILINE]SULFONYL}THIOPHENE-2-CARBOXYLIC ACID,,experimental,ampC,Beta-lactamase,target,,DB08306
"2-{HYDROXY[2-NITRO-4-(TRIFLUOROMETHYL)PHENYL]METHYLENE}CYCLOHEXANE-1,3-DIONE",,experimental,hpd,4-hydroxyphenylpyruvate dioxygenase,target,,DB08307
"SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER",,experimental,ksi,Steroid Delta-isomerase,target,,DB08308
"N-[(2R)-2-{[(2S)-2-(1,3-benzoxazol-2-yl)pyrrolidin-1-yl]carbonyl}hexyl]-N-hydroxyformamide",,experimental,def,Peptide deformylase,target,,DB08310
"6-CYCLOHEXYLMETHYLOXY-5-NITROSO-PYRIMIDINE-2,4-DIAMINE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08312
nocodazole,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB08313
"(2-AMINO-1,3-OXAZOL-5-YL)-(3-BROMOPHENYL)METHANONE",,experimental,accC,Biotin carboxylase,target,,DB08314
"2-AMINO-N,N-BIS(PHENYLMETHYL)-1,3-OXAZOLE-5-CARBOXAMIDE",,experimental,accC,Biotin carboxylase,target,,DB08315
"4-amino-7,7-dimethyl-7,8-dihydroquinazolin-5(6H)-one",,experimental,accC,Biotin carboxylase,target,,DB08316
"5-methyl-6-phenylquinazoline-2,4-diamine",,experimental,accC,Biotin carboxylase,target,,DB08317
"6-(2-phenoxyethoxy)-1,3,5-triazine-2,4-diamine",,experimental,accC,Biotin carboxylase,target,,DB08318
"2'-HYDROXY-1,1'-BIPHENYL-2-SULFINIC ACID",,experimental,soxB,2'-hydroxybiphenyl-2-sulfinate desulfinase,target,,DB08319
"(1S,2S,3R,6R)-4-(hydroxymethyl)-6-(octylamino)cyclohex-4-ene-1,2,3-triol",,experimental,MAN2A1,Alpha-mannosidase 2,target,,DB08321
"2-DEOXY-3,4-BIS-O-[3-(4-HYDROXYPHENYL)PROPANOYL]-L-THREO-PENTARIC ACID",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB08322
3-OXO-N-[(3S)-2-OXOPYRROLIDIN-3-YL]DODECANAMIDE,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB08323
N-3-OXO-DODECANOYL-L-HOMOSERINE LACTONE,,experimental,lasR,Transcriptional activator protein LasR,target,,DB08324
"2-(6-HYDROXY-1,3-BENZOTHIAZOL-2-YL)-1,3-THIAZOL-4(5H)-ONE",,experimental,ACSBG1,Long-chain-fatty-acid--CoA ligase ACSBG1,target,,DB08326
"2-(3,6-DIHYDROXYPHENYL)ACETIC ACID",,experimental,pac,Penicillin G acylase,target,,DB08327
PANTOTHENYL-AMINOETHANOL-11-PIVALIC ACID,,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB08328
SULTHIAME,,experimental,CA2,Carbonic anhydrase 2,target,,DB08329
"N-1H-imidazol-2-yl-N'-[4-(1H-imidazol-2-ylamino)phenyl]benzene-1,4-diamine",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08331
[2'-CARBOXYLETHYL]-10-METHYL-ANTHRACENE ENDOPEROXIDE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08332
4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,,experimental,MIF,Macrophage migration inhibitory factor,target,,DB08333
3-FLUORO-4-HYDROXYBENZALDEHYDE O-(CYCLOHEXYLCARBONYL)OXIME,,experimental,MIF,Macrophage migration inhibitory factor,target,,DB08334
"4-HYDROXYBENZALDEHYDE O-(3,3-DIMETHYLBUTANOYL)OXIME",,experimental,MIF,Macrophage migration inhibitory factor,target,,DB08335
"TERT-BUTYL [(1R)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE",,experimental,ampC,Beta-lactamase,target,,DB08336
"TERT-BUTYL [(1S)-2-METHYL-1-(1,3,4-OXADIAZOL-2-YL)PROPYL]CARBAMATE",,experimental,ampC,Beta-lactamase,target,,DB08337
"19-(cyclopropylamino)-4,6,7,15-tetrahydro-5H-16,1-(azenometheno)-10,14-(metheno)pyrazolo[4,3-o][1,3,9]triazacyclohexadecin-8(9H)-one",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08338
"6-(2,6-DICHLOROPHENYL)-2-{[3-(HYDROXYMETHYL)PHENYL]AMINO}-8-METHYLPYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE",,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB08339
"N,N'-DIPHENYLPYRAZOLO[1,5-A][1,3,5]TRIAZINE-2,4-DIAMINE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08340
"4-{[4-{[(1R,2R)-2-(dimethylamino)cyclopentyl]amino}-5-(trifluoromethyl)pyrimidin-2-yl]amino}-N-methylbenzenesulfonamide",,experimental,PTK2B,Protein-tyrosine kinase 2-beta,target,,DB08341
4-chloro-N-(3-methoxypropyl)-N-[(3S)-1-(2-phenylethyl)piperidin-3-yl]benzamide,,experimental,glmU,Bifunctional protein GlmU,target,,DB08344
"4-(2-(1H-IMIDAZOL-4-YL)ETHYLAMINO)-2-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08345
"(5Z)-13-CHLORO-14,16-DIHYDROXY-3,4,7,8,9,10-HEXAHYDRO-1H-2-BENZOXACYCLOTETRADECINE-1,11(12H)-DIONE",,experimental,HSP90AB1,Heat shock protein HSP 90-beta,target,,DB08346
4-{[(2S)-3-(tert-butylamino)-2-hydroxypropyl]oxy}-3H-indole-2-carbonitrile,,experimental,ADRB1,Beta-1 adrenergic receptor,target,,DB08347
"N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08349
"5-[3-(2-METHOXYPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-5-YL]-N,N-DIMETHYLPYRIDINE-3-CARBOXAMIDE",,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB08350
N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08351
"6-[4-(2-fluorophenyl)-1,3-oxazol-5-yl]-N-(1-methylethyl)-1,3-benzothiazol-2-amine",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08352
"2-(CYCLOHEXYLMETHYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08353
"2-(4-CHLOROBENZYLAMINO)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08354
"4-[4-(4-methoxyphenyl)-5-methyl-1H-pyrazol-3-yl]benzene-1,3-diol",,experimental,PDK4,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 4, mitochondrial",target,,DB08356
2-PHENYLAMINO-4-METHYL-5-ACETYL THIAZOLE,,experimental,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB08359
"2-(4-ETHYLPIPERAZIN-1-YL)-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZINE-8-CARBONITRILE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08360
"2-{[(1R,2S)-2-aminocyclohexyl]amino}-4-[(3-methylphenyl)amino]pyrimidine-5-carboxamide",,experimental,SYK,Tyrosine-protein kinase SYK,target,,DB08361
"N-(3-(8-CYANO-4-(PHENYLAMINO)PYRAZOLO[1,5-A][1,3,5]TRIAZIN-2-YLAMINO)PHENYL)ACETAMIDE",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08362
1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine,,experimental,TP53,Cellular tumor antigen p53,target,,DB08363
1-{[(1E)-(3-HYDROXY-2-METHYL-5-{[(TRIHYDROXY-LAMBDA^5^-PHOSPHANYL)OXY]METHYL}PYRIDIN-4-YL)METHYLIDENE]AMINO}UNDECAN-2-ONE,,experimental,cqsA,CAI-1 autoinducer synthase,target,,DB08364
"8-bromo-4-(2-chlorophenyl)-N-(2-hydroxyethyl)-6-methyl-1,3-dioxo-1,2,3,6-tetrahydropyrrolo[3,4-e]indole-7-carboxamide",,experimental,WEE1,Wee1-like protein kinase,target,,DB08365
"3-({3-[(1S,4aS,6S,7S,9S,9aR)-1,6-dimethyl-2-oxodecahydro-6,9-epoxy-4a,7-methanobenzo[7]annulen-1-yl]propanoyl}amino)-2,4-dihydroxybenzoic acid",,experimental,fabF,3-oxoacyl-[acyl-carrier-protein] synthase 2,target,,DB08366
(R)-2-(FORMYLOXY)-3-(PHOSPHONOOXY)PROPYL PENTANOATE,,experimental,glpG,Rhomboid protease GlpG,target,,DB08367
"OCTANE-1,3,5,7-TETRACARBOXYLIC ACID",,experimental,CPA1,Carboxypeptidase A1,target,,DB08368
1-(biphenyl-4-ylmethyl)-1H-imidazole,,experimental,CYP2B6,Cytochrome P450 2B6,target,,DB08369
S-(4-BROMOBENZYL)CYSTEINE,,experimental,GSTP1,Glutathione S-transferase P,target,,DB08370
"4,4'-BIS([H]METHYLSULFONYL)-2,2',5,5'-TETRACHLOROBIPHENYL",,experimental,SCGB1A1,Uteroglobin,target,,DB08373
PHENYLALANYLMETHYLCHLORIDE,,experimental,CTRB1,Chymotrypsinogen B,target,,DB08374
"(2R)-3-(phosphonooxy)propane-1,2-diyl diheptanoate",,experimental,,Phospholipase D,target,,DB08376
PARA-NITROPHENYL PHOSPHONOBUTANOYL D-ALANINE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08377
6-(4-chloro-2-fluoro-3-phenoxybenzyl)pyridazin-3(2H)-one,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08379
"2-(4-{(3S,5S)-5-[(3,3-difluoropyrrolidin-1-yl)carbonyl]pyrrolidin-3-yl}piperazin-1-yl)pyrimidine",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08382
"4,5-bis(4-methoxyphenyl)-2-thiophen-2-yl-1H-imidazole",,experimental,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,,DB08383
2-({4-[4-(pyridin-4-ylmethyl)-1H-pyrazol-3-yl]phenoxy}methyl)quinoline,,experimental,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,,DB08384
4-(quinolin-3-ylmethyl)piperidine-1-carboxylic acid,,experimental,FAAH,Fatty-acid amide hydrolase 1,target,,DB08385
2-{[4-(4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,,experimental,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,,DB08386
2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline,,experimental,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,,DB08387
"5-(2-ETHOXYETHYL)-5-[4-(4-FLUOROPHENOXY)PHENOXY]PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE",,experimental,MMP13,Collagenase 3,target,,DB08388
"6,7-DIMETHOXY-4-[(3R)-3-(2-NAPHTHYLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",,experimental,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,,DB08389
"(6S)-6-CYCLOPENTYL-6-[2-(3-FLUORO-4-ISOPROPOXYPHENYL)ETHYL]-4-HYDROXY-5,6-DIHYDRO-2H-PYRAN-2-ONE",,experimental,,Genome polyprotein,target,,DB08390
"6,7-DIMETHOXY-4-[(3R)-3-(QUINOXALIN-2-YLOXY)PYRROLIDIN-1-YL]QUINAZOLINE",,experimental,PDE10A,"cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A",target,,DB08391
"2-[5,6-BIS-(4-METHOXY-PHENYL)-FURO[2,3-D]PYRIMIDIN-4-YLAMINO]-ETHANOL",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08392
"2-[(5,6-DIPHENYLFURO[2,3-D]PYRIMIDIN-4-YL)AMINO]ETHANOL",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08393
PARA-NITROPHENYLPHOSPHONOBUTANOYL-GLYCINE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08394
2-(ETHOXYMETHYL)-4-(4-FLUOROPHENYL)-3-[2-(2-HYDROXYPHENOXY)PYRIMIDIN-4-YL]ISOXAZOL-5(2H)-ONE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08395
"4-{[(Z)-(5-OXO-2-PHENYL-1,3-OXAZOL-4(5H)-YLIDENE)METHYL]AMINO}BUTANOIC ACID",,experimental,,Ig heavy chain V-III region CAM,target,,DB08396
6-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALENE-2-CARBOXYLIC ACID,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08397
4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzyl)piperidine-1-carboxylic acid,,experimental,FAAH,Fatty-acid amide hydrolase 1,target,,DB08400
(2E)-2-({(2S)-2-CARBOXY-2-[(PHENOXYACETYL)AMINO]ETHOXY}IMINO)PENTANEDIOIC ACID,,experimental,pbp1b,Penicillin-binding protein 1B,target,,DB08401
"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEXANETHIOATE",,experimental,acpP,Acyl carrier protein,target,,DB08404
"S-(2-{[N-(2-HYDROXY-4-{[HYDROXY(OXIDO)PHOSPHINO]OXY}-3,3-DIMETHYLBUTANOYL)-BETA-ALANYL]AMINO}ETHYL) HEPTANETHIOATE",,experimental,acpP,Acyl carrier protein,target,,DB08405
"[N-(2,4-DIAMINOPTERIDIN-6-YL)-METHYL]-DIBENZ[B,F]AZEPINE",,experimental,DHFR,Dihydrofolate reductase,target,,DB08406
PLATENSIMYCIN,,experimental,fabF,3-oxoacyl-[acyl-carrier-protein] synthase 2,target,,DB08407
"(3R)-3-hydroxy-2,2-dimethyl-4-oxo-4-({3-oxo-3-[(2-sulfanylethyl)amino]propyl}amino)butyl 2,2-dimethylpropanoate",,experimental,phbA,Acetyl-CoA acetyltransferase,target,,DB08408
PARA-NITROBENZYL GLUTARYL GLYCINIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08410
PARA-NITROPHENYL PHOSPHONOBUTANOYL L-ALANINE,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08411
6-{4-[HYDROXY-(4-NITRO-PHENOXY)-PHOSPHORYL]-BUTYRYLAMINO}-HEXANOIC ACID,,experimental,IGHG1,Ig gamma-1 chain C region,target,,DB08412
"6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08414
"(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE",,experimental,CA2,Carbonic anhydrase 2,target,,DB08416
"(4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate",,experimental,CA2,Carbonic anhydrase 2,target,,DB08418
(1S)-1-(PHENOXYMETHYL)PROPYL METHYLPHOSPHONOCHLORIDOATE,,experimental,lipA,Lipase,target,,DB08419
1-{[1-(2-AMINO-3-PHENYL-PROPIONYL)-PYRROLIDINE-2-CARBONYL]-AMINO}-2-(3-CYANO-PHENYL)-ETHANEBORONIC ACID,,experimental,PRSS1,Trypsin-1,target,,DB08420
PIPERIDINE-2-CARBOXYLIC ACID TERT-BUTYLAMIDE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08421
[PHENYLALANINYL-PROLINYL]-[2-(PYRIDIN-4-YLAMINO)-ETHYL]-AMINE,,experimental,F2,Prothrombin,target,,DB08422
[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL][3-(PIPERIDIN-4-YLOXY)PHENYL]METHANONE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08423
"[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE",,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08424
"THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE",,experimental,F10,Coagulation factor X,target,,DB08426
PREPHENIC ACID,,experimental,aroH,Chorismate mutase AroH,target,,DB08427
N-({(2S)-1-[(3R)-3-amino-4-(3-chlorophenyl)butanoyl]pyrrolidin-2-yl}methyl)-3-(methylsulfonyl)benzamide,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08429
PARA-NITROPHENYL 1-THIO-BETA-D-GLUCOPYRANOSIDE,,experimental,LCTL,Lactase-like protein,target,,DB08430
"[(3R,4S)-4-HYDROXY-3-METHYL-2-OXOHEXYL]PHOSPHONIC ACID",,experimental,pikAIV,Type I polyketide synthase PikAIV,target,,DB08431
THYMIDINE-5'-THIOPHOSPHATE,,experimental,polA,DNA polymerase I,target,,DB08432
phenyl ethenesulfonate,,experimental,yopH,Tyrosine-protein phosphatase YopH,target,,DB08433
2-METHYLCARBAMOYL-3-(4-PHOSPHONOOXY-PHENYL)-CYCLOPROPANECARBOXYLIC ACID,,experimental,V-SRC,Tyrosine-protein kinase transforming protein Src,target,,DB08434
"(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid",,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB08435
"8-BENZO[1,3]DIOXOL-,5-YLMETHYL-9-BUTYL-9H-",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08436
"(2E,4R,5S)-2,3,4,5-TETRAHYDROXY-6-(PALMITOYLOXY)HEX-2-ENOIC ACID",,experimental,SP_0314,Hyaluronate lyase,target,,DB08438
parecoxib,,experimental,LTF,Lactotransferrin,target,,DB08439
"N-1,10-phenanthrolin-5-ylacetamide",,experimental,cybC,Soluble cytochrome b562,target,,DB08440
"6-BROMO-13-THIA-2,4,8,12,19-PENTAAZATRICYCLO[12.3.1.1~3,7~]NONADECA-1(18),3(19),4,6,14,16-HEXAENE 13,13-DIOXIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08441
"4-{[(2R)-2-(2-methylphenyl)pyrrolidin-1-yl]carbonyl}benzene-1,3-diol",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08442
"2-(1H-pyrrol-1-ylcarbonyl)benzene-1,3,5-triol",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08443
"3-[2-bromo-4-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-methylbenzonitrile",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08444
"(3R,4S)-1-[6-(6-METHOXYPYRIDIN-3-YL)PYRIMIDIN-4-YL]-4-(2,4,5-TRIFLUOROPHENYL)PYRROLIDIN-3-AMINE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08445
"3-[6-bromo-2-fluoro-3-(1H-pyrazolo[3,4-c]pyridazin-3-ylmethyl)phenoxy]-5-chlorobenzonitrile",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08446
3-{3-[(DIMETHYLAMINO)METHYL]-1H-INDOL-7-YL}PROPAN-1-OL,,experimental,PLA2G2E,Group IIE secretory phospholipase A2,target,,DB08447
"(4aS)-5-[(2,4-diaminopteridin-6-yl)methyl]-4a,5-dihydro-2H-dibenzo[b,f]azepin-8-ol",,experimental,DHFR,Dihydrofolate reductase,target,,DB08448
"2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-pyrrolo[2,3-b]pyridin-1-yl)acetic acid",,experimental,AKR1B1,Aldose reductase,target,,DB08449
N-1H-indazol-5-yl-2-(6-methylpyridin-2-yl)quinazolin-4-amine,,experimental,TGFBR1,TGF-beta receptor type-1,target,,DB08450
N-(QUINOLIN-8-YL)METHANESULFONAMIDE,,experimental,map,Methionine aminopeptidase,target,,DB08451
N-(5-METHYL-1H-PYRAZOL-3-YL)-2-PHENYLQUINAZOLIN-4-AMINE,,experimental,CAMK1D,Calcium/calmodulin-dependent protein kinase type 1D,target,,DB08454
"3-{[(2,2,5,5-TETRAMETHYL-1-OXO-4-PHENYL-2,5-DIHYDRO-1H-PYRROLIUM-3-YL)METHYL]DISULFANYL}-D-ALANINE",,experimental,E,Lysozyme,target,,DB08456
"4-(3,5-DIMETHYLPHENOXY)-5-(FURAN-2-YLMETHYLSULFANYLMETHYL)-3-IODO-6-METHYLPYRIDIN-2(1H)-ONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08457
(4-BROMOPHENYL)[4-({(2E)-4-[CYCLOPROPYL(METHYL)AMINO]BUT-2-ENYL}OXY)PHENYL]METHANONE,,experimental,shc,Squalene--hopene cyclase,target,,DB08458
"3-chloro-5-[2-chloro-5-(1H-pyrazolo[3,4-b]pyridin-3-ylmethoxy)phenoxy]benzonitrile",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08459
"3-{5-[(6-amino-1H-pyrazolo[3,4-b]pyridin-3-yl)methoxy]-2-chlorophenoxy}-5-chlorobenzonitrile",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08460
"3-[(4-AMINO-1-TERT-BUTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-3-YL)METHYL]PHENOL",,experimental,AR,Androgen receptor,target,,DB08461
N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB08462
"5-[2-(4-hydroxyphenyl)ethyl]benzene-1,3-diol",,experimental,LTA4H,Leukotriene A-4 hydrolase,target,,DB08466
"2,3,7,8-tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08468
"tert-butyl 4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine-1-carboxylate",,experimental,ethR,HTH-type transcriptional regulator EthR,target,,DB08469
"3-(4-fluorophenyl)-5-phenyl-4H-1,2,4-triazole",,experimental,ethR,HTH-type transcriptional regulator EthR,target,,DB08470
"1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine",,experimental,ethR,HTH-type transcriptional regulator EthR,target,,DB08471
(3R)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,,experimental,snf,Transporter,target,,DB08472
"5,6-dichloro-1-beta-D-ribofuranosyl-1H-benzimidazole",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08473
3-(CARBOXYAMIDE(2-CARBOXYAMIDE-2-TERTBUTYLETHYL))PENTAN,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08474
"[(4R)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE",,experimental,estA,Lipase EstA,target,,DB08475
3-AMINO-AZACYCLOTRIDECAN-2-ONE,,experimental,MMP8,Neutrophil collagenase,target,,DB08476
"5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene-2-carboxamide",,experimental,F10,Coagulation factor X,target,,DB08477
N-[2-chloro-5-(trifluoromethyl)phenyl]imidodicarbonimidic diamide,,experimental,TYMS,Thymidylate synthase,target,,DB08478
"N-(3,5-dimethoxyphenyl)imidodicarbonimidic diamide",,experimental,TYMS,Thymidylate synthase,target,,DB08479
4-HYDROXY-N-PROPARGYL-1(R)-AMINOINDAN,,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB08480
"4-METHYL-N-{(5E)-5-[(5-METHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}BENZENESULFONAMIDE",,experimental,,Genome polyprotein,target,,DB08481
[[1-[N-HYDROXY-ACETAMIDYL]-3-METHYL-BUTYL]-CARBONYL-LEUCINYL]-ALANINE ETHYL ESTER,,experimental,MMP1,Interstitial collagenase,target,,DB08482
4-AMINO-N-[(2-SULFANYLETHYL)CARBAMOYL]BENZENESULFONAMIDE,,experimental,FBP1,"Fructose-1,6-bisphosphatase 1",target,,DB08484
"(1S,4S,5S)-1,4,5-TRIHYDROXY-3-[3-(PHENYLTHIO)PHENYL]CYCLOHEX-2-ENE-1-CARBOXYLIC ACID",,experimental,aroQ,3-dehydroquinate dehydratase,target,,DB08485
3-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,,experimental,F10,Coagulation factor X,target,,DB08487
"4-{[(E)-2-(5-CHLOROTHIEN-2-YL)VINYL]SULFONYL}-1-(1H-PYRROLO[3,2-C]PYRIDIN-2-YLMETHYL)PIPERAZIN-2-ONE",,experimental,F10,Coagulation factor X,target,,DB08488
"N4-HYDROXY-2-ISOBUTYL-N1-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YL)-SUCCINAMIDE",,experimental,MMP7,Matrilysin,target,,DB08489
4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE,,experimental,MMP13,Collagenase 3,target,,DB08490
N-HYDROXY-2-[4-(4-PHENOXY-BENZENESULFONYL)-TETRAHYDRO-PYRAN-4-YL]-ACETAMIDE,,experimental,MMP1,Interstitial collagenase,target,,DB08491
(2E)-3-(2-OCT-1-YN-1-YLPHENYL)ACRYLIC ACID,,experimental,ALOX15,Arachidonate 15-lipoxygenase,target,,DB08492
"5-METHYL-3-(9-OXO-1,8-DIAZA-TRICYCLO[10.6.1.013,18]NONADECA-12(19),13,15,17-TETRAEN-10-YLCARBAMOYL)-HEXANOIC ACID",,experimental,MMP7,Matrilysin,target,,DB08493
"S-{2-[(2-chloro-4-sulfamoylphenyl)amino]-2-oxoethyl} 6-methyl-3,4-dihydroquinoline-1(2H)-carbothioate",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08494
4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXOPIPERAZIN-1-YL}METHYL)BENZENECARBOXIMIDAMIDE,,experimental,F10,Coagulation factor X,target,,DB08495
"(1S)-2-oxo-1-phenyl-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",,experimental,CASP3,Caspase-3,target,,DB08497
"(1S)-1-(3-chlorophenyl)-2-oxo-2-[(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-5-yl)amino]ethyl acetate",,experimental,CASP3,Caspase-3,target,,DB08498
"N-[3-(2-fluoroethoxy)phenyl]-N'-(1,3,4-trioxo-1,2,3,4-tetrahydroisoquinolin-6-yl)butanediamide",,experimental,CASP3,Caspase-3,target,,DB08499
"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(2-naphthyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB08500
"DIETHYL PROPANE-1,3-DIYLBISCARBAMATE",,experimental,stxB,Shiga-like toxin 1 subunit B,target,,DB08501
"5-(3,5-DICHLOROPHENYL)THIO-4-ISOPROPYL-1-(PYRIDIN-4-YL-METHYL)-1H-IMIDAZOL-2-YL-METHYL CARBAMATE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08502
"(3S,5R,7R,8S,9S,10R)-7-(hydroxymethyl)-3-(4-methylphenyl)-1,6-dioxa-2-azaspiro[4.5]decane-8,9,10-triol",,experimental,PYGM,"Glycogen phosphorylase, muscle form",target,,DB08503
"6-(4-{(1S,2S)-2-AMINO-1-[(DIMETHYLAMINO)CARBONYL]-3-[(3S)-3-FLUOROPYRROLIDIN-1-YL]-3-OXOPROPYL}PHENYL)-1H-[1,2,4]TRIAZOLO[1,5-A]PYRIDIN-4-IUM",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08504
methyl 4-bromo-N-[8-(hydroxyamino)-8-oxooctanoyl]-L-phenylalaninate,,experimental,hdaH,Histone deacetylase-like amidohydrolase,target,,DB08505
N-{(2S)-3-[(1R)-1-aminoethyl](hydroxy)phosphoryl-2-benzylpropanoyl}-L-phenylalanine,,experimental,pepN,Aminopeptidase N,target,,DB08506
N-[[2-METHYL-4-HYDROXYCARBAMOYL]BUT-4-YL-N]-BENZYL-P-[PHENYL]-P-[METHYL]PHOSPHINAMID,,experimental,MMP3,Stromelysin-1,target,,DB08507
N-BENZOYL-D-ALANINE,,experimental,pbp1b,Penicillin-binding protein 1b,target,,DB08508
1-[6-(2-CHLORO-4-METHYXYPHENOXY)-HEXYL]-IMIDAZOLE,,experimental,,Genome polyprotein,target,,DB08509
5-ALPHA-PREGNANE-3-BETA-OL-HEMISUCCINATE,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB08510
"6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB08511
"6-amino-2-[(1-naphthylmethyl)amino]-3,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB08512
"6-amino-2-[(thiophen-2-ylmethyl)amino]-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one",,experimental,tgt,Queuine tRNA-ribosyltransferase,target,,DB08514
(S)-(+)-2-[4-(FLUOROBENZYLOXY-BENZYLAMINO)PROPIONAMIDE],,experimental,MAOB,Amine oxidase [flavin-containing] B,target,,DB08516
"(2S)-5-hydroxy-2-(4-hydroxyphenyl)-7-methoxy-2,3-dihydro-4H-chromen-4-one",,experimental,fabZ,3-hydroxyacyl-[acyl-carrier-protein] dehydratase FabZ,target,,DB08517
"N~4~-(3-methyl-1H-indazol-6-yl)-N~2~-(3,4,5-trimethoxyphenyl)pyrimidine-2,4-diamine",,experimental,KDR,Vascular endothelial growth factor receptor 2,target,,DB08519
"(21S)-1AZA-4,4-DIMETHYL-6,19-DIOXA-2,3,7,20-TETRAOXOBICYCLO[19.4.0] PENTACOSANE",,experimental,FKBP1A,Peptidyl-prolyl cis-trans isomerase FKBP1A,target,,DB08520
4-(4-FLUOROPHENYL)-1-CYCLOROPROPYLMETHYL-5-(4-PYRIDYL)-IMIDAZOLE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08522
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE,,experimental,def,Peptide deformylase,target,,DB08524
HYDROXY[3-(6-METHYLPYRIDIN-2-YL)PROPYL]FORMAMIDE,,experimental,def,Peptide deformylase,target,,DB08525
CARBOBENZYLOXY-(L)-LEUCINYL-(L)LEUCINYL METHOXYMETHYLKETONE,,experimental,CTSH,Pro-cathepsin H,target,,DB08526
"2-AMINO-6-(3,5-DIMETHYLPHENYL)SULFONYLBENZONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08528
"(6E,11E)-HEPTADECA-6,11-DIENE-9,9-DIYLBIS(PHOSPHONIC ACID)",,experimental,GGPS1,Geranylgeranyl pyrophosphate synthase,target,,DB08529
"7-BENZYL-1,3-DIMETHYL-8-PIPERAZIN-1-YL-3,7-DIHYDRO-PURINE-2,6-DIONE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08530
"5-(2,3-dichlorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08531
"6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08532
"3-methyl-N-(pyridin-4-ylmethyl)imidazo[1,2-a]pyrazin-8-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08533
"5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08534
"3-bromo-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08535
"3-bromo-5-phenyl-N-(pyrimidin-5-ylmethyl)pyrazolo[1,5-a]pyridin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08536
"3-bromo-6-phenyl-N-(pyrimidin-5-ylmethyl)imidazo[1,2-a]pyridin-8-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08537
"N-((2-aminopyrimidin-5-yl)methyl)-5-(2,6-difluorophenyl)-3-ethylpyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08538
"3-cyclopropyl-5-phenyl-N-(pyridin-3-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08539
"2-[4-(2H-1,4-BENZOTHIAZINE-3-YL)-PIPERAZINE-1-LY]-1,3-THIAZOLE-4-CARBOXYLIC ACID ETHYLESTER",,experimental,,Genome polyprotein,target,,DB08540
"[(3S)-9-hydroxy-1-methyl-10-oxo-4,10-dihydro-3H-benzo[g]isochromen-3-yl]acetic acid",,experimental,actII,ActII protein,target,,DB08541
"3,4-dihydroxy-9,10-secoandrosta-1(10),2,4-triene-9,17-dione",,experimental,hsaC,Iron-dependent extradiol dioxygenase,target,,DB08542
1-[2-HYDROXY-3-(4-CYCLOHEXYL-PHENOXY)-PROPYL]-4-(2-PYRIDYL)-PIPERAZINE,,experimental,,Genome polyprotein,target,,DB08543
(3S)-N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,,experimental,snf,Transporter,target,,DB08544
(1R)-1-PHENYLETHYL 4-(ACETYLAMINO)BENZYLPHOSPHONATE,,experimental,,Hepatitis B virus receptor binding protein,target,,DB08545
"4-[(3AS,4R,7R,8AS,8BR)-2-(1,3-BENZODIOXOL-5-YLMETHYL)-7-HYDROXY-1,3-DIOXODECAHYDROPYRROLO[3,4-A]PYRROLIZIN-4-YL]BENZENECARBOXIMIDAMIDE",,experimental,F2,Prothrombin,target,,DB08546
PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB08547
"[(4S)-2,2-DIMETHYL-1,3-DIOXOLAN-4-YL]METHYL HYDROGEN HEX-5-ENYLPHOSPHONATE",,experimental,estA,Lipase EstA,target,,DB08548
"(3R)-METHYLCARBAMOYL-7-SULFOAMINO-3,4-DIHYDRO-1H-ISOQUINOLINE-2-CARBOXYLIC ACID BENZYL ESTER",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08549
"7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB08550
(1R)-1-(2-THIENYLACETYLAMINO)-1-PHENYLMETHYLBORONIC ACID,,experimental,ampC,Beta-lactamase,target,,DB08552
"(1E)-5-(1-piperidin-4-yl-3-pyridin-4-yl-1H-pyrazol-4-yl)-2,3-dihydro-1H-inden-1-one oxime",,experimental,BRAF,Serine/threonine-protein kinase B-raf,target,,DB08553
"1-(3-BROMOPHENYL)-7-CHLORO-6-METHOXY-3,4-DIHYDROISOQUINOLINE",,experimental,MAPK10,Mitogen-activated protein kinase 10,target,,DB08555
"5'-ACETYL-4-{[(2,4-DIMETHYLPHENYL)SULFONYL]AMINO}-2,2'-BITHIOPHENE-5-CARBOXYLIC ACID",,experimental,,Genome polyprotein,target,,DB08556
"2-[(2-methoxyethyl)amino]-4-(4-oxo-1,2,3,4-tetrahydro-9H-carbazol-9-yl)benzamide",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08557
"N-[(2S,4S,6R)-2-(DIHYDROXYMETHYL)-4-HYDROXY-3,3-DIMETHYL-7-OXO-4LAMBDA~4~-THIA-1-AZABICYCLO[3.2.0]HEPT-6-YL]-2-PHENYLACETAMIDE",,experimental,pac,Penicillin G acylase,target,,DB08559
3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB08560
"BENZYL 6-BENZYL-5,7-DIOXO-6,7-DIHYDRO-5H-[1,3]THIAZOLO[3,2-C]PYRIMIDINE-2-CARBOXYLATE",,experimental,MMP13,Collagenase 3,target,,DB08561
(2E)-N-{4-[(3-bromophenyl)amino]quinazolin-6-yl}-4-(dimethylamino)but-2-enamide,,experimental,SRC,Proto-oncogene tyrosine-protein kinase Src,target,,DB08564
L-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID,,experimental,CTRB1,Chymotrypsinogen B,target,,DB08565
D-1-NAPHTHYL-2-ACETAMIDO-ETHANE BORONIC ACID,,experimental,CTRB1,Chymotrypsinogen B,target,,DB08566
"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine",,experimental,snf,Transporter,target,,DB08567
4-(ACETYLAMINO)-5-AMINO-3-HYDROXYBENZOIC ACID,,experimental,NA,Neuraminidase,target,,DB08571
3-[(4-CHLOROANILINO)SULFONYL]THIOPHENE-2-CARBOXYLIC ACID,,experimental,ampC,Beta-lactamase,target,,DB08573
"(5R)-2-SULFANYL-5-[4-(TRIFLUOROMETHYL)BENZYL]-1,3-THIAZOL-4-ONE",,experimental,MLLT4,Afadin,target,,DB08574
"2-[(1S)-1-BENZYL-2-SULFANYLETHYL]-1H-IMIDAZO[4,5-C]PYRIDIN-5-IUM",,experimental,MME,Neprilysin,target,,DB08575
"1-(5-TERT-BUTYL-1,3,4-OXADIAZOL-2-YL)-2-(METHYLAMINO)ETHANONE",,experimental,pip,Proline iminopeptidase,target,,DB08576
3-[(3-(2-CARBOXYETHYL)-4-METHYLPYRROL-2-YL)METHYLENE]-2-INDOLINONE,,experimental,FGFR1,Fibroblast growth factor receptor 1,target,,DB08577
4-[(5-bromopyridin-2-yl)amino]-4-oxobutanoic acid,,experimental,,Genome polyprotein,target,,DB08578
"4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}aniline",,experimental,,Genome polyprotein,target,,DB08579
4-bromo-2-{[(2R)-2-(2-chlorobenzyl)pyrrolidin-1-yl]carbonyl}aniline,,experimental,,Genome polyprotein,target,,DB08580
"4-[(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)amino]-4-oxobutanoic acid",,experimental,,Genome polyprotein,target,,DB08581
"N-(4-bromo-2-{[(3R,5S)-3,5-dimethylpiperidin-1-yl]carbonyl}phenyl)-4-morpholin-4-yl-4-oxobutanamide",,experimental,,Genome polyprotein,target,,DB08582
"2-amino-5-[3-(1-ethyl-1H-pyrazol-5-yl)-1H-pyrrolo[2,3-b]pyridin-5-yl]-N,N-dimethylbenzamide",,experimental,ABL1,Tyrosine-protein kinase ABL1,target,,DB08583
"6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline",,experimental,MET,Hepatocyte growth factor receptor,target,,DB08584
"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] hexanethioate",,experimental,SCO5089,Actinorhodin polyketide synthase acyl carrier protein,target,,DB08585
"S-[2-({N-[(2S)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] octanethioate",,experimental,SCO5089,Actinorhodin polyketide synthase acyl carrier protein,target,,DB08586
SINAPINATE,,experimental,xynY,"Endo-1,4-beta-xylanase Y",target,,DB08587
2-({2-[(3R)-3-AMINOPIPERIDIN-1-YL]-4-OXOQUINAZOLIN-3(4H)-YL}METHYL)BENZONITRILE,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08588
SYRINGATE,,experimental,xynY,"Endo-1,4-beta-xylanase Y",target,,DB08589
1-(3-HYDROXYPROPYL)-2-[(3-NITROBENZOYL)AMINO]-1H-BENZIMIDAZOL-5-YL PIVALATE,,experimental,IRAK4,Interleukin-1 receptor-associated kinase 4,target,,DB08590
"5-(4-METHOXYBIPHENYL-3-YL)-1,2,5-THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08591
"4-{[4-({4-[(E)-2-cyanoethenyl]-2,6-dimethylphenyl}amino)pyrimidin-2-yl]amino}benzonitrile",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08592
"1,2,5-THIADIAZOLIDIN-3-ONE-1,1-DIOXIDE",,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08593
TERT-BUTYL 2-CYANO-2-METHYLHYDRAZINECARBOXYLATE,,experimental,CTSK,Cathepsin K,target,,DB08594
5'-deoxy-5'-piperidin-1-ylthymidine,,experimental,RNASE1,Ribonuclease pancreatic,target,,DB08596
N-[(4-methoxyphenyl)sulfonyl]-D-alanine,,experimental,MMP12,Macrophage metalloelastase,target,,DB08599
"5-CHLORO-8-METHYL-7-(3-METHYL-BUT-2-ENYL)-6,7,8,9-TETRAHYDRO-2H-2,7,9A-TRIAZA-BENZO[CD]AZULENE-1-THIONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08600
"3-(2,6-difluorophenyl)-2-(methylthio)quinazolin-4(3H)-one",,experimental,PDE7A,"High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A",target,,DB08602
N-[(1S)-5-amino-1-(chloroacetyl)pentyl]-4-methylbenzenesulfonamide,,experimental,,Protease 1,target,,DB08603
"(3R,4S)-1-[(4-AMINO-5H-PYRROLO[3,2-D]PYRIMIDIN-7-YL)METHYL]-4-[(METHYLSULFANYL)METHYL]PYRROLIDIN-3-OL",,experimental,mtnN,5'-methylthioadenosine/S-adenosylhomocysteine nucleosidase,target,,DB08606
"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",,experimental,CYP2C8,Cytochrome P450 2C8,target,,DB08607
"4-({(2R,5S)-2,5-DIMETHYL-4-[(2R)-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANOYL]PIPERAZIN-1-YL}CARBONYL)BENZONITRILE",,experimental,PDK2,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",target,,DB08608
"(N-{4-[(ETHYLANILINO)SULFONYL]-2-METHYLPHENYL}-3,3,3-TRIFLUORO-2-HYDROXY-2-METHYLPROPANAMIDE",,experimental,PDK2,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",target,,DB08609
N-(2-AMINOETHYL)-2-{3-CHLORO-4-[(4-ISOPROPYLBENZYL)OXY]PHENYL} ACETAMIDE,,experimental,PDK2,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 2, mitochondrial",target,,DB08610
"2-[(2',3',4'-TRIFLUOROBIPHENYL-2-YL)OXY]ETHANOL",,experimental,CTSS,Cathepsin S,target,,DB08611
"1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE",,experimental,CES1P1,Putative inactive carboxylesterase 4,target,,DB08612
"2,2,2-TRIFLUORO-1-{5-[(3-PHENYL-5,6-DIHYDROIMIDAZO[1,2-A]PYRAZIN-7(8H)-YL)CARBONYL]THIOPHEN-2-YL}ETHANE-1,1-DIOL",,experimental,HDAC4,Histone deacetylase 4,target,,DB08613
"3-[[(METHYLAMINO)SULFONYL]AMINO]-2-OXO-6-PHENYL-N-[3,3,3-TRIFLUORO-1-(1-METHYLETHYL)-2-OXOPHENYL]-1(2H)-PYRIDINE ACETAMIDE",,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB08614
"2-[4-(DIMETHYLAMINO)PHENYL]-6-HYDROXY-3-METHYL-1,3-BENZOTHIAZOL-3-IUM",,experimental,ACHE,Acetylcholinesterase,target,,DB08615
"4-(2,2,2-TRIFLUOROETHYL)-L-PHENYLALANINE",,experimental,YARS,"Tyrosine--tRNA ligase, cytoplasmic",target,,DB08617
3-(HYDROXY-PHENYL-PHOSPHINOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID METHYL ESTER,,experimental,IGHG2,Ig gamma-2 chain C region,target,,DB08618
TESTOSTERONE HEMISUCCINATE,,experimental,ncsA,Neocarzinostatin,target,,DB08619
"{(2Z)-3-[(6-chloropyridin-3-yl)methyl]-1,3-thiazolidin-2-ylidene}cyanamide",,experimental,CHRFAM7A,CHRNA7-FAM7A fusion protein,target,,DB08620
THIAMPHENICOL,,experimental,draA,Dr hemagglutinin structural subunit,target,,DB08621
"4-(4-CHLORO-PHENYL)-1-{3-[2-(4-FLUORO-PHENYL)-[1,3]DITHIOLAN-2-YL]-PROPYL}-PIPERIDIN-4-OL",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08622
"2-[CARBOXY-(2-THIOPHEN-2-YL-ACETYLAMINO)-METHYL]-5-METHYLENE-5,6-DIHYDRO-2H-[1,3]THIAZINE-4-CARBOXYLIC ACID",,experimental,ampC,Beta-lactamase,target,,DB08623
BENZOTHIAZOLE,,experimental,F2,Prothrombin,target,,DB08624
Thiorphan,,experimental,MME,Neprilysin,target,inhibitor,DB08626
"(5R)-4-HYDROXY-3,5-DIMETHYL-5-[(1E,3E)-2-METHYLPENTA-1,3-DIENYL]THIOPHEN-2(5H)-ONE",,experimental,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB08627
"(5R)-5-[(1E)-BUTA-1,3-DIENYL]-4-HYDROXY-3,5-DIMETHYLTHIOPHEN-2(5H)-ONE",,experimental,fabB,3-oxoacyl-[acyl-carrier-protein] synthase 1,target,,DB08628
"N-(4-CHLOROPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE-7-SULFONAMIDE",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB08631
"(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER",,experimental,METAP2,Methionine aminopeptidase 2,target,,DB08633
6-BENZYL-1-BENZYLOXYMETHYL-5-ISOPROPYL URACIL,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08634
N-(TRANS-4'-NITRO-4-STILBENYL)-N-METHYL-5-AMINO-PENTANOIC ACID,,experimental,,Ig heavy chain V-III region CAM,target,,DB08635
(3E)-4-(2-HYDROXYPHENYL)-2-OXOBUT-3-ENOIC ACID,,experimental,nahD,2-hydroxychromene-2-carboxylate isomerase,target,,DB08636
4-(2-METHOXYPHENYL)-2-OXOBUT-3-ENOIC ACID,,experimental,nahD,2-hydroxychromene-2-carboxylate isomerase,target,,DB08637
2-AMINO-3-(1-HYDROPEROXY-1H-INDOL-3-YL)PROPAN-1-OL,,experimental,katG,Catalase-peroxidase,target,,DB08638
"4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08639
"(2S,3S)-3-FORMYL-2-({[(4-METHYLPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB08640
"(2S,3S)-3-FORMYL-2-({[(4-NITROPHENYL)SULFONYL]AMINO}METHYL)PENTANOIC ACID",,experimental,CELA1,Chymotrypsin-like elastase family member 1,target,,DB08641
"(2R,6S)-6-{[methyl(3,4,5-trimethoxyphenyl)amino]methyl}-1,2,5,6,7,8-hexahydroquinazoline-2,4-diamine",,experimental,DHFR,Dihydrofolate reductase,target,,DB08642
2-(2-{2-[(BIPHENYL-4-YLMETHYL)-AMINO]-3-MERCAPTO-PENTANOYLAMINO}-ACETYLAMINO)-3-METHYL-BUTYRIC ACID METHYL ESTER,,experimental,MMP3,Stromelysin-1,target,,DB08643
{1-[2-(1-FORMYL-PROPYL)-3-METHANESULFONYLAMINO-PYRROLIDINE-1-CARBONYL]-2-METHYL-PROPYL}-CARBAMIC ACID TERT-BUTYL ESTER,,experimental,,Genome polyprotein,target,,DB08644
"6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE",,experimental,CA2,Carbonic anhydrase 2,target,,DB08645
TRAZEOLIDE,,experimental,IGKC,Ig kappa chain C region,target,,DB08647
"TRANS-(1S,2S)-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALEN-1-OL",,experimental,PNMT,Phenylethanolamine N-methyltransferase,target,,DB08654
"9-ACETYL-2,3,4,9-TETRAHYDRO-1H-CARBAZOL-1-ONE",,experimental,CREBBP,CREB-binding protein,target,,DB08655
5-amino-2-methyl-N-[(1R)-1-naphthalen-1-ylethyl]benzamide,,experimental,rep,Replicase polyprotein 1ab,target,,DB08656
2-(4-(2-((3-(5-(PYRIDIN-2-YLTHIO)THIAZOL-2-YL)UREIDO)METHYL)-1H-IMIDAZOL-4-YL)PHENOXY)ACETIC ACID,,experimental,fabK,Trans-2-enoyl-ACP reductase II,target,,DB08657
ETHYL HYDROGEN DIETHYLAMIDOPHOSPHATE,,experimental,BCHE,Cholinesterase,target,,DB08658
2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide,,experimental,CA2,Carbonic anhydrase 2,target,,DB08659
"1,2,5,8-tetrahydroxyanthracene-9,10-dione",,experimental,CSNK2A1,Casein kinase II subunit alpha,target,,DB08660
"1-(2,5-dideoxy-5-pyrrolidin-1-yl-beta-L-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione",,experimental,RNASE1,Ribonuclease pancreatic,target,,DB08661
3-[1-(4-BROMO-PHENYL)-2-METHYL-PROPYL]-4-HYDROXY-CHROMEN-2-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08662
4-HYDROXY-7-METHOXY-3-(1-PHENYL-PROPYL)-CHROMEN-2-ONE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08663
({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN-3-YL)-PROPYL]-PHENYLCARBAMOYL}-METHYL)-CARBAMIC ACID TERT-BUTYL ESTER,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08664
"6,11-DIHYDRO-11-ETHYL-6-METHYL-9-NITRO-5H-PYRIDO[2,3-B][1,5]BENZODIAZEPIN-5-ONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08665
5-IMINO-4-(3-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE,,experimental,map,Methionine aminopeptidase,target,,DB08666
4-(4-FLUORO-PHENYLAZO)-5-IMINO-5H-PYRAZOL-3-YLAMINE,,experimental,map,Methionine aminopeptidase,target,,DB08667
3-(5-AMINO-3-IMINO-3H-PYRAZOL-4-YLAZO)-BENZOIC ACID,,experimental,map,Methionine aminopeptidase,target,,DB08668
"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-METHYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",,experimental,map,Methionine aminopeptidase,target,,DB08669
"METHYL N-[(2S,3R)-3-AMINO-2-HYDROXY-3-(4-ISOPROPYLPHENYL)PROPANOYL]-D-ALANYL-D-LEUCINATE",,experimental,map,Methionine aminopeptidase,target,,DB08670
5-IMINO-4-(2-TRIFLUOROMETHYL-PHENYLAZO)-5H-PYRAZOL-3-YLAMINE,,experimental,map,Methionine aminopeptidase,target,,DB08671
4-[(3R)-3-{[2-(4-FLUOROPHENYL)-2-OXOETHYL]AMINO}BUTYL]BENZAMIDE,,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08672
"4-[(5-ISOPROPYL-1,3-THIAZOL-2-YL)AMINO]BENZENESULFONAMIDE",,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08673
"(6E)-7-{6-[(1E)-OCT-1-ENYL]-2,3-DIAZABICYCLO[2.2.1]HEPT-2-EN-5-YL}HEPT-6-ENOIC ACID",,experimental,PTGIS,Prostacyclin synthase,target,,DB08675
N-(5-ISOPROPYL-THIAZOL-2-YL)-2-PYRIDIN-3-YL-ACETAMIDE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08677
(4-ETHYLPHENYL)SULFAMIC ACID,,experimental,PTPRB,Receptor-type tyrosine-protein phosphatase beta,target,,DB08678
2-METHYL-FURAN-3-CARBOTHIOIC ACID [4-CHLORO-3-(3-METHYL-BUT-2-ENYLOXY)-PHENYL]-AMIDE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08679
N-[4-CLORO-3-(T-BUTYLOXOME)PHENYL-2-METHYL-3-FURAN-CARBOTHIAMIDE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08680
1-METHYL ETHYL 2-CHLORO-5-[[[(1-METHYLETHOXY)THIOOXO]METHYL]AMINO]-BENZOATE,,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08681
"1-METHYL ETHYL 1-CHLORO-5-[[(5,6DIHYDRO-2-METHYL-1,4-OXATHIIN-3-YL)CARBONYL]AMINO]BENZOATE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08682
"REL-(9R,12S)-9,10,11,12-TETRAHYDRO-9,12-EPOXY-1H-DIINDOLO[1,2,3-FG:3',2',1'-KL]PYRROLO[3,4-I][1,6]BENZODIAZOCINE-1,3(2H)-DIONE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08683
O-DECYL HYDROGEN THIOCARBONATE,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB08684
"1-(1,4-dimethyl-1,2,3,4-tetrahydroquinoxalin-6-yl)methanamine",,experimental,BURPS1710b_3237,Glutaryl-CoA dehydrogenase,target,,DB08685
"5,6,7,8,9,10-HEXAHYDRO-4-HYDROXY-3-(1-PHENYLPROPYL)CYCLOOCTA[B]PYRAN-2-ONE",,experimental,gag-pol,Gag-Pol polyprotein,target,,DB08686
undecan-2-one,,experimental,ACOT13,Acyl-coenzyme A thioesterase 13,target,,DB08688
D-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID,,experimental,CTRB1,Chymotrypsinogen B,target,,DB08692
L-1-(4-CHLOROPHENYL)-2-(ACETAMIDO)ETHANE BORONIC ACID,,experimental,CTRB1,Chymotrypsinogen B,target,,DB08693
3-(4-nitrophenyl)-1H-pyrazole,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB08695
"4-(2-aminoethoxy)-N-(3-chloro-5-piperidin-1-ylphenyl)-3,5-dimethylbenzamide",,experimental,PLAU,Urokinase-type plasminogen activator,target,,DB08697
"1-[(3S)-5-PHENYL-3-THIOPHEN-2-YL-3H-1,4-BENZODIAZEPIN-2-YL]AZETIDIN-3-OL",,experimental,murI,Glutamate racemase,target,,DB08698
"1-tert-butyl-3-(3-methylbenzyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine",,experimental,CAMK2G,Calcium/calmodulin-dependent protein kinase type II subunit gamma,target,,DB08699
"3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)pyridin-2-amine",,experimental,MET,Hepatocyte growth factor receptor,target,,DB08700
"2,5-DIPHENYLFURAN-3,4-DICARBOXYLIC ACID",,experimental,,Metallo-beta-lactamase L1,target,,DB08702
"12-(2-hydroxyethyl)-2-(1-methylethoxy)-13,14-dihydronaphtho[2,1-a]pyrrolo[3,4-c]carbazol-5(12H)-one",,experimental,MAP3K9,Mitogen-activated protein kinase kinase kinase 9,target,,DB08703
"[[(3R,4R,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-(pentanoylamino)oxan-2-ylidene]amino] N-phenylcarbamate",,experimental,nagZ,Beta-hexosaminidase,target,,DB08704
"6-(5-BROMO-2-HYDROXYPHENYL)-2-OXO-4-PHENYL-1,2-DIHYDROPYRIDINE-3-CARBONITRILE",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08705
"(2S)-({(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-4-OXO-4,5-DIHYDRO-1,3-THIAZOL-2-YL}AMINO)(4-FLUOROPHENYL)ACETIC ACID",,experimental,,Genome polyprotein,target,,DB08706
"4-[3-(4-chlorophenyl)-2,1-benzisoxazol-5-yl]pyrimidin-2-amine",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08707
"N-cyclohexyl-3-[3-(trifluoromethyl)phenyl][1,2,4]triazolo[4,3-b]pyridazin-6-amine",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08708
"2,3-diphenyl-1H-indole-7-carboxylic acid",,experimental,PIM1,Serine/threonine-protein kinase pim-1,target,,DB08709
"(5Z)-5-[(5-ETHYL-2-FURYL)METHYLENE]-2-{[(S)-(4-FLUOROPHENYL)(1H-TETRAZOL-5-YL)METHYL]AMINO}-1,3-THIAZOL-4(5H)-ONE",,experimental,,Genome polyprotein,target,,DB08710
VANILLATE,,experimental,xynY,"Endo-1,4-beta-xylanase Y",target,,DB08711
11-[(MERCAPTOCARBONYL)OXY]UNDECANOIC ACID,,experimental,fabH,3-oxoacyl-[acyl-carrier-protein] synthase 3,target,,DB08712
"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2N-METHYL-2H-TETRAZOL-5-YL]-PHENOL",,experimental,,Genome polyprotein,target,,DB08713
"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[4-METHYL-2H-TETRAZOL-2-YL]-PHENOL",,experimental,,Genome polyprotein,target,,DB08714
"2,6-DIMETHYL-1-(3-[3-METHYL-5-ISOXAZOLYL]-PROPANYL)-4-[2-METHYL-4-ISOXAZOLYL]-PHENOL",,experimental,,Genome polyprotein,target,,DB08715
"[(2S)-4-methyl-3-oxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-2-yl]acetic acid",,experimental,,Carboxylesterase,target,,DB08717
"4-(3-ethylthiophen-2-yl)benzene-1,2-diol",,experimental,map,Methionine aminopeptidase,target,,DB08718
"5-(5-(6-CHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08719
"5-(5-(4-(4,5-DIHYDRO-2-OXAZOLY)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08720
"5-(5-(2,6-DICHLORO-4-(4,5-DIHYDRO-2-OXAZOLYL)PHENOXY)PENTYL)-3-(HYDROXYETHYL OXYMETHYLENEOXYMETHYL) ISOXAZOLE",,experimental,,Genome polyprotein,target,,DB08721
5-(7-(6-CHLORO-4-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE,,experimental,,Genome polyprotein,target,,DB08722
5-(5-(4-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)PENTYL)-3-METHYL ISOXAZOLE,,experimental,,Genome polyprotein,target,,DB08724
5-(7-(5-HYDRO-4-ETHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE,,experimental,,Genome polyprotein,target,,DB08725
5-(7-(5-HYDRO-4-METHYL-2-OXAZOLYL)PHENOXY)HEPTYL)-3-METHYL ISOXAZOLE,,experimental,,Genome polyprotein,target,,DB08727
"5-ethoxy-4-(1-methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-yl)thiophene-2-sulfonamide",,experimental,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",target,,DB08729
3-FLUORO-5-MORPHOLIN-4-YL-N-[1-(2-PYRIDIN-4-YLETHYL)-1H-INDOL-6-YL]BENZAMIDE,,experimental,MAPK14,Mitogen-activated protein kinase 14,target,,DB08730
"2-[(1R)-2-carboxy-1-(naphthalen-1-ylmethyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindole-5-carboxylic acid",,experimental,ampC,Beta-lactamase,target,,DB08731
"(2R,3R)-N^1^-[(1S)-2,2-DIMETHYL-1-(METHYLCARBAMOYL)PROPYL]-N^4^-HYDROXY-2-(2-METHYLPROPYL)-3-{[(1,3-THIAZOL-2-YLCARBONYL)AMINO]METHYL}BUTANEDIAMIDE",,experimental,ADAM28,Disintegrin and metalloproteinase domain-containing protein 28,target,,DB08733
"6,6-DIMETHYL-1-[3-(2,4,5-TRICHLOROPHENOXY)PROPOXY]-1,6-DIHYDRO-1,3,5-TRIAZINE-2,4-DIAMINE",,experimental,TYMS,Thymidylate synthase,target,,DB08734
"(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA[C]CHROMEN-9-OL",,experimental,ESR1,Estrogen receptor,target,,DB08737
1-{3-oxo-3-[(2S)-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]propyl}-3-phenylquinoxalin-2(1H)-one,,experimental,PREP,Prolyl endopeptidase,target,,DB08738
"2-{3-[(2S)-4,4-difluoro-2-(pyrrolidin-1-ylcarbonyl)pyrrolidin-1-yl]-3-oxopropyl}-isoindole-1,3(2H)-dione",,experimental,PREP,Prolyl endopeptidase,target,,DB08739
"CYCLOHEXYLMETHYL-2,3-DIHYDROXY-5-METHYL-HEXYLAMIDE",,experimental,CTSD,Cathepsin D,target,,DB08740
"5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine",,experimental,folA,Dihydrofolate reductase,target,,DB08741
"2-({8-[(3R)-3-AMINOPIPERIDIN-1-YL]-1,3-DIMETHYL-2,6-DIOXO-1,2,3,6-TETRAHYDRO-7H-PURIN-7-YL}METHYL)BENZONITRILE",,experimental,DPP4,Dipeptidyl peptidase 4,target,,DB08743
"6-methoxy-9-methyl[1,3]dioxolo[4,5-h]quinolin-8(9H)-one",,experimental,NQO2,Ribosyldihydronicotinamide dehydrogenase [quinone],target,,DB08744
4-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINONE,,experimental,F10,Coagulation factor X,target,,DB08745
1-[[(1E)-2-(4-CHLOROPHENYL)ETHENYL]SULFONYL]-4-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]PIPERAZINE,,experimental,F10,Coagulation factor X,target,,DB08746
"(11R)-10-acetyl-11-(2,4-dichlorophenyl)-6-hydroxy-3,3-dimethyl-2,3,4,5,10,11-hexahydro-1H-dibenzo[b,e][1,4]diazepin-1-one",,experimental,,Genome polyprotein,target,,DB08747
3-(2-AMINO-6-BENZOYLQUINAZOLIN-3(4H)-YL)-N-CYCLOHEXYL-N-METHYLPROPANAMIDE,,experimental,BACE1,Beta-secretase 1,target,,DB08749
"1-[4-(AMINOMETHYL)BENZOYL]-5'-FLUORO-1'H-SPIRO[PIPERIDINE-4,2'-QUINAZOLIN]-4'-AMINE",,experimental,NOS2,"Nitric oxide synthase, inducible",target,,DB08750
"N,N'-DIMETHYL-N-(ACETYL)-N'-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)ETHYLENEDIAMINE",,experimental,HRAS,GTPase HRas,target,,DB08751
N-[(1S)-2-[(4-cyano-1-methylpiperidin-4-yl)amino]-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,,experimental,CTSS,Cathepsin S,target,,DB08752
"4-{(1E)-3-OXO-3-[(2-PHENYLETHYL)AMINO]PROP-1-EN-1-YL}-1,2-PHENYLENE DIACETATE",,experimental,def,Peptide deformylase,target,,DB08753
"(2E)-3-(3,4-DIHYDROXYPHENYL)-N-[2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE",,experimental,def,Peptide deformylase,target,,DB08754
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide,,experimental,CTSS,Cathepsin S,target,,DB08755
5-(2-chlorophenyl)furan-2-carbohydrazide,,experimental,map,Methionine aminopeptidase,target,,DB08757
"IMIDAZO[2,1-A]ISOQUINOLINE-2-CARBOHYDRAZIDE",,experimental,map,Methionine aminopeptidase,target,,DB08758
"[(3R,4S,5S,7R)-4,8-DIHYDROXY-3,5,7-TRIMETHYL-2-OXOOCTYL]PHOSPHONIC ACID",,experimental,pikAIV,Type I polyketide synthase PikAIV,target,,DB08759
(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid,,experimental,PPARG,Peroxisome proliferator-activated receptor gamma,target,,DB08760
"(3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine-2,5-dione",,experimental,cyp121,Mycocyclosin synthase,target,,DB08761
O-(((1R)-((N-PHENYLMETHOXYCARBONYL-L-ALANYL)AMINO)ETHYL)HYDROXYPHOSPHONO)-L-BENZYLACETIC ACID,,experimental,CPA1,Carboxypeptidase A1,target,,DB08762
[N-(BENZYLOXYCARBONYL)AMINO](4-AMIDINOPHENYL)METHANE-PHOSPHONATE,,experimental,PRSS1,Trypsin-1,target,,DB08763
4-BROMO-2-FLUORO-N-[(4E)-6-METHOXY-7-[(1-METHYLPIPERIDIN-4-YL)METHOXY]QUINAZOLIN-4(1H)-YLIDENE]ANILINE,,experimental,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,target,,DB08764
"L-PROLINE, 1-[(2S)-3-MERCAPTO-2-METHYL-1-OXOPROPYL]-4-(PHENYLTHIO)-, 4S",,experimental,LAP3,Cytosol aminopeptidase,target,,DB08766
N-(3-METHYLBUT-2-EN-1-YL)-9H-PURIN-6-AMINE,,experimental,CDK2deltaT,Cyclin-dependent kinase 2,target,,DB08768
"4-{2-[(7-amino-2-furan-2-yl[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)amino]ethyl}phenol",,experimental,ADORA2A,Adenosine receptor A2a,target,,DB08770
"(5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one",,experimental,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,target,,DB08771
"1-[(2S)-4-(5-phenyl-1H-pyrazolo[3,4-b]pyridin-4-yl)morpholin-2-yl]methanamine",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08774
BENZOYL-TYROSINE-ALANINE-METHYL KETONE,,experimental,CTSF,Cathepsin F,target,,DB08775
"N-(4-OXO-5,6,7,8-TETRAHYDRO-4H-[1,3]THIAZOLO[5,4-C]AZEPIN-2-YL)ACETAMIDE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08776
"5,6,7,8-TETRAHYDRO[1]BENZOTHIENO[2,3-D]PYRIMIDIN-4(3H)-ONE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08777
"[4-amino-2-(tert-butylamino)-1,3-thiazol-5-yl](phenyl)methanone",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08778
2-(methylsulfanyl)-5-(thiophen-2-ylmethyl)-1H-imidazol-4-ol,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08779
6-MORPHOLIN-4-YL-9H-PURINE,,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08780
"1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE",,experimental,CHEK1,Serine/threonine-protein kinase Chk1,target,,DB08781
4-(2-AMINOETHYL)BENZENESULFONAMIDE,,experimental,CA2,Carbonic anhydrase 2,target,,DB08782
(4-{(2S)-2-[(tert-butoxycarbonyl)amino]-3-methoxy-3-oxopropyl}phenyl)methaneseleninic acid,,experimental,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,target,,DB08783
2-(4-CHLORO-PHENYLAMINO)-NICOTINIC ACID,,experimental,NMRAL1,NmrA-like family domain-containing protein 1,target,,DB08784
4-METHYL-2H-CHROMEN-2-ONE,,experimental,celH,Endoglucanase H,target,,DB08785
4-(2-methoxyethoxy)-6-methylpyrimidin-2-amine,,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08786
"4-(2,4-dichlorophenyl)-5-phenyldiazenyl-pyrimidin-2-amine",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08787
"3,6-DIAMINO-5-CYANO-4-(4-ETHOXYPHENYL)THIENO[2,3-B]PYRIDINE-2-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08788
"2-AMINO-4-(2,4-DICHLOROPHENYL)-N-ETHYLTHIENO[2,3-D]PYRIMIDINE-6-CARBOXAMIDE",,experimental,HSP90AA1,Heat shock protein HSP 90-alpha,target,,DB08789
1-PHENYL-1H-PYRAZOLE-4-CARBOXYLIC ACID,,experimental,HPGDS,Hematopoietic prostaglandin D synthase,target,,DB08790
"1-[(2-NITROPHENYL)SULFONYL]-1H-PYRROLO[3,2-B]PYRIDINE-6-CARBOXAMIDE",,experimental,MET,Hepatocyte growth factor receptor,target,,DB08791
Sulfamoxole,Anti-Bacterial AgentsAnti-Infective Agents,approved,,Dihydropteroate synthetase,target,inhibitor,DB08798
Antazoline,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB08799
Chloropyramine,Histamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB08800
Isothipendyl,AntipruriticsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB08802
Nandrolone decanoate,Anabolic Agents,approvedillicit,AR,Androgen receptor,target,agonist,DB08804
Metiamide,Anti-Ulcer AgentsHistamine H2 Antagonists,experimental,HRH2,Histamine H2 receptor,target,antagonist,DB08805
Roxatidine acetate,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,HRH2,Histamine H2 receptor,target,antagonist,DB08806
Dichloroacetic Acid,,experimental,PDK1,"[Pyruvate dehydrogenase [lipoamide]] kinase isozyme 1, mitochondrial",target,inhibitor,DB08809
Ticagrelor,Platelet Aggregation Inhibitors,approved,P2RY12,P2Y purinoceptor 12,target,inhibitor,DB08816
Tafluprost,"Prostaglandins, SyntheticOphthalmics",approved,PTGFR,Prostaglandin F2-alpha receptor,target,agonist,DB08819
Ivacaftor,,approved,CFTR,Cystic fibrosis transmembrane conductance regulator,target,potentiator,DB08820
Azilsartan medoxomil,Angiotensin Receptor Antagonists,approved,AGTR1,Type-1 angiotensin II receptor,target,antagonist,DB08822
Lomitapide,Hypolipidemic Agents,approved,MTTP,Microsomal triglyceride transfer protein large subunit,target,antagonist,DB08827
Vismodegib,,approved,SMO,Smoothened homolog,target,antagonist,DB08828
Temocapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,experimentalinvestigational,ACE,Angiotensin-converting enzyme,target,inhibitor,DB08836
Uric Acid,Antioxidants,experimentalinvestigational,PYGL,"Glycogen phosphorylase, liver form",target,,DB08844
Pitavastatin,Hypolipidemic Agents,approved,HMGCR,3-hydroxy-3-methylglutaryl-coenzyme A reductase,target,inhibitor,DB08860
Fingolimod,,approvedinvestigational,S1PR5,Sphingosine 1-phosphate receptor 5,target,modulator,DB08868
Tesamorelin,,approvedinvestigational,GHRHR,Growth hormone-releasing hormone receptor,target,binder,DB08869
Brentuximab vedotin,,approved,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,target,binder,DB08870
Boceprevir,,approved,,NS3/4A protein,target,inhibitor,DB08873
Fidaxomicin,Antibiotics,approved,,RNA polymerase sigma factor,target,inhibitor,DB08874
Belimumab,Monoclonal antibodies,approved,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,target,neutralizer,DB08879
Teriflunomide,,approved,DHODH,"Dihydroorotate dehydrogenase (quinone), mitochondrial",target,inhibitor,DB08880
Vemurafenib,,approved,BRAF,Serine/threonine-protein kinase B-raf,target,inhibitor,DB08881
Linagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,DPP4,Dipeptidyl peptidase 4,target,inhibitor,DB08882
Perampanel,,approved,GRIA1,Glutamate receptor 1,target,antagonist,DB08883
Linaclotide,,approved,GUCY2C,Heat-stable enterotoxin receptor,target,agonist,DB08890
Mirabegron,"Muscle Relaxants, Genitourinary",approved,ADRB3,Beta-3 adrenergic receptor,target,agonist,DB08893
Peginesatide,Colony-Stimulating FactorsHematopoietic Agents,approved,EPOR,Erythropoietin receptor,target,stimulator,DB08894
Enzalutamide,Antineoplastic Agents,approved,AR,Androgen receptor,target,inhibitor,DB08899
Teduglutide,,approved,GLP2R,Glucagon-like peptide 2 receptor,target,agonist,DB08900
Raxibacumab,Anti-Infective AgentsMonoclonal antibodies,approved,,Protective antigen,target,antibody,DB08902
Bedaquiline,Antitubercular Agents,approved,,ATP synthase subunit c,target,inhibitor,DB08903
Certolizumab pegol,TNF inhibitor,approved,TNF,Tumor necrosis factor,target,neutralizer,DB08904
Fluticasone furoate,Corticosteroids,approved,NR3C1,Glucocorticoid receptor,target,agonist,DB08906
Dimethyl fumarate,Dermatologic AgentsImmunosuppressive AgentsRadiation-Sensitizing Agents,approvedinvestigational,,Kelch-like ECH-associated protein 1,target,binder,DB08908
"Insulin, isophane",Hypoglycemic AgentsAntidiabetic Agents,approved,INSR,Insulin receptor,target,agonist,DB08914
Epoetin Zeta,,approved,EPOR,Erythropoietin receptor,target,agonist,DB08923
Amperozide,,experimental,HTR2A,5-hydroxytryptamine receptor 2A,target,antagonist,DB08927
MK-8931,,investigational,BACE1,Beta-secretase 1,target,inhibitor,DB08929
Dolutegravir,,approved,,Integrase,target,inhibitor,DB08930
LULICONAZOLE,Antifungal Agents,approved,ERG11,Lanosterol 14-alpha demethylase,target,inhibitor,DB08933
Obinutuzumab,Antineoplastic Agents,approved,MS4A1,B-lymphocyte antigen CD20,target,antibody,DB08935
Chlorcyclizine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine Antagonists,approved,HRH1,Histamine H1 receptor,target,antagonist,DB08936
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCB11,Bile salt export pump,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,SLC10A1,Sodium/bile acid cotransporter,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00091
Cyclosporine,Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsAntifungal AgentsEnzyme Inhibitors,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00091
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,AMN,Protein amnionless,transporter,substrate,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,TCN1,Transcobalamin-1,transporter,substrate,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,TCN2,Transcobalamin-2,transporter,substrate,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,,Gastric intrinsic factor,transporter,substrate,DB00115
Cyanocobalamin,Vitamin B ComplexVitaminsAnti-anemic Agents,approvednutraceutical,CUBN,Cubilin,transporter,substrate,DB00115
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A7,Monocarboxylate transporter 2,transporter,substrateinhibitor,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A1,Monocarboxylate transporter 1,transporter,substrateinhibitor,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB00119
Pyruvic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB00119
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC44A1,Choline transporter-like protein 1,transporter,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC44A4,Choline transporter-like protein 4,transporter,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC44A2,Choline transporter-like protein 2,transporter,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC44A3,Choline transporter-like protein 3,transporter,substrate,DB00122
Choline,Lipotropic AgentsNootropic AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC5A7,High affinity choline transporter 1,transporter,substrate,DB00122
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB00123
L-Lysine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00123
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00125
L-Arginine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00125
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00127
Spermine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00127
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,SLC38A3,Sodium-coupled neutral amino acid transporter 3,transporter,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,SLC1A5,Neutral amino acid transporter B(0),transporter,substrate,DB00130
L-Glutamine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvedinvestigationalnutraceutical,SLC7A8,Large neutral amino acids transporter small subunit 2,transporter,substrate,DB00130
L-Tyrosine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A2,Monocarboxylate transporter 8,transporter,inhibitor,DB00135
L-Tyrosine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00135
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB00142
L-Glutamic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,nutraceutical,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00142
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00143
Glutathione,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC5,Multidrug resistance-associated protein 5,transporter,substrate,DB00143
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00149
L-Leucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A2,Monocarboxylate transporter 8,transporter,substrate,DB00149
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A2,Monocarboxylate transporter 8,transporter,inhibitor,DB00150
L-Tryptophan,"Antidepressive Agents, Second-GenerationDietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00150
Thiamine,Vitamin B ComplexVitamins,approvednutraceutical,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00152
Thiamine,Vitamin B ComplexVitamins,approvednutraceutical,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00152
Thiamine,Vitamin B ComplexVitamins,approvednutraceutical,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00152
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC11,ATP-binding cassette sub-family C member 11,transporter,substrate,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC46A1,Proton-coupled folate transporter,transporter,substrate,DB00158
Folic Acid,HematinicsVitamin B ComplexDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC25A32,Mitochondrial folate transporter/carrier,transporter,substrate,DB00158
Aspartame,Sweetening AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00168
Aspartame,Sweetening AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00168
Aspartame,Sweetening AgentsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00168
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC16A1,Monocarboxylate transporter 1,transporter,,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCB11,Bile salt export pump,transporter,substrate,DB00175
Pravastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00175
Valsartan,Angiotensin Receptor Antagonists,approvedinvestigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00177
Valsartan,Angiotensin Receptor Antagonists,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00177
Ramipril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00178
Ramipril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00178
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00182
Amphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimeticsAmphetamines,approvedillicit,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00182
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00184
Nicotine,Ganglionic StimulantsNicotinic AgonistsAppetite DepressantsAutonomic Agents,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00184
Troglitazone,,withdrawn,ABCB11,Bile salt export pump,transporter,inhibitor,DB00197
Troglitazone,,withdrawn,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00197
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00198
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00198
Oseltamivir,Antiviral AgentsEnzyme Inhibitors,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00198
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00199
Erythromycin,Gastrointestinal AgentsAnti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00199
Sildenafil,,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00203
Sildenafil,,approvedinvestigational,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB00203
Sildenafil,,approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB00203
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00206
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00206
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00206
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00206
Reserpine,Antihypertensive AgentsAdrenergic Uptake InhibitorsAntipsychotic AgentsAdrenergic Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00206
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00213
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00213
Pantoprazole,Anti-Ulcer AgentsProton Pump Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00213
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,SLC6A3,Sodium-dependent dopamine transporter,transporter,substrateinhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,SLC6A2,Sodium-dependent noradrenaline transporter,transporter,substrateinhibitor,DB00215
Citalopram,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAntidepressive Agents",approved,SLC6A4,Sodium-dependent serotonin transporter,transporter,substrateinhibitor,DB00215
Nelfinavir,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00220
Nelfinavir,,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00220
Nelfinavir,,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00220
Nelfinavir,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00220
Nelfinavir,,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00220
Indinavir,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00224
Indinavir,,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00224
Indinavir,,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00224
Indinavir,,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00224
Indinavir,,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00224
Indinavir,,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00224
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00227
Lovastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00227
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00242
Cladribine,Antineoplastic AgentsImmunosuppressive Agents,approvedinvestigational,SLC28A3,Solute carrier family 28 member 3,transporter,,DB00242
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,inhibitor,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00252
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00252
Doxycycline,Anti-Bacterial AgentsAntimalarialsTetracyclines,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00254
Doxycycline,Anti-Bacterial AgentsAntimalarialsTetracyclines,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00254
Doxycycline,Anti-Bacterial AgentsAntimalarialsTetracyclines,approvedinvestigational,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00254
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00255
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00255
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitorinducer,DB00257
Clotrimazole,"Antifungal Agents14-alpha Demethylase InhibitorsAnti-Infective Agents, Local",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB00257
Metoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00264
Metoprolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00264
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00274
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00274
Olmesartan,Angiotensin II Type 1 Receptor Blockers,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinducer,DB00275
Olmesartan,Angiotensin II Type 1 Receptor Blockers,approvedinvestigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00275
Olmesartan,Angiotensin II Type 1 Receptor Blockers,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00275
Liothyronine,Hormone Replacement Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,substrate,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrateinhibitor,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,substrateinhibitor,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00279
Liothyronine,Hormone Replacement Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB00279
Liothyronine,Hormone Replacement Agents,approved,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB00279
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00280
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00280
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00281
Lidocaine,"Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersAnesthetics, Local",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00281
Venlafaxine,Antidepressive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00285
Venlafaxine,Antidepressive Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inducer,DB00285
Conjugated Estrogens,Estrogens,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,inhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLC22A10,Solute carrier family 22 member 10,transporter,inhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrateinhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitor,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,OSTA,Organic solute transporter subunit alpha,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,OSTB,Organic solute transporter subunit beta,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,ABCC11,ATP-binding cassette sub-family C member 11,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,SLC22A11,Solute carrier family 22 member 11,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,substrate,DB00286
Conjugated Estrogens,Estrogens,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00286
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00300
Tenofovir,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00300
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00313
Valproic Acid,Enzyme InhibitorsAnticonvulsantsAntimanic AgentsGABA Agents,approvedinvestigational,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00313
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00316
Acetaminophen,"Analgesics, Non-NarcoticAntipyretics",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00316
Gefitinib,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00317
Gefitinib,,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00317
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCC6,Multidrug resistance-associated protein 6,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ABCC11,ATP-binding cassette sub-family C member 11,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB00328
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00328
Metformin,Antidiabetic Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00331
Metformin,Antidiabetic Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00331
Metformin,Antidiabetic Agents,approved,SLC22A3,Solute carrier family 22 member 3,transporter,substrate,DB00331
Metformin,Antidiabetic Agents,approved,SLC47A1,Multidrug and toxin extrusion protein 1,transporter,inhibitor,DB00331
Metformin,Antidiabetic Agents,approved,,Equilibrative nucleoside transporter 4,transporter,substrate,DB00331
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,SLC22A5,Solute carrier family 22 member 5,transporter,substrate,DB00332
Ipratropium bromide,Bronchodilator AgentsMuscarinic AntagonistsCholinergic AntagonistsAntispasmodics,approved,SLC22A4,Solute carrier family 22 member 4,transporter,substrate,DB00332
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00338
Omeprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump Inhibitors,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00338
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A11,Solute carrier family 22 member 11,transporter,substrateinhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00345
Aminohippurate,Indicators and ReagentsDiagnostic Agents,approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00345
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,SLC6A1,Sodium- and chloride-dependent GABA transporter 1,transporter,Other,DB00349
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,,Sodium- and chloride-dependent GABA transporter 3,transporter,Other,DB00349
Clobazam,AnticonvulsantsBenzodiazepines,approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00349
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00365
Grepafloxacin,Anti-Infective AgentsQuinolonesAntibiotics,withdrawn,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00365
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC6A2,Sodium-dependent noradrenaline transporter,transporter,substrate,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC22A3,Solute carrier family 22 member 3,transporter,substrateinhibitor,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00368
Norepinephrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-Agonists,approved,POU5F1,"POU domain, class 5, transcription factor 1",transporter,substrate,DB00368
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,inhibitor,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ABCB11,Bile salt export pump,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,OSTA,Organic solute transporter subunit alpha,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,OSTB,Organic solute transporter subunit beta,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrate,DB00390
Digoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitor,DB00390
Progesterone,ProgestinsContraceptive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00396
Progesterone,ProgestinsContraceptive Agents,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,inhibitor,DB00396
Sorafenib,Antineoplastic Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00398
Sorafenib,Antineoplastic Agents,approvedinvestigational,,RalA-binding protein 1,transporter,substrate,DB00398
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00413
Pramipexole,AntioxidantsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00413
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00415
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,SLC16A1,Monocarboxylate transporter 1,transporter,,DB00415
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00421
Spironolactone,DiureticsMineralocorticoid Receptor Antagonists,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00421
Allopurinol,Gout SuppressantsEnzyme InhibitorsAntimetabolitesFree Radical Scavengers,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00437
Allopurinol,Gout SuppressantsEnzyme InhibitorsAntimetabolitesFree Radical Scavengers,approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00437
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00438
Ceftazidime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00438
Cerivastatin,Hypolipidemic Agents,withdrawn,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00439
Cerivastatin,Hypolipidemic Agents,withdrawn,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00439
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,ABCC10,Multidrug resistance-associated protein 7,transporter,substrate,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,substrate,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,,Sodium/nucleoside cotransporter 1,transporter,,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,,Equilibrative nucleoside transporter 2,transporter,,DB00441
Gemcitabine,"Antiviral AgentsImmunosuppressive AgentsEnzyme InhibitorsAntimetabolites, AntineoplasticRadiation-Sensitizing Agents",approved,SLC28A3,Solute carrier family 28 member 3,transporter,substrate,DB00441
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,ABCC6,Multidrug resistance-associated protein 6,transporter,substrate,DB00444
Teniposide,Antineoplastic AgentsEnzyme InhibitorsNucleic Acid Synthesis Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00444
Loracarbef,Anti-Bacterial AgentsAntibiotics,withdrawn,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00447
Loracarbef,Anti-Bacterial AgentsAntibiotics,withdrawn,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00447
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00448
Lansoprazole,Enzyme InhibitorsAnti-Ulcer AgentsProton Pump InhibitorsAnti-Infective Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00448
Levothyroxine,,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrate,DB00451
Levothyroxine,,approved,SLC16A2,Monocarboxylate transporter 8,transporter,inhibitor,DB00451
Levothyroxine,,approved,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB00451
Levothyroxine,,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB00451
Levothyroxine,,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,,DB00451
Levothyroxine,,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB00451
Levothyroxine,,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,,DB00451
Levothyroxine,,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,,DB00451
Levothyroxine,,approved,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB00451
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00456
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00456
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00457
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00457
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00458
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00458
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00468
Quinine,"AntimalarialsAnalgesics, Non-NarcoticMuscle Relaxants, Central",approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00468
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00470
Dronabinol,"Analgesics, Non-NarcoticCannabinoid Receptor AgonistsHallucinogensPsychotropic Drugs",approvedillicit,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00470
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00477
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00477
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00485
Dicloxacillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00485
Fosinopril,,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00492
Fosinopril,,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00492
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00493
Cefotaxime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00493
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A2,Solute carrier family 22 member 2,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A7,Solute carrier family 22 member 7,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A8,Solute carrier family 22 member 8,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A11,Solute carrier family 22 member 11,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,,Sodium/nucleoside cotransporter 1,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,,Equilibrative nucleoside transporter 2,transporter,,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,ABCC5,Multidrug resistance-associated protein 5,transporter,substrate,DB00495
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00495
Cimetidine,Adjuvants,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00501
Cimetidine,Adjuvants,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A3,Solute carrier family 22 member 3,transporter,substrateinhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00501
Cimetidine,Adjuvants,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC47A1,Multidrug and toxin extrusion protein 1,transporter,inhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00501
Cimetidine,Adjuvants,approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrateinhibitor,DB00501
Ritonavir,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitorinducer,DB00503
Ritonavir,,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinducer,DB00503
Ritonavir,,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00503
Ritonavir,,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00503
Ritonavir,,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00503
Dextrothyroxine,Hypolipidemic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,,DB00509
Dextrothyroxine,Hypolipidemic Agents,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,,DB00509
Dextrothyroxine,Hypolipidemic Agents,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,,DB00509
Dextrothyroxine,Hypolipidemic Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,,DB00509
Dextrothyroxine,Hypolipidemic Agents,approved,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB00509
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ABCC5,Multidrug resistance-associated protein 5,transporter,inducer,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,SLC31A1,High affinity copper uptake protein 1,transporter,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,SLC31A2,Probable low affinity copper uptake protein 2,transporter,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ABCC6,Multidrug resistance-associated protein 6,transporter,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ATP7B,Copper-transporting ATPase 2,transporter,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ATP7A,Copper-transporting ATPase 1,transporter,substrate,DB00515
Cisplatin,Antineoplastic AgentsCross-Linking ReagentsRadiation-Sensitizing Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00515
Trandolapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00519
Trandolapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00519
Caspofungin,Antifungal Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00520
Caspofungin,Antifungal Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00520
Caspofungin,Antifungal Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00520
Caspofungin,Antifungal Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00520
Caspofungin,Antifungal Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00520
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,SLC31A1,High affinity copper uptake protein 1,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,ATP7B,Copper-transporting ATPase 2,transporter,substrate,DB00526
Oxaliplatin,Antineoplastic Agents,approvedinvestigational,ATP7A,Copper-transporting ATPase 1,transporter,substrate,DB00526
Foscarnet,Antiviral AgentsReverse Transcriptase Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00529
Foscarnet,Antiviral AgentsReverse Transcriptase Inhibitors,approved,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00529
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00530
Cefdinir,Anti-Bacterial AgentsAnti-Infective AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00535
Cefdinir,Anti-Bacterial AgentsAnti-Infective AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB00535
Cefdinir,Anti-Bacterial AgentsAnti-Infective AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00535
Guanidine,,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00536
Guanidine,,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00536
Guanidine,,approved,SLC22A3,Solute carrier family 22 member 3,transporter,substrateinhibitor,DB00536
Guanidine,,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00536
Guanidine,,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00536
Guanidine,,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00536
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,substrateinhibitor,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCB11,Bile salt export pump,transporter,substrate,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00541
Vincristine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approvedinvestigational,,RalA-binding protein 1,transporter,substrate,DB00541
Benazepril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00542
Benazepril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00542
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00544
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,ABCC5,Multidrug resistance-associated protein 5,transporter,substrate,DB00544
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00554
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00554
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00554
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCC11,ATP-binding cassette sub-family C member 11,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLC22A11,Solute carrier family 22 member 11,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLC46A1,Proton-coupled folate transporter,transporter,substrateinhibitor,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,,Folate transporter 1,transporter,substrate,DB00563
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,FOLR1,Folate receptor alpha,transporter,substrate,DB00563
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,,RalA-binding protein 1,transporter,substrate,DB00564
Carbamazepine,"AnticonvulsantsAntimanic AgentsAnalgesics, Non-Narcotic",approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00564
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,SLC47A1,Multidrug and toxin extrusion protein 1,transporter,substrate,DB00567
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00567
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitorinducer,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitorinducer,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCC6,Multidrug resistance-associated protein 6,transporter,inhibitor,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCB11,Bile salt export pump,transporter,substrateinhibitor,DB00570
Vinblastine,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00570
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00571
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00571
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00575
Clonidine,Antihypertensive AgentsSympatholyticsAnalgesicsAdrenergic alpha-2 Receptor Agonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00575
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB00577
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00577
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00577
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,,DB00577
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,SLC6A14,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),transporter,,DB00577
Valaciclovir,Antiviral AgentsProdrugs,approvedinvestigational,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,,DB00577
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC22A4,Solute carrier family 22 member 4,transporter,substrateinhibitor,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC22A5,Solute carrier family 22 member 5,transporter,substrate,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC22A16,Solute carrier family 22 member 16,transporter,substrate,DB00583
L-Carnitine,Vitamin B ComplexDietary Supplements,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00583
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00584
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB00584
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00584
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00584
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00584
Enalapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00584
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,inhibitor,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00586
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00594
Amiloride,DiureticsEpithelial Sodium Channel BlockersAcid Sensing Ion Channel BlockersSodium Channel Blockers,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00594
Oxytetracycline,Tetracyclines,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00595
Oxytetracycline,Tetracyclines,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00595
Oxytetracycline,Tetracyclines,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00595
Oxytetracycline,Tetracyclines,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00595
Ivermectin,InsecticidesAntiparasitic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00602
Ivermectin,InsecticidesAntiparasitic Agents,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00602
Ivermectin,InsecticidesAntiparasitic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00602
Ivermectin,InsecticidesAntiparasitic Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00602
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,ABCA3,ATP-binding cassette sub-family A member 3,transporter,substrate,DB00619
Testosterone,Androgens,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitorinducer,DB00624
Testosterone,Androgens,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,inducer,DB00624
Testosterone,Androgens,approvedinvestigational,SLC22A7,Solute carrier family 22 member 7,transporter,inducer,DB00624
Testosterone,Androgens,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00624
Testosterone,Androgens,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00624
Testosterone,Androgens,approvedinvestigational,SLC10A1,Sodium/bile acid cotransporter,transporter,inhibitor,DB00624
Testosterone,Androgens,approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,SLC22A4,Solute carrier family 22 member 4,transporter,substrate,DB00624
Testosterone,Androgens,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00624
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,,Sodium-coupled monocarboxylate transporter 1,transporter,,DB00627
Niacin,Vitamin B ComplexVasodilator AgentsHypolipidemic Agents,approvedinvestigationalnutraceutical,SLC16A3,Monocarboxylate transporter 4,transporter,,DB00627
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00635
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00635
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitor,DB00641
Simvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsHypolipidemic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00641
Stavudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00649
Stavudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approvedinvestigational,,Sodium/nucleoside cotransporter 1,transporter,,DB00649
Leucovorin,"Vitamin B ComplexVitaminsAntidotesAnti-anemic AgentsAntineoplastics, Adjuncts",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00650
Leucovorin,"Vitamin B ComplexVitaminsAntidotesAnti-anemic AgentsAntineoplastics, Adjuncts",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00650
Leucovorin,"Vitamin B ComplexVitaminsAntidotesAnti-anemic AgentsAntineoplastics, Adjuncts",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB00650
Latanoprost,,approvedinvestigational,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00654
Latanoprost,,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,,DB00654
Estrone,EstrogensAnti-menopausal Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinducer,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00655
Estrone,EstrogensAnti-menopausal Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00655
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00661
Verapamil,Anti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00661
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00667
Histamine Phosphate,Histamine AgentsDiagnostic Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00667
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00668
Epinephrine,Vasoconstrictor AgentsSympathomimeticsBronchodilator AgentsAdrenergic alpha-AgonistsMydriaticsAdrenergic beta-Agonists,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00668
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inducer,DB00669
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00669
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00669
Sumatriptan,Vasoconstrictor AgentsSerotonin AntagonistsSerotonin 5-HT1 Receptor AgonistsSerotonin Receptor Agonists,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00669
Cefixime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00671
Cefixime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB00671
Cefixime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00671
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00672
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00672
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00672
Chlorpropamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00672
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00675
Tamoxifen,"Antineoplastic Agents, HormonalBone Density Conservation AgentsEstrogen AntagonistsSelective Estrogen Receptor Modulators",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00675
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,,Solute carrier family 22 member 12,transporter,inhibitor,DB00678
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,,"Solute carrier family 2, facilitated glucose transporter member 9",transporter,inhibitor,DB00678
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00683
Midazolam,"Anti-Anxiety AgentsHypnotics and SedativesAnesthetics, IntravenousAdjuvants, AnesthesiaGABA Modulators",approvedillicit,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00683
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00688
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00688
Flurazepam,,approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00690
Flurazepam,,approvedillicit,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00690
Moexipril,Angiotensin-Converting Enzyme Inhibitors,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00691
Moexipril,Angiotensin-Converting Enzyme Inhibitors,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00691
Fluorescein,Contrast MediaFluorescent Dyes,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00693
Fluorescein,Contrast MediaFluorescent Dyes,approved,ABCB11,Bile salt export pump,transporter,substrate,DB00693
Fluorescein,Contrast MediaFluorescent Dyes,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00693
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCC6,Multidrug resistance-associated protein 6,transporter,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCB11,Bile salt export pump,transporter,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCC10,Multidrug resistance-associated protein 7,transporter,substrate,DB00694
Daunorubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00694
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitorinducer,DB00695
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00695
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00695
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00695
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB00695
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00695
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitorinducer,DB00701
Amprenavir,"Anti-HIV AgentsAntibiotics, AntitubercularHIV Protease Inhibitors",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00701
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB00709
Lamivudine,Anti-HIV AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,,DB00709
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00712
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00712
Oxacillin,Penicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00713
Oxacillin,Penicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00713
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,ABCC5,Multidrug resistance-associated protein 5,transporter,substrate,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,substrate,DB00718
Adefovir Dipivoxil,Antiviral AgentsReverse Transcriptase Inhibitors,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00718
Lisinopril,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00722
Lisinopril,,approvedinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00722
Rocuronium,"Muscle relaxant, Skeletal",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00728
Rocuronium,"Muscle relaxant, Skeletal",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00728
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00731
Hydrocortisone,Anti-Inflammatory Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00741
Hydrocortisone,Anti-Inflammatory Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00741
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CRABP1,Cellular retinoic acid-binding protein 1,transporter,substrate,DB00755
Tretinoin,Antineoplastic AgentsKeratolytic Agents,approvedinvestigationalnutraceutical,CRABP2,Cellular retinoic acid-binding protein 2,transporter,substrate,DB00755
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00759
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00759
Potassium Chloride,,approvedwithdrawn,SLC12A2,Solute carrier family 12 member 2,transporter,substrate,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A1,Solute carrier family 12 member 1,transporter,substrate,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A5,Solute carrier family 12 member 5,transporter,substrate,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A6,Solute carrier family 12 member 6,transporter,substrate,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A7,Solute carrier family 12 member 7,transporter,substrate,DB00761
Potassium Chloride,,approvedwithdrawn,SLC12A4,Solute carrier family 12 member 4,transporter,substrate,DB00761
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00762
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00762
Alprostadil,,approvedinvestigational,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB00770
Alprostadil,,approvedinvestigational,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB00770
Alprostadil,,approvedinvestigational,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,inhibitor,DB00770
Alprostadil,,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00770
Alprostadil,,approvedinvestigational,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,substrate,DB00770
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrateinhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCC6,Multidrug resistance-associated protein 6,transporter,substrateinhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCC10,Multidrug resistance-associated protein 7,transporter,substrateinhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB00773
Etoposide,"Antineoplastic Agents, Phytogenic",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00773
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,,DB00783
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,substrate,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,SLC47A1,Multidrug and toxin extrusion protein 1,transporter,substrate,DB00787
Aciclovir,"Antiviral AgentsNucleic Acids, Nucleotides, and Nucleosides",approved,,Multidrug and toxin extrusion protein 2,transporter,substrate,DB00787
Naproxen,,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00788
Naproxen,,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00788
Perindopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00790
Perindopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00790
Perindopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00790
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00795
Sulfasalazine,"Antirheumatic AgentsAnti-Inflammatory Agents, Non-SteroidalGastrointestinal AgentsAnti-Infective AgentsSulfonamides",approved,SLC46A1,Proton-coupled folate transporter,transporter,inhibitor,DB00795
Ribavirin,Antiviral AgentsAntimetabolites,approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,substrate,DB00811
Ribavirin,Antiviral AgentsAntimetabolites,approved,SLC28A3,Solute carrier family 28 member 3,transporter,substrate,DB00811
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00812
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00812
Phenylbutazone,"Anti-Inflammatory Agents, Non-Steroidal",approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00812
Cefaclor,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00833
Cefaclor,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00833
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitorinducer,DB00834
Mifepristone,"Hormone AntagonistsContraceptives, Oral, SyntheticAbortifacient Agents, SteroidalContraceptives, Postcoital, SyntheticLuteolytic AgentsMenstruation-Inducing Agents",approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB00834
Clofazimine,"Anti-Inflammatory Agents, Non-SteroidalLeprostatic AgentsColoring AgentsAntimycobacterialsDyes",approvedinvestigational,ABCB11,Bile salt export pump,transporter,inhibitor,DB00845
Clofazimine,"Anti-Inflammatory Agents, Non-SteroidalLeprostatic AgentsColoring AgentsAntimycobacterialsDyes",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00845
Aminolevulinic acid,Photosensitizing Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00855
Aminolevulinic acid,Photosensitizing Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB00855
Prednisolone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00860
Prednisolone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00860
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00863
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00863
Ranitidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00863
Tacrolimus,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00864
Tacrolimus,,approvedinvestigational,ABCA5,ATP-binding cassette sub-family A member 5,transporter,substrate,DB00864
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitorinducer,DB00877
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00877
Sirolimus,"Immunosuppressive AgentsAntifungal AgentsAnti-Bacterial AgentsAntibiotics, AntineoplasticMacrolides",approvedinvestigational,SLC47A1,Multidrug and toxin extrusion protein 1,transporter,,DB00877
Quinapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB00881
Quinapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approvedinvestigational,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB00881
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,substrateinhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00887
Bumetanide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00887
Didanosine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00900
Didanosine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,,DB00900
Didanosine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,,Equilibrative nucleoside transporter 2,transporter,,DB00900
Quinidine,Anti-Arrhythmia Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB00908
Quinidine,Anti-Arrhythmia Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00908
Phenformin,Hypoglycemic Agents,approvedwithdrawn,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00914
Phenformin,Hypoglycemic Agents,approvedwithdrawn,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00914
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00915
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00915
Amantadine,"Antiviral AgentsDopamine AgentsAntiparkinson AgentsAnalgesics, Non-Narcotic",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00915
Dinoprostone,OxytocicsProstaglandins,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrateinhibitor,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,OSTA,Organic solute transporter subunit alpha,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,OSTB,Organic solute transporter subunit beta,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,substrate,DB00917
Dinoprostone,OxytocicsProstaglandins,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00917
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00921
Buprenorphine,"Analgesics, OpioidNarcoticsNarcotic Antagonists",approvedillicitinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00921
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00925
Phenoxybenzamine,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-Antagonists,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00925
Famotidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00927
Famotidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB00927
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLC22A10,Solute carrier family 22 member 10,transporter,inhibitor,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB00936
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00936
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00939
Meclofenamic acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,inhibitor,DB00939
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,,DB00943
Zalcitabine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,,Equilibrative nucleoside transporter 2,transporter,,DB00943
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00945
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB00945
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00950
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00950
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB00950
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,,DB00950
Fexofenadine,"Anti-Allergic AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB00950
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,SLC31A1,High affinity copper uptake protein 1,transporter,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,SLC31A2,Probable low affinity copper uptake protein 2,transporter,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,ATP7A,Copper-transporting ATPase 1,transporter,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,ATP7B,Copper-transporting ATPase 2,transporter,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00958
Carboplatin,Antineoplastic AgentsCross-Linking Reagents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00958
Telmisartan,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00966
Telmisartan,,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00966
Telmisartan,,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB00966
Dactinomycin,"Anti-Bacterial AgentsProtein Synthesis InhibitorsNucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAntibiotics",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00970
Dactinomycin,"Anti-Bacterial AgentsProtein Synthesis InhibitorsNucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAntibiotics",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00970
Dactinomycin,"Anti-Bacterial AgentsProtein Synthesis InhibitorsNucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAntibiotics",approved,ABCC6,Multidrug resistance-associated protein 6,transporter,substrate,DB00970
Dactinomycin,"Anti-Bacterial AgentsProtein Synthesis InhibitorsNucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAntibiotics",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00970
Dactinomycin,"Anti-Bacterial AgentsProtein Synthesis InhibitorsNucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAntibiotics",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00970
Ezetimibe,Cholesterol Absorption Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,,ATP-binding cassette sub-family G member 5,transporter,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00973
Ezetimibe,Cholesterol Absorption Inhibitors,approved,,ATP-binding cassette sub-family G member 8,transporter,substrate,DB00973
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00975
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB00975
Dipyridamole,Platelet Aggregation InhibitorsPhosphodiesterase InhibitorsVasodilator Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00975
Ethinyl Estradiol,Estrogens,approved,ABCB11,Bile salt export pump,transporter,inhibitorinducer,DB00977
Ethinyl Estradiol,Estrogens,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,inducer,DB00977
Ethinyl Estradiol,Estrogens,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB00977
Ethinyl Estradiol,Estrogens,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00977
Lomefloxacin,Anti-Infective Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00978
Lomefloxacin,Anti-Infective Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00978
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,substrate,DB00987
Cytarabine,"Antiviral AgentsImmunosuppressive AgentsAntimetabolites, Antineoplastic",approvedinvestigational,SLC29A1,Equilibrative nucleoside transporter 1,transporter,substrate,DB00987
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,substrateinhibitor,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00988
Dopamine,Dopamine AgentsSympathomimeticsCardiotonic Agents,approved,POU5F1,"POU domain, class 5, transcription factor 1",transporter,substrate,DB00988
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCC6,Multidrug resistance-associated protein 6,transporter,substrateinhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,SLC22A16,Solute carrier family 22 member 16,transporter,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCB8,"ATP-binding cassette sub-family B member 8, mitochondrial",transporter,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCB11,Bile salt export pump,transporter,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,,RalA-binding protein 1,transporter,substrate,DB00997
Doxorubicin,"Antibiotics, AntineoplasticAntibiotics",approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00997
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01000
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01000
Cyclacillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01000
Ganciclovir,Antiviral Agents,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01004
Ganciclovir,Antiviral Agents,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01004
Ganciclovir,Antiviral Agents,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01004
Ganciclovir,Antiviral Agents,approvedinvestigational,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01004
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01009
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01009
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01016
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB01016
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01017
Minocycline,Anti-Bacterial AgentsTetracyclines,approvedinvestigational,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01017
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ABCB11,Bile salt export pump,transporter,inhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01026
Ketoconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01026
Topotecan,Topoisomerase I Inhibitors,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB01030
Topotecan,Topoisomerase I Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01030
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC6,Multidrug resistance-associated protein 6,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC16A1,Monocarboxylate transporter 1,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC10A1,Sodium/bile acid cotransporter,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A10,Solute carrier family 22 member 10,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ABCC11,ATP-binding cassette sub-family C member 11,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,,Solute carrier family 22 member 12,transporter,inhibitor,DB01032
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,,"Solute carrier family 2, facilitated glucose transporter member 9",transporter,inhibitor,DB01032
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,ABCC5,Multidrug resistance-associated protein 5,transporter,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,,Sodium/nucleoside cotransporter 2,transporter,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,SLC28A3,Solute carrier family 28 member 3,transporter,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,substrate,DB01033
Mercaptopurine,"Immunosuppressive AgentsAntimetabolitesNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticPurine analogues",approved,,Equilibrative nucleoside transporter 2,transporter,substrate,DB01033
Procainamide,Anti-Arrhythmia Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01035
Procainamide,Anti-Arrhythmia Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01035
Procainamide,Anti-Arrhythmia Agents,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB01035
Procainamide,Anti-Arrhythmia Agents,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01035
Procainamide,Anti-Arrhythmia Agents,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB01035
Melphalan,,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB01042
Melphalan,,approved,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB01042
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrateinhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,ABCC5,Multidrug resistance-associated protein 5,transporter,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01045
Rifampicin,"Enzyme InhibitorsAntitubercular AgentsNucleic Acid Synthesis InhibitorsLeprostatic AgentsAntibiotics, AntitubercularAntibiotics",approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB01045
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01050
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01050
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB01051
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01051
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01051
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01051
Novobiocin,Enzyme InhibitorsAnti-Bacterial AgentsNucleic Acid Synthesis Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01051
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,substrate,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,substrate,DB01053
Benzylpenicillin,Anti-Bacterial AgentsPenicillins,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB01053
Norfloxacin,Anti-Infective AgentsQuinolones,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01059
Norfloxacin,Anti-Infective AgentsQuinolones,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01059
Amoxicillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01060
Amoxicillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01060
Amoxicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01060
Atazanavir,Anti-HIV AgentsHIV Protease Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01072
Atazanavir,Anti-HIV AgentsHIV Protease Inhibitors,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB01072
Fludarabine,Antineoplastic Agents,approved,SLC29A1,Equilibrative nucleoside transporter 1,transporter,substrate,DB01073
Fludarabine,Antineoplastic Agents,approved,SLC28A3,Solute carrier family 28 member 3,transporter,,DB01073
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01075
Diphenhydramine,"Anti-Allergic AgentsHypnotics and SedativesAnesthetics, LocalHistamine H1 AntagonistsAntitussive AgentsAntiemeticsAntidyskinetics",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01075
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitor,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC5,Multidrug resistance-associated protein 5,transporter,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB01076
Atorvastatin,Anticholesteremic AgentsHydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB01076
Iloprost,,approvedinvestigational,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB01088
Iloprost,,approvedinvestigational,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,substrate,DB01088
Iloprost,,approvedinvestigational,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,substrate,DB01088
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitor,DB01092
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01092
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,substrate,DB01092
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB01092
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrate,DB01092
Ouabain,Enzyme InhibitorsCardiotonic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB01092
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,,DB01095
Fluvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB01095
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,SLC7A11,Cystine/glutamate transporter,transporter,,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCB11,Bile salt export pump,transporter,substrate,DB01098
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB01098
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01103
Quinacrine,Antineoplastic AgentsEnzyme InhibitorsAntimalarialsAntiprotozoal AgentsAntinematodal AgentsAnthelminticsAnticestodal Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01103
Cefuroxime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01112
Cefuroxime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01112
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01114
Chlorphenamine,Histamine H1 AntagonistsHistamine Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01114
Nifedipine,Dihydropyridines,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB01115
Nifedipine,Dihydropyridines,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB01115
Nifedipine,Dihydropyridines,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01115
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01124
Tolbutamide,Hypoglycemic AgentsAntidiabetic Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB01124
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,inhibitor,DB01132
Pioglitazone,Hypoglycemic Agents,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB01132
Levofloxacin,Quinolones,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01137
Levofloxacin,Quinolones,approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB01137
Levofloxacin,Quinolones,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01137
Levofloxacin,Quinolones,approvedinvestigational,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB01137
Sulfinpyrazone,Uricosuric Agents,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCC6,Multidrug resistance-associated protein 6,transporter,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01138
Sulfinpyrazone,Uricosuric Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrateinhibitor,DB01138
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01140
Cefadroxil,Anti-Bacterial AgentsCephalosporins,approvedwithdrawn,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01140
Cloxacillin,Penicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01147
Cloxacillin,Penicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01147
Cloxacillin,Penicillins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01147
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01151
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB01151
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLC22A2,Solute carrier family 22 member 2,transporter,,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLC22A6,Solute carrier family 22 member 6,transporter,,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLC22A7,Solute carrier family 22 member 7,transporter,,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLC22A8,Solute carrier family 22 member 8,transporter,,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLC22A11,Solute carrier family 22 member 11,transporter,,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,,DB01160
Dinoprost Tromethamine,"OxytocicsAbortifacient Agents, NonsteroidalAngiographyStimulants, Uterine",approved,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,,DB01160
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01165
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01165
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01165
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB01165
Ofloxacin,"Anti-Bacterial AgentsNucleic Acid Synthesis InhibitorsAnti-Infective AgentsAnti-Infective Agents, UrinaryQuinolones",approved,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB01165
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01169
Arsenic trioxide,Antineoplastic AgentsHomeopathic Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01169
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,ABCB11,Bile salt export pump,transporter,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inducer,DB01174
Phenobarbital,Hypnotics and SedativesAnticonvulsantsGABA ModulatorsExcitatory Amino Acid Antagonists,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01174
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01183
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01183
Acebutolol,Antihypertensive AgentsSympathomimeticsAdrenergic beta-1 Receptor AntagonistsAnti-Arrhythmia Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01193
Acebutolol,Antihypertensive AgentsSympathomimeticsAdrenergic beta-1 Receptor AntagonistsAnti-Arrhythmia Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01193
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01197
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01197
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01197
Tubocurarine,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB01199
Tubocurarine,"Neuromuscular Nondepolarizing AgentsNicotinic AntagonistsMuscle relaxant, Skeletal",approved,SLC22A2,Solute carrier family 22 member 2,transporter,,DB01199
Levetiracetam,Nootropic AgentsAnticonvulsants,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01202
Levetiracetam,Nootropic AgentsAnticonvulsants,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB01202
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB01204
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB01204
Mitoxantrone,Antineoplastic AgentsAnalgesics,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB01204
Sparfloxacin,,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01208
Sparfloxacin,,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB01208
Sparfloxacin,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01208
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01211
Clarithromycin,Anti-Bacterial AgentsProtein Synthesis InhibitorsMacrolides,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01211
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01212
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01212
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01212
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01212
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01212
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCB11,Bile salt export pump,transporter,substrateinhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCC10,Multidrug resistance-associated protein 7,transporter,substrateinhibitor,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB01229
Paclitaxel,"Antineoplastic Agents, PhytogenicTubulin Modulators",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB01229
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB01232
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,ABCB11,Bile salt export pump,transporter,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitorinducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01234
Dexamethasone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoidsAntiemetics",approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01234
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB01235
L-DOPA,Dopamine AgentsAntiparkinson AgentsAntidyskinetics,approved,SLC7A8,Large neutral amino acids transporter small subunit 2,transporter,,DB01235
Bromodiphenhydramine,Histamine Antagonists,approved,SLC47A1,Multidrug and toxin extrusion protein 1,transporter,inhibitor,DB01237
Bromodiphenhydramine,Histamine Antagonists,approved,SLC22A6,Solute carrier family 22 member 6,transporter,,DB01237
Docetaxel,Antineoplastic Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,ABCC10,Multidrug resistance-associated protein 7,transporter,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB01248
Docetaxel,Antineoplastic Agents,approvedinvestigational,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB01248
Dasatinib,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01254
Dasatinib,,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB01254
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01259
Lapatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approvedinvestigational,TAP1,Antigen peptide transporter 1,transporter,inhibitor,DB01259
Sunitinib,,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB01268
Sunitinib,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01268
Sunitinib,,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB01268
Sunitinib,,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01268
Cefamandole,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01326
Cefamandole,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01326
Cefamandole,Anti-Bacterial AgentsCephalosporins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01326
Cefamandole,Anti-Bacterial AgentsCephalosporins,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01326
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01327
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01327
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB01329
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01329
Cefradine,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01333
Cefradine,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB01333
Cefradine,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01333
Cefradine,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01333
Pancuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,substrateinhibitor,DB01337
Pancuronium,Neuromuscular Nondepolarizing AgentsNicotinic Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,,DB01337
Vecuronium,,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01339
Vecuronium,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01339
Cilazapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01340
Cilazapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB01340
Cilazapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB01340
Spirapril,,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB01348
Spirapril,,approved,SLC15A2,Solute carrier family 15 member 2,transporter,substrate,DB01348
Sodium bicarbonate,,approved,SLC4A4,Electrogenic sodium bicarbonate cotransporter 1,transporter,substrate,DB01390
Sodium bicarbonate,,approved,SLC4A7,Sodium bicarbonate cotransporter 3,transporter,substrate,DB01390
Sodium bicarbonate,,approved,SLC4A8,Electroneutral sodium bicarbonate exchanger 1,transporter,substrate,DB01390
Sodium bicarbonate,,approved,SLC4A5,Electrogenic sodium bicarbonate cotransporter 4,transporter,substrate,DB01390
Sodium bicarbonate,,approved,SLC4A10,Sodium-driven chloride bicarbonate exchanger,transporter,substrate,DB01390
Colchicine,Gout SuppressantsTubulin Modulators,approved,ABCB4,Multidrug resistance protein 3,transporter,inducer,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01394
Colchicine,Gout SuppressantsTubulin Modulators,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB01394
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB01396
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,inhibitor,DB01396
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01396
Tiotropium,Cholinergic Antagonists,approved,SLC22A5,Solute carrier family 22 member 5,transporter,substrate,DB01409
Tiotropium,Cholinergic Antagonists,approved,SLC22A4,Solute carrier family 22 member 4,transporter,substrate,DB01409
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01413
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB01413
Cefepime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01413
Cefacetrile,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB01414
Cefacetrile,Anti-Bacterial AgentsCephalosporins,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB01414
Ceftibuten,Cephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrateinhibitor,DB01415
Ceftibuten,Cephalosporins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB01415
Gamma Hydroxybutyric Acid,,approvedillicit,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB01440
Gamma Hydroxybutyric Acid,,approvedillicit,SLC16A1,Monocarboxylate transporter 1,transporter,inhibitor,DB01440
Gamma Hydroxybutyric Acid,,approvedillicit,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB01440
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC6A2,Sodium-dependent noradrenaline transporter,transporter,,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC6A3,Sodium-dependent dopamine transporter,transporter,,DB01454
"3,4-Methylenedioxymethamphetamine",,experimentalillicit,SLC6A4,Sodium-dependent serotonin transporter,transporter,,DB01454
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC22A3,Solute carrier family 22 member 3,transporter,inhibitor,DB01577
Methamphetamine,Adrenergic AgentsAdrenergic Uptake InhibitorsCentral Nervous System StimulantsDopamine AgentsDopamine Uptake InhibitorsSympathomimetics,approvedillicit,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB01577
Liotrix,Hormone Replacement Agents,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB01583
Liotrix,Hormone Replacement Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB01583
Liotrix,Hormone Replacement Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB01583
Liotrix,Hormone Replacement Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,substrate,DB01583
Liotrix,Hormone Replacement Agents,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB01583
Liotrix,Hormone Replacement Agents,approved,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrateinhibitor,DB01583
Liotrix,Hormone Replacement Agents,approved,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,substrateinhibitor,DB01583
Liotrix,Hormone Replacement Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01583
Liotrix,Hormone Replacement Agents,approved,SLC16A2,Monocarboxylate transporter 8,transporter,inhibitor,DB01583
Liotrix,Hormone Replacement Agents,approved,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB01583
Liotrix,Hormone Replacement Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB01583
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,ABCB11,Bile salt export pump,transporter,substrateinhibitorinducer,DB01586
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitorinducer,DB01586
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01586
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB01586
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,inhibitor,DB01586
Ursodeoxycholic acid,Cholagogues and Choleretics,approvedinvestigational,SLC10A1,Sodium/bile acid cotransporter,transporter,substrateinhibitor,DB01586
Cilastatin,,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01597
Cilastatin,,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01597
Valganciclovir,Antiviral Agents,approvedinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,,DB01610
Valganciclovir,Antiviral Agents,approvedinvestigational,SLC15A2,Solute carrier family 15 member 2,transporter,,DB01610
Valganciclovir,Antiviral Agents,approvedinvestigational,SLC6A14,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),transporter,,DB01610
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01645
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01645
D-Leucine,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB01746
D-Leucine,,experimental,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB01746
Acetoacetic Acid,,experimental,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB01762
Acetoacetic Acid,,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,substrateinhibitor,DB01762
Acetoacetic Acid,,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB01762
Acetoacetic Acid,,experimental,,Sodium-coupled monocarboxylate transporter 1,transporter,,DB01762
Hyperforin,,nutraceutical,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB01892
Hyperforin,,nutraceutical,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB01892
Glycochenodeoxycholic Acid,,experimental,ABCB11,Bile salt export pump,transporter,substrateinhibitor,DB02123
Glycochenodeoxycholic Acid,,experimental,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitor,DB02123
Glycochenodeoxycholic Acid,,experimental,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,substrate,DB02123
Glycochenodeoxycholic Acid,,experimental,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB02123
Cyclic Adenosine Monophosphate,,experimental,ABCC4,Multidrug resistance-associated protein 4,transporter,substrateinhibitor,DB02527
Cyclic Adenosine Monophosphate,,experimental,ABCC5,Multidrug resistance-associated protein 5,transporter,inhibitor,DB02527
Cyclic Adenosine Monophosphate,,experimental,ABCC11,ATP-binding cassette sub-family C member 11,transporter,substrateinhibitor,DB02527
Cyclic Adenosine Monophosphate,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,substrate,DB02527
Cyclic Adenosine Monophosphate,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB02527
Cyclic Adenosine Monophosphate,,experimental,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB02527
D-Phenylalanine,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB02556
D-Phenylalanine,,experimental,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB02556
Cholic Acid,,experimental,ABCB11,Bile salt export pump,transporter,substrateinhibitorinducer,DB02659
Cholic Acid,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB02659
Cholic Acid,,experimental,ABCC1,Multidrug resistance-associated protein 1,transporter,inducer,DB02659
Cholic Acid,,experimental,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitorinducer,DB02659
Cholic Acid,,experimental,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,substrateinhibitorinducer,DB02659
Cholic Acid,,experimental,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB02659
Cholic Acid,,experimental,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitorinducer,DB02659
Cholic Acid,,experimental,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inhibitor,DB02659
Cholic Acid,,experimental,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB02659
Cholic Acid,,experimental,SLC10A1,Sodium/bile acid cotransporter,transporter,substrateinhibitor,DB02659
Cholic Acid,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB02659
Cholic Acid,,experimental,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB02659
Cholic Acid,,experimental,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB02659
N-Cholylglycine,,experimental,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB02691
N-Cholylglycine,,experimental,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,,DB02691
N-Cholylglycine,,experimental,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB02691
Fusidic Acid,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB02703
Fusidic Acid,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB02703
S-(Methylmercury)-L-Cysteine,,experimental,SLC7A5,Large neutral amino acids transporter small subunit 1,transporter,,DB02750
S-(Methylmercury)-L-Cysteine,,experimental,SLC7A8,Large neutral amino acids transporter small subunit 2,transporter,,DB02750
D-Lactic Acid,,experimental,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB03066
D-Lactic Acid,,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,substrateinhibitor,DB03066
D-Lactic Acid,,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB03066
Acetylcholine,Vasodilator AgentsCholinergic AgonistsCholinergic Agents,experimental,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB03128
Acetylcholine,Vasodilator AgentsCholinergic AgonistsCholinergic Agents,experimental,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB03128
Acetic acid,Indicators and ReagentsAnti-Bacterial Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrateinhibitor,DB03166
Acetic acid,Indicators and ReagentsAnti-Bacterial Agents,approved,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB03166
Bestatin,Antineoplastic AgentsImmunosuppressive AgentsHypolipidemic Agents,experimental,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB03424
Bestatin,Antineoplastic AgentsImmunosuppressive AgentsHypolipidemic Agents,experimental,SLC15A2,Solute carrier family 15 member 2,transporter,substrateinhibitor,DB03424
Naringenin,,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB03467
Naringenin,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB03467
Naringenin,,experimental,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB03467
Naringenin,,experimental,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB03467
Glutaric Acid,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB03553
Glutaric Acid,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB03553
Glutaric Acid,,experimental,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB03553
Glutaric Acid,,experimental,SLC22A7,Solute carrier family 22 member 7,transporter,substrate,DB03553
Spermidine,,experimental,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB03566
Spermidine,,experimental,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB03566
Deoxycholic Acid,,experimental,ABCB11,Bile salt export pump,transporter,inducer,DB03619
Deoxycholic Acid,,experimental,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitor,DB03619
Deoxycholic Acid,,experimental,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,inhibitor,DB03619
Deoxycholic Acid,,experimental,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB03619
Benzoic Acid,Food Preservatives,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB03793
Benzoic Acid,Food Preservatives,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB03793
Benzoic Acid,Food Preservatives,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,,DB03793
Oxalic Acid,Reducing Agents,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB03902
Oxalic Acid,Reducing Agents,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB03902
Urea,,experimental,,Urea transporter 2,transporter,substrate,DB03904
Urea,,experimental,,Urea transporter 1,transporter,substrate,DB03904
D-Serine,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB03929
D-Serine,,experimental,SLC6A14,Sodium- and chloride-dependent neutral and basic amino acid transporter B(0+),transporter,,DB03929
Alpha-ketoisovalerate,,experimental,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB04074
Alpha-ketoisovalerate,,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,inhibitor,DB04074
Alpha-ketoisovalerate,,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB04074
Degraded Cephaloridine,,experimental,SLC22A5,Solute carrier family 22 member 5,transporter,,DB04133
Degraded Cephaloridine,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,,DB04133
Degraded Cephaloridine,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,,DB04133
Degraded Cephaloridine,,experimental,SLC22A11,Solute carrier family 22 member 11,transporter,,DB04133
Quercetin,Antioxidants,experimental,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitorinducer,DB04216
Quercetin,Antioxidants,experimental,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB04216
Quercetin,Antioxidants,experimental,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB04216
Quercetin,Antioxidants,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB04216
Quercetin,Antioxidants,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB04216
Quercetin,Antioxidants,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,inhibitor,DB04216
Quercetin,Antioxidants,experimental,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB04216
6-Deoxyglucose,,experimental,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB04319
6-Deoxyglucose,,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,inhibitor,DB04319
Taurocholic Acid,,experimental,ABCB11,Bile salt export pump,transporter,substrateinducer,DB04348
Taurocholic Acid,,experimental,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitorinducer,DB04348
Taurocholic Acid,,experimental,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrateinhibitorinducer,DB04348
Taurocholic Acid,,experimental,SLC10A2,Ileal sodium/bile acid cotransporter,transporter,substrateinducer,DB04348
Taurocholic Acid,,experimental,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB04348
Taurocholic Acid,,experimental,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitorinducer,DB04348
Taurocholic Acid,,experimental,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrateinhibitor,DB04348
Taurocholic Acid,,experimental,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB04348
Taurocholic Acid,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB04348
Taurocholic Acid,,experimental,ABCC10,Multidrug resistance-associated protein 7,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,substrateinhibitor,DB04348
Taurocholic Acid,,experimental,SLCO4A1,Solute carrier organic anion transporter family member 4A1,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,ABCC11,ATP-binding cassette sub-family C member 11,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,SLCO1C1,Solute carrier organic anion transporter family member 1C1,transporter,substrateinhibitor,DB04348
Taurocholic Acid,,experimental,SLCO3A1,Solute carrier organic anion transporter family member 3A1,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB04348
Taurocholic Acid,,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB04348
Taurocholic Acid,,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB04348
Taurocholic Acid,,experimental,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB04348
Taurocholic Acid,,experimental,OSTA,Organic solute transporter subunit alpha,transporter,substrate,DB04348
Taurocholic Acid,,experimental,OSTB,Organic solute transporter subunit beta,transporter,substrate,DB04348
Taurocholic Acid,,experimental,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB04348
Taurocholic Acid,,experimental,SLC7A11,Cystine/glutamate transporter,transporter,,DB04348
Lactic Acid,,experimental,SLC16A7,Monocarboxylate transporter 2,transporter,substrateinhibitor,DB04398
Lactic Acid,,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrateinhibitor,DB04398
Lactic Acid,,experimental,SLC16A1,Monocarboxylate transporter 1,transporter,substrateinhibitor,DB04398
Lactic Acid,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB04398
Lactic Acid,,experimental,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB04398
Lactic Acid,,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB04398
Deoxythymidine,,experimental,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB04485
Deoxythymidine,,experimental,SLC28A3,Solute carrier family 28 member 3,transporter,,DB04485
Caprylic acid,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB04519
Caprylic acid,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB04519
Caprylic acid,,experimental,SLC22A11,Solute carrier family 22 member 11,transporter,inhibitor,DB04519
Cholesterol,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB04540
Cholesterol,,experimental,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB04540
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC16A7,Monocarboxylate transporter 2,transporter,inhibitor,DB04552
Niflumic Acid,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC16A1,Monocarboxylate transporter 1,transporter,inhibitor,DB04552
Estriol,,approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB04573
Estriol,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinducer,DB04573
Aldosterone,,experimental,ABCB1,Multidrug resistance protein 1,transporter,substrateinducer,DB04630
Aldosterone,,experimental,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB04630
Aldosterone,,experimental,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitor,DB04630
Camptothecin,"Antineoplastic Agents, PhytogenicTopoisomerase I Inhibitors",experimental,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB04690
Camptothecin,"Antineoplastic Agents, PhytogenicTopoisomerase I Inhibitors",experimental,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB04690
Nilotinib,Antineoplastic Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB04868
Nilotinib,Antineoplastic Agents,approvedinvestigational,UGT1A1,UDP-glucuronosyltransferase 1-1,transporter,inhibitor,DB04868
Elacridar,"Antineoplastics, Adjuncts",investigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB04881
Elacridar,"Antineoplastics, Adjuncts",investigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB04881
Vandetanib,,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB05294
Vandetanib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB05294
dehydroepiandrosterone sulfate,,investigational,SLC22A8,Solute carrier family 22 member 8,transporter,,DB05804
dehydroepiandrosterone sulfate,,investigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB05804
dehydroepiandrosterone sulfate,,investigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,,DB05804
dehydroepiandrosterone sulfate,,investigational,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,,DB05804
dehydroepiandrosterone sulfate,,investigational,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,,DB05804
dehydroepiandrosterone sulfate,,investigational,,Solute carrier family 10 member 6,transporter,,DB05804
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB06151
Acetylcysteine,Antiviral AgentsFree Radical ScavengersExpectorants,approved,SLC22A6,Solute carrier family 22 member 6,transporter,,DB06151
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06207
Silodosin,Adrenergic alpha-1 Receptor Antagonists,approved,ABCB4,Multidrug resistance protein 3,transporter,substrate,DB06207
Droxidopa,Antiparkinson Agents,approvedinvestigational,SLC6A2,Sodium-dependent noradrenaline transporter,transporter,substrate,DB06262
Droxidopa,Antiparkinson Agents,approvedinvestigational,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB06262
SIMEPREVIR,Protease Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB06290
SIMEPREVIR,Protease Inhibitors,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrateinhibitor,DB06290
Saxagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB06335
Saxagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,SLCO4C1,Solute carrier organic anion transporter family member 4C1,transporter,substrate,DB06335
Saxagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB06335
Etravirine,Reverse Transcriptase Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB06414
Etravirine,Reverse Transcriptase Inhibitors,approved,ABCB4,Multidrug resistance protein 3,transporter,inhibitor,DB06414
Pazopanib,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06589
Pazopanib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB06589
Pazopanib,,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB06589
Pazopanib,,approved,UGT1A1,UDP-glucuronosyltransferase 1-1,transporter,inhibitor,DB06589
Apixaban,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06605
Apixaban,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB06605
Axitinib,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06626
Axitinib,,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB06626
Mepyramine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine Antagonists,approved,SLC22A4,Solute carrier family 22 member 4,transporter,,DB06691
Mepyramine,Anti-Allergic AgentsHistamine H1 AntagonistsHistamine Antagonists,approved,SLC22A5,Solute carrier family 22 member 5,transporter,,DB06691
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,inhibitorinducer,DB06710
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inducer,DB06710
Cabazitaxel,Antineoplastic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB06772
Cabazitaxel,Antineoplastic Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB06772
Cabazitaxel,Antineoplastic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB06772
Cabazitaxel,Antineoplastic Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,inhibitor,DB06772
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB08795
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB08795
Azidocillin,Anti-Bacterial AgentsPenicillins,approved,SLC15A2,Solute carrier family 15 member 2,transporter,inhibitor,DB08795
Vismodegib,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08828
Vismodegib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB08828
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB08834
Tauroursodeoxycholic acid,Antiviral AgentsCholagogues and CholereticsCholesterol Absorption Inhibitors,approvedinvestigational,SLC7A11,Cystine/glutamate transporter,transporter,,DB08834
Temocapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,experimentalinvestigational,SLC15A1,Solute carrier family 15 member 1,transporter,,DB08836
Temocapril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,experimentalinvestigational,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB08836
Tetraethylammonium,Potassium Channel Blockers,experimental,SLC22A1,Solute carrier family 22 member 1,transporter,,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,SLC22A2,Solute carrier family 22 member 2,transporter,,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,SLC22A3,Solute carrier family 22 member 3,transporter,,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,SLC22A4,Solute carrier family 22 member 4,transporter,,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,SLC22A5,Solute carrier family 22 member 5,transporter,,DB08837
Tetraethylammonium,Potassium Channel Blockers,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,,DB08837
Agmatine,,experimentalinvestigational,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB08838
Agmatine,,experimentalinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB08838
Agmatine,,experimentalinvestigational,SLC22A3,Solute carrier family 22 member 3,transporter,substrate,DB08838
Agmatine,,experimentalinvestigational,,Y+L amino acid transporter 1,transporter,substrate,DB08838
Acetylcarnitine,Vitamin B ComplexNootropic Agents,approvedinvestigational,SLC22A5,Solute carrier family 22 member 5,transporter,,DB08842
Acetylcarnitine,Vitamin B ComplexNootropic Agents,approvedinvestigational,,Solute carrier family 22 member 21,transporter,substrate,DB08842
Uric Acid,Antioxidants,experimentalinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,,DB08844
Uric Acid,Antioxidants,experimentalinvestigational,SLC22A8,Solute carrier family 22 member 8,transporter,,DB08844
Uric Acid,Antioxidants,experimentalinvestigational,,"Solute carrier family 2, facilitated glucose transporter member 9",transporter,substrate,DB08844
Ellagic Acid,Antineoplastic Agents,investigational,SLC22A6,Solute carrier family 22 member 6,transporter,,DB08846
Ellagic Acid,Antineoplastic Agents,investigational,SLC22A11,Solute carrier family 22 member 11,transporter,,DB08846
Pitavastatin,Hypolipidemic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,SLC10A1,Sodium/bile acid cotransporter,transporter,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB08860
Rilpivirine,,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB08864
Rilpivirine,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB08864
Rilpivirine,,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB08864
Rilpivirine,,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,inhibitor,DB08864
gabapentin enacarbil,,approved,,Sodium-coupled monocarboxylate transporter 1,transporter,substrate,DB08872
gabapentin enacarbil,,approved,SLC5A6,Sodium-dependent multivitamin transporter,transporter,substrate,DB08872
Vemurafenib,,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrateinhibitor,DB08881
Vemurafenib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB08881
Gadoxetate,Contrast MediaDiagnostic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB08884
Gadoxetate,Contrast MediaDiagnostic Agents,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,substrate,DB08884
Gadoxetate,Contrast MediaDiagnostic Agents,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,substrate,DB08884
Gadoxetate,Contrast MediaDiagnostic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB08884
Gadoxetate,Contrast MediaDiagnostic Agents,approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB08884
Mirabegron,"Muscle Relaxants, Genitourinary",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08893
Mirabegron,"Muscle Relaxants, Genitourinary",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,substrate,DB08893
Regorafenib,Antineoplastic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB08896
Regorafenib,Antineoplastic Agents,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB08896
Ponatinib,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB08901
Ponatinib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB08901
Ponatinib,,approved,ABCB11,Bile salt export pump,transporter,inhibitor,DB08901
Canagliflozin,Antidiabetic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB08907
Canagliflozin,Antidiabetic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB08907
Dabrafenib,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08912
Dabrafenib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB08912
Dabrafenib,,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB08912
Dabrafenib,,approved,SLCO1B3,Solute carrier organic anion transporter family member 1B3,transporter,inhibitor,DB08912
Dabrafenib,,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB08912
Dabrafenib,,approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB08912
Afatinib,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB08916
Afatinib,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrateinhibitor,DB08916
Gramicidin D,"Anti-Bacterial AgentsAnti-Infective AgentsAntibioticsAntibiotics, Topical",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00027
Vasopressin,Antidiuretic Agents,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00067
Tetrahydrofolic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB00116
L-Histidine,Dietary SupplementsMicronutrientsConditionally Essential Amino AcidsSupplements,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB00117
L-Phenylalanine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00120
Vitamin C,AntioxidantsVitaminsAscorbic Acid,approvednutraceutical,SLC23A1,Solute carrier family 23 member 1,transporter,,DB00126
L-Aspartic Acid,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00128
L-Serine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00133
L-Methionine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00134
L-Cystine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00138
Succinic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A8,Solute carrier family 22 member 8,transporter,substrate,DB00139
Riboflavin,Vitamin B ComplexPhotosensitizing Agents,approvednutraceutical,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00140
Glycine,Glycine AgentsDietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,substrateinhibitor,DB00145
Creatine,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00148
L-Cysteine,Dietary SupplementsNutritional SupportSupplements,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00151
L-Threonine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00156
L-Alanine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00160
L-Valine,"Dietary SupplementsMicronutrientsAmino Acids, Essential",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00161
L-Isoleucine,"Dietary SupplementsMicronutrientsAmino Acids, EssentialSupplements",approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00167
L-Proline,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00172
L-Asparagine,Dietary SupplementsMicronutrientsSupplementsNon-Essential Amino Acids,approvednutraceutical,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB00174
Fluvoxamine,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00176
Baclofen,"Neuromuscular AgentsMuscle relaxant, Skeletal",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00181
Bortezomib,,approvedinvestigational,SLC31A1,High affinity copper uptake protein 1,transporter,inhibitor,DB00188
Fluconazole,Antifungal Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00196
Caffeine,Central Nervous System StimulantsAppetite DepressantsPhosphodiesterase InhibitorsPurinergic P1 Receptor Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00201
Azithromycin,Anti-Bacterial AgentsMacrolides,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00207
Midodrine,Vasoconstrictor AgentsSympathomimeticsAdrenergic alpha-1 Receptor Agonists,approved,SLC15A1,Solute carrier family 15 member 1,transporter,,DB00211
Eletriptan,Serotonin AntagonistsSerotonin Receptor AgonistsAnti-migraine Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00216
Cefotiam,Anti-Bacterial AgentsCephalosporins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00229
Pregabalin,AnalgesicsAnticonvulsants,approvedillicitinvestigational,SLC1A1,Excitatory amino acid transporter 3,transporter,Other,DB00230
Reboxetine,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00234
Cycloserine,"AntimetabolitesAnti-Infective Agents, UrinaryAntibiotics, AntitubercularAntibiotics",approved,,Proton-coupled amino acid transporter 2,transporter,,DB00260
Amsacrine,Antineoplastic AgentsIntercalating Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00276
Theophylline,"Phosphodiesterase InhibitorsPurinergic P1 Receptor AntagonistsBronchodilator AgentsVasodilator AgentsMuscle Relaxants, Respiratory",approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB00277
Chlorambucil,"Antineoplastic Agents, Alkylating",approved,SLCO1A2,Solute carrier organic anion transporter family member 1A2,transporter,,DB00291
Morphine,"Analgesics, OpioidNarcotics",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00295
Tranexamic Acid,Antifibrinolytic Agents,approved,SLC15A2,Solute carrier family 15 member 2,transporter,,DB00302
Mitomycin,"Nucleic Acid Synthesis InhibitorsAntibiotics, AntineoplasticAlkylating AgentsCross-Linking Reagents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00305
Ethoxzolamide,DiureticsCarbonic Anhydrase Inhibitors,withdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00311
Codeine,"Analgesics, OpioidNarcoticsAntitussive Agents",approvedillicit,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB00318
Piperacillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00319
Dihydroergotamine,"Vasoconstrictor AgentsDopamine AgonistsAnalgesics, Non-NarcoticAnti-migraine Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00320
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00321
Methadone,"Analgesics, OpioidNarcoticsAntitussive Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00333
Olanzapine,Antipsychotic Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00334
Atenolol,Antihypertensive AgentsAdrenergic beta-1 Receptor AntagonistsSympatholyticsAnti-Arrhythmia Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00335
Terfenadine,"Anti-Arrhythmia AgentsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",withdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00342
Diltiazem,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00343
Protriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00344
Megestrol acetate,"Antineoplastic Agents, HormonalAppetite Stimulants",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00351
Tioguanine,"Antimetabolites, Antineoplastic",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00352
Mefloquine,Antimalarials,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00358
Vinorelbine,"Antineoplastic Agents, Phytogenic",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00361
Clozapine,Antipsychotic AgentsSerotonin AntagonistsGABA Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00363
Cidofovir,Antineoplastic AgentsAntiviral AgentsAnti-HIV AgentsRadiation-Sensitizing Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,substrateinhibitor,DB00369
Meprobamate,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsMuscle Relaxants, Central",approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00371
Timolol,Antihypertensive AgentsAnti-Arrhythmia AgentsAdrenergic beta-Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00373
Amlodipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel BlockersAntianginal Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00381
Tacrine,Nootropic AgentsCholinesterase InhibitorsParasympathomimetics,withdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00382
Zoledronate,Bone Density Conservation AgentsAntihypocalcemic AgentsAntiresorptivesBisphosphonates,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00399
Nisoldipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00401
Gentian Violet,"Anti-Infective Agents, Local",approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB00406
Rosiglitazone,,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB00412
Streptozocin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB00428
Trifluridine,Antiviral AgentsAntimetabolites,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00432
Trimethoprim,Anti-Infective Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitorinducer,DB00440
Betamethasone,Anti-Asthmatic AgentsAnti-Inflammatory AgentsGlucocorticoidsCorticosteroids,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00443
Epirubicin,"Antibiotics, Antineoplastic",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB00445
Chloramphenicol,Anti-Bacterial AgentsProtein Synthesis Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00446
Loratadine,"Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00455
Tenoxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB00469
Montelukast,Anti-Arrhythmia Agents,approved,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,substrate,DB00471
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00472
Lenalidomide,Antineoplastic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00480
Celecoxib,,approvedinvestigational,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00482
Buspirone,Anti-Anxiety AgentsHypnotics and SedativesSerotonin Receptor Agonists,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00490
Tolmetin,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00500
Haloperidol,Antipsychotic AgentsButyrophenonesAntidyskinetics,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00502
Triflupromazine,Antipsychotic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00508
Vancomycin,Anti-Bacterial Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00512
Dextromethorphan,Antitussive AgentsExcitatory Amino Acid Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00514
Albendazole,,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00518
Alitretinoin,Antineoplastic Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00523
Cyclophosphamide,"Antirheumatic AgentsImmunosuppressive AgentsAntineoplastic Agents, AlkylatingMutagensMyeloablative Agonists",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00531
Rofecoxib,,investigationalwithdrawn,ABCC4,Multidrug resistance-associated protein 4,transporter,inhibitor,DB00533
Ciprofloxacin,Anti-Infective AgentsQuinolones,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00537
Toremifene,"Antineoplastic Agents, HormonalBone Density Conservation AgentsSelective Estrogen Receptor Modulators",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00539
Zafirlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,Antagonist ,DB00549
Lamotrigine,AnticonvulsantsCalcium Channel BlockersAntidepressive Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00555
Bosentan,Antihypertensive Agents,approvedinvestigational,ABCB11,Bile salt export pump,transporter,inhibitor,DB00559
Carbenicillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00578
Nizatidine,Anti-Ulcer AgentsHistamine H2 Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00585
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00590
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00605
Cyclothiazide,Antihypertensive AgentsDiuretics,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00606
Nafcillin,Anti-Bacterial AgentsPenicillins,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00607
Chloroquine,Antirheumatic AgentsAntimalarialsAmebicides,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00608
Nicardipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00622
Fluphenazine,Antipsychotic AgentsDopamine AntagonistsPhenothiazines,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00623
Clofarabine,Purine analogues,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00631
Astemizole,Histamine Antagonists,approvedwithdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00637
Adenosine,Anti-Arrhythmia AgentsAnalgesicsVasodilator AgentsCardiovascular Agents,approvedinvestigational,SLC28A3,Solute carrier family 28 member 3,transporter,,DB00640
Mebendazole,Tubulin ModulatorsAntinematodal Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00643
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB00656
Acamprosate,Alcohol Deterrents,approvedinvestigational,SLC36A1,Proton-coupled amino acid transporter 1,transporter,,DB00659
Cephaloglycin,Anti-Bacterial AgentsCephalosporins,approved,SLC22A5,Solute carrier family 22 member 5,transporter,inhibitor,DB00689
Ergotamine,,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00696
Nitrofurantoin,"Anti-Infective AgentsAnti-Infective Agents, Urinary",approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00698
Methazolamide,,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00703
Naltrexone,Appetite DepressantsNarcotic AntagonistsCentral Nervous System DepressantsAlcohol Antagonists,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00704
Paroxetine,Serotonin Uptake InhibitorsAntidepressive Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00715
Norethindrone,"Contraceptives, Oral, Synthetic",approved,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB00717
Trimipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00726
Risperidone,Antipsychotic AgentsSerotonin AntagonistsDopamine Antagonists,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00734
Riluzole,,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB00740
Mannitol,"Sweetening AgentsDiuretics, Osmotic",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00742
Scopolamine,Muscarinic AntagonistsAdjuvantsAntispasmodics,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00747
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00749
Epinastine,Histamine H1 AntagonistsHistamine AntagonistsOphthalmics,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00751
Clopidogrel,Platelet Aggregation Inhibitors,approvednutraceutical,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00758
Nalidixic Acid,Anti-Bacterial Agents,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00779
Candesartan,Antihypertensive AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00796
Gentamicin,Aminoglycosides,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00798
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00802
Biperiden,Antiparkinson AgentsMuscarinic AntagonistsParasympatholyticsAntidyskinetics,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00810
Fentanyl,"Anesthetics, IntravenousAnalgesics, OpioidNarcoticsAdjuvants, AnesthesiaAdjuvants",approvedillicitinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00813
Meloxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ABCC4,Multidrug resistance-associated protein 4,transporter,substrate,DB00814
Acetazolamide,DiureticsAnticonvulsantsCarbonic Anhydrase Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00819
Carprofen,"Anti-Inflammatory Agents, Non-SteroidalPhotosensitizing Agents",approvedwithdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00821
Cinoxacin,,approvedwithdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00827
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00829
Trifluoperazine,Antipsychotic AgentsAntiemeticsDopamine AntagonistsPhenothiazines,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00831
Loperamide,Antidiarrheals,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB00836
Penicillamine,Antirheumatic AgentsChelating AgentsAntidotes,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00859
Diflunisal,"Anti-Inflammatory Agents, Non-Steroidal",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00861
Flupentixol,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approvedwithdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00875
Eprosartan,,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inducer,DB00876
Chlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00880
Clomifene,"Fertility Agents, FemaleEstrogen AntagonistsSelective Estrogen Receptor Modulators",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00882
Ethacrynic acid,Enzyme InhibitorsDiuretics,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00903
Cocaine,"Vasoconstrictor AgentsDopamine Uptake InhibitorsAnesthetics, Local",approvedillicit,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB00907
Repaglinide,Hypoglycemic AgentsAntidiabetic AgentsMeglitinides,approvedinvestigational,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,substrate,DB00912
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00934
Norgestimate,"Contraceptives, Oral, SyntheticContraceptive Agents",approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,substrate,DB00957
Methylprednisolone,Anti-Inflammatory AgentsGlucocorticoidsNeuroprotective AgentsAntiemetics,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB00959
Desloratadine,"Cholinergic AntagonistsHistamine H1 Antagonists, Non-SedatingHistamine Antagonists",approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00967
Methyldopa,Antihypertensive AgentsSympatholyticsAdrenergic alpha-2 Receptor Agonists,approved,SLC15A1,Solute carrier family 15 member 1,transporter,inhibitor,DB00968
Azelastine,"Anti-Allergic AgentsLipoxygenase InhibitorsBronchodilator AgentsHistamine H1 Antagonists, Non-Sedating",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB00972
Hydrochlorothiazide,Antihypertensive AgentsDiureticsSodium Chloride Symporter Inhibitors,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB00999
Metyrapone,Enzyme InhibitorsAntimetabolites,approved,ABCC3,Canalicular multispecific organic anion transporter 2,transporter,inducer,DB01011
Felodipine,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel BlockersDihydropyridines,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01023
Selegiline,Antiparkinson AgentsNeuroprotective AgentsMonoamine Oxidase InhibitorsAntidyskineticsDopaminergics,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01037
Memantine,Dopamine AgentsAntiparkinson AgentsExcitatory Amino Acid AntagonistsAntidyskinetics,approvedinvestigational,SLC22A2,Solute carrier family 22 member 2,transporter,substrate,DB01043
Nitrendipine,Antihypertensive AgentsVasodilator AgentsCalcium Channel Blockers,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01054
Melatonin,AntioxidantsCentral Nervous System Depressants,approvednutraceutical,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01065
Promethazine,Anti-Allergic AgentsAntipruriticsHistamine H1 Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01069
Tegaserod,Serotonin Receptor Agonists,investigationalwithdrawn,SLC6A4,Sodium-dependent serotonin transporter,transporter,substrateinhibitor,DB01079
Vigabatrin,Enzyme InhibitorsAnticonvulsantsGABA Agents,approved,SLC36A1,Proton-coupled amino acid transporter 1,transporter,,DB01080
Streptomycin,Aminoglycosides,approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01082
Benzocaine,"Anesthetics, Local",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01086
Hesperetin,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01094
Leflunomide,Antirheumatic AgentsImmunosuppressive AgentsEnzyme InhibitorsAdjuvants,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB01097
Pimozide,Antipsychotic AgentsDopamine AntagonistsAnti-Dyskinesia Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01100
Sertraline,Serotonin Uptake InhibitorsAntidepressive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01104
Miconazole,Antifungal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01110
Amiodarone,Enzyme InhibitorsAnti-Arrhythmia AgentsVasodilator Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitorinducer,DB01118
Rabeprazole,Enzyme InhibitorsAnti-Ulcer Agents,approvedinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB01129
Carvedilol,Antihypertensive AgentsVasodilator AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic beta-Antagonists,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01136
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01142
Nefazodone,"Antidepressive Agents, Second-GenerationAntidepressive Agents",approvedwithdrawn,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB01149
Terazosin,Adrenergic alpha-1 Receptor Antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01162
Itraconazole,Antifungal AgentsAntiprotozoal Agents14-alpha Demethylase Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01167
Idarubicin,"Antibiotics, AntineoplasticAntibiotics",approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB01177
Propafenone,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01182
Domperidone,,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01184
Estramustine,"Antineoplastic Agents, HormonalAntineoplastic Agents, Alkylating",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01196
Bromocriptine,Hormone AntagonistsAntiparkinson AgentsDopamine AgonistsAntidyskinetics,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB01200
Nadolol,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01203
Ketamine,"AnalgesicsExcitatory Amino Acid AntagonistsAnestheticsAnesthetics, Dissociative",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01221
Quetiapine,Antipsychotic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01224
Chlorprothixene,Antipsychotic AgentsDopamine Antagonists,approvedwithdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01239
Gemfibrozil,Hypolipidemic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB01241
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01242
Bepridil,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsCalcium Channel Blockers,approvedwithdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01244
Ergonovine,Oxytocics,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01253
Sitagliptin,Dipeptidyl-Peptidase IV Inhibitors,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01261
Posaconazole,Antifungal Agents,approvedinvestigational,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01263
Oxtriphylline,Bronchodilator Agents,approved,SLC22A7,Solute carrier family 22 member 7,transporter,inhibitor,DB01303
St. John's Wort,,nutraceutical,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB01323
Ceftizoxime,Anti-Bacterial AgentsCephalosporins,approved,SLC15A1,Solute carrier family 15 member 1,transporter,substrate,DB01332
Troleandomycin,Anti-Bacterial AgentsMacrolides,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01361
Mibefradil,,withdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01388
Bezafibrate,Hypolipidemic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB01393
Neostigmine,,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01400
Pranlukast,Anti-Asthmatic AgentsLeukotriene Antagonists,approved,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB01411
Aminophenazone,Pyrazolones,approvedwithdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01424
Antipyrine,"Anti-Inflammatory Agents, Non-Steroidal",approved,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB01435
Oxprenolol,Anti-Anxiety AgentsAntihypertensive AgentsSympatholyticsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approved,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB01580
Ketazolam,Benzodiazepines,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB01587
Nitrazepam,Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsGABA Modulators,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01595
Lopinavir,Anti-HIV AgentsHIV Protease Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB01601
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01614
Pipotiazine,Phenothiazines,approved,SLC22A1,Solute carrier family 22 member 1,transporter,,DB01621
Thioproperazine,Phenothiazines,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB01622
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,SLC22A1,Solute carrier family 22 member 1,transporter,,DB01623
trans-2-hydroxycinnamic acid,,experimental,SLC22A8,Solute carrier family 22 member 8,transporter,inhibitor,DB01650
D-Alanine,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB01786
Phosphoenolpyruvate,,experimental,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB01819
Putrescine,,experimental,SLC22A4,Solute carrier family 22 member 4,transporter,inhibitor,DB01917
Formic Acid,Anti-Bacterial Agents,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB01942
Staurosporine,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB02010
Daidzin,Enzyme InhibitorsAlcohol Deterrents,experimental,ABCG2,ATP-binding cassette sub-family G member 2,transporter,inhibitor,DB02115
Platelet Activating Factor,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inducer,DB02261
Glyceraldehyde-3-Phosphate,,experimental,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB02263
Flufenamic Acid,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB02266
Cyclic Guanosine Monophosphate,,experimental,SLC22A6,Solute carrier family 22 member 6,transporter,,DB02315
Myricetin,,experimental,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB02375
Aminoguanidine,,experimental,SLC22A2,Solute carrier family 22 member 2,transporter,inhibitor,DB02533
Forskolin,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB02587
Uridine,,experimental,SLC29A1,Equilibrative nucleoside transporter 1,transporter,,DB02745
Phthalic Acid,,experimental,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB02746
Pregnenolone,,experimental,,Solute carrier family 10 member 6,transporter,,DB02789
Tetraphenylphosphonium,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB02791
D-Proline,,experimental,SLC36A1,Proton-coupled amino acid transporter 1,transporter,,DB02853
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB02901
Alpha-Aminoisobutyric Acid,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,substrate,DB02952
Beta-Alanine,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,substrate,DB03107
Sphingosine,,experimental,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB03203
D-Tryptophan,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB03225
Flavopiridol,Antineoplastic AgentsProtein Kinase InhibitorsGrowth Inhibitors,experimentalinvestigational,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB03496
Glucose-6-Phosphate,,experimental,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB03581
Oxyphenbutazone,"Anti-Inflammatory Agents, Non-Steroidal",experimentalwithdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB03585
Phenacetin,"Analgesics, Non-Narcotic",withdrawn,SLC22A6,Solute carrier family 22 member 6,transporter,inhibitor,DB03783
Palmitic Acid,Enzyme Inhibitors,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB03796
Rhodamine 6g,,experimental,ABCC1,Multidrug resistance-associated protein 1,transporter,substrate,DB03825
D-Tyrosine,,experimental,SLC16A10,Monocarboxylate transporter 10,transporter,inhibitor,DB03839
3-Phenylpyruvic Acid,,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB03884
Oxamic Acid,,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB03940
Glycerol,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB04077
"(1,10 Phenanthroline)-(Tri-Carbon Monoxide) Rhenium (I)",,experimental,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB04100
Citric Acid,AnticoagulantsChelating Agents,nutraceutical,SLCO2B1,Solute carrier organic anion transporter family member 2B1,transporter,inhibitor,DB04272
Inosine,,investigational,SLC28A3,Solute carrier family 28 member 3,transporter,,DB04335
"Glyoxalate, Glyoxylate",,experimental,SLC16A3,Monocarboxylate transporter 4,transporter,substrate,DB04343
P-Nitrophenol,,experimental,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB04417
"Fructose-1,6-Diphosphate",,experimental,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,inhibitor,DB04551
Arachidonic Acid,,experimental,SLCO2A1,Solute carrier organic anion transporter family member 2A1,transporter,substrate,DB04557
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,SLC22A1,Solute carrier family 22 member 1,transporter,inhibitor,DB04574
5-methyltetrahydrofolate,,experimental,ABCC2,Canalicular multispecific organic anion transporter 1,transporter,inhibitor,DB04789
Buformin,Hypoglycemic Agents,withdrawn,SLC22A1,Solute carrier family 22 member 1,transporter,substrate,DB04830
Zimelidine,Serotonin Uptake Inhibitors,withdrawn,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB04832
Debrisoquin,Antihypertensive AgentsAdrenergic AgentsSympatholytics,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB04840
Dronedarone,Anti-Arrhythmia Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB04855
Indacaterol,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB05039
Gallium nitrate,,approvedinvestigational,,Transferrin receptor,transporter,,DB05260
Telaprevir,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB05521
ado-trastuzumab emtansine,Antineoplastic AgentsTubulin ModulatorsMonoclonal antibodies,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB05773
Abiraterone,,approved,ABCC1,Multidrug resistance-associated protein 1,transporter,inhibitor,DB05812
Eltrombopag,Thrombopoietic Agents,approved,SLCO1B1,Solute carrier organic anion transporter family member 1B1,transporter,inhibitor,DB06210
Tolvaptan,Vasopressin receptor antagonists,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB06212
Rivaroxaban,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06228
Temsirolimus,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB06287
Dapagliflozin,sodium-glucose cotransporter 2 inhibitor ,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06292
Gaboxadol,,investigational,SLC36A1,Proton-coupled amino acid transporter 1,transporter,substrate,DB06554
Bosutinib,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB06616
Vilazodone,Serotonin Uptake InhibitorsSerotonin Receptor AgonistsAntidepressive Agents,approved,SLC6A4,Sodium-dependent serotonin transporter,transporter,,DB06684
Dabigatran etexilate,Antithrombins,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06695
Fesoterodine,"Muscarinic AntagonistsAnti-Incontinence AgentsAntispasmodicsMuscle Relaxants, Genitourinary",approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB06702
Iobenguane,Diagnostic Agents,approved,SLC6A2,Sodium-dependent noradrenaline transporter,transporter,substrate,DB06704
Pralatrexate,,approved,,Folate transporter 1,transporter,substrate,DB06813
Ticagrelor,Platelet Aggregation Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB08816
Ivacaftor,,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB08820
Ioflupane I 123,Diagnostic Agents,approved,SLC6A3,Sodium-dependent dopamine transporter,transporter,,DB08824
Lomitapide,Hypolipidemic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB08827
Dehydroascorbic Acid,Vitamins,experimental,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1",transporter,,DB08830
2-deoxyglucose,Antineoplastic AgentsAntiviral AgentsAntimetabolitesDiagnostic Agents,experimentalinvestigational,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1",transporter,,DB08831
Spaglumic Acid,Mast Cell Stabilizers,approved,SLC36A1,Proton-coupled amino acid transporter 1,transporter,substrateOther,DB08835
Hydroxyproline,,approvedexperimental,SLC36A1,Proton-coupled amino acid transporter 1,transporter,,DB08847
Crizotinib,Protein Kinase Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB08865
Brentuximab vedotin,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08870
Boceprevir,,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08873
Fidaxomicin,Antibiotics,approved,ABCB1,Multidrug resistance protein 1,transporter,substrateinhibitor,DB08874
Aminopterin,Folic Acid Antagonists,investigationalwithdrawn,SLC46A1,Proton-coupled folate transporter,transporter,,DB08878
Teriflunomide,,approved,ABCG2,ATP-binding cassette sub-family G member 2,transporter,substrate,DB08880
Linagliptin,Dipeptidyl-Peptidase IV InhibitorsAntidiabetic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08882
Carfilzomib,Antineoplastic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08889
Arbaclofen Placarbil,,investigational,SLC16A1,Monocarboxylate transporter 1,transporter,substrate,DB08892
Enzalutamide,Antineoplastic Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,inhibitor,DB08899
Fluticasone furoate,Corticosteroids,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08906
Pomalidomide,Immunosuppressive Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08910
Levomilnacipran,Serotonin Uptake Inhibitors,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08918
SOFOSBUVIR,Antiviral Agents,approved,ABCB1,Multidrug resistance protein 1,transporter,substrate,DB08934
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RBP5,Retinol-binding protein 5,carrier,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RBP7,Retinoid-binding protein 7,carrier,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RBP4,Retinol-binding protein 4,carrier,,DB00162
Vitamin A,VitaminsVitamin AAnti-acne preparations,approvednutraceutical,RBP2,Retinol-binding protein 2,carrier,,DB00162
Liothyronine,Hormone Replacement Agents,approved,TTR,Transthyretin,carrier,,DB00279
Liothyronine,Hormone Replacement Agents,approved,SERPINA7,Thyroxine-binding globulin,carrier,,DB00279
Liothyronine,Hormone Replacement Agents,approved,ALB,Serum albumin,carrier,,DB00279
Gefitinib,,approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00317
Gefitinib,,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB00317
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ALB,Serum albumin,carrier,,DB00321
Amitriptyline,"Adrenergic Uptake InhibitorsAnalgesics, Non-NarcoticAntidepressive Agents, Tricyclic",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00321
Olanzapine,Antipsychotic Agents,approvedinvestigational,ALB,Serum albumin,carrier,,DB00334
Olanzapine,Antipsychotic Agents,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00334
Levothyroxine,,approved,TTR,Transthyretin,carrier,,DB00451
Levothyroxine,,approved,SERPINA7,Thyroxine-binding globulin,carrier,,DB00451
Levothyroxine,,approved,ALB,Serum albumin,carrier,,DB00451
Pethidine,Adjuvants,approved,ALB,Serum albumin,carrier,,DB00454
Pethidine,Adjuvants,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00454
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,ALB,Serum albumin,carrier,substrate,DB00472
Fluoxetine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsSerotonin Agents",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB00472
Celecoxib,,approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00482
Celecoxib,,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB00482
Alitretinoin,Antineoplastic Agents,approvedinvestigational,CRABP2,Cellular retinoic acid-binding protein 2,carrier,,DB00523
Alitretinoin,Antineoplastic Agents,approvedinvestigational,CRABP1,Cellular retinoic acid-binding protein 1,carrier,,DB00523
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00530
Erlotinib,Protein Kinase Inhibitors,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB00530
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ALB,Serum albumin,carrier,,DB00540
Nortriptyline,"Adrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00540
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,TTR,Transthyretin,carrier,,DB00586
Diclofenac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ALB,Serum albumin,carrier,,DB00586
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,ALB,Serum albumin,carrier,substrate,DB00619
Imatinib,Antineoplastic AgentsProtein Kinase Inhibitors,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB00619
Testosterone,Androgens,approvedinvestigational,ALB,Serum albumin,carrier,other/unknown,DB00624
Testosterone,Androgens,approvedinvestigational,SHBG,Sex hormone-binding globulin,carrier,other/unknown,DB00624
Mitotane,"Antineoplastic Agents, Hormonal",approved,SHBG,Sex hormone-binding globulin,carrier,,DB00648
Mitotane,"Antineoplastic Agents, Hormonal",approved,SERPINA6,Corticosteroid-binding globulin,carrier,,DB00648
Warfarin,AnticoagulantsRodenticides,approved,ALB,Serum albumin,carrier,,DB00682
Warfarin,AnticoagulantsRodenticides,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00682
Norethindrone,"Contraceptives, Oral, Synthetic",approved,ALB,Serum albumin,carrier,substrate,DB00717
Norethindrone,"Contraceptives, Oral, Synthetic",approved,SHBG,Sex hormone-binding globulin,carrier,substrate,DB00717
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,ALB,Serum albumin,carrier,,DB00731
Nateglinide,Hypoglycemic AgentsMeglitinides,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00731
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,SHBG,Sex hormone-binding globulin,carrier,,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,ALB,Serum albumin,carrier,,DB00783
Estradiol,EstrogensContraceptive AgentsAnti-menopausal Agents,approvedinvestigational,FABP2,"Fatty acid-binding protein, intestinal",carrier,,DB00783
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00802
Alfentanil,"Anesthetics, IntravenousAnalgesics, OpioidNarcotics",approvedillicit,ALB,Serum albumin,carrier,,DB00802
Diflunisal,"Anti-Inflammatory Agents, Non-Steroidal",approved,TTR,Transthyretin,carrier,,DB00861
Diflunisal,"Anti-Inflammatory Agents, Non-Steroidal",approved,ALB,Serum albumin,carrier,,DB00861
Tacrolimus,,approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00864
Tacrolimus,,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB00864
Phenprocoumon,Anticoagulants,approved,ALB,Serum albumin,carrier,,DB00946
Phenprocoumon,Anticoagulants,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00946
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB01232
Saquinavir,HIV Protease Inhibitors,approvedinvestigational,ALB,Serum albumin,carrier,,DB01232
Bismuth Subsalicylate,Antidiarrheals,approved,ALB,Serum albumin,carrier,binder,DB01294
Bismuth Subsalicylate,Antidiarrheals,approved,TF,Serotransferrin,carrier,,DB01294
Acenocoumarol,Anticoagulants,approved,ALB,Serum albumin,carrier,,DB01418
Acenocoumarol,Anticoagulants,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB01418
Liotrix,Hormone Replacement Agents,approved,TTR,Transthyretin,carrier,,DB01583
Liotrix,Hormone Replacement Agents,approved,SERPINA7,Thyroxine-binding globulin,carrier,,DB01583
Liotrix,Hormone Replacement Agents,approved,ALB,Serum albumin,carrier,,DB01583
Stearic acid,Pharmaceutic Aids,experimental,FABP3,"Fatty acid-binding protein, heart",carrier,,DB03193
Stearic acid,Pharmaceutic Aids,experimental,ALB,Serum albumin,carrier,,DB03193
Palmitic Acid,Enzyme Inhibitors,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,FABP5,"Fatty acid-binding protein, epidermal",carrier,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,FABP3,"Fatty acid-binding protein, heart",carrier,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,FABP2,"Fatty acid-binding protein, intestinal",carrier,,DB03796
Palmitic Acid,Enzyme Inhibitors,experimental,ALB,Serum albumin,carrier,,DB03796
Oleic Acid,,experimental,FABP7,"Fatty acid-binding protein, brain",carrier,,DB04224
Oleic Acid,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB04224
Oleic Acid,,experimental,FABP3,"Fatty acid-binding protein, heart",carrier,,DB04224
Oleic Acid,,experimental,FABP1,"Fatty acid-binding protein, liver",carrier,,DB04224
Oleic Acid,,experimental,ALB,Serum albumin,carrier,,DB04224
Oleic Acid,,experimental,GC,Vitamin D-binding protein,carrier,,DB04224
1-Anilino-8-Naphthalene Sulfonate,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB04474
1-Anilino-8-Naphthalene Sulfonate,,experimental,TTR,Transthyretin,carrier,,DB04474
Arachidonic Acid,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB04557
Arachidonic Acid,,experimental,ALB,Serum albumin,carrier,,DB04557
Arachidonic Acid,,experimental,FABP2,"Fatty acid-binding protein, intestinal",carrier,,DB04557
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,SHBG,Sex hormone-binding globulin,carrier,,DB04574
Estropipate,Contraceptive AgentsHormone Replacement Agents,approved,ALB,Serum albumin,carrier,,DB04574
NRP409,Hormone Replacement Agents,investigational,TTR,Transthyretin,carrier,,DB05235
NRP409,Hormone Replacement Agents,investigational,SERPINA7,Thyroxine-binding globulin,carrier,,DB05235
Vandetanib,,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,binder,DB05294
Vandetanib,,approved,ALB,Serum albumin,carrier,binder,DB05294
Telaprevir,,approved,ALB,Serum albumin,carrier,substrate,DB05521
Telaprevir,,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB05521
Abiraterone,,approved,ALB,Serum albumin,carrier,substrate,DB05812
Abiraterone,,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB05812
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,ALB,Serum albumin,carrier,,DB06710
Methyltestosterone,"Antineoplastic Agents, HormonalAnabolic AgentsHormone Replacement Agents",approved,SHBG,Sex hormone-binding globulin,carrier,,DB06710
MYRISTIC ACID,,experimental,ALB,Serum albumin,carrier,,DB08231
MYRISTIC ACID,,experimental,FABP2,"Fatty acid-binding protein, intestinal",carrier,,DB08231
MYRISTIC ACID,,experimental,APOM,Apolipoprotein M,carrier,,DB08231
Ivacaftor,,approved,ALB,Serum albumin,carrier,substrate,DB08820
Ivacaftor,,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB08820
Vismodegib,,approved,ALB,Serum albumin,carrier,substrate,DB08828
Vismodegib,,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB08828
Pitavastatin,Hypolipidemic Agents,approved,ALB,Serum albumin,carrier,substrate,DB08860
Pitavastatin,Hypolipidemic Agents,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB08860
Vemurafenib,,approved,ALB,Serum albumin,carrier,substrate,DB08881
Vemurafenib,,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB08881
Mirabegron,"Muscle Relaxants, Genitourinary",approved,ALB,Serum albumin,carrier,substrate,DB08893
Mirabegron,"Muscle Relaxants, Genitourinary",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB08893
Canagliflozin,Antidiabetic Agents,approved,ALB,Serum albumin,carrier,substrate,DB08907
Canagliflozin,Antidiabetic Agents,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,substrate,DB08907
Hyaluronidase,"Adjuvants, AnesthesiaPermeabilizing Agents",approvedinvestigational,ALB,Serum albumin,carrier,inhibitor,DB00070
Alpha-Linolenic Acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FABP7,"Fatty acid-binding protein, brain",carrier,,DB00132
Xanthophyll,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,ALB,Serum albumin,carrier,,DB00137
Dihomo-<U+03B3>-linolenic acid,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FABP7,"Fatty acid-binding protein, brain",carrier,,DB00154
Icosapent,Dietary SupplementsMicronutrientsSupplements,approvednutraceutical,FABP7,"Fatty acid-binding protein, brain",carrier,,DB00159
Vitamin E,AntioxidantsVitaminsDietary SupplementsMicronutrientsSupplements,approvednutraceutical,TTPA,Alpha-tocopherol transfer protein,carrier,,DB00163
Cholecalciferol,Bone Density Conservation AgentsVitaminsAntithyroid AgentsVitamin DAntihypocalcemic Agents,approvednutraceutical,GC,Vitamin D-binding protein,carrier,,DB00169
Valsartan,Angiotensin Receptor Antagonists,approvedinvestigational,ALB,Serum albumin,carrier,,DB00177
Flunisolide,,approvedinvestigational,SERPINA6,Corticosteroid-binding globulin,carrier,,DB00180
Hydroxocobalamin,HematinicsVitamin B ComplexNutritional SupportAnti-anemic Agents,approved,TCN2,Transcobalamin-2,carrier,substrate,DB00200
Enflurane,"Anesthetics, InhalationAnesthetics",approved,ALB,Serum albumin,carrier,,DB00228
Alclometasone,AntipruriticsCorticosteroids,approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00240
Phenytoin,AnticonvulsantsVoltage-Gated Sodium Channel Blockers,approved,ALB,Serum albumin,carrier,,DB00252
Medrysone,Anti-Inflammatory Agents,approved,SERPINA6,Corticosteroid-binding globulin,carrier,,DB00253
Diethylstilbestrol,"CarcinogensEstrogens, Non-Steroidal",approved,TTR,Transthyretin,carrier,,DB00255
Cefmetazole,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,,DB00274
Disopyramide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,other/unknown,DB00280
Etomidate,"Hypnotics and SedativesAnesthetics, Intravenous",approved,SLC2A1,"Solute carrier family 2, facilitated glucose transporter member 1",carrier,inhibitor,DB00292
Fluorometholone,Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids,approved,SERPINA6,Corticosteroid-binding globulin,carrier,,DB00324
Indomethacin,"Gout SuppressantsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsCardiovascular AgentsTocolytic Agents",approvedinvestigational,ALB,Serum albumin,carrier,,DB00328
Sucralfate,,approved,ALB,Serum albumin,carrier,,DB00364
Beclomethasone,Anti-Arrhythmia AgentsCorticosteroids,approvedinvestigational,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00394
Rosiglitazone,,approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00412
Ampicillin,Anti-Bacterial AgentsPenicillins,approved,ALB,Serum albumin,carrier,other/unknown,DB00415
Cefpiramide,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,,DB00430
Cefalotin,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,binder,DB00456
Prazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00457
Imipramine,"Adrenergic Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00458
Acitretin,Keratolytic Agents,approved,ALB,Serum albumin,carrier,,DB00459
Chlorpromazine,Antipsychotic AgentsPhenothiazines,approved,ALB,Serum albumin,carrier,,DB00477
Zidovudine,Anti-HIV AgentsAntimetabolitesReverse Transcriptase Inhibitors,approved,ALB,Serum albumin,carrier,,DB00495
Amoxapine,"Antidepressive Agents, Second-GenerationSerotonin Uptake InhibitorsAdrenergic Uptake InhibitorsDopamine AntagonistsNeurotransmitter Uptake Inhibitors",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00543
Fluorouracil,"Immunosuppressive AgentsAntimetabolitesAntimetabolites, Antineoplastic",approved,ALB,Serum albumin,carrier,,DB00544
Piroxicam,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approvedinvestigational,ALB,Serum albumin,carrier,,DB00554
Methotrexate,"Antirheumatic AgentsDermatologic AgentsImmunosuppressive AgentsEnzyme InhibitorsFolic Acid AntagonistsNucleic Acid Synthesis InhibitorsAntimetabolites, AntineoplasticAbortifacient Agents, NonsteroidalAbortifacient Agents",approved,ALB,Serum albumin,carrier,,DB00563
Cephalexin,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,other/unknown,DB00567
Propranolol,Antihypertensive AgentsAnti-Arrhythmia AgentsVasodilator AgentsAdrenergic beta-Antagonists,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00571
Fenoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsPropionates",approved,ALB,Serum albumin,carrier,,DB00573
Sulfamethizole,Anti-Infective Agents,approved,ALB,Serum albumin,carrier,,DB00576
Fluticasone Propionate,,approved,SERPINA6,Corticosteroid-binding globulin,carrier,,DB00588
Doxazosin,Antihypertensive AgentsAdrenergic alpha-1 Receptor AntagonistsAdrenergic alpha-Antagonists,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00590
Fluocinolone Acetonide,Anti-Inflammatory AgentsGlucocorticoids,approvedinvestigational,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00591
Halobetasol Propionate,,approved,SERPINA6,Corticosteroid-binding globulin,carrier,,DB00596
Sulindac,"Anti-Inflammatory Agents, Non-Steroidal",approved,ALB,Serum albumin,carrier,,DB00605
Triamcinolone,Anti-Inflammatory AgentsGlucocorticoids,approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00620
Prednisone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,ALB,Serum albumin,carrier,substrate,DB00635
Estrone,EstrogensAnti-menopausal Agents,approved,ALB,Serum albumin,carrier,,DB00655
Trazodone,"Antidepressive Agents, Second-GenerationAnti-Anxiety AgentsSerotonin Uptake Inhibitors",approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00656
Flumethasone Pivalate,,approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00663
Losartan,Antihypertensive AgentsAnti-Arrhythmia AgentsAngiotensin II Type 1 Receptor BlockersAngiotensin Receptor Antagonists,approved,ALB,Serum albumin,carrier,substrate,DB00678
Mycophenolate mofetil,Immunosuppressive Agents,approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00688
Furosemide,DiureticsSodium Potassium Chloride Symporter Inhibitors,approved,ALB,Serum albumin,carrier,,DB00695
Tamsulosin,Adrenergic alpha-1 Receptor Antagonists,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00706
Flurbiprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics",approvedinvestigational,ALB,Serum albumin,carrier,other/unknown,DB00712
Hydrocortisone,Anti-Inflammatory Agents,approved,SHBG,Sex hormone-binding globulin,carrier,,DB00741
Gadobenate Dimeglumine,Contrast Media,approved,ALB,Serum albumin,carrier,binder,DB00743
Etodolac,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors",approvedinvestigational,ALB,Serum albumin,carrier,,DB00749
Isoflurane,"Anesthetics, InhalationAnesthetics",approved,ALB,Serum albumin,carrier,,DB00753
Tetracycline,Anti-Bacterial AgentsProtein Synthesis InhibitorsAntiprotozoal AgentsTetracyclines,approved,ALB,Serum albumin,carrier,,DB00759
Irinotecan,"Antineoplastic Agents, PhytogenicRadiation-Sensitizing AgentsTopoisomerase I InhibitorsProdrugs",approvedinvestigational,ALB,Serum albumin,carrier,substrate,DB00762
Oxcarbazepine,Anticonvulsants,approved,ALB,Serum albumin,carrier,substrate,DB00776
Naproxen,,approved,ALB,Serum albumin,carrier,,DB00788
Sodium lauryl sulfate,Surface-Active Agents,approved,ALB,Serum albumin,carrier,binder,DB00815
Propofol,"Hypnotics and SedativesAnesthetics, Intravenous",approvedinvestigational,ALB,Serum albumin,carrier,,DB00818
Diazepam,"Anti-Anxiety AgentsHypnotics and SedativesAnticonvulsantsAnesthetics, IntravenousAdjuvants, AnesthesiaGABA ModulatorsMuscle Relaxants, CentralAntiemetics",approvedillicit,ALB,Serum albumin,carrier,,DB00829
Flurandrenolide,Anti-Inflammatory AgentsGlucocorticoids,approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00846
Drostanolone,,approvedillicit,SHBG,Sex hormone-binding globulin,carrier,,DB00858
Prednisolone,"Antineoplastic Agents, HormonalAnti-Inflammatory AgentsGlucocorticoids",approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00860
Iron Dextran,HematinicsAnti-anemic AgentsSupplements,approved,TF,Serotransferrin,carrier,substrate,DB00893
Rimexolone,Corticosteroids,approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB00896
Ethacrynic acid,Enzyme InhibitorsDiuretics,approved,ALB,Serum albumin,carrier,,DB00903
Quinidine,Anti-Arrhythmia Agents,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00908
Repaglinide,Hypoglycemic AgentsAntidiabetic AgentsMeglitinides,approvedinvestigational,ALB,Serum albumin,carrier,,DB00912
Etretinate,,withdrawn,CRABP1,Cellular retinoic acid-binding protein 1,carrier,,DB00926
Methacycline,Anti-Bacterial AgentsTetracyclines,approved,ALB,Serum albumin,carrier,,DB00931
Maprotiline,"Antidepressive Agents, Second-GenerationAdrenergic Uptake InhibitorsAntidepressive Agents",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB00934
Salicylic acid,Antifungal AgentsAnti-Infective AgentsKeratolytic Agents,approved,ALB,Serum albumin,carrier,other/unknown,DB00936
Acetylsalicylic acid,"Fibrinolytic AgentsPlatelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAntipyreticsSalicylates",approved,ALB,Serum albumin,carrier,other/unknown,DB00945
Auranofin,Antirheumatic Agents,approved,ALB,Serum albumin,carrier,,DB00995
Ketoprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase Inhibitors",approved,ALB,Serum albumin,carrier,,DB01009
Sulfamethoxazole,Anti-Infective AgentsSulfonamides,approved,ALB,Serum albumin,carrier,,DB01015
Glyburide,Hypoglycemic AgentsAnti-Arrhythmia AgentsAntidiabetic Agents,approved,ALB,Serum albumin,carrier,,DB01016
Probenecid,"Adjuvants, PharmaceuticUricosuric Agents",approved,ALB,Serum albumin,carrier,,DB01032
Gatifloxacin,QuinolonesAntibiotics,approvedinvestigational,ALB,Serum albumin,carrier,other/unknown,DB01044
Fluocinonide,Anti-Allergic AgentsAnti-Inflammatory AgentsGlucocorticoids,approvedinvestigational,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB01047
Ibuprofen,"Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase InhibitorsAnalgesics, Non-Narcotic",approved,ALB,Serum albumin,carrier,,DB01050
Tocainide,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel BlockersSodium Channel Blockers,approved,ALB,Serum albumin,carrier,other/unknown,DB01056
Clonazepam,AnticonvulsantsGABA ModulatorsBenzodiazepines,approvedillicit,ALB,Serum albumin,carrier,,DB01068
Dimethyl sulfoxide,Free Radical ScavengersSolventsCryoprotective Agents,approved,TTR,Transthyretin,carrier,,DB01093
Rosuvastatin,Hydroxymethylglutaryl-CoA Reductase Inhibitors,approved,ALB,Serum albumin,carrier,substrate,DB01098
Gliclazide,Hypoglycemic AgentsAntidiabetic Agents,approved,ALB,Serum albumin,carrier,,DB01120
Sulfinpyrazone,Uricosuric Agents,approved,FABP2,"Fatty acid-binding protein, intestinal",carrier,,DB01138
Doxepin,Adrenergic Uptake InhibitorsAntidepressive Agents,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,other/unknown,DB01142
Cloxacillin,Penicillins,approved,ALB,Serum albumin,carrier,,DB01147
Desipramine,"Enzyme InhibitorsAdrenergic Uptake InhibitorsAntidepressive Agents, TricyclicAntidepressive Agents",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB01151
Bupropion,"Antidepressive Agents, Second-GenerationDopamine Uptake Inhibitors",approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB01156
Halothane,"Anesthetics, InhalationAnesthetics",approved,ALB,Serum albumin,carrier,,DB01159
Naloxone,Narcotic AntagonistsCentral Nervous System Depressants,approved,ALB,Serum albumin,carrier,substrate,DB01183
Fluoxymesterone,Anabolic Agents,approvedillicit,SHBG,Sex hormone-binding globulin,carrier,,DB01185
Desflurane,"Anesthetics, Inhalation",approved,ALB,Serum albumin,carrier,,DB01189
Captopril,Angiotensin-Converting Enzyme InhibitorsAntihypertensive Agents,approved,ALB,Serum albumin,carrier,other/unknown,DB01197
Ceftriaxone,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,other/unknown,DB01212
Sevoflurane,"Platelet Aggregation InhibitorsAnesthetics, Inhalation",approved,ALB,Serum albumin,carrier,,DB01236
Clomipramine,"Serotonin Uptake InhibitorsAntidepressive Agents, Tricyclic",approved,ALB,Serum albumin,carrier,substrate,DB01242
Insulin Detemir,Antidiabetic Agents,approved,ALB,Serum albumin,carrier,other/unknown,DB01307
Fosphenytoin,Anticonvulsants,approved,ALB,Serum albumin,carrier,other/unknown,DB01320
Cefazolin,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,other/unknown,DB01327
Cefonicid,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,other/unknown,DB01328
Cefoperazone,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,other/unknown,DB01329
Cefotetan,Anti-Bacterial AgentsCephalosporins,approved,ALB,Serum albumin,carrier,,DB01330
Penbutolol,Antihypertensive AgentsAdrenergic beta-Antagonists,approvedinvestigational,ORM1,Alpha-1-acid glycoprotein 1,carrier,other/unknown,DB01359
Paramethasone,,approved,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB01384
Digitoxin,Enzyme InhibitorsAnti-Arrhythmia AgentsCardiotonic Agents,approved,ALB,Serum albumin,carrier,,DB01396
Magnesium salicylate,,approved,ALB,Serum albumin,carrier,,DB01397
Danazol,,approved,SHBG,Sex hormone-binding globulin,carrier,,DB01406
Ciclesonide,,approvedinvestigational,SERPINA6,Corticosteroid-binding globulin,carrier,binder,DB01410
Ajmaline,Anti-Arrhythmia Agents,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB01426
Aprindine,Anti-Arrhythmia AgentsVoltage-Gated Sodium Channel Blockers,approved,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB01429
Alfacalcidol,Bone Density Conservation Agents,approvednutraceutical,GC,Vitamin D-binding protein,carrier,substrate,DB01436
Sulfamerazine,Sulfonamides,approved,ALB,Serum albumin,carrier,,DB01581
Sulfamethazine,Sulfonamides,approved,ALB,Serum albumin,carrier,,DB01582
Ketazolam,Benzodiazepines,approved,ALB,Serum albumin,carrier,,DB01587
Acepromazine,Hypnotics and SedativesAntipsychotic AgentsDopamine Antagonists,approved,ALB,Serum albumin,carrier,,DB01614
Pipotiazine,Phenothiazines,approved,ALB,Serum albumin,carrier,,DB01621
Thioproperazine,Phenothiazines,approved,ALB,Serum albumin,carrier,,DB01622
Thiothixene,Antipsychotic AgentsDopamine AntagonistsThioxanthenes,approved,ALB,Serum albumin,carrier,,DB01623
Genistein,Protein Kinase InhibitorsAnticarcinogenic AgentsPhytoestrogens,investigational,TTR,Transthyretin,carrier,,DB01645
"3,3',5,5'-Tetraiodothyroacetic Acid",,experimental,TTR,Transthyretin,carrier,,DB01751
All-Trans Axerophthene,,experimental,RBP4,Retinol-binding protein 4,carrier,,DB01770
"6,4'-Dihydroxy-3-Methyl-3',5'-Dibromoflavone",,experimental,TTR,Transthyretin,carrier,,DB01838
Butenoic Acid,,experimental,FABP1,"Fatty acid-binding protein, liver",carrier,,DB02074
"1-{2-[2-(2-Methoxyethoxy)Ethoxy]Ethoxy}-4-(1,1,3,3-Tetramethylbutyl)Benzene",,experimental,TTPA,Alpha-tocopherol transfer protein,carrier,,DB02080
3-Sulfinoalanine,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB02153
O-Trifluoromethylphenyl Anthranilic Acid,,experimental,TTR,Transthyretin,carrier,,DB02179
S-Methylcysteine,,experimental,FABP1,"Fatty acid-binding protein, liver",carrier,,DB02216
Flufenamic Acid,,experimental,TTR,Transthyretin,carrier,,DB02266
2-Methoxyestradiol,Antineoplastic AgentsTubulin Modulators,investigational,SHBG,Sex hormone-binding globulin,carrier,,DB02342
"2,4,6-Tribromophenol",,experimental,TTR,Transthyretin,carrier,,DB02417
Cholic Acid,,experimental,FABP1,"Fatty acid-binding protein, liver",carrier,,DB02659
"N-(M-Trifluoromethylphenyl) Phenoxazine-4,6-Dicarboxylic Acid",,experimental,TTR,Transthyretin,carrier,,DB02698
Resveratrol,"Platelet Aggregation InhibitorsAnti-Inflammatory Agents, Non-SteroidalEnzyme InhibitorsAntioxidantsAntineoplastic Agents, PhytogenicAnticarcinogenic AgentsAntimutagenic Agents",experimentalinvestigational,TTR,Transthyretin,carrier,,DB02709
1-Hexadecanosulfonic Acid,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB02776
Dihydrotestosterone,AndrogensSteroids,experimentalillicit,SHBG,Sex hormone-binding globulin,carrier,,DB02901
2-[(2-Oxo-2-Piperidin-1-Ylethyl)Thio]-6-(Trifluoromethyl)Pyrimidin-4(1h)-One,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB03009
Pentabromophenol,,experimental,TTR,Transthyretin,carrier,,DB03167
"3',5'-Dinitro-N-Acetyl-L-Thyronine",,experimental,TTR,Transthyretin,carrier,,DB03239
"3,5,3',5'-Tetrachloro-Biphenyl-4,4'-Diol",,experimental,TTR,Transthyretin,carrier,,DB03346
Oxyphenbutazone,"Anti-Inflammatory Agents, Non-Steroidal",experimentalwithdrawn,ALB,Serum albumin,carrier,,DB03585
Decanoic Acid,Antifungal Agents,experimental,ALB,Serum albumin,carrier,,DB03600
"Dibenzofuran-4,6-Dicarboxylic Acid",,experimental,TTR,Transthyretin,carrier,,DB03682
"Docosa-4,7,10,13,16,19-Hexaenoic Acid",,experimental,FABP7,"Fatty acid-binding protein, brain",carrier,,DB03756
Propanoic Acid,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB03766
Carbazole Butanoic Acid,,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB03851
"N-(5,5,8,8-Tetramethyl-5,8-Dihydro-Naphthalen-2-Yl)-Terephthalamic Acid",,experimental,CRABP1,Cellular retinoic acid-binding protein 1,carrier,,DB03873
"5-Alpha-Androstane-3-Beta,17beta-Diol",,experimental,SHBG,Sex hormone-binding globulin,carrier,,DB03882
N-Ethyl Retinamide,,experimental,RBP4,Retinol-binding protein 4,carrier,,DB03917
"5-Alpha-Androstane-3-Beta,17-Alpha-Diol",,experimental,SHBG,Sex hormone-binding globulin,carrier,,DB03926
"Cysteine-Methylene-Carbamoyl-1,10-Phenanthroline",,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB04437
"2-HYDROXY-3,5-DIIODOBENZOIC ACID",,experimental,TTR,Transthyretin,carrier,,DB04674
Iodipamide,Contrast Media,approved,ALB,Serum albumin,carrier,binder,DB04711
"2-[3,5-DICHLORO-4-(2-{2-[2(2-MERCAPTOETHOXY)ETHOXY]ETHOXY}ETHOXY)PHENYLAMINO]BENZOIC ACID",,experimental,TTR,Transthyretin,carrier,,DB04756
Nomifensine,Dopamine Uptake Inhibitors,withdrawn,ORM1,Alpha-1-acid glycoprotein 1,carrier,,DB04821
Dronedarone,Anti-Arrhythmia Agents,approved,ALB,Serum albumin,carrier,substrate,DB04855
Fenretinide,Antineoplastic AgentsAnticarcinogenic Agents,investigational,RBP4,Retinol-binding protein 4,carrier,,DB05076
Gallium nitrate,,approvedinvestigational,TF,Serotransferrin,carrier,substrate,DB05260
transdermal testosterone gel,,approvedinvestigational,SHBG,Sex hormone-binding globulin,carrier,,DB05275
Fx-1006A,,investigational,TTR,Transthyretin,carrier,,DB05352
CRx-119,,investigational,SERPINA6,Corticosteroid-binding globulin,carrier,,DB05688
Rufinamide,,approved,ALB,Serum albumin,carrier,substrate,DB06201
Prasugrel,Platelet Aggregation Inhibitors,approved,ALB,Serum albumin,carrier,substrate,DB06209
SIMEPREVIR,Protease Inhibitors,approved,ALB,Serum albumin,carrier,binder,DB06290
Gadofosveset trisodium,Contrast MediaDiagnostic Agents,approved,ALB,Serum albumin,carrier,substrate,DB06705
Fospropofol,Hypnotics and Sedatives,approvedillicit,ALB,Serum albumin,carrier,substrate,DB06716
3-[({(1E)-[2-(trifluoromethyl)phenyl]methylidene}amino)oxy]propanoic acid,,experimental,TTR,Transthyretin,carrier,,DB06885
"2-(2,6-DICHLOROPHENYL)-1,3-BENZOXAZOLE-6-CARBOXYLIC ACID",,experimental,TTR,Transthyretin,carrier,,DB06907
"2',6'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",,experimental,TTR,Transthyretin,carrier,,DB06935
2-[({4-[2-(trifluoromethyl)phenyl]piperidin-1-yl}carbonyl)amino]benzoic acid,,experimental,RBP4,Retinol-binding protein 4,carrier,,DB06985
"2',4'-DICHLORO-4-HYDROXY-1,1'-BIPHENYL-3-CARBOXYLIC ACID",,experimental,TTR,Transthyretin,carrier,,DB07047
5-aminonaphthalene-1-sulfonic acid,,experimental,TTR,Transthyretin,carrier,,DB07176
(2S)-3-[(9H-fluoren-9-ylideneamino)oxy]-2-methylpropanoic acid,,experimental,TTR,Transthyretin,carrier,,DB07201
3-[(9H-fluoren-9-ylideneamino)oxy]propanoic acid,,experimental,TTR,Transthyretin,carrier,,DB07240
3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid,,experimental,TTR,Transthyretin,carrier,,DB07282
"9-benzyl-2,3,4,9-tetrahydro-1H-carbazole-8-carboxylic acid",,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB07283
Azapropazone,,approvedexperimental,ALB,Serum albumin,carrier,,DB07402
3-CARBOXY-4-METHYL-5-PROPYL-2-FURANPROPIONIC,,experimental,ALB,Serum albumin,carrier,,DB07517
"N-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethylbenzamide",,experimental,TTR,Transthyretin,carrier,,DB07693
"2,5-dichloro-N-(3,5-dibromo-4-hydroxyphenyl)benzamide",,experimental,TTR,Transthyretin,carrier,,DB07694
"N-(3,5-dibromo-4-hydroxyphenyl)-4-hydroxy-3,5-dimethylbenzamide",,experimental,TTR,Transthyretin,carrier,,DB07695
"3',5'-DIFLUOROBIPHENYL-4-CARBOXYLIC ACID",,experimental,TTR,Transthyretin,carrier,,DB07753
"3',5'-DIBROMO-2',4,4',6'-TETRAHYDROXY AURONE",,experimental,TTR,Transthyretin,carrier,,DB07775
"(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione",,experimental,SERPINA6,Corticosteroid-binding globulin,carrier,,DB07886
"5-(3-carbamoylbenzyl)-5,6,7,8,9,10-hexahydrocyclohepta[b]indole-4-carboxylic acid",,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB07945
"METHYL N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINATE",,experimental,TTR,Transthyretin,carrier,,DB07962
"N-[(2',4'-DIFLUORO-4-HYDROXY-5-IODOBIPHENYL-3-YL)CARBONYL]-BETA-ALANINE",,experimental,TTR,Transthyretin,carrier,,DB07963
3-SULFOOXY-1H-INDOLE,,experimental,ALB,Serum albumin,carrier,,DB07992
"2,6-dimethyl-4-[(E)-2-phenylethenyl]phenol",,experimental,TTR,Transthyretin,carrier,,DB08100
"2,6-dibromo-4-[(E)-2-phenylethenyl]phenol",,experimental,TTR,Transthyretin,carrier,,DB08101
"3,5-dibromobiphenyl-4-ol",,experimental,TTR,Transthyretin,carrier,,DB08102
"2,6-dibromo-4-phenoxyphenol",,experimental,TTR,Transthyretin,carrier,,DB08103
"N-(3,5-dibromo-4-hydroxyphenyl)benzamide",,experimental,TTR,Transthyretin,carrier,,DB08104
"1,3,3-trimethyl-2-[(1E,3E)-3-methylpenta-1,3-dien-1-yl]cyclohexene",,experimental,CRABP2,Cellular retinoic acid-binding protein 2,carrier,,DB08127
"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIMETHYLPHENOL",,experimental,TTR,Transthyretin,carrier,,DB08205
"4-(1,3-BENZOXAZOL-2-YL)-2,6-DIBROMOPHENOL",,experimental,TTR,Transthyretin,carrier,,DB08206
"2-(3,5-DIMETHYLPHENYL)-1,3-BENZOXAZOLE",,experimental,TTR,Transthyretin,carrier,,DB08207
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,,experimental,ALB,Serum albumin,carrier,,DB08298
"9-(4-HYDROXY-2,6-DIMETHYL-PHENYL)-3,7-DIMETHYL-NONA-4,6,8-TRIENOIC ACID",,experimental,CRABP2,Cellular retinoic acid-binding protein 2,carrier,,DB08455
"6-(2,3,4,5,6,7-HEXAHYDRO-2,4,4-TRIMETHYL-1-METYLENEINDEN-2-YL)-3-METHYLHEXA-2,4-DIENOIC ACID",,experimental,CRABP2,Cellular retinoic acid-binding protein 2,carrier,,DB08467
"(5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE",,experimental,FABP4,"Fatty acid-binding protein, adipocyte",carrier,,DB08607
"4-HYDROXY-3-[(1S,3R)-3-HYDROXY-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE",,experimental,ALB,Serum albumin,carrier,,DB08735
"4-HYDROXY-3-[(1S,3S)-3-HYDROXY-1-PHENYLBUTYL]-2H-CHROMEN-2-ONE",,experimental,ALB,Serum albumin,carrier,,DB08736
Tofacitinib,,approved,ALB,Serum albumin,carrier,,DB08895
Enzalutamide,Antineoplastic Agents,approved,ALB,Serum albumin,carrier,substrate,DB08899
MACITENTAN,Vasodilator Agents,approved,ALB,Serum albumin,carrier,binder,DB08932
